Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"6HGS",,"X-RAY DIFFRACTION",2.28,45.98,"VAPOR DIFFUSION, SITTING DROP",8.5,"NaOAc, PEG4000, Glycerol, Tris",293,"10.1074/jbc.RA119.009087","5GP","6HGS",39.58,"1.55","1.55","Crystal Structure of Human APRT wild type in complex with GMP","DSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6HGS"
"6HGV",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, HANGING DROP",,"1 uL protein solution Protein (5-10 mg/mL , 50 mM NaCl, 50 mM sodium phosphate, 10% glycerol (98%), 2 mM DTT at pH 7.4) was mixed in different ratios (2/1, 1/1, 1/2) with precipitant solution (23 %-28 % (w/v) polyethylenglycol (PEG) 6000, 70 mM ammonium acetat, 200 mM magnesium acetat, 100 mM sodium cacodylate at pH 6.1-6.5)",277,"10.1021/acsmedchemlett.9b00075","G3Q","6HGV",40.04,"2","2","Soluble epoxide hydrolase in complex with talinolol","MASLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMLLEHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","6HGV"
"6HGW",,"X-RAY DIFFRACTION",2.49,50.58,"VAPOR DIFFUSION, HANGING DROP",,"1 uL protein solution Protein (5-10 mg/mL , 50 mM NaCl, 50 mM sodium phosphate, 10% glycerol (98%), 2 mM DTT at pH 7.4) was mixed in different ratios (2/1, 1/1, 1/2) with precipitant solution (23 %-28 % (w/v) polyethylenglycol (PEG) 6000, 70 mM ammonium acetat, 200 mM magnesium acetat, 100 mM sodium cacodylate at pH 6.1-6.5)",277,,,"6HGW",39.97,"2.407","2.407","Soluble epoxide hydrolase in complex with 2-(4-fluorophenyl)-N-(4-phenoxybenzyl)ethanamine","MASLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMLLEHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","6HGW"
"6HGX",,"X-RAY DIFFRACTION",2.44,49.69,"VAPOR DIFFUSION, HANGING DROP",,"1 uL protein solution Protein (5-10 mg/mL , 50 mM NaCl, 50 mM sodium phosphate, 10% glycerol (98%), 2 mM DTT at pH 7.4) was mixed in different ratios (2/1, 1/1, 1/2) with precipitant solution (23 %-28 % (w/v) polyethylenglycol (PEG) 6000, 70 mM ammonium acetat, 200 mM magnesium acetat, 100 mM sodium cacodylate at pH 6.1-6.5)",277,"10.1021/acsmedchemlett.9b00075","G3T","6HGX",40.06,"2.16","2.16","Soluble epoxide hydrolase in complex with 1-(4-((4-(tert-butyl)morpholin-2-yl)methoxy)phenyl)-3-cyclohexylurea","MASLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMLLEHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","6HGX"
"6HGY",,"X-RAY DIFFRACTION",1.9,35.33,"VAPOR DIFFUSION",,"0.05M MES pH 6.0, 0.1M Na-Oxalate, 0.1M CaCl2",277,"10.1021/acs.orglett.8b03821",,"6HGY",24.32,"2.2","2.2","CRYSTAL STRUCTURE OF CATHEPSIN K WITH N-DESMETHYL THALASSOSPIRAMIDE C","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6HGY"
"6HH1",,"X-RAY DIFFRACTION",2.38,48.32,"VAPOR DIFFUSION, HANGING DROP",7.4,"9.3 mg/mL protein in 250 mM NaCl, 25 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.5 mM TCEP, 1.2 mM 3G8, 0.1% w/w V8 protease. 800 nL of protein was mixed with 800 nL of crystallization solution (0.1 M Tris-HCl pH 9.1, 1.5 M diammonium hydrogen phosphate) and incubated over 0.4 mL crystallization solution in 24 well VDX plates. Crystals were cryo-protected with 20% v/v ethylene glycol.",293,,,"6HH1",34.67,"2.25","2.25","Structure of c-Kit with allosteric inhibitor 3G8","GNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit,Mast/stem cell growth factor receptor Kit","1","6HH1"
,,,,,,,,,,,,,,,,,"Homo sapiens","KIT, SCFR"
"6HH2",,"X-RAY DIFFRACTION",3.15,60.95,"VAPOR DIFFUSION, HANGING DROP",,"2M NaCl
0.1M MES pH 6.5",288,"10.1080/21541248.2019.1666623","GDP","6HH2",20.95,"1.449","1.449","Rab29 small GTPase bound to GDP","GSHMGSRDHLFKVLVVGDAAVGKTSLVQRYSQDSFSKHYKSTVGVDFALKVLQWSDYEIVRLQLWDIAGLERFTSMTRLYYRDASAAVIMFDVTNATTFSNSQRWKQDLDSKLTLPNGEPVPALLLANKSDLSPWAVSRDQIDRFSKENGFTGWTETSVKENKNINEAMRVLIEKMMRNS","Homo sapiens","RAB29, RAB7L1","Ras-related protein Rab-7L1","1","6HH2"
"6HH6",,"X-RAY DIFFRACTION",2.5,50.73,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M AMMONIUM SULFATE, 0.1 M PCTP PH 7.5",293.15,"10.1016/j.chembiol.2018.11.001",,"6HH6",61.85,"1.85","1.85","Human poly(ADP-ribose) glycohydrolase in complex with ADP-HPM","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6HH6"
"6HHF",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, HANGING DROP",5.2,"1.25 mM Na-acetate, 3.75 mM Na-citrate, 15% v/v PEG 2000 MME, pH 5.2, 3 mg/mL Akt1 (in 25 mM TRIS, 100 mM NaCl, 10 % Glycerol, 5 mM DTT, pH 7.5), 1 uL reservoir + 1 uL protein solution",293,"10.1158/0008-5472.CAN-18-2861","G4K","6HHF",52.34,"2.9","2.9","Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib","GSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","6HHF"
"6HHG",,"X-RAY DIFFRACTION",2.22,44.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.25 mM Na-acetate, 3.75 mM Na-citrate, 15% v/v PEG 2000 MME, pH 7.5, 3 mg/mL Akt1 (in 25 mM TRIS, 100 mM NaCl, 10 % Glycerol, 5 mM DTT, pH 7.5), 1 uL reservoir + 1 uL protein solution",293,"10.1039/c8sc05212c",,"6HHG",52.38,"2.3","2.3","Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27","GSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","6HHG"
"6HHH",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.25 mM Na-acetate, 3.75 mM Na-citrate, 15% v/v PEG 2000 MME, pH 7.5, 3 mg/mL Akt1, (in 25 mM TRIS, 100 mM NaCl, 10 % Glycerol, 5 mM DTT, pH 7.5), 1ul reservoir + 1ul protein solution",293,"10.1039/c8sc05212c",,"6HHH",52.29,"2.7","2.7","Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31","GSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","6HHH"
"6HHI",,"X-RAY DIFFRACTION",2.19,43.88,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.25 mM Na-acetate, 3.75 mM Na-citrate, 21% v/v PEG 2000 MME, pH 6.5, 3 mg/mL Akt1 (in 25 mM TRIS, 100 mM NaCl, 10 % Glycerol, 5 mM DTT, pH 7.5), 1ul reservoir + 1ul protein solution",293,"10.1039/c8sc05212c","G4N","6HHI",52.33,"2.7","2.7","Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 30b","GSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","6HHI"
"6HHJ",,"X-RAY DIFFRACTION",2.2,44.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.25 mM Na-acetate, 3.75 mM Na-citrate, 15 % v/v PEG 2000 MME, pH 7.5, 3 mg/mL Akt1 (in 25 mM TRIS, 100 mM NaCl, 10 % Glycerol, 5 mM DTT, pH 7.5), 1ul reservoir + 1ul protein solution",293,"10.1039/c8sc05212c",,"6HHJ",52.36,"2.3","2.3","Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b","GSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","6HHJ"
"6HHO",,"X-RAY DIFFRACTION",2.46,49.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"25mM Tris HCl, 150mM NaCl, 1mM DTT, 10% glycerol, pH7.5 and 4mM GSK547",277,"10.1016/j.ccell.2018.10.006",,"6HHO",69.99,"3.49","3.49","Crystal structure of RIP1 kinase in complex with GSK547","MDYKDDDDKMQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6HHO"
"6HHR",,"X-RAY DIFFRACTION",2.84,56.66,"VAPOR DIFFUSION, HANGING DROP",6.5,"Sodium cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jcim.8b00614",,"6HHR",23.66,"2","2","Hsp90 in complex with 5-(2,4-Dihydroxy-phenyl)-4-(2-fluoro-phenyl)-2,4-dihydro-[1,2,4]triazole-3-thione","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6HHR"
"6HI3",,"X-RAY DIFFRACTION",3.91,68.57,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HI3",15.78,"2.4","2.4","The ATAD2 bromodomain in complex with compound 4","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HI3"
"6HI4",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HI4",15.87,"1.69","1.69","The ATAD2 bromodomain in complex with compound 7","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HI4"
"6HI5",,"X-RAY DIFFRACTION",4.01,69.33,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HI5",16.56,"1.59","1.59","The ATAD2 bromodomain in complex with compound 8","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HI5"
"6HI6",,"X-RAY DIFFRACTION",4,69.28,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HI6",16.23,"1.64","1.64","The ATAD2 bromodomain in complex with compound 9","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HI6"
"6HI7",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HI7",15.95,"1.743","1.743","The ATAD2 bromodomain in complex with compound 10","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HI7"
"6HI8",,"X-RAY DIFFRACTION",4.04,69.59,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HI8",15.87,"1.9","1.9","The ATAD2 bromodomain in complex with compound 11","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HI8"
"6HIA",,"X-RAY DIFFRACTION",4.04,69.53,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HIA",15.9,"1.897","1.897","The ATAD2 bromodomain in complex with compound 13","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HIA"
"6HIB",,"X-RAY DIFFRACTION",4.14,70.27,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HIB",15.88,"2.029","2.029","The ATAD2 bromodomain in complex with compound 14","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HIB"
"6HIC",,"X-RAY DIFFRACTION",4.11,70.09,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HIC",16.38,"1.768","1.768","The ATAD2 bromodomain in complex with compound 15","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HIC"
"6HID",,"X-RAY DIFFRACTION",4.11,70.05,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HID",16.44,"1.768","1.768","The ATAD2 bromodomain in complex with compound 16","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HID"
"6HIE",,"X-RAY DIFFRACTION",4.13,70.24,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6HIE",15.95,"2.05","2.05","The ATAD2 bromodomain in complex with compound 17","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HIE"
"6HIJ","3.56","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0049-1",,"6HIJ",155.68,"3.56",,"Cryo-EM structure of the human ABCG2-MZ29-Fab complex with cholesterol and PE lipids docked","MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS","Homo sapiens","ABCG2, ABCP, BCRP, BCRP1, MXR","ATP-binding cassette sub-family G member 2","1","6HIJ"
"6HJ2",,"X-RAY DIFFRACTION",2.56,51.97,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM Imidazole
10% Isopropanol
(dry co-crystallization with ligand)",291,,,"6HJ2",36.77,"2.28","2.28","Crystal structure of hPXR in complex with dabrafenib","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","6HJ2"
"6HJJ",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M lithium sulfate,
0.1 M sodium acetate pH 4.5, 50 % w/v polyethylene glycol 400;",295,"10.1021/acschembio.8b00592","G7T","6HJJ",33.88,"2.13","2.13","Crystal structure of Aurora-A L210C catalytic domain in complex with ASDO6 ligand","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLICEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLAGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNAQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6HJJ"
"6HJK",,"X-RAY DIFFRACTION",2.67,54,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium sulfate, 0.1 M tri-sodium citrate pH 5.6, 25 % w/v polyethylene glycol 4000",295,"10.1021/acschembio.8b00592","G7W","6HJK",33.52,"2.4","2.4","Crystal Structure of Aurora-A L210C catalytic domain in complex with ASDO2","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLICEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLAGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNAQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6HJK"
"6HK6",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 10% ethylene glycol, 0.1 M bis-tris-propane pH 6.5 and 0.2 M sodium/potassium tartrat",293,"10.1098/rsob.190037",,"6HK6",386.8,"2.35","2.35","Human RIOK2 bound to inhibitor","SMGKVNVAKLRYMSRDDFRVLTAVEMGMKNHEIVPGSLIASIASLKHGGCNKVLRELVKHKLIAWERTKTVQGYRLTNAGYDYLALKTLSSRQVVESVGNQMGVGKESDIYIVANEEGQQFALKLHRLGRTSFRNLKNKRDYHKYRHNVSWLYLSRLSAMKEFAYMKALYERKFPVPKPIDYNRHAVVMELINGYPLCQIHHVEDPASVYDEAMELIVKLANHGLIHGDFNEFNLILDESDHITMIDFPQMVSTSHPNAEWYFDRDVKCIKDFFMKRFSYESELFPTFKDIRREDTLDVEVSASGYTKEMQADDELLHPLGPDDKNIETK","Homo sapiens","RIOK2, RIO2","Serine/threonine-protein kinase RIO2","1","6HK6"
"6HK7",,"X-RAY DIFFRACTION",3.07,59.96,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.2M potassium fluoride
22% PEG 3350",293,"10.1021/acs.jctc.9b00104","G8N","6HK7",40.13,"3.2","3.2","Crystal structure of GSK-3B in complex with pyrazine inhibitor C50","KVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHA","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","6HK7"
"6HK8",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION, HANGING DROP",,"25% (v/v) 1,4-dioxane, 20% ethylene glycol",293,,,"6HK8",16.34,"2.111","2.111","Crystal structure of TEX12 delta-Ctip","GSMGKDEALEKDLNDVSKEINLMLSTYAKLLSERAAVDASYIDEIDELFKEANAIENFLIQKREFLRQR","Homo sapiens","TEX12","Testis-expressed protein 12","1","6HK8"
"6HK9",,"X-RAY DIFFRACTION",2.48,50.38,"VAPOR DIFFUSION, HANGING DROP",,"200 mM Calcium acetate, 40% MPD",293,,,"6HK9",18.48,"1.454","1.454","Crystal structure of TEX12 F102A F109E V116A","GSMGKDEALEKDLNDVSKEINLMLSTYAKLLSERAAVDASYIDEIDELFKEANAIENALIQKREELRQRFTAIANTLHR","Homo sapiens","TEX12","Testis-expressed protein 12","1","6HK9"
"6HKC",,"SOLUTION NMR",,,,,,,"10.1126/science.aao4827",,"6HKC",8.52,,,"Solution structure of the Sushi 1 domain of GABAbR1a","GPTSEGCQIIHPPWEGGIRYRGLTRDQVKAINFLPVDYEIEYVCRGEREVVGPKVRKCLANGSWTDMDTPSRCVR","Homo sapiens","GABBR1, GPRC3A","Gamma-aminobutyric acid type B receptor subunit 1","1","6HKC"
"6HKG",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION",4.6,"2.04 M ammonium sulfate, 0.1 M sodium acetate pH 4.6

Cryoprotected in 2.1 M ammonium sulfate, 0.1 M sodium acetate pH 4.6 and 25 % (v/v) ethylene glycol",298,"10.1073/pnas.1810927115",,"6HKG",84.85,"1.87","1.87","Structure of FISW84 Fab Fragment","EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYGMAWVRQAPGKGLEWVSFISATGLSTYFADSVKGRFTISRDTTKNTLYLQMNSLRADDTAVYFCARMRRTMIAFGGNDFWGQGTLVTVSSASTKGPSVFPLAPSGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"FISW84 Fab Fragment Heavy Chain","1","6HKG"
,,,,,,,,,,,,,,,,"EVVMTQSPATLSVSPGEGATLSCRASQSVNTNVAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISTLQSEDFAVYYCQQYSNWPPITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"FISW84 Fab Fragment Light Chain","2","6HKG"
,,,,,,,,,,,,,,,,"EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYGMAWVRQAPGKGLEWVSFISATGLSTYFADSVKGRFTISRDTTKNTLYLQMNSLRADDTAVYFCARMRRTMIAFGGNDFWGQGTLVTVSSASTKGPSVFLGCLVKDYFPEPVTVSWNSGATSGVHTFPAVLQSSGLYSLSSVVTVPYICNVNHKPSNTKVDK","Homo sapiens",,"FISW84 Fab Fragment Heavy Chain","3","6HKG"
,,,,,,,,,,,,,,,,"EVVMTQSPATLSVSPGEGATLSCRASQSVNTNVAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISTLQSEDFAVYYCQQYSNWPPITFGQGTRLEIKRTVAAPSVFIFPPTASVVCLLNNFYPRENSQESVTEQDSKDSTYSLSSTLT","Homo sapiens",,"FISW84 Fab Fragment Light Chain","4","6HKG"
"6HKI",,"X-RAY DIFFRACTION",2.51,50.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M sodium citrate tribasic, 17% polyethylene glycol 3350",291,"10.1107/S2059798318016595",,"6HKI",205.81,"3.3","3.3","Crystal structure of surface entropy mutant of human O-GlcNAc hydrolase","MVQKESQATLEERESELSSNPAASAGASLEPPAAPAPGEDNPAGAGGAAVAGAAGGARRFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSRQVAHSGAKASVVDGTPLVAAPSLNATTVVTTVYQEPIMSQGAALSGEPTTLTKEEEKKQPDEEPMDMVVEKQEETDHKNDNQILSEIVEAKMAEELKPMDTDKESIAESKSPEMSMQEDCISDIAPMQTDEQTNKEQFVPGPNEKPLYTAEPVTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSAKIAEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQPPPLTPTSKVYTIRPYFPKDEASVYKICREMYDDGVGLPFQSQPDLIGDKLVGGLLSLSLDYCFVLEDEDGICGYALGTVDVTPFIKKCKISWIPFMQEKYTKPNGDKELSEAEKIMLSFHEEQEVLPETFLANFPSLIKMDIHKKVTDPSVAKSMMACLLSSLKANGSRGAFCEVRPDDKRILEFYSKLGCFEIAKMEGFPKDVVILGRSL","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","Protein O-GlcNAcase","1","6HKI"
"6HKJ",,"X-RAY DIFFRACTION",3.38,63.65,"VAPOR DIFFUSION, HANGING DROP",8,"34 % (v/v) pentaerythritol propoxylate PO/OH 5/4
2 % (w/v) PEG 3350 
100 mM Tris-HCl, pH 8.0",293,"10.1021/acsmedchemlett.8b00318","G8W","6HKJ",82.93,"2.09","2.09","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor RNA 2-19-1","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6HKJ"
"6HKM",,"X-RAY DIFFRACTION",3.01,59.21,"VAPOR DIFFUSION, SITTING DROP",,"11% PEG 4000, 100mM MgCl2, 160mM sodium formate, 100mM MES pH 6.75, 10mM Tris pH 8.5",293,"10.1021/acs.jmedchem.8b01606","G92","6HKM",40.19,"2.47","2.47","Crystal structure of Compound 1 with ERK5","FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI","Homo sapiens","MAPK7, BMK1, ERK5, PRKM7","Mitogen-activated protein kinase 7","1","6HKM"
"6HKN",,"X-RAY DIFFRACTION",3.18,61.29,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 4000, 100mM MgCl2, 180mM Sodium formate, 100 mM MES pH 6.5, 10mM Tris pH 8.0",293,"10.1021/acs.jmedchem.8b01606","G9E","6HKN",39.47,"2.33","2.33","Crystal structure of Compound 35 with ERK5","EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARRE","Homo sapiens","MAPK7, BMK1, ERK5, PRKM7","Mitogen-activated protein kinase 7","1","6HKN"
"6HKQ",,"X-RAY DIFFRACTION",1.87,34.24,"VAPOR DIFFUSION, HANGING DROP",8,"Reservoir made from 0.2 M ammonium sulfate, 20% (w/v) PEG 3350. Prio to crystal set-up, the protein was modified with covalent inhibitor, purified via gelfiltration and concentrated to 13.5 mg/ml in 50 mM TrisHCl pH 8.0, 150 mM NaCl, 5mM TCEP",293,"10.1107/S2059798320016125",,"6HKQ",21.16,"1.54","1.54","Human GPX4 in complex with covalent Inhibitor ML162 (S enantiomer)","MCASRDDWRCARSMHEFSAKDIDGHMVNLDKYRGFVCIVTNVASQUGKTEVNYTQLVDLHARYAESGLRILAFPCNQFGKQEPGSNEEIKEFAAGYNVKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGCVVKRYGPMEEPLVIEKDLPHYFHHHHHH","Homo sapiens","GPX4","Phospholipid hydroperoxide glutathione peroxidase","1","6HKQ"
"6HKR",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, HANGING DROP",,"PEG5000, TRIS HCL, Sodium Acetate",293,"10.1021/acsmedchemlett.8b00420",,"6HKR",16.5,"1.5","1.5","Human Cellular Retinoic Acid Binding Protein II (CRABPII) with bound synthetic retinoid DC271.","MPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTRELTNDGELILTMTADDVVCTRVYVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6HKR"
"6HKW",,"X-RAY DIFFRACTION",3.76,67.29,"VAPOR DIFFUSION, SITTING DROP",,"ammonium sulfate, PEG 4000, glycerol",291,"10.1016/j.str.2018.12.002",,"6HKW",211.67,"3.09","3.09","Crystal structure of human SDS22","GEFMAAERGAGQQQSQEMMEVDRRVESEESGDEEGKKHSSGIVADLSEQSLKDGEERGEEDPEEEHELPVDMETINLDRDAEDVDLNHYRIGKIEGFEVLKKVKTLCLRQNLIKCIENLEELQSLRELDLYDNQIKKIENLEALTELEILDISFNLLRNIEGVDKLTRLKKLFLVNNKISKIENLSNLHQLQMLELGSNRIRAIENIDTLTNLESLFLGKNKITKLQNLDALTNLTVLSMQSNRLTKIEGLQNLVNLRELYLSHNGIEVIEGLENNNKLTMLDIASNRIKKIENISHLTELQEFWMNDNLLESWSDLDELKGARSLETVYLERNPLQKDPQYRRKVMLALPSVRQIDATFVRF","Homo sapiens","PPP1R7, SDS22","Protein phosphatase 1 regulatory subunit 7","1","6HKW"
"6HKX",,"X-RAY DIFFRACTION",2.4,48.86,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES, pH 5.5, 25.5% PEG 3350 and 0.25 M (NH4)2SO4

or

0.1 M HEPES, pH 6.5, 0.2 M K2HPO4, 33% PEG 3350",277,"10.1158/1535-7163.MCT-19-0154","GCE","6HKX",84.07,"2.8","2.8","Eg5-inhibitor complex","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","6HKX"
"6HKY",,"X-RAY DIFFRACTION",2.85,56.91,"VAPOR DIFFUSION, SITTING DROP",,"0.04 M KH2PO4 and 12.5% PEG 8000",277,"10.1158/1535-7163.MCT-19-0154","GCE","6HKY",125.78,"2.75","2.75","Eg5-inhibitor complex","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","6HKY"
"6HKZ",,"X-RAY DIFFRACTION",3.45,64.4,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4
2 % (w/v) PEG 3350 
100 mM Tris-HCl, pH 8.0",293,"10.1021/acsmedchemlett.8b00318","GBZ","6HKZ",82.94,"2.09","2.09","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor RNA 2-49-1","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6HKZ"
"6HM0",,"X-RAY DIFFRACTION",2.33,47.19,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG 3350
0.2 M NH4F",293,"10.1021/acs.jmedchem.8b01413","GBW","6HM0",30.41,"2.4","2.4","Crystal structure of human BRD9 bromodomain in complex with a PROTAC","SMLKLSAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKERLLALKRSMS","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6HM0"
"6HM6",,"X-RAY DIFFRACTION",2.07,40.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 1500, HEPES, glycerol, tacsimate.",293,"10.1016/j.bmcl.2018.09.022","GDK","6HM6",32.47,"2.1","2.1","CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PYRIDINYLOXYMETHYL)PYRIDINE INHIBITOR","PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN","Homo sapiens","SYK","SPLEEN TYROSINE KINASE","1","6HM6"
"6HM7",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 3350, bistrispropane, sodium bromide",293,"10.1016/j.bmcl.2018.09.022","GDH","6HM7",32.89,"1.64","1.64","CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PHENOXYMETHYL)PYRIDINE INHIBITOR","PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","6HM7"
"6HMB",,"X-RAY DIFFRACTION",2.49,50.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"180 MICROLITER ENZYME STOCK SOLUTION (6 MG/ML IN 500 MM NACL, 25 MM TRIS/HCL, PH 8.5) WERE MIXED and incubated WITH 20 MIKROLITER of a STOCK SOLUTION of the inhibitor 4B0 (10 MM 4B0 IN DMSO). 20 MICROLITERS OF the resulting solution WERE MIXED WITH 10 MICROLITERS OF RESERVOIR SOLUTION (900 MM LICL, 28 % (W/V) PEG 6000, 100 MM TRIS/HCL, PH 8.5) IN EACH WELL OF A CRYSTALLIZATION PLATE. A SINGLE MACROSEED, grown UNDER THE SAME CONDITIONS, WAS ADDED TO EACH DROPLET of the plate. THE DROPLETS WERE EQUILIBRATED AT 293.15 K using the sitting drop variant of the VAPOR DIFFUSION method. This procedure generated large single crystals of a CK2alpha'/4B0 complex. Afterwards, the inhibitor 4B0 was exchanged against CX-4945 by an extensive soaking procedure of several steps.",293.15,"10.1021/acsomega.8b03415","3NG","6HMB",43.92,"1.04","1.04","STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA'; CSNK2A2 Gene product) IN COMPLEX WITH the inhibitor CX-4945 (Silmitasertib)","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6HMB"
"6HMC",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, SITTING DROP",8.5,"180 MICROLITER ENZYME STOCK SOLUTION (6 MG/ML IN 500 MM NACL, 25 MM TRIS/HCL, PH 8.5) WERE MIXED and incubated WITH 20 MIKROLITER of a STOCK SOLUTION of the inhibitor 4B0 (10 MM 4B0 IN DMSO). 20 MICROLITERS OF the resulting solution WERE MIXED WITH 10 MICROLITERS OF RESERVOIR SOLUTION (900 MM LICL, 28 % (W/V) PEG 6000, 100 MM TRIS/HCL, PH 8.5) IN EACH WELL OF A CRYSTALLIZATION PLATE. A SINGLE MACROSEED, grown UNDER THE SAME CONDITIONS, WAS ADDED TO EACH DROPLET of the plate. THE DROPLETS WERE EQUILIBRATED AT 293.15 K using the sitting drop variant of the VAPOR DIFFUSION method. This procedure generated large single crystals of a CK2alpha'/4B0 complex. Afterwards, the inhibitor 4B0 was exchanged against THN27 by an extensive soaking procedure of several steps.",293.15,"10.1021/acsomega.8b03415",,"6HMC",43.71,"1.03","1.03","STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA'; CSNK2A2 gene product) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR THN27","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6HMC"
"6HMD",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, SITTING DROP",8.5,"180 MICROLITER ENZYME STOCK SOLUTION (6 MG/ML IN 500 MM NACL, 25 MM TRIS/HCL, PH 8.5) WAS MIXED and incubated WITH 20 MIKROLITER of a STOCK SOLUTION of the inhibitor 4B0 (10 MM 4B0 IN DMSO). 20 MICROLITERS OF the resulting solution WAS MIXED WITH 10 MICROLITERS OF RESERVOIR SOLUTION (700 MM LICL, 28 % (W/V) PEG 6000, 100 MM TRIS/HCL, PH 8.5) IN EACH WELL OF A CRYSTALLIZATION PLATE. A SINGLE MACROSEED, grown UNDER THE SAME CONDITIONS, WAS ADDED TO EACH DROPLET of the plate. THE DROPLETS WERE EQUILIBRATED AT 293.15 K using the sitting drop variant of the VAPOR DIFFUSION method. This procedure generated large single crystals of a CK2alpha'/4B0 complex. Afterwards, the inhibitor 4B0 was exchanged against AR18 by an extensive soaking procedure of several steps.",293.15,"10.1021/acsomega.8b03415",,"6HMD",43.51,"1","1","STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA'; CSNK2A2 gene product) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR AR18","HMGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6HMD"
"6HME",,"X-RAY DIFFRACTION",3.11,60.39,"VAPOR DIFFUSION, SITTING DROP",6.5,"180 MICROLITERS OF ENZYME SOLUTION (6 MG/ML CK2ALPHA, 0.025 M TRIS/HCL, PH 8.5, 0.5 M NACL) WERE MIXED WITH 20 MICROLITERS OF INHIBITOR STOCK SOLUTION (0.010 M INHIBITOR THN27 IN DMSO). THIS MIXTURE WAS INCUBATED FOR 30 MIN AT ROOM TEMPERATURE. THE RESERVOIR SOLUTION OF THE CRYSTALLIZATION EXPERIMENT WAS 0.2 M AMMONIUM SULFATE, 0.1 M SODIUM CACODYLATE TRIHYDRATE, PH 6.5, 30% (W/V) PEG 8,000. PRIOR TO EQUILIBRATION THE CRYSTALLIZATION DROP WAS COMPOSED OF 10 MICROLITERS RESERVOIR SOLUTION PLUS 20 MICROLITERS ENZYME/INHIBITOR MIXTURE.",293.15,"10.1021/acsomega.8b03415",,"6HME",85.43,"1.85","1.85","LOW-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA; CSNK2A1 gene product) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR THN27","MGSSHHHHHHSQDPMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HME"
"6HMI",,"SOLUTION NMR",,,,,,,"10.1038/s41589-019-0384-5",,"6HMI",6.98,,,"Solution structure of the RNA duplex formed by the 5'-end of U1snRNA and the 5'-splice site of SMN2 exon7","AUACUUACCUG","Homo sapiens",,"RNA (5'-R(*AP*UP*AP*CP*(PSU)P*(PSU)P*AP*CP*CP*UP*G)-3')","1","6HMI"
,,,,,,,,,,,,,,,,"GGAGUAAGUCU","Homo sapiens",,"RNA (5'-R(*GP*GP*AP*GP*UP*AP*AP*GP*UP*CP*U)-3')","2","6HMI"
"6HMK",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"750 nL purified protein at 7.5 mg/mL in 50 mM HEPES, pH 7.0, 150 mM NaCl, 2 mM DTT was mixed with 250 nL of seed stock and 1000 nL of a  precipitant consisting of 18-23 % (w/v) PEG-3350, 0.2 M ammonium sulphate, 0.1 M PCTP pH 7.5.  Seed stock was prepared using a Seed BeadTM (Hampton Research) from a co-crystal of GS-PARG(448-976 [K617A, Q618A, K619A, E688A, K689A, K690A]) with ADP-ribose, with co-crystallisation mother liquor (19 % (w/v) PEG-3350, 0.2 M ammonium sulphate, 0.1 M PCTP pH 7.5) as the stabilising solution. The final volume of the seed stock was 100 microL.",293,"10.1021/acs.jmedchem.8b01407","7JC","6HMK",62.15,"2.06","2.06","POLYADPRIBOSYL GLYCOHYDROLASE IN COMPLEX WITH PDD00016690","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6HMK"
"6HML",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"Mix 750 nL purified protein at 7.5 mg per mL in 50mM HEPES, pH 7.0, 150 mM NaCl, 2mM DTT with 250 nL of seed stock and 1000 nL of a  precipitant consisting of 18-23 percent PEG 3350, 0.2 M ammonium sulphate, 0.1 M PCTP pH 7.5.  Seed stock was prepared using a Seed Bead from a co-crystal with ADP-ribose, with co-crystallisation mother liquor (19 percent PEG 3350, 0.2 M ammonium sulphate, 0.1 M PCTP pH 7.5) as the stabilising solution",293,"10.1021/acs.jmedchem.8b01407",,"6HML",62.32,"2.25","2.25","POLYADPRIBOSYL GLYCOSIDASE IN COMPLEX WITH PDD00017299","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6HML"
"6HMM",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, SITTING DROP",7.5,"Mix purified protein in 50 mM HEPES, pH 7.0, 150 mM NaCl, 2 mM DTT at 7.5 mg/mL with a precipitant consisting of 28% PEG-3350, 0.2 M magnesium chloride, 0.1 M PCTP (0.04 M sodium propionate, 0.02 M sodium cacodylate, 0.04 M Bis-Tris propane) pH 7.5.",293,"10.1021/acs.jmedchem.8b01407","7JB","6HMM",61.87,"1.9","1.9","POLYADPRIBOSYL GLYCOHYDROLASE IN COMPLEX WITH PDD00013907","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6HMM"
"6HMN",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"Protein at 7.5 mg/mL in 50 mM HEPES, pH 7.0, 150 mM NaCl, 2 mM DTT was mixed with precipitant consisting of 18 - 23 percent PEG-3350, 0.2 M ammonium sulphate, 0.1 M PCTP pH 7.5 in a 1:1 ratio to give a 4 microL drop",293,"10.1021/acs.jmedchem.8b01407",,"6HMN",61.71,"2.87","2.87","POLYADPRIBOSYL GLYCOSIDASE IN COMPLEX WITH PDD00014909","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6HMN"
"6HMO",,"SOLUTION NMR",,,,,,,"10.1038/s41589-019-0384-5",,"6HMO",7.37,,,"Solution structure of the RNA duplex formed by the 5'-end of U1snRNA and the 5'-splice site of SMN2 exon7 in complex with the SMN-C5 splicing modifier","AUACUUACCUG","Homo sapiens",,"RNA (5'-R(*AP*UP*AP*CP*(PSU)P*(PSU)P*AP*CP*CP*UP*G)-3')","1","6HMO"
,,,,,,,,,,,,,,,,"GGAGUAAGUCU","Homo sapiens",,"RNA (5'-R(*GP*GP*AP*GP*UP*AP*AP*GP*UP*CP*U)-3')","2","6HMO"
"6HMP",,"X-RAY DIFFRACTION",2.1,41.52,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium citrate tribasic pH 7.0
20 % w/v Polyethylene glycol 3,350",293,"10.1039/c9pp00010k","GEW","6HMP",74.11,"2.039","2.039","Crystal structure of human Casein Kinase I delta in complex with a photoswitchable 2-Azoimidazole-based Inhibitor (compound 3)","MGSSHHHHHHSSGLVPRGSHMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6HMP"
"6HMQ",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"180 MICROLITERs ENZYME STOCK SOLUTION (6 MG/ML IN 500 MM NACL, 25 MM TRIS/HCL, PH 8.5) WERE MIXED and Incubated WITH 20 MIKROLITERS of a STOCK SOLUTION of the inhibitor 4B0 (10 MM 4B0 IN DMSO). 20 MICROLITERS OF resulting solution WERE MIXED WITH 10 MICROLITERS OF RESERVOIR SOLUTION (900 MM LICL, 28 % (W/V) PEG 6000, 100 MM TRIS/HCL, PH 8.5) IN EACH WELL OF A CRYSTALLIZATION PLATE. A SINGLE MACROSEED, grown UNDER THE SAME CONDITIONS, WAS ADDED TO EACH DROPLET on the plate. THE DROPLETS WERE EQUILIBRATED AT 293.15 K using the sitting drop variant of the VAPOR DIFFUSION method.",293.15,"10.1021/acsomega.8b03415",,"6HMQ",44.21,"0.97","0.97","STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA'; CSNK2A2 GENE PRODUCT) IN COMPLEX WITH THE BENZOTRIAZOLE-TYPE INHIBITOR MB002","MGSSHHHHHHSQDPMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSSGLTAAR","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6HMQ"
"6HMR",,"X-RAY DIFFRACTION",2.17,43.32,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Sodium malonate pH 6.0
20 % Polyethylene glycol 3,350",293,"10.1039/c9pp00010k","GE5","6HMR",74.1,"1.782","1.782","Crystal structure of human Casein Kinase I delta in complex with a photoswitchable 2-Azothiazole-based inhibitor (compound 2)","MGSSHHHHHHSSGLVPRGSHMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6HMR"
"6HMX",,"X-RAY DIFFRACTION",3.81,67.7,"VAPOR DIFFUSION, HANGING DROP",7,"100mM Mes pH7
12% PEG400
250mM CaCl2",293,"10.1021/acsmedchemlett.8b00344",,"6HMX",72.14,"2.53","2.53","RIP2 Kinase Catalytic Domain complex with N(4,5dimethyl1Hpyrazol3yl)7methoxy6(2methylpropane2sulfonyl)quinolin4amine","GMNGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLK","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6HMX"
"6HN3",,"X-RAY DIFFRACTION",1.91,35.61,"VAPOR DIFFUSION, HANGING DROP",6,"Protein 17.6 mg/ml in 0.050 M TRIS-HCL PH 8.0, 0.15 M NACL, 0.005 M TCEP. Reservoir solution 0.1 M MES PH 6.0, 18% (w/v) PEG 3350, 5% (v/v) ethanol. Cryo buffer was reservoir buffer supplemented with 15% glycerol",298,"10.1107/S2059798320016125",,"6HN3",20.64,"1.01","1.01","wildtype form (apo) of human GPX4 with Se-Cys46","MCASRDDWRCARSMHEFSAKDIDGHMVNLDKYRGFVCIVTNVASQUGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGKQEPGSNEEIKEFAAGYNVKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGCVVKRYGPMEEPLVIEKDLPHYFHHHHHH","Homo sapiens","GPX4","Phospholipid hydroperoxide glutathione peroxidase","1","6HN3"
"6HN6",,"X-RAY DIFFRACTION",3.07,59.95,"VAPOR DIFFUSION, HANGING DROP",7,"0.45 M AMMONIUM CITRATE, 30 mM KCl, 4% GLYCEROL, 5 mM CHAPS, pH 7.0",289,"10.1107/S2053230X18018022",,"6HN6",34.16,"2.71","2.71","A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor RXR-ALPHA","MGSSHHHHHHSSGLVPRGSHKREAVQEERQRGKDRNENEVESTSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","6HN6"
"6HNF",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.8b00771",,"6HNF",10.1,,,"Structure in solution of human fibronectin type III-domain 14","GHMDAPSNLRFLATTPNSLLVSWQPPRARITGYIIKYEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGRKKT","Homo sapiens","FN1, FN","Fibronectin","1","6HNF"
"6HNO",,"X-RAY DIFFRACTION",2.57,52.14,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 6000 20%; Hepes 0.1 M pH 7.00; DMSO 5%",291,"10.1016/j.jsbmb.2019.02.009",,"6HNO",29.27,"1.68","1.68","17beta-hydroxysteroid dehydrogenase 14 variant S205 - mutant H93A","GHMATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHAPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPSGS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6HNO"
"6HNW",,"X-RAY DIFFRACTION",1.98,37.76,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1021/acs.jnatprod.8b00889","CUE","6HNW",40.61,"2","2","Human protein kinase CK2 alpha in complex with coumestrol","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HNW"
"6HNY",,"X-RAY DIFFRACTION",1.96,37.35,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1021/acs.jnatprod.8b00889",,"6HNY",40.83,"1.65","1.65","Human protein kinase CK2 alpha in complex with boldine","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HNY"
"6HOP",,"X-RAY DIFFRACTION",1.97,37.59,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1111/febs.15111",,"6HOP",41.22,"1.55","1.55","Human protein kinase CK2 alpha in complex with curcumin degradation products","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HOP"
"6HOQ",,"X-RAY DIFFRACTION",1.98,37.96,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1111/febs.15111",,"6HOQ",40.82,"1.55","1.55","Human protein kinase CK2 alpha in complex with ferulic acid","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HOQ"
"6HOR",,"X-RAY DIFFRACTION",1.98,37.74,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1111/febs.15111",,"6HOR",40.7,"1.8","1.8","Human protein kinase CK2 alpha in complex with feruloylmethane","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HOR"
"6HOT",,"X-RAY DIFFRACTION",1.98,37.85,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1111/febs.15111",,"6HOT",40.74,"1.5","1.5","Human protein kinase CK2 alpha in complex with ferulic aldehyde","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HOT"
"6HOU",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1111/febs.15111",,"6HOU",40.5,"1.8","1.8","Human protein kinase CK2 alpha in complex with vanillin","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HOU"
"6HOV",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",7.5,"16% PEG 3350, 20% ethylene glycol",277,"10.1111/febs.15111",,"6HOV",15.42,"1.85","1.85","Crystal Structure of BRD4 first bromodomain in complex with ferulic acid","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6HOV"
"6HOY",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, HANGING DROP",5.7,"1.6 M (NH4)2SO4, 10% PEG 400, and Bis-Tris buffer pH 5.7",293,"10.1021/acs.jmedchem.8b01455","TSN","6HOY",70.36,"1.7","1.7","Human Sirt6 in complex with ADP-ribose and the inhibitor trichostatin A","GIDPFTADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRIN","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6HOY"
"6HP8",,"X-RAY DIFFRACTION",4.22,70.82,"EVAPORATION",6.75,"0.46 M Na-citrate",293,,,"6HP8",312.54,"2.5","2.5","Crystal structure of DPP8 in complex with Val-BoroPro","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","6HP8"
"6HP9",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION",,"1:2 protein to mother liquor

Protein: 
12 mg/ml in 50 mM HEPES pH 7.5, 300 mM NaCl, 0.5 mM TCEP, 2% DMSO, 1 mM compound

Mother liquor:
25% PEG 1500",277,"10.1021/acs.jmedchem.9b00365","GKB","6HP9",72.47,"1.96","1.96","Structure of the kinase domain of human DDR1 in complex with a 2-Amino-2,3-Dihydro-1H-Indene-5-Carboxamide-based inhibitor","SMPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6HP9"
"6HPH",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, SITTING DROP",,"Na-acetate, PEG 8K, PEG1K",277,"10.1093/nar/gkz028",,"6HPH",46.01,"1.13","1.13","Crystal structure of human Pif1 helicase in complex with AMP-PNP","SRMQLSEEQAAVLRAVLKGQSIFFTGSAGTGKSYLLKRILGSLPPTGTVATASTGVAACHIGGTTLHAFAGIGSGQAPLAQCVALAQRPGVRQGWLNCQRLVIDEISMVEADLFDKLEAVARAVRQQNKPFGGIQLIICGDFLQLPPVTKGSQPPRFCFQSKSWKRCVPVTLELTKVWRQADQTFISLLQAVRLGRCSDEVTRQLQATASHKVGRDGIVATRLCTHQDDVALTNERRLQELPGKVHRFEAMDSNPELASTLDAQCPVSQLLQLKLGAQVMLVKNLSVSRGLVNGARGVVVGFEAEGRGLPQVRFLCGVTEVIHADRWTVQATGGQLLSRQQLPLQLAWAMSIHKSQGMTLDCVEISLGRVFASGQAYVALSRARSLQGLRVLDFDPMAVRCDPRVLHFYATLRRGRSL","Homo sapiens","PIF1, C15orf20","ATP-dependent DNA helicase PIF1","1","6HPH"
"6HPI",,"SOLUTION NMR",,,,,,,,,"6HPI",17.7,,,"NMR structure of the pro-inflammatory cytokine interleukin-36alpha","MEKALKIDTPQQGSIQDINHRVWVLQDQTLIAVPRKDRMSPVTIALISCRHVETLEKDRGNPIYLGLNGLNLCLMCAKVGDQPTLQLKEKDIMDLYNQPEPVKSFLFYHSQSGRNSTFESVAFPGWFIAVSSEGGCPLILTQELGKANTTDFGLTMLF","Homo sapiens","IL36A, FIL1E, IL1E, IL1F6","Interleukin-36 alpha","1","6HPI"
"6HPO",,"X-RAY DIFFRACTION",2.48,50.35,"VAPOR DIFFUSION",,"40 mM PIPES, 20% PEG 2000, pH 6.8",291,"10.1073/pnas.1902639116",,"6HPO",51.98,"1.67","1.67","Crystallographic structure of the catalytic domain of Human Phenylalanine Hydroxylase (hPAH CD) in complex with iron at 1.6 Angstrom","MSTAVLENPGLGRKLSDFGQETSYIEDNCNQNGAISLIFSLKEEVGALAKVLRLFEENDVNLTHIESRPSRLKKDEYEFFTHLDKRSLPALTNIIKILRHDIGATVHELSRDKKKDTVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVLDNTQQLKILADSINSEIGILCSALQKIK","Homo sapiens","PAH","Phenylalanine-4-hydroxylase","1","6HPO"
"6HPQ",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION, SITTING DROP",,"Na-acetate, PEG 2K MME, Tris-Cl",277,"10.1093/nar/gkz028",,"6HPQ",92.75,"1.43","1.43","Crystal structure of human Pif1 helicase in complex with AMP-PNP, brominated crystal form.","SRMQLSEEQAAVLRAVLKGQSIFFTGSAGTGKSYLLKRILGSLPPTGTVATASTGVAACHIGGTTLHAFAGIGSGQAPLAQCVALAQRPGVRQGWLNCQRLVIDEISMVEADLFDKLEAVARAVRQQNKPFGGIQLIICGDFLQLPPVTKGSQPPRFCFQSKSWKRCVPVTLELTKVWRQADQTFISLLQAVRLGRCSDEVTRQLQATASHKVGRDGIVATRLCTHQDDVALTNERRLQELPGKVHRFEAMDSNPELASTLDAQCPVSQLLQLKLGAQVMLVKNLSVSRGLVNGARGVVVGFEAEGRGLPQVRFLCGVTEVIHADRWTVQATGGQLLSRQQLPLQLAWAMSIHKSQGMTLDCVEISLGRVFASGQAYVALSRARSLQGLRVLDFDPMAVRCDPRVLHFYATLRRGRSL","Homo sapiens","PIF1, C15orf20","ATP-dependent DNA helicase PIF1","1","6HPQ"
"6HPT",,"X-RAY DIFFRACTION",2.48,50.34,"VAPOR DIFFUSION, SITTING DROP",,"Li2SO4, PEG 2K MME, MES",277,"10.1093/nar/gkz028",,"6HPT",48.05,"1.44","1.44","Crystal structure of human Pif1 helicase, apoform.","SRMQLSEEQAAVLRAVLKGQSIFFTGSAGTGKSYLLKRILGSLPPTGTVATASTGVAACHIGGTTLHAFAGIGSGQAPLAQCVALAQRPGVRQGWLNCQRLVIDEISMVEADLFDKLEAVARAVRQQNKPFGGIQLIICGDFLQLPPVTKGSQPPRFCFQSKSWKRCVPVTLELTKVWRQADQTFISLLQAVRLGRCSDEVTRQLQATASHKVGRDGIVATRLCTHQDDVALTNERRLQELPGKVHRFEAMDSNPELASTLDAQCPVSQLLQLKLGAQVMLVKNLSVSRGLVNGARGVVVGFEAEGRGLPQVRFLCGVTEVIHADRWTVQATGGQLLSRQQLPLQLAWAMSIHKSQGMTLDCVEISLGRVFASGQAYVALSRARSLQGLRVLDFDPMAVRCDPRVLHFYATLRRGRSLSLESPDDDEAASDQENMDPIL","Homo sapiens","PIF1, C15orf20","ATP-dependent DNA helicase PIF1","1","6HPT"
"6HPU",,"X-RAY DIFFRACTION",5.51,77.68,"VAPOR DIFFUSION, SITTING DROP",,"MES, Ca-acetate, PEG 20K, PEG550 MME",274,"10.1093/nar/gkz028",,"6HPU",92.08,"3.96","3.96","Crystal structure of human Pif1 helicase in complex with ADP-AlF4","SRMQLSEEQAAVLRAVLKGQSIFFTGSAGTGKSYLLKRILGSLPPTGTVATASTGVAACHIGGTTLHAFAGIGSGQAPLAQCVALAQRPGVRQGWLNCQRLVIDEISMVEADLFDKLEAVARAVRQQNKPFGGIQLIICGDFLQLPPVTKGSQPPRFCFQSKSWKRCVPVTLELTKVWRQADQTFISLLQAVRLGRCSDEVTRQLQATASHKVGRDGIVATRLCTHQDDVALTNERRLQELPGKVHRFEAMDSNPELASTLDAQCPVSQLLQLKLGAQVMLVKNLSVSRGLVNGARGVVVGFEAEGRGLPQVRFLCGVTEVIHADRWTVQATGGQLLSRQQLPLQLAWAMSIHKSQGMTLDCVEISLGRVFASGQAYVALSRARSLQGLRVLDFDPMAVRCDPRVLHFYATLRRGRSL","Homo sapiens","PIF1, C15orf20","ATP-dependent DNA helicase PIF1","1","6HPU"
"6HPW",,"X-RAY DIFFRACTION",2.13,42.37,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2M ammonium acetate, 0.1M bis-tris, pH 5.5",293.15,"10.1021/acs.jmedchem.8b01457","GKT","6HPW",19.28,"1.9","1.9","Crystal structure of ENL (MLLT1) in complex with compound 20","SMDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6HPW"
"6HPX",,"X-RAY DIFFRACTION",2.19,43.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% medium molecular weight PEG smears, 0.1M citrate, pH 5.5",293.15,"10.1021/acs.jmedchem.8b01457",,"6HPX",18.94,"2.3","2.3","Crystal structure of ENL (MLLT1) in complex with compound 19","SMDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6HPX"
"6HPY",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.2M ammonium sulfate, 0.1M bis-tris, pH 5.5",293.15,"10.1021/acs.jmedchem.8b01457",,"6HPY",18.92,"2","2","Crystal structure of ENL (MLLT1) in complex with compound 12","SMDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6HPY"
"6HPZ",,"X-RAY DIFFRACTION",2.15,42.82,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 1500",293.15,"10.1021/acs.jmedchem.8b01457",,"6HPZ",18.62,"2.3","2.3","Crystal structure of ENL (MLLT1) in complex with acetyllysine","SMDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6HPZ"
"6HQ0",,"X-RAY DIFFRACTION",2.14,42.5,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 2000MME, 0.1M KBr",293.15,"10.1021/acs.jmedchem.8b01457",,"6HQ0",18.62,"1.81","1.81","Crystal structure of ENL (MLLT1), apo form","SMDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6HQ0"
"6HQ1",,"SOLUTION NMR",,,,,,,,,"6HQ1",8.16,,,"Solution structure of the globular domain from human histone H1.0","GDHPKYSDMIVAAIQAEKNRAGSSRQSIQKYIKSHYKVGENADSQIKLSIKRLVTTGVLKQTKGVGASGSFRLAK","Homo sapiens","H1F0, H1FV, H1-0","Histone H1.0","1","6HQ1"
"6HQ9",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium sulphate, 0.1 M Acetate pH 4.5, 18% PEG 4000",277,,,"6HQ9",15.64,"1.982","1.982","Crystal structure of the Tudor domain of human ERCC6-L2","SMKDIWHPGERCLAPSPDNGKLCEASIKSITVDENGKSFAVVLYADFQERKIPLKQLQEVKFVKDCPRN","Homo sapiens","ERCC6L2, C9orf102, RAD26L","DNA excision repair protein ERCC-6-like 2","1","6HQ9"
"6HQX",,"X-RAY DIFFRACTION",2.06,40.18,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.70 M, pH = 7.8, saturated with p-Chloromercuribenzoic acid",291,"10.1021/acschembio.9b00895","4JC","6HQX",30.98,"1.097","1.097","Human Carbonic Anhydrase II in complex with 4-Ethylbenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6HQX"
"6HR3",,"X-RAY DIFFRACTION",2.06,40.37,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammoniumsulfate 2.70 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid.",291,"10.1021/acschembio.9b00895","4JE","6HR3",30.77,"1.02","1.02","Human Carbonic Anhydrase II in complex with 4-Propylbenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6HR3"
"6HRE","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1007/s00401-018-1914-z",,"6HRE",275.52,"3.2",,"Paired helical filament from sporadic Alzheimer's disease brain","MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6HRE"
"6HRF","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1007/s00401-018-1914-z",,"6HRF",275.52,"3.3",,"Straight filament from sporadic Alzheimer's disease brain","MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6HRF"
"6HRH",,"X-RAY DIFFRACTION",2.32,46.96,"VAPOR DIFFUSION, SITTING DROP",,"0.1M bis-tris pH 6.7, 25% PEG3350, 0.3M magnesium chloride",293.15,,,"6HRH",105,"2.3","2.3","Structure of human erythroid-specific 5'-aminolevulinate synthase, ALAS2","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","6HRH"
"6HRL",,"X-RAY DIFFRACTION",4.1,70.01,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.26M ammonium sulfate, 0.2M lithium sulfate, 0.1M tris pH 8.5",293,,,"6HRL",62.27,"2.6","2.6","Crystal structure of the Kelch domain of human KLHL17","GAGPVLFAVGGGSLFAIHGDCEAYDTRTDRWHVVASMSTRRARVGVAAVGNRLYAVGGYDGTSDLATVESYDPVTNTWQPEVSMGTRRSCLGVAALHGLLYSAGGYDGASCLNSAERYDPLTGTWTSVAAMSTRRRYVRVATLDGNLYAVGGYDSSSHLATVEKYEPQVNVWSPVASMLSRRSSAGVAVLEGALYVAGGNDGTSCLNSVERYSPKAGAWESVAPMNIRRSTHDLVAMDGWLYAVGGNDGSSSLNSIEKYNPRTNKWVAASCMFTRRSSVGVAVLELL","Homo sapiens","KLHL17, AF","Kelch-like protein 17","1","6HRL"
"6HRP",,"X-RAY DIFFRACTION",2.26,45.61,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES",293,"10.1016/j.bmcl.2019.03.001",,"6HRP",33.16,"1.12","1.12","CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-3,4-dihydroisoquinolin-1-one","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6HRP"
"6HRR",,"X-RAY DIFFRACTION",2.52,51.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% Jeffamine M-600
0.1 M MES pH 6.5
50 mM CsCl",293,"10.1016/j.str.2019.04.016",,"6HRR",46.17,"2","2","Structure of the TRPML2 ELD at pH 6.5","AFKEDNTVAFKHLFLKGYSGTDEDDYSCSVYTQEDAYESIFFAINQYHQLKDITLGTLGYGENEDNRIGLKVCKQHYKKGTMFPSNETLNIDNDVELDCVQLDLQDLSKKPPDWKNSSFFRLEFYRLLQVEISFHLKGIDLQTIHSRELPDCYVFQNTIIFDNKAHSGKIKIYFDSDAKIEECKDLNIFGS","Homo sapiens","MCOLN2","Mucolipin-2","1","6HRR"
"6HRS",,"X-RAY DIFFRACTION",2.37,48.13,"VAPOR DIFFUSION, HANGING DROP",4.5,"25% PEG 550 MME
0.1 M Na-Acetate pH 4.5",293,"10.1016/j.str.2019.04.016",,"6HRS",184.85,"2.95","2.95","Structure of the TRPML2 ELD at pH 4.5","SNQLVVAFKEDNTVAFKHLFLKGYSGTDEDDYSCSVYTQEDAYESIFFAINQYHQLKDITLGTLGYGENEDNRIGLKVCKQHYKKGTMFPSNETLNIDNDVELDCVQLDLQDLSKKPPDWKNSSFFRLEFYRLLQVEISFHLKGIDLQTIHSRELPDCYVFQNTIIFDNKAHSGKIKIYFDSDAKIEECKDLNIFGSTQ","Homo sapiens","MCOLN2","Mucolipin-2","1","6HRS"
"6HRT",,"X-RAY DIFFRACTION",2.26,45.69,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES",293,"10.1016/j.bmcl.2019.03.001","GMW","6HRT",33.19,"1.36","1.36","CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 12-(6-tert-butyl-8-fluoro-1-oxo-phthalazin-2-yl)-9-hydroxy-6-methyl-4-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-azatricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,11,13-pentaen-5-one","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6HRT"
"6HSC",,"X-RAY DIFFRACTION",2.24,45.06,"VAPOR DIFFUSION, HANGING DROP",,"34% PEG 3350, 25mM sodium Phosphate pH 7, Aristolochic Acid I.",298,,,"6HSC",142.81,"1.9","1.9","Structure of Human Serum Albumin in complex with Aristolochic Acid at 1.9 A resolution","MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6HSC"
"6HSK",,"X-RAY DIFFRACTION",3.13,60.72,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis Tris Propane pH 7.5, 0.2 M NaNO3, 17-21% PEG 3350",293,"10.1021/acs.jmedchem.8b01087","GOK","6HSK",85.3,"2.096","2.096","Crystal structure of a human HDAC8 L6 loop mutant complexed with Quisinostat","GSHMEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTISGDRLGCFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVV","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","6HSK"
"6HT0",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 0.2M ammonium sulfate, 0.1M bis-tris pH 5.5 or 25% PEG Smear Medi-um, 0.1M citrate pH 5.5",293.15,"10.1002/anie.201810617","GQ8","6HT0",19.32,"1.8","1.8","Crystal structure of MLLT1 (ENL) YEATS domain in complexed with compound 94","SMDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6HT0"
"6HT1",,"X-RAY DIFFRACTION",2.17,43.41,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 0.2M ammonium sulfate, 0.1M bis-tris pH 5.5 or 25% PEG Smear Medi-um, 0.1M citrate pH 5.5",293.15,"10.1002/anie.201810617","GQ5","6HT1",19.33,"2.1","2.1","Crystal structure of MLLT1 (ENL) YEATS domain in complexed with SGC-iMLLT (compound 92)","SMDNQCTVQVRLELGHRAQLRKKPTTEGFTHDWMVFVRGPEQCDIQHFVEKVVFWLHDSFPKPRRVCKEPPYKVEESGYAGFIMPIEVHFKNKEEPRKVCFTYDLFLNLEGNPPVNHLRCEKLTFNNPTTEFRYKLLRAGGVMVMPEGAHHHHHH","Homo sapiens","MLLT1, ENL, LTG19, YEATS1","Protein ENL","1","6HT1"
"6HU6",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION, SITTING DROP",,"1.7 M (NH4)2SO4, 100 mM Tri-sodium citrate pH 6.2",295,"10.26508/lsa.201800187",,"6HU6",18.27,"1.904","1.904","Structure of ARF1 RNA","GAGUGCCAGAAGCUGCCUC","Homo sapiens",,"RNA (19-MER)","1","6HU6"
,,,,,,,,,,,,,,,,"GAGGCAGUUUCUGGUACUC","Homo sapiens",,"RNA (19-MER)","2","6HU6"
,,,,,,,,,,,,,,,,"GAGUGCCAGA","Homo sapiens",,"RNA (5'-R(*GP*AP*GP*UP*GP*CP*CP*AP*GP*A)-3')","3","6HU6"
,,,,,,,,,,,,,,,,"CUGGUACUC","Homo sapiens",,"RNA (5'-R(*CP*UP*GP*GP*UP*AP*CP*UP*C)-3')","4","6HU6"
"6HUD","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-09133-w",,"6HUD",73.1,"4",,"Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain (AL) amyloidosis patient.","NFMLTQPHSVSESPGKTLTISCTGSSASIASHYVQWYQQRPGGAPTTLIYENDQRPSEVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGNNHWVFGGGTKLTVLSQPKAAPSVTLFPPSSEELQANKAT","Homo sapiens",,"Monoclonal immunoglobulin light chains (LC)","1","6HUD"
"6HUE",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, SITTING DROP",,"100mM BIS-TRIS pH 5.5, 200mM LiSO4 and 20% PEG3350",277,"10.1098/rsob.180108",,"6HUE",92.98,"2.85","2.85","ParkinS65N","MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQNIVHIVQRPWRKGQEMNATNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV","Homo sapiens","PRKN, PARK2","E3 ubiquitin-protein ligase parkin","1","6HUE"
"6HUF",,"X-RAY DIFFRACTION",2.99,58.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% (v/v) ethylene glycol, 10% (w/v) PEG 8000, 30 mM MgCl2, 30 mM CaCl2 and 100 mM HEPES pH 7.5",293,"10.1107/S2059798318017825",,"6HUF",340.93,"2.82","2.82","Coping with strong translational non-crystallographic symmetry and extreme anisotropy in molecular replacement with Phaser: human Rab27a","GSDGDYDYLIKFLALGDSGVGKTSVLYQYTDGKFNSKFITTVGIDFREKTIYRNDKRIKLQLWDTAGLERFRSLTTAFFRDAMGFLLLFDLTNEESFLNVRNWISQLKTHAYSENPDIVLCGNKSDLEDERVVAAAEARQLAEHYGIPYFETSAANGTNISQAIEMLLDLIMKRMERSVDKS","Homo sapiens","RAB27A, RAB27","Ras-related protein Rab-27A","1","6HUF"
"6HV0",,"X-RAY DIFFRACTION",2.77,55.53,"VAPOR DIFFUSION, HANGING DROP",,"20% polyethylene glycol 3350, 0.2 M sodium acetate and 0.1 bis-tris propane (pH 6.5)",293,"10.1021/acs.jmedchem.8b01721",,"6HV0",48.08,"2.73","2.73","IRE1 kinase/RNase in complex with imidazo[1,2-b]pyridazin-8-amine compound 33","SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6HV0"
"6HV2",,"X-RAY DIFFRACTION",2.35,47.58,"VAPOR DIFFUSION",,"50 mM glycine, 20% PEG4000, 1 M ammonium formate, pH 9.4",293,"10.1002/anie.201812348",,"6HV2",19.86,"1.709","1.709","MMP-13 in complex with the peptide IMISF","EYNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGD","Homo sapiens","MMP13","Collagenase 3","1","6HV2"
,,,,,,,,,,,,,,,,"IMISF","Homo sapiens","MMP13","Collagenase 3","2","6HV2"
"6HVB",,"SOLUTION NMR",,,,,,,"10.1021/acs.jmedchem.8b01601",,"6HVB",1.08,,,"NMR structure of Urotensin Peptide Asp-c[Cys-Phe-(N-Me)Trp-Lys-Tyr-Cys]-Val in SDS solution","DCFWKYCV","Homo sapiens","UTS2, UNQ525/PRO1068","Urotensin-2","1","6HVB"
"6HVC",,"SOLUTION NMR",,,,,,,"10.1021/acs.jmedchem.8b01601",,"6HVC",1.08,,,"NMR structure of Urotensin Peptide Asp-c[Cys-Phe-Trp-(N-Me)Lys-Tyr-Cys]-Val in SDS solution","DCFWXYCV","Homo sapiens","UTS2, UNQ525/PRO1068","Urotensin-2","1","6HVC"
"6HVD",,"X-RAY DIFFRACTION",2.89,57.44,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.20M Na2SO4;  0.1M BTProp pH 8.5;  20.0% PEG 3350;  10.0% EtGly",277,,,"6HVD",35.42,"1.63","1.63","Human SLK bound to a maleimide inhibitor","SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKAEVTEEVEDGKE","Homo sapiens","SLK, KIAA0204, STK2","STE20-like serine/threonine-protein kinase","1","6HVD"
"6HVH",,"X-RAY DIFFRACTION",3.9,68.47,"VAPOR DIFFUSION, SITTING DROP",7,"2% Tacsimate, 10% PEG3350, 0.1M MES/imidazole pH 7.0",277,"10.1002/cmdc.201800569","GV2","6HVH",60.8,"2.36","2.36","Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 1","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","6HVH"
"6HVI",,"X-RAY DIFFRACTION",3.88,68.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.16M Monosaccharides, 30% GOL_P4K, 0.1M MOPS/Hepes pH 7.5",277,"10.1002/cmdc.201800569","GV5","6HVI",60.82,"1.96","1.96","Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 2","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","6HVI"
"6HVJ",,"X-RAY DIFFRACTION",3.91,68.54,"VAPOR DIFFUSION, SITTING DROP",7,"2% Tacsimate, pH 7.0; 5% 2-propanol; 0.1M imidazole; 8% PEG3350",277,"10.1002/cmdc.201800569","GV8","6HVJ",60.67,"2.28","2.28","Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 3","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","6HVJ"
"6HVK",,"SOLUTION NMR",,,,,,,"10.1016/j.jbc.2021.101057",,"6HVK",1.46,,,"Pepducin UT-Pep2 a biased allosteric agonist of Urotensin-II receptor","XRPLDTVQRPKGYX","Homo sapiens","UTS2R, GPR14","Urotensin-2 receptor","1","6HVK"
"6HWO",,"X-RAY DIFFRACTION",2.62,53.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES pH 7.5",293,"10.1016/j.bmc.2019.06.026","FFZ","6HWO",174.3,"1.99","1.99","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1335","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6HWO"
"6HWS",,"X-RAY DIFFRACTION",3.52,65.05,"VAPOR DIFFUSION, HANGING DROP",7,"3.5 M Sodium Formate, pH 7.0",291,,,"6HWS",32.55,"1.75","1.75","Keap1 - inhibitor complex","APKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6HWS"
"6HWT",,"X-RAY DIFFRACTION",2.19,43.86,"VAPOR DIFFUSION, HANGING DROP",,"100 mM MES pH 5.6-6.2, 20-30 % PEG4000, 40mM BOG",293,"10.1039/c9pp00010k",,"6HWT",42.94,"1.7","1.7","Crystal structure of p38alpha in complex with a reduced photoswitchable 2-Azothiazol-based Inhibitor (compound 31)","GSHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6HWT"
"6HWU",,"X-RAY DIFFRACTION",2.32,46.92,"VAPOR DIFFUSION, HANGING DROP",,"100 mM MES pH 5.6-6.2, 20-30 % PEG4000, 40mM BOG",293,"10.1039/c9pp00010k","GE5","6HWU",42.94,"2.3","2.3","Crystal structure of p38alpha in complex with a photoswitchable 2-Azothiazol-based Inhibitor (compound 2)","GSHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6HWU"
"6HWV",,"X-RAY DIFFRACTION",2.17,43.42,"VAPOR DIFFUSION, HANGING DROP",,"100 mM MES pH 5.6-6.2, 20-30 % PEG4000, 40mM BOG",293,"10.1039/c9pp00010k","GEW","6HWV",42.95,"1.7","1.7","Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (compound 3)","GSHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6HWV"
"6HWZ",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION",9,"28-31% PEG4000, 0.2 M Sodium acetate, 0.1 M Tris pH 8.5-9.0",296,"10.1039/c8cc08562e","GXE","6HWZ",58.26,"1.64","1.64","Selenols: a new class of Carbonic Anhydrase inhibitors","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6HWZ"
"6HX1",,"X-RAY DIFFRACTION",3,59.01,"VAPOR DIFFUSION, SITTING DROP",,"0 % Isopropanol
10 % PEG4000
0.10 M Na-citrate pH=5.75
Protein at 9mg/mL was in 20 mM TRIS/Cl pH=8.0, 150 mM NaCl, 5 mM DTT, and 2mM compound was added to the protein before setting up trays.",277,"10.1021/acs.jmedchem.8b01721","GXK","6HX1",46.76,"2.14","2.14","IRE1 ALPHA IN COMPLEX WITH imidazo[1,2-b]pyridazin-8-amine compound 2","SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHE","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","6HX1"
"6HX5",,"X-RAY DIFFRACTION",2.1,41.29,"VAPOR DIFFUSION",8,"1.5 M sodium citrate, Tris 50 mM",296,"10.1039/c8cc08562e","GXE","6HX5",29.51,"1.44","1.44","Selenols: a new class of Carbonic Anhydrase inhibitors","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6HX5"
"6HX7",,"X-RAY DIFFRACTION",2.12,41.92,"VAPOR DIFFUSION, SITTING DROP",7,"Prot 115uM in 150mM NaCl 50mM Hepes pH 8.0 mixed with hit 1-5 of the LMB screen (Molecular Dimensions): 4 M Ammonium acetate 0.1 M Bis-Tris propane 7.0 (cryo + Glycerol 20%)",294,"10.1111/febs.14843",,"6HX7",138.69,"1.8","1.8","Crystal structure of human R180T variant of ORNITHINE AMINOTRANSFERASE at 1.8 Angstrom","MTSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGTTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF","Homo sapiens","OAT","Ornithine aminotransferase, mitochondrial","1","6HX7"
"6HXD",,"X-RAY DIFFRACTION",2.06,40.18,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammoniumsulfate 2.70 M, pH 0 7.8, staurated para-Chloromercuribenzoic acid.",291,"10.1021/acschembio.9b00895","6YP","6HXD",30.79,"1.119","1.119","Human Carbonic Anhydrase II in complex with 4-Butylbenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6HXD"
"6HXF",,"X-RAY DIFFRACTION",3.48,64.64,"VAPOR DIFFUSION, SITTING DROP",,"0.10M MgCl2;  0.1M TRIS pH 8.0;  20.0% PEG 6K;  10.0% EtGly",277,,,"6HXF",140.28,"2.09","2.09","Human STK10 bound to a maleimide inhibitor","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","Serine/threonine-protein kinase 10","1","6HXF"
"6HXK",,"X-RAY DIFFRACTION",2.29,46.18,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Na2SO4 pH 6.7
20% PEG3350

Protein sample buffer:
20 mM HEPES pH 7.4
150 mM NaCl
supplemented with 50 mM Citrate pH 7.4",293,"10.1038/s41586-019-1095-5",,"6HXK",121.62,"1.85","1.85","Structure of the citryl-CoA lyase core module of human ATP citrate lyase in complex with citrate","GSHMKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ATP-citrate synthase","1","6HXK"
"6HXL",,"X-RAY DIFFRACTION",2.15,42.84,"VAPOR DIFFUSION, SITTING DROP",7,"21% PEG8000 0.1 M HEPES pH 7.0
0.15 M ammonium sulphate

Protein sample buffer
20 mM HBS, 150 mM NaCl, pH 7.4 supplemented with 50 mM citrate pH 7.4 and 10 mM CoASH",293,"10.1038/s41586-019-1095-5",,"6HXL",247.63,"1.35","1.35","Structure of the citryl-CoA lyase core module of human ATP citrate lyase in complex with citrate and CoASH (space group P21)","GSHMKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ATP-citrate synthase","1","6HXL"
"6HXM",,"X-RAY DIFFRACTION",2.59,52.46,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Na/K phosphate pH 5.5 0.1 M RbCl
0.1 M Na-citrate pH 5.5
25% PEG Smear Medium
25% PEG400 Citrate, CoAS

Protein sample buffer
20 mM HEPES pH 7.4, 150 mM NaCL supplemented with 50 mM citrate pH 7.4 and 10 mM CoASH",293,"10.1038/s41586-019-1095-5",,"6HXM",61.93,"1.3","1.3","Structure of the citryl-CoA lyase core module of human ATP citrate lyase in complex with citrate and CoASH in space group C2221","GSHMKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ATP-citrate synthase","1","6HXM"
"6HXR",,"X-RAY DIFFRACTION",2.71,54.66,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% Poly(ethylene glycol) 3350, 0.2M ammonium acetate, 0.1M Bis-Tris, 1mM EB-47",277,,,"6HXR",101.82,"2.9","2.9","Human PARP16 (ARTD15) IN COMPLEX WITH EB-47","MHHHHHHSSGVDLGTENLYFQSMGWAAAREAAGRDMLAADLRCSLFASALQSYKRDSVLRPFPASYARGDCKDFEALLADASKLPNLKELLQSSGDNHKRAWDLVSWILSSKVLTIHSAGKAEFEKIQKLTGAPHTPVPAPDFLFEIEYFDPANAKFYETKGERDLIYAFHGSRLENFHSIIHNGLHCHLNKTSLFGEGTYLTSDLSLALIYSPHGHGWQHSLLGPILSCVAVCEVIDHPDVKCQTKKKDSKEIDRRRARIKHSEGGDIPPKYFVVTNNQLLRVKYLLVYSQKPPKRA","Homo sapiens","PARP16, ARTD15, C15orf30","Mono [ADP-ribose] polymerase PARP16","1","6HXR"
"6HXS",,"X-RAY DIFFRACTION",2.72,54.77,"VAPOR DIFFUSION, SITTING DROP",,"16% Poly(ethylene glycol) 3350, 0.4M sodium sulfate, 3mM Carba-NAD",277,,,"6HXS",102.62,"2.05","2.05","Human PARP16 (ARTD15) IN COMPLEX WITH CARBA-NAD","MHHHHHHSSGVDLGTENLYFQSMGWAAAREAAGRDMLAADLRCSLFASALQSYKRDSVLRPFPASYARGDCKDFEALLADASKLPNLKELLQSSGDNHKRAWDLVSWILSSKVLTIHSAGKAEFEKIQKLTGAPHTPVPAPDFLFEIEYFDPANAKFYETKGERDLIYAFHGSRLENFHSIIHNGLHCHLNKTSLFGEGTYLTSDLSLALIYSPHGHGWQHSLLGPILSCVAVCEVIDHPDVKCQTKKKDSKEIDRRRARIKHSEGGDIPPKYFVVTNNQLLRVKYLLVYSQKPPKRA","Homo sapiens","PARP16, ARTD15, C15orf30","Mono [ADP-ribose] polymerase PARP16","1","6HXS"
"6HXT",,"X-RAY DIFFRACTION",2.3,46.43,"VAPOR DIFFUSION, HANGING DROP",7.3,"8%(w/v) PEG6,000, 100 mM Tris-HC",293,"10.1016/j.str.2020.04.010",,"6HXT",50.21,"2.55","2.55","Crystal structure of the head domain of human CCDC61","GSMDQPAGLQVDYVFRGVEHAVRVMVSGQVLELEVEDRMTADQWRGEFDAGFIEDLTHKTGNFKQFNIFCHMLESALTQSSESVTLDLLTYTDLESLRNRKMGGRPGSLAPRSAQLNSKRYLILIYSVEFDRIHYPLPLPYQGKP","Homo sapiens","CCDC61","Coiled-coil domain-containing protein 61","1","6HXT"
"6HXU",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, SITTING DROP",,"100 mM MES pH6
30% v/w PEG 6000",285,"10.1016/j.chembiol.2019.08.009",,"6HXU",21.39,"1.19","1.19","Crystal structure of Human RHOB Q63L in complex with GTP","MAAIRKKLVVVGDGACGKTCLLIVFSKDEFPEVYVPTVFENYVADIEVDGKQVELALWDTAGLEDYDRLRPLSYPDTDVILMCFSVDSPDSLENIPEKWVPEVKHFCPNVPIILVANKKDLRSDEHVRTELARMKQEPVRTDDGRAMAVRIQAYDYLECSAKTKEGVREVFETATRAALQKRY","Homo sapiens","RHOB, ARH6, ARHB","Rho-related GTP-binding protein RhoB","1","6HXU"
"6HYC",,"X-RAY DIFFRACTION",2.48,50.35,"VAPOR DIFFUSION, SITTING DROP",7,"1.5 M DL Malic Acid pH=7.0, 100 mM Bis-Tris Propane pH=6.2, 0.9 mM Thesit, 0.98 mM BH4, 25 mM DTT and 1 mM reduced glutathione",291,"10.1073/pnas.1902639116",,"6HYC",208.44,"3.18","3.18","The structure of full-length human phenylalanine hydroxylase in complex with the cofactor and negative regulator tetrahydrobiopterin","MSTAVLENPGLGRKLSDFGQETSYIEDNCNQNGAISLIFSLKEEVGALAKVLRLFEENDVNLTHIESRPSRLKKDEYEFFTHLDKRSLPALTNIIKILRHDIGATVHELSRDKKKDTVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVLDNTQQLKILADSINSEIGILCSALQKIK","Homo sapiens","PAH","Phenylalanine-4-hydroxylase","1","6HYC"
"6HYG",,"X-RAY DIFFRACTION",3.12,60.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"5 mM zinc acetate, 100 mM sodium cacodylate pH 6.5, 9 % (w/v) polyethylene glycol 8000",293,"10.1073/pnas.1819085116",,"6HYG",53.65,"2.31","2.31","Heteromeric tandem IgG4/IgG1 Fc","DKTHTCPSCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSKYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLSCAVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLVSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSKSCDKTGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSGGGGSCPSCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSDYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLWCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSGEC","Homo sapiens",,"IgHG1 and IgHG4 hybrid","1","6HYG"
"6HYJ",,"X-RAY DIFFRACTION",2.46,50.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"CaCl2 0.15 M; sodium cacodylate 0.1 M pH 6.5; PEG 2000 20%",293,"10.1107/S2059798319006867",,"6HYJ",50.4,"1.929","1.929","PSPH Human phosphoserine phosphatase","MISHSELRKLFYSADAVCFDVDSTVIREEGIDELAKICGVEDAVSEMTRRAMGGAVPFKAALTERLALIQPSREQVQRLIAEQPPHLTPGIRELVSRLQERNVQVFLISGGFRSIVEHVASKLNIPATNVFANRLKFYFNGEYAGFDETQPTAESGGKGKVIKLLKEKFHFKKIIMIGDGATDMEACPPADAFIGFGGNVIRQQVKDNAKWYITDFVELLGELE","Homo sapiens","PSPH","Phosphoserine phosphatase","1","6HYJ"
"6HYS",,"X-RAY DIFFRACTION",2.51,50.92,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% 2-Methyl-2,4-pentanediol, 100mM Sodium Acetate, 6% DMSO",291,"10.1042/BCJ20190383",,"6HYS",312.15,"2.6","2.6","Crystal structure of DHX8 helicase domain bound to ADP at 2.6 angstrom","ASYGKKTQMSILEQRESLPIYKLKEQLVQAVHDNQILIVIGETGSGKTTQITQYLAEAGYTSRGKIGCTQPRRVAAMSVAKRVSEEFGCCLGQEVGYTIRFEDCTSPETVIKYMTDGMLLRECLIDPDLTQYAIIMLDEAHERTIHTDVLFGLLKKTVQKRQDMKLIVTSATLDAVKFSQYFYEAPIFTIPGRTYPVEILYTKEPETDYLDASLITVMQIHLTEPPGDILVFLTGQEEIDTACEILYERMKSLGPDVPELIILPVYSALPSEMQTRIFDPAPPGSRKVVIATNIAETSLTIDGIYYVVDPGFVKQKVYNSKTGIDQLVVTPISQAQAKQRAGRAGRTGPGKCYRLYTERAYRDEMLTTNVPEIQRTNLASTVLSLKAMGINDLLSFDFMDAPPMETLITAMEQLYTLGALDDEGLLTRLGRRMAEFPLEPMLCKMLIMSVHLGCSEEMLTIVSMLSVQNVFYRPKDKQALADQKKAKFHQTEGDHLTLLAVYNSWKNNKFSNPWCYENFIQARSLRRAQDIRKQMLGIMDRHKLDVVSCGKSTVRVQKAICSGFFRNAAKKDPQEGYRTLIDQQVVYIHPSSALFNRQPEWVVYHELVLTTKEYMREVTTIDPRWLVEFAPAFFKVSDPTKLSKQKKQQRLEPLYNRYEEPNAWRISRAFRRR","Homo sapiens","DHX8, DDX8","ATP-dependent RNA helicase DHX8","1","6HYS"
"6HYT",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% 2-Methyl-2,4-pentanediol, 100 mM Sodium Acetate,  6%DMSO",291,"10.1042/BCJ20190383",,"6HYT",311.38,"2.33","2.33","Crystal structure of DHX8 helicase domain bound to ADP at 2.3 Angstrom","ASYGKKTQMSILEQRESLPIYKLKEQLVQAVHDNQILIVIGETGSGKTTQITQYLAEAGYTSRGKIGCTQPRRVAAMSVAKRVSEEFGCCLGQEVGYTIRFEDCTSPETVIKYMTDGMLLRECLIDPDLTQYAIIMLDEAHERTIHTDVLFGLLKKTVQKRQDMKLIVTSATLDAVKFSQYFYEAPIFTIPGRTYPVEILYTKEPETDYLDASLITVMQIHLTEPPGDILVFLTGQEEIDTACEILYERMKSLGPDVPELIILPVYSALPSEMQTRIFDPAPPGSRKVVIATNIAETSLTIDGIYYVVDPGFVKQKVYNSKTGIDQLVVTPISQAQAKQRAGRAGRTGPGKCYRLYTERAYRDEMLTTNVPEIQRTNLASTVLSLKAMGINDLLSFDFMDAPPMETLITAMEQLYTLGALDDEGLLTRLGRRMAEFPLEPMLCKMLIMSVHLGCSEEMLTIVSMLSVQNVFYRPKDKQALADQKKAKFHQTEGDHLTLLAVYNSWKNNKFSNPWCYENFIQARSLRRAQDIRKQMLGIMDRHKLDVVSCGKSTVRVQKAICSGFFRNAAKKDPQEGYRTLIDQQVVYIHPSSALFNRQPEWVVYHELVLTTKEYMREVTTIDPRWLVEFAPAFFKVSDPTKLSKQKKQQRLEPLYNRYEEPNAWRISRAFRRR","Homo sapiens","DHX8, DDX8","ATP-dependent RNA helicase DHX8","1","6HYT"
"6HYY",,"X-RAY DIFFRACTION",2.57,52.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.05 M CaCl2; sodium cacodylate 0.1 M pH 6.5; PEG 2000 20%",293,"10.1107/S2059798319006867",,"6HYY",49.53,"1.566","1.566","Human phosphoserine phosphatase with serine and phosphate","SELRKLFYSADAVCFDVDSTVIREEGIDELAKICGVEDAVSEMTRRAMGGAVPFKAALTERLALIQPSREQVQRLIAEQPPHLTPGIRELVSRLQERNVQVFLISGGFRSIVEHVASKLNIPATNVFANRLKFYFNGEYAGFDETQPTAESGGKGKVIKLLKEKFHFKKIIMIGDGATDMEACPPADAFIGFGGNVIRQQVKDNAKWYITDFVELLGELEE","Homo sapiens","PSPH","Phosphoserine phosphatase","1","6HYY"
"6HZM","3.09","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-018-0680-3",,"6HZM",145.83,"3.09",,"Cryo-EM structure of the ABCG2 E211Q mutant bound to ATP and Magnesium (alternative placement of Magnesium into the cryo-EM density)","MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDQPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS","Homo sapiens","ABCG2, ABCP, BCRP, BCRP1, MXR","ATP-binding cassette sub-family G member 2","1","6HZM"
"6HZN",,"X-RAY DIFFRACTION",5,75.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"Ammonium acetate 200 mM,
MES 0.1 M (pH 6.5), 
Glycerol ethoxylate 30% v/v,
Xylitol 6%",293.15,,,"6HZN",89.48,"2.41","2.41","Crystal structure of human dermatan sulfate epimerase 1","YITDENPEVMIPFTNANYDSHPMLYFSRAEVAELQLRAASSHEHIAARLTEAVHTMLSSPLEYLPPWDPKDYSARWNEIFGNNLGALAMFCVLYPENIEARDMAKDYMERMAAQPSWLVKDAPWDEVPLAHSLVGFATAYDFLYNYLSKTQQEKFLEVIANASGYMYETSYRRGWGFQYLHNHQPTNCMALLTGSLVLMNQGYLQEAYLWTKQVLTIMEKSLVLLREVTDGSLYEGVAYGSYTTRSLFQYMFLVQRHFNINHFGHPWLKQHFAFMYRTILPGFQRTVAIADSNYNWFYGPESQLVFLDKFVMRNGSGNWLADQIRRNRVVEGPGTPSKGQRWCTLHTEFLWYDGSLKSVPPPDFGTPTLHYFEDWGVVTYGSALPAEINRSFLSFKSGKLGGRAIYDIVHRNKYKDWIKGWRNFNAGHEHPDQNSFTFAPNGVPFITEALYGPKYTFFNNVLMFSPAVSKSCFSPWVGQVTEDCSSKWSKYKHDLAASCQGRVVAAEEKNGVVFIRGEGVGAYNPQLNLKNVQRNLILLHPQLLLLVDQIHLGEESPLETAASFFHNVDVPFEETVVDGVHGAFIRQRDGLYKMYWMDDTGYSEKATFASVTYPRGYPYNGTNYVNVTMHLRSPITRAAYLFIGPSIDVQSFTVHGDSQQLDVFIATSKHAYATYLWTGEATGQSAFAQVIADRHKILFDRNSAIKSSIVPEVKDYAAIVEQNLQHFKPVFQLLEKQILSRVRNTASFRKTAEHHHHHHHH","Homo sapiens","DSE, SART2","Dermatan-sulfate epimerase","1","6HZN"
"6HZU",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION",,"30 % PEG6000_50
0.10 M MES pH 6.00",277,"10.1021/acs.jmedchem.9b00533","GYQ","6HZU",70.22,"2.2","2.2","HUMAN JAK1 IN COMPLEX WITH LASW1393","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6HZU"
"6HZV",,"X-RAY DIFFRACTION",2.52,51.3,"VAPOR DIFFUSION",,"30% PEG3350, 0.1M BIS-TRIS, 0.2M MgCl, pH 6.0",277,"10.1021/acs.jmedchem.9b00533","GYW","6HZV",132.38,"2.46","2.46","HUMAN JAK3 IN COMPLEX WITH LASW959 PROTEIN IN COMPLEX WITH LIGAND","TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6HZV"
"6HZX",,"X-RAY DIFFRACTION",3.14,60.82,"EVAPORATION",6,"Ammonium sulfate 0.2M, sodium acetate 0.1M, ph 6.0, PEG 4000 16%, sodium azide 3 mM.
HCA 0.3 mM, foldamere 0.3 mM.",293,"10.1002/chem.201902942",,"6HZX",67.74,"2.91","2.91","Protein-aromatic foldamer complex crystal structure","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6HZX"
"6HZZ",,"X-RAY DIFFRACTION",3.2,61.54,"VAPOR DIFFUSION, SITTING DROP",6,"21.5% P2K MME, 0.1 M Na cacodylate pH 6.0)",293,"10.1073/pnas.1818333116",,"6HZZ",124.81,"2.52","2.52","Structure of human D-glucuronyl C5 epimerase","DYKDDDDKVLGLKYEEIDCLINDEHTIKGRREGNEVFLPFTWVEKYFDVYGKVVQYDGYDRFEFSHSYSKVYAQRAPYHPDGVFMSFEGYNVEVRDRVKCISGVEGVPLSTQWGPQGYFYPIQIAQYGLSHYSKNLTEKPPHIEVYETAEDRDKNKPNDWTVPKGCFMANVADKSRFTNVKQFIAPETSEGVSLQLGNTKDFIISFDLKFLTNGSVSVVLETTEKNQLFTIHYVSNAQLIAFKERDIYYGIGPRTSWSTVTRDLVTDLRKGVGLSNTKAVKPTKIMPKKVVRLIAKGKGFLDNITISTTAHMAAFFAASDWLVRNQDEKGGWPIMVTRKLGEGFKSLEPGWYSAMAQGQAISTLVRAYLLTKDHIFLNSALRATAPYKFLSEQHGVKAVFMNKHDWYEEYPTTPSSFVLNGFMYSLIGLYDLKETAGEKLGKEARSLYERGMESLKAMLPLYDTGSGTIYDLRHFMLGIAPNLARWDYHTTHINQLQLLSTIDESPVFKEFVKRWKSYLKGSRAKHN","Homo sapiens","GLCE, KIAA0836","D-glucuronyl C5-epimerase","1","6HZZ"
"6I01",,"X-RAY DIFFRACTION",3.08,60.04,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Na acetate pH 5.5, 24% MPEG 5K and 0.1 M MES pH 6.5, 1.25 M lithium acetate",293,"10.1073/pnas.1818333116",,"6I01",129.44,"2.1","2.1","Structure of human D-glucuronyl C5 epimerase in complex with substrate","DYKDDDDKVLGLKYEEIDCLINDEHTIKGRREGNEVFLPFTWVEKYFDVYGKVVQYDGYDRFEFSHSYSKVYAQRAPYHPDGVFMSFEGYNVEVRDRVKCISGVEGVPLSTQWGPQGYFYPIQIAQYGLSHYSKNLTEKPPHIEVYETAEDRDKNKPNDWTVPKGCFMANVADKSRFTNVKQFIAPETSEGVSLQLGNTKDFIISFDLKFLTNGSVSVVLETTEKNQLFTIHYVSNAQLIAFKERDIYYGIGPRTSWSTVTRDLVTDLRKGVGLSNTKAVKPTKIMPKKVVRLIAKGKGFLDNITISTTAHMAAFFAASDWLVRNQDEKGGWPIMVTRKLGEGFKSLEPGWYSAMAQGQAISTLVRAYLLTKDHIFLNSALRATAPYKFLSEQHGVKAVFMNKHDWYEEYPTTPSSFVLNGFMYSLIGLYDLKETAGEKLGKEARSLYERGMESLKAMLPLYDTGSGTIYDLRHFMLGIAPNLARWDFHTTHINQLQLLSTIDESPVFKEFVKRWKSYLKGSRAKHN","Homo sapiens","GLCE, KIAA0836","D-glucuronyl C5-epimerase","1","6I01"
"6I02",,"X-RAY DIFFRACTION",3.11,60.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Na acetate pH 5.5, 24% MPEG 5K and 0.1 M MES pH 6.5, 1.25 M lithium acetate",293,"10.1073/pnas.1818333116",,"6I02",129.3,"2.45","2.45","Structure of human D-glucuronyl C5 epimerase in complex with product","DYKDDDDKVLGLKYEEIDCLINDEHTIKGRREGNEVFLPFTWVEKYFDVYGKVVQYDGYDRFEFSHSYSKVYAQRAPYHPDGVFMSFEGYNVEVRDRVKCISGVEGVPLSTQWGPQGYFYPIQIAQYGLSHYSKNLTEKPPHIEVYETAEDRDKNKPNDWTVPKGCFMANVADKSRFTNVKQFIAPETSEGVSLQLGNTKDFIISFDLKFLTNGSVSVVLETTEKNQLFTIHYVSNAQLIAFKERDIYYGIGPRTSWSTVTRDLVTDLRKGVGLSNTKAVKPTKIMPKKVVRLIAKGKGFLDNITISTTAHMAAFFAASDWLVRNQDEKGGWPIMVTRKLGEGFKSLEPGWYSAMAQGQAISTLVRAYLLTKDHIFLNSALRATAPYKFLSEQHGVKAVFMNKHDWYEEYPTTPSSFVLNGFMYSLIGLYDLKETAGEKLGKEARSLYERGMESLKAMLPLYDTGSGTIYDLRHFMLGIAPNLARWDFHTTHINQLQLLSTIDESPVFKEFVKRWKSYLKGSRAKHN","Homo sapiens","GLCE, KIAA0836","D-glucuronyl C5-epimerase","1","6I02"
"6I0B",,"X-RAY DIFFRACTION",3.1,60.38,"VAPOR DIFFUSION, HANGING DROP",,"MES pH 6.5
Ammonium Sulphate",293,"10.1016/j.ejmech.2019.02.021","9A5","6I0B",63.29,"2.384","2.384","Human butyrylcholinesterase in complex with the S enantiomer of a chlorotacrine-tryptophan multi-target inhibitor.","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6I0B"
"6I0C",,"X-RAY DIFFRACTION",3.12,60.55,"VAPOR DIFFUSION, HANGING DROP",,"MES pH 6.5
Ammonium Sulfate",293,"10.1016/j.ejmech.2019.02.021",,"6I0C",63.01,"2.675","2.675","Human butyrylcholinesterase in complex with the R enantiomer of a chlorotacrine-tryptophan multi-target inhibitor.","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6I0C"
"6I0J",,"X-RAY DIFFRACTION",2.33,47.17,"VAPOR DIFFUSION, HANGING DROP",9,"28% PEG4000, 0.2 M Sodium acetate, Tris 100 mM",296,"10.1016/j.ejmech.2019.111600","ACT","6I0J",59.16,"1.35","1.35","Crystal structure of human carbonic anhydrase I in complex with the 4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl sulfamate inhibitor","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6I0J"
"6I0L",,"X-RAY DIFFRACTION",2.36,47.88,"VAPOR DIFFUSION, HANGING DROP",9,"28% PEG 4000, 0,2 M Sodium acetate, Tris 100 mM",296,"10.1016/j.ejmech.2019.111600","ACT","6I0L",59.12,"1.4","1.4","Crystal structure of human carbonic anhydrase I in complex with the 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[2-(4-sulfamoylphenyl)ethyl]urea inhibitor","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6I0L"
"6I0M",,"X-RAY DIFFRACTION",3.27,62.43,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium citrate, pH 5.5
0.2 M lithium sulphate
15% (v/v) ethanol",295,"10.1016/j.jmb.2019.01.020",,"6I0M",116.66,"2.567","2.567","Structure of human IMP dehydrogenase, isoform 2, bound to GDP","GSHMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6I0M"
"6I0O",,"X-RAY DIFFRACTION",3.26,62.27,"VAPOR DIFFUSION, SITTING DROP",,"25% (w/v) PEG-1500
0.1 M Buffer MIB (malonic acid, imadazole, boric acid), pH 9.0",295,"10.1016/j.jmb.2019.01.020",,"6I0O",117.95,"2.623","2.623","Structure of human IMP dehydrogenase, isoform 2, bound to GTP","GSHMADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF","Homo sapiens","IMPDH2, IMPD2","Inosine-5'-monophosphate dehydrogenase 2","1","6I0O"
"6I0Q",,"X-RAY DIFFRACTION",1.93,36.36,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium sulfate and 20% PEG 3350",293,"10.1021/acs.jmedchem.9b01087",,"6I0Q",12.18,"2.3","2.3","Crystal structure of BTB domain of KCTD16 hexamer","SFPEVVELNVGGQVYFTRHSTLISIPHSLLWKMFSPKRDTANDLAKDSKGRFFIDRDGFLFRYILDYLRDRQVVLPDHFPEKGRLKREAEYFQLPDLVKLLTP","Homo sapiens","KCTD16, KIAA1317","BTB/POZ domain-containing protein KCTD16","1","6I0Q"
"6I0W",,"X-RAY DIFFRACTION",2.06,40.34,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammoniumsulfate 2.70 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid.",291,"10.1021/acschembio.9b00895",,"6I0W",31.51,"1.04","1.04","Human Carbonic Anhydrase II in complex with 4-Methoxybenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6I0W"
"6I0Z",,"X-RAY DIFFRACTION",2.25,45.23,"VAPOR DIFFUSION, SITTING DROP",,"16-20% PEG 3350, 200 mM LiAc, 4% glycerol",292,"10.1016/j.bmcl.2019.01.035","GZQ","6I0Z",109.64,"1.77","1.77","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 1","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I0Z"
"6I10",,"X-RAY DIFFRACTION",2.52,51.13,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035","GZK","6I10",55.26,"2.1","2.1","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 2","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I10"
"6I11",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035","H0H","6I11",55.02,"1.67","1.67","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 3","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I11"
"6I12",,"X-RAY DIFFRACTION",2.38,48.34,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035","H08","6I12",55.05,"1.65","1.65","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 5","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I12"
"6I13",,"X-RAY DIFFRACTION",2.53,51.46,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035","H0Q","6I13",55.24,"1.79","1.79","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 7","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I13"
"6I14",,"X-RAY DIFFRACTION",2.38,48.26,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035","GZN","6I14",55.09,"1.73","1.73","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 9","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I14"
"6I15",,"X-RAY DIFFRACTION",2.52,51.19,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035",,"6I15",55.11,"1.91","1.91","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 11","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I15"
"6I16",,"X-RAY DIFFRACTION",2.38,48.25,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035",,"6I16",55.09,"2","2","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 15","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I16"
"6I17",,"X-RAY DIFFRACTION",2.36,47.92,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035","GZW","6I17",55.23,"1.56","1.56","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 24","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I17"
"6I18",,"X-RAY DIFFRACTION",2.36,47.82,"VAPOR DIFFUSION, SITTING DROP",5,"18-22% PEG 8000, 100-130 mM MgAc2, 100 mM citric acid pH 5.0",292,"10.1016/j.bmcl.2019.01.035","H0N","6I18",55.47,"1.49","1.49","CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH BDP-13176","MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6I18"
"6I1B",,"SOLUTION NMR",,,,,,,"10.1021/bi00223a005",,"6I1B",17.4,,,"HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN-1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","INTERLEUKIN-1 BETA","1","6I1B"
"6I1U",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammoniumsulfate 2.70 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid.",291,"10.1021/acschembio.9b00895","3W8","6I1U",31.16,"1.08","1.08","Human Carbonic Anhydrase II in complex with 4-Ethoxybenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6I1U"
"6I29",,"X-RAY DIFFRACTION",3.38,63.62,"VAPOR DIFFUSION, HANGING DROP",3.5,"2.1M (NH4)SO4, 0.1M Citrate pH 3.5",298,,,"6I29",11.89,"2.1","2.1","X-ray structure of the p53-MDM2 inhibitor NMI801 bound to HDM2 at 2.1A resolution","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","Human E3 Ubiquitin-Protein Ligase MDM2","1","6I29"
"6I2F",,"X-RAY DIFFRACTION",2.05,39.96,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammoniumsulfate 2.70 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid.",291,"10.1021/acschembio.9b00895","3W6","6I2F",30.99,"1.198","1.198","Human Carbonic Anhydrase II in complex with 4-Propoxybenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6I2F"
"6I2U",,"X-RAY DIFFRACTION",2.47,50.25,"VAPOR DIFFUSION, SITTING DROP",,"0.03 M MgCl2.6H20, 0.03 M CaCl2.2H20, 0.1 M MOPS/HEPES-Na pH 7.5, 20% (v/v) PEG 500 MME, 10% (w/v) PEG 20 000",295,"10.1016/j.redox.2019.101318",,"6I2U",34.29,"2.5","2.5","Aurora-A kinase domain in complex with Coenzyme A","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6I2U"
"6I2Y",,"X-RAY DIFFRACTION",2.35,47.77,"VAPOR DIFFUSION, SITTING DROP",,"0.2M sodium chloride -- 25% PEG3350 -- 0.1M bis-tris pH 5.5",277,,,"6I2Y",69.75,"2.56","2.56","Human STK10 bound to Foretinib","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLAIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","Serine/threonine-protein kinase 10","1","6I2Y"
"6I33",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES pH 7, 6 % PEG3350, 10 mM DTT",293,,,"6I33",220.14,"2.3","2.3","Crystal structure of human glycine decarboxylase (P-protein)","MAAAGASRLLERLLPRHDDFARRHIGPGDKDQREMLQTLGLASIDELIEKTVPANIRLKRPLKMEDPVCENEILATLHAISSKNQIWRSYIGMGYYNCSVPQTILRNLLENSGWITQYTPYQPEVSQGRLESLLNYQTMVCDITGLDMANASLLDEGTAAAEALQLCYRHNKRRKFLVDPRCHPQTIAVVQTRAKYTGVLTELKLPCEMDFSGKDVSGVLFQYPDTEGKVEDFTELVERAHQSGSLACCATDLLALCILRPPGEFGVDIALGSSQRFGVPLGYGGPHAAFFAVRESLVRMMPGRMVGVTRDATGKEVYRLALQTREQHIRRDKATSNICTAQALLANMAAMFAIYHGSHGLEHIARRVHNATLILSEGLKRAGHQLQHDLFFDTLKIQCGCSVKEVLGRAAQRQINFRLFEDGTLGISLDETVNEKDLDDLLWIFGCESSAELVAESMGEECRGIPGSVFKRTSPFLTHQVFNSYHSETNIVRYMKKLENKDISLVHSMIPLGSCTMKLNSSSELAPITWKEFANIHPFVPLDQAQGYQQLFRELEKDLCELTGYDQVCFQPNSGAQGEYAGLATIRAYLNQKGEGHRTVCLIPKSAHGTNPASAHMAGMKIQPVEVDKYGNIDAVHLKAMVDKHKENLAAIMITYPSTNGVFEENISDVCDLIHQHGGQVYLDGANMNAQVGICRPGDFGSDVSHLNLHKTFCIPHGGGGPGMGPIGVKKHLAPFLPNHPVISLKRNEDACPVGTVSAAPWGSSSILPISWAYIKMMGGKGLKQATETAILNANYMAKRLETHYRILFRGARGYVGHEFILDTRPFKKSANIEAVDVAKRLQDYGFHAPTMSWPVAGTLMVEPTESEDKAELDRFCDAMISIRQEIADIEEGRIDPRVNPLKMSPHSLTCVTSSHWDRPYSREVAAFPLPFVKPENKFWPTIARIDDIYGDQHLVCTCPPMEVYESPFSEQKRASSGHHHHHH","Homo sapiens","GLDC, GCSP","Glycine dehydrogenase (decarboxylating), mitochondrial","1","6I33"
"6I35",,"X-RAY DIFFRACTION",2.38,48,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES pH 7, 6 % PEG3350, 10 mM DTT",293,,,"6I35",440.47,"2","2","Crystal structure of human glycine decarboxylase (P-protein) bound with pyridoxyl-glycine-5'-monophosphate","MAAAGASRLLERLLPRHDDFARRHIGPGDKDQREMLQTLGLASIDELIEKTVPANIRLKRPLKMEDPVCENEILATLHAISSKNQIWRSYIGMGYYNCSVPQTILRNLLENSGWITQYTPYQPEVSQGRLESLLNYQTMVCDITGLDMANASLLDEGTAAAEALQLCYRHNKRRKFLVDPRCHPQTIAVVQTRAKYTGVLTELKLPCEMDFSGKDVSGVLFQYPDTEGKVEDFTELVERAHQSGSLACCATDLLALCILRPPGEFGVDIALGSSQRFGVPLGYGGPHAAFFAVRESLVRMMPGRMVGVTRDATGKEVYRLALQTREQHIRRDKATSNICTAQALLANMAAMFAIYHGSHGLEHIARRVHNATLILSEGLKRAGHQLQHDLFFDTLKIQCGCSVKEVLGRAAQRQINFRLFEDGTLGISLDETVNEKDLDDLLWIFGCESSAELVAESMGEECRGIPGSVFKRTSPFLTHQVFNSYHSETNIVRYMKKLENKDISLVHSMIPLGSCTMKLNSSSELAPITWKEFANIHPFVPLDQAQGYQQLFRELEKDLCELTGYDQVCFQPNSGAQGEYAGLATIRAYLNQKGEGHRTVCLIPKSAHGTNPASAHMAGMKIQPVEVDKYGNIDAVHLKAMVDKHKENLAAIMITYPSTNGVFEENISDVCDLIHQHGGQVYLDGANMNAQVGICRPGDFGSDVSHLNLHKTFCIPHGGGGPGMGPIGVKKHLAPFLPNHPVISLKRNEDACPVGTVSAAPWGSSSILPISWAYIKMMGGKGLKQATETAILNANYMAKRLETHYRILFRGARGYVGHEFILDTRPFKKSANIEAVDVAKRLQDYGFHAPTMSWPVAGTLMVEPTESEDKAELDRFCDAMISIRQEIADIEEGRIDPRVNPLKMSPHSLTCVTSSHWDRPYSREVAAFPLPFVKPENKFWPTIARIDDIYGDQHLVCTCPPMEVYESPFSEQKRASSGHHHHHH","Homo sapiens","GLDC, GCSP","Glycine dehydrogenase (decarboxylating), mitochondrial","1","6I35"
"6I3C",,"X-RAY DIFFRACTION",2.14,42.61,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.2M 1,6-Hexanediol; 0.2M 1-Butanol; 0.2M 1,2-Propanediol; 0.2M 2-Propanol; 0.2M 1,4-Butanediol; 0.2M 1,3-Propanediol), 0.1M Imidazole; MES monohydrate (acid) pH 6.5, 50% v/v pre-cipitant mix (25% v/v MPD; 25% PEG 1000; 25% PEG 3350) Morpheus condition D4",277,"10.1021/acscatal.9b00174",,"6I3C",26.59,"1.336","1.336","Crystal structure of Human soluble catechol O-methyltransferase in complex with 3,5-dinitrocatechol and S-adensoyl-L-methionine","HHHHHHENLYFQGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","6I3C"
"6I3D",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M amino acid stock (0.2M L-Na-Glutamate; 0.2M Alananine (racemic); 0.2M Glycine; 0.2M Lysine HCL (racemic); 0.2M Serine (racemic), 0.1M Imidazole; MES monohydrate (acid) pH 6.5, 50% v/v precipitant mix (25% v/v MPD; 25% PEG 1000; 25% PEG 3350) Morpheus condition H4",277,"10.1021/acscatal.9b00174",,"6I3D",53.15,"1.45","1.45","Crystal structure of Human soluble catechol O-methyltransferase in complex with 3,5-dinitrocatechol and Sinefungin","HHHHHHENLYFQGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP","Homo sapiens","COMT","Catechol O-methyltransferase","1","6I3D"
"6I3E",,"X-RAY DIFFRACTION",2.06,40.41,"VAPOR DIFFUSION, HANGING DROP",7.8,"Trisodium citrate dihydrate 1.40 M, Tris 0.1 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid.",291,"10.1021/acschembio.9b00895","H1Z","6I3E",31.25,"1.07","1.07","Human Carbonic Anhydrase II in complex with 4-Butylbenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6I3E"
"6I3I",,"X-RAY DIFFRACTION",3.55,65.36,"VAPOR DIFFUSION, SITTING DROP",,"1.5M ammonium sulfate,
0.1M Tris pH8.5
12% glycerol",293,"10.1074/jbc.RA118.006608",,"6I3I",50.87,"2.97","2.97","Crystal structure of reactive center loop (RCL) cleaved angiotensinogen","DRVYIHPFHLVIHNESTCEQLAKANAGKPKDPTFIPAPIQAKTSPVDEKALQDQLVLVAAKLDTEDKLRAAMVGMLANFLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKQCTSRLDAHKVLSALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDFTELDVAAEKIDRFMQAVTGWKTGSSLMGASVDSTLAFNTYVHFQGKMKGFSLLAEPQEFWVDQSTSVSVPMLSGMGTFQHWSDIQDQFSVTQVPFTESASLLLIQPHYASDLDKVEGLTFQQNSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLLAQAELPAILHTELNLQKLSNDRIRVGEVLNSIFFELEADEREPTESTQQLNKPEVLEVTLNRPFLFAVYDQSATALHFLGRVANPLSTAHHHHHH","Homo sapiens","AGT, SERPINA8","Angiotensinogen","1","6I3I"
"6I3N","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2020.01.003",,"6I3N",229.41,"3.1",,"Helical MyD88 death domain filament","SNAMAAGGPGAGSAAPVSSTSSLPLAALNMRVRRRLSLFLNVRTQVAADWTALAEEMDFEYLEIRQLETQADPTGRLLDAWQGRPGASVGRLLELLTKLGRDDVLLELGPSIEEDCQKYILKQQQEEAEKPLQVAAVDSSVPRTAELAGITTLDWSHPQFEK","Homo sapiens","MYD88","Myeloid differentiation primary response protein MyD88","1","6I3N"
"6I3S",,"X-RAY DIFFRACTION",2.25,45.48,"VAPOR DIFFUSION, HANGING DROP",4.5,"2.10 M (NH4)2SO4, 0.10 M Na acetate",293,"10.1002/cmdc.201800617",,"6I3S",11.75,"1.77","1.77","Crystal structure of MDM2 in complex with compound 13.","QIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","6I3S"
"6I3U",,"X-RAY DIFFRACTION",3.09,60.13,"VAPOR DIFFUSION, HANGING DROP",7,"1.4 M Sodium Malonate pH 7.0, 0.1 M Bis-Tris Propane pH 7.0",293,"10.1021/acs.jmedchem.8b01819","H2E","6I3U",70.64,"2.09","2.09","Optimization of potent and selective ATM inhibitors suitable for a proof-of-concept study in Huntington's disease models","SMSKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLAKSANMPAQLFFKTEDGGKYPVLFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFLQWIQGSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIH","Homo sapiens","PIK3C3, VPS34","Phosphatidylinositol 3-kinase catalytic subunit type 3","1","6I3U"
"6I44",,"X-RAY DIFFRACTION",2.34,47.5,"EVAPORATION",7.5,"0.1M carboxylic acid, 0.1M Hepes/mops pH 7.5, 12.5%MPD, 12.5%PEG1000, 12.5%PEG3350",293,"10.1111/jth.14418",,"6I44",72.81,"1.36","1.36","Allosteric activation of human prekallikrein by apple domain disc rotation","RSHHHHHHGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKAEACKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTQSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILQLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLQYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSAEAGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDAGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA","Homo sapiens","KLKB1, KLK3","Plasma kallikrein","1","6I44"
"6I4P",,"X-RAY DIFFRACTION",3.07,59.94,"VAPOR DIFFUSION, SITTING DROP",6.9,"2 M ammonium sulfate, 2(v/v)% PEG 400, 0.1 M Bis-Tris (pH 6.9)",293,"10.1093/hmg/ddz177",,"6I4P",108.22,"1.6","1.6","Crystal structure of the disease-causing G194C mutant of the human dihydrolipoamide dehydrogenase","MASWSHPQFEKGALEVLFQGPGADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELCSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF","Homo sapiens","DLD, GCSL, LAD, PHE3","Dihydrolipoyl dehydrogenase, mitochondrial","1","6I4P"
"6I4Q",,"X-RAY DIFFRACTION",3.07,59.88,"VAPOR DIFFUSION, SITTING DROP",6.9,"2 M ammonium sulfate, 1.5 (v/v)% PEG 400, 0.1 M Bis-Tris (pH 6.9)",293,"10.1093/hmg/ddz177",,"6I4Q",108.22,"1.75","1.75","Crystal structure of the human dihydrolipoamide dehydrogenase at 1.75 Angstrom resolution","MASWSHPQFEKGALEVLFQGPGADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF","Homo sapiens","DLD, GCSL, LAD, PHE3","Dihydrolipoyl dehydrogenase, mitochondrial","1","6I4Q"
"6I4R",,"X-RAY DIFFRACTION",3.06,59.83,"VAPOR DIFFUSION, SITTING DROP",6.5,"2 M ammonium sulfate, 2 (v/v)% PEG 400, 0.1 M Bis-Tris (pH 6.5)",293,"10.1093/hmg/ddz177",,"6I4R",107.93,"1.439","1.439","Crystal structure of the disease-causing R460G mutant of the human dihydrolipoamide dehydrogenase at 1.44 Angstrom resolution","MASWSHPQFEKGALEVLFQGPGADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFGEANLAASFGKSINF","Homo sapiens","DLD, GCSL, LAD, PHE3","Dihydrolipoyl dehydrogenase, mitochondrial","1","6I4R"
"6I4S",,"X-RAY DIFFRACTION",3.05,59.65,"VAPOR DIFFUSION, SITTING DROP",7,"2 M ammonium sulfate, 2 (v/v)% PEG 400, 0.1 M Hepes (pH 7.5)",293,"10.1093/hmg/ddz177",,"6I4S",107.61,"1.75","1.75","Crystal structure of the disease-causing R447G mutant of the human dihydrolipoamide dehydrogenase","MASWSHPQFEKGALEVLFQGPGADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIAGVCHAHPTLSEAFREANLAASFGKSINF","Homo sapiens","DLD, GCSL, LAD, PHE3","Dihydrolipoyl dehydrogenase, mitochondrial","1","6I4S"
"6I4T",,"X-RAY DIFFRACTION",3,58.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"2 M ammonium sulfate, 2 (v/v)% PEG 400, 0.1 M Hepes (pH 7.5)",293,"10.1093/hmg/ddz177",,"6I4T",107.89,"1.823","1.823","Crystal structure of the disease-causing I445M mutant of the human dihydrolipoamide dehydrogenase","MASWSHPQFEKGALEVLFQGPGADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDMARVCHAHPTLSEAFREANLAASFGKSINF","Homo sapiens","DLD, GCSL, LAD, PHE3","Dihydrolipoyl dehydrogenase, mitochondrial","1","6I4T"
"6I4U",,"X-RAY DIFFRACTION",3,58.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"2 M ammonium sulfate, 2(v/v)% PEG 400, 0.1 M Hepes (pH 7.5)",293,"10.1093/hmg/ddz177",,"6I4U",108.09,"1.84","1.84","Crystal structure of the disease-causing G426E mutant of the human dihydrolipoamide dehydrogenase","MASWSHPQFEKGALEVLFQGPGADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAEEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF","Homo sapiens","DLD, GCSL, LAD, PHE3","Dihydrolipoyl dehydrogenase, mitochondrial","1","6I4U"
"6I4V",,"X-RAY DIFFRACTION",2.33,47.12,"VAPOR DIFFUSION, HANGING DROP",5.75,"20% PEG 1500, 0.1M SPG (succinate-phosphate-glycine), 0.5mM DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid)",293,,,"6I4V",45.93,"1.78","1.78","Alpha-1-antitrypsin Queen's (K154N) variant","MRGSHHHHHHTDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEANKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHSKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","6I4V"
"6I4Z",,"X-RAY DIFFRACTION",2.61,52.81,"VAPOR DIFFUSION, SITTING DROP",7.3,"2 M ammonium sulfate, 1.5 (v/v)% PEG 400, 0.1 M Hepes (pH7.3)",293,"10.1093/hmg/ddz177",,"6I4Z",430.1,"2.342","2.342","Crystal structure of the disease-causing P453L mutant of the human dihydrolipoamide dehydrogenase","MASWSHPQFEKGALEVLFQGPGADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHLTLSEAFREANLAASFGKSINF","Homo sapiens","DLD, GCSL, LAD, PHE3","Dihydrolipoyl dehydrogenase, mitochondrial","1","6I4Z"
"6I57",,"SOLUTION NMR",,,,,,,"10.1042/BCJ20190198",,"6I57",14.38,,,"NMR structure of the third TPR domain of the human SPAG1 protein","GPHMTFKALKEEGNQCVNDKNYKDALSKYSECLKINNKECAIYTNRALCYLKLCQFEEAKQDCDQALQLADGNVKAFYRRALAHKGLKNYQKSLIDLNKVILLDPSIIEAKMELEEVTRLLNLKD","Homo sapiens","SPAG1","Sperm-associated antigen 1","1","6I57"
"6I58",,"X-RAY DIFFRACTION",3,59.07,"EVAPORATION",7.5,"0.1 M SODIUM HEPES AND 22% (V/V) PEG
 1000, PH 7.5, EVAPORATION, TEMPERATURE 293K",293,"10.1111/jth.14418",,"6I58",69.27,"2.6","2.6","Allosteric activation of human prekallikrein by apple domain disc rotation","ECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDMKGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITKLDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFTFFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTDFLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKILHGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XI","1","6I58"
"6I5E",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, SITTING DROP",7.4,"22.5% PEG 3350, 0.2 M malic acid",277.15,"10.1038/s42003-019-0426-2",,"6I5E",79.09,"2.6","2.6","X-ray structure of apo human soluble Epoxide Hydrolase C-terminal Domain (hsEH CTD)","MHHHHHHSTENLYFQGSSTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","6I5E"
"6I5G",,"X-RAY DIFFRACTION",2.35,47.64,"VAPOR DIFFUSION, SITTING DROP",7.4,"22.5% PEG 3350, 0.2 M malic acid",277.15,"10.1038/s42003-019-0426-2","PTG","6I5G",80.47,"2","2","X-ray structure of human soluble Epoxide Hydrolase C-terminal Domain (hsEH CTD)in complex with 15d-PGJ2","MHHHHHHSTENLYFQGSSTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","6I5G"
"6I5H",,"X-RAY DIFFRACTION",2.54,51.67,"VAPOR DIFFUSION, SITTING DROP",9,"23% PEG 6000, 0.1M bicine",277,"10.1002/anie.201810312",,"6I5H",40.35,"1.49","1.49","Crystal structure of CLK1 in complex with furanopyrimidin VN412","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6I5H"
"6I5I",,"X-RAY DIFFRACTION",2.54,51.55,"VAPOR DIFFUSION, SITTING DROP",9,"20% PEG 6000, 0.1M bicine pH 9.0",277,"10.1002/anie.201810312",,"6I5I",40.68,"1.6","1.6","Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound 12h","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6I5I"
"6I5K",,"X-RAY DIFFRACTION",2.58,52.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"24-28% 1,2-propanediol, 5% glycerol, 0.1M sodium/potassium phosphate",277,"10.1002/anie.201810312",,"6I5K",120.48,"2.3","2.3","Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound VN345 (derivative of compound 12h)","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6I5K"
"6I5L",,"X-RAY DIFFRACTION",2.58,52.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"24-28% 1,2-propanediol, 5% glycerol, 0.1M sodium/potassium phosphate",277,"10.1002/anie.201810312",,"6I5L",120.67,"2.55","2.55","Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound VN316 (derivative of compound 12h)","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6I5L"
"6I61",,"X-RAY DIFFRACTION",2.54,51.62,"VAPOR DIFFUSION",8.5,"0-100 mM Sodium Acetate
100 mM Tris
23-26% PEG 8000",293,"10.1007/s00018-019-03129-x","H3W","6I61",28.07,"1.65","1.65","Crystal structure of human ERRg LBD in complex with bisphenol-B","GPHMLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6I61"
"6I62",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, HANGING DROP",8.5,"0-100 mM Sodium Acetate
100 mM Tris
23-26% PEG 8000",293,"10.1007/s00018-019-03129-x","27N","6I62",27.19,"1.65","1.65","Crystal structure of human ERRg LBD in complex with HPTE","LNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6I62"
"6I63",,"X-RAY DIFFRACTION",2.72,54.82,"VAPOR DIFFUSION",8.5,"0-100 mM Sodium Acetate
100 mM Tris
23-26% PEG8000",293,"10.1007/s00018-019-03129-x","2OH","6I63",27.11,"2.229","2.229","Crystal structure of human ERRg LBD in complex with bisphenol-A","LNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6I63"
"6I64",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION",8.5,"0-100 mM Sodium Acetate
100 mM Tris
23-26% PEG8000",293,"10.1007/s00018-019-03129-x","H48","6I64",27.79,"1.91","1.91","Crystal structure of human ERRg LBD in complex with bisphenol-E","GPHMLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6I64"
"6I65",,"X-RAY DIFFRACTION",2.61,52.86,"VAPOR DIFFUSION",8.5,"0-100 mM Sodium acetat
100 mM Tris
23-26% PEG8000",293,"10.1007/s00018-019-03129-x","H3Z","6I65",27.44,"1.5","1.5","Crystal structure of human ERRg LBD in complex with 4-iso-propylphenol","GPHMLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6I65"
"6I66",,"X-RAY DIFFRACTION",2.57,52.23,"VAPOR DIFFUSION",8.5,"0-100 mM Sodium acetate
100 mM Tris
23-26% PEG8000",293,"10.1007/s00018-019-03129-x","H4Q","6I66",27.64,"1.6","1.6","Crystal structure of human ERRg LBD in complex with 4-sec-butylphenol","GPHMLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6I66"
"6I67",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION",8.5,"0-100 mM Sodium acetate
100 mM Tris
23-26% PEG8000",293,"10.1007/s00018-019-03129-x","H42","6I67",27.63,"1.75","1.75","Crystal structure of human ERRg LBD in complex with tetrahydro-2-naphtol","GPHMLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6I67"
"6I6C",,"X-RAY DIFFRACTION",2.16,43.15,"VAPOR DIFFUSION",,"20.00 %w/v PEG 3350, 0.10 M BIS-TRIS PROPAN PH=6.50, 0.10 M NABR",293.15,"10.1021/acs.jmedchem.9b00218",,"6I6C",62.5,"1.72","1.72","SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 2","MGHHHHHHENLYFQGMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","6I6C"
"6I6F",,"X-RAY DIFFRACTION",2.17,43.47,"VAPOR DIFFUSION",,"20.00 %w/v PEG 3350, 0.10 M BIS-TRIS PROP PH 6.50, 0.10 M NABR",293.15,"10.1021/acs.jmedchem.9b00218",,"6I6F",62.43,"1.94","1.94","SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 1","MGHHHHHHENLYFQGMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","6I6F"
"6I6P",,"X-RAY DIFFRACTION",2.18,43.71,"VAPOR DIFFUSION",,"15.00 %w/v PEG 3350, 0.40 M MG FORMATE",293.15,"10.1021/acs.jmedchem.9b00218","H4T","6I6P",62.17,"1.62","1.62","SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 3","MGHHHHHHENLYFQGMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","6I6P"
"6I6R",,"X-RAY DIFFRACTION",2.38,48.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 0.26 M Sodium potassium tartrate, 20 % w/v PEG3350",293,"10.1002/chem.201804662",,"6I6R",143.04,"2.02","2.02","New Irreversible a-l-Iduronidase Inhibitors and Activity-Based Probes","EAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","6I6R"
"6I6T",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION",,"20.00 %w/v PEG 3350, 0.10 M BIS-TRIS PROPAN PH=8.00, 0.20 M NABB",293.15,"10.1021/acs.jmedchem.9b00218",,"6I6T",62.58,"1.79","1.79","SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 5","MGHHHHHHENLYFQGMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","6I6T"
"6I6V",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION",,"15.00 %w/v PEG 3350, 0.40 M MG FORMATE",293.15,"10.1021/acs.jmedchem.9b00218",,"6I6V",62.36,"1.43","1.43","SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 6","MGHHHHHHENLYFQGMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","6I6V"
"6I6X",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.26 M Sodium potassium tartrate, 20 % w/v PEG3350",293,"10.1002/chem.201804662",,"6I6X",145.02,"2.39","2.39","New Irreversible a-l-Iduronidase Inhibitors and Activity-Based Probes","EAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGRGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","6I6X"
,,,,,,,,,,,,,,,,"EAPHLVQVDAARALWPLRRFWRSTGFCPPLPHSQADPYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGQGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","2","6I6X"
"6I6Z",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, HANGING DROP",6,"1:1 (v:v) of hCPA1/8
complex at 16.1 mg/mL
and a reservoir solution
of 20% w/v PEG3350,
0.2 M MgCl 2 , 0.1 M
HEPES, pH 6.0.",283,"10.1021/acs.jmedchem.8b01465",,"6I6Z",70.2,"1.72","1.72","Crystal structure of the human CARBOXYPEPTIDASE A1 in complex with the PHOSPHINIC INHIBITOR Acetyl-Tyr-Ala-Y(PO2CH2)-homoPhe-OH","ARSTDTFNYATYHTLEEIYDFLDLLVAENPHLVSKIQIGNTYEGRPIYVLKFSTGGSKRPAIWIDTGIHSREWVTQASGVWFAKKITQDYGQDAAFTAILDTLDIFLEIVTNPDGFAFTHSTNRMWRKTRSHTAGSLCIGVDPNRNWDAGFGLSGASSNPCSETYHGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPYGYKTEPVPDQDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTIDWTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTLNHP","Homo sapiens","CPA1, CPA","Carboxypeptidase A1","1","6I6Z"
"6I74",,"X-RAY DIFFRACTION",2.14,42.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1039/c8ob02888e","H5Z","6I74",16.2,"0.959","0.959","Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative 1","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6I74"
"6I75",,"X-RAY DIFFRACTION",1.94,36.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1039/c8ob02888e","H5T","6I75",16.2,"1.171","1.171","Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative 2","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6I75"
"6I76",,"X-RAY DIFFRACTION",2.09,41.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1039/c8ob02888e","H5N","6I76",16.23,"1.2","1.2","Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative-3","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6I76"
"6I77",,"X-RAY DIFFRACTION",2.08,41,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1039/c8ob02888e","H5Q","6I77",16.2,"1.219","1.219","Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative-4","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6I77"
"6I78",,"X-RAY DIFFRACTION",2.12,42,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1039/c8ob02888e","H5H","6I78",16.22,"1.15","1.15","Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative 5","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6I78"
"6I79",,"X-RAY DIFFRACTION",2.09,41.29,"VAPOR DIFFUSION",,"15.00 %w/v PEG 3350, 0.50 M MG FORMATE",293.15,"10.1021/acs.jmedchem.9b00218",,"6I79",61.94,"1.63","1.63","SEPIAPTERIN REDUCTASE IN COMPLEX WITH COMPOUND 4","MGHHHHHHENLYFQGMEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK","Homo sapiens","SPR","Sepiapterin reductase","1","6I79"
"6I7G",,"X-RAY DIFFRACTION",3.55,65.41,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Tris pH 7.5; 20% PEG 300; 5% PEG8K; 10% Glycerol",293,"10.15252/embj.2019102177",,"6I7G",80.69,"2.7","2.7","Crystal structure of dimeric wild type FICD complexed with ATP","SLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGKSLEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","6I7G"
"6I7H",,"X-RAY DIFFRACTION",2.84,56.65,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris pH 8.5; 0.05 M Magnesium Chloride; 40% Ethanol",293,"10.15252/embj.2019102177",,"6I7H",39.43,"2.25","2.25","Crystal structure of dimeric FICD mutant K256S","SLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGSSLEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","6I7H"
"6I7I",,"X-RAY DIFFRACTION",2.66,53.85,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis-Tris pH 6.5; 0.2 M Magnesium Chloride; 25% PEG3350",293,"10.15252/embj.2019102177",,"6I7I",40.25,"2.33","2.33","Crystal structure of dimeric FICD mutant K256A complexed with MgATP","SLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGASLEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","6I7I"
"6I7J",,"X-RAY DIFFRACTION",4.07,69.77,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris pH 8.5; 2.0 M Ammonium Sulphate",293,"10.15252/embj.2019102177",,"6I7J",42.02,"2.65","2.65","Crystal structure of monomeric FICD mutant L258D","SLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGKSDEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","6I7J"
"6I7K",,"X-RAY DIFFRACTION",4.96,75.24,"VAPOR DIFFUSION, SITTING DROP",,"1.0 M Sodium Chloride; 10% Ethanol",293,"10.15252/embj.2019102177",,"6I7K",40.03,"2.54","2.54","Crystal structure of monomeric FICD mutant L258D complexed with MgATP","SLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGKSDEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","6I7K"
"6I7L",,"X-RAY DIFFRACTION",4.95,75.19,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M Sodium Chloride; 10% Ethanol",293,"10.15252/embj.2019102177",,"6I7L",39.98,"2.32","2.32","Crystal structure of monomeric FICD mutant L258D complexed with MgAMP-PNP","SLEARAALNQALEMKRQGKREKAQKLFMHALKMDPDFVDALTEFGIFSEEDKDIIQADYLYTRALTISPYHEKALVNRDRTLPLVEEIDQRYFSIIDSKVKKVMSIPKGNSALRRVMEETYYHHIYHTVAIEGNTLTLSEIRHILETRYAVPGKSDEEQNEVIGMHAAMKYINTTLVSRIGSVTISDVLEIHRRVLGYVDPVEAGRFRTTQVLVGHHIPPHPQDVEKQMQEFVQWLNSEEAMNLHPVEFAALAHYKLVYIHPFIDGNGRTSRLLMNLILMQAGYPPITIRKEQRSDYYHVLEAANEGDVRPFIRFIAKCTETTLDTLLFATTEYSVALPEAQP","Homo sapiens","FICD, HIP13, HYPE, UNQ3041/PRO9857","Adenosine monophosphate-protein transferase FICD","1","6I7L"
"6I7U",,"X-RAY DIFFRACTION",2.33,47.21,"VAPOR DIFFUSION, HANGING DROP",5.5,"22.5% PEG 1500, 0.1M SPG (succinate-phosphate-glycine) pH 5.5",293,,,"6I7U",45.67,"1.55","1.55","Alpha-1-antitrypsin (Ala250Met) in the native conformation","MRGSHHHHHHTDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATMIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","6I7U"
"6I7X",,"X-RAY DIFFRACTION",2.22,44.66,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG3350
10% ethylene glycol
0.1M bis-tris-propane pH 8.5
0.02M sodium/potassium phosphate",277,,,"6I7X",15.79,"1.2","1.2","Crystal Structure of the first bromodomain of BRD4 in complex with RT53","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6I7X"
"6I7Y",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350
10% ethylene glycol
0.1M bis-tris-propane pH 7.5
0.2M sodium sulfate",277,,,"6I7Y",15.84,"1","1","Crystal Structure of the first bromodomain of BRD4 in complex with RT56","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6I7Y"
"6I80",,"X-RAY DIFFRACTION",2.68,54.11,"VAPOR DIFFUSION, SITTING DROP",7,"30% PEG1000
0.1M MMT pH 7.0",277,,,"6I80",27.05,"1.14","1.14","Crystal Structure of the second bromodomain of BRD2 in complex with RT53","SMEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6I80"
"6I81",,"X-RAY DIFFRACTION",3.17,61.14,"VAPOR DIFFUSION, SITTING DROP",7,"30% PEG1000
0.1M MMT pH 7.0",277,,,"6I81",13.86,"1.74","1.74","Crystal Structure of the second bromodomain of BRD2 in complex with RT56","SMEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6I81"
"6I82",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M sodium citrate pH 4.5-5.5, 
2.0 M sodium formate

drop size 500 nl + 500 nl

RET at 3 mg/ml in 20 mM Tris pH 8.0, 100 mM NaCl, 1 mM DTT",291,"10.1021/acsmedchemlett.9b00615","H6W","6I82",73.36,"2.05","2.05","Crystal structure of partially phosphorylated RET V804M tyrosine kinase domain complexed with PDD00018412","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIMEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","Proto-oncogene tyrosine-protein kinase receptor Ret","1","6I82"
"6I83",,"X-RAY DIFFRACTION",2.72,54.82,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium citrate pH 4.5-5.5, 
2.0 M sodium formate

drop size 500 nl + 500 nl

RET at 3 mg/ml in 20 mM Tris pH 8.0, 100 mM NaCl, 1 mM DTT",291,"10.1021/acsmedchemlett.9b00615","H72","6I83",36.86,"1.88","1.88","Crystal structure of phosphorylated RET V804M tyrosine kinase domain complexed with PDD00018366","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIMEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","Proto-oncogene tyrosine-protein kinase receptor Ret","1","6I83"
"6I8B",,"X-RAY DIFFRACTION",2.85,56.83,"VAPOR DIFFUSION, SITTING DROP",,"55% MPD and 0.1 M SPG buffer pH 5.5",277,"10.1021/acs.jmedchem.9b00562",,"6I8B",53.11,"1.76","1.76","Crystal structure of Spindlin1 in complex with the inhibitor VinSpinIn","MPRRNIVGCRIQHGWKEGNGPVTQWKGTVLDQVPVNPSLYLIKYDGFDCVYGLELNKDERVSALEVLPDRVATSRISDAHLADTMIGKAVEHMFETEDGSKDEWRGMVLARAPVMNTWFYITYEKDPVLYMYQLLDDYKEGDLRIMPDSNDSPPAEREPGEVVDSLVGKQVEYAKEDGSKRTGMVIHQVEAKPSVYFIKFDDDFHIYVYDLVKTSAENLYFQ","Homo sapiens","SPIN1, OCR, SPIN","Spindlin-1","1","6I8B"
"6I8L",,"X-RAY DIFFRACTION",2.85,56.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"55% MPD and 0.1 M SPG buffer",277,"10.1021/acs.jmedchem.9b00562",,"6I8L",26.28,"1.58","1.58","Crystal structure of Spindlin1 in complex with the inhibitor TD001851a","MPRRNIVGCRIQHGWKEGNGPVTQWKGTVLDQVPVNPSLYLIKYDGFDCVYGLELNKDERVSALEVLPDRVATSRISDAHLADTMIGKAVEHMFETEDGSKDEWRGMVLARAPVMNTWFYITYEKDPVLYMYQLLDDYKEGDLRIMPDSNDSPPAEREPGEVVDSLVGKQVEYAKEDGSKRTGMVIHQVEAKPSVYFIKFDDDFHIYVYDLVKTSAENLYFQ","Homo sapiens","SPIN1, OCR, SPIN","Spindlin-1","1","6I8L"
"6I8Y",,"X-RAY DIFFRACTION",2.89,57.39,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris pH=6.5,0.2M CaCl2, 45% MPD",277,"10.1021/acs.jmedchem.9b00562",,"6I8Y",26.59,"1.52","1.52","Crystal structure of Spindlin1 in complex with the Methyltransferase inhibitor A366","MPRRNIVGCRIQHGWKEGNGPVTQWKGTVLDQVPVNPSLYLIKYDGFDCVYGLELNKDERVSALEVLPDRVATSRISDAHLADTMIGKAVEHMFETEDGSKDEWRGMVLARAPVMNTWFYITYEKDPVLYMYQLLDDYKEGDLRIMPDSNDSPPAEREPGEVVDSLVGKQVEYAKEDGSKRTGMVIHQVEAKPSVYFIKFDDDFHIYVYDLVKTSAENLYFQ","Homo sapiens","SPIN1, OCR, SPIN","Spindlin-1","1","6I8Y"
"6I8Z",,"X-RAY DIFFRACTION",2.56,51.87,"VAPOR DIFFUSION, SITTING DROP",6,"7%PEG1500, 100 mM SPG buffer, 5 mg/mL",277,"10.1021/acs.jmedchem.8b01826","H82","6I8Z",32.8,"1.99","1.99","Crystal structure of PTK2 in complex with BI-4464.","GSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","Focal adhesion kinase 1","1","6I8Z"
"6I99",,"X-RAY DIFFRACTION",2.35,50.1,"VAPOR DIFFUSION, SITTING DROP",8,"imidazole-malate, PEG 600",293.15,,,"6I99",66.21,"2.001","2.001","Bone Marrow Tyrosine Kinase in Chromosome X in complex with a newly designed covalent inhibitor JS24","HHHHHHENLYFQGELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH","Homo sapiens","BMX","Cytoplasmic tyrosine-protein kinase BMX","1","6I99"
"6I9B",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz144",,"6I9B",20.58,,,"NMR structure of the La module from human LARP4A","NSAVSTEDLKECLKKQLEFCFSRENLSKDLYLISQMDSDQFIPIWTVANMEEIKKLTTDPDLILEVLRSSPMVQVDEKGEKVRPSHKRCIVILREIPETTPIEEVKGLFKSENCPKVISCEFAHNSNWYITFQSDTDAQQAFKYLREEVKTFQGKPIMARIKAINTFFAKNGYRLMD","Homo sapiens","LARP4, PP13296","La-related protein 4","1","6I9B"
"6I9C",,"X-RAY DIFFRACTION",2.35,47.63,"VAPOR DIFFUSION, SITTING DROP",7.4,"100 mM HEPES pH 7.4, 18 % (w/v) PEG 6,000, 1M LiCl",277,"10.15252/emmm.201809324",,"6I9C",31.67,"1.77","1.77","Structure of the OTU domain of OTULIN G281R mutant","GPLSVAPEMDIMDYCKKEWRGNTQKATCMKMGYEEVSQKFTSIRRVRGDNYCALRATLFQAMSQAVGLPPWLQDPELMLLPEKLISKYNWIKQWKLGLKFDGKNEDLVDKIKESLTLLRKKWAGLAEMRTAEARQIACDELFTNEAEEYSLYEAVKFLMLNRAIELYNDKEKGKEVPFFSVLLFARDTSNDPGQLLRNHLNQVRHTGGLEQVEMFLLAYAVRHTIQVYRLSKYNTEEFITVYPTDPPKDWPVVTLIAEDDRHYNIPVR","Homo sapiens","OTULIN, FAM105B","Ubiquitin thioesterase otulin","1","6I9C"
"6I9H",,"SOLUTION NMR",,,,,,,"10.26508/lsa.201900295",,"6I9H",9.81,,,"Solution structure of TRIM28 RING domain","GPGGAEALELLEHCGVCRERLRPEREPRLLPCLHSACSACLGPAAPAAANSSGDGGAAGDGTVVDCPVCKQQCFSKDIVENYFMRDSGSKAATD","Homo sapiens","TRIM28, KAP1, RNF96, TIF1B","Transcription intermediary factor 1-beta","1","6I9H"
"6I9J",,"X-RAY DIFFRACTION",2.14,42.51,"VAPOR DIFFUSION, SITTING DROP",4.6,"20% isopropanol, 0.2M calcium chloride, 0.1M sodium acetate pH 4.6",293,"10.1038/s41598-019-44943-4",,"6I9J",12.73,"2","2","Human transforming growth factor beta2 in a tetragonal crystal form","ALDAAYCFRNVQDNCCLRPLYIDFKRDLGWKWIHEPKGYNANFCAGACPYLWSSDTQHSRVLSLYNTINPEASASPCCVSQDLEPLTILYYIGKTPKIEQLSNMIVKSCKCS","Homo sapiens","TGFB2","Transforming growth factor beta-2 proprotein","1","6I9J"
"6I9L",,"X-RAY DIFFRACTION",2.33,47.33,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M BIS-TRIS PH 6.5, 15.0 % PEG3350, 0.002 M MNCL2, 300 NL SITTING DROPS (SAMPLE:WELL, 2:1 RATIO)",298,"10.1038/s41598-022-24154-0",,"6I9L",30.08,"1.53","1.53","JmjC domain-containing protein 5 (JMJD5) in complex with Mn and pyridine-2,4-dicarboxylic acid (2,4-PDCA)","MHHHHHHSSGVDLGTENLYFQSTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","JmjC domain-containing protein 5","1","6I9L"
"6I9M",,"X-RAY DIFFRACTION",2.33,47.33,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis-Tris pH 6.5, 15.0 % PEG3350, 0.002 M MnCl2",298,"10.1038/s41598-022-24154-0",,"6I9M",30.34,"1.65","1.65","JmjC domain-containing protein 5 (JMJD5) in complex with Mn and R-2-hydroxyglutarate","MHHHHHHSSGVDLGTENLYFQSTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","JmjC domain-containing protein 5","1","6I9M"
"6I9N",,"X-RAY DIFFRACTION",2.33,47.33,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 15.0 % PEG3350, 0.002 M MnCl2",298,"10.1038/s41598-022-24154-0",,"6I9N",30.15,"1.361","1.361","JmjC domain-containing protein 5 (JMJD5) in complex with Mn and L-2-hydroxyglutarate","MHHHHHHSSGVDLGTENLYFQSTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","JmjC domain-containing protein 5","1","6I9N"
"6I9S",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Sodium format pH 7 and 20% PEG 3350",277,"10.1016/j.cell.2019.02.004",,"6I9S",47.9,"2.48","2.48","hRobo2 Extracellular Domains 2-3","DYKDDDDKRPHLEVALLRDDFRQNPTDVVVAAGEPAILECQPPRGHPEPTIYWKKDKVRIDDKEERISIRGGKLMISNTRKSDAGMYTCVGTNMVGERDSDPAELTVFERPTFLRRPINQVVLEEEAVEFRCQVQGDPQPTVRWKKDDADLPRGRYDIKDDYTLRIKKTMSTDEGTYMCIAENRVGKMEASATLTVRAKLGSHHHHHH","Homo sapiens","ROBO2, KIAA1568","Roundabout homolog 2","1","6I9S"
"6IA0",,"SOLUTION NMR",,,,,,,"10.1021/jacs.8b12748",,"6IA0",7.61,,,"Human telomeric G-quadruplex with 8-oxo-G substitution in the central G-quartet","TTGGGTTAGGGTTAGGGTTAGGGA","Homo sapiens",,"hTel-oxoG10","1","6IA0"
"6IA4",,"SOLUTION NMR",,,,,,,"10.1021/jacs.8b12748",,"6IA4",7.61,,,"Human telomeric G-quadruplex with 8-oxo-G substitution in the outer G-quartet","TTGGGTTAGGGTTAGGGTTAGGGA","Homo sapiens",,"hTel-oxoG21","1","6IA4"
"6IAA",,"X-RAY DIFFRACTION",3.28,62.47,"VAPOR DIFFUSION, HANGING DROP",,"protein concentrated to 13.5 mg/ml and precipitant mixture containing 10% PEG 8000, 0.1M HEPES pH 7 - 7.125, 9.5% Ethylene glycol and 2% MPD",293,"10.1016/j.cell.2019.02.004",,"6IAA",291.93,"3.6","3.6","hRobo2 ectodomain","DYKDDDDKRPHSRLRQEDFPPRIVEHPSDVIVSKGEPTTLNCKAEGRPTPTIEWYKDGERVETDKDDPRSHRMLLPSGSLFFLRIVHGRRSKPDEGSYVCVARNYLGEAVSRNASLEVALLRDDFRQNPTDVVVAAGEPAILECQPPRGHPEPTIYWKKDKVRIDDKEERISIRGGKLMISNTRKSDAGMYTCVGTNMVGERDSDPAELTVFERPTFLRRPINQVVLEEEAVEFRCQVQGDPQPTVRWKKDDADLPRGRYDIKDDYTLRIKKTMSTDEGTYMCIAENRVGKMEASATLTVRAPPQFVVRPRDQIVAQGRTVTFPCETKGNPQPAVFWQKEGSQNLLFPNQPQQPNSRCSVSPTGDLTITNIQRSDAGYYICQALTVAGSILAKAQLEVTDVLTDRPPPIILQGPANQTLAVDGTALLKCKATGDPLPVISWLKEGFTFPGRDPRATIQEQGTLQIKNLRISDTGTYTCVATSSSGETSWSAVLDVTESGATISKNYDLSDLPGPPSKPQVTDVTKNSVTLSWQPGTPGTLPASAYIIEAFSQSVSNSWQTVANHVKTTLYTVRGLRPNTIYLFMVRAINPQGLSDPSPMSDPVRTQDISPPAQGVDHRQVQKELGDVLVRLHNPVVLTPTTVQVTWTVDRQPQFIQGYRVMYRQTSGLQATSSWQNLDAKVPTERSAVLVNLKKGVTYEIKVRPYFNEFQGMDSESKTVRTTEEAPSAPPQSVTVLTVGSYNSTSISVSWDPPPPDHQNGIIQEYKIWCLGNETRFHINKTVDAAIRSVIIGGLFPGIQYRVEVAASTSAGVGVKSEPQPIIIGRRNEVVITENNNSITEQITDVVKQPKLGSHHHHHH","Homo sapiens","ROBO2, KIAA1568","Roundabout homolog 2","1","6IAA"
"6IAG",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES pH 7.5",293,,,"6IAG",172.73,"2","2","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-637","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IAG"
"6IAR",,"X-RAY DIFFRACTION",2.5,50.77,"VAPOR DIFFUSION, SITTING DROP",6.5,"#61 WELL D5: 12% PEG 3350, 0.16M MGCL2,
0.08M PCTP PH6.5,  0.2M LICL",293,"10.1021/acs.jmedchem.8b01837",,"6IAR",27.47,"1.84","1.84","Tricyclic indazoles a novel class of selective estrogen receptor degrader antagonists","ALSLTADQMVSALLDAEPPILYSEYDPTRPFSMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAH","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6IAR"
"6IAY",,"X-RAY DIFFRACTION",2.33,47.11,"VAPOR DIFFUSION, HANGING DROP",5.75,"22.5% PEG 1500, 0.1M SPG (succinate-phosphate-glycine) pH 5.75",293,,,"6IAY",45.66,"1.9","1.9","Alpha-1-antitrypsin Queen's (Lys154Asn) variant","MRGSHHHHHHTDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEANKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHSKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","6IAY"
"6IB0",,"X-RAY DIFFRACTION",2.34,47.5,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodium Citrate, 20 % PEG3350",277,"10.1021/acs.jmedchem.9b00102",,"6IB0",36.64,"2.6","2.6","The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3a","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6IB0"
"6IB2",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodiumcitrate
20 % PEG3500",277,"10.1021/acs.jmedchem.9b00102",,"6IB2",36.62,"2.1","2.1","The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 4a","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKKCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6IB2"
"6IB6",,"SOLUTION NMR",,,,,,,"10.3390/ijms21197280",,"6IB6",10.94,,,"Solution structure of the water-soluble LU-domain of human Lypd6 protein","MFKCFTCEKAADNYECNRWAPDIYCPRETRYCYTQHTMEVTGNSISVTKRCVPLEECLSTGCRDSEHEGHKVCTSCCEGNICNLPLPRNETDATFA","Homo sapiens","LYPD6, UNQ3023/PRO9821","Ly6/PLAUR domain-containing protein 6","1","6IB6"
"6IBD",,"X-RAY DIFFRACTION",2.15,42.77,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M bis-tris, 14% (w/v) PEG 2000 MME, 12% (w/v) PEG 3350",293,,,"6IBD",52.88,"1.48","1.48","The Phosphatase and C2 domains of Human SHIP1","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","6IBD"
"6IBE",,"X-RAY DIFFRACTION",2.27,45.79,"VAPOR DIFFUSION, SITTING DROP",6,"0.15 M ammonium nitrate, 0.1 M MES, 5% (v/v) ethylene glycol, 5% (w/v) PEG 2000, 5% (w/v) PEG 3350, 5% (w/v) PEG 4000, 5% (w/v) PEG 5000 MME",277,,,"6IBE",33.96,"1.45","1.45","The FERM domain of Human EPB41L3","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Band 4.1-like protein 3","1","6IBE"
"6IBF",,"X-RAY DIFFRACTION",2.61,52.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES pH 7.5",293,,,"6IBF",173.71,"2.31","2.31","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-417","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IBF"
"6IBK",,"X-RAY DIFFRACTION",2.82,56.43,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000 (50%), sodium acetate (pH 4.6) and  lithium sulfate,",293,,,"6IBK",97.12,"1.99","1.99","Crystal structure of human alpha-galactosidase A in complex with alpha-galactose configured cyclosulfamidate ME763","LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLL","Homo sapiens","GLA","Alpha-galactosidase A","1","6IBK"
"6IBM",,"X-RAY DIFFRACTION",2.8,56.11,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000 (50%), sodium acetate (pH 4.6) and lithium sulfate",293,,,"6IBM",97.16,"2.07","2.07","Crystal structure of human alpha-galactosidase A in complex with alpha-galactose configured cyclosulfate ME776","LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLL","Homo sapiens","GLA","Alpha-galactosidase A","1","6IBM"
"6IBR",,"X-RAY DIFFRACTION",2.81,56.2,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000 (50%), sodium acetate (pH 4.6) and lithium sulfate",293,,,"6IBR",96.14,"2.02","2.02","Crystal structure of human alpha-galactosidase A in complex with alpha-galactose configured cyclophellitol epoxide LWA481","LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLL","Homo sapiens","GLA","Alpha-galactosidase A","1","6IBR"
"6IBT",,"X-RAY DIFFRACTION",2.81,56.28,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000 (50%), sodium acetate (pH 4.6) and lithium sulfate",293,,,"6IBT",95.68,"2.04","2.04","Crystal structure of human alpha-galactosidase A in complex with alpha-galactose configured cyclophellitol aziridine ME737","LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLL","Homo sapiens","GLA","Alpha-galactosidase A","1","6IBT"
"6IBX",,"X-RAY DIFFRACTION",3.89,68.37,"VAPOR DIFFUSION, SITTING DROP",,"2% Tacsimate, 10% PEG3350, 0.1M MES/imidazole pH 7.0",277,"10.1016/j.bmcl.2018.12.034","H9Z","6IBX",51.08,"2.11","2.11","Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 5","ELTQSRVQKIWVPVNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSE","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","6IBX"
"6IBY",,"X-RAY DIFFRACTION",3.87,68.18,"VAPOR DIFFUSION, SITTING DROP",,"25% GOL-P4K, 0.12M Monosaccharides, Buffer System2, pH 7.0",277,"10.1016/j.bmcl.2018.12.034",,"6IBY",51.07,"2.51","2.51","Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 6","ELTQSRVQKIWVPNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSE","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","6IBY"
"6IBZ",,"X-RAY DIFFRACTION",3.88,68.31,"VAPOR DIFFUSION, SITTING DROP",,"2% Tacsimate, pH7.0; 5% 2-propanol; 0.1M imidazole; 8% PEG3350",277,"10.1016/j.bmcl.2018.12.034","HAW","6IBZ",51.21,"2.44","2.44","Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 7","ELTQSRVQKIWVPVDHNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSE","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","6IBZ"
"6IC0",,"X-RAY DIFFRACTION",3.79,67.57,"VAPOR DIFFUSION, SITTING DROP",,"2% Tacsimate, pH7.0; 5% 2-propanol; 0.1M imidazole; 8% PEG3350",277,"10.1016/j.bmcl.2018.12.034",,"6IC0",50.94,"2.6","2.6","Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 4","ELTQSRVQKIWVPVNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERS","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","6IC0"
"6IC2",,"X-RAY DIFFRACTION",2.1,41.37,"VAPOR DIFFUSION",8,"1.7 M sodium citrate, 50 mM Tris pH 8.0",296,"10.1039/c8cc09568j","BBJ","6IC2",29.79,"1.15","1.15","Polypharmacology of Epacadostat: a Potent and Selective Inhibitor of the Tumor Associated Carbonic Anhydrases IX and XII","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6IC2"
"6IC3","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-09032-0",,"6IC3",97.42,"3.3",,"AL amyloid fibril from a lambda 1 light chain","VLTQPPSASGTPGQRVTISCSGRSSNIGRNLVKWYQQFPGTAPKLLIYSNDQRPSGVPDRFSGSKSGTSASLAVSGLQSEDEADYYCAAWDATLNAWVFGGGTKLTVLSQPKAAPS","Homo sapiens",,"lambda 1 light chain fragment, residues 3-118","1","6IC3"
"6IC5",,"X-RAY DIFFRACTION",2.81,56.2,"VAPOR DIFFUSION, SITTING DROP",5.6,"20.0 % (w/v) PEG 3000
0.1 M sodium citrate pH 5.6",291,"10.1016/j.bcp.2019.04.006",,"6IC5",41.33,"2","2","Human cathepsin-C in complex with dipeptidyl cyclopropyl nitrile inhibitor 2","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","6IC5"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHT","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","2","6IC5"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","3","6IC5"
"6IC6",,"X-RAY DIFFRACTION",2.79,55.9,"VAPOR DIFFUSION, SITTING DROP",5,"20.0 % (w/v) PEG 6000
0.1 M sodium citrate pH 5.0",291,"10.1016/j.bcp.2019.04.006",,"6IC6",41.49,"1.898","1.898","Human cathepsin-C in complex with cyclopropyl peptidyl nitrile inhibitor 1","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","6IC6"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","2","6IC6"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","3","6IC6"
"6IC7",,"X-RAY DIFFRACTION",2.79,55.94,"VAPOR DIFFUSION, SITTING DROP",,"20.0 % (w/v) PEG 3000
0.2 M ammonium citrate dibasic
2.5 mM DTT",291,"10.1016/j.bcp.2019.04.006",,"6IC7",41.3,"2","2","Human cathepsin-C in complex with dipeptidyl cyclopropyl nitrile inhibitor 3","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","6IC7"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHT","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","2","6IC7"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","3","6IC7"
"6ICG",,"X-RAY DIFFRACTION",2.5,50.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Sodium chloride, 0.1 M HEPES (pH 7.5), 1.6 M Ammonium sulfate",293,"10.2142/biophysico.16.0_80",,"6ICG",22.57,"1.15","1.15","Grb2 SH2 domain in phosphopeptide free form","GSWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIE","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","6ICG"
"6ICH",,"X-RAY DIFFRACTION",2.74,55.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES monohydrate (pH 6.5), 12% PEG 20,000",293,"10.2142/biophysico.16.0_80",,"6ICH",11,"2","2","Grb2 SH2 domain in domain swapped dimer form","GSWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIE","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","6ICH"
"6ICI",,"X-RAY DIFFRACTION",2.61,52.95,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bicine-NaOH pH 9.2, 7% MPD",293,"10.1107/S2052252519015409",,"6ICI",84.14,"2.3","2.3","Crystal structure of human MICAL3","MGSSHHHHHHSSGLVPRGSHMASMTGGEEMGRDPNSMEERKHETMNPAHVLFDRFVQATTCKGTLKAFQELCDHLELKPKDYRSFYHKLKSKLNYWKAKALWAKLDKRGSHKDYKKGKACTNTKCLIIGAGPCGLRTAIDLSLLGAKVVVIEKRDAFSRNNVLHLWPFTIHDLRGLGAKKFYGKFCAGAIDHISIRQLQLILLKVALILGIEIHVNVEFQGLIQPPEDQENERIGWRALVHPKTHPVSEYEFEVIIGGDGRRNTLEGFRRKEFRGKLAIAITANFINRNTTAEAKVEEISGVAFIFNQKFFQELREATGIDLENIVYYKDDTHYFVMTAKKQSLLDKGVILHDYADTELLLSRENVDQEALLSYAREAADFSTQQQLPSLDFAINHYGQPDVAMFDFTCMYASENAALVREQNGHQLLVALVGDSLLEPFWPMGTGIARGFLAAMDSAWMVRSWSLGTSPLEVLAERESIYRLLPQTTPENVSKNFSQYSIDPVTRYPNINVNFLRPSQVRHLYDTGETKDIHLEMESLVNSRTTPKLTRNESVARSSKLLGWCQRQTDGYAGVNVTDLTMSWKSGLALCAIIHRYRPDLIDFDSLDEQNVEKNNQLAFDIAEKELGISPIMTGKEMASVGEPDKLSMVMYLTQFYEMFKDSLPSSDTLDLNAEEKAVLIASTRSPISFLSKLGQTISRKRSPKDKKEKDLDGAGKRRKTSQSEEEEAPRGHRGER","Homo sapiens","MICAL3, KIAA0819, KIAA1364","[F-actin]-monooxygenase MICAL3","1","6ICI"
"6IDJ",,"X-RAY DIFFRACTION",3.39,63.76,"VAPOR DIFFUSION, HANGING DROP",4.9,"100 MM SODIUM ACETATE, 1.8-1.9 M         AMMONIUM SULPHATE, 40 MM C11DAO, 20.8 MM DDAO, 2 MM DIHYDROOROTATE,",293,"10.3390/genes11121468",,"6IDJ",44.08,"1.9","1.9","Crystal structure of human DHODH in complex with ferulenol","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6IDJ"
"6IE1",,"X-RAY DIFFRACTION",3.26,62.28,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Sodium malonate pH 4.0, 
12%PEG3,350",277,"10.1038/s41467-018-07938-9",,"6IE1",59.99,"2.48","2.48","Crystal Structure of ELMO2(Engulfment and cell motility protein 2)","GPGSMPPPSDIVKVAIEWPGANAQLLEIDQKRPLASIIKEVCDGWSLPNPEYYTLRYADGPQLYITEQTRSDIKNGTILQLAISPSRAARQLMERTQSSNMETRLDAMKELAKLSADVTFATEFINMDGIIVLTRLVESGTKLLSHYSEMLAFTLTAFLELMDHGIVSWDMVSITFIKQIAGYVSQPMVDVSILQRSLAILESMVLNSQSLYQKIAEEITVGQLISHLQVSNQEIQTYAIALINALFLKAPEDKRQDMANAFAQKHLRSIILNHVIRGNRPIKTEMAHQLYVLQVLTFNLLEERMMTKMDPNDQAQRDIIFELRRIAFDAESDPSNAPGSGTEKRKAMYTKDYKMLGFTNHINPAMDFTQTPPGMLALDNMLYLAKVHQDTYIRIVLENSSREDKHECPFGRSAIELTKMLCEILQVGELPNEGRNDYHPMFFTHDRAFEELFGICIQLLNKTWKEMRATAEDFNKVMQVVREQITRALPSKPNSLDQFKSKLRSLSYSEILRLRQSERMSQDD","Homo sapiens","ELMO2, CED12A, KIAA1834","Engulfment and cell motility protein 2","1","6IE1"
"6IE2",,"X-RAY DIFFRACTION",3.05,59.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"5% PEG3350, 5% MPD, 100mM CaCl2, 200mM NaF, 100mM Bis-Tris pH6.5",286,"10.1038/s41422-019-0233-9",,"6IE2",352.71,"2.8","2.8","Crystal structure of methyladenine demethylase","MGKMAAAVGSVATLATEPGEDAFRKLFRFYRQSRPGTADLEGVIDFSAAHAARGKGPGAQKVIKSQLNVSSVSEQNAYRAGLQPVSKWQAYGLKGYPGFIFIPNPFLPGYQWHWVKQCLKLYSQKPNVCNLDKHMSKEETQDLWEQSKEFLRYKEATKRRPRSLLEKLRWVTVGYHYNWDSKKYSADHYTPFPSDLGFLSEQVAAACGFEDFRAEAGILNYYRLDSTLGIHVDRSELDHSKPLLSFSFGQSAIFLLGGLQRDEAPTAMFMHSGDIMIMSGFSRLLNHAVPRVLPNPEGEGLPHCLEAPLPAVLPRDSMVEPCSMEDWQVCASYLKTARVNMTVRQVLATDQNFPLEPIEDEKRDISTEGFCHLDDQNSEVKRARINPDS","Homo sapiens","ALKBH1, ABH, ABH1, ALKBH","Nucleic acid dioxygenase ALKBH1","1","6IE2"
"6IE3",,"X-RAY DIFFRACTION",2.03,39.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"5% ethanol, 5% MPD, 100 mM NaF, 100 mM HepespH7.5",286,"10.1038/s41422-019-0233-9",,"6IE3",43.99,"1.97","1.97","Crystal structure of methyladenine demethylase","MGKMAAAVGSVATLATEPGEDAFRKLFRFYRQSRPGTADLEGVIDFSAAHAARGKGPGAQKVIKSQLNVSSVSEQNAYRAGLQPVSKWQAYGLKGYPGFIFIPNPFLPGYQWHWVKQCLKLYSQKPNVCNLDKHMSKEETQDLWEQSKEFLRYKEATKRRPRSLLEKLRWVTVGYHYNWDSKKYSADHYTPFPSDLGFLSEQVAAACGFEDFRAEAGILNYYRLDSTLGIHVDRSELDHSKPLLSFSFGQSAIFLLGGLQRDEAPTAMFMHSGDIMIMSGFSRLLNHAVPRVLPNPEGEGLPHCLEAPLPAVLPRDSMVEPCSMEDWQVCASYLKTARVNMTVRQVLATDQNFPLEPIEDEKRDISTEGFCHLDDQNSEVKRARINPDS","Homo sapiens","ALKBH1, ABH, ABH1, ALKBH","Nucleic acid dioxygenase ALKBH1","1","6IE3"
"6IEG",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, HANGING DROP",,"15 mM Tricine pH 8.5, 12% (w/v) PEG 4000",293.15,"10.1101/gad.322602.118",,"6IEG",229.23,"3.55","3.55","Crystal structure of human MTR4","MSYYHHHHHHDYDIPTTENLYFQGAMDPEFTDEPIFGKKPRIEESITEDLSLADLMPRVKVQSVETVEGCTHEVALPAEEDYLPLKPRVGKAAKEYPFILDAFQREAIQCVDNNQSVLVSAHTSAGKTVCAEYAIALALREKQRVIFTSPIKALSNQKYREMYEEFQDVGLMTGDVTINPTASCLVMTTEILRSMLYRGSEVMREVAWVIFDEIHYMRDSERGVVWEETIILLPDNVHYVFLSATIPNARQFAEWICHLHKQPCHVIYTDYRPTPLQHYIFPAGGDGLHLVVDENGDFREDNFNTAMQVLRDAGDLAKGDQKGRKGGTKGPSNVFKIVKMIMERNFQPVIIFSFSKKDCEAYALQMTKLDFNTDEEKKMVEEVFSNAIDCLSDEDKKLPQVEHVLPLLKRGIGIHHGGLLPILKETIEILFSEGLIKALFATETFAMGINMPARTVLFTNARKFDGKDFRWISSGEYIQMSGRAGRRGMDDRGIVILMVDEKMSPTIGKQLLKGSADPLNSAFHLTYNMVLNLLRVEEINPEYMLEKSFYQFQHYRAIPGVVEKVKNSEEQYNKIVIPNEESVVIYYKIRQQLAKLGKEIEEYIHKPKYCLPFLQPGRLVKVKNEGDDFGWGVVVNFSKKSNVKPNSGELDPLYVVEVLLRCSKESLKNSATEAAKPAKPDEKGEMQVVPVLVHLLSAISSVRLYIPKDLRPVDNRQSVLKSIQEVQKRFPDGIPLLDPIDDMGIQDQGLKKVIQKVEAFEHRMYSHPLHNDPNLETVYTLCEKKAQIAIDIKSAKRELKKARTVLQMDELKCRKRVLRRLGFATSSDVIEMKGRVACEISSADELLLTEMMFNGLFNDLSAEQATALLSCFVFQENSSEMPKLTEQLAGPLRQMQECAKRIAKVSAEAKLEIDEETYLSSFKPHLMDVVYTWATGATFAHICKMTDVFEGSIIRCMRRLEELLRQMCQAAKAIGNTELENKFAEGITKIKRDIVFAASLYL","Homo sapiens","MTREX, DOB1, KIAA0052, MTR4, SKIV2L2","Exosome RNA helicase MTR4","1","6IEG"
"6IET",,"X-RAY DIFFRACTION",2.03,39.43,"VAPOR DIFFUSION, HANGING DROP",,"30%(w/v)5000 MME, 100mM Tris base/ Hydrochloric acid pH 8.0, 200mM Lithium sulfate",293,"10.1038/s41467-019-12126-4",,"6IET",22.74,"2.101","2.101","The crystal structure of TRIM66 PHD-Bromo domain","PHMENEDFCAVCLNGGELLCCDRCPKVFHLSCHVPALTSFPGGEWVCTLCRSLTQPEMEYDSENASHNQPGKRASPGLSMYDQKKCEKLVLSLCCNNLSLPFHEPVSPLARHYYQIIKRPMDLSTIRRKLQKKDPAHYTTPEEVVSDVRLMFWNCAKFNYPDSEVAEAGRSLENFFEGWLKEIYPEKRFAQPRQED","Homo sapiens","TRIM66, C11orf29, KIAA0298","Tripartite motif-containing protein 66","1","6IET"
"6IEZ",,"X-RAY DIFFRACTION",2.52,51.26,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCl buffer, pH 5.9, containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"6IEZ",27.49,"1.9","1.9","Crystal structure of CERT START domain in complex with compound B16","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","6IEZ"
"6IF0",,"X-RAY DIFFRACTION",2.52,51.25,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCL buffer, pH 5.9 containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"6IF0",27.49,"1.8","1.8","Crystal structure of CERT START domain in complex with compound D16","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","6IF0"
"6IF9",,"SOLUTION NMR",,,,,,,"10.1016/j.jsb.2019.02.003",,"6IF9",21.16,,,"Solution-state NMR structure of G57W human gammaS crystallin","MSKTGTKITFYEDKNFQGRRYDCDCDCADFHTYLSRCNSIKVEGGTWAVYERPNFAWYMYILPQGEYPEYQRWMGLNDRLSSCRAVHLPSGGQYKIQIFEKGDFSGQMYETTEDCPSIMEQFHMREIHSCKVLEGVWIFYELPNYRGRQYLLDKKEYRKPIDWGAASPAVQSFRRIVE","Homo sapiens","CRYGS, CRYG8","Gamma-crystallin S","1","6IF9"
"6IG8",,"X-RAY DIFFRACTION",2.5,50.71,"VAPOR DIFFUSION, HANGING DROP",8.5,"11 mg/mL protein, 22.5-35% PEG 4000, 0.1M Tris-HCL pH 8.5, 0.2M MgCl2",277,"10.1016/j.bmcl.2018.10.051",,"6IG8",36.94,"1.8","1.8","Crystal structure of CSF-1R kinase domain with a small molecular inhibitor, JTE-952","WKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor","1","6IG8"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSF1R, FMS"
"6IGO",,"X-RAY DIFFRACTION",2.47,50.16,"VAPOR DIFFUSION",,"100mM Tris-HCl pH 8.5, 1.15M (NH4)2HPO4",293,"10.1016/j.bbrc.2018.10.161",,"6IGO",91.32,"2.746","2.746","Crystal structure of myelin protein zero-like protein 1 (MPZL1)","SALEVYTPKEIFVANGTQGKLTCKFKSTSTTGGLTSVSWSFQPEGADTTVSFFHYSQGQVYLGNYPPFKDRISWAGDLDKKDASINIENMQFIHNGTYICDVKNPPDIVVQPGHIRLYVVEKENLPVLEHHHHHH","Homo sapiens","MPZL1, PZR, UNQ849/PRO1787","Myelin protein zero-like protein 1","1","6IGO"
"6IGT",,"X-RAY DIFFRACTION",2.62,57.68,"VAPOR DIFFUSION",,"50mM MES pH5.6, 100 mM (NH4)2SO4, 10mM MgCl2, 20% (w/v) PEG8000",277,"10.1016/j.bbrc.2018.10.161",,"6IGT",60.85,"2.404","2.404","MPZL1 mutant - V145G, Q146K, P147T and G148S","SALEVYTPKEIFVANGTQGKLTCKFKSTSTTGGLTSVSWSFQPEGADTTVSFFHYSQGQVYLGNYPPFKDRISWAGDLDKKDASINIENMQFIHNGTYICDVKNPPDIVGKTSHIRLYVVEKENLPVLEHHHHHH","Homo sapiens","MPZL1, PZR, UNQ849/PRO1787","Myelin protein zero-like protein 1","1","6IGT"
"6IGW",,"X-RAY DIFFRACTION",2.55,56.45,"VAPOR DIFFUSION",,"20mM Tris-HCl pH 8.5, 1M Li2SO4, 1.8%(w/v) PEG8000",293,"10.1016/j.bbrc.2018.10.161",,"6IGW",15.18,"1.979","1.979","MPZL1 mutant - S86G, V145G, Q146K,P147T,G148S","SALEVYTPKEIFVANGTQGKLTCKFKSTSTTGGLTSVSWSFQPEGADTTVGFFHYSQGQVYLGNYPPFKDRISWAGDLDKKDASINIENMQFIHNGTYICDVKNPPDIVGKTSHIRLYVVEKENLPVLEHHHHHH","Homo sapiens","MPZL1, PZR, UNQ849/PRO1787","Myelin protein zero-like protein 1","1","6IGW"
"6IIE",,"X-RAY DIFFRACTION",2.82,56.33,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES, 1.0 M succinic acid, 2 % PEG monomethyl ether 2000, 10 % glycerol",296,"10.1002/pro.3572",,"6IIE",11.27,"2.142","2.142","Crystal structure of human diacylglycerol kinase alpha EF-hand domains bound to Ca2+","HMEGGRPEDKLEFTFKLYDTDRNGILDSSEVDKIILQMMRVAEYLDWDVSELRPILQEMMKEIDYDGSGSVSQAEWVRAGATTVPLLVLLGLE","Homo sapiens","DGKA, DAGK, DAGK1","Diacylglycerol kinase alpha","1","6IIE"
"6IIK",,"X-RAY DIFFRACTION",2.78,55.82,"VAPOR DIFFUSION, HANGING DROP",,"NH4F. PEG 3350, glycine, Cscl",277,"10.1038/s41422-018-0091-x","IU1","6IIK",91.81,"1.97","1.97","USP14 catalytic domain with IU1","QLASAMELPCGLTNLGNTCYMNATVQCIRSVPELKDALKRYAGALRASGEMASAQYITAALRDLFDSMDKTSSSIPPIILLQFLHMAFPQFAEKGEQGQYLQQDANECWIQMMRVLQQKLEAIEDDSVKETDSSSASAATPSKKKSLIDQFFGVEFETTMKCTESEEEEVTKGKENQLQLSCFINQEVKYLFTGLKLRLQEEITKQSPTLQRNALYIKSSKISRLPAYLTIQMVRFFYKEKESVNAKVLKDVKFPLMLDMYELCTPELQEKMVSFRSKFKDLEDKKVNQQPNTSDKKSSPQKEVKYEPFSFADDIGSNNCGYYDLQAVLTHQGRSSSSGHYVSWVKRKQDEWIKFDDDKVSIVTPEDILRLSGGGDWHIAYVLLYGPRRVEIMEEESEQ","Homo sapiens","USP14, TGT","Ubiquitin carboxyl-terminal hydrolase 14","1","6IIK"
"6IIL",,"X-RAY DIFFRACTION",2.9,57.65,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, NH4F, glycine, Cscl",277,"10.1038/s41422-018-0091-x","A8F","6IIL",91.87,"2.2","2.2","USP14 catalytic domain bind to IU1-47","QLASAMELPCGLTNLGNTCYMNATVQCIRSVPELKDALKRYAGALRASGEMASAQYITAALRDLFDSMDKTSSSIPPIILLQFLHMAFPQFAEKGEQGQYLQQDANECWIQMMRVLQQKLEAIEDDSVKETDSSSASAATPSKKKSLIDQFFGVEFETTMKCTESEEEEVTKGKENQLQLSCFINQEVKYLFTGLKLRLQEEITKQSPTLQRNALYIKSSKISRLPAYLTIQMVRFFYKEKESVNAKVLKDVKFPLMLDMYELCTPELQEKMVSFRSKFKDLEDKKVNQQPNTSDKKSSPQKEVKYEPFSFADDIGSNNCGYYDLQAVLTHQGRSSSSGHYVSWVKRKQDEWIKFDDDKVSIVTPEDILRLSGGGDWHIAYVLLYGPRRVEIMEEESEQ","Homo sapiens","USP14, TGT","Ubiquitin carboxyl-terminal hydrolase 14","1","6IIL"
"6IIM",,"X-RAY DIFFRACTION",2.92,57.81,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, NH4F, Cscl, glycine",277,"10.1038/s41422-018-0091-x",,"6IIM",91.9,"2.21","2.21","USP14 catalytic domain with IU1-206","QLASAMELPCGLTNLGNTCYMNATVQCIRSVPELKDALKRYAGALRASGEMASAQYITAALRDLFDSMDKTSSSIPPIILLQFLHMAFPQFAEKGEQGQYLQQDANECWIQMMRVLQQKLEAIEDDSVKETDSSSASAATPSKKKSLIDQFFGVEFETTMKCTESEEEEVTKGKENQLQLSCFINQEVKYLFTGLKLRLQEEITKQSPTLQRNALYIKSSKISRLPAYLTIQMVRFFYKEKESVNAKVLKDVKFPLMLDMYELCTPELQEKMVSFRSKFKDLEDKKVNQQPNTSDKKSSPQKEVKYEPFSFADDIGSNNCGYYDLQAVLTHQGRSSSSGHYVSWVKRKQDEWIKFDDDKVSIVTPEDILRLSGGGDWHIAYVLLYGPRRVEIMEEESEQ","Homo sapiens","USP14, TGT","Ubiquitin carboxyl-terminal hydrolase 14","1","6IIM"
"6IIN",,"X-RAY DIFFRACTION",2.87,57.15,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, NH4F, Cscl, glycine",277,"10.1038/s41422-018-0091-x",,"6IIN",88.73,"2.53","2.53","USP14 catalytic domain with IU1-248","MELPCGLTNLGNTCYMNATVQCIRSVPELKDALKRYAGALRASGEMASAQYITAALRDLFDSMDKTSSSIPPIILLQFLHMAFPQFAEKGEQGQYLQQDANECWIQMMRVLQQKLEAIEDDSVKETDSSSASAATPSKKKSLIDQFFGVEFETTMKCTESEEEEVTKGKENQLQLSCFINQEVKYLFTGLKLRLQEEITKQSPTLQRNALYIKSSKISRLPAYLTIQMVRFFYKEKESVNAKVLKDVKFPLMLDMYELCTPELQEKMVSFRSKFKDLEDKKVNQQPNTSDKKSSPQKEVKYEPFSFADDIGSNNCGYYDLQAVLTHQGRSSSSGHYVSWVKRKQDEWIKFDDDKVSIVTPEDILRLSGGGDWHIAYVLLYGPRRV","Homo sapiens","USP14, TGT","Ubiquitin carboxyl-terminal hydrolase 14","1","6IIN"
"6IIP",,"X-RAY DIFFRACTION",1.85,33.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M ammonium sulphate, 0.1 M MES monohydrate, pH 6.5, and 30% w/v polyethylene glycol monomethyl ether 5000",293,,,"6IIP",21.1,"0.951","0.951","Apo-form structure of the HRP3 PWWP domain","SEYKAGDLVFAKMKGYPHWPARIDELPEGAVKPPANKYPIFFFGTHETAFLGPKDLFPYKEYKDKFGKSNKRKGFNEGLWEIENNPGV","Homo sapiens","HDGFL3, HDGF2, HDGFRP3, CGI-142","Hepatoma-derived growth factor-related protein 3","1","6IIP"
"6IJH",,"X-RAY DIFFRACTION",2.11,41.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes (pH 7.5), 0.2M MgCl2, 18% PEG 3350, 50mM 2-mercaptoethanol",277,"10.1021/acs.jmedchem.9b00224",,"6IJH",79.9,"2.6","2.6","Crystal structure of PDE10 in complex with inhibitor AF-399/14387019","HMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6IJH"
"6IJI",,"X-RAY DIFFRACTION",2.12,42,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes (pH 7.5), 0.2M MgCl2, 18% PEG 3350, 50mM 2-mercaptoethanol",277,"10.1021/acs.jmedchem.9b00224",,"6IJI",75.73,"2.7","2.7","Crystal structure of PDE10 in complex with inhibitor 2b","HMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6IJI"
"6IJL",,"X-RAY DIFFRACTION",2.24,45.08,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Magnesium acetate, 17% PEG 3350",293,"10.1021/acsmedchemlett.9b00170",,"6IJL",50.25,"2.351","2.351","Crystal structure of SmyD3 in complex with covalent inhibitor 5","MEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","6IJL"
"6IJV",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.1c00281",,"6IJV",9,,,"Solution NMR structure of a 14-mer dsDNA complexed with a novel NIR fluorescent probe QCy-DT","CGCGAAATTTCGCG","Homo sapiens",,"DNA (5'-D(*CP*GP*CP*GP*AP*AP*AP*TP*TP*TP*CP*GP*CP*G)-3')","1","6IJV"
"6IJW",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.1c00281",,"6IJW",7.77,,,"SOLUTION NMR STRUCTURE OF A DODECAMERIC dsDNA COMPLEXED WITH A NIR FLUORESCENT PROBE QCy-DT","CGCGAATTCGCG","Homo sapiens",,"DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3')","1","6IJW"
"6IJX",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, HANGING DROP",,"23-27% (w/v) PEG 4000, 100 mM Hepes, 10mM CaCl2, 0.4M NaCl",289,"10.1016/j.bmc.2018.10.044","JMS","6IJX",37.88,"2.2","2.2","Crystal Structure of AKR1C1 complexed with meclofenamic acid","MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEATKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWCNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAVEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY","Homo sapiens","AKR1C1, DDH, DDH1","Aldo-keto reductase family 1 member C1","1","6IJX"
"6IJY",,"X-RAY DIFFRACTION",1.88,34.7,"COUNTER-DIFFUSION",,"sodium citrate, cacodylate, sodium chloride, glycerol",293,,,"6IJY",37.31,"1.04","1.04","Crystal structure of human MTH1(G2K/C87A/C104S mutant) in complex with 8-oxo-dGTP determined using a crystal obtained under microgravity","MKASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFATDSIQGTPVESDEMRPSWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6IJY"
"6IL3",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, HANGING DROP",10.5,"0.2 M Lithium Sulfate, 0.1 M CAPS, pH 10.5, 1.2 M Sodium dihydrogen phosphate, 0.8 M Di-potassium hydrogen phosphate",291,,,"6IL3",45.2,"2.5","2.5","Crystal structure of the FLT3 kinase bound to a small molecule inhibitor","MSYYHHHHHHDYDIPTTENLYFQSIAHKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV","Homo sapiens","FLT3, CD135, FLK2, STK1","Receptor-type tyrosine-protein kinase FLT3","1","6IL3"
,,,,,,,,,,,,,,,,,"Homo sapiens","FLT3, CD135, FLK2, STK1"
"6ILH",,"X-RAY DIFFRACTION",2.95,58.24,"VAPOR DIFFUSION, SITTING DROP",,"13% PEG 2000 MME, 0.4M Ammonium acetate pH8.0",291,"10.1074/jbc.RA118.006356",,"6ILH",121.62,"2.501","2.501","Crystal Structure of human lysyl-tRNA synthetase L350H mutant","MSVDPNQYYKIRSQAIHQLKVNGEDPYPHKFHVDISLTDFIQKYSHLQPGDHLTDITLKVAGRIHAKRASGGKLIFYDLRGEGVKLQVMANSRNYKSEEEFIHINNKLRRGDIIGVQGNPGKTKKGELSIIPYEITLLSPCLHMLPHLHFGLKDKETRYRQRYLDLILNDFVRQKFIIRSKIITYIRSFLDELGFLEIETPMMNIIPGGAVAKPFITYHNELDMNLYMRIAPELYHKMLVVGGIDRVYEIGRQFRNEGIDLTHNPEFTTCEFYMAYADYHDHMEITEKMVSGMVKHITGSYKVTYHPDGPEGQAYDVDFTPPFRRINMVEELEKALGMKLPETNLFETEETRKILDDICVAKAVECPPPRTTARLLDKLVGEFLEVTCINPTFICDHPQIMSPLAKWHRSKEGLTERFELFVMKKEICNAYTELNDPMRQRQLFEEQAKAKAAGDDEAMFIDENFCTALEYGLPPTAGWGMGIDRVAMFLTDSNNIKEVLLFPAMKPEDKKENLEHHHHHH","Homo sapiens","KARS, KIAA0070, KARS1","Lysine-tRNA ligase","1","6ILH"
"6ILI",,"X-RAY DIFFRACTION",1.85,33.54,"VAPOR DIFFUSION, HANGING DROP",6.5,"SODIUM CITRATE, cacodylate, NACL",293,"10.1074/jbc.M116.749713",,"6ILI",37.13,"1.45","1.45","Crystal structure of human MTH1(G2K/D120N mutant) in complex with 8-oxo-dGTP at pH 6.5","MKASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDNSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6ILI"
"6ILZ",,"X-RAY DIFFRACTION",2.37,48.19,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M BIS-TRIS 6.5, 28 % w/v Polyethylene glycol monomethyl ether 2000",293,"10.1021/acsmedchemlett.8b00546",,"6ILZ",160.92,"3.261","3.261","Crystal structure of PKCiota in complex with inhibitor","GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL","Homo sapiens","PRKCI, DXS1179E","Protein kinase C iota type","1","6ILZ"
"6IM5",,"X-RAY DIFFRACTION",2.07,40.58,"VAPOR DIFFUSION, SITTING DROP",,"4% (v/v) 2-propanol, 100 mM sodium phosphate dibasic/citric acid (pH 4.5), and 200 mM lithium sulfate",291,,,"6IM5",53.64,"1.701","1.701","YAP-binding domain of human TEAD1","GSHMASMTGGQQMGRGSIGTTKLRLVEFSAFLEQQRDPDSYNKHLFVHIGHANHSYSDPLLESVDIRQIYDKFPEKKGGLKELFGKGPQNAFFLVKFWADLNCNIQDDAGAFYGVTSQYESSENMTVTCSTKVCSFGKQVVEKVETEYARFENGRFVYRINRSPMCEYMINFIHKLKHLPEKYMMNSVLENFTILLVVTNRDTQETLLCMACVFEVSNSEHGAQHHIYRLVKD","Homo sapiens","TEAD1, TCF13, TEF1","Transcriptional enhancer factor TEF-1","1","6IM5"
"6IM6",,"X-RAY DIFFRACTION",2.38,48.24,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 0.2 M MgCl2, 10% isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AH3","6IM6",81.7,"1.702","1.702","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IM6"
"6IMB",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 0.2 M MgCl2, 10% Isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AH9","6IMB",81.79,"1.549","1.549","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IMB"
"6IMD",,"X-RAY DIFFRACTION",2.39,48.56,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 0.2 M MaCl2, 10% Isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AH9","6IMD",81.55,"1.499","1.499","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IMD"
"6IMI",,"X-RAY DIFFRACTION",2.4,48.81,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 0.2 M MgCl2, 10% Isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AH6","6IMI",81.55,"1.46","1.46","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IMI"
"6IMO",,"X-RAY DIFFRACTION",2.41,48.9,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 0.2 M MgCl2, 10% Isoprpanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AJL","6IMO",81.84,"1.55","1.55","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IMO"
"6IMQ",,"X-RAY DIFFRACTION",1.96,37.34,"VAPOR DIFFUSION, HANGING DROP",,"PEG6K",298,"10.1038/s41467-019-11746-0",,"6IMQ",24.33,"2.06","2.06","Crystal structure of PML B1-box multimers","GSRQIVDAQAVCTRCKESADFWCFECEQLLCAKCFEAHQWFLKHEARPLAE","Homo sapiens","PML, MYL, PP8675, RNF71, TRIM19","Protein PML","1","6IMQ"
"6IMR",,"X-RAY DIFFRACTION",2.39,48.55,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES, 0.2 M MgCl2, 10% Isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AJX","6IMR",82,"1.503","1.503","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IMR"
"6IMT",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 0.2 M MgCl2, 10% Isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AK0","6IMT",81.76,"1.483","1.483","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IMT"
"6IMX",,"X-RAY DIFFRACTION",1.71,28.03,"VAPOR DIFFUSION, HANGING DROP",,"27% PEG400, 0.1 M MES pH 6.5, 0.4 M CaCl2",293,"10.1021/acs.jmedchem.8b01700",,"6IMX",35.21,"1.602","1.602","Crystal structure of V30M mutated transthyretin in complex with 18-Crown-6","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6IMX"
"6IMY",,"X-RAY DIFFRACTION",1.68,26.74,"VAPOR DIFFUSION, HANGING DROP",,"27% PEG400, 0.1 M MES pH 6.5, 0.4 M CaCl2",293,"10.1021/acs.jmedchem.8b01700",,"6IMY",35.4,"1.501","1.501","Crystal structure of V30M mutated transthyretin in complex with 4'-caroboxybenzo-18-Crown-6","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6IMY"
"6IMZ",,"X-RAY DIFFRACTION",2.04,39.61,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 1.8 mM ZnSO4, 6% sucrose, 0.1 M Bis-Tris pH 6.1",293,,,"6IMZ",20.26,"2.1","2.1","Crystal structure of MTH1 in complex with 18-Crown-6","MASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTVLEHHHHHH","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6IMZ"
"6IN0",,"X-RAY DIFFRACTION",2.23,44.96,"VAPOR DIFFUSION, HANGING DROP",,"13% PEG2000 monomethyl ether, 0.1 M MES pH 6.5, 0.1 M sodium acetate",293,,,"6IN0",34.6,"1.501","1.501","Crystal structure of EphA3 in complex with 18-Crown-6","MAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDLEHHHHHH","Homo sapiens","EPHA3, ETK, ETK1, HEK, TYRO4","Ephrin type-A receptor 3","1","6IN0"
"6IN1",,"X-RAY DIFFRACTION",2.1,41.42,"VAPOR DIFFUSION, SITTING DROP",,"4 M sodium formate, 0.1 M Tris-HCl pH 8.0",293,,,"6IN1",16.85,"1.5","1.5","Crystal structure of the first bromodomain of BRD4 in complex with 18-Crown-6","MHHHHHHMSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6IN1"
"6IN2",,"X-RAY DIFFRACTION",1.92,35.83,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG4000, 0.1 M sodium acetate pH 4.4, 0.2 M ammonium acetate",293,,,"6IN2",15.24,"1.75","1.75","Crystal structure of BRD1 in complex with 18-Crown-6","HRLTPLTVLLRSVLDQLQDKDPARIFAQPVSLKEVPDYLDHIKHPMDFATMRKRLEAQGYKNLHEFEEDFDLIIDNCMKYNARDTVFYRAAVRLRDQGGVVLRQARREVDSIGLEEASGLEHHHHHH","Homo sapiens","BRD1, BRL, BRPF2","Bromodomain-containing protein 1","1","6IN2"
"6IN3",,"X-RAY DIFFRACTION",4.39,72.01,"VAPOR DIFFUSION, HANGING DROP",,"1.8 M ammonium sulfate, 22 mM acetic acid, 78 mM sodium acetate",293,,"SAH","6IN3",40.18,"2.3","2.3","Crystal structure of DOT1L in complex with 18-Crown-6","MKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKLEHHHHHH","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","6IN3"
"6IN4",,"X-RAY DIFFRACTION",1.9,35.4,"VAPOR DIFFUSION, HANGING DROP",,"1.8 M ammonium sulfate, 0.1 M MES pH 6.5, 100 mM 18-crown-6",293,,,"6IN4",33.89,"1.8","1.8","Crystal structure of apo DAPK1 in the presence of 18-crown-6","MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSLEHHHHHH","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","6IN4"
"6IND",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 0.2 M MgCl2, 10% Isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AKO","6IND",81.46,"1.872","1.872","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6IND"
"6INK",,"X-RAY DIFFRACTION",2.36,47.95,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES, 0.2 M MgCl2, 10% Isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AKU","6INK",81.35,"1.7","1.7","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6INK"
"6INL",,"X-RAY DIFFRACTION",2.04,39.79,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0, 0.1M NaCl, 20% PEG monomethyl ether 550",298,"10.1107/S2053230X20009243","AJR","6INL",34.46,"1.75","1.75","Crystal structure of CDK2 IN complex with Inhibitor CVT-313","SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6INL"
"6INM",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 0.2 M MgCl2, 10% Isopropanol, 30% EG, 18% PEG 3350",277,"10.1021/acs.jmedchem.9b00518","AKU","6INM",81.16,"1.999","1.999","Crystal structure of PDE4D complexed with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6INM"
"6INN",,"X-RAY DIFFRACTION",6.54,81.2,"VAPOR DIFFUSION, HANGING DROP",,"0.5 M ammonium sulfate, 0.1 M sodium citrate tribasic dihydrate (pH 5.6), 1.0 M lithium sulfate monohydrate",291.15,"10.1016/j.jsb.2019.09.001",,"6INN",283.85,"3.001","3.001","Crystal structure of the CysR-CTLD3 fragment of human MR at acidic pH (pH 5.6)","TRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSKTDWVAITLYACDSKSEFQKWECKNDTLLGIKGEDLFFNYGNRQEKNIMLYKGSGLWSRWKIYGTTDNLCSRGYEAMYTLLGNANGATCAFPFKFENKWYADCTSAGRSDGWLWCGTTTDYDTDKLFGYCPLKFEGSESLWNKDPLTSVSYQINSKSALTWHQARKSCQQQNAELLSITEIHEQTYLTGLTSSLTSGLWIGLNSLSFNSGWQWSDRSPFRYLNWLPGSPSAEPGKSCVSLNPGKNAKWENLECVQKLGYICKKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKIHRDEKKIQRDALTTCRKEGGDLTSIHTIEELDFIISQLGYEPNDELWIGLNDIKIQMYFEWSDGTPVTFTKWLRGEPSHENNRQEDCVVMKGKDGYWADRGCEWPLGYICKMKSRSQGPEIVEVEKGCRKGWKKHHFYCYMIGHTLSTFAEANQTCNNENAYLTTIEDRYEQAFLTSFVGLRPEKYFWTGLSDIQTKGTFQWTIEEEVRFTHWNSDMPGRKPGCVAMRTGIAGGLWDVLKCDEKAKFVCKHWAHHHHHH","Homo sapiens","MRC1, CLEC13D, CLEC13DL, MRC1L1","Macrophage mannose receptor 1","1","6INN"
"6INO",,"X-RAY DIFFRACTION",4.04,69.57,"VAPOR DIFFUSION, SITTING DROP",,"2.0 M sodium chloride, 0.1 M sodium acetate trihydrate (pH 4.6)",291.15,"10.1016/j.jsb.2019.09.001",,"6INO",108.83,"3.054","3.054","Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH (pH 4.6)","TRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSKTDWVAITLYACDSKSEFQKWECKNDTLLGIKGEDLFFNYGNRQEKNIMLYKGSGLWSRWKIYGTTDNLCSRGYEAMYTLLGNANGATCAFPFKFENKWYADCTSAGRSDGWLWCGTTTDYDTDKLFGYCPLKFEGSESLWNKDPLTSVSYQINSKSALTWHQARKSCQQQNAELLSITEIHEQTYLTGLTSSLTSGLWIGLNSLSFNSGWQWSDRSPFRYLNWLPGSPSAEPGKSCVSLNPGKNAKWENLECVQKLGYICKKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKIHRDEKKIQRDALTTCRKEGGDLTSIHTIEELDFIISQLGYEPNDELWIGLNDIKIQMYFEWSDGTPVTFTKWLRGEPSHENNRQEDCVVMKGKDGYWADRGCEWPLGYICKMKSHHHHHH","Homo sapiens","MRC1, CLEC13D, CLEC13DL, MRC1L1","Macrophage mannose receptor 1","1","6INO"
"6INU",,"X-RAY DIFFRACTION",4.06,69.71,"VAPOR DIFFUSION, SITTING DROP",,"0.01 M cobalt chloride hexahydrate, 0.1 M sodium acetate trihydrate (pH 4.6), 1.0 M 1,6-Hexanediol",291.15,"10.1016/j.jsb.2019.09.001",,"6INU",108.83,"2.65","2.65","Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH (pH 4.6)","TRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSKTDWVAITLYACDSKSEFQKWECKNDTLLGIKGEDLFFNYGNRQEKNIMLYKGSGLWSRWKIYGTTDNLCSRGYEAMYTLLGNANGATCAFPFKFENKWYADCTSAGRSDGWLWCGTTTDYDTDKLFGYCPLKFEGSESLWNKDPLTSVSYQINSKSALTWHQARKSCQQQNAELLSITEIHEQTYLTGLTSSLTSGLWIGLNSLSFNSGWQWSDRSPFRYLNWLPGSPSAEPGKSCVSLNPGKNAKWENLECVQKLGYICKKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKIHRDEKKIQRDALTTCRKEGGDLTSIHTIEELDFIISQLGYEPNDELWIGLNDIKIQMYFEWSDGTPVTFTKWLRGEPSHENNRQEDCVVMKGKDGYWADRGCEWPLGYICKMKSHHHHHH","Homo sapiens","MRC1, CLEC13D, CLEC13DL, MRC1L1","Macrophage mannose receptor 1","1","6INU"
"6INV",,"X-RAY DIFFRACTION",2.48,50.45,"VAPOR DIFFUSION, SITTING DROP",,"1.0 M lithium chloride, 0.1 M citric acid (pH 4.0), 10% (w/v) PEG 6000",291.15,"10.1016/j.jsb.2019.09.001",,"6INV",54.41,"3.3","3.3","Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH (pH 4.0)","TRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSKTDWVAITLYACDSKSEFQKWECKNDTLLGIKGEDLFFNYGNRQEKNIMLYKGSGLWSRWKIYGTTDNLCSRGYEAMYTLLGNANGATCAFPFKFENKWYADCTSAGRSDGWLWCGTTTDYDTDKLFGYCPLKFEGSESLWNKDPLTSVSYQINSKSALTWHQARKSCQQQNAELLSITEIHEQTYLTGLTSSLTSGLWIGLNSLSFNSGWQWSDRSPFRYLNWLPGSPSAEPGKSCVSLNPGKNAKWENLECVQKLGYICKKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKIHRDEKKIQRDALTTCRKEGGDLTSIHTIEELDFIISQLGYEPNDELWIGLNDIKIQMYFEWSDGTPVTFTKWLRGEPSHENNRQEDCVVMKGKDGYWADRGCEWPLGYICKMKSHHHHHH","Homo sapiens","MRC1, CLEC13D, CLEC13DL, MRC1L1","Macrophage mannose receptor 1","1","6INV"
"6IO0",,"X-RAY DIFFRACTION",2.72,54.75,"VAPOR DIFFUSION, SITTING DROP",7,"1.5M ammonium citrate tribasic (pH 7.0), 2.5mM DTT. micro-seeding.",293,"10.1158/1535-7163.MCT-18-1349","AOU","6IO0",97.01,"2.2","2.2","Human IDH1 R132C mutant complexed with compound A.","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGCHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6IO0"
"6IOE",,"X-RAY DIFFRACTION",3.99,69.2,"VAPOR DIFFUSION, SITTING DROP",,"1.2 M potassium sodium tartrate tetrahydrate, 0.1 M Tris (pH 8.5)",291.15,"10.1016/j.jsb.2019.09.001",,"6IOE",108.83,"2.9","2.9","Crystal structure of the CysR-CTLD2 fragment of human MR at basic pH (pH 8.5)","TRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSKTDWVAITLYACDSKSEFQKWECKNDTLLGIKGEDLFFNYGNRQEKNIMLYKGSGLWSRWKIYGTTDNLCSRGYEAMYTLLGNANGATCAFPFKFENKWYADCTSAGRSDGWLWCGTTTDYDTDKLFGYCPLKFEGSESLWNKDPLTSVSYQINSKSALTWHQARKSCQQQNAELLSITEIHEQTYLTGLTSSLTSGLWIGLNSLSFNSGWQWSDRSPFRYLNWLPGSPSAEPGKSCVSLNPGKNAKWENLECVQKLGYICKKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKIHRDEKKIQRDALTTCRKEGGDLTSIHTIEELDFIISQLGYEPNDELWIGLNDIKIQMYFEWSDGTPVTFTKWLRGEPSHENNRQEDCVVMKGKDGYWADRGCEWPLGYICKMKSHHHHHH","Homo sapiens","MRC1, CLEC13D, CLEC13DL, MRC1L1","Macrophage mannose receptor 1","1","6IOE"
"6IOM",,"X-RAY DIFFRACTION",3.35,63.32,"VAPOR DIFFUSION, SITTING DROP",3.6,"22.5%(w/v) polyethylene glycol 4000, 0.1M citric acid in pH 3.6",293,,,"6IOM",44.24,"2.594","2.594","Crystal structure of human C4.4A","LECYSCVQKADDGCSPNKMKTVKCAPGVDVCTEAVGAVETIHGQFSLAVRGCGSGLPGKNDRGLDLHGLLAFIQLQQCAQDRCNAKLNLTSRALDPAGNESAYPPNGVECYSCVGLSREACQGTSPPVVSCYNASDHVYKGCFDGNVTLTAANVTVSLPVRGCVQDEFCTRDGVTGPGFTLSGSCCQGSRCNSDLRNKTYF","Homo sapiens","C4.4A, LYPD3, UNQ491/PRO1007","Ly6/PLAUR domain-containing protein 3","1","6IOM"
"6IOZ",,"X-RAY DIFFRACTION",3.66,66.43,"VAPOR DIFFUSION, HANGING DROP",,"1.0 M LiCl
0.1M MES (pH 6.0)
20% w/v PEG 6K",291,,,"6IOZ",61.51,"3.1","3.1","Structural insights of idursulfase beta","TDALNVLLIIVDDLRPSLGCYGDKLVRSPNIDQLASHSLLFQNAFAQQAVAAPSRVSFLTGRRPDTTRLYDFNSYWRVHAGNFSTIPQYFKENGYVTMSVGKVFHPGISSNHTDDSPYSWSFPPYHPSSEKYENTKTCRGPDGELHANLLCPVDVLDVPEGTLPDKQSTEQAIQLLEKMKTSASPFFLAVGYHKPHIPFRYPKEFQKLYPLENITLAPDPEVPDGLPPVAYNPWMDIRQREDVQALNISVPYGPIPVDFQRKIRQSYFASVSYLDTQVGRLLSALDDLQLANSTIIAFTSDHGWALGEHGEWAKYSNFDVATHVPLIFYVPGRTASLPEAGEKLFPYLDPFDSASQLMEPGRQSMDLVELVSLFPTLAGLAGLQVPPRCPVPSFHVELCREGKNLLKHFRFRDLEEDPYLPGNPRELIAYSQYPRPSDIPQWNSDKPSLKDIKIMGYSIRTIDYRYTVWVGFNPDEFLANFSDIHAGELYFVDSDPLQDHNMYNDSQGGDLFQLLMP","Homo sapiens","IDS, SIDS","Iduronate 2-sulfatase","1","6IOZ"
"6IP3",,"X-RAY DIFFRACTION",2.83,56.57,"VAPOR DIFFUSION, HANGING DROP",,"0.05M sodium cacodylate (pH = 7.2), 0.4M ammonium sulfate, 0.05M KCl, 0.01M CaCl2, 15% PEG400",291,"10.1093/nar/gkz419",,"6IP3",7.1,"1.4","1.4","Structure of human telomeric DNA at 1.4 Angstroms resolution","AGGGTTAGGGTTAGGGTTAGGG","Homo sapiens",,"DNA (5'-D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3')","1","6IP3"
"6IP7",,"X-RAY DIFFRACTION",2.77,55.54,"VAPOR DIFFUSION, HANGING DROP",,"0.05M potassium cacodylate (pH7.2), 0.625M ammonium acetate, 0.2M KCl, 15% PEG400",291,"10.1093/nar/gkz419",,"6IP7",7.2,"1.55","1.55","Structure of human telomeric DNA with 5-Selenophene-modified deoxyuridine at residue 11","AGGGTTAGGGXTAGGGTTAGGG","Homo sapiens",,"DNA (22-MER)","1","6IP7"
"6IPB",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION, SITTING DROP",,"18% PEG 3350, 0.2M Na-Tartrate, 0.2M KCl, 2% glycerol",298,"10.1016/j.bcp.2019.113753",,"6IPB",86.34,"1.78","1.78","Crystal Structure of the Cofactor-binding Domain of the Human Phase II Drug Metabolism Enzyme UGT2B15","MGSSHHHHHHHHLEVLFQGPHMMKPAKPLPKEMEEFVQSSGENGIVVFSLGSMISNMSEESANMIASALAQIPQKVLWRFDGKKPNTLGSNTRLYKWLPQNDLLGHPKTKAFITHGGTNGIYEAIYHGIPMVGIPLFADQHDNIAHMKAKGAALSVDIRTMSSRDLLNALKSVINDPVYKENVMKLSRIHH","Homo sapiens","UGT2B15, UGT2B8","UDP-glucuronosyltransferase 2B15","1","6IPB"
"6IPC",,"X-RAY DIFFRACTION",3.11,60.44,"EVAPORATION",,"0.1 M HEPES pH 7.5;
10% PEG 6000;
5% MPD",293.15,"10.1038/s41467-019-08788-9",,"6IPC",326.02,"4.443","4.443","Non-native human ferritin 8-mer","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDADDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6IPC"
,,,,,,,,,,,,,,,,"TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDADDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","2","6IPC"
"6IPH",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","DTP","6IPH",41.04,"1.65","1.65","Binary Complex of Human DNA Polymerase Mu with MndATP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6IPH"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6IPI",,"X-RAY DIFFRACTION",2.46,50,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","DCP","6IPI",41.02,"1.8","1.8","Binary Complex of Human DNA Polymerase Mu with MndCTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6IPI"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6IPJ",,"X-RAY DIFFRACTION",2.45,49.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","TTP","6IPJ",41.03,"1.98","1.98","Binary Complex of Human DNA Polymerase Mu with MndTTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu,DNA-directed DNA/RNA polymerase mu","1","6IPJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6IPK",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","8DG","6IPK",41.5,"2.15","2.15","Binary Complex of Human DNA Polymerase Mu with Mn8oxodGTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6IPK"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6IPL",,"X-RAY DIFFRACTION",2.46,50.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","DTP","6IPL",41.15,"1.64","1.64","Binary Complex of Human DNA Polymerase Mu with MgdATP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6IPL"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6IPM",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","DCP","6IPM",41.22,"1.72","1.72","Binary Complex of Human DNA Polymerase Mu with MgdCTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6IPM"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6IPN",,"X-RAY DIFFRACTION",2.46,49.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","DGT","6IPN",41.16,"1.6","1.6","Binary Complex of Human DNA Polymerase Mu with MgdGTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6IPN"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6IPO",,"X-RAY DIFFRACTION",3.67,66.49,"EVAPORATION",,"magnesium chloride, PEG 400, TRIS",293.15,"10.1038/s41467-019-08788-9",,"6IPO",40.76,"2.998","2.998","Ferritin mutant C90A/C102A/C130A/D144C","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDADDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLIKELGCHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6IPO"
"6IPP",,"X-RAY DIFFRACTION",3.63,66.1,"EVAPORATION",7,"Sodium chloride,MPD,TRIS",293.17,"10.1038/s41467-019-08788-9",,"6IPP",40.75,"2.699","2.699","Non-native ferritin 8-mer mutant-C90A/C102A/C130A/D144C","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDADDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLIKELGCHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6IPP"
"6IPQ",,"X-RAY DIFFRACTION",3.08,60.03,"EVAPORATION",,"200mM MgCl2, 3.4M 1,6-Hexanediol, 100mM Tris/HCl",293,"10.1038/s41467-019-08788-9",,"6IPQ",20.38,"3.103","3.103","Non-native ferritin 8-mer mutant-C90A/C102A/C130A","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDADDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6IPQ"
"6IPY",,"X-RAY DIFFRACTION",1.52,18.85,"VAPOR DIFFUSION, SITTING DROP",3.5,"0.1M Citric acid pH 3.5 and 25%(w/v) Polyethylene glycol 3,350",295,"10.1042/BCJ20201002",,"6IPY",9.28,"1.343","1.343","His-tagged Fyn SH3 domain R96I mutant","NFVLEGDIHMTGVTLFVALYDYEAITEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSILEHHHHHH","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","6IPY"
"6IPZ",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.08M Sodium acetate trihydrate pH 4.6, 1.6M Ammonium sulfate, 20%(v/v)  Glycerol",295,"10.1042/BCJ20201002",,"6IPZ",8.38,"1.576","1.576","Fyn SH3 domain R96W mutant, crystallized with 18-crown-6","LLVPRGSTGVTLFVALYDYEAWTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSI","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","6IPZ"
"6IQ5",,"X-RAY DIFFRACTION",6.8,81.91,"VAPOR DIFFUSION, HANGING DROP",,"pH7.4, PEG 8000, ethylene glycol, HEPES, CHPAS",298,"10.1016/j.bmc.2018.11.045",,"6IQ5",106.09,"3.7","3.7","Crystal Structure of CYP1B1 and Inhibitor Having Azide Group","QAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPSFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPVKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLD","Homo sapiens","CYP1B1","Cytochrome P450 1B1","1","6IQ5"
"6IQ6",,"X-RAY DIFFRACTION",2.35,47.68,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Sodium Acetate, 0.1 M HEPES-NaOH pH 7.5, 22 % (w/v) PEG 4000, 4.4 % (v/v) Formamide",290,"10.14348/molcells.2019.0114",,"6IQ6",289.44,"2.29","2.29","Crystal structure of GAPDH","MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","6IQ6"
"6IQE",,"X-RAY DIFFRACTION",3.37,63.45,"VAPOR DIFFUSION",4.5,"1.0 M (NH4)Cl, 0.1 M Na-acetate pH 4.5",293,"10.1016/j.isci.2019.08.056",,"6IQE",9.82,"1.701","1.701","Human prohibitin 2","GSFSREYTAAVEAKQVAQQEAQRAQFLVEKAKQEQRQKIVQAEGEAEAAKMLGEALSKNPGYIKLRKIRAAQNISKTIALEHHHHHH","Homo sapiens","PHB2, BAP, REA","Prohibitin-2","1","6IQE"
"6IQN",,"X-RAY DIFFRACTION",2.77,55.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES pH6.5, 18% PEG 8000",293,"10.1016/j.bmcl.2019.126775",,"6IQN",68.28,"2.54","2.54","Crystal structure of TrkA kinase with ligand","SVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6IQN"
"6IR0",,"SOLUTION NMR",,,,,,,"10.1002/pro.3610",,"6IR0",8.31,,,"Zinc finger domain of the human DTX protein","NYTEELKVPPDEDCIICMEKLSTASGYSDVTDSKALGSLAVGHLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKT","Homo sapiens","DTX2, KIAA1528, RNF58","Probable E3 ubiquitin-protein ligase DTX2","1","6IR0"
"6IRV",,"X-RAY DIFFRACTION",2.81,56.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"10% PEG 3350, 0.4M sodium nitrate, 0.1M bis-Tris propane",293,"10.1126/science.aav0080",,"6IRV",118.79,"2.7","2.7","Crystal structure of the human cap-specific adenosine methyltransferase","ENLYFQGSHVYWDLDIQTNAVIKHRGPSEVLPPHPEVELLRSQLILKLRQHYRELCQQREGIEPPRESFNRWMLERKVVDKGSDPLLPSNCEPVVSPSMFREIMNDIPIRLSRIKFREEAKRLLFKYAEAARRLIESRSASPDSRKVVKWNVEDTFSWLRKDHSASKEDYMDRLEHLRRQCGPHVSAAAKDSVEGICSKIYHISLEYVKRIREKHLAILKENNISEEVEAPEVEPRLVYCYPVRLAVSAPPMPSVEMHMENNVVCIRYKGEMVKVSRNYFSKLWLLYRYSCIDDSAFERFLPRVWCLLRRYQMMFGVGLYEGTGLQGSLPVHVFEALHRLFGVSFECFASPLNCYFRQYCSAFPDTDGYFGSRGPCLDFAPLSGSFEANPPFCEELMDAMVSHFERLLESSPEPLSFIVFIPEWREPPTPALTRMEQSRFKRHQLILPAFEHEYRSGSQHICKKEEMHYKAVHNTAVLFLQNDPGFAKWAPTPERLQELSAAYRQSGR","Homo sapiens","PCIF1, C20orf67, CAPAM, PPP1R121","Phosphorylated CTD-interacting factor 1","1","6IRV"
"6IRW",,"X-RAY DIFFRACTION",2.79,55.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"9% PEG 3350, 0.2M sodium nitrate, 0.1M bis-Tris propane",293,"10.1126/science.aav0080",,"6IRW",119.55,"2.9","2.9","Crystal structure of the human cap-specific adenosine methyltransferase bound to SAH","ENLYFQGSHVYWDLDIQTNAVIKHRGPSEVLPPHPEVELLRSQLILKLRQHYRELCQQREGIEPPRESFNRWMLERKVVDKGSDPLLPSNCEPVVSPSMFREIMNDIPIRLSRIKFREEAKRLLFKYAEAARRLIESRSASPDSRKVVKWNVEDTFSWLRKDHSASKEDYMDRLEHLRRQCGPHVSAAAKDSVEGICSKIYHISLEYVKRIREKHLAILKENNISEEVEAPEVEPRLVYCYPVRLAVSAPPMPSVEMHMENNVVCIRYKGEMVKVSRNYFSKLWLLYRYSCIDDSAFERFLPRVWCLLRRYQMMFGVGLYEGTGLQGSLPVHVFEALHRLFGVSFECFASPLNCYFRQYCSAFPDTDGYFGSRGPCLDFAPLSGSFEANPPFCEELMDAMVSHFERLLESSPEPLSFIVFIPEWREPPTPALTRMEQSRFKRHQLILPAFEHEYRSGSQHICKKEEMHYKAVHNTAVLFLQNDPGFAKWAPTPERLQELSAAYRQSGR","Homo sapiens","PCIF1, C20orf67, CAPAM, PPP1R121","Phosphorylated CTD-interacting factor 1","1","6IRW"
"6ISB",,"X-RAY DIFFRACTION",2.66,53.84,"EVAPORATION",,"0.1 M Tris (pH 7.5) and 0.8 M Na/K hydrogen phosphate",277,"10.1073/pnas.1815716116",,"6ISB",79.25,"2.5","2.5","crystal structure of human CD226","EEVLWHTSVPFAENMSLECVYPSMGILTQVEWFKIGTQQDSIAIFSPTHGMVIRKPYAERVYFLNSTMASNNMTLFFRNASEDDVGYYSCSLYTYPQGTWQKVIQVVQSDSFEAAVPSNSHIVSEPGKNVTLTCQPQMTWPVQAVRWEKIQPRQIDLLTYCNLVHGRNFTSKFPRQIVSNCSHGRWSVIVIPDVTVSDSGLYRCYLQASAGENETFVMRLTVAEGKTDNQYT","Homo sapiens","CD226, DNAM1","CD226 antigen","1","6ISB"
"6ISM",,"X-RAY DIFFRACTION",1.79,31.21,"VAPOR DIFFUSION, SITTING DROP",,"Magnesium chloride hexahydrate, HEPES pH 7.5,  Polyethylene glycol monomethyl ether 550",291,"10.1016/j.immuni.2019.02.016",,"6ISM",22.5,"1.25","1.25","Crystal structure of intracellular B30.2 domain of BTN3A1 mutant","MGAYNEAKKAAFKPADVILDPKTANPILLVSEDQRSVQRAKEPQDLPDNPERFNWHYCVLGCESFISGRHYWEVEVGDRKEWHIGVCSKNVQRKGWVKMTPENGFWTMGLTDGNKYRTLTEPRTNLKLPKPPKKVGVFLDYETGDISFYNAVDGSHIHTFLDVSFSEALYPVFRILTLEPTALTICPALEHHHHHH","Homo sapiens","BTN3A1, BTF5","Butyrophilin subfamily 3 member A1","1","6ISM"
"6ISN",,"X-RAY DIFFRACTION",3.33,63.11,"VAPOR DIFFUSION, HANGING DROP",,"MES, pH 6.0, PEG3350",289,,,"6ISN",54.18,"1.98","1.98","Phosphoglycerate mutase 1 complexed with a small molecule inhibitor","AAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGD","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","6ISN"
"6ISW",,"X-RAY DIFFRACTION",2.61,52.89,"VAPOR DIFFUSION, HANGING DROP",,"0.05M potassium cacodylate (pH = 7.2), 0.7M ammonium sulfate, 0.05M KCl, 0.01M CaCl2 and 12.5% PEG400.",291,"10.1093/nar/gkz419",,"6ISW",7.2,"2.3","2.3","Structure of human telomeric DNA with 5-selenophene-modified deoxyuridine at residue 12","AGGGTTAGGGTXAGGGTTAGGG","Homo sapiens",,"DNA (22-MER)","1","6ISW"
"6ITA",,"X-RAY DIFFRACTION",1.95,37.05,"VAPOR DIFFUSION, SITTING DROP",,"Sodium Fluoride, Polyethylene Glycol 3350",291,"10.1016/j.immuni.2019.02.016",,"6ITA",22.43,"1.2","1.2","Crystal structure of intracellular B30.2 domain of BTN3A1 mutant","MGAYNEWKKALFKPADVILDPKTANPILLVSEDQRSVQRAKEPQDLPDNPERFNAHYCVLGCESFISGRHYWEVEVGDRKEWHIGVCSKNVQRKGAVKMTPENGFWTMGLTDGNKYRTLTEPRTNLKLPKPPKKVGVFLDYETGDISFYNAVDGSHIHTFLDVSFSEALYPVFRILTLEPTALTICPALEHHHHHH","Homo sapiens","BTN3A1, BTF5","Butyrophilin subfamily 3 member A1","1","6ITA"
"6ITH",,"SOLUTION NMR",,,,,,,"10.1002/1873-3468.13335",,"6ITH",4.72,,,"Structure of the transmembrane domain of syndecan 2 in micelles","MEQSTEVLAAVIAGGVIGFLFAIFLILLLVYRMRKHHHHHH","Homo sapiens","SDC2, HSPG1","Syndecan-2","1","6ITH"
"6ITJ",,"X-RAY DIFFRACTION",2.74,55.17,"VAPOR DIFFUSION",,"0.1M Bis-Tris pH 6.5, 0.3M (NH4)2SO4, 15-20% PEG10000, 5% EG",277,"10.1021/acs.jmedchem.9b00510","AXU","6ITJ",70.9,"1.994","1.994","Crystal structure of FGFR1 kinase domain in complex with compound 3","AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6ITJ"
"6ITT",,"X-RAY DIFFRACTION",2.58,56.89,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 3350, 0.1M sodium citrate tribasic dihydrate, pH 5.6, 3% ethylene glycol, 2% benzamidine hydrochloride",291,,,"6ITT",76.37,"2.103","2.103","Crystal structure of unactivated c-KIT in complex with compound","YLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","6ITT"
,,,,,,,,,,,,,,,,,"Homo sapiens","KIT, SCFR"
"6ITV",,"X-RAY DIFFRACTION",2.35,47.63,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 3350, 0.1M sodium citrate tribasic dihydrate, pH 5.6, 3% ethylene glycol, 3% 1,6-hexanediol",291,,,"6ITV",38.27,"1.881","1.881","Crystal structure of activated c-KIT in complex with compound","YLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","6ITV"
,,,,,,,,,,,,,,,,,"Homo sapiens","KIT, SCFR"
"6IUO",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES pH7.5, 1.3 M (NH4)2SO4",293,"10.1021/acs.jmedchem.9b00510",,"6IUO",36.42,"2.3","2.3","Crystal structure of FGFR4 kinase domain in complex with a covalent inhibitor","MGSSHHHHHHSSGLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6IUO"
"6IUP",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MES pH5.5, 0.2M Li2SO4, 18% PEG3350",277,"10.1021/acs.jmedchem.9b00510","AX0","6IUP",36.48,"2","2","Crystal structure of FGFR4 kinase domain in complex with compound 5","MGSSHHHHHHSSGLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6IUP"
"6IUX",,"X-RAY DIFFRACTION",2.03,39.52,"VAPOR DIFFUSION, SITTING DROP",,"0.2M ammonium chloride pH 6.3, 20% PEG-3350",291,,,"6IUX",42.56,"1.195","1.195","Crystal structure of a hydrolase protein","MGSSHHHHHHSQDLEVLFQGPGSEKYVAAMVLSAAGDALGYYNGKWEFLQDGEKIHRQLAQLGGLDALDVGRWRVSDDTVMHLATAEALVEAGKAPKLTQLYYLLAKHYQDCMEDMDGRAPGGASVHNAMQLKPGKPNGWRIPFNSHEGGCGAAMRAMCIGLRFPHHSQLDTLIQVSIESGRMTHHHPTGYLGALASALFTAYAVNSRPPLQWGKGLMELLPEAKKYIVQSGYFVEENLQHWSYFQTKWENYLKLRGILDGESAPTFPESFGVKERDQFYTSLSYSGWGGSSGHDAPMIAYDAVLAAGDSWKELAHRAFFHGGDSDSTAAIAGCWWGVMYGFKGVSPSNYEKLEYRNRLEETARALYSLGSKEDTVISL","Homo sapiens","ADPRH, ARH1","[Protein ADP-ribosylarginine] hydrolase","1","6IUX"
"6IW3",,"X-RAY DIFFRACTION",2.72,54.79,"VAPOR DIFFUSION, SITTING DROP",8,"20% (w/v) PEG 6000, Tris-HCl pH 8.0, 200 mM lithium chloride",277,"10.1107/S2053230X18018290",,"6IW3",9.31,"1.64","1.64","High resolution structure of Dvl2-DIX Y27W/C80S mutant","GETKVIYHLDEEETPWLVKIPVPAERITLGDFKSVLQRPAGAKYFFKSMDQDFGVVKEEISDDNARLPSFNGRVVSWLVSSD","Homo sapiens","DVL2","Segment polarity protein dishevelled homolog DVL-2","1","6IW3"
"6IW6",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM Hepes-NaOH, pH 7.0, 20% (w/v) PEG 3350, 3% MPD, 200 mM Ammonium Citrate and 3% (w/v) 1,5-Diaminopentane dihydrochloride",293,"10.1038/s41467-019-09966-5",,"6IW6",104.66,"2.402","2.402","Crystal structure of the Lin28-interacting module of human TUT4","MSEMDYLENATVIDESALTPEQRLGLKQAEERLERDHIFRLEKRSPEYTNCRYLCKLCLIHIENIQGAHKHIKEKRHKKNILEKQEESELRSLPPPSPAHLAALSVAVIELAKEHGITDDDLRVRQEIVEEMSKVITTFLPECSLRLYGSSLTRFALKSSDVNIDIKFPPKMNHPDLLIKVLGILKKNVLYVDVESDFHAKVPVVVCRDRKSGLLCRVSAGNDMACLTTDLLTALGKIEPVFIPLVLAFRYWAKLCYIDSQTDGGIPSYCFALMVMFFLQQRKPPLLPCLLGSWIEGFDPKRMDDFQLKGIVEEKFVKWECNSSSATKEKHGKSPLALETPNRVSLGQLWLELLKFYTLDFALEEYVICVRIQDILTRENKNWPKRRIAIEDPFSVKRNVARSLNSQLVYEYVVERFRAAYRYFACPQTKGGNKSTVDFKLEHHHHHH","Homo sapiens","TUT4, KIAA0191, ZCCHC11","Terminal uridylyltransferase 4,Terminal uridylyltransferase 4","1","6IW6"
,,,,,,,,,,,,,,,,,"Homo sapiens","TUT4, KIAA0191, ZCCHC11"
"6IWI",,"X-RAY DIFFRACTION",2.66,53.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 0.2 M MgSO4, 20% PEG 3350",293,"10.1021/acs.jmedchem.9b00123",,"6IWI",40.62,"2.155","2.155","Crystal structure of PDE5A in complex with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","6IWI"
"6IWQ",,"X-RAY DIFFRACTION",3.37,63.49,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Lithium sulfate monohydrate, 12%(w/v) Polyethylene glycol 4,000, 0.1M Sodium citrate tribasic dihydrate pH 5.6, 5mM UDP, 5mM MnCl2",293,"10.1016/j.bbrc.2019.01.084",,"6IWQ",413.51,"2.95","2.95","Crystal structure of GalNAc-T7 with Mn2+","PGEDRFKPVVPWPHVEGVEVDLESIRRINKAKNEQEHHAGGDSQKDIMQRQYLTFKPQTFTYHDPVLRPGILGNFEPKEPEPPGVVGGPGEKAKPLVLGPEFKQAIQASIKEFGFNMVASDMISLDRSVNDLRQEECKYWHYDENLLTSSVVIVFHNEGWSTLMRTVHSVIKRTPRKYLAEIVLIDDFSNKEHLKEKLDEYIKLWNGLVKVFRNERREGLIQARSIGAQKAKLGQVLIYLDAHCEVAVNWYAPLVAPISKDRTICTVPLIDVINGNTYEIIPQGGGDEDGYARGAWDWSMLWKRVPLTPQEKRLRKTKTEPYRSPAMAGGLFAIEREFFFELGLYDPGLQIWGGENFEISYKIWQCGGKLLFVPCSRVGHIYRLEGWQGNPPPIYVGSSPTLKNYVRVVEVWWDEYKDYFYASRPESQALPYGDISELKKFREDHNCKSFKWFMEEIAYDITSHYPLPPKNVDWGEIRGFETAYCIDSMGKTNGGFVELGPCHRMGGNQLFRINEANQLMQYDQCLTKGADGSKVMITHCNLNEFKEWQYFKNLHRFTHIPSGKCLDRSEVLHQVFISNCDSSKTTQKWEMNNIHSV","Homo sapiens","GALNT7","N-acetylgalactosaminyltransferase 7","1","6IWQ"
"6IWR",,"X-RAY DIFFRACTION",3.31,62.84,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Lithium sulfate monohydrate, 12%(w/v) Polyethylene glycol 4,000, 0.1M Sodium citrate tribasic dihydrate pH 5.6, 5mM UDP, 5mM MnCl2",293,"10.1016/j.bbrc.2019.01.084",,"6IWR",414.75,"2.604","2.604","Crystal structure of GalNAc-T7 with UDP, GalNAc and Mn2+","PGEDRFKPVVPWPHVEGVEVDLESIRRINKAKNEQEHHAGGDSQKDIMQRQYLTFKPQTFTYHDPVLRPGILGNFEPKEPEPPGVVGGPGEKAKPLVLGPEFKQAIQASIKEFGFNMVASDMISLDRSVNDLRQEECKYWHYDENLLTSSVVIVFHNEGWSTLMRTVHSVIKRTPRKYLAEIVLIDDFSNKEHLKEKLDEYIKLWNGLVKVFRNERREGLIQARSIGAQKAKLGQVLIYLDAHCEVAVNWYAPLVAPISKDRTICTVPLIDVINGNTYEIIPQGGGDEDGYARGAWDWSMLWKRVPLTPQEKRLRKTKTEPYRSPAMAGGLFAIEREFFFELGLYDPGLQIWGGENFEISYKIWQCGGKLLFVPCSRVGHIYRLEGWQGNPPPIYVGSSPTLKNYVRVVEVWWDEYKDYFYASRPESQALPYGDISELKKFREDHNCKSFKWFMEEIAYDITSHYPLPPKNVDWGEIRGFETAYCIDSMGKTNGGFVELGPCHRMGGNQLFRINEANQLMQYDQCLTKGADGSKVMITHCNLNEFKEWQYFKNLHRFTHIPSGKCLDRSEVLHQVFISNCDSSKTTQKWEMNNIHSV","Homo sapiens","GALNT7","N-acetylgalactosaminyltransferase 7","1","6IWR"
"6IWS",,"SOLUTION NMR",,,,,,,,,"6IWS",8.59,,,"Solution structure of the J-domain of Tid1, a Mitochondrial Hsp40/DnaJ Protein","HMLAKEDYYQILGVPRNASQKEIKKAYYQLAKKYHPDTNKDDPKAKEKFSQLAEAYEVLSDEVKRKQYDAYGS","Homo sapiens","DNAJA3, HCA57, TID1","DnaJ homolog subfamily A member 3, mitochondrial","1","6IWS"
"6IWV",,"X-RAY DIFFRACTION",2.64,53.41,"VAPOR DIFFUSION, HANGING DROP",6.3,"0.1 M Bis-Tris pH 6.3, 1.9 M Ammonium sulfate",293,"10.1002/pro.3581",,"6IWV",15.71,"1.52","1.52","Crystal structure of a single strand DNA binding protein","SAVPSDSQAREKLALYVYEYLLHVGAQKSAQTFLSEIRWEKNITLGEPPGFLHSWWCVFWDLYCAAPE","Homo sapiens","SSBP2, SSDP2","Single-stranded DNA-binding protein 2","1","6IWV"
"6IXE",,"X-RAY DIFFRACTION",3.18,61.29,"VAPOR DIFFUSION, SITTING DROP",,"0.1M succinic acid (pH 7.0), 12% PEG 3350",293,"10.26508/lsa.201900297",,"6IXE",26.81,"3.35","3.35","Crystal structure of SeMet apo SH3BP5 (I41)","SHVDPRIQGELEKLNQSTDDINRRETELEDARQKFRSVLVEATVKLDELVKKIGKAVEDSKPYWEARRVARQAQLEAQKATQDFQRATEVLRAAKETISLAEQRLLEDDKRQFDSAWQEMLNHATQRVAEAEQTKTRSELVHKETAARYNAAMGRMRQLEKKLKRAINKSKPYFELKAKYYVQLEQLKKTVDDLQAKLTLAKGEYKMALKNLEMISDEIHEAAASSAM","Homo sapiens","SH3BP5, SAB","SH3 domain-binding protein 5","1","6IXE"
"6IXF",,"X-RAY DIFFRACTION",2.66,53.82,"VAPOR DIFFUSION, SITTING DROP",,"0.1M succinic acid (pH 7.0), 12% PEG 3350",293,"10.26508/lsa.201900297",,"6IXF",53.38,"3.6","3.6","Crystal structure of SeMet apo SH3BP5 (P41)","SHVDPRIQGELEKLNQSTDDINRRETELEDARQKFRSVLVEATVKLDELVKKIGKAVEDSKPYWEARRVARQAQLEAQKATQDFQRATEVLRAAKETISLAEQRLLEDDKRQFDSAWQEMLNHATQRVAEAEQTKTRSELVHKETAARYNAAMGRMRQLEKKLKRAINKSKPYFELKAKYYVQLEQLKKTVDDLQAKLTLAKGEYKMALKNLEMISDEIHEAAASSAM","Homo sapiens","SH3BP5, SAB","SH3 domain-binding protein 5","1","6IXF"
"6IXG",,"X-RAY DIFFRACTION",2.92,57.93,"VAPOR DIFFUSION, SITTING DROP",,"0.4M Mg(NO3)2, 0.1M Tris-Cl pH 8.0, 22% PEG 8000",293,"10.26508/lsa.201900297",,"6IXG",52.94,"3.801","3.801","Crystal structure of native apo SH3BP5 (P41)","SHVDPRIQGELEKLNQSTDDINRRETELEDARQKFRSVLVEATVKLDELVKKIGKAVEDSKPYWEARRVARQAQLEAQKATQDFQRATEVLRAAKETISLAEQRLLEDDKRQFDSAWQEMLNHATQRVMEAEQTKTRSELVHKETAARYNAAMGRMRQLEKKLKRAINKSKPYFELKAKYYVQLEQLKKTVDDLQAKLTLAKGEYKMALKNLEMISDEIHEAAASSAM","Homo sapiens","SH3BP5, SAB","SH3 domain-binding protein 5","1","6IXG"
"6IY1",,"X-RAY DIFFRACTION",2.07,40.47,"VAPOR DIFFUSION, HANGING DROP",,"0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4",293,,,"6IY1",114.64,"2.11","2.11","Structure of human Ras-related protein Rab11","DYLFKVVLIGDSGVGKSNLLSRFTRNEFNLESKSTIGVEFATRSIQVDGKTIKAQIWDTAGQERYRAITSAYYRGAVGALLVYDIAKHLTYENVERWLKELRDHADSNIVIMLVGNKSDLRHLRAVPTDEARAFAEKNGLSFIETSALDSTNVEAAFQTILTEIY","Homo sapiens","RAB11A, RAB11","Ras-related protein Rab-11A","1","6IY1"
,,,,,,,,,,,,,,,,"EYDYLFKVVLIGDSGVGKSNLLSRFTRNEFNLESKSTIGVEFATRSIQVDGKTIKAQIWDTAGQERYRAITSAYYRGAVGALLVYDIAKHLTYENVERWLKELRDHADSNIVIMLVGNKSDLRHLRAVPTDEARAFAEKNGLSFIETSALDSTNVEAAFQTILTEIY","Homo sapiens","RAB11A, RAB11","Ras-related protein Rab-11A","2","6IY1"
,,,,,,,,,,,,,,,,"DEYDYLFKVVLIGDSGVGKSNLLSRFTRNEFNLESKSTIGVEFATRSIQVDGKTIKAQIWDTAGQERYRAITSAYYRGAVGALLVYDIAKHLTYENVERWLKELRDHADSNIVIMLVGNKSDLRHLRAVPTDEARAFAEKNGLSFIETSALDSTNVEAAFQTILTEIY","Homo sapiens","RAB11A, RAB11","Ras-related protein Rab-11A","3","6IY1"
"6IY5",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa495",,"6IY5",3.19,,,"NMR solution structures of 5'-ATTCTATTCT-3","ATTCTATTCT","Homo sapiens",,"DNA (5'-D(*AP*TP*TP*CP*TP*AP*TP*TP*CP*T)-3')","1","6IY5"
"6IYY",,"X-RAY DIFFRACTION",2.17,43.29,"EVAPORATION",7,"1.6M Ammonium Sulfate, 0.1M Tris-HCl",289,"10.1016/j.jmb.2019.02.019",,"6IYY",35.64,"1.796","1.796","Crystal structure of human WIPI3,loop deletion mutant","GPGSPHGNGLLYAGFNQDHGCFACGMENGFRVYNTDPLKEKEKQEFLEGGVGHVEMLFRCNYLALVGGGKKKVMIWDDLKKKTVIEIEFSTEVKAVKLRRDRIVVVLDSMIKVFTFTHNPHQLHVFETCYNPKGLCVLCPNSNNSLLAFPGTHTGHVQLVDLASTEKPPVDIPAHEGVLSCIALNLQGTRIATASEKGTLIRIFDTSSGHLIQELRRGSQAANIYCINFNQDASLICVSSDHGTVHIFAAEDPKSKWSFSKFQVPSGSPCICAFGTEPNAVIAICADGSYYKFLFNPKGECIRDVYAQFLEMTDDKL","Homo sapiens","WIPI3, WDR45B, WDR45L","WD repeat domain phosphoinositide-interacting protein 3","1","6IYY"
"6IZB",,"X-RAY DIFFRACTION",2.82,56.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES pH 6.5, 25 % (w/v) PEG 300",296,,,"6IZB",17.96,"1.899","1.899","Flexible loop truncated human TCTP","MIIYRDLISHDEMFSDIYKIREIADGLCLEVEGKMVSGGITGVDIVMNHHLQETSFTKEAYKKYIKDYMKSIKGKLEEQRPERVKPFMTGAAEQIKHILANFKNYQFFIGENMNPDGMVALLDYREDGVTPYMIFFKDGLEMEKCLEHHHHHH","Homo sapiens","TPT1","Translationally-controlled tumor protein","1","6IZB"
"6IZE",,"X-RAY DIFFRACTION",1.94,36.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES pH 6.5, 0.2 M ammonium acetate, 25 % (w/v) PEG 1500",296,,,"6IZE",78.48,"2.29","2.29","Dimeric human TCTP","MIIYRDLISHDEMFSDIYKIREIADGLCLEVEGKMVSRTEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTKEAYKKYIKDYMKSIKGKLEEQRPERVKPFMTGAAEQIKHILANFKNYQFFIGENMNPDGMVALLDYREDGVTPYMIFFKDGLEMEKC","Homo sapiens","TPT1","Translationally-controlled tumor protein","1","6IZE"
"6IZP",,"SOLUTION NMR",,,,,,,,,"6IZP",10.33,,,"Solution structure of the complex of naphthyridine carbamate dimer and an RNA with UGGAA-UGGAA pentad","GUACUGGAACAUGUUUCAUGUGGAAGUAC","Homo sapiens",,"RNA (29-MER)","1","6IZP"
"6IZQ",,"X-RAY DIFFRACTION",2.53,51.37,"EVAPORATION",,"22-27% PEG 3350, 0.15M sodium malate, pH 7.0",298,"10.1021/acs.jmedchem.9b00297","XJ2","6IZQ",151.77,"2.449","2.449","PRMT4 bound with a bicyclic compound","SAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYT","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6IZQ"
"6J04",,"X-RAY DIFFRACTION",2.46,49.96,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.16M ammonium sulfate, 0.08M sodium acetate pH4.6, 20% (w/v) PEG4000; 20% (v/v) glycerol",293,"10.1038/s41586-019-1722-1",,"6J04",58.51,"1.899","1.899","Crystal structure of full length human LC3B delta G120 mutant (2_125)","GPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETFMKLSV","Homo sapiens","MAP1LC3B, MAP1ALC3","Microtubule-associated proteins 1A/1B light chain 3B","1","6J04"
"6J06",,"X-RAY DIFFRACTION",4.94,75.12,"VAPOR DIFFUSION, SITTING DROP",,"Lithium Sulfate monohydrate, tri-Sodium Citrate dihydrate, Ammonium Sulfate",298,"10.1016/j.immuni.2019.02.016",,"6J06",70.52,"2.65","2.65","Crystal structure of intracellular B30.2 domain of BTN3A1 in complex with HMBPP-08","MGAYNEWKKALFKPADVILDPKTANPILLVSEDQRSVQRAKEPQDLPDNPERFNWHYCVLGCESFISGRHYWEVEVGDRKEWHIGVCSKNVQRKGWVKMTPENGFWTMGLTDGNKYRTLTEPRTNLKLPKPPKKVGVFLDYETGDISFYNAVDGSHIHTFLDVSFSEALYPVFRILTLEPTALTICPALEHHHHHH","Homo sapiens","BTN3A1, BTF5","Butyrophilin subfamily 3 member A1","1","6J06"
"6J0G",,"X-RAY DIFFRACTION",1.95,36.85,"VAPOR DIFFUSION, SITTING DROP",,"Sodium Acetate trihydrate , Tris Hydrochloride ,Polyethylene Glycol 4000",298,"10.1016/j.immuni.2019.02.016","H6P","6J0G",102.14,"1.6","1.6","Crystal structure of intracellular B30.2 domain of BTN3A3 mutant in complex with HMBPP","MGSSHHHHHHSSGLVPRGSHMENLYFQGAGAGAAYHEWKMALFKPADVILDPDTANAILLVSEDQRSVQRAEEPRDLPDNPERFEWHYCVLGCENFTSGRHYWEVEVGDRKEWHIGVCSKNVERKKGWVKMTPENGYWTMGLTDGNKYRALTEPRTNLKLPEPPRKVGIFLDYETGEISFYNATDGSHIYTFPHASFSEPLYPVFRILTLEPTALTICPIP","Homo sapiens","BTN3A3, BTF3","Butyrophilin subfamily 3 member A3","1","6J0G"
"6J0K",,"X-RAY DIFFRACTION",1.76,30.22,"VAPOR DIFFUSION, SITTING DROP",,"Isopropanol ,Imidazole, PEG 8000",298,"10.1016/j.immuni.2019.02.016","H6P","6J0K",51.07,"2","2","Crystal structure of intracellular B30.2 domain of BTN3A3 mutant in complex with HMBPP","MGSSHHHHHHSSGLVPRGSHMENLYFQGAGAGAAYHEWKMALFKPADVILDPDTANAILLVSEDQRSVQRAEEPRDLPDNPERFEWHYCVLGCENFTSGRHYWEVEVGDRKEWHIGVCSKNVERKKGWVKMTPENGYWTMGLTDGNKYRALTEPRTNLKLPEPPRKVGIFLDYETGEISFYNATDGSHIYTFPHASFSEPLYPVFRILTLEPTALTICPIP","Homo sapiens","BTN3A3, BTF3","Butyrophilin subfamily 3 member A3","1","6J0K"
"6J0L",,"X-RAY DIFFRACTION",2.03,39.38,"VAPOR DIFFUSION, SITTING DROP",,"BIS-TRIS ,Ammonium sulfate",298,"10.1016/j.immuni.2019.02.016",,"6J0L",51.31,"1.95","1.95","Crystal structure of intracellular B30.2 domain of BTN3A3 mutant in complex with sulfate ion","MGSSHHHHHHSSGLVPRGSHMENLYFQGAGAGAAYHEWKMALFKPADVILDPDTANAILLVSEDQRSVQRAEEPRDLPDNPERFEWHYCVLGCENFTSGRHYWEVEVGDRKEWHIGVCSKNVERKKGWVKMTPENGYWTMGLTDGNKYRALTEPRTNLKLPEPPRKVGIFLDYETGEISFYNATDGSHIYTFPHASFSEPLYPVFRILTLEPTALTICPIP","Homo sapiens","BTN3A3, BTF3","Butyrophilin subfamily 3 member A3","1","6J0L"
"6J0O",,"X-RAY DIFFRACTION",2.58,52.24,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCL buffer, pH5.9 containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"6J0O",27.49,"1.8","1.8","Crystal structure of CERT START domain in complex with compound SC1","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","6J0O"
"6J12",,"SOLUTION NMR",,,,,,,,,"6J12",3.6,,,"Three-dimensional Solution NMR Structure of KYE28-PEG48 in Microgel","KYEITTIHNLFRKLTHRLFRRNFGYTLR","Homo sapiens","SERPIND1, HCF2","Heparin cofactor 2","1","6J12"
"6J1L",,"X-RAY DIFFRACTION",2.14,42.57,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG8000, 0.2M (NH4)2SO4,0.1M BisTris, PH7.2",293,"10.1021/acs.jmedchem.9b00327",,"6J1L",95.08,"2.3","2.3","Crystal Structure Analysis of the ROR gamma(C455E)","EGDIHMKKGYHHHHHLVPRGSAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLEKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6J1L"
"6J1X",,"X-RAY DIFFRACTION",2.31,46.68,"VAPOR DIFFUSION, SITTING DROP",,"100mM Tris-HCl pH 7.0, 15% v/v reagent alcohol",289.15,"10.1038/s41467-019-11224-7",,"6J1X",65.26,"2.3","2.3","WWP1 close conformation","GPGSEFRPQPLPPGWERRVDDRRRVYYVDHNTRTTTWQRPTMESVRNFEQWQSQRNQLQGAMQQFNQRYLYSASMLAAENDPYGPLPPGWEKRVDSTDRVYFVNHNTKTTQWEDPRTQGLQNEEPLPEGWEIRYTREGVRYFVDHNTRTTTFKDPRNGKSSVTKGGPQIAYERGFRWKLAHFRYLCQSNALPSHVKINVSRQTLFEDSFQQIMALKPYDLRRRLYVIFRGEEGLDYGGLAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASTINPDHLSYFCFIGRFIAMALFHGKFIDTGFSLPFYKRMLSKKLTIKDLESIDTEFYNSLIWIRDNNIEECGLEMYFSVDMEILGKVTSHDLKLGGSNILVTEENKDEYIGLMTEWRFSRGVQEQTKAFLDGFNEVVPLQWLQYFDEKELEVMLCGMQEVDLADWQRNTVYRHYTRNSKQIIWFWQFVKETDNEVRMRLLQFVTGTCRLPLGGFAELMGSNGPQKFCIEKVGKDTWLPRSHTCFNRLDLPPYKSYEQLKEKLLFAIEETEGFGQE","Homo sapiens","WWP1","NEDD4-like E3 ubiquitin-protein ligase WWP1","1","6J1X"
"6J1Y",,"X-RAY DIFFRACTION",2.33,47.12,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Sodium malonate pH 5.0, 12% w/v Polyethyleneglycol 3350",289.15,"10.1038/s41467-019-11224-7",,"6J1Y",122.41,"2.55","2.55","Semi-open conformation E3 ligase","GPGSEFQRPTMESVRNFEQWQSQRNQLQGAMQQFNQRYLYSASMLAAENDPYGPLPPGWEKRVDSTDRVYFVNHNTKTTQWEDPRTQGLQNEEPLPEGWEIRYTREGVRYFVDHNTRTTTFKDPRNGKSSVTKGGPQIAYERGFRWKLAHFRYLCQSNALPSHVKINVSRQTLFEDSFQQIMALKPYDLRRRLYVIFRGEEGLDYGGLAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASTINPDHLSYFCFIGRFIAMALFHGKFIDTGFSLPFYKRMLSKKLTIKDLESIDTEFYNSLIWIRDNNIEECGLEMYFSVDMEILGKVTSHDLKLGGSNILVTEENKDEYIGLMTEWRFSRGVQEQTKAFLDGFNEVVPLQWLQYFDEKELEVMLCGMQEVDLADWQRNTVYRHYTRNSKQIIWFWQFVKETDNEVRMRLLQFVTGTCRLPLGGFAELMGSNGPQKFCIEKVGKDTWLPRSHTCFNRLDLPPYKSYEQLKEKLLFAIEETEGFGQE","Homo sapiens","WWP1","NEDD4-like E3 ubiquitin-protein ligase WWP1","1","6J1Y"
"6J1Z",,"X-RAY DIFFRACTION",2.14,42.56,"VAPOR DIFFUSION, SITTING DROP",,"0.1M HEPES sodium pH 7.5, 10% v/v 2-Propanol, 20% w/v PEG 4000",289.15,"10.1038/s41467-019-11224-7",,"6J1Z",57.13,"2.7","2.7","WWP2 semi-open conformation","GPGSEFRPLPPGWEKRTDPRGRFYYVDHNTRTTTWQRPTAEYVRNYEQWQSQRNQLQGAMQHFSQRFLYQSSSASTDHDPLGPENLYFQGESGTKQGSPGAYDRSFRWKYHQFRFLCHSNALPSHVKISVSRQTLFEDSFQQIMNMKPYDLRRRLYIIMRGEEGLDYGGIAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASSINPDHLTYFRFIGRFIAMALYHGKFIDTGFTLPFYKRMLNKRPTLKDLESIDPEFYNSIVWIKENNLEECGLELYFIQDMEILGKVTTHELKEGGESIRVTEENKEEYIMLLTDWRFTRGVEEQTKAFLDGFNEVAPLEWLRYFDEKELELMLCGMQEIDMSDWQKSTIYRHYTKNSKQIQWFWQVVKEMDNEKRIRLLQFVTGTCRLPVGGFAELIGSNGPQKFCIDKVGKETWLPRSHTCFNRLDLPPYKSYEQLREKLLYAIEETEGFGQE","Homo sapiens","WWP2","NEDD4-like E3 ubiquitin-protein ligase WWP2","1","6J1Z"
,,,,,,,,,,,,,,,,,"Homo sapiens","WWP2"
"6J37",,"SOLUTION NMR",,,,,,,"10.1080/07391102.2019.1621211",,"6J37",2.57,,,"DNA minidumbbell structure of two CTTG repeats","CTTGCTTG","Homo sapiens",,"DNA (5'-D(*CP*TP*TP*GP*CP*TP*TP*G)-3')","1","6J37"
"6J3B",,"X-RAY DIFFRACTION",3.68,66.57,"VAPOR DIFFUSION, HANGING DROP",,"HEPES pH4.6, 2M AMMONIUM SULPHATE, 30% Glycerol",293,"10.1002/2211-5463.12658","B5O","6J3B",42.22,"1.6","1.6","Crystal structure of human DHODH in complex with inhibitor 1289","ATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6J3B"
"6J3C",,"X-RAY DIFFRACTION",3.66,66.41,"VAPOR DIFFUSION, HANGING DROP",,"hepes pH4.6, 2M AMMONIUM SULPHATE, 30% Glycerol",293,"10.1002/2211-5463.12658","B5X","6J3C",41.36,"1.851","1.851","Crystal structure of human DHODH in complex with inhibitor 1291","ATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6J3C"
"6J3O",,"X-RAY DIFFRACTION",2.97,58.58,"VAPOR DIFFUSION, SITTING DROP",,"100 mM HEPES pH 8.2, 26% PEG10000 (v/v), 4% glycol",277,"10.1021/acs.jmedchem.9b00096","B4L","6J3O",33.81,"2.11","2.11","Crystal structure of the human PCAF bromodomain in complex with compound 12","MHHHHHHSSGVDLGTENLYFQSMGKEKSKEPRDPDQLYSTLKSILQQVKSHQSAWPFMEPVKRTEAPGYYEVIRFPMDLKTMSERLKNRYYVSKKLFMADLQRVFTNCKEYNPPESEYYKCANILEKFFFSKIKEAGLID","Homo sapiens","KAT2B, PCAF","Histone acetyltransferase KAT2B","1","6J3O"
"6J3P",,"X-RAY DIFFRACTION",1.98,37.98,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350",293,"10.1021/acs.jmedchem.9b00096","B8O","6J3P",32.79,"1.598","1.598","Crystal structure of the human GCN5 bromodomain in complex with compound (R,R)-36n","MHHHHHHSSGVDLGTENLYFQSMELKDPDQLYTTLKNLLAQIKSHPSAWPFMEPVKKSEAPDYYEVIRFPIDLKTMTERLRSRYYVTRKLFVADLQRVIANCREYNPPDSEYCRCASALEKFFYFKLKEGGLIDK","Homo sapiens","KAT2A, GCN5, GCN5L2","Histone acetyltransferase KAT2A","1","6J3P"
"6J44",,"X-RAY DIFFRACTION",2.83,56.58,"VAPOR DIFFUSION, SITTING DROP",7,"1.8 M Ammonium citrate tribasic",289,"10.1016/j.bbrc.2019.05.050",,"6J44",17.54,"2.06","2.06","Crystal structure of the redefined DNA-binding domain of human XPA","GSHMEFDYVICEECGKEFMDSYLMNHFDLPTCDNCRDADDKHKLITKTEAKQEYLLKDCDLEKREPPLKFIVKKNPHHSQWGDMKLYLKLQIVKRSLEVWGSQEALEEAKEVRQENREKMKQKKFDKKVKELRRAVRSSVWKRET","Homo sapiens","XPA, XPAC","DNA repair protein complementing XP-A cells","1","6J44"
"6J4A",,"X-RAY DIFFRACTION",3.51,64.98,"EVAPORATION",,"PEG 8000, Hepes, ethylene glycol",293,,,"6J4A",255.06,"3.99","3.99","Human H chain ferritin with an extension peptide","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6J4A"
"6J4I",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA118.006642",,"6J4I",12.39,,,"A conserved and buried edge-to-face aromatic interaction in SUMO is vital for the SUMO pathway","RGSHHHHHHGSMSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRLLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGG","Homo sapiens","SUMO1, SMT3C, SMT3H3, UBL1, OK/SW-cl.43","Small ubiquitin-related modifier 1","1","6J4I"
"6J53",,"X-RAY DIFFRACTION",2.08,40.74,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES pH 7.5, PEG 3350",291,"10.1038/s41467-019-12710-8",,"6J53",28.4,"1.52","1.52","Crystal structure of human HINT1 complexing with ATP","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6J53"
"6J58",,"X-RAY DIFFRACTION",2.09,41.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES pH 7.5, PEG 3350",291,"10.1038/s41467-019-12710-8",,"6J58",28.4,"1.521","1.521","Crystal structure of human HINT1 complexing with AP4A","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6J58"
"6J5L",,"X-RAY DIFFRACTION",3.11,60.42,"VAPOR DIFFUSION, SITTING DROP",5.3,"0.65 M Ammonium sulfate, 0.1 M Sodium Citrate pH 5.3",293,"10.1016/j.bmcl.2019.06.018","B9C","6J5L",34.74,"2.3","2.3","Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10e","GAMGSGIRVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6J5L"
"6J5S",,"X-RAY DIFFRACTION",2.09,41.25,"VAPOR DIFFUSION, SITTING DROP",,"HEPES pH 7.5, PEG 3350",291,"10.1038/s41467-019-12710-8",,"6J5S",28.94,"1.02","1.02","Crystal structure of human HINT1 mutant complexing with AP5A","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLAVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6J5S"
"6J5Z",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION, SITTING DROP",,"HEPES pH 7.5, PEG 3350",291,"10.1038/s41467-019-12710-8",,"6J5Z",56.47,"1.3","1.3","Crystal structure of human HINT1 mutant complexing with AP3A","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLAVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6J5Z"
"6J60","0.96","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1038/s41467-019-09902-7",,"6J60",0.88,"0.96, 0.96","0.96","hnRNP A1 reversible amyloid core GFGGNDNFG (residues 209-217)","GFGGNDNFG","Homo sapiens","HNRNPA1, HNRPA1","9-mer peptide (GFGGNDNFG) from Heterogeneous nuclear ribonucleoprotein A1","1","6J60"
"6J64",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION, SITTING DROP",,"HEPES pH 7.5, PEG3350",291,"10.1038/s41467-019-12710-8",,"6J64",28.88,"0.95","0.95","Crystal structure of human HINT1 mutant complexing with AP4A","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLAVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6J64"
"6J65",,"X-RAY DIFFRACTION",2.16,43.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES pH 7.5, PEG3 350",291,"10.1038/s41467-019-12710-8",,"6J65",56.9,"1.42","1.42","Crystal structure of human HINT1 mutant complexing with AP4A II","SLMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLAVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6J65"
"6J6M",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M MIB buffer pH7, 25% (w/v) PEG 1500",293,"10.1021/acs.jmedchem.9b00687",,"6J6M",31.89,"1.25","1.25","Co-crystal structure of BTK kinase domain with Zanubrutinib","GSGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6J6M"
"6J6V",,"X-RAY DIFFRACTION",2.5,50.82,"EVAPORATION",,"sodium nitrate",295,,,"6J6V",12.42,"1.2","1.2","Crystal structure of heat shock factor 4-DBD","VPAFLGKLWALVGDPGTDHLIRWSPSGTSFLVSDQSRFAKEVLPQYFKHSNMASFVRQLNMYGFRKVVSIEQGGLLRPERDHVEFQHPSFVRGREQLLERVRRKV","Homo sapiens","HSF4","Heat shock factor protein 4","1","6J6V"
"6J6W",,"X-RAY DIFFRACTION",2.4,48.79,"EVAPORATION",,"sodium nitrate",295,,,"6J6W",24.62,"1.693","1.693","Mutant K23N of heat shock factor 4-DBD","VPAFLGNLWALVGDPGTDHLIRWSPSGTSFLVSDQSRFAKEVLPQYFKHSNMASFVRQLNMYGFRKVVSIEQGGLLRPERDHVEFQHPSFVRGREQLLERVRRKV","Homo sapiens","HSF4","Heat shock factor protein 4","1","6J6W"
"6J7G",,"X-RAY DIFFRACTION",3.27,62.37,"EVAPORATION",,"Amonium Sulfate, HEPES",293,"10.1038/s41467-019-08788-9",,"6J7G",488.27,"3.868","3.868","Human H-ferritin mutant-C90A/C102A/C130A/D144C","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDADDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLIKELGCHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6J7G"
"6J81",,"X-RAY DIFFRACTION",2.56,51.89,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodiumcitrate/HCL buffer, pH 5.9 containing 24% PEG3350 and 0.2 n-octyl-beta-D-glucoside",293,,,"6J81",27.48,"1.8","1.8","Crystal structure of CERT START domain in complex with compound E14","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","6J81"
"6J9O",,"X-RAY DIFFRACTION",2.05,40.04,"VAPOR DIFFUSION, SITTING DROP",7,"1.4 M sodium malonate, 0.1 M Bis-Tris propane, pH 7.0",291,"10.1038/s41421-019-0086-x",,"6J9O",26.09,"1.397","1.397","Crystal structure of a free scFv molecule from a group 2 influenza A viruses HA binding antibody AF4H1K1","GSQVQLVESGGGVVQPGTSLRLSCEASGFTSSAYAMHWVRQAPGKGLEWVAVITFDGGYQYYADSVKGRFTISRDISRNTLHLHMNSLRAEDTAVYYCARDPLTKLLPFDWVSGGYFDYWGQGTLVTVSS","Homo sapiens",,"Heavy chain of AF4H1K1 scFv","1","6J9O"
,,,,,,,,,,,,,,,,"DIVMTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYRASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSFTFGQGTKVEIKR","Homo sapiens",,"Light chain of AF4H1K1 scFv","2","6J9O"
"6JAS",,"X-RAY DIFFRACTION",3.82,67.82,"EVAPORATION",6.6,"PIPES-NaOH 0.1M pH 6.6, di-sodium malonate 8 mM, glycerol 18%, PEG3350 17%",298,,,"6JAS",75.69,"2.501","2.501","Human serum transferrin with iron citrate bound","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","6JAS"
"6JBJ","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-019-0222-z",,"6JBJ",147.26,"3.6",,"Cryo-EM structure of human lysosomal cobalamin exporter ABCD4","MASWSHPQFEKGGGARGGSGGGSWSHPQFEKGFDYKDDDDKGTAVAGPAPGAGARPRLDLQFLQRFLQILKVLFPSWSSQNALMFLTLLCLTLLEQFVIYQVGLIPSQYYGVLGNKDLEGFKTLTFLAVMLIVLNSTLKSFDQFTCNLLYVSWRKDLTEHLHRLYFRGRAYYTLNVLRDDIDNPDQRISQDVERFCRQLSSMASKLIISPFTLVYYTYQCFQSTGWLGPVSIFGYFILGTVVNKTLMGPIVMKLVHQEKLEGDFRFKHMQIRVNAEPAAFYRAGHVEHMRTDRRLQRLLQTQRELMSKELWLYIGINTFDYLGSILSYVVIAIPIFSGVYGDLSPAELSTLVSKNAFVCIYLISCFTQLIDLSTTLSDVAGYTHRIGQLRETLLDMSLKSQDCEILGESEWGLDTPPGWPAAEPADTAFLLERVSISAPSSDKPLIKDLSLKISEGQSLLITGNTGTGKTSLLRVLGGLWTSTRGSVQMLTDFGPHGVLFLPQKPFFTDGTLREQVIYPLKEVYPDSGSADDERILRFLELAGLSNLVARTEGLDQQVDWNWYDVLSPGEMQRLSFARLFYLQPKYAVLDQATSALTEEVESELYRIGQQLGMTFISVGHRQSLEKFHSLVLKLCGGGRWELMRIKVE","Homo sapiens","ABCD4, PXMP1L","ATP-binding cassette sub-family D member 4","1","6JBJ"
"6JBM",,"X-RAY DIFFRACTION",2.56,51.99,"VAPOR DIFFUSION, SITTING DROP",6,"Ammonium sulfate, PEG8000",293,"10.1002/1873-3468.13386",,"6JBM",92.73,"2.1","2.1","Crystal structure of the TRIM14 PRYSPRY domain","TLLKTSPSPERSLLLKYARTPTLDPDTMHARLRLSADRLTVRCGLLGSLGPVPVLRFDALWQVLARDCFATGRHYWEVDVQEAGAGWWVGAAYASLRRRGASAAARLGCNRQSWCLKRYDLEYWAFHDGQRSRLRPRDDLDRLGVFLDYEAGVLAFYDVTGGMSHLHTFRATFQEPLYPALRLWEGAISIPRLPHHHHHH","Homo sapiens","TRIM14, KIAA0129","Tripartite motif-containing protein 14","1","6JBM"
"6JC2",,"X-RAY DIFFRACTION",3.05,59.72,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 10000, 0.2M ammonium sulfate, 0.1M Acetate pH5.0",293,,,"6JC2",48.76,"2.65","2.65","Crystal structure of the Fab fragment of ipilimumab","QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHHHHHH","Homo sapiens",,"ipilimumab fab heavy chain","1","6JC2"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"ipilimumab fab light chain","2","6JC2"
"6JCO",,"X-RAY DIFFRACTION",3.45,64.39,"VAPOR DIFFUSION",8.5,"15% glycerol, 1.5M ammonium sulfate, 0.1M tris HCl pH8.5",298.1,"10.1073/pnas.1902189116",,"6JCO",160.55,"2.88","2.88","Crystal structure of calcium free human gelsolin amyloid mutant D187N","HPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQRLFQVKGRRVVRATEVPVSWESFNNGNCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAELAA","Homo sapiens","GSN","Gelsolin","1","6JCO"
"6JD0",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION",,"PEG 4000, 2-propanol etc",293,"10.1093/protein/gzab005",,"6JD0",45.01,"1.805","1.805","Structure of mutant human cathepsin L, engineered for GAG binding","MHHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKMTLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWRKKGYVTPVKNQGQCGSSWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGYMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDLDHAVLVVGYGFESTESDNNKYWLVKNSWGEEWGNKGYVKMAKDRRNHCGIASLASYPTV","Homo sapiens","CTSL, CTSL1","Cathepsin L1","1","6JD0"
"6JD8",,"X-RAY DIFFRACTION",1.8,31.66,"VAPOR DIFFUSION",,"PEG 4000, 2-propanol",293,"10.1093/protein/gzab005",,"6JD8",41.88,"1.457","1.457","Structure of a proline specific mutant of human cathepsin L","MHHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKMTLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAFGDMTSEEFRQVMNGFQNRKPRKGKVFQEPLFYEAPRSVDWREKGYVTPVKNQGQCGSSWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGYMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDLDHAVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASLASYPTV","Homo sapiens","CTSL, CTSL1","Cathepsin L1","1","6JD8"
"6JDW",,"X-RAY DIFFRACTION",3.83,68,,7,"pH 7.0",,"10.1074/jbc.274.5.3026",,"6JDW",44.44,"2.5","2.5","CRYSTAL STRUCTURE OF HUMAN L-ARGININE:GLYCINE AMIDINOTRANSFERASE IN COMPLEX WITH GAMMA-AMINO BUTYRIC ACID","STQAATASSRNSCAADDKATEPLPKDCPVSSYNEWDPLEEVIVGRAENACVPPFTIEVKANTYEKYWPFYQKQGGHYFPKDHLKKAVAEIEEMCNILKTEGVTVRRPDPIDWSLKYKTPDFESTGLYSAMPRDILIVVGNEIIEAPMAWRSRFFEYRAYRSIIKDYFHRGAKWTTAPKPTMADELYNQDYPIHSVEDRHKLAAQGKFVTTEFEPCFDAADFIRAGRDIFAQRSQVTNYLGIEWMRRHLAPDYRVHIISFKDPNPMHIDATFNIIGPGIVLSNPDRPCHQIDLFKKAGWTIITPPTPIIPDDHPLWMSSKWLSMNVLMLDEKRVMVDANEVPIQKMFEKLGITTIKVNIRNANSLGGGFHCWTCDVRRRGTLQSYLD","Homo sapiens","AT38H, GATM, AGAT","PROTEIN (L-ARGININE:GLYCINE AMIDINOTRANSFERASE)","1","6JDW"
"6JE7",,"X-RAY DIFFRACTION",2.89,57.46,"VAPOR DIFFUSION, HANGING DROP",,"1.2M ammonium sulfate, 1%(v/v) 1,4-1,1,1,3,3,3-Hexafluoro-2-propanol",281,,,"6JE7",66.34,"3.9","3.9","Crystal structure of human serum albumin crystallized by ammonium sulfate","AHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALG","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6JE7"
"6JEC",,"X-RAY DIFFRACTION",1.91,35.47,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Sodium Acetate 20%(w/v) PEG 3350",289,,,"6JEC",8.22,"2.049","2.049","Structure of a triple-helix region of human collagen type II","XPPGPPGPPGRAGEPGLQGPAGPPGPPGPPG","Homo sapiens","COL1A2","human collagen type II","1","6JEC"
"6JEG",,"X-RAY DIFFRACTION",3.46,64.49,"VAPOR DIFFUSION",8.5,"15% glycerol, 1.5M ammonium sulfate, 0.1M tris HCl, pH8.5",298,"10.1073/pnas.1902189116",,"6JEG",161.39,"2.975","2.975","Crystal structure of calcium free human gelsolin amyloid mutant G167R","VEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQRLFQVKRRRVVRATEVPVSWESFNNGDCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAELAA","Homo sapiens","GSN","Gelsolin","1","6JEG"
"6JEH",,"X-RAY DIFFRACTION",3.37,63.47,"VAPOR DIFFUSION",8.5,"15% glycerol, 1.5M ammonium sulfate, 0.1M tris HCl pH8.5",298,"10.1073/pnas.1902189116",,"6JEH",160.65,"2.95","2.95","Crystal structure of calcium free human gelsolin amyloid mutant D187Y","HPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQRLFQVKGRRVVRATEVPVSWESFNNGYCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAELAA","Homo sapiens","GSN","Gelsolin","1","6JEH"
"6JEY",,"X-RAY DIFFRACTION",2.61,52.87,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-HCl pH 7.4, 0.8 M sodium citrate",293,"10.1016/j.chembiol.2020.01.006",,"6JEY",64,"2.2","2.2","Covalent bond formation between ynone moiety of synthetic fatty acid and hPPARg-LBD","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6JEY"
"6JF0",,"X-RAY DIFFRACTION",2.57,52.16,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-HCl pH 7.4, 0.8 M sodium citrate",293,"10.1016/j.chembiol.2020.01.006",,"6JF0",63.62,"3.4","3.4","Covalent labeling of hPPARg-LBD by turn-on fluorescent probe mediated by conjugate addition and cyclization","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6JF0"
"6JFB",,"X-RAY DIFFRACTION",2.27,45.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris, pH 7.5, 0.2 M NaCl, 14% w/v polyethylene glycol 3350",277,,,"6JFB",241.98,"2.12","2.12","Crystal structure of human pyruvate kinase M2 isoform","MGSSHHHHHHSSGLVPRGSHMMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM Isoform M2","1","6JFB"
"6JGM",,"X-RAY DIFFRACTION",2.04,39.85,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0, 0.1M NaCl, 20% PEG monomethyl ether 550",293,,,"6JGM",34.49,"2.3","2.3","Crystal structure of CDK2 IN complex with Inhibitor NU-6140","SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6JGM"
"6JHD",,"SOLUTION NMR",,,,,,,,,"6JHD",19.51,,,"Solution structure of IFN alpha8","CDLPQTHSLGNRRALILLAQMRRISPFSCLKDRHDFEFPQEEFDDKQFQKAQAISVLHEMIQQTFNLFSTKDSSAALDETLLDEFYIELDQQLNDLESCVMQEVGVIESPLMYEDSILAVRKYFQRITLYLTEKKYSSCAWEVVRAEIMRSFSLSINLQKRLKSKE","Homo sapiens","IFNA8","Interferon alpha-8","1","6JHD"
"6JI3",,"X-RAY DIFFRACTION",2.19,43.77,"EVAPORATION",,"3.2-3.8 M NAFORMATE,10% GLYCEROL",293,,,"6JI3",15.04,"2.2","2.2","BRD4-BD1 bound with ligand 103","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6JI3"
"6JI4",,"X-RAY DIFFRACTION",2.21,44.37,"EVAPORATION",,"3.2-3.8 M NAFORMATE,10% GLYCEROL",293,,,"6JI4",15.01,"1.6","1.6","brd4-bd1 bound with ligand 138","NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6JI4"
"6JI5",,"X-RAY DIFFRACTION",2.17,43.21,"EVAPORATION",,"3.2-3.8 M NAFORMATE,10% GLYCEROL",293,,,"6JI5",15.16,"2","2","brd4-bd1 bound with ligand 167","NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6JI5"
"6JIB",,"X-RAY DIFFRACTION",3.14,60.88,"VAPOR DIFFUSION, SITTING DROP",6.5,"28% i-PrOH, 0.1M bis-Tris, pH 6.5, 3% PEG 200, 10 mM spermidine",293,"10.1021/acsmedchemlett.9b00069","BQF","6JIB",72.48,"2.25","2.25","Human MTHFD2 in complex with DS44960156","MGSSHHHHHHSSGENLYFQGEAVVISGRKLAQQIKQEVRQEVEEWVASGNKRPHLSVILVGENPASHSYVLNKTRAAAVVGINSETIMKPASISEEELLNLINKLNNDDNVDGLLVQLPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWEIIKRTGIPTLGKNVVVAGRSKNVGMPIAMLLHTDGAHERPGGDATVTISHRYTPKEQLKKHTILADIVISAAGIPNLITADMIKEGAAVIDVGINRVHDPVTAKPKLVGDVDFEGVRQKAGYITPVPGGVGPMTVAMLMKNTIIAAKKVLRLEERE","Homo sapiens","MTHFD2, NMDMC","Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial","1","6JIB"
"6JID",,"X-RAY DIFFRACTION",3.15,60.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"28% i-PrOH, 0.1M bis-Tris, pH 6.5, 3% PEG 200, 10mM spermidine",293,"10.1021/acsmedchemlett.9b00069","BQC","6JID",71.74,"2.5","2.5","Human MTHFD2 in complex with Compound 1","MGSSHHHHHHSSGENLYFQGEAVVISGRKLAQQIKQEVRQEVEEWVASGNKRPHLSVILVGENPASHSYVLNKTRAAAVVGINSETIMKPASISEEELLNLINKLNNDDNVDGLLVQLPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWEIIKRTGIPTLGKNVVVAGRSKNVGMPIAMLLHTDGAHERPGGDATVTISHRYTPKEQLKKHTILADIVISAAGIPNLITADMIKEGAAVIDVGINRVHDPVTAKPKLVGDVDFEGVRQKAGYITPVPGGVGPMTVAMLMKNTIIAAKKVLRLEERE","Homo sapiens","MTHFD2, NMDMC","Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial","1","6JID"
"6JIO",,"X-RAY DIFFRACTION",2.17,43.31,"EVAPORATION",,"22% PEG 3350, 0.1 M Tris HCl pH 8.5",281,"10.1016/j.ejmech.2019.06.011",,"6JIO",125.18,"2.6","2.6","Human LXR-beta in complex with a ligand","MGHHHHHHGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPASGSASQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHEGSGSGSHKILHRLLQDSSS","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","6JIO"
"6JJ0",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz1015",,"6JJ0",7.41,,,"NMR structure of the 1:1 complex of a carbazole derivative BMVC bound to c-MYC G-quadruplex","TGAGGGTGGGTAGGGTGGGTAA","Homo sapiens",,"MycG4","1","6JJ0"
"6JJ3",,"X-RAY DIFFRACTION",2.01,38.96,"VAPOR DIFFUSION, SITTING DROP",,"4.0M HCOONa",295,"10.1021/acs.jmedchem.9b01010","BS6","6JJ3",15.35,"1.718","1.718","BRD4 in complex with 138A","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6JJ3"
"6JJ5",,"X-RAY DIFFRACTION",2.01,38.84,"VAPOR DIFFUSION, SITTING DROP",,"4.0M HCOONa",295,,,"6JJ5",15.27,"1.2","1.2","BRD4 in complex with 259","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6JJ5"
"6JJ6",,"X-RAY DIFFRACTION",1.99,38.29,"VAPOR DIFFUSION, SITTING DROP",,"4.0M HCOONa",295,,,"6JJ6",15.35,"1.4","1.4","BRD4 in complex with 500","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6JJ6"
"6JJB",,"X-RAY DIFFRACTION",2.02,39.11,"VAPOR DIFFUSION, SITTING DROP",,"4.0M HCOONa",295,"10.1021/acs.jmedchem.9b01010","BT0","6JJB",15.25,"1.508","1.508","BRD4 in complex with ZZM1","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6JJB"
"6JJR",,"X-RAY DIFFRACTION",2.24,45.21,"VAPOR DIFFUSION, HANGING DROP",7.2,"25% (w/v) polyethylene glycol (PEG) 3350, 0.2 M potassium sodium tartrate (PST) pH 7.2",277,"10.1021/acs.jmedchem.9b01154","BU0","6JJR",43.12,"1.834","1.834","Crystal structure of human chitotriosidase-1 (hChit1) catalytic domain in complex with compound 2-8-14","AKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLPYLPSGTPEHHHHHH","Homo sapiens","CHIT1","Chitotriosidase-1","1","6JJR"
"6JJU",,"X-RAY DIFFRACTION",3.89,68.35,"LIPIDIC CUBIC PHASE",7.7,"28.5% PEG 250DME, 50 mM ammonium nitrate, 100 mM tris(hydroxymethyl)aminomethane",289,"10.1016/j.celrep.2019.03.106",,"6JJU",113.31,"3.2","3.2","Structure of Ca2+ ATPase","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPAILE","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","6JJU"
"6JK6",,"X-RAY DIFFRACTION",2.31,46.64,"VAPOR DIFFUSION, HANGING DROP",7.2,"25% (w/v) polyethylene glycol (PEG) 3350, 0.2 M potassium sodium tartrate (PST), pH 7.2",277,"10.1021/acs.jmedchem.9b01154","BV0","6JK6",43.56,"1.571","1.571","Crystal structure of human chitotriosidase-1 (hCHIT) catalytic domain in complex with compound 2-8-s2","AKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLPYLPSGTPEHHHHHH","Homo sapiens","CHIT1","Chitotriosidase-1","1","6JK6"
"6JKE",,"X-RAY DIFFRACTION",2.48,50.49,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.8M Ammonium sulphate, 100mM MES pH 6.5, 5mM DTT, PEG 10%, 5% Glycerol",293,"10.1042/BCJ20200339",,"6JKE",44.49,"1.5","1.5","Discovery and the crystal structure of NS5 in complex with the N-terminal bromodomain of BRD2.","GRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKN","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6JKE"
"6JKG",,"X-RAY DIFFRACTION",2.2,44.16,"VAPOR DIFFUSION, SITTING DROP",,"0.5 M magnesium chloride, 0.02 M lithium chloride, 33% PEG1000, 0.02 M Glycine, and pH 10.0",293,"10.1007/s00018-020-03490-2",,"6JKG",54.51,"2.9","2.9","The NAD+-free form of human NSDHL","KVNQNQAKRCTVIGGSGFLGQHMVEQLLARGYAVNVFDIQQGFDNPQVRFFLGDLCSRQDLYPALKGVNTVFHCASPPPSSNNKELFYRVNYIGTKNVIETCKEAGVQKLILTSSASVIFEGVDIKNGTEDLPYAMKPIDYYTETKILQERAVLGANDPEKNFLTTAIRPHGIFGPRDPQLVPILIEAARNGKMKFVIGNGKNLVDFTFVENVVHGHILAAEQLSRDSTLGGKAFHILEHHHHHH","Homo sapiens","NSDHL, H105E3","Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating","1","6JKG"
"6JKH",,"X-RAY DIFFRACTION",2.22,44.74,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M calcium chloride, 44% PEG400, 0.1 M Tris, and pH 8.0",293,"10.1007/s00018-020-03490-2",,"6JKH",55.84,"3","3","The NAD+-bound form of human NSDHL","KVNQNQAKRCTVIGGSGFLGQHMVEQLLARGYAVNVFDIQQGFDNPQVRFFLGDLCSRQDLYPALKGVNTVFHCASPPPSSNNKELFYRVNYIGTKNVIETCKEAGVQKLILTSSASVIFEGVDIKNGTEDLPYAMKPIDYYTETKILQERAVLGANDPEKNFLTTAIRPHGIFGPRDPQLVPILIEAARNGKMKFVIGNGKNLVDFTFVENVVHGHILAAEQLSRDSTLGGKAFHILEHHHHHH","Homo sapiens","NSDHL, H105E3","Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating","1","6JKH"
"6JKJ",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Ammonium acetate, 0.1M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3350",289,"10.1107/S2053230X1900623X",,"6JKJ",45.79,"1.9","1.9","Crystal structure of human SPSB2 in the apo-state","MGDLSCPEGLEELLSAPPPDLGAQRRHGWNPKDCSENIEVKEGGLYFERRPVAQSTDGARGKRGYSRGLHAWEISWPLEQRGTHAVVGVATALAPLQTDHYAALLGSNSESWGWDIGRGKLYHQSKGPGAPQYPAGTQGEQLEVPERLLVVLDMEEGTLGYAIGGTYLGPAFRGLKGRTLYPAVSAVWGQCQVRIRYLGERGSHHHHHH","Homo sapiens","SPSB2, GRCC9, SSB2","SPRY domain-containing SOCS box protein 2","1","6JKJ"
"6JKL",,"X-RAY DIFFRACTION",1.7,27.66,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M NaCl, 0.1 M Imidazole:HCl pH 8.0, 30%(w/v) PEG 8000",289,,,"6JKL",7.29,"2.148","2.148","Structure of a triple-helix region of human collagen type II","XPPGPPGPPGDDGPSGAEGPPGPPGPPGX","Homo sapiens",,"A triple-helix region of human collagen type II","1","6JKL"
"6JKN",,"X-RAY DIFFRACTION",2.71,54.69,"EVAPORATION",6,"0.1M sodium cacodylate pH 6.0, 80mM KCl, 12mM NaCl, 12mM spermine tetrahydrochloride, 50% MPD",289,"10.1093/nar/gkz221",,"6JKN",6.95,"1.401","1.401","Crystal Structure of G-quadruplex Formed by Bromo-substituted Human Telomeric DNA","GGGTTAGGGTTAGGGTTAGGG","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*TP*TP*AP*GP*(BGM)P*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*(BGM)P*G)-3')","1","6JKN"
"6JL7",,"X-RAY DIFFRACTION",2.54,51.59,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M MES pH6.5, 0.5 M Ammonium nitrate, 25% polyethylene glycol 400",293,"10.1371/journal.pbio.3000746",,"6JL7",50.49,"2.5","2.5","crystal structure of TBC1D23 N terminal domain","GWEKDLEEALEAGGCDLETLRNIIQGRPLPADLRAKVWKIALNVAGKGDSLASWDGILDLPEQNTIHKDCLQFIDQLSVPEEKAAELLLDIESVITFYCKSRNIKYSTSLSWIHLLKPLVHLQLPRSDLYNCFYAIMNKYIPRDCSQKGRPFHLFRLLIQYHEPELCSYLDTKKITPDSYALNWLGSLFACYCSTEVTQAIWDGYLQQADPFFIYFLMLIILVNAKEVILTQESDSKEEVIKFLENTPSSLNIEDIEDLFSLAQYYCSKTPASFRKDNHHLFGSTLLGIKDDDADLSQALCLAISVSEILQANQLQGEGVRFFVVDCRPAEQYNAGHLSTAFHLDSDLMLQNPSEFAQSVKSLLEAQKQSIESGSIAGGEHLCFMGSGREEEDMYMNMVLAHFLQKNKEYVSIASGGFMALQQHLADINVDGPENGYGHWIAST","Homo sapiens","TBC1D23, NS4ATP1","TBC1 domain family member 23","1","6JL7"
"6JLB",,"X-RAY DIFFRACTION",3.24,62.01,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl (pH 8.5), 0.9 M Lithium chloride, 7% (v/v) PEG 8000",287,"10.1038/s41467-019-11684-x",,"6JLB",140.22,"3.205","3.205","Crystal structure of lamin A/C fragment and assembly mechanisms of intermediate filaments","GAMDMETPSQRRATRSGAQASSTPLSPTRITRLQEKEDLQELNDRLAVYIDRVRSLETENAGLRLRITESEEVVSREVSGIKAAYEAELGDARKTLDSVAKERARLQLELSKVREEFKELKARNTKKEGDLIAAQARLKDLEALLNSKEAALSTALSEKRTLEGELHDLRGQVAKLEAALGEAKKQLQDEMLRRVDAENRLQTMKEELDFQKNIYSEELRETKRRHETRLVEIDNGKQREFESRLADALQELRAQHEDQVEQYKKELEKTYSAKLDNARQSAERNSNLVGAAHEELQQSRIRID","Homo sapiens","LMNA, LMN1","Lamin A/C","1","6JLB"
"6JLD",,"X-RAY DIFFRACTION",2.31,46.68,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Citric acid pH 3.5, 
25% w/v Polyethylene glycol 3,350
3% Methanol",298,"10.1107/S2052252519007668",,"6JLD",92.56,"2","2","Crystal structure of a human ependymin related protein","ADPHHHHHHHHAPRPCQAPQQWEGRQVMYQQSSGRNSRALLSYDGLNQRVRVLDERKALIPCKRLFEYILLYKDGVMFQIDQATKQCSKMTLTQPWDPLDIPQNSTFEDQYSIGGPQEQITVQEWSDRKSARSYETWIGIYTVKDCYPVQETFTINYSVILSTRFFDIQLGIKDPSVFTPPSTCQMAQLEKMSEDCSW","Homo sapiens","EPDR1, MERP1, UCC1","Mammalian ependymin-related protein 1","1","6JLD"
"6JLI",,"X-RAY DIFFRACTION",3.04,64.47,"VAPOR DIFFUSION",6,"20% PEG3350, 0.2M Ammonium sulfate pH6.0",293,"10.1016/j.jsb.2019.06.007",,"6JLI",15.54,"1.778","1.778","Crystal structure of CTLD7 domain of human PLA2R","NTSDMYPMPNTLEYGNRTYKIINANMTWYAAIKTCLMHKAQLVSITDQYHQSFLTVVLNRLGYAHWIGLFTTDNGLNFDWSDGTKSSFTFWKDEESSLLGDCVFADSNGRWHSTACESFLQGAICHVHHHHHH","Homo sapiens","PLA2R1, CLEC13C","Secretory phospholipase A2 receptor","1","6JLI"
"6JLR",,"X-RAY DIFFRACTION",3.23,61.92,"VAPOR DIFFUSION, HANGING DROP",7.7,"23% polyacrylic acid 5100, 2% 2-methyl-2,4-pentane diol, 100mM Hepes pH 7.7",293,"10.1021/acs.jmedchem.9b01582",,"6JLR",35.94,"2.901","2.901","Crystal structure of wild type MNK2 in complex with inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6JLR"
"6JM4",,"X-RAY DIFFRACTION",2.04,39.68,"VAPOR DIFFUSION, SITTING DROP",7,"1.8 M DL-Malic acid (pH 7.0), 0.1 M Tris-HCl (pH 7.0)",291,"10.14348/molcells.2019.0096",,"6JM4",45.23,"3.20014839602","3.20014839602","The crystal structure of PB1 homo-dimer of human P62/SQSTM1","MASLTVKAYLLGKEDAAREIRRFSFSFSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRAERGDLVAFSSDEELTMAMSYVKDDIFRIYIKEK","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","1","6JM4"
,,,,,,,,,,,,,,,,"MASLTVKAYLLGKEDAAREIARFSFSFSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEK","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","2","6JM4"
"6JM5",,"X-RAY DIFFRACTION",2.57,52.22,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M MES pH6.5, 0.5 M Ammonium nitrate, 25% polyethylene glycol 400",293,"10.1073/pnas.1909316116",,"6JM5",27.81,"1.6","1.6","Crystal structure of TBC1D23 C terminal domain","EVVNIQTWINKPDVKHHFPCKEVKESGHMFPSHLLVTATHMYCLREIVSRKGLAYIQSRQALNSVVKITSKKKHPELITFKYGNSSASGIEILAIERYLIPNAGDATKAIKQQIMKVLDALES","Homo sapiens","TBC1D23, NS4ATP1","TBC1 domain family member 23","1","6JM5"
"6JMD",,"X-RAY DIFFRACTION",3.68,66.54,"VAPOR DIFFUSION, HANGING DROP",,"hepes pH4.6, 2M AMMONIUM SULPHATE, 30% Glycerol",293,"10.1021/acs.jmedchem.0c00512","BVO","6JMD",41.29,"1.781","1.781","Crystal structure of human DHODH in complex with inhibitor 1223","ATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6JMD"
"6JME",,"X-RAY DIFFRACTION",3.67,66.49,"VAPOR DIFFUSION, HANGING DROP",,"hepes pH4.6, 2M AMMONIUM SULPHATE, 30% Glycerol",293,"10.1021/acs.jmedchem.0c00512","BVU","6JME",41.51,"1.8","1.8","Crystal structure of human DHODH in complex with inhibitor 0946","ATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6JME"
"6JMF",,"X-RAY DIFFRACTION",2.68,54.03,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M BisTrisPropane, 0.2 M Sodium Salfate, 15% PEG 3350, 10% Ethylene glycol",277,"10.1021/acsmedchemlett.8b00631",,"6JMF",43.04,"2","2","Crystal structure of human tyrosine-protein kinase Fes/Fps in complex with compound 4","GPEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQEYVLSVLWDGLPRHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR","Homo sapiens","FES, FPS","Tyrosine-protein kinase Fes/Fps","1","6JMF"
"6JNO",,"X-RAY DIFFRACTION",2.32,46.99,"VAPOR DIFFUSION, SITTING DROP",8,"20% (w/v) Polyethylene glycol 3350, 0.2M Mg(OAc)2",295,"10.1021/acs.jmedchem.9b00995",,"6JNO",108.9,"2.65","2.65","RXRa structure complexed with CU-6PMN","GSSHSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","6JNO"
"6JOB",,"X-RAY DIFFRACTION, SOLUTION SCATTERING",3.48,64.66,"VAPOR DIFFUSION, HANGING DROP",,"sodium citrate tribase dihydrate, 1,6-Hexanediol",293.15,,,"6JOB",255.25,"2.93","2.93","Ferritin variant with ""GMG"" motif","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGLMVGGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6JOB"
"6JOI",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, HANGING DROP",,"0.1M NaCl, 0.1M Tris pH 8.0, 15% PEG 4000",293,,,"6JOI",43.47,"3.1","3.1","Crystal structure of PDGFRA T674I in complex with crenolanib by co-crystallization","HHHHHHDYDIPTTENLYFQGAMDKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIIEYCFYGDLVNYLHKNRDSFLSHKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSD","Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA","Platelet-derived growth factor receptor alpha","1","6JOI"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA"
"6JOJ",,"X-RAY DIFFRACTION",3.99,69.18,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES pH6.9, 1.6M (NH4)2SO4, 0.1M NaCl",293,,,"6JOJ",41.47,"2.6","2.6","Crystal structure of PDGFRA T674I in complex with crenolanib by soaking","GAMDKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFLSHKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSD","Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA","Platelet-derived growth factor receptor alpha","1","6JOJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA"
"6JOK",,"X-RAY DIFFRACTION",4.17,70.48,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES pH6.9, 1.6M (NH4)2SO4, 0.1M NaCl",293,,,"6JOK",41.06,"3.8","3.8","Crystal structure of PDGFRA in complex with sunitinib by soaking","GAMDKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFLSHKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSD","Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA","Platelet-derived growth factor receptor alpha","1","6JOK"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA"
"6JOL",,"X-RAY DIFFRACTION",2.28,45.98,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Sodium citrate pH4.5, 20% PEG 4000",293,,,"6JOL",41.08,"1.9","1.9","Crystal structure of PDGFRA in complex with imatinib by co-crystallization","GAMDKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFLSHKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSD","Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA","Platelet-derived growth factor receptor alpha","1","6JOL"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA"
"6JPE",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES pH 5.5, 18% PEG4K, 0.15 M (NH4)2SO4, and 4% (v/v) formamide",298,"10.1021/acs.jmedchem.0c00044",,"6JPE",35.41,"1.601","1.601","Crystal structure of FGFR4 kinase domain with irreversible inhibitor 1","GPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGAFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6JPE"
"6JPJ",,"X-RAY DIFFRACTION",2.25,45.26,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MES pH 5.5, 20% PEG 4000, 0.15M (NH4)2SO4, 4% (v/v) formamide",277,"10.1039/c9cc02052g","FGF","6JPJ",35.36,"2.638","2.638","Crystal structure of FGF401 in complex of FGFR4","GPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGAFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDEVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6JPJ"
"6JPP",,"SOLUTION NMR",,,,,,,,,"6JPP",12.77,,,"Solution structure of ELMO1 RBD","GMPPPADIVKVAIEWPGAYPKLMEIDQKKPLSAIIKEVCDGWSLANHEYFALQHADSSNFYITEKNRNEIKNGTILRLTTSPAQNAQQLHERIQSSSMDAKLEALKDLASLSRD","Homo sapiens","ELMO1, KIAA0281","Engulfment and cell motility protein 1","1","6JPP"
"6JPS",,"X-RAY DIFFRACTION",3.33,63.01,"VAPOR DIFFUSION, HANGING DROP",,"magnesium chloride, Tris, 1,6-hexanediol",293,"10.1039/c9an01110b",,"6JPS",522.27,"3.503","3.503","Human H chain ferritin mutant-MBP","GMTCAACTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin","1","6JPS"
"6JPT",,"X-RAY DIFFRACTION",2.63,53.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% PEG2000 monomethyl ether, 0.1 M potassium thiocyanate",293,"10.3390/ijms20092231",,"6JPT",13.22,"0.96","0.96","Crystal structure of human PAC3 homodimer (trigonal form)","MEDTPLVISKQKTEVVCGVPTQVVCTAFSSHILVVVTQFGKMGTLVSLEPSSVASDVSKPVLTTKVLLGQDEPLIHVFAKNLVAFVSQEAGNRAVLLAVAVKDKSMEGLKALREVIRVCQVW","Homo sapiens","PSMG3, C7orf48, PAC3","Proteasome assembly chaperone 3","1","6JPT"
"6JQR",,"X-RAY DIFFRACTION",3.35,63.26,"VAPOR DIFFUSION",,"buffer, salt, precipitant",293,"10.18632/oncotarget.27222","C6F","6JQR",39.34,"2.2","2.2","Crystal structure of FLT3 in complex with gilteritinib","RYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE","Homo sapiens","FLT3","Receptor-type tyrosine-protein kinase FLT3,Receptor-type tyrosine-protein kinase FLT3","1","6JQR"
,,,,,,,,,,,,,,,,,"Homo sapiens","FLT3"
"6JR3","14.5","ELECTRON MICROSCOPY",,,,,,,"10.1007/s10822-020-00311-3",,"6JR3",34.91,"14.5",,"Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as rigid body","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","6JR3"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","6JR3"
"6JRJ",,"X-RAY DIFFRACTION",3.61,65.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M HEPES pH 8.5, 40% PEG 400, 0.15 M NaCl, 5 mM tris(2-carboxyethyl)-phosphine (TCEP)",298,"10.1021/acs.jmedchem.9b00576",,"6JRJ",38.09,"2.943","2.943","The structure of co-crystals of 8r-B-EGFR T790M/C797S complex","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6JRJ"
"6JRK",,"X-RAY DIFFRACTION",3.5,64.87,"VAPOR DIFFUSION, HANGING DROP",8,"38% PEG 300, 150 mM KCl, 0.1 M HEPES (pH 8.0), 50 mM Gly3, 5 mM Co-enzyme A (pH 8.0), 2 mM TCEP",298,"10.1021/acs.jmedchem.9b00576",,"6JRK",38.08,"2.796","2.796","The structure of co-crystals of 8r-B-EGFR WT complex","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6JRK"
"6JRX",,"X-RAY DIFFRACTION",3.38,63.59,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES pH8.5, 40% PEG400, 0.15 M NaCl, 5 mM tris(2-carboxyethyl)-phosphine (TCEP)",298,"10.1021/acs.jmedchem.9b00664",,"6JRX",38.25,"2.201","2.201","EGFR T790M/C797S in complex with compound 6i","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6JRX"
"6JSE",,"X-RAY DIFFRACTION",2.75,59.53,"VAPOR DIFFUSION, SITTING DROP",,"0.2M sodium citrate tribasic pH6.5, 0.2M ammonium iodide, 18.4%(w/v) PEG5000MME",293,"10.1021/acs.jmedchem.9b00309","C6R","6JSE",47.7,"2","2","Crystal Structure of BACE1 in complex with N-(3-((4S,5R)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6JSE"
"6JSF",,"X-RAY DIFFRACTION",2.79,60.28,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M sodium citrate, 0.2 M ammonium iodide, 18.4%(w/v) polyethylene glycol 5000 monomethyl ether, pH 6.5",293.15,"10.1021/acs.jmedchem.9b00309","C7X","6JSF",47.91,"2.3","2.3","Crystal Structure of BACE1 in complex with N-(3-((4S,5S)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6JSF"
"6JSG",,"X-RAY DIFFRACTION",3,59.06,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M sodium citrate, 0.2 M ammonium iodide, 18.8%(w/v) polyethylene glycol 5000 monomethyl ether, pH 6.5",293.15,"10.1021/acs.jmedchem.9b00309","C6U","6JSG",47.36,"2.3","2.3","Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-chloropyridine-2-carboxamide","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6JSG"
"6JSN",,"X-RAY DIFFRACTION",3,59.06,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M sodium citrate, 0.2 M ammonium iodide, 19%(w/v) polyethylene glycol 5000 monomethyl ether, pH 6.5",293.15,"10.1021/acs.jmedchem.9b00309",,"6JSN",47.76,"2.6","2.6","Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6JSN"
"6JT3",,"X-RAY DIFFRACTION",3,59,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M sodium citrate tribasic pH 6.5, 0.2 M ammonium iodide, 20.3% w/v PEG 5000MME",293.15,"10.1021/acs.jmedchem.9b01140","C83","6JT3",47.24,"2.4","2.4","Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6JT3"
"6JT4",,"X-RAY DIFFRACTION",2.73,59.96,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M sodium citrate tribasic pH 6.5, 0.2 M ammonium iodide, 20.5% w/v PEG 5000MME",293.15,"10.1002/cmdc.201900478","C86","6JT4",47.42,"2.2","2.2","Crystal Structure of BACE1 in complex with N-{3-[(4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6JT4"
"6JTG",,"X-RAY DIFFRACTION",3.34,63.18,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Potassium thiocyanate and 20%(w/v) Polyethylene glycol
3350 (pH 7.0)",289,"10.1083/jcb.201907098",,"6JTG",39.51,"2.4","2.4","Structural insights into G domain dimerization and pathogenic mutations of OPA1","SLIDMYSEVLDVLSDYDASYNTQDHLPRVVVVGDQSAGKTSVLEMIAQARIFPRGSGEMMTRSPVKVTLSEGPHHVALFKDSSREFDLTKEEDLAALRHEIELRMRKNVKEGCTVSPETISLNVKGPGLQRMVLVDLPGVINTVTSGMAPDTKETIFSISKAYMQNPNAIILCIQDGSVDAERSIVTDLVSQMDPHGRRTIFVLTKVDLAEKNVASPSRIQQIIEGKLFPMKALGYFAVVTGKGNSSESIEAIREYEEEFFQNSKLLKTSMLKAHQVTTRNLSLAVSDCFWKMVRESVEQQADSFKATRFNLETEWKNGSGSGSGGSDLKKVREIQEKLDAFIEALHQEK","Homo sapiens","OPA1","Dynamin-like 120 kDa protein, mitochondrial,OPA1 protein","1","6JTG"
,,,,,,,,,,,,,,,,,"Homo sapiens","OPA1"
"6JTZ",,"X-RAY DIFFRACTION",2.44,49.51,"VAPOR DIFFUSION, HANGING DROP",7,"65% v/v Tacsimate pH=7.0",298,"10.1093/nar/gkab968",,"6JTZ",80.38,"2.797","2.797","Crystal Structure of hRecQ1_D2-Zn-WH containing mutation on beta-hairpin","MGSSHHHHHHSSGLVPRGSHMNRPNLYYEVRQKPSNTEDFIEDIVKLINGRYKGQSGIIYCFSQKDSEQVTVSLQNLGIHAGAYHANLEPEDKTTVHRKWSANEIQVVVATVAFGMGIDKPDVRFVIHHSMSKSMENYYQESGRAGRDDMKADCILYYGFGDIFRISSMVVMENVGQQKLYEMVSYCQNISKCRRVLMAQHFDEVWNSEACNKMCDNCCKDSAFERKNITEYCRDLIKILKQAEELNEKLTPLKLIDSWMGKGAAKLRVAGVVAPTLPREDLEKIIAHFLIQQYLKEDYSAAISYLKIGPKANLLNNEAHAITMQVTKSTQNSFRAESSQTCHSEQGDKKME","Homo sapiens","RECQL, RECQ1, RECQL1","ATP-dependent DNA helicase Q1","1","6JTZ"
"6JUT",,"X-RAY DIFFRACTION",1.86,33.72,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Bis-Tris pH 5.5, 25% PEG3350, 0.2M NaCl",298,"10.1021/acs.jmedchem.9b00664","C9O","6JUT",35.9,"2.1","2.1","Crystal structure of ZAK in complex with compound 6k","GAMGSGASFVQIKFDDLQFFENCGGGSFGSVYRAKWISQDKEVAVKKLLKIEKEAEILSVLSHRNIIQFYGVILEPPNYGIVTEYASLGSLYDYINSNRSEEMDMDHIMTWATDVAKGMHYLHMEAPVKVIHRDLKSRNVVIAADGVLKICDFGASRFHNHTTHMSLVGTFPWMAPEVIQSLPVSETCDTYSYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLHQCWEADAKKRPSFKQIISILESMSNDTSLPDKCNSFLHNKAEWRCEIEATLERLKKLERDLSFKEQELK","Homo sapiens","ZAK, MAP3K20, MLTK, HCCS4","Mitogen-activated protein kinase kinase kinase MLT","1","6JUT"
"6JUU",,"X-RAY DIFFRACTION",1.84,33.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris pH 6.5, 28% PEG2000MME",298,"10.1021/acs.jmedchem.9b00664","C9R","6JUU",35.87,"1.903","1.903","Crystal structure of ZAK in complex with compound 6r","GAMGSGASFVQIKFDDLQFFENCGGGSFGSVYRAKWISQDKEVAVKKLLKIEKEAEILSVLSHRNIIQFYGVILEPPNYGIVTEYASLGSLYDYINSNRSEEMDMDHIMTWATDVAKGMHYLHMEAPVKVIHRDLKSRNVVIAADGVLKICDFGASRFHNHTTHMSLVGTFPWMAPEVIQSLPVSETCDTYSYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLHQCWEADAKKRPSFKQIISILESMSNDTSLPDKCNSFLHNKAEWRCEIEATLERLKKLERDLSFKEQELK","Homo sapiens","ZAK, MAP3K20, MLTK, HCCS4","Mitogen-activated protein kinase kinase kinase MLT","1","6JUU"
"6JUX",,"X-RAY DIFFRACTION",2.66,53.68,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES, 1.5 M Ammonium sulfate",293,"10.1021/acsomega.9b04245","C9U","6JUX",34.93,"1.75","1.75","Crystal structure of human ALK2 kinase domain with R206H mutation in complex with RK-71807","QRTVAHQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6JUX"
"6JV3",,"X-RAY DIFFRACTION",2.47,50.17,"VAPOR DIFFUSION, SITTING DROP",6,"0.08M Sodium chloride,0.012M Potassium chloride, 0.02M Magnesium chloride hexahydrate 0.04M Sodium cacodylate trihydrate pH 6.0 30% MPD, 0.012M Spermine tetrahydrochloride",277,"10.1039/c9sc02807b",,"6JV3",12.3,"2.851","2.851","Crystal structure of 5-hydoxylmethylcytosine containing decamer dsDNA","CCAGXGCTGG","Homo sapiens",,"DNA (5'-D(*CP*CP*AP*GP*(5HC)P*GP*CP*TP*GP*G)-3')","1","6JV3"
"6JV5",,"X-RAY DIFFRACTION",2.05,39.97,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.02M Magnesium chloride hexahydrate,0.04MSodium cacodylate trihydrate pH 5.5, 40% MPD,0.002M Hexammine cobalt(III) chloride",277,"10.1039/c9sc02807b",,"6JV5",3.06,"1.401","1.401","Crystal structure of 5-methylcytosine containing decamer dsDNA","CCAGCGCTGG","Homo sapiens",,"DNA (5'-D(*CP*CP*AP*GP*(5CM)P*GP*CP*TP*GP*G)-3')","1","6JV5"
"6JV9",,"X-RAY DIFFRACTION",2.35,47.63,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES (pH 6.0), 15% (v/v) PEG 400, 0.1 M calcium acetate",287,"10.26508/lsa.201900478",,"6JV9",237.6,"2.26","2.26","Crystal Structure of Human CRMP2 1-532, unmodified","MHHHHHHHMSYQGKKNIPRITSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAELRGVPRGLYDGPVCEVSVTPKTVTPASSAKTSPAKQQAPPVR","Homo sapiens","DPYSL2, CRMP2, ULIP2","Dihydropyrimidinase-related protein 2","1","6JV9"
"6JVB",,"X-RAY DIFFRACTION",2.74,55.03,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES (pH 6.0), 15% (v/v) PEG 400, 0.1M calcium acetate",287,"10.26508/lsa.201900478",,"6JVB",237.04,"2","2","Crystal Structure of Human CRMP2 1-532, AGE-modified","MHHHHHHHMSYQGKKNIPRITSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAELRGVPRGLYDGPVCEVSVTPKTVTPASSAKTSPAKQQAPPVR","Homo sapiens","DPYSL2, CRMP2, ULIP2","Dihydropyrimidinase-related protein 2","1","6JVB"
"6JVF",,"X-RAY DIFFRACTION",2.26,45.52,"EVAPORATION",3.75,"30% PEG6 000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVF",35.94,"1.73","1.73","Crystal structure of human apo MTH1","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVF"
"6JVG",,"X-RAY DIFFRACTION",2.28,46.06,"EVAPORATION",3.75,"30% PEG6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVG",36.39,"1.844","1.844","Crystal structure of human MTH1 in complex with compound MI0639","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVG"
"6JVH",,"X-RAY DIFFRACTION",2.27,45.83,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVH",36.38,"2.04","2.04","Crystal structure of human MTH1 in complex with compound MI0320","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVH"
"6JVI",,"X-RAY DIFFRACTION",2.28,45.99,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVI",36.68,"2.249","2.249","Crystal structure of human MTH1 in complex with compound MI0861","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVI"
"6JVJ",,"X-RAY DIFFRACTION",2.27,45.75,"EVAPORATION",3.75,"30% PEG6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVJ",36.41,"2.297","2.297","Crystal structure of human MTH1 in complex with compound MI1006","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVJ"
"6JVK",,"X-RAY DIFFRACTION",2.26,45.5,"EVAPORATION",3.75,"30% PEG6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVK",36.17,"2.1","2.1","Crystal structure of human MTH1 in complex with compound MI1012","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVK"
"6JVL",,"X-RAY DIFFRACTION",2.26,45.5,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVL",36.22,"1.9","1.9","Crystal structure of human MTH1 in complex with compound MI1014","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVL"
"6JVM",,"X-RAY DIFFRACTION",2.28,45.94,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVM",36.2,"2.098","2.098","Crystal structure of human MTH1 in complex with compound MI1016","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVM"
"6JVN",,"X-RAY DIFFRACTION",2.28,45.96,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVN",36.36,"2.102","2.102","Crystal structure of human MTH1 in complex with compound MI1020","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVN"
"6JVO",,"X-RAY DIFFRACTION",2.26,45.55,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVO",36.18,"1.902","1.902","Crystal structure of human MTH1 in complex with compound MI1022","GASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVO"
"6JVP",,"X-RAY DIFFRACTION",2.27,45.78,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVP",36.41,"2.206","2.206","Crystal structure of human MTH1 in complex with compound MI1024","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVP"
"6JVQ",,"X-RAY DIFFRACTION",2.28,46.14,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVQ",36.41,"2.197","2.197","Crystal structure of human MTH1 in complex with compound MI1025","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVQ"
"6JVR",,"X-RAY DIFFRACTION",2.27,45.78,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVR",36.15,"2.295","2.295","Crystal structure of human MTH1 in complex with compound MI1026","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVR"
"6JVS",,"X-RAY DIFFRACTION",2.28,46.16,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVS",36.23,"2.1","2.1","Crystal structure of human MTH1 in complex with compound MI1029","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVS"
"6JVT",,"X-RAY DIFFRACTION",2.27,45.84,"EVAPORATION",3.75,"30% PEG 6000, 200 mM Lithium sulphate, 100 mM Sodium acetate pH 3.75",298,"10.1016/j.bioorg.2021.104813",,"6JVT",36.47,"1.801","1.801","Crystal structure of human MTH1 in complex with compound MI1030","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6JVT"
"6JWA",,"X-RAY DIFFRACTION",2.01,38.75,"VAPOR DIFFUSION, SITTING DROP",,"ethylene glycol",277,"10.1107/S2053230X19008951","5ID","6JWA",41.24,"1.781","1.781","Crystal structure of CK2a1 with 5-iodotubercidin","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6JWA"
"6JWD",,"SOLUTION NMR",,,,,,,"10.1039/d0cc00221f",,"6JWD",6.73,,,"structure of RET G-quadruplex in complex with berberine","GGGGCGGGGCGGGGCGGGGT","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*GP*CP*GP*GP*GP*GP*CP*GP*GP*GP*GP*CP*GP*GP*GP*GP*T)-3')","1","6JWD"
"6JWE",,"SOLUTION NMR",,,,,,,"10.1039/d0cc00221f",,"6JWE",6.79,,,"structure of RET G-quadruplex in complex with colchicine","GGGGCGGGGCGGGGCGGGGT","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*GP*CP*GP*GP*GP*GP*CP*GP*GP*GP*GP*CP*GP*GP*GP*GP*T)-3')","1","6JWE"
"6JWL",,"X-RAY DIFFRACTION",3.23,61.91,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.1M HEPES pH 7.8, 40% PEG 400, 0.15M NaCl, 5mM TCEP",293,"10.1021/acs.jmedchem.0c00891",,"6JWL",38.16,"2.551","2.551","Crystal structure of EGFR 696-1022 L858R in complex with AZD9291","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6JWL"
"6JX0",,"X-RAY DIFFRACTION",4.25,71.09,"VAPOR DIFFUSION, HANGING DROP",7,"1.3 M Ammonium tartrate dibasic, 0.1 M BIS-TRIS propane pH 7.0",293,"10.1021/acs.jmedchem.0c00891",,"6JX0",39.26,"2.53","2.53","Crystal structure of EGFR 696-1022 T790M in complex with AZD9291 prepared by co-crystallization","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6JX0"
"6JX4",,"X-RAY DIFFRACTION",3.43,64.14,"VAPOR DIFFUSION, HANGING DROP",8,"38% PEG 300, 150 mM KCl, 0.1 M HEPES (pH 8.0), 50mM Glycyl-glycyl-glycine, 5 mM Co-enzyme A (pH 8.0), 2 mM TCEP.",293,"10.1021/acs.jmedchem.0c00891",,"6JX4",38.15,"2.531","2.531","Crystal structure of EGFR 696-1022 T790M in complex with AZD9291 prepared by soaking","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6JX4"
"6JX5",,"X-RAY DIFFRACTION",3.93,68.74,"VAPOR DIFFUSION",,"100mM Bis Tris (pH 5.5), 200mM Ammonium sulfate",296.15,"10.1074/jbc.RA119.010327",,"6JX5",133.63,"2.402","2.402","Hect domain of AREL1","SETFQDKVNFFQRELRQVHMKRPHSKVTLKVSRHALLESSLKATRNFSISDWSKNFEVVFQDEEALDWGGPRREWFELICKALFDTTNQLFTRFSDNNQALVHPNPNRPAHLRLKMYEFAGRLVGKCLYESSLGGAYKQLVRARFTRSFLAQIIGLRMHYKYFETDDPEFYKSKVCFILNNDMSEMELVFAEEKYNKSGQLDKVVELMTGGAQTPVTNANKIFYLNLLAQYRLASQVKEEVEHFLKGLNELVPENLLAIFDENELELLMCGTGDISVSDFKAHAVVVGGSWHFREKVMRWFWTVVSSLTQEELARLLQFTTGSSQLPPGGFAALCPSFQIIAAPTHSTLPTAHTCFNQLCLPTYDSYEEVHRMLQLAISEGCEGFGML","Homo sapiens","AREL1, KIAA0317","Apoptosis-resistant E3 ubiquitin protein ligase 1","1","6JX5"
"6JX6",,"X-RAY DIFFRACTION",2.42,49.17,"VAPOR DIFFUSION",,"200mM Potassium Phosphate Monobasic, 20% PEG 3350",296,"10.1074/jbc.RA119.010327",,"6JX6",83.15,"2.805","2.805","Tetrameric form of Smac","AVPIAQKSEPHSLSSEALMRRAVSLVTDSTSTFLSQTTYALIEAITEYTKAVYTLTSLYRQYTSLLGKMNSEEEDEVWQVIIGARAEMTSKHQEYLKLETTWMTAVGLSEMAAEAAYQTGADQASITARNHIQLVKLQVEEVHQLSRKAETKLAEAQIEELRQKTQEEGEERAESEQEAYLRED","Homo sapiens","DIABLO, SMAC","Diablo homolog, mitochondrial","1","6JX6"
"6JXT",,"X-RAY DIFFRACTION",3.02,59.34,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Potassium sodium tartrate tetrahydrate, 20% w/v Polyethylene glycol 3350",293,"10.1021/acs.jmedchem.0c00891",,"6JXT",37.98,"2.307","2.307","Crystal structure of EGFR 696-1022 WT in complex with AZD9291 prepared by cocrystallization","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6JXT"
"6JYP",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, SITTING DROP",,"0.05M sodium citrate at pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,,,"6JYP",28.15,"2.25","2.25","Crystal structure of uPA_H99Y in complex with 3-azanyl-5-(azepan-1-yl)-N-[bis(azanyl)methylidene]-6-chloranyl-pyrazine-2-carboxamide","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAYHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6JYP"
"6JYQ",,"X-RAY DIFFRACTION",2.14,42.55,"VAPOR DIFFUSION, SITTING DROP",,"0.05M sodium citrate at pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,,,"6JYQ",28.18,"1.75","1.75","Crystal structure of uPA_H99Y in complex with 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(furan-2-yl)pyrazine-2-carboxamide","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAYHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6JYQ"
"6JYU",,"X-RAY DIFFRACTION",2.52,51.13,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Tris, 20% glycerol ethoxylate, 10% tetrahydrofuran",289,,,"6JYU",56.63,"1.89","1.89","Crystal structure of Human G6PD Canton","SDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELLEAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPH","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","6JYU"
"6JZ0",,"X-RAY DIFFRACTION",3.4,63.8,"VAPOR DIFFUSION, HANGING DROP",7,"1.0M Ammonium citrate tribase, 0.1M Bis-Tris propane, pH7.0",291,"10.1021/acs.jmedchem.9b00722",,"6JZ0",37.78,"2.86","2.86","Crystal structure of EGFR kinase domain in complex with compound 78","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQ","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6JZ0"
"6K04",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, SITTING DROP",,"0.2M ammonium sulfate, 25% PEG 4000",289,"10.1016/j.ejmech.2019.111633","CQF","6K04",13.56,"1.251","1.251","Crystal structure of BRD2(BD2)with ligand BY27 bound","GKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6K04"
"6K05",,"X-RAY DIFFRACTION",2.48,50.5,"VAPOR DIFFUSION, SITTING DROP",,"25-30% PEG MME 5000, 0.2M ammonium sulfate, 0.1M MES pH 6.7",293,"10.1016/j.ejmech.2019.111633","CQF","6K05",44.42,"1.935","1.935","Crystal structure of BRD2(BD1)with ligand BY27 bound","GRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKN","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6K05"
"6K0J",,"X-RAY DIFFRACTION",3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",,"0.36 M-0.5 M sodium citrate tribasic dihydrate, 0.01 M sodium borate, pH 7.5-9.5",291,"10.1073/pnas.1912033116","CQO","6K0J",38.1,"2.352","2.352","The co-crystal structure of DYRK2 with a small molecule inhibitor","QVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNNKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDAKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRAA","Homo sapiens","DYRK2","Dual specificity tyrosine-phosphorylation-regulated kinase 2","1","6K0J"
"6K0O",,"X-RAY DIFFRACTION",1.98,37.8,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M citric acid pH3.5, 15% PEG 3350",293,"10.1186/s13567-021-00969-z",,"6K0O",22.54,"1.99","1.99","The crystal structure of human CD163-like homolog SRCR8","RSPRLVGADMPCSGRVEVKHADTWRSVCDSDFSLHAANVLCRELNCGDAISLSVGDHFGKGNGLTWAEKFQCEGSETHLALCPIVQHPEDTCIHSREVGVVCST","Homo sapiens","CD163L1, CD163B, M160, UNQ6434/PRO23202","Scavenger receptor cysteine-rich type 1 protein M160","1","6K0O"
"6K17",,"X-RAY DIFFRACTION",2.32,46.97,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, 2-(N-morpholino)ethanesulfonic acid, Calcium acetate, Dithiothreitol",277,"10.1093/nar/gkz454",,"6K17",48.88,"1.602","1.602","Crystal structure of EXD2 exonuclease domain","KAKVVTVSQEAEWDQIEPLLRSELEDFPVLGIDCEWVNLEGKASPLSLLQMASPSGLCVLVRLPKLICGGKTLPRTLLDILADGTILKVGVGCSEDASKLLQDYGLVVRGCLDLRYLAMRQRNNLLCNGLSLKSLAETVLNFPLDKSLLLRCSNWDAETLTEDQVIYAARDAQISVALFLHLLGYPFSRNSPGEKNDDHSSWRKVLEKCQGVVDIPFRSK","Homo sapiens","EXD2, C14orf114, EXDL2","Exonuclease 3'-5' domain-containing protein 2","1","6K17"
"6K18",,"X-RAY DIFFRACTION",2.3,46.6,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, 2-(N-morpholino)ethanesulfonic acid, Calcium acetate, Dithiothreitol, Manganese chloride",277,"10.1093/nar/gkz454",,"6K18",48.9,"2.303","2.303","Crystal structure of EXD2 exonuclease domain soaked in Mn","KAKVVTVSQEAEWDQIEPLLRSELEDFPVLGIDCEWVNLEGKASPLSLLQMASPSGLCVLVRLPKLICGGKTLPRTLLDILADGTILKVGVGCSEDASKLLQDYGLVVRGCLDLRYLAMRQRNNLLCNGLSLKSLAETVLNFPLDKSLLLRCSNWDAETLTEDQVIYAARDAQISVALFLHLLGYPFSRNSPGEKNDDHSSWRKVLEKCQGVVDIPFRSK","Homo sapiens","EXD2, C14orf114, EXDL2","Exonuclease 3'-5' domain-containing protein 2","1","6K18"
"6K19",,"X-RAY DIFFRACTION",2.35,47.64,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, 2-(N-morpholino)ethanesulfonic acid, Calcium acetate, Dithiothreitol, Magnesium chloride",277,"10.1093/nar/gkz454",,"6K19",48.84,"2.202","2.202","Crystal structure of EXD2 exonuclease domain soaked in Mg","KAKVVTVSQEAEWDQIEPLLRSELEDFPVLGIDCEWVNLEGKASPLSLLQMASPSGLCVLVRLPKLICGGKTLPRTLLDILADGTILKVGVGCSEDASKLLQDYGLVVRGCLDLRYLAMRQRNNLLCNGLSLKSLAETVLNFPLDKSLLLRCSNWDAETLTEDQVIYAARDAQISVALFLHLLGYPFSRNSPGEKNDDHSSWRKVLEKCQGVVDIPFRSK","Homo sapiens","EXD2, C14orf114, EXDL2","Exonuclease 3'-5' domain-containing protein 2","1","6K19"
"6K1A",,"X-RAY DIFFRACTION",2.3,46.47,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, 2-(N-morpholino)ethanesulfonic acid, Calcium acetate, Dithiothreitol, Manganese chloride, Magnesium chloride",277,"10.1093/nar/gkz454",,"6K1A",48.95,"2.602","2.602","Crystal structure of EXD2 exonuclease domain soaked in Mn and Mg","KAKVVTVSQEAEWDQIEPLLRSELEDFPVLGIDCEWVNLEGKASPLSLLQMASPSGLCVLVRLPKLICGGKTLPRTLLDILADGTILKVGVGCSEDASKLLQDYGLVVRGCLDLRYLAMRQRNNLLCNGLSLKSLAETVLNFPLDKSLLLRCSNWDAETLTEDQVIYAARDAQISVALFLHLLGYPFSRNSPGEKNDDHSSWRKVLEKCQGVVDIPFRSK","Homo sapiens","EXD2, C14orf114, EXDL2","Exonuclease 3'-5' domain-containing protein 2","1","6K1A"
"6K1B",,"X-RAY DIFFRACTION",2.3,46.64,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, 2-(N-morpholino)ethanesulfonic acid, Calcium acetate, Dithiothreitol, Manganese chloride, Deoxyguanosine monophosphate",277,"10.1093/nar/gkz454",,"6K1B",49.01,"2.605","2.605","Crystal structure of EXD2 exonuclease domain soaked in Mn and dGMP","KAKVVTVSQEAEWDQIEPLLRSELEDFPVLGIDCEWVNLEGKASPLSLLQMASPSGLCVLVRLPKLICGGKTLPRTLLDILADGTILKVGVGCSEDASKLLQDYGLVVRGCLDLRYLAMRQRNNLLCNGLSLKSLAETVLNFPLDKSLLLRCSNWDAETLTEDQVIYAARDAQISVALFLHLLGYPFSRNSPGEKNDDHSSWRKVLEKCQGVVDIPFRSK","Homo sapiens","EXD2, C14orf114, EXDL2","Exonuclease 3'-5' domain-containing protein 2","1","6K1B"
"6K1C",,"X-RAY DIFFRACTION",2.34,47.54,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, 2-(N-morpholino)ethanesulfonic acid, Calcium acetate, Dithiothreitol, Magnesium chloride, Deoxyguanosine monophosphate",277,"10.1093/nar/gkz454",,"6K1C",48.84,"2.45","2.45","Crystal structure of EXD2 exonuclease domain soaked in Mg and dGMP","KAKVVTVSQEAEWDQIEPLLRSELEDFPVLGIDCEWVNLEGKASPLSLLQMASPSGLCVLVRLPKLICGGKTLPRTLLDILADGTILKVGVGCSEDASKLLQDYGLVVRGCLDLRYLAMRQRNNLLCNGLSLKSLAETVLNFPLDKSLLLRCSNWDAETLTEDQVIYAARDAQISVALFLHLLGYPFSRNSPGEKNDDHSSWRKVLEKCQGVVDIPFRSK","Homo sapiens","EXD2, C14orf114, EXDL2","Exonuclease 3'-5' domain-containing protein 2","1","6K1C"
"6K1D",,"X-RAY DIFFRACTION",2.34,47.35,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, 2-(N-morpholino)ethanesulfonic acid, Calcium acetate, Dithiothreitol, Manganese Chloride, Guanosine monophosphate",277,"10.1093/nar/gkz454",,"6K1D",49.01,"3","3","Crystal structure of EXD2 exonuclease domain soaked in Mn and GMP","KAKVVTVSQEAEWDQIEPLLRSELEDFPVLGIDCEWVNLEGKASPLSLLQMASPSGLCVLVRLPKLICGGKTLPRTLLDILADGTILKVGVGCSEDASKLLQDYGLVVRGCLDLRYLAMRQRNNLLCNGLSLKSLAETVLNFPLDKSLLLRCSNWDAETLTEDQVIYAARDAQISVALFLHLLGYPFSRNSPGEKNDDHSSWRKVLEKCQGVVDIPFRSK","Homo sapiens","EXD2, C14orf114, EXDL2","Exonuclease 3'-5' domain-containing protein 2","1","6K1D"
"6K1E",,"X-RAY DIFFRACTION",2.34,47.46,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, 2-(N-morpholino)ethanesulfonic acid, Calcium acetate, Dithiothreitol, Magnesium chloride, guanosine monophosphate",277,"10.1093/nar/gkz454",,"6K1E",48.89,"2.9","2.9","Crystal structure of EXD2 exonuclease domain soaked in Mg and GMP","KAKVVTVSQEAEWDQIEPLLRSELEDFPVLGIDCEWVNLEGKASPLSLLQMASPSGLCVLVRLPKLICGGKTLPRTLLDILADGTILKVGVGCSEDASKLLQDYGLVVRGCLDLRYLAMRQRNNLLCNGLSLKSLAETVLNFPLDKSLLLRCSNWDAETLTEDQVIYAARDAQISVALFLHLLGYPFSRNSPGEKNDDHSSWRKVLEKCQGVVDIPFRSK","Homo sapiens","EXD2, C14orf114, EXDL2","Exonuclease 3'-5' domain-containing protein 2","1","6K1E"
"6K1Z",,"X-RAY DIFFRACTION",2.57,52.09,"VAPOR DIFFUSION, SITTING DROP",,"0.02M Citric acid/0.08M BIS-TRIS propane (pH 8.8), 16% w/v Polyethylene glycol 3350",293.15,"10.1371/journal.ppat.1007876",,"6K1Z",68.37,"2.307","2.307","Crystal structure of farnesylated hGBP1","GSMASEIHMTGPMCLIENTNGRLMANPEALKILSAITQPMVVVAIVGLYRTGKSYLMNKLAGKKKGFSLGSTVQSHTKGIWMWCVPHPKKPGHILVLLDTEGLGDVEKGDNQNDSWIFALAVLLSSTFVYNSIGTINQQAMDQLYYVTELTHRIRSKSSPDENENEVEDSADFVSFFPDFVWTLRDFSLDLEADGQPLTPDEYLTYSLKLKKGTSQKDETFNLPRLCIRKFFPKKKCFVFDRPVHRRKLAQLEKLQDEELDPEFVQQVADFCSYIFSNSKTKTLSGGIQVNGPRLESLVLTYVNAISSGDLPCMENAVLALAQIENSAAVQKAIAHYEQQMGQKVQLPTETLQELLDLHRDSEREAIEVFIRSSFKDVDHLFQKELAAQLEKKRDDFCKQNQEASSDRCSALLQVIFSPLEEEVKAGIYSKPGGYRLFVQKLQDLKKKYYEEPRKGIQAEEILQTYLKSKESMTDAILQTDQTLTEKEKEIEVERVKAESAQASAKMLQEMQRKNEQMMEQKERSYQEHLKQLTEKMENDRVQLLKEQERTLALKLQEQEQLLKEGFQKESRIMKNEIQDLQTKMRRRKACTIS","Homo sapiens","GBP1","Guanylate-binding protein 1","1","6K1Z"
"6K22",,"X-RAY DIFFRACTION",2.22,44.71,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M  Potassium Citrate Tribasic pH 8.3
0.1 M HEPES pH 7.5 
17% PEG3350 
50uM CaCl2
2mM TCEP",287,"10.1016/j.jsb.2019.10.003",,"6K22",37.54,"2.747","2.747","Crystal structure of Ca-bound human Annexin A5 in low salt condition","MGAQVLRGTVTDFPGFDERADAETLRKAMKGLGTDEESILTLLTSRSNAQRQEISAAFKTLFGRDLLDDLKSELTGKFEKLIVALMKPSRLYDAYELKHALKGAGTNEKVLTEIIASRTPEELRAIKQVYEEEYGSSLEDDVVGDTSGYYQRMLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELKWGTDEEKFITIFGTRSVSHLRKVFDKYMTISGFQIEETIDRETSGNLEQLLLAVVKSIRSIPAYLAETLYYAMKGAGTDDHTLIRVMVSRSEIDLFNIRKEFRKNFATSLYSMIKGDTSGDYKKALLLLCGEDDHHHHHHHHHH","Homo sapiens","ANXA5, ANX5, ENX2, PP4","Annexin A5","1","6K22"
"6K25",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodium phosphate dibasic dehydrate
20% w/v Polyethylene glycol 3,350
2 mM TCEP",288,"10.1016/j.jsb.2019.10.003",,"6K25",37.42,"2.401","2.401","Crystal structure of Ca-unbound human Annexin A5 in low salt condition","MGAQVLRGTVTDFPGFDERADAETLRKAMKGLGTDEESILTLLTSRSNAQRQEISAAFKTLFGRDLLDDLKSELTGKFEKLIVALMKPSRLYDAYELKHALKGAGTNEKVLTEIIASRTPEELRAIKQVYEEEYGSSLEDDVVGDTSGYYQRMLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELKWGTDEEKFITIFGTRSVSHLRKVFDKYMTISGFQIEETIDRETSGNLEQLLLAVVKSIRSIPAYLAETLYYAMKGAGTDDHTLIRVMVSRSEIDLFNIRKEFRKNFATSLYSMIKGDTSGDYKKALLLLCGEDDHHHHHHHHHH","Homo sapiens","ANXA5, ANX5, ENX2, PP4","Annexin A5","1","6K25"
"6K2C",,"X-RAY DIFFRACTION",3.54,65.26,"VAPOR DIFFUSION",,"100mM HEPES 7.5, 20% PEG 10000",296,"10.1042/BCJ20200027",,"6K2C",44.58,"2.703","2.703","Extended Hect domain of UBE3C E3 Ligase","AAVPFEERVKIFQRLIYADKQEVQGDGPFLDGINVTIRRNYIYEDAYDKLSPENEPDLKKRIRVHLLNAHGLDEAGIDGGGIFREFLNELLKSGFNPNQGFFKTTNEGLLYPNPAAQMLVGDSFARHYYFLGRMLGKALYENMLVELPFAGFFLSKLLGTSADVDIHHLASLDPEVYKNLLFLKSYEDDVEELGLNFTVVNNDLGEAQVVELKFGGKDIPVTSANRIAYIHLVADYRLNRQIRQHCLAFRQGLANVVSLEWLRMFDQQEIQVLISGAQVPISLEDLKSFTNYSGGYSADHPVIKVFWRVVEGFTDEEKRKLLKFVTSCSRPPLLGFKELYPAFCIHNGGSDLERLPTASTCMNLLKLPEFYDETLLRSKLLYAIECAAGFELS","Homo sapiens","UBE3C, KIAA0010, KIAA10","Ubiquitin-protein ligase E3C","1","6K2C"
"6K2K",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2019.06.101",,"6K2K",6.38,,,"Solution structure of MUL1-RING domain","GSLKSACVVCLSSFKSCVFLECGHVCSCTECYRALPEPKKCPICRQAITRVIPLYNS","Homo sapiens","MUL1, C1orf166, GIDE, MAPL, MULAN, RNF218","Mitochondrial ubiquitin ligase activator of NFKB 1","1","6K2K"
"6K2U",,"X-RAY DIFFRACTION",5.03,75.56,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M MMT (Malic Acid, MES and TRIS (1:2:2 Molar Ratio), pH 5.5 adjusted with HCl), 0.1M magnesium chloride, 0.1M zinc acetate 12% PEG8000",289,"10.1016/j.molcel.2020.03.016",,"6K2U",9.34,"2.554","2.554","Crystal structure of Thr66 ADP-ribosylated ubiquitin","SMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBC","Polyubiquitin-C","1","6K2U"
"6K2Y",,"X-RAY DIFFRACTION",2.28,46.14,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1111/febs.15441",,"6K2Y",32.79,"1.57","1.57","Human Galectin-14","GSHMSSLPVPYTLPVSLPVGSCVIITGTPILTFVKDPQLEVNFYTGMDEDSDIAFQFRLHFGHPAIMNSCVFGIWRYEEKCYYLPFEDGKPFELCIYVRHKEYKVMVNGQRIYNFAHRFPPASVKMLQVFRDISLTRVLISD","Homo sapiens","LGALS14, PPL13","Placental protein 13-like","1","6K2Y"
"6K2Z",,"X-RAY DIFFRACTION",2.26,45.68,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1111/febs.15441",,"6K2Z",33.47,"2","2","Human Galectin-14 with lactose","GSHMSSLPVPYTLPVSLPVGSCVIITGTPILTFVKDPQLEVNFYTGMDEDSDIAFQFRLHFGHPAIMNSCVFGIWRYEEKCYYLPFEDGKPFELCIYVRHKEYKVMVNGQRIYNFAHRFPPASVKMLQVFRDISLTRVLISD","Homo sapiens","LGALS14, PPL13","Placental protein 13-like","1","6K2Z"
"6K3N",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, HANGING DROP",,"0.05M HEPES, 0.75M sodium citrate, 5% glycerol, pH 7.5,",293,"10.1021/acs.chemrestox.9b00379","CW6","6K3N",26.03,"1.97","1.97","Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with BPA-monoF","KPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6K3N"
"6K4G",,"X-RAY DIFFRACTION",2.98,58.79,"VAPOR DIFFUSION",6.1,"9%(w/v) PEG4000, 0.1M sodium citrate pH 6.0, 0.1M magnesium acetate, 0.1M lithium acetate",293,"10.1016/j.str.2022.04.004",,"6K4G",91.42,"2.7","2.7","Crystal structure of the PI5P4Kbeta-GMPPNP complex","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","6K4G"
"6K4H",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION",,"9%(w/v) PEG4000, 0.1M sodium citrate pH 6.0, 0.1M magnesium acetate, 0.1M lithium acetate",293,"10.1016/j.str.2022.04.004",,"6K4H",91.38,"2.55","2.55","Crystal structure of the PI5P4Kbeta-AMPPNP complex","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","6K4H"
"6K4I",,"SOLUTION NMR",,,,,,,"10.1002/pro.3734",,"6K4I",8.56,,,"The partially disordered conformation of ubiquitin (Q41N variant)","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQNRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","ubiquitin","1","6K4I"
"6K4J",,"X-RAY DIFFRACTION",3.73,67.06,"LIPIDIC CUBIC PHASE",6.5,"PEG 200",298,"10.1038/s41467-020-15459-7",,"6K4J",26.11,"2.701","2.701","Crystal Structure of the the CD9","GSREFMPVKGGTKCIKYLLFGFNFIFWLAGIAVLAIGLWLRFDSQTKSIFEQETNNNNSSFYTGVYILIGAGALMMLVGFLGCCGAVQESQCMLGLFFGFLLVIFAIEIAAAIWGYSHKDEVIKEVQEFYKDTYNKLKTKDEPQRETLKAIHYALNCCGLAGGVEQFISDICPKKDVLESCPDAIKEVFDNKFHIIGAVGIGIAVVMIFGMIFSMILCCAIRRNREMV","Homo sapiens","CD9, MIC3, TSPAN29, GIG2","CD9 antigen","1","6K4J"
"6K4N","9.8","ELECTRON MICROSCOPY",,,,,,,"10.1021/acs.biochem.9b00333",,"6K4N",72.1,"9.8, 9.8",,"Cryo-EM structure of p300","KKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQPQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQD","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","6K4N"
"6K6U",,"X-RAY DIFFRACTION",2.2,44.21,"VAPOR DIFFUSION, SITTING DROP",,"Tacsimate,Tris,PEG 3350",291,"10.1016/j.bbrc.2019.08.107",,"6K6U",33.11,"2.27","2.27","Crystal structure of the human YTHDC2 YTH domain","GHMPVRYFIMKSSNLRNLEISQQKGIWSTTPSNERKLNRAFWESSIVYLVFSVQGSGHFQGFSRMSSEIGREKSQDWGSAGLGGVFKVEWIRKESLPFQFAHHLLNPWNDNKKVQISRDGQELEPLVGEQLLQLWERLPLGEK","Homo sapiens","YTHDC2","3'-5' RNA helicase YTHDC2","1","6K6U"
"6K7P",,"X-RAY DIFFRACTION",2.51,50.9,"EVAPORATION",4.5,"0.3 M sodium citrate, 0.1 M sodium citrate-citrate acid pH 4.5, 25% PEG 3350",291,"10.1038/s41421-020-0142-6",,"6K7P",30.47,"2.4","2.4","Crystal structure of human AFF4-THD domain","RRTKLVFDDRNYSADHYLQEAKKLKHNADALSDRFEKAVYYLDAVVSFIECGNALEKNAQESKSPFPMYSETVDLIKYTMKLKNYLAPDATAADKRLTVLCLRCESLLYLRLFKLKKENALKYSKTLTEHLKNSYNNSQAPSPGLGSKAVGMPSPVSPKLSPGNSGNYSSGASSASASGSSVTIPQKIHQMAASYVQVTSNFLYATEIWDQAEQLSKEQKEFFAELDKVMGPLIFNASIMTDLVRYTRQGLHWLRQDAKLISLEHHHHHH","Homo sapiens","AFF4, AF5Q31, MCEF, HSPC092","AF4/FMR2 family member 4","1","6K7P"
"6K7V","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-20319-5",,"6K7V",146.45,"3.7, 3.7",,"Structure of NLRP1 CARD filament","GPGDYKDDDDKDAPQLLHFVDQYREQLIARVTSVEVVLDKLHGQVLSQEQYERVLAENTRPSQMRKLFSLSQSWDRKCKDGLYQALKETHPHLIMELWEKGSKK","Homo sapiens","NLRP1, CARD7, DEFCAP, KIAA0926, NAC, NALP1","NACHT, LRR and PYD domains-containing protein 1","1","6K7V"
"6K7W",,"SOLUTION NMR",,,,,,,"10.1042/BCJ20200536",,"6K7W",10.15,,,"Solution Structure of the CS1 Domain of USP19","TPELALDWRQSAEEVIVKLRVGVGPLQLEDVDAAFTDTDCVVRFAGGQQWGGVFYAEIKSSCAKVQTRKGSLLHLTLPKKVPMLTWPSLLVE","Homo sapiens","USP19, KIAA0891, ZMYND9","Ubiquitin carboxyl-terminal hydrolase 19","1","6K7W"
"6K8J","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-20319-5",,"6K8J",139.2,"3.3, 3.3",,"Structure of NLRC4 CARD filament","GPGVDEALREAQTKSAMNFIKDNSRALIQRMGMTVIKQITDDLFVWNVLNREEVNIICCEKVEQDAARGIIHMILKKGSESCNLFLKSLKEWNYPLFQDLN","Homo sapiens","NLRC4, CARD12, CLAN, CLAN1, IPAF, UNQ6189/PRO20215","NLR family CARD domain-containing protein 4","1","6K8J"
"6K95",,"X-RAY DIFFRACTION",2.96,58.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"14%(w/v) polyethylene-glycol 8,000 (PEG 8000), 14% PEG, 100mM HEPES (pH 7.5)",295,"10.3390/biom10010031",,"6K95",62.39,"2.29","2.29","Crystal structural of human glutathione-specific gamma-glutamylcyclotransferase 2 (ChaC2)","MWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGKPGRVVTLVEDPAGCVWGVAYRLPVGKEEEVKAYLDFGEKGGYRTTTVIFYPKDPTTKPFSVLLYIGTCDNPDYLGPAPLEDIAEQIFNAAGPSGRNTEYLFELANSIRNLVPEEADEHLFALEKLVKERLEGKQNLNCI","Homo sapiens","CHAC2","Glutathione-specific gamma-glutamylcyclotransferase 2","1","6K95"
"6K99","4.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-20319-5",,"6K99",117.3,"4.1, 4.1",,"Structure of ASC CARD filament","LHFIDQHRAALIARVTNVEWLLDALYGKVLTDEQYQAVRAEPTNPSKMRKLFSFTPAWNWTCKDLLLQALRESQSYLVEDLER","Homo sapiens","PYCARD, ASC, CARD5, TMS1","Apoptosis-associated speck-like protein containing a CARD","1","6K99"
"6K9F","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-20319-5",,"6K9F",125.35,"3.7, 3.7",,"Structure of unknow protein 4","GPGMAAFVKENHRQLQARMGDLKGVLDDLQDNEVLTENEKELVEQEKTRQSKNEALLSMVEKKGDLALDVLFRSISERDPYLVSYLRQQNL","Homo sapiens","CARD8, KIAA0955, NDPP1, DACAR","Caspase recruitment domain-containing protein 8","1","6K9F"
"6K9G",,"X-RAY DIFFRACTION",2.14,42.39,"EVAPORATION",,"22% PEG 3350, 0.1M Tris HCl pH 8.5",281,"10.1016/j.ejmech.2020.112240",,"6K9G",126.88,"2.8","2.8","Human LXR-beta in complex with an agonist","MGHHHHHHGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPASGSASQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHEGSGSGSHKILHRLLQDSSS","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","6K9G"
"6K9H",,"X-RAY DIFFRACTION",2.3,46.43,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG 3350, 0.1 M Tris HCl, pH 8.5",281,"10.1016/j.ejmech.2020.112240","D40","6K9H",63.07,"2.5","2.5","Human LXR-beta in complex with an agonist","MGHHHHHHGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPASGSASQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHEGSGSGSHKILHRLLQDSSS","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","6K9H"
"6K9K","7.82","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-019-0205-0",,"6K9K",351.13,"7.82",,"Monomeric human ATM (Ataxia telangiectasia mutated) kinase","MSLVLNDLLICCRQLEHDRATERKKEVEKFKRLIRDPETIKHLDRHSDSKQGKYLNWDAVFRFLQKYIQKETECLRIAKPNVSASTQASRQKKMQEISSLVKYFIKCANRRAPRLKCQELLNYIMDTVKDSSNGAIYGADCSNILLKDILSVRKYWCEISQQQWLELFSVYFRLYLKPSQDVHRVLVARIIHAVTKGCCSQTDGLNSKFLDFFSKAIQCARQEKSSSGLNHILAALTIFLKTLAVNFRIRVCELGDEILPTLLYIWTQHRLNDSLKEVIIELFQLQIYIHHPKGAKTQEKGAYESTKWRSILYNLYDLLVNEISHIGSRGKYSSGFRNIAVKENLIELMADICHQVFNEDTRSLEISQSYTTTQRESSDYSVPCKRKKIELGWEVIKDHLQKSQNDFDLVPWLQIATQLISKYPASLPNCELSPLLMILSQLLPQQRHGERTPYVLRCLTEVALCQDKRSNLESSQKSDLLKLWNKIWCITFRGISSEQIQAENFGLLGAIIQGSLVEVDREFWKLFTGSACRPSCPAVCCLTLALTTSIVPGTVKMGIEQNMCEVNRSFSLKESIMKWLLFYQLEGDLENSTEVPPILHSNFPHLVLEKILVSLTMKNCKAAMNFFQSVPECEHHQKDKEELSFSEVEELFLQTTFDKMDFLTIVRECGIEKHQSSIGFSVHQNLKESLDRCLLGLSEQLLNNYSSEITNSETLVRCSRLLVGVLGCYCYMGVIAEEEAYKSELFQKAKSLMQCAGESITLFKNKTNEEFRIGSLRNMMQLCTRCLSNCTKKSPNKIASGFFLRLLTSKLMNDIADICKSLASFIKKPFDRGEVESMEDDTNGNLMEVEDQSSMNLFNDYPDSSVSDANEPGESQSTIGAINPLAEEYLSKQDLLFLDMLKFLCLCVTTAQTNTVSFRAADIRRKLLMLIDSSTLEPTKSLHLHMYLMLLKELPGEEYPLPMEDVLELLKPLSNVCSLYRRDQDVCKTILNHVLHVVKNLGQSNMDSENTRDAQGQFLTVIGAFWHLTKERKYIFSVRMALVNCLKTLLEADPYSKWAILNVMGKDFPVNEVFTQFLADNHHQVRMLAAESINRLFQDTKGDSSRLLKALPLKLQQTAFENAYLKAQEGMREMSHSAENPETLDEIYNRKSVLLTLIAVVLSCSPICEKQALFALCKSVKENGLEPHLVKKVLEKVSETFGYRRLEDFMASHLDYLVLEWLNLQDTEYNLSSFPFILLNYTNIEDFYRSCYKVLIPHLVIRSHFDEVKSIANQIQEDWKSLLTDCFPKILVNILPYFAYEGTRDSGMAQQRETATKVYDMLKSENLLGKQIDHLFISNLPEIVVELLMTLHEPANSSASQSTDLCDFSGDLDPAPNPPHFPSHVIKATFAYISNCHKTKLKSILEILSKSPDSYQKILLAICEQAAETNNVYKKHRILKIYHLFVSLLLKDIKSGLGGAWAFVLRDVIYTLIHYINQRPSCIMDVSLRSFSLCCDLLSQVCQTAVTYCKDALENHLHVIVGTLIPLVYEQVEVQKQVLDLLKYLVIDNKDNENLYITIKLLDPFPDHVVFKDLRITQQKIKYSRGPFSLLEEINHFLSVSVYDALPLTRLEGLKDLRRQLELHKDQMVDIMRASQDNPQDGIMVKLVVNLLQLSKMAINHTGEKEVLEAVGSCLGEVGPIDFSTIAIQHSKDASYTKALKLFEDKELQWTFIMLTYLNNTLVEDCVKVRSAAVTCLKNILATKTGHSFWEIYKMTTDPMLAYLQPFRTSRKKFLEVPRFDKENPFEGLDDINLWIPLSENHDIWIKTLTCAFLDSGGTKCEILQLLKPMCEVKTDFCQTVLPYLIHDILLQDTNESWRNLLSTHVQGFFTSCLRHFSQTSRSTTPANLDSESEHFFRCCLDKKSQRTMLAVVDYMRRQKRPSSGTIFNDAFWLDLNYLEVAKVAQSCAAHFTALLYAEIYADKKSMDDQEKRSLAFEEGSQSTTISSLSEKSKEETGISLQDLLLEIYRSIGEPDSLYGCGGGKMLQPITRLRTYEHEAMWGKALVTYDLETAIPSSTRQAGIIQALQNLGLCHILSVYLKGLDYENKDWCPELEELHYQAAWRNMQWDHCTSVSKEVEGTSYHESLYNALQSLRDREFSTFYESLKYARVKEVEEMCKRSLESVYSLYPTLSRLQAIGELESIGELFSRSVTHRQLSEVYIKWQKHSQLLKDSDFSFQEPIMALRTVILEILMEKEMDNSQRECIKDILTKHLVELSILARTFKNTQLPERAIFQIKQYNSVSCGVSEWQLEEAQVFWAKKEQSLALSILKQMIKKLDASCAANNPSLKLTYTECLRVCGNWLAETCLENPAVIMQTYLEKAVEVAGNYDGESSDELRNGKMKAFLSLARFSDTQYQRIENYMKSSEFENKQALLKRAKEEVGLLREHKIQTNRYTVKVQRELELDELALRALKEDRKRFLCKAVENYINCLLSGEEHDMWVFRLCSLWLENSGVSEVNGMMKRDGMKIPTYKFLPLMYQLAARMGTKMMGGLGFHEVLNNLISRISMDHPHHTLFIILALANANRDEFLTKPEVARRSRITKNVPKQSSQLDEDRTEAANRIICTIRSRRPQMVRSVEALCDAYIILANLDATQWKTQRKGINIPADQPITKLKNLEDVVVPTMEIKVDHTGEYGNLVTIQSFKAEFRLAGGVNLPKIIDCVGSDGKERRQLVKGRDDLRQDAVMQQVFQMCNTLLQRNTETRKRKLTICTYKVVPLSQRSGVLEWCTGTVPIGEFLVNNEDGAHKRYRPNDFSAFQCQKKMMEVQKKSFEEKYEVFMDVCQNFQPVFRYFCMEKFLDPAIWFEKRLAYTRSVATSSIVGYILGLGDRHVQNILINEQSAELVHIDLGVAFEQGKILPTPETVPFRLTRDIVDGMGITGVEGVFRRCCEKTMEVMRNSQETLLTIVEVLLYDPLFDWTMNPLKALYLQQRPEDETELHPTLNADDQECKRNLSDIDQSFNKVAERVLMRLQEKLKGVEEGTVLSVGGQVNLLIQQAIDPKNLSRLFPGWKAWV","Homo sapiens","ATM","Serine-protein kinase ATM","1","6K9K"
"6K9L","4.27","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-019-0205-0",,"6K9L",702.26,"4.27",,"4.27 Angstrom resolution cryo-EM structure of human dimeric ATM kinase","MSLVLNDLLICCRQLEHDRATERKKEVEKFKRLIRDPETIKHLDRHSDSKQGKYLNWDAVFRFLQKYIQKETECLRIAKPNVSASTQASRQKKMQEISSLVKYFIKCANRRAPRLKCQELLNYIMDTVKDSSNGAIYGADCSNILLKDILSVRKYWCEISQQQWLELFSVYFRLYLKPSQDVHRVLVARIIHAVTKGCCSQTDGLNSKFLDFFSKAIQCARQEKSSSGLNHILAALTIFLKTLAVNFRIRVCELGDEILPTLLYIWTQHRLNDSLKEVIIELFQLQIYIHHPKGAKTQEKGAYESTKWRSILYNLYDLLVNEISHIGSRGKYSSGFRNIAVKENLIELMADICHQVFNEDTRSLEISQSYTTTQRESSDYSVPCKRKKIELGWEVIKDHLQKSQNDFDLVPWLQIATQLISKYPASLPNCELSPLLMILSQLLPQQRHGERTPYVLRCLTEVALCQDKRSNLESSQKSDLLKLWNKIWCITFRGISSEQIQAENFGLLGAIIQGSLVEVDREFWKLFTGSACRPSCPAVCCLTLALTTSIVPGTVKMGIEQNMCEVNRSFSLKESIMKWLLFYQLEGDLENSTEVPPILHSNFPHLVLEKILVSLTMKNCKAAMNFFQSVPECEHHQKDKEELSFSEVEELFLQTTFDKMDFLTIVRECGIEKHQSSIGFSVHQNLKESLDRCLLGLSEQLLNNYSSEITNSETLVRCSRLLVGVLGCYCYMGVIAEEEAYKSELFQKAKSLMQCAGESITLFKNKTNEEFRIGSLRNMMQLCTRCLSNCTKKSPNKIASGFFLRLLTSKLMNDIADICKSLASFIKKPFDRGEVESMEDDTNGNLMEVEDQSSMNLFNDYPDSSVSDANEPGESQSTIGAINPLAEEYLSKQDLLFLDMLKFLCLCVTTAQTNTVSFRAADIRRKLLMLIDSSTLEPTKSLHLHMYLMLLKELPGEEYPLPMEDVLELLKPLSNVCSLYRRDQDVCKTILNHVLHVVKNLGQSNMDSENTRDAQGQFLTVIGAFWHLTKERKYIFSVRMALVNCLKTLLEADPYSKWAILNVMGKDFPVNEVFTQFLADNHHQVRMLAAESINRLFQDTKGDSSRLLKALPLKLQQTAFENAYLKAQEGMREMSHSAENPETLDEIYNRKSVLLTLIAVVLSCSPICEKQALFALCKSVKENGLEPHLVKKVLEKVSETFGYRRLEDFMASHLDYLVLEWLNLQDTEYNLSSFPFILLNYTNIEDFYRSCYKVLIPHLVIRSHFDEVKSIANQIQEDWKSLLTDCFPKILVNILPYFAYEGTRDSGMAQQRETATKVYDMLKSENLLGKQIDHLFISNLPEIVVELLMTLHEPANSSASQSTDLCDFSGDLDPAPNPPHFPSHVIKATFAYISNCHKTKLKSILEILSKSPDSYQKILLAICEQAAETNNVYKKHRILKIYHLFVSLLLKDIKSGLGGAWAFVLRDVIYTLIHYINQRPSCIMDVSLRSFSLCCDLLSQVCQTAVTYCKDALENHLHVIVGTLIPLVYEQVEVQKQVLDLLKYLVIDNKDNENLYITIKLLDPFPDHVVFKDLRITQQKIKYSRGPFSLLEEINHFLSVSVYDALPLTRLEGLKDLRRQLELHKDQMVDIMRASQDNPQDGIMVKLVVNLLQLSKMAINHTGEKEVLEAVGSCLGEVGPIDFSTIAIQHSKDASYTKALKLFEDKELQWTFIMLTYLNNTLVEDCVKVRSAAVTCLKNILATKTGHSFWEIYKMTTDPMLAYLQPFRTSRKKFLEVPRFDKENPFEGLDDINLWIPLSENHDIWIKTLTCAFLDSGGTKCEILQLLKPMCEVKTDFCQTVLPYLIHDILLQDTNESWRNLLSTHVQGFFTSCLRHFSQTSRSTTPANLDSESEHFFRCCLDKKSQRTMLAVVDYMRRQKRPSSGTIFNDAFWLDLNYLEVAKVAQSCAAHFTALLYAEIYADKKSMDDQEKRSLAFEEGSQSTTISSLSEKSKEETGISLQDLLLEIYRSIGEPDSLYGCGGGKMLQPITRLRTYEHEAMWGKALVTYDLETAIPSSTRQAGIIQALQNLGLCHILSVYLKGLDYENKDWCPELEELHYQAAWRNMQWDHCTSVSKEVEGTSYHESLYNALQSLRDREFSTFYESLKYARVKEVEEMCKRSLESVYSLYPTLSRLQAIGELESIGELFSRSVTHRQLSEVYIKWQKHSQLLKDSDFSFQEPIMALRTVILEILMEKEMDNSQRECIKDILTKHLVELSILARTFKNTQLPERAIFQIKQYNSVSCGVSEWQLEEAQVFWAKKEQSLALSILKQMIKKLDASCAANNPSLKLTYTECLRVCGNWLAETCLENPAVIMQTYLEKAVEVAGNYDGESSDELRNGKMKAFLSLARFSDTQYQRIENYMKSSEFENKQALLKRAKEEVGLLREHKIQTNRYTVKVQRELELDELALRALKEDRKRFLCKAVENYINCLLSGEEHDMWVFRLCSLWLENSGVSEVNGMMKRDGMKIPTYKFLPLMYQLAARMGTKMMGGLGFHEVLNNLISRISMDHPHHTLFIILALANANRDEFLTKPEVARRSRITKNVPKQSSQLDEDRTEAANRIICTIRSRRPQMVRSVEALCDAYIILANLDATQWKTQRKGINIPADQPITKLKNLEDVVVPTMEIKVDHTGEYGNLVTIQSFKAEFRLAGGVNLPKIIDCVGSDGKERRQLVKGRDDLRQDAVMQQVFQMCNTLLQRNTETRKRKLTICTYKVVPLSQRSGVLEWCTGTVPIGEFLVNNEDGAHKRYRPNDFSAFQCQKKMMEVQKKSFEEKYEVFMDVCQNFQPVFRYFCMEKFLDPAIWFEKRLAYTRSVATSSIVGYILGLGDRHVQNILINEQSAELVHIDLGVAFEQGKILPTPETVPFRLTRDIVDGMGITGVEGVFRRCCEKTMEVMRNSQETLLTIVEVLLYDPLFDWTMNPLKALYLQQRPEDETELHPTLNADDQECKRNLSDIDQSFNKVAERVLMRLQEKLKGVEEGTVLSVGGQVNLLIQQAIDPKNLSRLFPGWKAWV","Homo sapiens","ATM","Serine-protein kinase ATM","1","6K9L"
"6K9M",,"X-RAY DIFFRACTION",2.12,42.11,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG3350, 0.1 M Tris HCl, pH8.5",281,"10.1016/j.ejmech.2020.112793",,"6K9M",126.01,"2.9","2.9","Human LXR-beta in complex with an agonist","MGHHHHHHGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPASGSASQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHEGSGSGSHKILHRLLQDSSS","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","6K9M"
"6K9Y",,"X-RAY DIFFRACTION",2.69,54.22,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, ammonium nitrate",293,"10.1074/jbc.RA119.011019",,"6K9Y",154.36,"2.2","2.2","Crystal structure of human VAT-1","GPHMAAASPPLLRCLVLTGFGGYDKVKLQSRPAAPPAPGPGQLTLRLRACGLNFADLMARQGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRKAGDRVMVLNRSGMWQEEVTVPSVQTFLIPEAMTFEEAAALLVNYITAYMVLFDFGNLQPGHSVLVHMAAGGVGMAAVQLCRTVENVTVFGTASASKHEALKENGVTHPIDYHTTDYVDEIKKISPKGVDIVMDPLGGSDTAKGYNLLKPMGKVVTYGMANLLTGPKRNLMALARTWWNQFSVTALQLLQANRAVCGFHLGYLDGEVELVSGVVARLLALYNQGHIKPHIDSVWPFEKVADAMKQMQEKKNVGKVLLVPGPEKEN","Homo sapiens","VAT1","Synaptic vesicle membrane protein VAT-1 homolog","1","6K9Y"
"6KAJ",,"X-RAY DIFFRACTION",2.91,57.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"4-8% PEG 4,000, 0.1 M HEPES-NaOH (pH7.5), 0.5 M LiCl2 and 20 mM BaCl2",293,"10.1038/s41467-019-14220-z",,"6KAJ",204.91,"2.2249","2.2249","Crystal structure of FKRP in complex with Ba ion","GGRPAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG","Homo sapiens","FKRP","Fukutin-related protein","1","6KAJ"
"6KAK",,"X-RAY DIFFRACTION",2.96,58.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"4-8% PEG 4,000, 0.1 M HEPES-NaOH (pH7.5), and 0.2 M MgCl2",293,"10.1038/s41467-019-14220-z",,"6KAK",202.31,"2.056","2.056","Crystal structure of FKRP in complex with Mg ion","GGRPAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG","Homo sapiens","FKRP","Fukutin-related protein","1","6KAK"
"6KAL",,"X-RAY DIFFRACTION",2.91,57.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"4-8% PEG 4,000, 0.1 M HEPES-NaOH (pH7.5) and 0.2 M MgCl2",293,"10.1038/s41467-019-14220-z",,"6KAL",203.4,"2.6","2.6","Crystal structure of FKRP in complex with Mg ion and CMP","GGRPAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG","Homo sapiens","FKRP","Fukutin-related protein","1","6KAL"
"6KAM",,"X-RAY DIFFRACTION",2.98,58.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"4-8 % PEG 4,000, 0.1 M HEPES-NaOH (pH7.5),
0.5 M LiCl2 and 20 mM BaCl2",293,"10.1038/s41467-019-14220-z",,"6KAM",205.46,"2.46","2.46","Crystal structure of FKRP in complex with Ba ion, CDP-ribtol, and sugar acceptor","GGRPAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG","Homo sapiens","FKRP","Fukutin-related protein","1","6KAM"
"6KAN",,"X-RAY DIFFRACTION",2.95,58.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"4-8% PEG 4,000, 0.1 M HEPES-NaOH (pH7.5),0.5 M LiCl2, and 20 mM BaCl2",293,"10.1038/s41467-019-14220-z",,"6KAN",202.6,"2.251","2.251","Crystal structure of FKRP in complex with Ba ion","GGRPAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG","Homo sapiens","FKRP","Fukutin-related protein","1","6KAN"
"6KAX",,"X-RAY DIFFRACTION",2.26,45.6,"VAPOR DIFFUSION",,"0.1M HEPES (pH 7.0), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KAX",31.2,"1.23","1.23","X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin) co-crystals obtained by cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KAX"
"6KAY",,"X-RAY DIFFRACTION",2.29,46.35,"VAPOR DIFFUSION",,"0.1M Bis-Tris(pH 6.5), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KAY",31.45,"1.735","1.735","X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by soaking","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KAY"
"6KAZ",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION",,"0.1M Bis-Tris(pH 6.5), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KAZ",31.44,"1.48","1.48","X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by soaking","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KAZ"
"6KB0",,"X-RAY DIFFRACTION",2.27,45.89,"VAPOR DIFFUSION",,"0.1 M Bis-Tris(pH 6.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB0",31.24,"1.35","1.35","X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic acid (ETYA) co-crystals obtained by soaking","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB0"
"6KB1",,"X-RAY DIFFRACTION",2.25,45.34,"VAPOR DIFFUSION",,"0.1 M Bis-Tris(pH 6.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB1",31.24,"1.25","1.25","X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystals obtained by soaking","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB1"
"6KB2",,"X-RAY DIFFRACTION",2.37,48.14,"VAPOR DIFFUSION",,"0.1M HEPES (pH 7.0), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB2",31.5,"1.95","1.95","X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by soaking","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB2"
"6KB3",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION",,"0.1M Tris (pH 8.5), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB3",31.45,"1.45","1.45","X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB3"
"6KB4",,"X-RAY DIFFRACTION",2.26,45.47,"VAPOR DIFFUSION",,"0.1M Tris (pH 8.0), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB4",31.44,"1.42","1.42","X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB4"
"6KB5",,"X-RAY DIFFRACTION",2.29,46.27,"VAPOR DIFFUSION",,"0.1M Tris (pH 8.0), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB5",31.24,"1.95","1.95","X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic Acid (ETYA) co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB5"
"6KB6",,"X-RAY DIFFRACTION",2.26,45.58,"VAPOR DIFFUSION",,"0.1 M HEPES (pH 7.0), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB6",31.24,"1.431","1.431","X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB6"
"6KB7",,"X-RAY DIFFRACTION",2.27,45.89,"VAPOR DIFFUSION",,"0.1M HEPES (pH 7.0), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB7",31.5,"2.14","2.14","X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB7"
"6KB8",,"X-RAY DIFFRACTION",2.29,46.18,"VAPOR DIFFUSION",,"0.1 M Bis-Tris (pH 6.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB8",31.45,"1.47","1.47","X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB8"
"6KB9",,"X-RAY DIFFRACTION",2.26,45.62,"VAPOR DIFFUSION",,"0.1M Tris (pH 8.0), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KB9",31.44,"1.55","1.55","X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KB9"
"6KBA",,"X-RAY DIFFRACTION",2.35,47.59,"VAPOR DIFFUSION",,"0.1 M HEPES (pH 7.0), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KBA",31.5,"1.82","1.82","X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by co-crystallization","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KBA"
"6KBI",,"X-RAY DIFFRACTION",3.4,63.81,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M lithium sulfate, 0.1 M Tris buffer (pH 8.5) and 11% (w/v) PEG4000.",293,,,"6KBI",140.33,"3","3","Crystal structure of ErbB3 N418Q mutant","SEVGNSQAVCPGTLNGLSVTGDAENQYQTLYKLYERCEVVMGNLEIVLTGHNADLSFLQWIREVTGYVLVAMNEFSTLPLPNLRVVRGTQVYDGKFAIFVMLNYNTNSSHALRQLRLTQLTEILSGGVYIEKNDKLCHMDTIDWRDIVRDRDAEIVVKDNGRSCPPCHEVCKGRCWGPGSEDCQTLTKTICAPQCNGHCFGPNPNQCCHDECAGGCSGPQDTDCFACRHFNDSGACVPRCPQPLVYNKLTFQLEPNPHTKYQYGGVCVASCPHNFVVDQTSCVRACPPDKMEVDKNGLKMCEPCGGLCPKACEGTGSGSRFQTVDSSNIDGFVNCTKILGNLDFLITGLNGDPWHKIPALDPEKLNVFRTVREITGYLNIQSWPPHMHNFSVFSNLTTIGGRSLYNRGFSLLIMKNLQVTSLGFRSLKEISAGRIYISANRQLCYHHSLNWTKVLRGPTEERLDIKHNRPRRDCVAEGKVCDPLCSSGGCWGPGPGQCLSCRNYSRGGVCVTHCNFLNGEPREFAHEAECFSCHPECQPMEGTATCNGSGSDTCAQCAHFRDGPHCVSSCPHGVLGAKGPIYKYPDVQNECRPCHENCTQGCKGPELQDCLGQTLVLIGK","Homo sapiens","ERBB3, HER3","Receptor tyrosine-protein kinase erbB-3","1","6KBI"
"6KBP",,"X-RAY DIFFRACTION",2.22,44.58,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M ammonium acetate
12.5% (w/v) polyethylene glycol 4000
10% (v/v) glycerol
0.1 M sodium citrate, pH 8.0",288,,,"6KBP",157.81,"2.25","2.25","Crystal structure of human D-amino acid oxidase mutant (P219L) complexed with benzoate","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDLERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKK","Homo sapiens","DAO, DAMOX","D-amino-acid oxidase","1","6KBP"
"6KC5",,"X-RAY DIFFRACTION",2.16,42.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM HEPES-Na (pH 7.5), 200 mM NaCl, 25% PEG 3,350",293,"10.1038/s42003-020-0882-8",,"6KC5",26.52,"1.543","1.543","HOIP-HOIPIN1 complex","GPGHMPEYQAQGLAMYLQENGIDCPKCKFSYALARGGCMHFHCTQCRHQFCSGCYNAFYAKNKCPEPNCRVKKSLHGHHPRDCLFYLRDWTALRLQKLLQDNNVMFNTEPPAGARAVPGGGCRVIEQKEVPNGLRDEACGKETPAGYAGLCQAHYKEYLVSLINAHSLDPATLYEVEELETATERYLHVRPQPLAGEDPPAYQARLLQKLTEEVPLGQSIPRRRK","Homo sapiens","RNF31, ZIBRA","E3 ubiquitin-protein ligase RNF31","1","6KC5"
"6KC6",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, SITTING DROP",8,"200 mM KCl, 20% PEG3,350",293,"10.1038/s42003-020-0882-8",,"6KC6",157.64,"2.123","2.123","HOIP-HOIPIN8 complex","GPGHMPEYQAQGLAMYLQENGIDCPKCKFSYALARGGCMHFHCTQCRHQFCSGCYNAFYAKNKCPEPNCRVKKSLHGHHPRDCLFYLRDWTALRLQKLLQDNNVMFNTEPPAGARAVPGGGCRVIEQKEVPNGLRDEACGKETPAGYAGLCQAHYKEYLVSLINAHSLDPATLYEVEELETATERYLHVRPQPLAGEDPPAYQARLLQKLTEEVPLGQSIPRRRK","Homo sapiens","RNF31, ZIBRA","E3 ubiquitin-protein ligase RNF31","1","6KC6"
"6KCZ",,"SOLUTION NMR",,,,,,,"10.1002/pro.3675",,"6KCZ",11.08,,,"Solution structure of the ZnF-UBP domain of USP20/VDU2","MGDSRDLCPHLDSIGEVTKEDLLLKSKGTCQSCGVTGPNLWACLQVACPYVGCGESFADHSTIHAQAKKHNLTVNLTTFRLWCYACEKEVFLEQRLAAP","Homo sapiens","USP20, KIAA1003, LSFR3A, VDU2","Ubiquitin carboxyl-terminal hydrolase 20","1","6KCZ"
"6KDX",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, SITTING DROP",,"50mM Bis-tris propane pH6.0, 50mM Magnesium sulfate, 15% PEG 3350",296,"10.1016/j.bmc.2019.07.010","D6X","6KDX",79.71,"2.44","2.44","Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6KDX"
"6KDZ",,"X-RAY DIFFRACTION",2.2,43.99,"VAPOR DIFFUSION, SITTING DROP",,"50mM Bis-tris propane pH6.0, 50mM Magnesium sulfate, 15% PEG 3350",296,"10.1016/j.bmc.2019.07.010",,"6KDZ",79.75,"3.1","3.1","Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6KDZ"
"6KE0",,"X-RAY DIFFRACTION",2.2,44.07,"VAPOR DIFFUSION, SITTING DROP",,"50mM Bis-tris propane pH 6.0, 50mM Magnesium sulfate, 15% PEG 3350",296,"10.1016/j.bmc.2019.07.010",,"6KE0",79.75,"2.95","2.95","Crystal structure of PDE10A in complex with a triazolopyrimidine inhibitor","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6KE0"
"6KE2",,"X-RAY DIFFRACTION",3.2,61.53,"VAPOR DIFFUSION, HANGING DROP",,"0.1M bincine pH 9.0, 2M MgCl2",285,"10.1039/c9cc05247j",,"6KE2",21.37,"1.798","1.798","ABloop reengineered Ferritin Nanocage","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6KE2"
"6KE4",,"X-RAY DIFFRACTION",3.22,61.77,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bincine pH 9.0, 2M MgCl2",295,"10.1039/c9cc05247j",,"6KE4",21.16,"2.3","2.3","ABloop reengineered Ferritin Nanocage","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6KE4"
"6KEC",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, HANGING DROP",7.4,"6 M sodium formate, 10% glycerol",287,"10.3390/molecules26061686",,"6KEC",15.56,"1.35","1.35","Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 4-ethoxy-5,16-dimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.6.1.03,8.013,17]heptadeca-1(17),3,5,7,9,13,15-heptaen-12-one","GSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KEC"
"6KED",,"X-RAY DIFFRACTION",2.14,42.4,"VAPOR DIFFUSION, SITTING DROP",,"4M Sodium formate, 15% glycerol",289,,,"6KED",15.55,"2.54844688054","2.54844688054","BRD4 Bromodomain1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KED"
"6KEE",,"X-RAY DIFFRACTION",2.06,40.19,"VAPOR DIFFUSION, SITTING DROP",,"4M Sodium Formate, 15% glycerol",289,,,"6KEE",15.54,"2.12154661767","2.12154661767","Crystal structure of BRD4 Bromodomain1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KEE"
"6KEF",,"X-RAY DIFFRACTION",2.09,41.19,"VAPOR DIFFUSION, SITTING DROP",,"4M Sodium Formate, 15% glycerol",289.15,,,"6KEF",15.51,"2.44467544859","2.44467544859","BRD4 Bromodomain1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KEF"
"6KEG",,"X-RAY DIFFRACTION",2.08,40.95,"VAPOR DIFFUSION, SITTING DROP",,"4M sodium formate, 15% glycerol",289,,,"6KEG",15.56,"2.232","2.232","BRD4 Bromodomain1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KEG"
"6KEH",,"X-RAY DIFFRACTION",2.08,40.85,"VAPOR DIFFUSION, HANGING DROP",7.4,"6 M Sodium formate, 10% Glycerol",287,"10.3390/molecules26061686",,"6KEH",15.52,"1.553","1.553","Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 6,16-dimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.6.1.03,8.013,17]heptadeca-1(17),3,5,7,9,13,15-heptaen-12-one","GSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KEH"
"6KEI",,"X-RAY DIFFRACTION",2.05,40.05,"VAPOR DIFFUSION, HANGING DROP",7.4,"6 M Sodium formate, 10% Glycerol",287,"10.3390/molecules26061686",,"6KEI",15.5,"1.451","1.451","Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 16-methoxy-11-methyl-6-[(pyridin-2-yl)methoxy]-2-oxa-11-azatetracyclo[8.6.1.03,8.013,17]heptadeca-1(16),3,5,7,9,13(17),14-heptaen-12-one","GSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KEI"
"6KEJ",,"X-RAY DIFFRACTION",2.04,39.73,"VAPOR DIFFUSION, HANGING DROP",7.4,"6 M Sodium Formate, 10% Glycerol",287,"10.3390/molecules26061686",,"6KEJ",15.51,"1.85","1.85","Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 6-[2-(diethylamino)ethoxy]-16-methoxy-11-methyl-2-oxa-11-azatetracyclo[8.6.1.03,8.013,17]heptadeca-1(17),3,5,7,9,13,15-heptaen-12-one","GSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KEJ"
"6KEK",,"X-RAY DIFFRACTION",2.04,39.73,"VAPOR DIFFUSION, HANGING DROP",7.4,"6 M sodium formate, 10% glycerol",287,"10.3390/molecules26061686",,"6KEK",15.64,"1.553","1.553","Crystal structure of BRD4 bromodomain 1 (BD1) in complex with 6-hydroxy-16-methoxy-11-methyl-2-oxa-11-azatetracyclo[8.6.1.03,8.013,17]heptadeca-1(16),3,5,7,9,13(17),14-heptaen-12-one","GSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6KEK"
"6KFI",,"SOLUTION NMR",,,,,,,"10.1002/anie.202002422",,"6KFI",8.8,,,"NMR solution structure of the 1:1 complex of Tel26 G-quadruplex and a tripodal cationic fluorescent probe NBTE","AAAGGGTTAGGGTTAGGGTTAGGGAA","Homo sapiens",,"G-quadruplex DNA (26-MER)","1","6KFI"
"6KFJ",,"SOLUTION NMR",,,,,,,"10.1002/anie.202002422",,"6KFJ",8.76,,,"NMR solution structure of the 1:1 complex of wtTel26 G-quadruplex and a tripodal cationic fluorescent probe NBTE","TTAGGGTTAGGGTTAGGGTTAGGGTT","Homo sapiens",,"G-quadruplex DNA wtTel26","1","6KFJ"
"6KG2",,"X-RAY DIFFRACTION",3.17,61.15,"VAPOR DIFFUSION, SITTING DROP",6.5,"28% I-PROH, 0.1M BIS-TRIS, PH 6.5, 3% PEG 200, 10 MM SPERMIDINE",293,"10.1021/acs.jmedchem.9b01113","D8C","6KG2",73.04,"2.25","2.25","Human MTHFD2 in complex with Compound 18","MGSSHHHHHHSSGENLYFQGEAVVISGRKLAQQIKQEVRQEVEEWVASGNKRPHLSVILVGENPASHSYVLNKTRAAAVVGINSETIMKPASISEEELLNLINKLNNDDNVDGLLVQLPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWEIIKRTGIPTLGKNVVVAGRSKNVGMPIAMLLHTDGAHERPGGDATVTISHRYTPKEQLKKHTILADIVISAAGIPNLITADMIKEGAAVIDVGINRVHDPVTAKPKLVGDVDFEGVRQKAGYITPVPGGVGPMTVAMLMKNTIIAAKKVLRLEERE","Homo sapiens","MTHFD2, NMDMC","Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial","1","6KG2"
"6KGB",,"X-RAY DIFFRACTION",1.71,27.92,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG400, 0.2 M CaCl2, 0.1 M MES-NaOH pH 6.5",293,"10.1111/jnc.15162",,"6KGB",34.4,"1.3","1.3","Crystal structure of E61K mutated transthyretin","MRGSHHHHHHGSMASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTKEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPK","Homo sapiens","TTR, PALB","Transthyretin","1","6KGB"
"6KGJ",,"X-RAY DIFFRACTION",3.82,67.78,"VAPOR DIFFUSION, SITTING DROP",,"0.4M ammonium sulfate, 0.1M sodium citrate tribasic dihydrate pH 5.6, 1.0M lithium sulfate monohydrate",293,"10.1074/jbc.RA119.010912",,"6KGJ",46.43,"1.8","1.8","M1Q-hNTAQ1 C28S","QEGNGPAAVHYQPASPPRDACVYSSCYSEENVWKLCEYIKNHDQYPLEECYAVFISNERKMIPIWKQQARPGDGPVIWDYHVVLLHVSSGGQSFIYDLDTVLPFPCLFDTYVEDAIKSDDDIHPQFRRKFRVICADSYLKNFASDRSHMKDSSGNWREPPPPYPCIETGDSKMNLNDFISMDPKVGWGAVYTLSEFTHRFGS","Homo sapiens","WDYHV1, C8orf32, NTAQ1","Protein N-terminal glutamine amidohydrolase","1","6KGJ"
"6KGO",,"X-RAY DIFFRACTION",3.75,67.17,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MES (pH 6.2-6.3), 0.2M diammonium tartrate, 0.0005M TCEP, 10% PEG3350",293,"10.1002/cmdc.202000014",,"6KGO",76.1,"2.25","2.25","LSD1-S2157 five-membered ring adduct model","GPLGSHMSGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAM","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","6KGO"
"6KGP",,"X-RAY DIFFRACTION",3.75,67.17,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MES (pH 6.2-6.3), 0.2M diammonium tartrate, 0.0005M TCEP, 10% PEG3350",293,"10.1002/cmdc.202000014",,"6KGP",76.1,"2.25","2.25","LSD1-S2157 N5 adduct model","GPLGSHMSGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAM","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","6KGP"
"6KGQ",,"X-RAY DIFFRACTION",3.73,67.05,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES (pH 7.5), 5% MPD, 3.5-4.0% PEG MME 2000",293,"10.1002/cmdc.202000014",,"6KGQ",75.53,"2.32","2.32","LSD1-FCPA-MPE five-membered ring adduct model","GPLGSHMSGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAM","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","6KGQ"
"6KGR",,"X-RAY DIFFRACTION",3.73,67.05,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES (pH 7.5), 5% MPD, 3.5-4.0% PEG MME 2000",293,"10.1002/cmdc.202000014",,"6KGR",75.53,"2.32","2.32","LSD1-FCPA-MPE N5 adduct model","GPLGSHMSGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAM","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","6KGR"
"6KHD",,"X-RAY DIFFRACTION",1.69,27.41,"VAPOR DIFFUSION, HANGING DROP",8,"8% (v/v) Tacsimate, 18% (w/v) PEG 3350, 3% (v/v) Glycerol",293,"10.1155/2019/6125068",,"6KHD",173.02,"2.7","2.7","Crystal structure of CLK1 in complex with CX-4945","MRHSKRTYCPDWDDKDWDYGKWRSSSSHKRRKRSHSSAQENKRCKYNHSKMCDSHYLESRSINEKDYHSRRYIDEYRNDYTQGCEPGHRQRDHESRYQNHSSKSSGRSGRSSYKSKHRIHHSTSHRRSHGKSHRRKRTRSVEDDEEGHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6KHD"
"6KHE",,"X-RAY DIFFRACTION",1.92,35.99,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Bis-Tris pH 5.5, 0.2M MgCl2, 25% (w/v) PEG 3350",293,"10.1155/2019/6125068","3NG","6KHE",60.56,"2.8","2.8","Crystal structure of CLK2 in complex with CX-4945","MPHPRRYHSSERGSRGSYREHYRSRKHKRRRSRSWSSSSDRTRRRRREDSYHVRSRSSYDDRSSDRRVYDRRYCGSYRRNDYSRDRGDAYYDTDYRHSYEYQRENSSYRSQRSSRRKHRRRRRRSRTFSRSSSQHSSRRAKSVEDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSRDISR","Homo sapiens","CLK2","Dual specificity protein kinase CLK2","1","6KHE"
"6KHF",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION, HANGING DROP",7,"60% (v/v) Tacsimate pH 7.0, 0.025% dichloromethane",293,"10.1155/2019/6125068","3NG","6KHF",59.02,"2.598","2.598","Crystal structure of CLK3 in complex with CX-4945","MHHCKRYRSPEPDPYLSYRWKRRRSYSREHEGRLRYPSRREPPPRRSRSRSHDRLPYQRRYRERRDSDTYRCEERSPSFGEDYYGPSRSRHRRRSRERGPYRTRKHAHHCHKRRTRSCSSASSRSQQSSKRSSRSVEDDKEGHLVCRIGDWLQEDYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6KHF"
"6KHV",,"SOLUTION NMR",,,,,,,"10.1042/BCJ20200536",,"6KHV",13.34,,,"Solution Structure of the CS2 Domain of USP19","VDEPESMVNLAFVKNDSYEKGPDSVVVHVYVKEICRDTSRVLFREQDFTLIFQTRDGNFLRLHPGCGPHTTFRWQVKLRNLIEPEQCTFCFTASRIDICLRKRQSQRWGGLEAP","Homo sapiens","USP19, KIAA0891, ZMYND9","Ubiquitin carboxyl-terminal hydrolase 19","1","6KHV"
"6KHZ",,"X-RAY DIFFRACTION",3.04,59.49,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.17 M Ammonium sulfate, 0.085 M Sodium cacodylate trihydrate pH 6.5, 22-30 % w/v Polyethylene glycol 8000",293,"10.1074/jbc.RA119.010912",,"6KHZ",22.18,"2.8","2.8","p62/SQSTM1 ZZ domain with Gly-peptide","GEEEDVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPF","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","1","6KHZ"
"6KID",,"X-RAY DIFFRACTION",4.37,71.88,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES (pH 7.1), 0.42 M Ammonium sulfate, 24 % PEG3350",293,"10.1016/j.celrep.2021.109031",,"6KID",136.88,"3.15","3.15","Crystal structure of human leucyl-tRNA synthetase, ATP-bound form","MRGSHHHHHHGSMAERKGTAKVDFLKKIEKEIQQKWDTERVFEVNASNLEKQTSKGKYFVTFPYPYMNGRLHLGHTFSLSKCEFAVGYQRLKGKCCLFPFGLHCTGMPIKACADKLKREIELYGCPPDFPDEEEEEEETSVKTEDIIIKDKAKGKKSKAAAKAGSSKYQWGIMKSLGLSDEEIVKFSEAEHWLDYFPPLAIQDLKRMGLKVDWRRSFITTDVNPYYDSFVRWQFLTLRERNKIKFGKRYTIYSPKDGQPCMDHDRQTGEGVGPQEYTLLKLKVLEPYPSKLSGLKGKNIFLVAATLRPETMFGQTNCWVRPDMKYIGFETVNGDIFICTQKAARNMSYQGFTKDNGVVPVVKELMGEEILGASLSAPLTSYKVIYVLPMLTIKEDKGTGVVTSVPSDSPDDIAALRDLKKKQALRAKYGIRDDMVLPFEPVPVIEIPGFGNLSAVTICDELKIQSQNDREKLAEAKEKIYLKGFYEGIMLVDGFKGQKVQDVKKTIQKKMIDAGDALIYMEPEKQVMSRSSDECVVALCDQWYLDYGEENWKKQTSQCLKNLETFCEETRRNFEATLGWLQEHACSRTYGLGTHLPWDEQWLIESLSDSTIYMAFYTVAHLLQGGNLHGQAESPLGIRPQQMTKEVWDYVFFKEAPFPKTQIAKEKLDQLKQEFEFWYPVDLRVSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVRANGHLLLNSEKMSKSTGNFLTLTQAIDKFSADGMRLALADAGDTVEDANFVEAMADAGILRLYTWVEWVKEMVANWDSLRSGPASTFNDRVFASELNAGIIKTDQNYEKMMFKEALKTGFFEFQAAKDKYRELAVEGMHRELVFRFIEVQTLLLAPFCPHLCEHIWTLLGKPDSIMNASWPVAGPVNEVLIHSSQYLMEVTHDLRLRLKNYMMPAKGKKTDKQPLQKPSHCTIYVAKNYPPWQHTTLSVLRKHFEANNGKLPDNKVIASELGSMPELKKYMKKVMPFVAMIKENLEKMGPRILDLQLEFDEKAVLMENIVYLTNSLELEHIEVKFASEAEDKIREDCCPGKPLNVFRIEPGVSVSLVNPQPSNGHFSTKIEIRQGDNCDSIIRRLMKMNRGIKDLSKVKLMRFDDPLLGPRRVPVLGKEYTEKTPISEHAVFNVDLMSKKIHLTENGIRVDIGDTIIYLVH","Homo sapiens","LARS, KIAA1352, LARS1","Leucine--tRNA ligase, cytoplasmic","1","6KID"
"6KIE",,"X-RAY DIFFRACTION",4.63,78.89,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES (pH 7.1), 0.42 M Ammonium sulfate, 24% PEG3350",273,"10.1016/j.celrep.2021.109031",,"6KIE",123.88,"3.15","3.15","Crystal structure of human leucyl-tRNA synthetase, Leu-AMS-bound form","MRGSHHHHHHGSMAERKGTAKVDFLKKIEKEIQQKWDTERVFEVNASNLEKQTSKGKYFVTFPYPYMNGRLHLGHTFSLSKCEFAVGYQRLKGKCCLFPFGLHCTGMPIKACADKLKREIELYGCPPDFPDEEEEEEETSVKTEDIIIKDKAKGKKSKAAAKAGSSKYQWGIMKSLGLSDEEIVKFSEAEHWLDYFPPLAIQDLKRMGLKVDWRRSFITTDVNPYYDSFVRWQFLTLRERNKIKFGKRYTIYSPKDGQPCMDHDRQTGEGVGPQEYTLLKLKVLEPYPSKLSGLKGKNIFLVAATLRPETMFGQTNCWVRPDMKYIGFETVNGDIFICTQKAARNMSYQGFTKDNGVVPVVKELMGEEILGASLSAPLTSYKVIYVLPMLTIKEDKGTGVVTSVPSDSPDDIAALRDLKKKQALRAKYGIRDDMVLPFEPVPVIEIPGFGNLSAVTICDELKIQSQNDREKLAEAKEKIYLKGFYEGIMLVDGFKGQKVQDVKKTIQKKMIDAGDALIYMEPEKQVMSRSSDECVVALCDQWYLDYGEENWKKQTSQCLKNLETFCEETRRNFEATLGWLQEHACSRTYGLGTHLPWDEQWLIESLSDSTIYMAFYTVAHLLQGGNLHGQAESPLGIRPQQMTKEVWDYVFFKEAPFPKTQIAKEKLDQLKQEFEFWYPVDLRVSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVRANGHLLLNSEKMSKSTGNFLTLTQAIDKFSADGMRLALADAGDTVEDANFVEAMADAGILRLYTWVEWVKEMVANWDSLRSGPASTFNDRVFASELNAGIIKTDQNYEKMMFKEALKTGFFEFQAAKDKYRELAVEGMHRELVFRFIEVQTLLLAPFCPHLCEHIWTLLGKPDSIMNASWPVAGPVNEVLIHSSQYLMEVTHDLRLRLKNYMMPAKGKKTDKQPLQKPSHCTIYVAKNYPPWQHTTLSVLRKHFEANNGKLPDNKVIASELGSMPELKKYMKKVMPFVAMIKENLEKMGPRILDLQLEFDEKAVLMENIVYLTNSLELEHIEVKFASEAEDKIREDCCPGKPLNVF","Homo sapiens","LARS1, KIAA1352, LARS","Leucine--tRNA ligase, cytoplasmic","1","6KIE"
"6KJ1","0.65","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1021/acs.analchem.9b01162",,"6KJ1",0.66,"0.65, 0.65","0.65","200kV MicroED structure of FUS (37-42) SYSGYS solved from merged datasets at 0.65 A","SYSGYS","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","6KJ1"
"6KJ2","0.67","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1021/acs.analchem.9b01162",,"6KJ2",0.66,"0.67, 0.67","0.67","200kV MicroED structure of FUS (37-42) SYSGYS solved from single crystal at 0.67 A","SYSGYS","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","6KJ2"
"6KJ3","0.6","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1021/acs.analchem.9b01162",,"6KJ3",0.66,"0.6, 0.6","0.6","120kV MicroED structure of FUS (37-42) SYSGYS solved from merged datasets at 0.60 A","SYSGYS","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","6KJ3"
"6KJ4","0.65","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1021/acs.analchem.9b01162",,"6KJ4",0.66,"0.65, 0.65","0.65","120kV MicroED structure of FUS (37-42) SYSGYS solved from single crystal at 0.65 A","SYSGYS","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","6KJ4"
"6KJW",,"X-RAY DIFFRACTION",2.48,50.42,"VAPOR DIFFUSION, SITTING DROP",,"Bis-Tris",298,"10.1093/glycob/cwz081",,"6KJW",16.4,"1.36","1.36","Galectin-13 variant C136S","GSHMSSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFRFRVHFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVSVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","6KJW"
"6KJX",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwz081",,"6KJX",16.4,"1.53","1.53","Galectin-13 variant C138S","GSHMSSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFRFRVHFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVSN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","6KJX"
"6KJY",,"X-RAY DIFFRACTION",2.49,50.5,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwz081",,"6KJY",16.39,"1.5","1.5","Galectin-13 variant C136S/C138S","GSHMSSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFRFRVHFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVSVSN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","6KJY"
"6KJZ",,"X-RAY DIFFRACTION",2.55,51.86,"VAPOR DIFFUSION",7.4,"0.1 M HEPES (pH 7.4), 0.1 M MgCl2, 15-20% PE G3350, 10% isopropanol, 25% ethylene glycol",277,"10.1021/acs.jmedchem.0c00060","MKU","6KJZ",76.67,"2.20000094865","2.20000094865","Crystal structure of PDE4D catalytic domain complexed with compound 1","KTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQ","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6KJZ"
"6KK0",,"X-RAY DIFFRACTION",2.57,52.12,"VAPOR DIFFUSION",7.4,".1 M HEPES (pH 7.4), 0.1 M MgCl2, 15-20% PEG 3350, 10% isopropanol, 25% ethylene glycol",277,"10.1021/acs.jmedchem.0c00060","M36","6KK0",76.41,"2.20008760676","2.20008760676","Crystal structure of PDE4D catalytic domain complexed with compound 4e","TEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIP","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6KK0"
"6KKR","2.9","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aay3129",,"6KKR",248.43,"2.9, 2.9",,"human KCC1 structure determined in KCl and detergent GDN","MPHFTVVPVDGPRRGDYDNLEGLSWVDYGERAELDDSDGHGNHRESSPFLSPLEASRGIDYYDRNLALFEEELDIRPKVSSLLGKLVSYTNLTQGAKEHEEAESGEGTRRRAAEAPSMGTLMGVYLPCLQNIFGVILFLRLTWMVGTAGVLQALLIVLICCCCTLLTAISMSAIATNGVVPAGGSYFMISRSLGPEFGGAVGLCFYLGTTFAAAMYILGAIEILLTYIAPPAAIFYPSGAHDTSNATLNNMRVYGTIFLTFMTLVVFVGVKYVNKFASLFLACVIISILSIYAGGIKSIFDPPVFPVCMLGNRTLSRDQFDICAKTAVVDNETVATQLWSFFCHSPNLTTDSCDPYFMLNNVTEIPGIPGAAAGVLQENLWSAYLEKGDIVEKHGLPSADAPSLKESLPLYVVADIATSFTVLVGIFFPSVTGIMAGSNRSGDLRDAQKSIPVGTILAIITTSLVYFSSVVLFGACIEGVVLRDKYGDGVSRNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHGKVNGEPTWALLLTALIAELGILIASLDMVAPILSMFFLMCYLFVNLACAVQTLLRTPNWRPRFKYYHWALSFLGMSLCLALMFVSSWYYALVAMLIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKYPRLLTFASQLKAGKGLTIVGSVIQGSFLESYGEAQAAEQTIKNMMEIEKVKGFCQVVVASKVREGLAHLIQSCGLGGMRHNSVVLGWPYGWRQSEDPRAWKTFIDTVRCTTAAHLALLVPKNIAFYPSNHERYLEGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQMDDNSIQMKKDLAVFLYHLRLEAEVEVVEMHNSDISAYTYERTLMMEQRSQMLRQMRLTKTEREREAQLVKDRHSALRLESLYSDEEDESAVGADKIQMTWTRDKYMTETWDPSHAPDNFRELVHIKPDQSNVRRMHTAVKLNEVIVTRSHDARLVLLNMPGPPRNSEGDENYMEFLEVLTEGLERVLLVRGGGREVITIYSLEWSHPQFEK","Homo sapiens","SLC12A4, KCC1","Solute carrier family 12 member 4","1","6KKR"
"6KKT","2.9","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aay3129",,"6KKT",248.43,"2.9, 2.9",,"human KCC1 structure determined in KCl and lipid nanodisc","MPHFTVVPVDGPRRGDYDNLEGLSWVDYGERAELDDSDGHGNHRESSPFLSPLEASRGIDYYDRNLALFEEELDIRPKVSSLLGKLVSYTNLTQGAKEHEEAESGEGTRRRAAEAPSMGTLMGVYLPCLQNIFGVILFLRLTWMVGTAGVLQALLIVLICCCCTLLTAISMSAIATNGVVPAGGSYFMISRSLGPEFGGAVGLCFYLGTTFAAAMYILGAIEILLTYIAPPAAIFYPSGAHDTSNATLNNMRVYGTIFLTFMTLVVFVGVKYVNKFASLFLACVIISILSIYAGGIKSIFDPPVFPVCMLGNRTLSRDQFDICAKTAVVDNETVATQLWSFFCHSPNLTTDSCDPYFMLNNVTEIPGIPGAAAGVLQENLWSAYLEKGDIVEKHGLPSADAPSLKESLPLYVVADIATSFTVLVGIFFPSVTGIMAGSNRSGDLRDAQKSIPVGTILAIITTSLVYFSSVVLFGACIEGVVLRDKYGDGVSRNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHGKVNGEPTWALLLTALIAELGILIASLDMVAPILSMFFLMCYLFVNLACAVQTLLRTPNWRPRFKYYHWALSFLGMSLCLALMFVSSWYYALVAMLIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKYPRLLTFASQLKAGKGLTIVGSVIQGSFLESYGEAQAAEQTIKNMMEIEKVKGFCQVVVASKVREGLAHLIQSCGLGGMRHNSVVLGWPYGWRQSEDPRAWKTFIDTVRCTTAAHLALLVPKNIAFYPSNHERYLEGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQMDDNSIQMKKDLAVFLYHLRLEAEVEVVEMHNSDISAYTYERTLMMEQRSQMLRQMRLTKTEREREAQLVKDRHSALRLESLYSDEEDESAVGADKIQMTWTRDKYMTETWDPSHAPDNFRELVHIKPDQSNVRRMHTAVKLNEVIVTRSHDARLVLLNMPGPPRNSEGDENYMEFLEVLTEGLERVLLVRGGGREVITIYSLEWSHPQFEK","Homo sapiens","SLC12A4, KCC1","Solute carrier family 12 member 4","1","6KKT"
"6KKU","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aay3129",,"6KKU",248.28,"3.5, 3.5",,"human KCC1 structure determined in NaCl and GDN","MPHFTVVPVDGPRRGDYDNLEGLSWVDYGERAELDDSDGHGNHRESSPFLSPLEASRGIDYYDRNLALFEEELDIRPKVSSLLGKLVSYTNLTQGAKEHEEAESGEGTRRRAAEAPSMGTLMGVYLPCLQNIFGVILFLRLTWMVGTAGVLQALLIVLICCCCTLLTAISMSAIATNGVVPAGGSYFMISRSLGPEFGGAVGLCFYLGTTFAAAMYILGAIEILLTYIAPPAAIFYPSGAHDTSNATLNNMRVYGTIFLTFMTLVVFVGVKYVNKFASLFLACVIISILSIYAGGIKSIFDPPVFPVCMLGNRTLSRDQFDICAKTAVVDNETVATQLWSFFCHSPNLTTDSCDPYFMLNNVTEIPGIPGAAAGVLQENLWSAYLEKGDIVEKHGLPSADAPSLKESLPLYVVADIATSFTVLVGIFFPSVTGIMAGSNRSGDLRDAQKSIPVGTILAIITTSLVYFSSVVLFGACIEGVVLRDKYGDGVSRNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHGKVNGEPTWALLLTALIAELGILIASLDMVAPILSMFFLMCYLFVNLACAVQTLLRTPNWRPRFKYYHWALSFLGMSLCLALMFVSSWYYALVAMLIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKYPRLLTFASQLKAGKGLTIVGSVIQGSFLESYGEAQAAEQTIKNMMEIEKVKGFCQVVVASKVREGLAHLIQSCGLGGMRHNSVVLGWPYGWRQSEDPRAWKTFIDTVRCTTAAHLALLVPKNIAFYPSNHERYLEGHIDVWWIVHDGGMLMLLPFLLRQHKVWRKCRMRIFTVAQMDDNSIQMKKDLAVFLYHLRLEAEVEVVEMHNSDISAYTYERTLMMEQRSQMLRQMRLTKTEREREAQLVKDRHSALRLESLYSDEEDESAVGADKIQMTWTRDKYMTETWDPSHAPDNFRELVHIKPDQSNVRRMHTAVKLNEVIVTRSHDARLVLLNMPGPPRNSEGDENYMEFLEVLTEGLERVLLVRGGGREVITIYSLEWSHPQFEK","Homo sapiens","SLC12A4, KCC1","Solute carrier family 12 member 4","1","6KKU"
"6KLA",,"X-RAY DIFFRACTION",2.6,52.69,"VAPOR DIFFUSION, HANGING DROP",5.6,"PEG 4000, sodium citrate tribasic dihydrate, pH5.6, glycerol",291.15,"10.1021/acs.jmedchem.9b01229",,"6KLA",38.05,"2.109","2.109","Crystal structure of human c-KIT kinase domain in complex with compound 15a","YLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","6KLA"
,,,,,,,,,,,,,,,,,"Homo sapiens","KIT, SCFR"
"6KLZ",,"X-RAY DIFFRACTION",2.11,41.59,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1107/S2052252520011008",,"6KLZ",29.52,"0.9","0.9","Human Carbonic Anhydrase II V143I variant 00 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAILGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6KLZ"
"6KM0",,"X-RAY DIFFRACTION",2.09,41.27,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1107/S2052252520011008",,"6KM0",29.57,"0.93","0.93","Human Carbonic Anhydrase II V143I variant 07 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAILGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6KM0"
"6KM1",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1107/S2052252520011008",,"6KM1",29.61,"1.05","1.05","Human Carbonic Anhydrase II V143I variant 13 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAILGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6KM1"
"6KM2",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1107/S2052252520011008",,"6KM2",29.61,"0.9","0.9","Human Carbonic Anhydrase II V143I variant 15 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAILGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6KM2"
"6KM3",,"X-RAY DIFFRACTION",2.07,40.65,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1107/S2052252520011008",,"6KM3",29.45,"1.15","1.15","Human Carbonic Anhydrase II native 00 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6KM3"
"6KM4",,"X-RAY DIFFRACTION",2.08,41,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1107/S2052252520011008",,"6KM4",29.53,"1.15","1.15","Human Carbonic Anhydrase II native 07 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6KM4"
"6KM5",,"X-RAY DIFFRACTION",2.08,40.79,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1107/S2052252520011008",,"6KM5",29.53,"1.151","1.151","Human Carbonic Anhydrase II native 13 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6KM5"
"6KM6",,"X-RAY DIFFRACTION",2.07,40.72,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 100 mM Tris-HCl",293,"10.1107/S2052252520011008",,"6KM6",29.53,"1.15","1.15","Human Carbonic Anhydrase II native 15 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6KM6"
"6KM7",,"X-RAY DIFFRACTION",2.81,56.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES-Na, pH 7.5, 2% w/v PEG 400, 2.0 M ammonium sulfate",289,"10.1093/nar/gkz819",,"6KM7",87.01,"1.801","1.801","The structural basis for the internal interaction in RBBP5","SGQNYPEEADGTLDCISMALTCTFNRWGTLLAVGCNDGRIVIWDFLTRGIAKIISAHIHPVCSLCWSRDGHKLVSASTDNIVSQWDVLSGDCDQRFRFPSPILKVQYHPRDQNKVLVCPMKSAPVMLTLSDSKHVVLPVDDDSDLNVVASFDRRGEYIYTGNAKGKILVLKTDSQDLVASFRVTTGTSNTTAIKSIEFARKGSCFLINTADRIIRVYDGREILTCGRDGEPEPMQKLQDLVNRTPWKKCCFSGDGEYIVAGSARQHALYIWEKSIGNLVKILHGTRGELLLDVAWHPVRPIIASISSGVVSIWAQNQ","Homo sapiens","RBBP5, RBQ3","Retinoblastoma-binding protein 5","1","6KM7"
,,,,,,,,,,,,,,,,"DEELEDSKALLYLPIAPEVEDPEENPYGPPPDGSQPPKKKPKTTNIELQGVPNDEVHPLLGVKGDGKSK","Homo sapiens","RBBP5, RBQ3","Retinoblastoma-binding protein 5","2","6KM7"
"6KN4",,"SOLUTION NMR",,,,,,,"10.1080/07391102.2020.1730969",,"6KN4",9.76,,,"HUMAN PARALLEL STRANDED 7-MER G-QUADRUPLEX COMPLEXED WITH 2 ADRIAMYCIN (DM2) MOLECULES","TTAGGGT","Homo sapiens",,"DNA (5'-D(*TP*TP*AP*GP*GP*GP*T)-3')","1","6KN4"
"6KN5",,"X-RAY DIFFRACTION",2.3,46.48,"VAPOR DIFFUSION, HANGING DROP",,"sodium dihydrogen phosphate, potassium monohydrogen phosphate, 2-(N-morpholino)ethanesulfonic acid",289.15,"10.1038/s42003-020-0898-0",,"6KN5",29.77,"2.2","2.2","Crystal structure of AFF4 C-terminal domain","GSKPRRTKLVFDDRNYSADHYLQEAKKLKHNADALSDRFEKAVYYLDAVVSFIECGNALEKNAQESKSPFPMYSETVDLIKYTMKLKNYLAPDATAADKRLTVLCLRCESLLYLRLFKLKKENALKYSKTLTEHLKNSYNNSQAPSPGLGSKAVGMPSPVSPKLSPGNSGNYSSGASSASASGSSVTIPQKIHQMAASYVQVTSNFLYATEIWDQAEQLSKEQKEFFAELDKVMGPLIFNASIMTDLVRYTRQGLHWLRQDAKLIS","Homo sapiens","AFF4, AF5Q31, MCEF, HSPC092","AF4/FMR2 family member 4","1","6KN5"
"6KNR",,"X-RAY DIFFRACTION",4.13,70.21,"VAPOR DIFFUSION, HANGING DROP",,"0.28M K Na Tartrate",291,"10.1016/j.ejmech.2020.112501",,"6KNR",55.75,"2.804","2.804","Crystal structure of Estrogen-related receptor gamma ligand-binding domain with DN200699","GPLGSMLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6KNR"
"6KO0",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes (pH 7.5), 0.2 M MgCl2, 18% PEG 3350, 50 mM 2-mercaptoethanol",277,"10.1021/acschemneuro.0c00024",,"6KO0",75.52,"2.60002905998","2.60002905998","The crystal structue of PDE10A complexed with 1i","MSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6KO0"
"6KO1",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION",7.5,"0.1 M Hepes (pH 7.5), 0.2 M MgCl2, 18% PEG 3350, 50 mM 2-mercaptoethanol",277,"10.1021/acschemneuro.0c00024",,"6KO1",75.59,"2.7","2.7","The crystal structue of PDE10A complexed with 2d","MSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6KO1"
"6KOF",,"X-RAY DIFFRACTION",2.83,56.6,"VAPOR DIFFUSION, HANGING DROP",6,"PEG3350, Ammonium fluoride,MES",291,"10.1021/acs.jmedchem.9b01549","DO9","6KOF",92.76,"2.263","2.263","Crystal structure of indoleamine 2,3-dioxygenagse 1 (IDO1) in complex with compound 47","MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6KOF"
"6KOI",,"X-RAY DIFFRACTION",3.57,65.57,"VAPOR DIFFUSION",4.3,"0.1 M sodium acetate trihydrate pH 4.3, 1.8 M sodium formate",293,"10.1016/j.jmb.2020.06.010",,"6KOI",451.96,"3.5","3.5","Crystal structure of SNX11-PXe domain in dimer form.","MSENQEQEEVITVRVQDPRVQNEGSWNSYVDYKIFLHTNSKAFTAKTSCVRRRYREFVWLRKQLQRNAGLVPVPELPGKSTFFGTSDEFIEKRRQGLQHFLEKVLQSVVLLSDSQLHLFLQSQLSVPEIEACVQGRSTMTVSDAILRYAMSNLEHHHHHH","Homo sapiens","SNX11","Sorting nexin-11","1","6KOI"
"6KOJ",,"X-RAY DIFFRACTION",1.93,36.15,"VAPOR DIFFUSION",4.6,"0.1 M NaAc pH 4.6, 2% v/v Tacsimate pH 4.0, 16% w/v PEG 3350",293,"10.1016/j.jmb.2020.06.010",,"6KOJ",35.16,"2.14","2.14","Crystal structure of SNX11-PXe domain in complex with PI(3,5)P2","MSENQEQEEVITVRVQDPRVQNEGSWNSYVDYKIFLHTNSKAFTAKTSCVRRRYREFVWLRKQLQRNAGLVPVPELPGKSTFFGTSDEFIEKRRQGLQHFLEKVLQSVVLLSDSQLHLFLQSQLSVPEIEACVQGRLEHHHHHH","Homo sapiens","SNX11","Sorting nexin-11","1","6KOJ"
"6KOR",,"X-RAY DIFFRACTION",2.29,46.29,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES-NaOH (pH 7.5),
20% PEG 10,000",293.15,"10.1261/rna.072959.119",,"6KOR",22.24,"2.602","2.602","Crystal structure of the RRM domain of SYNCRIP","GSHMASNNRLFVGSIPKSKTKEQILEEFSKVTEGLTDVILYHQPDDKKKNRGFCFLEYEDHKTAAQARRRLMSGKVKVWGNVGTVEWADPIEDPDPEVMAKVKVLFVRNLANTVTEEILEKAFSQFGKLERVKKLKDYAFIHFDERDGAVKAMEEMNGKDLEGENIEIVFAKPPDQKRKERKAQRQAAKNQMY","Homo sapiens","SYNCRIP, HNRPQ, NSAP1","Heterogeneous nuclear ribonucleoprotein Q","1","6KOR"
"6KOW",,"SOLUTION NMR",,,,,,,"10.1007/s13238-019-0644-x",,"6KOW",8.74,,,"Retracted state of S65/T66 double-phosphorylated ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","6KOW"
"6KOX",,"SOLUTION NMR",,,,,,,"10.1007/s13238-019-0644-x",,"6KOX",8.74,,,"Relaxed state of S65/T66 double-phosphorylated ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","6KOX"
"6KPS",,"X-RAY DIFFRACTION",2.85,56.91,"VAPOR DIFFUSION, HANGING DROP",6,"PEG3350, Ammonium Fluoride, MES",291,"10.1021/acs.jmedchem.9b01549","DU6","6KPS",92.72,"2.249","2.249","Crystal structure of indoleamine 2,3-dioxygenagse 1 (IDO1) in complex with compound 36","MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6KPS"
"6KQP",,"X-RAY DIFFRACTION",2.54,51.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM sodium citrate, pH 5.6, 200mM potassium sodium tartrate, 2M ammonium sulfate",294,"10.1038/s41589-020-0626-6",,"6KQP",25.59,"2.4","2.4","NSD1 SET domain in complex with SAM","DKKPPPYKHIKVNRPIGRVQIFTADLSEIPRCNCKATDENPCGIDSECINRMLLYECHPTVCPAGGRCQNQCFSKRQYPEVEIFRTLQRGWGLRTKTDIKKGEFVNEYVGELIDEEECRARIRYAQEHDITNFYMLTLDKDRIIDAGPKGNYARFMNHCCQPNCETQKWSVNGDTRVGLFALSDIKAGTELTFNYNLECLGNGKTVCKCGAPNCSGFLGV","Homo sapiens","NSD1, ARA267, KMT3B","Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific","1","6KQP"
"6KQQ",,"X-RAY DIFFRACTION",2.92,57.81,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG 8000, 100mM sodium cacodylate, pH 6.5, 200mM calcium Acetate",290,"10.1038/s41589-020-0626-6",,"6KQQ",52.88,"1.8","1.8","NSD1 SET domain in complex with BT3 and SAM","NDKKPPPYKHIKVNRPIGRVQIFTADLSEIPRCNCKATDENPCGIDSECINRMLLYECHPTVCPAGGRCQNQCFSKRQYPEVEIFRTLQRGWGLRTKTDIKKGEFVNEYVGELIDEEECRARIRYAQEHDITNFYMLTLDKDRIIDAGPKGNYARFMNHCCQPNCETQKWSVNGDTRVGLFALSDIKAGTELTFNYNLECLGNGKTVCKCGAPNCSGFLGVRP","Homo sapiens","NSD1, ARA267, KMT3B","Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific","1","6KQQ"
"6KQU",,"X-RAY DIFFRACTION",3.45,64.38,"VAPOR DIFFUSION",,"2.2M Sodium chloride, 0.1M BIS-TRIS propane pH 7.0",277,"10.1016/j.biochi.2020.07.003",,"6KQU",14.67,"2","2","Crystal structure of phospholipase A2","NLVQFGVMIEKMTGKSALQYGDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","6KQU"
"6KQV",,"SOLUTION NMR",,,,,,,"10.1042/BCJ20200536",,"6KQV",9.99,,,"Solution Structure of the UbL Domain of USP19","KQKVLPVFYFAREPHSKPIKFLVSVSKENSTASEVLDSLSQSVHVKPENLRLAEVIKNRFHRVFLPSHSLDTVSPSDTLLCFELLSSE","Homo sapiens","USP19, KIAA0891, ZMYND9","Ubiquitin carboxyl-terminal hydrolase 19","1","6KQV"
"6KQY",,"X-RAY DIFFRACTION",4.36,71.77,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES (pH 7.1), 0.42 M Ammonium sulfate, 24 % PEG3350",293,"10.1016/j.celrep.2021.109031",,"6KQY",136.41,"3.3","3.3","Crystal structure of human leucyl-tRNA synthetase, Leucine-bound form","MRGSHHHHHHGSMAERKGTAKVDFLKKIEKEIQQKWDTERVFEVNASNLEKQTSKGKYFVTFPYPYMNGRLHLGHTFSLSKCEFAVGYQRLKGKCCLFPFGLHCTGMPIKACADKLKREIELYGCPPDFPDEEEEEEETSVKTEDIIIKDKAKGKKSKAAAKAGSSKYQWGIMKSLGLSDEEIVKFSEAEHWLDYFPPLAIQDLKRMGLKVDWRRSFITTDVNPYYDSFVRWQFLTLRERNKIKFGKRYTIYSPKDGQPCMDHDRQTGEGVGPQEYTLLKLKVLEPYPSKLSGLKGKNIFLVAATLRPETMFGQTNCWVRPDMKYIGFETVNGDIFICTQKAARNMSYQGFTKDNGVVPVVKELMGEEILGASLSAPLTSYKVIYVLPMLTIKEDKGTGVVTSVPSDSPDDIAALRDLKKKQALRAKYGIRDDMVLPFEPVPVIEIPGFGNLSAVTICDELKIQSQNDREKLAEAKEKIYLKGFYEGIMLVDGFKGQKVQDVKKTIQKKMIDAGDALIYMEPEKQVMSRSSDECVVALCDQWYLDYGEENWKKQTSQCLKNLETFCEETRRNFEATLGWLQEHACSRTYGLGTHLPWDEQWLIESLSDSTIYMAFYTVAHLLQGGNLHGQAESPLGIRPQQMTKEVWDYVFFKEAPFPKTQIAKEKLDQLKQEFEFWYPVDLRVSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVRANGHLLLNSEKMSKSTGNFLTLTQAIDKFSADGMRLALADAGDTVEDANFVEAMADAGILRLYTWVEWVKEMVANWDSLRSGPASTFNDRVFASELNAGIIKTDQNYEKMMFKEALKTGFFEFQAAKDKYRELAVEGMHRELVFRFIEVQTLLLAPFCPHLCEHIWTLLGKPDSIMNASWPVAGPVNEVLIHSSQYLMEVTHDLRLRLKNYMMPAKGKKTDKQPLQKPSHCTIYVAKNYPPWQHTTLSVLRKHFEANNGKLPDNKVIASELGSMPELKKYMKKVMPFVAMIKENLEKMGPRILDLQLEFDEKAVLMENIVYLTNSLELEHIEVKFASEAEDKIREDCCPGKPLNVFRIEPGVSVSLVNPQPSNGHFSTKIEIRQGDNCDSIIRRLMKMNRGIKDLSKVKLMRFDDPLLGPRRVPVLGKEYTEKTPISEHAVFNVDLMSKKIHLTENGIRVDIGDTIIYLVH","Homo sapiens","LARS, KIAA1352, LARS1","Leucine--tRNA ligase, cytoplasmic","1","6KQY"
"6KR0",,"X-RAY DIFFRACTION",2.09,41.29,"VAPOR DIFFUSION",,"0.1 M Tirs-HCl pH 9.0, 0.2 M calcium chloride, 3.25 M sodium formate",293,,,"6KR0",124.53,"2.3","2.3","Crystal structure of HL homo-diabody","MKYLLPTAAAGLLLLAAQPAMAGSEVQLVESGGGLVQPGGSLRLSCAASGYSFTGYTMNWVRQAPGKGLEWVALINPYKGVSTYNQKFKDRFTISVDKSKNTAYLQMNSLRAEDTAVYYCARSGYYGDSDWYFDVWGQGTLVTVSSAASGGGGSDIQMTQSPSSLSASVGDRVTITCRASQDLATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIKAAAAEQKLISEEDLNLGGGMRGSHHHHHH","Homo sapiens",,"HL diabody","1","6KR0"
"6KR7",,"X-RAY DIFFRACTION",4.34,76.07,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES (pH 7.1), 0.42 M Ammonium sulfate, 24 % PEG3350",293,"10.1016/j.celrep.2021.109031",,"6KR7",136.74,"4","4","Crystal structure of methylated human leucyl-tRNA synthetase, Leu-AMS-bound form","MRGSHHHHHHGSMAERKGTAKVDFLKKIEKEIQQKWDTERVFEVNASNLEKQTSKGKYFVTFPYPYMNGRLHLGHTFSLSKCEFAVGYQRLKGKCCLFPFGLHCTGMPIKACADKLKREIELYGCPPDFPDEEEEEEETSVKTEDIIIKDKAKGKKSKAAAKAGSSKYQWGIMKSLGLSDEEIVKFSEAEHWLDYFPPLAIQDLKRMGLKVDWRRSFITTDVNPYYDSFVRWQFLTLRERNKIKFGKRYTIYSPKDGQPCMDHDRQTGEGVGPQEYTLLKLKVLEPYPSKLSGLKGKNIFLVAATLRPETMFGQTNCWVRPDMKYIGFETVNGDIFICTQKAARNMSYQGFTKDNGVVPVVKELMGEEILGASLSAPLTSYKVIYVLPMLTIKEDKGTGVVTSVPSDSPDDIAALRDLKKKQALRAKYGIRDDMVLPFEPVPVIEIPGFGNLSAVTICDELKIQSQNDREKLAEAKEKIYLKGFYEGIMLVDGFKGQKVQDVKKTIQKKMIDAGDALIYMEPEKQVMSRSSDECVVALCDQWYLDYGEENWKKQTSQCLKNLETFCEETRRNFEATLGWLQEHACSRTYGLGTHLPWDEQWLIESLSDSTIYMAFYTVAHLLQGGNLHGQAESPLGIRPQQMTKEVWDYVFFKEAPFPKTQIAKEKLDQLKQEFEFWYPVDLRVSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVRANGHLLLNSEKMSKSTGNFLTLTQAIDKFSADGMRLALADAGDTVEDANFVEAMADAGILRLYTWVEWVKEMVANWDSLRSGPASTFNDRVFASELNAGIIKTDQNYEKMMFKEALKTGFFEFQAAKDKYRELAVEGMHRELVFRFIEVQTLLLAPFCPHLCEHIWTLLGKPDSIMNASWPVAGPVNEVLIHSSQYLMEVTHDLRLRLKNYMMPAKGKKTDKQPLQKPSHCTIYVAKNYPPWQHTTLSVLRKHFEANNGKLPDNKVIASELGSMPELKKYMKKVMPFVAMIKENLEKMGPRILDLQLEFDEKAVLMENIVYLTNSLELEHIEVKFASEAEDKIREDCCPGKPLNVFRIEPGVSVSLVNPQPSNGHFSTKIEIRQGDNCDSIIRRLMKMNRGIKDLSKVKLMRFDDPLLGPRRVPVLGKEYTEKTPISEHAVFNVDLMSKKIHLTENGIRVDIGDTIIYLVH","Homo sapiens","LARS, KIAA1352, LARS1","Leucine--tRNA ligase, cytoplasmic","1","6KR7"
"6KR8",,"SOLUTION NMR",,,,,,,"10.1038/s41589-019-0457-5",,"6KR8",38.56,,,"Structure of the beta2 adrenergic receptor in the full agonist bound state","GTQQRDEVWVVGMGIVMSLIVLAIVFGNVLVITAICKFERLQTVTNYFITSLAVADLVMGLAVVPFGAAHILTKTWTFGNFWCEFWTSIDVLCVTASIWTLCVIAVDRYFAICSPFKYQSLLTKCKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYAEETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNVSQVEQDGRTGHGHRRSSKFACKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYSRSPDFRCAFQELLAARRSSVKAHHHHHHHHHH","Homo sapiens","ADRB2, ADRB2R, B2AR","beta 2 adrenergic receptor","1","6KR8"
"6KRO",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris pH 8.5, 1.6M (NH4)2HPO4",277,"10.1021/acs.jmedchem.0c00045","DU9","6KRO",25.37,"1.9","1.9","Tankyrase-2 in complex with RK-582","NTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMK","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6KRO"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","6KRO"
"6KSQ",,"X-RAY DIFFRACTION",2.23,44.74,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.5 M (NH4)2SO4, 5% Glycerol, 29.5% PEG 3350, PH 8.5",277,"10.1016/j.isci.2020.100857",,"6KSQ",33.96,"2.202","2.202","Middle Domain of Human HSP90 Alpha","MHHHHHHSSGVDLGTENLYFQSNATKPIWTRNPDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPED","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6KSQ"
"6KSW","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1371/journal.pbio.3000790",,"6KSW",211.11,"3.6",,"Cryo-EM structure of the human concentrative nucleoside transporter CNT3","MEDDDEEMQQKGCLERRYDTVCGFCRKHKTTLRHIIWGILLAGYLVMVISACVLNFHRALPLFVITVAAIFFVVWDHLMAKYEHRIDEMLSPGRRLLNSHWFWLKWVIWSSLVLAVIFWLAFDTAKLGQQQLVSFGGLIMYIVLLFLFSKYPTRVYWRPVLWGIGLQFLLGLLILRTDPGFIAFDWLGRQVQTFLEYTDAGASFVFGEKYKDHFFAFKVLPIVVFFSTVMSMLYYLGLMQWIIRKVGWIMLVTTGSSPIESVVASGNIFVGQTESPLLVRPYLPYITKSELHAIMTAGFSTIAGSVLGAYISFGVPSSHLLTASVMSAPASLAAAKLFWPETEKPKITLKNAMKMESGDSGNLLEAATQGASSSISLVANIAVNLIAFLALLSFMNSALSWFGNMFDYPQLSFELICSYIFMPFSFMMGVEWQDSFMVARLIGYKTFFNEFVAYEHLSKWIHLRKEGGPKFVNGVQQYISIRSEIIATYALCGFANIGSLGIVIGGLTSMAPSRKRDIASGAVRALIAGTVACFMTACIAGILSSTPVDINCHHVLENAFNSTFPGNTTKVIACCQSLLSSTVAKGPGEVIPGGNHSLYSLKGCCTLLNPSTFNCNGISNTFLEWSHPQFEK","Homo sapiens","SLC28A3, CNT3","Solute carrier family 28 member 3","1","6KSW"
"6KUW",,"X-RAY DIFFRACTION",2.52,51.1,"LIPIDIC CUBIC PHASE",,"sodium phosphate monobasic (0.1M), Hepes pH6.5-6.9 (0.1M), PEG400 24-35%",293,,,"6KUW",115.58,"2.8","2.8","Crystal structure of human alpha2C adrenergic G protein-coupled receptor.","GGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQWWCGVYLALDVLFCTSSAVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTGIDCSFWNESYLTGSRDERKKSLLSKFGMDEGVTFMFIGRFDRGQKGVDVLLKAIEILSSKKEFQEMRFIIIGKGDPELEGWARSLEEKHGNVKVITEMLSREFVRELYGSVDFVIIPSYFEPFGLVALEAMCLGAIPIASAVGGLRDIITNETGILVKAGDPGELANAILKALELSRSDLSKFRENCKKRAMSFSVAQAREKRFTFVLAVVMGVWVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRR","Homo sapiens","ADRA2C, ADRA2L2, ADRA2RL2","Alpha-2C adrenergic receptor","1","6KUW"
"6KUX",,"X-RAY DIFFRACTION",4.25,71.06,"LIPIDIC CUBIC PHASE",,"0.1M Sodium citrate tribasic dihydrate pH 5.0, 290mM Ammonium chloride, 30% PEG400, 7% glycerol",293,,,"6KUX",45.86,"2.7","2.7","Crystal structures of the alpha2A adrenergic receptor in complex with an antagonist RSC.","GGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFTSRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSAWHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIITVWVISAVISFPPLISIEKKGGGGGPQPAEPRCEINDQKWYVISSCIGSFFAPCLIMILVYVRIYQIAKRRTADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLTAVGCSVPRTLFKFFFWFGYCNSSLNPVIYTIFNHDFRRAFKKILCRGD","Homo sapiens","ADRA2A, ADRA2R, ADRAR","alpha2A adrenergic receptor","1","6KUX"
"6KUY",,"X-RAY DIFFRACTION",4.1,70.01,"LIPIDIC CUBIC PHASE",,"0.1M HEPES sodium pH 7.4, 310mM Ammonium tartrate dibasic, 36.5% PEG400",293,,,"6KUY",44.84,"3.2","3.2","Crystal structure of the alpha2A adrenergic receptor in complex with a partial agonist","GGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFTSRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSAWHLCAISLDRYWSITQAIEYNLKRTPRRIKAIILTVWVISAVISFPPLISIEKKGGGGGPQPAEPRCEINDQKWYVISSCIGSFFAPCLIMILVYVRIYQIAKRRTADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLTAVGCSVPRTLFKFFFWFGYCNSSLNPVIYTIFNHDFRRAFKKILCRGD","Homo sapiens","ADRA2A, ADRA2R, ADRAR","Alpha2A adrenergic receptor","1","6KUY"
"6KVG",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa751",,"6KVG",28.45,,,"The solution structure of human Orc6","GPGSMGSELIGRLAPRLGLAEPDMLRKAEEYLRLSRVKCVGLSARTTETSSAVMCLDLAASWMKCPLDRAYLIKLSGLNKETYQSCLKSFECLLGLNSNIGIRDLAVQFSCIEAVNMASKILKSYESSLPQTQQVDLDLSRPLFTSAALLSACKILKLKVDKNKMVATSGVKKAIFDRLCKQLEKIGQQVDREPGDVATPPRKRKKIVVEAPAKEMEKVEEMPHKPQKDEDLTQDYEEWKRKILENAASAQKATAE","Homo sapiens","ORC6, ORC6L","Origin recognition complex subunit 6","1","6KVG"
"6KW7",,"X-RAY DIFFRACTION",2.8,56.04,"VAPOR DIFFUSION, HANGING DROP",6.3,"PEG3350, Ammonium Fluoride, MES",291,"10.1021/acs.jmedchem.9b01549",,"6KW7",92.56,"3.02","3.02","Crystal structure of indoleamine 2,3-dioxygenagse 1 (IDO1) in complex with compound 12","MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6KW7"
"6KWX","3.75","ELECTRON MICROSCOPY",,,,,,,"10.1371/journal.pbio.3000654",,"6KWX",217.25,"3.75",,"cryo-EM structure of human PA200","MGTTRSTMSYYHHHHHHDYDIPTTENLYFQGAMDPMEPAERAGVGEPPEPGGRPEPGPRGFVPQKEIVYNKLLPYAERLDAESDLQLAQIKCNLGRAVQLQELWPGGLFWTRKLSTYIRLYGRKFSKEDHVLFIKLLYELVSIPKLEISMMQGFARLLINLLKKKELLSRADLELPWRPLYDMVERILYSKTEHLGLNWFPNSVENILKTLVKSCRPYFPADATAEMLEEWRPLMCPFDVTMQKAITYFEIFLPTSLPPELHHKGFKLWFDELIGLWVSVQNLPQWEGQLVNLFARLATDNIGYIDWDPYVPKIFTRILRSLNLPVGSSQVLVPRFLTNAYDIGHAVIWITAMMGGPSKLVQKHLAGLFNSITSFYHPSNNGRWLNKLMKLLQRLPNSVVRRLHRERYKKPSWLTPVPDSHKLTDQDVTDFVQCIIQPVLLAMFSKTGSLEAAQALQNLALMRPELVIPPVLERTYPALETLTEPHQLTATLSCVIGVARSLVSGGRWFPEGPTHMLPLLMRALPGVDPNDFSKCMITFQFIATFSTLVPLVDCSSVLQERNDLTEVERELCSATAEFEDFVLQFMDRCFGLIESSTLEQTREETETEKMTHLESLVELGLSSTFSTILTQCSKEIFMVALQKVFNFSTSHIFETRVAGRMVADMCRAAVKCCPEESLKLFVPHCCSVITQLTMNDDVLNDEELDKELLWNLQLLSEITRVDGRKLLLYREQLVKILQRTLHLTCKQGYTLSCNLLHHLLRSTTLIYPTEYCSVPGGFDKPPSEYFPIKDWGKPGDLWNLGIQWHVPSSEEVSFAFYLLDSFLQPELVKLQHCGDGKLEMSRDDILQSLTIVHNCILGSGNLLPPLKGEPVTNLVPSMVSLEETKLYTGLEYDLSRENHREVIATVIRKLLNHILDNSEDDTKSLFLIIKIIGDLLQFQGSHKHEFDSRWKSFNLVKKSMENRLHGKKQHIRALLIDRVMLQHELRTLTVEGCEYKKIHQDMIRDLLRLSTSSYSQVRNKAQQTFFAALGAYNFCCRDIIPLVLEFLRPDRQGVTQQQFKGALYCLLGNHSGVCLANLHDWDCIVQTWPAIVSSGLSQAMSLEKPSIVRLFDDLAEKIHRQYETIGLDFTIPKSCVEIAELLQQSKNPSINQILLSPEKIKEGIKRQQEKNADALRNYENLVDTLLDGVEQRNLPWKFEHIGIGLLSLLLRDDRVLPLRAIRFFVENLNHDAIVVRKMAISAVAGILKQLKRTHKKLTINPCEISGCPKPTQIIAGDRPDNHWLHYDSKTIPRTKKEWESSCFVEKTHWGYYTWPKNMVVYAGVEEQPKLGRSREDMTEAEQIIFDHFSDPKFVEQLITFLSLEDRKGKDKFNPRRFCLFKGIFRNFDDAFLPVLKPHLEHLVADSHESTQRCVAEIIAGLIRGSKHWTFEKVEKLWELLCPLLRTALSNITVETYNDWGACIATSCESRDPRKLHWLFELLLESPLSGEGGSFVDACRLYVLQGGLAQQEWRVPELLHRLLKYLEPKLTQVYKNVRERIGSVLTYIFMIDVSLPNTTPTISPHVPEFTARILEKLKPLMDVDEEIQNHVMEENGIGEEDERTQGIKLLKTILKWLMASAGRSFSTAVTEQLQLLPLFFKIAPVENDNSYDELKRDAKLCLSLMSQGLLYPHQVPLVLQVLKQTARSSSWHARYTVLTYLQTMVFYNLFIFLNNEDAVKDIRWLVISLLEDEQLEVREMAATTLSGLLQCNFLTMDSPMQIHFEQLCKTKLPKKRKRDPGSVGDTIPSAELVKRHAGVLGLGACVLSSPYDVPTWMPQLLMNLSAHLNDPQPIEMTVKKTLSNFRRTHHDNWQEHKQQFTDDQLLVLTDLLVSPCYYA","Homo sapiens","PSME4, KIAA0077","Proteasome activator complex subunit 4","1","6KWX"
"6KX2",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION, SITTING DROP",4.5,"10 mg/mL mutant, 0.2M NaCl; 0.1M acetate Na (pH 4.5) and 1.26M ammonium sulfate",289,"10.1002/advs.202000098",,"6KX2",20.88,"1.454","1.454","Crystal structure of GDP bound RhoA protein","MAAIRKKLVIVGDGAVGKTSLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMVFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMETSAKTKDGVREVFEMATRAALQA","Homo sapiens","RHOA, ARH12, ARHA, RHO12","Transforming protein RhoA","1","6KX2"
"6KX3",,"X-RAY DIFFRACTION",2.88,57.22,"VAPOR DIFFUSION, SITTING DROP",4.5,"10 mg/mL mutant, 0.2M NaCl, 0.1M acetate Na (pH 4.5), 1.26M ammonium sulfate",289,"10.1002/advs.202000098",,"6KX3",21.14,"1.981","1.981","Crystal structure of RhoA protein with covalent inhibitor DC-Rhoin","MAAIRKKLVIVGDGAVGKTSLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMVFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMETSAKTKDGVREVFEMATRAALQA","Homo sapiens","RHOA, ARH12, ARHA, RHO12","Transforming protein RhoA","1","6KX3"
"6KXA",,"X-RAY DIFFRACTION",2.02,39.23,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1093/glycob/cwaa080",,"6KXA",16.07,"1.23","1.23","Galectin-3 CRD binds to GalA dimer","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6KXA"
"6KXB",,"X-RAY DIFFRACTION",2.03,39.55,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1093/glycob/cwaa080",,"6KXB",16.25,"1.5","1.5","Galectin-3 CRD binds to GalA trimer","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6KXB"
"6KXW",,"X-RAY DIFFRACTION",3.57,65.59,"EVAPORATION",,"30% v/v PEG 400, 50mM CAPS, pH 10.0, 0.16% w/v 1,5-Naphthalenedisulfonic acid disodium, 0.16% w/v Naphthalene-1,3,6-trisulfonic acid trisodium, 0.16% 1,4-piperazinediethanesulfonic acid",277,,,"6KXW",149.24,"3.7","3.7","Crystal structure of human aquaporin AQP7 in bound to glycerol","MVQASGHRRSTRGSKMVSWSVIAKIQEILQRKMVREFLAEFMSTYVMMVFGLGSVAHMVLNKKYGSYLGVNLGFGFGVTMGVHVAGRISGAHMNAAVTFANCALGRVPWRKFPVYVLGQFLGSFLAAATIYSLFYTAILHFSGGQLMVTGPVATAGIFATYLPDHMTLWRGFLNEAWLTGMLQLCLFAITDQENNPALPGTEALVIGILVVIIGVSLGMNTGYAINPSRDLPPRIFTFIAGWGKQVFSNGENWWWVPVVAPLLGAYLGGIIYLVFIGSTIPREPLKLEDSVAYEDHGITVLPKMGSHEPTISPLTPVSVSPANRSSVHPAPPLHESMALEHF","Homo sapiens","AQP7, AQP7L, AQP9","Aquaporin-7","1","6KXW"
"6KXZ",,"SOLUTION NMR",,,,,,,"10.1016/j.bmc.2020.115761",,"6KXZ",9.76,,,"HUMAN PARALLEL STRANDED 7-MER G-QUADRUPLEX COMPLEXED WITH 2 EPIRUBICIN (EPI) MOLECULES","TTAGGGT","Homo sapiens",,"[TTAGGGT]4-EPI-Complex","1","6KXZ"
"6KY0",,"X-RAY DIFFRACTION",2.61,52.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"3M sodium acetate trihydrate (pH 7.0)",295,,,"6KY0",61.34,"2.06","2.06","Crystal structural of active-site human glutathione-specific gamma-glutamylcyclotransferase 2(ChaC2) mutant with Glutamate 74 replaced by Glutamine","KVPRGSHMWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGKPGRVVTLVEDPAGCVWGVAYRLPVGKEEQVKAYLDFGEKGGYRTTTVIFYPKDPTTKPFSVLLYIGTCDNPDYLGPAPLEDIAEQIFNAAGPSGRNTEYLFELANSIRNLVPEEADEHLFALEKLVKER","Homo sapiens","CHAC2","Glutathione-specific gamma-glutamylcyclotransferase 2","1","6KY0"
"6KY1",,"X-RAY DIFFRACTION",2.57,52.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"3 M sodium acetate trihydrate (pH 7.0)",295,,,"6KY1",61.68,"2.04","2.04","Crystal structural of human glutathione-specific gamma-glutamylcyclotransferase 2 (ChaC2)mutant with Glutamate 83 replaced by Glutamine","KVPRGSHMWVFGYGSLIWKVDFPYQDKLVGYITNYSRRFWQGSTDHRGVPGKPGRVVTLVEDPAGCVWGVAYRLPVGKEEEVKAYLDFGQKGGYRTTTVIFYPKDPTTKPFSVLLYIGTCDNPDYLGPAPLEDIAEQIFNAAGPSGRNTEYLFELANSIRNLVPEEADEHLFALEKLVKERL","Homo sapiens","CHAC2","Glutathione-specific gamma-glutamylcyclotransferase 2","1","6KY1"
"6KYA",,"X-RAY DIFFRACTION",2.5,50.79,"VAPOR DIFFUSION, SITTING DROP",,"12-20% PEG4000
0.1 M Tris-HCl pH 8.5
0.2 M CaCl2
25% Ethylene glycol",293,"10.1021/acs.jmedchem.9b02128",,"6KYA",192.19,"2.89","2.89","Crystal structure of human TLR8 in complex TH1027","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","6KYA"
"6KYP",,"X-RAY DIFFRACTION",3.05,59.67,"VAPOR DIFFUSION",,"0.1 M Tris (pH 8.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6KYP",63.59,"2.86","2.86","X-ray structure of human PPARalpha ligand binding domain-GW9662-clofibric acid co-crystals obtained by delipidation and co-crystallization","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6KYP"
"6KYQ",,"X-RAY DIFFRACTION",3.76,67.3,"VAPOR DIFFUSION, HANGING DROP",,"1.6M NaH2PO4, 1.6M K2HPO4, PH7.8",293,,,"6KYQ",73.39,"2.141","2.141","Crystal structure of DCLK1 Autoinhibited Kinase Domain","GSGFQIPATITERYKVGRTIGDGNFAVVKECVERSTAREYALKIIKKSKCRGKEHMIQNEVSILRRVKHPNIVLLIEEMDVPTELYLVMELVKGGDLFDAITSTNKYTERDASGMLYNLASAIKYLHSLNIVHRDIKPENLLVYEHQDGSKSLKLGDFGLATIVDGPLYTVCGTPTYVAPEIIAETGYGLKVDIWAAGVITYILLCGFPPFRGSGDDQEVLFDQILMGQVDFPSPYWDNVSDSAKELITMMLLVDVDQRFSAVQVLEHPWVNDDGLPENEHQLSVAGKIKKHFNTGPKPNSTAAGVSVIATTALDKERQVFRRRRNQD","Homo sapiens","DCLK1, DCAMKL1, DCDC3A, KIAA0369","Serine/threonine-protein kinase DCLK1","1","6KYQ"
"6KYR",,"X-RAY DIFFRACTION",3.86,68.09,"VAPOR DIFFUSION, HANGING DROP",,"1.6M NaH2PO4/K2HPO4, PH 7.8",293,,,"6KYR",73.5,"2.206","2.206","Crystal structure of DCLK1 mutant (P675L) Autoinhibited Kinase Domain","GSGFQIPATITERYKVGRTIGDGNFAVVKECVERSTAREYALKIIKKSKCRGKEHMIQNEVSILRRVKHPNIVLLIEEMDVPTELYLVMELVKGGDLFDAITSTNKYTERDASGMLYNLASAIKYLHSLNIVHRDIKPENLLVYEHQDGSKSLKLGDFGLATIVDGPLYTVCGTPTYVAPEIIAETGYGLKVDIWAAGVITYILLCGFPPFRGSGDDQEVLFDQILMGQVDFPSPYWDNVSDSAKELITMMLLVDVDQRFSAVQVLEHPWVNDDGLPENEHQLSVAGKIKKHFNTGPKLNSTAAGVSVIATTALDKERQVFRRRRNQD","Homo sapiens","DCLK1, DCAMKL1, DCDC3A, KIAA0369","Serine/threonine-protein kinase DCLK1","1","6KYR"
"6KZ5",,"X-RAY DIFFRACTION",3.46,64.4,"VAPOR DIFFUSION, HANGING DROP",,"Crystals of apo-LBD was obtained at 4 degrees Celsius by hanging drop vapor diffusion. The droplets consisted of a 1:1 (v/v) mixture of LBD at 6 mg/ml, and the well solution consisted of 100 mM sodium citrate (pH 4.6), 22% glycerol and 5% PEG4000. Crystals appeared after 24-48 h and were ready for data collection in 7 d.",277.15,"10.1073/pnas.2002997117",,"6KZ5",57.81,"4.45","4.45","Crystal Structure Analysis of the Csn-B-bounded NUR77 Ligand binding Domain","MSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","NR4A1, GFRP1, HMR, NAK1","Nuclear receptor subfamily 4 group A member 1","1","6KZ5"
"6KZB",,"X-RAY DIFFRACTION",2.58,52.28,"VAPOR DIFFUSION, HANGING DROP",,"Potassium chloride, Magnesium acetate tetrahydrate, Sodium cacodylate, Polyethylene glycol 8000",293.15,"10.3390/ijms21030791",,"6KZB",233.81,"3.55","3.55","Transglutaminase2 complexed with calcium","MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTPANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRRSSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLEPFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGEEVKVRMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA","Homo sapiens","TGM2","Protein-glutamine gamma-glutamyltransferase 2","1","6KZB"
"6KZC",,"X-RAY DIFFRACTION",2.14,42.57,"VAPOR DIFFUSION, HANGING DROP",,"0.1MMES, pH
6.0, 0.15M (NH4)2SO4, 15% PEG 4000",277,"10.1016/j.ejmech.2019.06.064","DZC","6KZC",36.35,"2","2","crystal structure of TRKc in complex with 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methyl-N-(3-((4- methylpiperazin-1-yl)methyl)-5- (trifluoromethyl)phenyl)benzamide","TYVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRLFNPSGNDFCIWCEVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATPIYLDILG","Homo sapiens","NTRK3, TRKC","NT-3 growth factor receptor","1","6KZC"
"6KZD",,"X-RAY DIFFRACTION",2.14,42.59,"VAPOR DIFFUSION, HANGING DROP",,"0.1MMES, pH
6.0, 0.15M (NH4)2SO4, 15% PEG 4000",277,"10.1016/j.ejmech.2019.06.064","DZ6","6KZD",36.51,"1.708","1.708","Crystal structure of TRKc in complex with 3-((6-(4-aminophenyl)imidazo[1,2-a]pyrazin-3-yl)ethynyl)- N-(3-isopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-2- methylbenzamide","TYVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRLFNPSGNDFCIWCEVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATPIYLDILG","Homo sapiens","NTRK3, TRKC","NT-3 growth factor receptor","1","6KZD"
"6KZE",,"X-RAY DIFFRACTION",2.25,45.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes (pH 7.5), 0.2 M, MgCl2, 18% PEG 3350, 50 mM 2-mercaptoethanol",277,,,"6KZE",75.79,"2.50003487525","2.50003487525","The crystal structue of PDE10A complexed with 4d","SICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6KZE"
"6KZI",,"X-RAY DIFFRACTION",3.61,65.96,"VAPOR DIFFUSION, HANGING DROP",8,"0.4M potassium sodium tartrate tetrahydrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/acs.jcim.0c00245",,"6KZI",33.64,"2.8","2.8","Crystal structure of Ser/Thr kinase Pim1 in complex with thioridazine derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6KZI"
"6KZO","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-1801-3",,"6KZO",262.39,"3.3",,"membrane protein","MDEEEDGAGAEESGQPRSFMRLNDLSGAGGRPGPGSAEKDPGSADSEAEGLPYPALAPVVFFYLSQDSRPRSWCLRTVCNPWFERISMLVILLNCVTLGMFRPCEDIACDSQRCRILQAFDDFIFAFFAVEMVVKMVALGIFGKKCYLGDTWNRLDFFIVIAGMLEYSLDLQNVSFSAVRTVRVLRPLRAINRVPSMRILVTLLLDTLPMLGNVLLLCFFVFFIFGIVGVQLWAGLLRNRCFLPENFSLPLSVDLERYYQTENEDESPFICSQPRENGMRSCRSVPTLRGDGGGGPPCGLDYEAYNSSSNTTCVNWNQYYTNCSAGEHNPFKGAINFDNIGYAWIAIFQVITLEGWVDIMYFVMDAHSFYNFIYFILLIIVGSFFMINLCLVVIATQFSETKQRESQLMREQRVRFLSNASTLASFSEPGSCYEELLKYLVYILRKAARRLAQVSRAAGVRVGLLSSPAPLGGQETQPSSSCSRSHRRLSVHHLVHHHHHHHHHYHLGNGTLRAPRASPEIQDRDANGSRRLMLPPPSTPALSGAPPGGAESVHSFYHADCHLEPVRCQAPPPRSPSEASGRTVGSGKVYPTVHTSPPPETLKEKALVEVAASSGPPTLTSLNIPPGPYSSMHKLLETQSTGACQSSCKISSPCLKADSGACGPDSCPYCARAGAGEVELADREMPDSDSEAVYEFTQDAQHSDLRDPHSRRQRSLGPDAEPSSVLAFWRLICDTFRKIVDSKYFGRGIMIAILVNTLSMGIEYHEQPEELTNALEISNIVFTSLFALEMLLKLLVYGPFGYIKNPYNIFDGVIVVISVWEIVGQQGGGLSVLRTFRLMRVLKLVRFLPALQRQLVVLMKTMDNVATFCMLLMLFIFIFSILGMHLFGCKFASERDGDTLPDRKNFDSLLWAIVTVFQILTQEDWNKVLYNGMASTSSWAALYFIALMTFGNYVLFNLLVAILVEGFQAEGDANKSESEPDFFSPSLDGDGDRKKCLALVSLGEHPELRKSLLPPLIIHTAATPMSLPKSTSTGLGEALGPASRRTSSSGSAEPGAAHEMKSPPSARSSPHSPWSAASSWTSRRSSRNSLGRAPSLKRRSPSGERRSLLSGEGQESQDEEESSEEERASPAGSDHRHRGSLEREAKSSFDLPDTLQVPGLHRTASGRGSASEHQDCNGKSASGRLARALRPDDPPLDGDDADDEGNLSKGERVRAWIRARLPACCLERDSWSAYIFPPQSRFRLLCHRIITHKMFDHVVLVIIFLNCITIAMERPKIDPHSAERIFLTLSNYIFTAVFLAEMTVKVVALGWCFGEQAYLRSSWNVLDGLLVLISVIDILVSMVSDSGTKILGMLRVLRLLRTLRPLRVISRAQGLKLVVETLMSSLKPIGNIVVICCAFFIIFGILGVQLFKGKFFVCQGEDTRNITNKSDCAEASYRWVRHKYNFDNLGQALMSLFVLASKDGWVDIMYDGLDAVGVDQQPIMNHNPWMLLYFISFLLIVAFFVLNMFVGVVVENFHKCRQHQEEEEARRREEKRLRRLEKKRRNLMLDDVIASGSSASAASEAQCKPYYSDYSRFRLLVHHLCTSHYLDLFITGVIGLNVVTMAMEHYQQPQILDEALKICNYIFTVIFVLESVFKLVAFGFRRFFQDRWNQLDLAIVLLSIMGITLEEIEVNASLPINPTIIRIMRVLRIARVLKLLKMAVGMRALLDTVMQALPQVGNLGLLFMLLFFIFAALGVELFGDLECDETHPCEGLGRHATFRNFGMAFLTLFRVSTGDNWNGIMKDTLRDCDQESTCYNTVISPIYFVSFVLTAQFVLVNVVIAVLMKHLEESNKEAKEEAELEAELELEMKTLSPQPHSPLGSPFLWPGVEGPDSPDSPKPGALHPAAHARSASHFSLEHPTMQPHPTELPGPDLLTVRKSGVSRTHSLPNDSYMCRHGSTAEGPLGHRGWGLPKAQSGSVLSVHSQPADTSYILQLPKDAPHLLQPHSAPTWGTIPKLPPPGRSPLAQRPLRRQAAIRTDSLDVQGLGSREDLLAEVSGPSPPLARAYSFWGQSSTQAQQHSRSHSKISKHMTPPAPCPGPEPNWGKGPPETRSSLELDTELSWISGDLLPPGGQEEPPSPRDLKKCYSVEAQSCQRRPTSWLDEQRRHSIAVSCLDSGSQPHLGTDPSNLGGQPLGGPGSRPKKKLSPPSITIDPPESQGPRTPPSPGICLRRRAPSSDSKDPLASGPPDSMAASPSPKKDVLSLSGLSSDPADLDP","Homo sapiens","CACNA1G, KIAA1123","Voltage-dependent T-type calcium channel subunit alpha-1G","1","6KZO"
"6KZP","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-1801-3","DZR","6KZP",247.67,"3.1",,"calcium channel-ligand","MHHHHHHHHGDYKDDDDKGTDEEEDGAGAEESGQPRSFMRLNDLSGAGGRPGPGSAEKDPGSADSEAEGLPYPALAPVVFFYLSQDSRPRSWCLRTVCNPWFERISMLVILLNCVTLGMFRPCEDIACDSQRCRILQAFDDFIFAFFAVEMVVKMVALGIFGKKCYLGDTWNRLDFFIVIAGMLEYSLDLQNVSFSAVRTVRVLRPLRAINRVPSMRILVTLLLDTLPMLGNVLLLCFFVFFIFGIVGVQLWAGLLRNRCFLPENFSLPLSVDLERYYQTENEDESPFICSQPRENGMRSCRSVPTLRGDGGGGPPCGLDYEAYNSSSNTTCVNWNQYYTNCSAGEHNPFKGAINFDNIGYAWIAIFQVITLEGWVDIMYFVMDAHSFYNFIYFILLIIVGSFFMINLCLVVIATQFSETKQRESQLMREQRVRFLSNASTLASFSEPGSCYEELLKYLVYILRKAARRLAQVSRAAGVRVGLLSSPAPLGGQETQPSSSCSRSHRRLSVHHLVHHHHHHHHHYHLGACQSSCKISSPCLKADSGACGPDSCPYCARAGAGEVELADREMPDSDSEAVYEFTQDAQHSDLRDPHSRRQRSLGPDAEPSSVLAFWRLICDTFRKIVDSKYFGRGIMIAILVNTLSMGIEYHEQPEELTNALEISNIVFTSLFALEMLLKLLVYGPFGYIKNPYNIFDGVIVVISVWEIVGQQGGGLSVLRTFRLMRVLKLVRFLPALQRQLVVLMKTMDNVATFCMLLMLFIFIFSILGMHLFGCKFASERDGDTLPDRKNFDSLLWAIVTVFQILTQEDWNKVLYNGMASTSSWAALYFIALMTFGNYVLFNLLVAILVEGFQAEGDANKSESEPDFFSPSLDGDGDRKKCLALVSLGEHPELRKSLLPPLIIHTAATPMSLPKSTSTGLGEALGPASRRTSSSGSAEPGAAHEMKSPPSARSSPHSPWSAASSWTSRRSSRNSLGRAPSLKRRSPSGERRSLLSGEGQESQDEEESSEEERASPAGSDHRHRGSLEREAKSSFDLPDTLQVPGLHRTASGRGSASEHQDCNGKSASGRLARALRPDDPPLDGDDADDEGNLSKGERVRAWIRARLPACCLERDSWSAYIFPPQSRFRLLCHRIITHKMFDHVVLVIIFLNCITIAMERPKIDPHSAERIFLTLSNYIFTAVFLAEMTVKVVALGWCFGEQAYLRSSWNVLDGLLVLISVIDILVSMVSDSGTKILGMLRVLRLLRTLRPLRVISRAQGLKLVVETLMSSLKPIGNIVVICCAFFIIFGILGVQLFKGKFFVCQGEDTRNITNKSDCAEASYRWVRHKYNFDNLGQALMSLFVLASKDGWVDIMYDGLDAVGVDQQPIMNHNPWMLLYFISFLLIVAFFVLNMFVGVVVENFHKCRQHQEEEEARRREEKRLRRLEKKRRNLMLDDVIASGSSASAASEAQCKPYYSDYSRFRLLVHHLCTSHYLDLFITGVIGLNVVTMAMEHYQQPQILDEALKICNYIFTVIFVLESVFKLVAFGFRRFFQDRWNQLDLAIVLLSIMGITLEEIEVNASLPINPTIIRIMRVLRIARVLKLLKMAVGMRALLDTVMQALPQVGNLGLLFMLLFFIFAALGVELFGDLECDETHPCEGLGRHATFRNFGMAFLTLFRVSTGDNWNGIMKDTLRDCDQESTCYNTVISPIYFVSFVLTAQFVLVNVVIAVLMKHLEESNKEAKEEAELEAELELEMKTLSPQPHSPLGSPFLWPGVEGPDSPDSPKPGALHPAAHARSASHFSLEHPTMQPHPTELPGPDLLTVRKSGVSRTHSLPNDSYMCRHGSTAEGPLGHRGWGLPKAQSGSVLSVHSQPADTSYILQLPKDAPHLLQPHSAPTWGTIPKLPPPGRSPLAQRPLRRQAAIRTDSLDVQGLGSREDLLAEVSGPSPPLARAYSFWGQSSTQAQQHSRSHSKISKHMTPPAPCPGPEPNWGKGPPETRSSLELDTELSWISGDLLPPGGQEEPPSPRDLKKCYSVEAQSCQRRPTSWLDEQRRHSIAVSCLDSGSQPHLGTDPSNLGGQPLGGPGSRPKKKLSPPSITIDPPESQGPRTPPSPGICLRRRAPSSDSKDPLASGPPDSMAASPSPKKDVLSLSGLSSDPADLDP","Homo sapiens","CACNA1G, KIAA1123","Voltage-dependent T-type calcium channel subunit alpha-1G,Voltage-dependent T-type calcium channel subunit alpha-1G","1","6KZP"
,,,,,,,,,,,,,,,,,"Homo sapiens","CACNA1G, KIAA1123"
"6L04",,"X-RAY DIFFRACTION",2.12,42.02,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate at pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5%
PEG 400",298,,,"6L04",28.03,"2.21","2.21","Crystal structure of uPA_H99Y in complex with 31F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAYHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6L04"
"6L05",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate at pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5%
PEG 400",298,,,"6L05",28,"2.49","2.49","Crystal structure of uPA_H99Y in complex with 50F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAYHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6L05"
"6L0L",,"SOLUTION NMR",,,,,,,"10.1016/j.csbj.2021.04.046",,"6L0L",9.22,,,"Hydra-1ubq de nova designed by Hydra based on ubiquitin","GPGSLEIKIRTTEGRTLTVDVKPDRTIEELMEKLKEQTGVPPEQLRVIYNGRELEPRTTLEEYNITPGVTLELKTRSSGHGT","Homo sapiens",,"Hydra-1ubq","1","6L0L"
"6L0O",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION, HANGING DROP",,"2.0-2.2M (NH4)2SO4, 0.1M Tris-HCl pH 8.0",293,"10.1016/j.bbrc.2020.03.150",,"6L0O",9.74,"1.21","1.21","WH domain of human MCM8","MARSMSNRSTAKRFISALNNVAERTYNNIFQFHQLRQIAKELNIQVADFENFIGSLNDQGYLLKKGPKVYQLQTMHHHHHH","Homo sapiens","MCM8, C20orf154","DNA helicase MCM8","1","6L0O"
"6L0X",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 6000, 0.1M citric acid, PH 4.0",293,"10.1021/acs.jpclett.0c02039",,"6L0X",18.34,"1.3","1.3","The First Tudor Domain of PHF20L1","GSHMPPNRPGITFEIGARLEALDYLQKWYPSRIEKIDYEEGKMLVHFERWSHRYDEWIYWDSNRLRPLER","Homo sapiens","PHF20L1, CGI-72","PHD finger protein 20-like protein 1","1","6L0X"
"6L10",,"X-RAY DIFFRACTION",1.97,37.67,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 8000, 0.2M (NH4)2SO4, 0.1mM MES, PH 6.5",293,"10.1021/acs.jpclett.0c02039",,"6L10",35.94,"1.6","1.6","PHF20L1 Tudor1 - MES","GSHMPPNRPGITFEIGARLEALDYLQKWYPSRIEKIDYEEGKMLVHFERWSHRYDEWIYWDSNRLRPLER","Homo sapiens","PHF20L1, CGI-72","PHD finger protein 20-like protein 1","1","6L10"
"6L11",,"X-RAY DIFFRACTION",3.54,65.21,"VAPOR DIFFUSION, HANGING DROP",8,"0.4M potassium sodium tartrate tetrahydrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/acs.jcim.0c00245","E2C","6L11",33.65,"2.05","2.05","Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6L11"
"6L12",,"X-RAY DIFFRACTION",3.58,65.67,"VAPOR DIFFUSION, HANGING DROP",8,"0.4M potassium sodium tartrate tetrahydrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/acs.jcim.0c00245","E2R","6L12",33.62,"1.87","1.87","Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6L12"
"6L13",,"X-RAY DIFFRACTION",3.54,65.21,"VAPOR DIFFUSION, HANGING DROP",8,"0.4M potassium sodium tartrate tetrahydrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/acs.jcim.0c00245","E2F","6L13",33.62,"2.24","2.24","Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6L13"
"6L14",,"X-RAY DIFFRACTION",3.6,65.87,"VAPOR DIFFUSION, HANGING DROP",8,"0.4M potassium sodium tartrate tetrahydrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/acs.jcim.0c00245","E2L","6L14",33.64,"1.95","1.95","Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6L14"
"6L15",,"X-RAY DIFFRACTION",3.58,65.61,"VAPOR DIFFUSION, HANGING DROP",8,"0.4M potassium sodium tartrate tetrahydrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/acs.jcim.0c00245",,"6L15",33.64,"2.6","2.6","Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6L15"
"6L16",,"X-RAY DIFFRACTION",3.58,65.67,"VAPOR DIFFUSION, HANGING DROP",8,"0.4M potassium sodium tartrate tetrahydrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/acs.jcim.0c00245","E2U","6L16",33.67,"2.1","2.1","Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6L16"
"6L17",,"X-RAY DIFFRACTION",3.55,65.31,"VAPOR DIFFUSION, HANGING DROP",8,"0.4M potassium sodium tartrate tetrahydrate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/acs.jcim.0c00245",,"6L17",33.65,"1.75","1.75","Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives","GPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6L17"
"6L1C",,"X-RAY DIFFRACTION",3.09,60.18,"VAPOR DIFFUSION, SITTING DROP",,"1.6M lithium sulfate, 0.1M Tris, PH 8.0",293,"10.1021/acs.jpclett.0c02039",,"6L1C",9.02,"1.58","1.58","Crystal Structure Of of PHF20L1 Tudor1 Y24L mutant","GSHMPPNRPGITFEIGARLEALDLLQKWYPSRIEKIDYEEGKMLVHFERWSHRYDEWIYWDSNRLRPLER","Homo sapiens","PHF20L1, CGI-72","PHD finger protein 20-like protein 1","1","6L1C"
"6L1D",,"X-RAY DIFFRACTION",3.5,64.86,"VAPOR DIFFUSION, HANGING DROP",9,"0.1 M Bicine pH 9.0, 30% PEG 1000",287,"10.1016/j.bbrc.2019.10.054",,"6L1D",47.77,"1.95","1.95","Structure of human StAR-related lipid transfer protein 4","GSAMGSEGLSDVASFATKLKNTLIQYHSIEEDKWRVAKKTKDVTVWRKPSEEFNGYLYKAQGVIDDLVYSIIDHIRPGPSRLDWDSLMTSLDILENFEENCCVMRYTTAGQLWNIISPREFVDFSYTVGYKEGLLSCGISLDWDEKRPEFVRGYNHPCGWFCVPLKDNPNQSLLTGYIQTDLRGMIPQSAVDTAMASTLTNFYGDLRKAL","Homo sapiens","STARD4","StAR-related lipid transfer protein 4","1","6L1D"
"6L1E",,"X-RAY DIFFRACTION",2.09,41.09,"VAPOR DIFFUSION, HANGING DROP",,"10mM MES pH4.0, 12.5% 2-propanol, 20%(w/v) PEG 2000",289,,,"6L1E",27.46,"2.0939","2.0939","Crystal structure of middle domain of hSSRP1","GDAICIFRELQCLTPRGRYDIRIYPTFLHLHGKTFDYKIPYTTVLRLFLLPHKDQRQMFFVISLDPPIKQGQTRYHFLILLFSKDEDISLTLNMNEEEVEKRFEGRLTKNMSGSLYEMVSRVMKALVNRKITVPGNFQGHSGAQCITCSYKASSGLLYPLERGFIYVHKPPVHIRFDEISFVNFARGTTTTRSFDFEIETKQGTQYTFSSIEREEYGKLFDFVNAKKLNIKNRGL","Homo sapiens","SSRP1, FACT80","FACT complex subunit SSRP1","1","6L1E"
"6L1I",,"X-RAY DIFFRACTION",1.78,30.72,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 4000, 0.2M Lithium Sulfate, 0.1M Tris, PH 8.0",293,"10.1021/acs.jpclett.0c02039",,"6L1I",8.93,"1.849","1.849","Crystal Structure Of of PHF20L1 Tudor1 Y24W/Y29W mutant","GSHMPPNRPGITFEIGARLEALDWLQKWWPSRIEKIDYEEGKMLVHFERWSHRYDEWIYWDSNRLRPLER","Homo sapiens","PHF20L1, CGI-72","PHD finger protein 20-like protein 1","1","6L1I"
"6L1M",,"X-RAY DIFFRACTION",1.83,32.87,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES pH 6.0, 25% PEG 3350, 200 mM NaCl",287,"10.1016/j.bbrc.2019.10.054",,"6L1M",23.47,"1.7","1.7","Structure of human StAR-related lipid transfer protein 4 mutant - LWNI107-110GG","GSAMGSEGLSDVASFATKLKNTLIQYHSIEEDKWRVAKKTKDVTVWRKPSEEFNGYLYKAQGVIDDLVYSIIDHIRPGPSRLDWDSLMTSLDILENFEENCCVMRYTTAGQGGISPREFVDFSYTVGYKEGLLSCGISLDWDEKRPEFVRGYNHPCGWFCVPLKDNPNQSLLTGYIQTDLRGMIPQSAVDTAMASTLTNFYGDLRKAL","Homo sapiens","STARD4","StAR-related lipid transfer protein 4","1","6L1M"
"6L1P",,"X-RAY DIFFRACTION",1.99,38.04,"VAPOR DIFFUSION, HANGING DROP",,"1.6M magnesium sulfate, 0.1mM MES, PH 6.5",293,"10.1021/acs.jpclett.0c02039","E3X","6L1P",36.1,"1.231","1.231","Crystal structure of PHF20L1 in complex with Hit 1","GSHMPPNRPGITFEIGARLEALDYLQKWYPSRIEKIDYEEGKMLVHFERWSHRYDEWIYWDSNRLRPLER","Homo sapiens","PHF20L1, CGI-72","PHD finger protein 20-like protein 1","1","6L1P"
"6L1R",,"X-RAY DIFFRACTION",2.07,40.52,"VAPOR DIFFUSION, HANGING DROP",,"30%(w/v) PEG 1500, 40% 1,2-Butanediol",287,,,"6L1R",11.83,"1.79843948699","1.79843948699","Crystal structure of N-terminal domain of human SSRP1","GPMAETLEFNDVYQEVKGSMNDGRLRLSRQGIIFKNSKTGKVDNIQAGELTEGIWRRVALGHGLKLLTKNGHVYKYDGFRESEFEKLSDFFKTHYRLELMEK","Homo sapiens","SSRP1, FACT80","FACT complex subunit SSRP1","1","6L1R"
"6L1S",,"X-RAY DIFFRACTION",2.48,50.48,"VAPOR DIFFUSION",8,"0.2M Imidazole, 0.4M NaH2PO4/1.6M K2HPO4, 0.2M NaCl",293,"10.3390/ijms21207515",,"6L1S",17.89,"1.3611","1.3611","Crystal structure of DUSP22 mutant_C88S","GPMGNGMNKILPGLYIGNFKDARDAEQLSKNKVTHILSVHDSARPMLEGVKYLCIPAADSPSQNLTRHFKESIKFIHECRLRGESCLVHSLAGVSRSVTLVIAYIMTVTDFGWEDALHTVRAGRSCANPNVGFQRQLQEFEKHEVHQYRQWLKEEYG","Homo sapiens","DUSP22, JSP1, LMWDSP2, MKPX","Dual specificity protein phosphatase 22","1","6L1S"
"6L1T","3.22","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1922741117",,"6L1T",145.56,"3.22",,"Cryo-EM structure of phosphorylated Tyr39 a-synuclein amyloid fibril","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6L1T"
"6L1U","3.37","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1922741117",,"6L1U",218.34,"3.37",,"Cryo-EM structure of phosphorylated Tyr39 alpha-synuclein amyloid fibril","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6L1U"
"6L1Z",,"X-RAY DIFFRACTION",2,38.61,"VAPOR DIFFUSION, SITTING DROP",,"Ethylene Glycol",277,"10.1016/j.bmcl.2019.126837",,"6L1Z",40.78,"1.90820949507","1.90820949507","Crystal structure of CK2a1 with hematein","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein Kinase 2 subunit alpha","1","6L1Z"
"6L20",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",,"PEG 8000",277,"10.1016/j.bmcl.2019.126837",,"6L20",161.4,"3.08735128172","3.08735128172","Crystal structure of CK2a2 with hematein","GPLGSMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQS","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6L20"
"6L21",,"X-RAY DIFFRACTION",1.94,36.73,"VAPOR DIFFUSION, SITTING DROP",,"Ethylene glycol",277,"10.1016/j.bmcl.2019.126837",,"6L21",40.71,"2.05451776886","2.05451776886","Crystal structure of CK2a1 H160A with hematein","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPANVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6L21"
"6L22",,"X-RAY DIFFRACTION",1.95,36.9,"VAPOR DIFFUSION, SITTING DROP",,"25% Ethylene Glycol",277,"10.1016/j.bmcl.2019.126837",,"6L22",40.8,"2.12318084151","2.12318084151","Crystal structure of CK2a1 H115Y with hematein","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEYVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6L22"
"6L23",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, SITTING DROP",,"Ethylene glycol",277,"10.1016/j.bmcl.2019.126837",,"6L23",41.35,"1.9744942746","1.9744942746","Crystal structure of CK2a1 V116I with hematein","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHINNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6L23"
"6L24",,"X-RAY DIFFRACTION",2.01,38.69,"VAPOR DIFFUSION, SITTING DROP",,"Ethylene glycol",277,"10.1016/j.bmcl.2019.126837",,"6L24",40.82,"2.40009490218","2.40009490218","Crystal structure of CK2a1 H115Y/V116I with hematein","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEYINNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6L24"
"6L30",,"X-RAY DIFFRACTION",2.85,56.85,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.95-1.05 M Potassium/Sodium Tartrate
0.2 M Lithium Sulfate
1 mM TCEP",291,"10.1073/pnas.1913054117",,"6L30",80.7,"2.8","2.8","Crystal structure of the epithelial cell transforming 2 (ECT2)","GHMGSSGGCTSMMNLVLCFTGFRKKEELVRLVTLVHHMGGVIRKDFNSKVTHLVANCTQGEKFRVAVSLGTPIMKPEWIYKAWERRNEQDFYAAVDDFRNEFKVPPFQDCILSFLGFSDEEKTNMEEMTEMQGGKYLPLGDERCTHLVVEENIVKDLPFEPSKKLYVVKQEWFWGSIQMDARAGETMYLYEKANTPELKKSVSMLSLNTPNSNRKRRRLKETLAQLSRETDVSPFPPRKRPSAEHSLSIGSLLDISNTPESSINYGDTPKSCTKSSKSSTPVPSKQSARWQVAKELYQTESNYVNILATIIQLFQVPLEEEGQRGGPILAPEEIKTIFGSIPDIFDVHTKIKDDLEDLIVNWDESKSIGDIFLKYSKDLVKTYPPFVNFFEMSKETIIKCEKQKPRFHAFLKINQAKPECGRQSLVELLIRPVQRLPSVALLLNDLKKHTADENPDKSTLEKAIGSLKEVMTHINEDKRKTEAQKQIFDVVYEVDGCPANLLSSHRSLVQRVETISLGEHPCDRGEQVTLFLFNDCLEIARKRHKVIGTFRSPHGQTRPPASLKHIHLMPLSQIKKVLDIRETEDCHNAFALLVRPPTEQANVLLSFQMTSDELPKENWLKMLCRHVANTICKADAENLIYTADPESFEVNTKDMDSTLSRASRAIKKTSKKVTRAFSFSKTPKRALRRALMTSHGSVEGRHHHHHH","Homo sapiens","ECT2","Protein ECT2","1","6L30"
"6L34",,"X-RAY DIFFRACTION",4.13,70.23,"VAPOR DIFFUSION, HANGING DROP",,"2M DL-malic acid PH7.0, 0.1M BIS-TRIS propane pH7.0.",289,,,"6L34",8.12,"1.996","1.996","Crystal structure of the HMG domain of human FACT complex subunit SSRP1","KRPMSAYMLWLNASREKIKSDHPGISITDLSKKAGEIWKGMSKEKKEEWDRKAEDARRDYEKAMKEYE","Homo sapiens","SSRP1, FACT80","FACT complex subunit SSRP1","1","6L34"
"6L36",,"X-RAY DIFFRACTION",3.11,60.39,"VAPOR DIFFUSION",,"0.1 M Tris (pH 8.0), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6L36",64.01,"3.301","3.301","X-ray structure of human PPARalpha ligand binding domain-GW9662-fenofibric acid co-crystals obtained by delipidation and co-crystallization","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6L36"
"6L37",,"X-RAY DIFFRACTION",3.07,59.89,"VAPOR DIFFUSION",,"0.1 M Tris (pH 8.0), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6L37",63.95,"2.91","2.91","X-ray structure of human PPARalpha ligand binding domain-GW9662-ciprofibrate co-crystals obtained by delipidation and co-crystallization","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6L37"
"6L38",,"X-RAY DIFFRACTION",3.12,60.56,"VAPOR DIFFUSION",,"0.1 M Tris (pH 8.0), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6L38",62.82,"2.761","2.761","X-ray structure of human PPARalpha ligand binding domain-GW9662-gemfibrozil co-crystals obtained by delipidation and co-crystallization","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6L38"
"6L3R",,"X-RAY DIFFRACTION",2.5,50.84,"VAPOR DIFFUSION, HANGING DROP",,"Sodium acetate buffer, PEG3350, Lithium sulfate",300,,,"6L3R",154.64,"2","2","Crystal structure of Ribonucleotide reductase R1 subunit, RRM1 in complex with 4-bromo-N-((1S,2R)-2-(naphthalen-1-yl)-1-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)propyl)benzenesulfonamide","GAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTR","Homo sapiens","RRM1, RR1","Ribonucleoside-diphosphate reductase large subunit","1","6L3R"
"6L3T","2.34","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.aba4996",,"6L3T",194.07,"2.34",,"Human Cx31.3/GJC3 connexin hemichannel in the absence of calcium","MCGRFLRRLLAEESRRSTPVGRLLLPVLLGFRLVLLAASGPGVYGDEQSEFVCHTQQPGCKAACFDAFHPLSPLRFWVFQVILVAVPSALYMGFTLYHVIWHWELSGKGKEEETLIQGREGNTDVPGAGSLRLLWAYVAQLGARLVLEGAALGLQYHLYGFQMPSSFACRREPCLGSITCNLSRPSEKTIFLKTMFGVSGFCLLFTFLELVLLGLGRWWRTWKHKSSSSKYFLTSESTRRHKKATDSLPVVETKEQFQEAVPGRSLAQEKQRPVGPRDA","Homo sapiens","GJC3, GJE1","Gap junction gamma-3 protein","1","6L3T"
"6L3U","2.53","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.aba4996",,"6L3U",194.31,"2.53",,"Human Cx31.3/GJC3 connexin hemichannel in the presence of calcium","MCGRFLRRLLAEESRRSTPVGRLLLPVLLGFRLVLLAASGPGVYGDEQSEFVCHTQQPGCKAACFDAFHPLSPLRFWVFQVILVAVPSALYMGFTLYHVIWHWELSGKGKEEETLIQGREGNTDVPGAGSLRLLWAYVAQLGARLVLEGAALGLQYHLYGFQMPSSFACRREPCLGSITCNLSRPSEKTIFLKTMFGVSGFCLLFTFLELVLLGLGRWWRTWKHKSSSSKYFLTSESTRRHKKATDSLPVVETKEQFQEAVPGRSLAQEKQRPVGPRDA","Homo sapiens","GJC3, GJE1","Gap junction gamma-3 protein","1","6L3U"
"6L3V","2.63","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.aba4996",,"6L3V",193.47,"2.63",,"The R15G mutant of human Cx31.3/GJC3 connexin hemichannel","MCGRFLRRLLAEESGRSTPVGRLLLPVLLGFRLVLLAASGPGVYGDEQSEFVCHTQQPGCKAACFDAFHPLSPLRFWVFQVILVAVPSALYMGFTLYHVIWHWELSGKGKEEETLIQGREGNTDVPGAGSLRLLWAYVAQLGARLVLEGAALGLQYHLYGFQMPSSFACRREPCLGSITCNLSRPSEKTIFLKTMFGVSGFCLLFTFLELVLLGLGRWWRTWKHKSSSSKYFLTSESTRRHKKATDSLPVVETKEQFQEAVPGRSLAQEKQRPVGPRDA","Homo sapiens","GJC3, GJE1","Gap junction gamma-3 protein","1","6L3V"
"6L47","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-16288-4",,"6L47",116.15,"3.5",,"Structure of the human sterol O-acyltransferase 1 in complex with CI-976","MKEVGSHFDDFVTNLIEKSASLDNGGCALTTFSVLEGEKNNHRAKDLRAPPEQGKIFIARRSLLDELLEVDHIRTIYHMFIALLILFILSTLVVDYIDEGRLVLEFSLLSYAFGKFPTVVWTWWIMFLSTFSVPYFLFQHWATGYSKSSHPLIRSLFHGFLFMIFQIGVLGFGPTYVVLAYTLPPASRFIIIFEQIRFVMKAHSFVRENVPRVLNSAKEKSSTVPIPTVNQYLYFLFAPTLIYRDSYPRNPTVRWGYVAMKFAQVFGCFFYVYYIFERLCAPLFRNIKQEPFSARVLVLCVFNSILPGVLILFLTFFAFLHCWLNAFAEMLRFGDRMFYKDWWNSTSYSNYYRTWNVVVHDWLYYYAYKDFLWFFSKRFKSAAMLAVFAVSAVVHEYALAVCLSFFYPVLFVLFMFFGMAFNFIVNDSRKKPIWNVLMWTSLFLGNGVLLCFYSQEWYARQHCPLKNPTFLDYVRPRSWTCRYVF","Homo sapiens","SOAT1, ACACT, ACACT1, ACAT, ACAT1, SOAT, STAT","Sterol O-acyltransferase 1","1","6L47"
"6L48","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-16288-4",,"6L48",115.36,"3.5",,"Structure of the human sterol O-acyltransferase 1 in resting state","MKEVGSHFDDFVTNLIEKSASLDNGGCALTTFSVLEGEKNNHRAKDLRAPPEQGKIFIARRSLLDELLEVDHIRTIYHMFIALLILFILSTLVVDYIDEGRLVLEFSLLSYAFGKFPTVVWTWWIMFLSTFSVPYFLFQHWATGYSKSSHPLIRSLFHGFLFMIFQIGVLGFGPTYVVLAYTLPPASRFIIIFEQIRFVMKAHSFVRENVPRVLNSAKEKSSTVPIPTVNQYLYFLFAPTLIYRDSYPRNPTVRWGYVAMKFAQVFGCFFYVYYIFERLCAPLFRNIKQEPFSARVLVLCVFNSILPGVLILFLTFFAFLHCWLNAFAEMLRFGDRMFYKDWWNSTSYSNYYRTWNVVVHDWLYYYAYKDFLWFFSKRFKSAAMLAVFAVSAVVHEYALAVCLSFFYPVLFVLFMFFGMAFNFIVNDSRKKPIWNVLMWTSLFLGNGVLLCFYSQEWYARQHCPLKNPTFLDYVRPRSWTCRYVF","Homo sapiens","SOAT1, ACACT, ACACT1, ACAT, ACAT1, SOAT, STAT","Sterol O-acyltransferase 1","1","6L48"
"6L4B",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"200 mM sodium citrate tribasic dehydrate, 20% PEG 3350",295,"10.3390/biom10010090",,"6L4B",248.7,"2.2","2.2","Crystal structure of human WT NDRG3","MDELQDVQLTEIKPLLNDKNGTRNFQDFDCQEHDIETTHGVVHVTIRGLPKGNRPVILTYHDIGLNHKSCFNAFFNFEDMQEITQHFAVCHVDAPGQQEGAPSFPTGYQYPTMDELAEMLPPVLTHLSLKSIIGIGVGAGAYILSRFALNHPELVEGLVLINVDPCAKGWIDWAASKLSGLTTNVVDIILAHHFGQEELQANLDLIQTYRMHIAQDINQDNLQLFLNSYNGRRDLEIERPILGQNDNKSKTLKCSTLLVVGDNSPAVEAVVECNSRLNPINTTLLKMADCGGLPQVVQPGKLTEAFKYFLQGMGYIPSASMTRLARSRTHSTSSSLGSGESPFSRSVTSNQSDGTQESCESPDVLDRHQTMEVSC","Homo sapiens","NDRG3","Protein NDRG3","1","6L4B"
"6L4G",,"X-RAY DIFFRACTION",1.96,37.17,"VAPOR DIFFUSION, HANGING DROP",7,"200 mM ammonium citrate tribasic pH 7.0 and 20% PEG3350",295,"10.3390/biom10010090",,"6L4G",83.04,"3.304","3.304","Crystal structure of human NDRG3 I171M/S176H mutant","MDELQDVQLTEIKPLLNDKNGTRNFQDFDCQEHDIETTHGVVHVTIRGLPKGNRPVILTYHDIGLNHKSCFNAFFNFEDMQEITQHFAVCHVDAPGQQEGAPSFPTGYQYPTMDELAEMLPPVLTHLSLKSIIGIGVGAGAYILSRFALNHPELVEGLVLINVDPCAKGWMDWAAHKLSGLTTNVVDIILAHHFGQEELQANLDLIQTYRMHIAQDINQDNLQLFLNSYNGRRDLEIERPILGQNDNKSKTLKCSTLLVVGDNSPAVEAVVECNSRLNPINTTLLKMADCGGLPQVVQPGKLTEAFKYFLQGMGYIPSASMTRLARSRTHSTSSSLGSGESPFSRSVTSNQSDGTQESCESPDVLDRHQTMEVSC","Homo sapiens","NDRG3","Protein NDRG3","1","6L4G"
"6L4H",,"X-RAY DIFFRACTION",2.88,57.35,"VAPOR DIFFUSION, HANGING DROP",,"200 mM sodium citrate tribasic dehydrate, 20% PEG 3350",295,"10.3390/biom10010090",,"6L4H",165.73,"3.4","3.4","Crystal structure of human NDRG3 C30S mutant","MDELQDVQLTEIKPLLNDKNGTRNFQDFDSQEHDIETTHGVVHVTIRGLPKGNRPVILTYHDIGLNHKSCFNAFFNFEDMQEITQHFAVCHVDAPGQQEGAPSFPTGYQYPTMDELAEMLPPVLTHLSLKSIIGIGVGAGAYILSRFALNHPELVEGLVLINVDPCAKGWIDWAASKLSGLTTNVVDIILAHHFGQEELQANLDLIQTYRMHIAQDINQDNLQLFLNSYNGRRDLEIERPILGQNDNKSKTLKCSTLLVVGDNSPAVEAVVECNSRLNPINTTLLKMADCGGLPQVVQPGKLTEAFKYFLQGMGYIPSASMTRLARSRTHSTSSSLGSGESPFSRSVTSNQSDGTQESCESPDVLDRHQTMEVSC","Homo sapiens","NDRG3","Protein NDRG3","1","6L4H"
"6L4K",,"X-RAY DIFFRACTION",2.48,50.4,"EVAPORATION",,"PEG3350, 50 mM potassium phosphate (pH 7.5), 5% glycerol, and 4% DMSO.",293,,,"6L4K",135.9,"2.09","2.09","Human serum albumin-Palmitic acid-Cu compound","HKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAAL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6L4K"
"6L4S","3.37","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-16386-3",,"6L4S",32.41,"3.37",,"cryo-em structure of alpha-synuclein fiber mutation type E46K","KKGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQ","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6L4S"
"6L53","3.63","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-019-0255-3",,"6L53",410.97,"3.63",,"Structure of SMG1","MSRRAPGSRLSSGGGGGGTKYPRSWNDWQPRTDSASADPDNLKYSSSRDRGGSSSYGLQPSNSAVVSRQRHDDTRVHADIQNDEKGGYSVNGGSGENTYGRKSLGQELRVNNVTSPEFTSVQHGSRALATKDMRKSQERSMSYSDESRLSNLLRRITREDDRDRRLATVKQLKEFIQQPENKLVLVKQLDNILAAVHDVLNESSKLLQELRQEGACCLGLLCASLSYEAEKIFKWIFSKFSSSAKDEVKLLYLCATYKALETVGEKKAFSSVMQLVMTSLQSILENVDTPELLCKCVKCILLVARCYPHIFSTNFRDTVDILVGWHIDHTQKPSLTQQVSGWLQSLEPFWVADLAFSTTLLGQFLEDMEAYAEDLSHVASGESVDEDVPPPSVSLPKLAALLRVFSTVVRSIGERFSPIRGPPITEAYVTDVLYRVMRCVTAANQVFFSEAVLTAANECVGVLLGSLDPSMTIHCDMVITYGLDQLENCQTCGTDYIISVLNLLTLIVEQINTKLPSSFVEKLFIPSSKLLFLRYHKEKEVVAVAHAVYQAVLSLKNIPVLETAYKLILGEMTCALNNLLHSLQLPEACSEIKHEAFKNHVFNVDNAKFVVIFDLSALTTIGNAKNSLIGMWALSPTVFALLSKNLMIVHSDLAVHFPAIQYAVLYTLYSHCTRHDHFISSSLSSSSPSLFDGAVISTVTTATKKHFSIILNLLGILLKKDNLNQDTRKLLMTWALEAAVLMKKSETYAPLFSLPSFHKFCKGLLANTLVEDVNICLQACSSLHALSSSLPDDLLQRCVDVCRVQLVHSGTRIRQAFGKLLKSIPLDVVLSNNNHTEIQEISLALRSHMSKAPSNTFHPQDFSDVISFILYGNSHRTGKDNWLERLFYSCQRLDKRDQSTIPRNLLKTDAVLWQWAIWEAAQFTVLSKLRTPLGRAQDTFQTIEGIIRSLAAHTLNPDQDVSQWTTADNDEGHGNNQLRLVLLLQYLENLEKLMYNAYEGCANALTSPPKVIRTFFYTNRQTCQDWLTRIRLSIMRVGLLAGQPAVTVRHGFDLLTEMKTTSLSQGNELEVTIMMVVEALCELHCPEAIQGIAVWSSSIVGKNLLWINSVAQQAEGRFEKASVEYQEHLCAMTGVDCCISSFDKSVLTLANAGRNSASPKHSLNGESRKTVLSKPTDSSPEVINYLGNKACECYISIADWAAVQEWQNAIHDLKKSTSSTSLNLKADFNYIKSLSSFESGKFVECTEQLELLPGENINLLAGGSKEKIDMKKLLPNMLSPDPRELQKSIEVQLLRSSVCLATALNPIEQDQKWQSITENVVKYLKQTSRIAIGPLRLSTLTVSQSLPVLSTLQLYCSSALENTVSNRLSTEDCLIPLFSEALRSCKQHDVRPWMQALRYTMYQNQLLEKIKEQTVPIRSHLMELGLTAAKFARKRGNVSLATRLLAQCSEVQLGKTTTAQDLVQHFKKLSTQGQVDEKWGPELDIEKTKLLYTAGQSTHAMEMLSSCAISFCKSVKAEYAVAKSILTLAKWIQAEWKEISGQLKQVYRAQHQQNFTGLSTLSKNILTLIELPSVNTMEEEYPRIESESTVHIGVGEPDFILGQLYHLSSVQAPEVAKSWAALASWAYRWGRKVVDNASQGEGVRLLPREKSEVQNLLPDTITEEEKERIYGILGQAVCRPAGIQDEDITLQITESEDNEEDDMVDVIWRQLISSCPWLSELDESATEGVIKVWRKVVDRIFSLYKLSCSAYFTFLKLNAGQIPLDEDDPRLHLSHRVEQSTDDMIVMATLRLLRLLVKHAGELRQYLEHGLETTPTAPWRGIIPQLFSRLNHPEVYVRQSICNLLCRVAQDSPHLILYPAIVGTISLSSESQASGNKFSTAIPTLLGNIQGEELLVSECEGGSPPASQDSNKDEPKSGLNEDQAMMQDCYSKIVDKLSSANPTMVLQVQMLVAELRRVTVLWDELWLGVLLQQHMYVLRRIQQLEDEVKRVQNNNTLRKEEKIAIMREKHTALMKPIVFALEHVRSITAAPAETPHEKWFQDNYGDAIENALEKLKTPLNPAKPGSSWIPFKEIMLSLQQRAQKRASYILRLEEISPWLAAMTNTEIALPGEVSARDTVTIHSVGGTITILPTKTKPKKLLFLGSDGKSYPYLFKGLEDLHLDERIMQFLSIVNTMFATINRQETPRFHARHYSVTPLGTRSGLIQWVDGATPLFGLYKRWQQREAALQAQKAQDSYQTPQNPGIVPRPSELYYSKIGPALKTVGLSLDVSRRDWPLHVMKAVLEELMEATPPNLLAKELWSSCTTPDEWWRVTQSYARSTAVMSMVGYIIGLGDRHLDNVLIDMTTGEVVHIDYNVCFEKGKSLRVPEKVPFRMTQNIETALGVTGVEGVFRLSCEQVLHIMRRGRETLLTLLEAFVYDPLVDWTAGGEAGFAGAVYGGGGQQAESKQSKREMEREITRSLFSSRVAEIKVNWFKNRDEMLVVLPKLDGSLDEYLSLQEQLTDVEKLQGKLLEEIEFLEGAEGVDHPSHTLQHRYSEHTQLQTQQRAVQEAIQVKLNEFEQWITHYQAAFNNLEATQLASLLQEISTQMDLGPPSYVPATAFLQNAGQAHLISQCEQLEGEVGALLQQRRSVLRGCLEQLHHYATVALQYPKAIFQKHRIEQWKTWMEELICNTTVERCQELYRKYEMQYAPQPPPTVCQFITATEMTLQRYAADINSRLIRQVERLKQEAVTVPVCEDQLKEIERCIKVFLHENGEEGSLSLASVIISALCTLTRRNLMMEGAASSAGEQLVDLTSRDGAWFLEELCSMSGNVTCLVQLLKQCHLVPQDLDIPNPMEASETVHLANGVYTSLQELNSNFRQIIFPEALRCLMKGEYTLESMLHELDGLIEQTTDGVPLQTLVESLQAYLRNAAMGLEEETHAHYIDVARLLHAQYGELIQPRNGSVDETPKMSAGQMLLVAFDGMFAQVETAFSLLVEKLNKMEIPIAWRKIDIIREARSTQVNFFDDDNHRQVLEEIFFLKRLQTIKEFFRLCGTFSKTLSGSSSLEDQNTVNGPVQIVNVKTLFRNSCFSEDQMAKPIKAFTADFVRQLLIGLPNQALGLTLCSFISALGVDIIAQVEAKDFGAESKVSVDDLCKKAVEHNIQIGKFSQLVMNRATVLASSYDTAWKKHDLVRRLETSISSCKTSLQRVQLHIAMFQWQHEDLLINRPQAMSVTPPPRSAILTSMKKKLHTLSQIETSIATVQEKLAALESSIEQRLKWAGGANPALAPVLQDFEATIAERRNLVLKESQRASQVTFLCSNIIHFESLRTRTAEALNLDAALFELIKRCQQMCSFASQFNSSVSELELRLLQRVDTGLEHPIGSSEWLLSAHKQLTQDMSTQRAIQTEKEQQIETVCETIQNLVDNIKTVLTGHNRQLGDVKHLLKAMAKDEEAALADGEDVPYENSVRQFLGEYKSWQDNIQTVLFTLVQAMGQVRSQEHVEMLQEITPTLKELKTQSQSIYNNLVSFASPLVTDATNECSSPTSSATYQPSFAAAVRSNTGQKTQPDVMSQNARKLIQKNLATSADTPPSTVPGTGKSVACSPKKAVRDPKTGKAVQERNSYAVSVWKRVKAKLEGRDVDPNRRMSVAEQVDYVIKEATNLDNLAQLYEGWTAWV","Homo sapiens","SMG1, ATX, KIAA0421, LIP","Serine/threonine-protein kinase SMG1","1","6L53"
"6L5H",,"X-RAY DIFFRACTION",1.8,31.73,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES pH 7.0, 14% PEG 4000",295,"10.1016/j.jmb.2020.04.012",,"6L5H",22.93,"1.3","1.3","Crystal structure of human rootletin 1108-1200","GAMESTVNALTSELRDLRAQREEAAAAHAQEVRRLQEQARDLGKQRDSCLREAEELRTQLRLLEDARDGLRRELLEAQRKLRESQEGREVQRQEAGEW","Homo sapiens","CROCC, KIAA0445","Rootletin","1","6L5H"
"6L5J",,"X-RAY DIFFRACTION",2.8,56.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris pH 7.5, 4% PEG 6000",278,"10.1016/j.jmb.2020.04.012",,"6L5J",100.47,"2.77","2.77","Crystal structure of human rootletin 1108-1317","GAMESTVNALTSELRDLRAQREEAAAAHAQEVRRLQEQARDLGKQRDSCMREAEELRTQLRLMEDARDGLRRELLEAQRKLRESQEGREVQRQEAGELRRSLGEGAKEREALRRSNEELRSAVKKAESERISLKLANEDKEQKLALLEEARTAVGKEAGELRTGLQEVERSRLEARRELQELRRQMKMLDSENTRLGRELAELQGRLALGERAEW","Homo sapiens","CROCC, KIAA0445","Rootletin","1","6L5J"
"6L5L",,"X-RAY DIFFRACTION",2.28,46.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% pET3350, 0.2M Na2HPO4",293,"10.1002/advs.202000532",,"6L5L",41.76,"3.1","3.1","Crystal structure of human DEAD-box RNA helicase DDX21 at apo state","SFSNFPISEETIKLLKGRGVTFLFPIQAKTFHHVYSGKDLIAQARTGTGKTFSFAIPLIEKLHGELQDRKRGRAPQVLVLAPTRELANQVSKDFSDITKKLSVACFYGGTPYGGQFERMRNGIDILVGTPGRIKDHIQNGKLDLTKLKHVVLDEVDQMLDMGFADQVEEILSVAYKKDSEDNPQTLLFSATCPHWVFNVAKKYMKSTYEQVDLIKTAITVEHLAIKCHWTQRAAVIGDVIRVYSGHQGRTIIFCETKKEAQELSQNSAIKQDAQSLHGDIPQKQREITLKGFRNGSFGVLVATNVAARGLDIPEVDLVIQSSPPKDVESYIHRSGRTGRAGRTGVCICFYQHKEEYQLVQVEQKAGIKFKRI","Homo sapiens","DDX21","Nucleolar RNA helicase 2","1","6L5L"
"6L5M",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION, SITTING DROP",7.5,"19% pEG3350, 0.18M ammonium citrate, 40mM myo-inositol",277,"10.1002/advs.202000532",,"6L5M",213.15,"2.7","2.7","Crystal structure of human DEAD-box RNA helicase DDX21 in complex with AMP","SFSNFPISEETIKLLKGRGVTFLFPIQAKTFHHVYSGKDLIAQARTGTGKTFSFAIPLIEKLHGELQDRKRGRAPQVLVLAPTRELANQVSKDFSDITKKLSVACFYGGTPYGGQFERMRNGIDILVGTPGRIKDHIQNGKLDLTKLKHVVLDEVDQMLDMGFADQVEEILSVAYKKDSEDNPQTLLFSATCPHWVFNVAKKYMKSTYEQVDLIGKKTQKTAITVEHLAIKCHWTQRAAVIGDVIRVYSGHQGRTIIFCETKKEAQELSQNSAIKQDAQSLHGDIPQKQREITLKGFRNGSFGVLVATNVAARGLDIPEVDLVIQSSPPKDVESYIHRSGRTGRAGRTGVCICFYQHKEEYQLVQVEQKAGIKFKRI","Homo sapiens","DDX21","Nucleolar RNA helicase 2","1","6L5M"
"6L5O",,"X-RAY DIFFRACTION",2.28,46.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% pEG3350, 0.2m Magnesium acetate",293,"10.1002/advs.202000532",,"6L5O",42.28,"1.8","1.8","Crystal structure of human DEAD-box RNA helicase DDX21 at post-hydrolysis state","SFSNFPISEETIKLLKGRGVTFLFPIQAKTFHHVYSGKDLIAQARTGTGKTFSFAIPLIEKLHGELQDRKRGRAPQVLVLAPTRELANQVSKDFSDITKKLSVACFYGGTPYGGQFERMRNGIDILVGTPGRIKDHIQNGKLDLTKLKHVVLDEVDQMLDMGFADQVEEILSVAYKKDSEDNPQTLLFSATCPHWVFNVAKKYMKSTYEQVDLIKTAITVEHLAIKCHWTQRAAVIGDVIRVYSGHQGRTIIFCETKKEAQELSQNSAIKQDAQSLHGDIPQKQREITLKGFRNGSFGVLVATNVAARGLDIPEVDLVIQSSPPKDVESYIHRSGRTGRAGRTGVCICFYQHKEEYQLVQVEQKAGIKFKRI","Homo sapiens","DDX21","Nucleolar RNA helicase 2","1","6L5O"
"6L64",,"X-RAY DIFFRACTION",2.66,53.77,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium sulfate, 0.1 M MES monohydrate pH 6.5, 10 % (v/v) 1,4-dioxane",293,"10.1016/j.bbrc.2020.02.037",,"6L64",17.18,"2.08","2.08","X-ray structure of human galectin-10 in complex with D-glucose","GSMSLLPVPYTEAASLSTGSTVTIKGRPLVCFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6L64"
"6L67",,"X-RAY DIFFRACTION",2.67,53.89,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium sulfate, 0.1 M MES monohydrate pH 6.5, 10 % (v/v) 1,4-dioxane",293,"10.1016/j.bbrc.2020.02.037",,"6L67",17,"1.97","1.97","X-ray structure of human galectin-10 in complex with D-galactose","GSMSLLPVPYTEAASLSTGSTVTIKGRPLVCFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6L67"
"6L68",,"X-RAY DIFFRACTION",2.69,54.32,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium sulfate, 0.1 M MES monohydrate pH 6.5, 10 % (v/v) 1,4-dioxane",293,"10.1016/j.bbrc.2020.02.037",,"6L68",17,"1.92","1.92","X-ray structure of human galectin-10 in complex with D-allose","GSMSLLPVPYTEAASLSTGSTVTIKGRPLVCFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6L68"
"6L6A",,"X-RAY DIFFRACTION",2.7,54.41,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium sulfate, 0.1 M MES monohydrate pH 6.5, 10 % (v/v) 1,4-dioxane",293,"10.1016/j.bbrc.2020.02.037",,"6L6A",16.82,"1.81","1.81","X-ray structure of human galectin-10 in complex with D-mannose","GSMSLLPVPYTEAASLSTGSTVTIKGRPLVCFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6L6A"
"6L6B",,"X-RAY DIFFRACTION",2.7,54.4,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium sulfate, 0.1 M MES monohydrate pH 6.5, 10 % (v/v) 1,4-dioxane",293,"10.1016/j.bbrc.2020.02.037",,"6L6B",16.81,"1.802","1.802","X-ray structure of human galectin-10 in complex with L-fucose","GSMSLLPVPYTEAASLSTGSTVTIKGRPLVCFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6L6B"
"6L6C",,"X-RAY DIFFRACTION",2.68,54.19,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium sulfate, 0.1 M MES monohydrate pH 6.5, 10 % (v/v) 1,4-dioxane",293,"10.1016/j.bbrc.2020.02.037",,"6L6C",16.94,"1.77","1.77","X-ray structure of human galectin-10 in complex with D-arabinose","GSMSLLPVPYTEAASLSTGSTVTIKGRPLVCFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6L6C"
"6L6D",,"X-RAY DIFFRACTION",2.71,54.66,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium sulfate, 0.1 M MES monohydrate pH 6.5, 10 % (v/v) 1,4-dioxane",293,"10.1016/j.bbrc.2020.02.037",,"6L6D",16.87,"1.93","1.93","X-ray structure of human galectin-10 in complex with D-N-acetylgalactosamine","GSMSLLPVPYTEAASLSTGSTVTIKGRPLVCFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6L6D"
"6L6E",,"X-RAY DIFFRACTION",2.96,58.46,"VAPOR DIFFUSION, HANGING DROP",,"0.2M MgSO4, 0.1M Na cacodylate pH 6.8, 18 % PEG 3350",277,"10.1021/acs.jmedchem.0c00853",,"6L6E",39.66,"1.92","1.92","Human PDE5 catalytic core in complex with avanafil","METRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQELEHHHHHH","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","6L6E"
"6L6I",,"X-RAY DIFFRACTION",3.97,69.05,"VAPOR DIFFUSION, HANGING DROP",,"0.2M magnesium formate dehydrate, 14% PEG3350",293,,,"6L6I",155.77,"3.24","3.24","hASIC1a co-crystallized with Mamb-1","GSGGSGLEVLFQGPSTLHGLAHIFSYERLSLKRALWALCFLGSLAVLLCVCTERVQYYFHYHHVTKLDEVAASQLTFPAVTLCNLNEFRFSQVSKNDLYHAGELLALLNNRYEIPDTQMADEKQLEILQDKANFRSFKPKPFNMREFYDRAGHDIRDMLLSCHFRGEVCSAEDFKVVFTRYGKCYTFNSGRDGRPRLKTMKGGTGNGLEIMLDIQQDEYLPVWGETDETSFEAGIKVQIHSQDEPPFIDQLGFGVAPGFQTFVACQEQRLIYLPPPWGTCKAVTMDSDLDFFDSYSITACRIDCETRYLVENCNCRMVHMPGDAPYCTPEQYKECADPALDFLVEKDQEYCVCEMPCNLTRYGKELSMVKIPSKASAKYLAKKFNKSEQYIGENILVLDIFFEVLNYETIEQKKAYEIAGLLGDIGGQMGLFIGASILTVLELFDYAYEVIKHK","Homo sapiens","ASIC1, ACCN2, BNAC2","Acid-sensing ion channel 1","1","6L6I"
"6L6N",,"X-RAY DIFFRACTION",4.27,71.2,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M sodium acetate pH7.0, 14% w/v PEG3350",293,,,"6L6N",156.34,"2.86","2.86","hASIC1a co-crystallized with Nafamostat","GSGGSGLEVLFQGPSTLHGLAHIFSYERLSLKRALWALCFLGSLAVLLCVCTERVQYYFHYHHVTKLDEVAASQLTFPAVTLCNLNEFRFSQVSKNDLYHAGELLALLNNRYEIPDTQMADEKQLEILQDKANFRSFKPKPFNMREFYDRAGHDIRDMLLSCHFRGEVCSAEDFKVVFTRYGKCYTFNSGRDGRPRLKTMKGGTGNGLEIMLDIQQDEYLPVWGETDETSFEAGIKVQIHSQDEPPFIDQLGFGVAPGFQTFVACQEQRLIYLPPPWGTCKAVTMDSDLDFFDSYSITACRIDCETRYLVENCNCRMVHMPGDAPYCTPEQYKECADPALDFLVEKDQEYCVCEMPCNLTRYGKELSMVKIPSKASAKYLAKKFNKSEQYIGENILVLDIFFEVLNYETIEQKKAYEIAGLLGDIGGQMGLFIGASILTVLELFDYAYEVIKHK","Homo sapiens","ASIC1, ACCN2, BNAC2","Acid-sensing ion channel 1","1","6L6N"
"6L6P",,"X-RAY DIFFRACTION",4.27,71.21,"VAPOR DIFFUSION, HANGING DROP",8,"4% Tascimate pH 8.0, 12% w/v PEG3350",293,,,"6L6P",156.76,"3.08","3.08","hASIC2a co-crystallized with Mamb-1","GSGGSGLEVLFQGPQPSSIQIFANTSTLHGIRHIFVYGPLTIRRVLWAVAFVGSLGLLLVESSERVSYYFSYQHVTKVDEVVAQSLVFPAVTLCNLNGFRFSRLTTNDLYHAGELLALLDVNLQIPDPHLADPSVLEALRQKANFKHYKPKQFSMLEFLHRVGHDLKDMMLYCKFKGQECGHQDFTTVFTKYGKCYMFNSGEDGKPLLTTVKGGTGNGLEIMLDIQQDEYLPIWGETEETTFEAGVKVQIHSQSEPPFIQELGFGVAPGFQTFVATQEQRLTYLPPPWGECRSSEMGLDFFPVYSITACRIDCETRYIVENCNCRMVHMPGDAPFCTPEQHKECAEPALGLLAEKDSNYCLCRTPCNLTRYNKELSMVKIPSKTSAKYLEKKFNKSEKYISENILVLDIFFEALNYETIEQKKAYEVAALLGDIGGQMGLFIGASILTILELFDYIYELIKEK","Homo sapiens","ASIC2, ACCN, ACCN1, BNAC1, MDEG","Acid-sensing ion channel 2","1","6L6P"
"6L72",,"X-RAY DIFFRACTION",2.37,48.01,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES, pH=6.5, 6%-20% (w/v) PEG10000",291,,,"6L72",35.24,"2.501","2.501","Sirtuin 2 demyristoylation native final product","GSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQ","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","6L72"
"6L7K",,"SOLUTION NMR",,,,,,,"10.1016/j.bpj.2019.12.005",,"6L7K",15.04,,,"solution structure of hIFABP V60C/Y70C variant.","AFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIECVFELGVTFNCNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD","Homo sapiens","FABP2, FABPI","Fatty acid-binding protein, intestinal","1","6L7K"
"6L7L",,"X-RAY DIFFRACTION",2.44,49.57,"VAPOR DIFFUSION, HANGING DROP",,"Sodium acetate buffer, PEG3350, Lithium sulfate",300,,,"6L7L",154.94,"2.171","2.171","Crystal structure of Ribonucleotide reductase R1 subunit, RRM1 in complex with 5-chloro-2-(N-((1S,2R)-2-(2,3-dihydro-1H-inden-4-yl)-1-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)propyl)sulfamoyl)benzamide","GAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTR","Homo sapiens","RRM1, RR1","Ribonucleoside-diphosphate reductase large subunit","1","6L7L"
"6L7S",,"X-RAY DIFFRACTION",3.05,59.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"4-8% PEG 4,000, 0.1 M HEPES-NaOH (pH7.5), and 0.2 M MgCl2",293,"10.1038/s41467-019-14220-z",,"6L7S",202.06,"2.41","2.41","Crystal structure of FKRP in complex with Mg ion, Zinc peak data","GGRPAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG","Homo sapiens","FKRP","Fukutin-related protein","1","6L7S"
"6L7T",,"X-RAY DIFFRACTION",2.96,58.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"4-8% PEG 4000, 0.1 M HEPES-NaOH (pH 7.5), 0.2 M MgCl2",293,"10.1038/s41467-019-14220-z",,"6L7T",202.06,"2.41","2.41","Crystal structure of FKRP in complex with Mg ion, Zinc low remote data","GGRPAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG","Homo sapiens","FKRP","Fukutin-related protein","1","6L7T"
"6L7U",,"X-RAY DIFFRACTION",2.94,58.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"4-8% PEG 4000, 0.1 M HEPES-NaOH (pH 7.5),0.5 M LiCl2, 20 mM BaCl2",293,"10.1038/s41467-019-14220-z",,"6L7U",202.02,"2.24","2.24","Crystal structure of FKRP in complex with Ba ion, Ba-SAD data","GGRPAGPRVTVLVREFEAFDNAVPELVDSFLQQDPAQPVVVAADTLPYPPLALPRIPNVRLALLQPALDRPAAASRPETYVATEFVALVPDGARAEAPGLLERMVEALRAGSARLVAAPVATANPARCLALNVSLREWTARYGAAPAAPRCDALDGDAVVLLRARDLFNLSAPLARPVGTSLFLQTALRGWAVQLLDLTFAAARQPPLATAHARWKAEREGRARRAALLRALGIRLVSWEGGRLEWFGCNKETTRCFGTVVGDTPAYLYEERWTPPCCLRALRETARYVVGVLEAAGVRYWLEGGSLLGAARHGDIIPWDYDVDLGIYLEDVGNCEQLRGAEAGSVVDERGFVWEKAVEGDFFRVQYSESNHLHVDLWPFYPRNGVMTKDTWLDHRQDVEFPEHFLQPLVPLPFAGFVAQAPNNYRRFLELKFGPGVIENPQYPNPALLSLTGSG","Homo sapiens","FKRP","Fukutin-related protein","1","6L7U"
"6L87",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2021.167224",,"6L87",26.6,,,"Solution structure of the tandem PWWP-ARID domains of human RBBP1","NDELLGKVVSVVSATERTEWYPALVISPSCNDDITVKKDQCLVRSFIDSKFYSIARKDIKEVDILNLPESELSTKPGLQKASIFLKTRVVPDNWKMDISEILESSSSKDKEKELDPEERDNFLQQLYKFMEDRGTPINKPPVLGYKDLNLFKLFRLVYHQGGCDNIDSGAVWKQIYMDLGIPILNSAASYNVKTAYRKYLYGFEEYCRSANIQFRTVHHHELEHHHHHH","Homo sapiens","ARID4A, RBBP1, RBP1","AT-rich interactive domain-containing protein 4A","1","6L87"
"6L88",,"X-RAY DIFFRACTION",2.98,58.66,"VAPOR DIFFUSION, HANGING DROP",8,"2.0-2.5 M sodium nitrate, 0.1 M Tris-HCl pH 8.0",293,"10.1002/1873-3468.13746","E6R","6L88",118.5,"3","3","Crystal structure of mineralocorticoid receptor ligand binding domain in complex with esaxerenone","GTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLSSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKSPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK","Homo sapiens","NR3C2, MCR, MLR","Mineralocorticoid receptor","1","6L88"
"6L89",,"X-RAY DIFFRACTION",2.55,51.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.2 M sodium citrate tribasic dihydrate, 0.1 M HEPES pH 7.5",295,"10.3390/biom10020275","E7C","6L89",66.24,"2.1","2.1","Human PPARgamma ligand binding domain complexed with Butyrolactone 1","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6L89"
"6L8B",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.2 M Sodium citrate tribasic dihydrate, 0.1 M HEPES pH 7.5",295,"10.3390/biom10020275",,"6L8B",64.56,"2.102","2.102","The ligand-free structure of human PPARgamma LBD","AEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6L8B"
"6L8M",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz1207",,"6L8M",6.92,,,"WNT DNA promoter mutant G-quadruplex","GGGTCACCGGGCAGTGGGCGGG","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*TP*CP*AP*CP*CP*GP*GP*GP*CP*AP*GP*TP*GP*GP*GP*CP*GP*GP*G)-3')","1","6L8M"
"6L8R",,"SOLUTION NMR",,,,,,,"10.1038/s41467-021-25416-7",,"6L8R",3.8,,,"membrane-bound PD-L1-CD","GPRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6L8R"
"6L8T",,"X-RAY DIFFRACTION",2.77,55.56,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium acetate, 20% (w/v) PEG 3350",293.15,"10.1016/j.antiviral.2020.104757",,"6L8T",143.18,"1.766","1.766","Crystal structure of the Fab fragment of a humanized HBV therapeutic antibody","DVVMTQSPLSLPVTLGEPASISCRSSQSLVHSYGDTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVETEDLGVYYCSQNTHVPYTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Antibody light chain","1","6L8T"
,,,,,,,,,,,,,,,,"EVQLQESGPGLVKPSQTLSLTCAVSGSSITYGYHWNWIRQFPGNKLEWIGYISYDGSVLYNPSLENRVTITRDTSKNQFFLKLSSVTAEDTAKYYCASGFDHWGQGTTLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTH","Homo sapiens",,"Antibody heavy chain","2","6L8T"
"6L8U",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, SITTING DROP",,"20% (w/v) PEG3350, 200 mM CaCl2.",293,"10.1093/nar/gkz1216",,"6L8U",131.34,"2.925","2.925","Crystal structure of human BCDIN3D in complex with SAH","MGSSHHHHHHSSGLVPRGSHMETAAEEESRVLAPGAAPFGNFPHYSRFHPPEQRLRLLPPELLRQLFPESPENGPILGLDVGCNSGDLSVALYKHFLSLASREFRLLCCDIDPVLVKRAEKECPFPDALTFITLDFMNQRTRKVLLSSFLSQFGRSVFDIGFCMSITMWIHLNHGDHGLWEFLAHLSSLCHYLLVEPQPWKCYRAAARRLRKLGLHDFDHFHSLAIRGDMPNQIVQILTQDHGMELICCFGNTSWDRSLLLFRAKQTIETHPIPESLIEKGKEK","Homo sapiens","BCDIN3D","RNA 5'-monophosphate methyltransferase","1","6L8U"
"6L8V",,"SOLUTION NMR",,,,,,,"10.15252/embj.2020106438",,"6L8V",17.98,,,"membrane-bound Bax helix2-helix5 domain","GPGSMDASTKKLSESLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTK","Homo sapiens","BAX, BCL2L4","Apoptosis regulator BAX","1","6L8V"
"6L92",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz1207",,"6L92",6.9,,,"A basket type G-quadruplex in WNT DNA promoter","GGGCCACCGGGCAGTGGGCGGG","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*CP*CP*AP*CP*CP*GP*GP*GP*CP*AP*GP*TP*GP*GP*GP*CP*GP*GP*G)-3')","1","6L92"
"6L93",,"X-RAY DIFFRACTION",4.46,72.39,"VAPOR DIFFUSION, HANGING DROP",5,"0.125 M sodium citrate (pH 5.0), 5% PEG 8000, 2.5% (v/v) glycerol",277,"10.1107/S2053230X20001533",,"6L93",185,"4.47","4.47","X-ray structure of the ligand-free human TRPV1 ankyrin repeat domain","GSPNSSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHVDSSGRIVTD","Homo sapiens","TRPV1, VR1","Transient receptor potential cation channel subfamily V member 1","1","6L93"
"6L95",,"SOLUTION NMR",,,,,,,,,"6L95",5.82,,,"transmembrane-domain of Bax","GTPTWQTVTIFVAGVLTASLTIWKKMG","Homo sapiens","BAX, BCL2L4","Apoptosis regulator BAX","1","6L95"
"6L98",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES
15% glycerol
15% PEG6000",283,,,"6L98",45.28,"1.77","1.77","Crystalline cast nephropathy-causing Bence-Jones protein AK: An entire immunoglobulin lambda light chain dimer","YVLTQPPSVSVAPGKTARIACEGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPDRFSGSNSGNTAALTISRVEAGDEADYFCQVWDSNSNHQVFGGGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Bence-Jones protein lambda light chain AK","1","6L98"
"6L99",,"SOLUTION NMR",,,,,,,,,"6L99",8.34,,,"Zinc finger of RING finger protein 144A","ALDPLVSCKLCLGEYPVEQMTTIAQCQCIFCTLCLKQYVELLIKEGLETAISCPDAACPKQGHLQENEIECMVAA","Homo sapiens","RNF144A, KIAA0161, RNF144, UBCE7IP4","E3 ubiquitin-protein ligase RNF144A","1","6L99"
"6L9K",,"X-RAY DIFFRACTION",2.88,57.25,"VAPOR DIFFUSION, SITTING DROP",,"1.1 M ammonium tartrate dibasic pH 7.0",277.15,"10.1073/pnas.2100588118",,"6L9K",21.66,"1.8","1.8","H2-Ld a1a2 complexed with A5 peptide","GPHSMRYYETATSRRGLGEPRYTSVGYVDDKEFVRFDSDAENPRYEPQVPWMEQEGPEYWERITQIAKGQEQWFRVNLRTLLGYYNQSAGGTHTLQRMYGCDVGSDGRLLRGYEQFAYDGCDYIALNEDLRTWTAADMAAQITRRKWEQAGAAEYYRAYLEGECVEWLHRYLKNG","Homo sapiens",,"H2-Ld a1a2","1","6L9K"
,,,,,,,,,,,,,,,,"SPSYAYHQF","Homo sapiens",,"SER-PRO-SER-TYR-ALA-TYR-HIS-GLN-PHE","2","6L9K"
"6L9L",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION, SITTING DROP",,"1.0 M lithium sulfate, 0.1 M imidazole malate pH 6.5 and 2% w/v PEG 8000",277.15,"10.1073/pnas.2100588118",,"6L9L",140.92,"2.399","2.399","1D4 TCR recognition of H2-Ld a1a2 A5 Peptide Complexes","GPHSMRYYETATSRRGLGEPRYTSVGYVDDKEFVRFDSDAENPRYEPQVPWMEQEGPEYWERITQIAKGQEQWFRVNLRTLLGYYNQSAGGTHTLQRMYGCDVGSDGRLLRGYEQFAYDGCDYIALNEDLRTWTAADMAAQITRRKWEQAGAAEYYRAYLEGECVEWLHRYLKNG","Homo sapiens",,"H2-Ld a1a2","1","6L9L"
,,,,,,,,,,,,,,,,"AKTTQPDSMESTEGETVHLPCSHATISGNEYIYWYRQVPLQGPEYVTHGLQQNTTNSMAFLAIASDRKSSTLILTHVSLRDAAVYHCILQGTGSKLSFGKGAKLTVSPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"T Cell Receptor","2","6L9L"
,,,,,,,,,,,,,,,,"AVTQSPRNKVTVTGGNVTLSCRQTNSHNYMYWYRQDTGHGLRLIHYSYGAGNLQIGDVPDGYKATRTTQEDFFLLLELASPSQTSLYFCASSDGDYEQYFGPGTRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"T Cell Receptor","3","6L9L"
,,,,,,,,,,,,,,,,"SPSYAYHQF","Homo sapiens",,"SER-PRO-SER-TYR-ALA-TYR-HIS-GLN-PHE","4","6L9L"
"6L9M",,"X-RAY DIFFRACTION",2.58,52.36,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M sodium malonate pH 5.0, 15-20 % PEG 3350 and 5% 1, 6-Hexanediol",277.15,"10.1073/pnas.2100588118",,"6L9M",179.84,"2.6","2.6","H2-Ld complexed with AH1 peptide","AGPHSMRYFETAVSRPGLGEPRYISVGYVDNKEFVRFDSDAENPRYEPQAPWMEQEGPEYWERITQIAKGQEQWFRVNLRTLLGYYNQSAGGTHTLQWMYGCDVGSDGRLLRGYEQFAYDGCDYIALNEDLKTWTAADMAAQITRRKWEQAGAAEYYRAYLEGECVEWLHRYLKNGNATLLRTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGTFQKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRWEPP","Homo sapiens",,"H2-Ld","1","6L9M"
,,,,,,,,,,,,,,,,"IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDWSFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM","Homo sapiens",,"b2m","2","6L9M"
,,,,,,,,,,,,,,,,"SPSYVYHQF","Homo sapiens",,"SER-PRO-SER-TYR-VAL-TYR-HIS-GLN-PHE","3","6L9M"
"6L9N",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium malonate pH 5.0, 15-20 % PEG 3350 and 5% 1, 6-Hexanediol",298,"10.1073/pnas.2100588118",,"6L9N",179.73,"2.6","2.6","H2-Ld complexed with A5 peptide","AGPHSMRYFETAVSRPGLGEPRYISVGYVDNKEFVRFDSDAENPRYEPQAPWMEQEGPEYWERITQIAKGQEQWFRVNLRTLLGYYNQSAGGTHTLQWMYGCDVGSDGRLLRGYEQFAYDGCDYIALNEDLKTWTAADMAAQITRRKWEQAGAAEYYRAYLEGECVEWLHRYLKNGNATLLRTDSPKAHVTHHPRSKGEVTLRCWALGFYPADITLTWQLNGEELTQDMELVETRPAGDGTFQKWASVVVPLGKEQNYTCRVYHEGLPEPLTLRWEPP","Homo sapiens",,"MHC","1","6L9N"
,,,,,,,,,,,,,,,,"IQKTPQIQVYSRHPPENGKPNILNCYVTQFHPPHIEIQMLKNGKKIPKVEMSDMSFSKDWSFYILAHTEFTPTETDTYACRVKHDSMAEPKTVYWDRDM","Homo sapiens",,"b2m","2","6L9N"
,,,,,,,,,,,,,,,,"SPSYAYHQF","Homo sapiens",,"SER-PRO-SER-TYR-ALA-TYR-HIS-GLN-PHE","3","6L9N"
"6L9O",,"X-RAY DIFFRACTION",2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis-Tris 5.5 25% w/vPEG 3350",277.15,,,"6L9O",15.05,"1.42","1.42","Crystal structure of FABP7 apo","MVEAFCATWKLTNSQNFDEYMKALGVGFATRQVGNVTKPTVIISQEGDKVVIRTLSTFKNTEISFQLGEEFDETTADDRNCKSVVSLDGDKLVHIQKWDGKETNFVREIKDGKMVMTLTFGDVVAVRHYEKAAA","Homo sapiens","FABP7, BLBP, FABPB, MRG","Fatty acid-binding protein, brain","1","6L9O"
"6LBF",,"X-RAY DIFFRACTION",3.7,66.76,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Tris-HCl, pH 8.5, 0.1M Guanidine hydrochloride, 0.8M Potassium sodium tartrate tetrahydrate, 0.5% w/v Polyethylene glycol monomethyl ether 5000",291,"10.1038/s41589-020-00704-3",,"6LBF",79.11,"3.252","3.252","Crystal structure of FEM1B","MEGLAGYVYKAASEGKVLTLAALLLNRSESDIRYLLGYVSQQGGQRSTPLIIAARNGHAKVVRLLLEHYRVQTQQTGTVRFDGYVIDGATALWCAAGAGHFEVVKLLVSHGANVNHTTVTNSTPLRAACFDGRLDIVKYLVENNANISIANKYDNTCLMIAAYKGHTDVVRYLLEQRADPNAKAHCGATALHFAAEAGHIDIVKELIKWRAAIVVNGHGMTPLKVAAESCKADVVELLLSHADCDRRSRIEALELLGASFANDRENYDIIKTYHYLYLAMLERFQDGDNILEKEVLPPIHAYGNRTECRNPQELESIRQDRDALHMEGLIVRERILGADNIDVSHPIIYRGAVYAD","Homo sapiens","FEM1B, F1AA, KIAA0396","Protein fem-1 homolog B","1","6LBF"
"6LCA",,"X-RAY DIFFRACTION",1.93,36.28,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.5 M Ammonium sulfate
0.1 M Sodium citrate tribasic dehydrate
1.0 M Lithium sulfate monohydrate
0.01 M GSH
0.01 M GSSG",293,,,"6LCA",86.94,"2.4","2.4","Crystal structure of human Dishevelled1 PDZ domain homotrimer","GPLGSDHSLNIVTVTLNMERHHFLGISIVGQSNDRGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDDAVRVLREIVSQTGPISLTVAKATD","Homo sapiens","DVL1","Segment polarity protein dishevelled homolog DVL-1","1","6LCA"
"6LCB",,"X-RAY DIFFRACTION",1.95,37.01,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.5 M Ammonium sulfate
0.1 M Sodium citrate tribasic dehydrate
1.0 M Lithium sulfate monohydrate
1.0 M Guanidine hydrochloride",293,,,"6LCB",11.33,"1.4","1.4","Crystal structure of human Dishevelled1 PDZ domain with its inhibitor NPL3009","GPLGSDHSLNIVTVTLNMERHHFLGISIVGQSNDRGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNDVNFENMSNDDAVRVLREIVSQTGPISLTVAKATD","Homo sapiens","DVL1","Segment polarity protein dishevelled homolog DVL-1","1","6LCB"
"6LE1",,"X-RAY DIFFRACTION",2.64,53,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M MES Monohydrate pH- 6.5, 30% PEG MME 5000, 0.2M Ammonium sulphate",293,"10.1002/pro.4083",,"6LE1",10.9,"2.3","2.3","Structure of RRM2 domain of DND1 protein","MGSSHHHHHHSSGLVPRGSHMELSVDGLPPNLTRSALLLALQPLGPGLQEARLLPSPGPAPGQIALLKFSSHRAAAMAKKALVEGQSHLCGEQVAVEWLK","Homo sapiens","DND1, RBMS4","Dead end protein homolog 1","1","6LE1"
"6LF0",,"X-RAY DIFFRACTION",3.59,65.72,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Lithium sulfate, 0.1M Tris-HCl pH 7.3",291,"10.1038/s41589-020-00704-3",,"6LF0",89.31,"2.11","2.11","Structure of FEM1C","MDLKTAVFNAARDGKLRLLTKLLASKSKEEVSSLISEKTNGATPLLMAARYGHLDMVEFLLEQCSASIEVGGSVNFDGETIEGAPPLWAASAAGHLKVVQSLLNHGASVNNTTLTNSTPLRAACFDGHLEIVKYLVEHKADLEVSNRHGHTCLMISCYKGHKEIAQYLLEKGADVNRKSVKGNTALHDCAESGSLDIMKMLLMYCAKMEKDGYGMTPLLSASVTGHTNIVDFLTHHAQTSKTERINALELLGATFVDKKRDLLGALKYWKKAMNMRYSDRTNIISKPVPQTLIMAYDYAKEVNSAEELEGLIADPDEMRMQALLIRERILGPSHPDTSYYIRYRGAVYADSGNFKRCINLWKYALDMQQSNLDPLSPMTASSLLSFAELFSFMLQDRAKGLLG","Homo sapiens","FEM1C, KIAA1785","Protein fem-1 homolog C","1","6LF0"
"6LFH",,"X-RAY DIFFRACTION",1.93,36.35,"VAPOR DIFFUSION, HANGING DROP",4.5,"Lysozyme sample (14 mg/mL) in 2.5 mM HEPES, 0.12 M lithium chloride mixed with reservoir solution containing 30 mM sodium phosphate, 2.5 M sodium chloride",298,"10.1002/anie.202000491",,"6LFH",14.98,"1.46","1.46","X-ray crystal structure of chemically synthesized human lysozyme","KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV","Homo sapiens","LYZ, LZM","Lysozyme C","1","6LFH"
"6LG4",,"X-RAY DIFFRACTION",2.04,39.74,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,,,"6LG4",15.11,"1.85","1.85","crystal structure of the first bromodomain of human BRD4 in complex with compound BDF-1024","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6LG4"
"6LG5",,"X-RAY DIFFRACTION",2,38.54,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,,,"6LG5",15.16,"1.83","1.83","Crystal Structure of the first bromodomain of human BRD4 in complex with compound BDF-1038","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6LG5"
"6LG6",,"X-RAY DIFFRACTION",2.1,41.35,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,,,"6LG6",15.18,"1.98","1.98","Crystal Structure of the first bromodomain of human BRD4 in complex with compound BDF-1021","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6LG6"
"6LG7",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,,,"6LG7",15.13,"1.83","1.83","Crystal Structure of the first bromodomain of human BRD4 in complex with compound BDF-2030","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6LG7"
"6LG8",,"X-RAY DIFFRACTION",2,38.49,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,,,"6LG8",15.13,"1.58","1.58","crystal structure of the first bromodomain of human BRD4 in complex with compound BDF-2138","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6LG8"
"6LG9",,"X-RAY DIFFRACTION",2.07,40.56,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,,,"6LG9",15.19,"1.81","1.81","crystal structure of the first bromodomain of human BRD4 in complex with compound BDF-2143","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6LG9"
"6LH4",,"X-RAY DIFFRACTION",2.78,55.82,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Sodium thiocyanate, 20% PEG 3350",291.1,"10.1016/j.dnarep.2020.102899",,"6LH4",107.68,"1.999","1.999","Crystal structural of MacroD1-ADPr complex","TSTDWKEAKSFLKGLSDKQREEHYFCKDFVRLKKIPTWKEMAKGVAVKVEEPRYKKDKQLNEKISLLRSDITKLEVDAIVNAANSSLLGGGGVDGCIHRAAGPLLTDECRTLQSCKTGKAKITGGYRLPAKYVIHTVGPIAYGEPSASQAAELRSCYLSSLDLLLEHRLRSVAFPCISTGVFGYPCEAAAEIVLATLREWLEQHKDKVDRLIICVFLEKDEDIYRSRLPHYFPVA","Homo sapiens","MACROD1, LRP16","ADP-ribose glycohydrolase MACROD1","1","6LH4"
"6LHM",,"X-RAY DIFFRACTION",2.75,55.32,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Carboxylic acids, 0.1M Buffer system 3 pH 8.5, 50% v/v Precipitant Mix 3",293,"10.1016/j.neuron.2020.03.028",,"6LHM",158.69,"3.4","3.4","Structure of human PYCR2","SMSVGFIGAGQLAYALARGFTAAGILSAHKIIASSPEMNLPTVSALRKMGVNLTRSNKETVKHSDVLFLAVKPHIIPFILDEIGADVQARHIVVSCAAGVTISSVEKKLMAFQPAPKVIRCMTNTPVVVQEGATVYATGTHALVEDGQLLEQLMSSVGFCTEVEEDLIDAVTGLSGSGPAYAFMALDALADGGVKMGLPRRLAIQLGAQALLGAAKMLLDSEQHPCQLKDNVCSPGGATTHALHFLESGGFRSLLINAVEASCIRTRELQSMADQEKISPAALKKTLLDRVKLESPTVSTL","Homo sapiens","PYCR2","Pyrroline-5-carboxylate reductase 2","1","6LHM"
"6LHR",,"X-RAY DIFFRACTION",2.62,53.1,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3000, Sodium citrate",293,"10.1038/s41598-021-81409-y",,"6LHR",155.19,"2.62","2.62","Crystal structure of the complex between Vesicle Amine Transport-1 and NADP","GPASPPLLRCLVLTGFGGYDKVKLQSRPAAPPAPGPGQLTLRLRACGLNFADLMARQGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRKAGDRVMVLNRSGMWQEEVTVPSVQTFLIPEAMTFEEAAALLVNYITAYMVLFDFGNLQPGHSVLVHMAAGGVGMAAVQLCRTVENVTVFGTASASKHEALKENGVTHPIDYHTTDYVDEIKKISPKGVDIVMDPLGGSDTAKGYNLLKPMGKVVTYGMANLLTGPKRNLMALARTWWNQFSVTALQLLQANRAVCGFHLGYLDGEVELVSGVVARLLALYNQGHIKPHIDSVWPFEKVADAMKQMQEKKNVGKVLLVPGPEKEN","Homo sapiens","VAT1","Synaptic vesicle membrane protein VAT-1 homolog","1","6LHR"
"6LIG",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Sodium chloride, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350",295,,,"6LIG",92.87,"2.62","2.62","Crystal structure of human Glutamate oxaloacetate transaminase 1 (GOT1) in complex with AH","PPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKIANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGTGALRIGADFLARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLENAPEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWAIRYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPPAQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWNHITDQIGMFSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ","Homo sapiens","GOT1","Glutamate oxaloacetate transaminase 1","1","6LIG"
"6LIH",,"X-RAY DIFFRACTION",2.22,44.58,"EVAPORATION",7,"protein concentration 10 mg/ML, 2.8-3.8M sodium formate, 10% glycerol",289,,,"6LIH",15.14,"1.6203054097","1.6203054097","BRD4 BD1 bound with compound 10","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6LIH"
"6LII",,"X-RAY DIFFRACTION",2.65,53.64,"VAPOR DIFFUSION, SITTING DROP",,"Sodium nitrate, PEG 3350, BisTris",293,"10.1038/s41598-021-81409-y",,"6LII",152.22,"2.3","2.3","A quinone oxidoreductase","GPASPPLLRCLVLTGFGGYDKVKLQSRPAAPPAPGPGQLTLRLRACGLNFADLMARQGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRKAGDRVMVLNRSGMWQEEVTVPSVQTFLIPEAMTFEEAAALLVNYITAYMVLFDFGNLQPGHSVLVHMAAGGVGMAAVQLCRTVENVTVFGTASASKHEALKENGVTHPIDYHTTDYVDEIKKISPKGVDIVMDPLGGSDTAKGYNLLKPMGKVVTYGMANLLTGPKRNLMALARTWWNQFSVTALQLLQANRAVCGFHLGYLDGEVELVSGVVARLLALYNQGHIKPHIDSVWPFEKVADAMKQMQEKKNVGKVLLVPGPEKEN","Homo sapiens","VAT1","Synaptic vesicle membrane protein VAT-1 homolog","1","6LII"
"6LIL",,"X-RAY DIFFRACTION",2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Ammonium citrate tribasic pH 7.0, 20% w/v Polyethylene glycol 3,350",293,"10.1016/j.bbrc.2020.04.102",,"6LIL",94.27,"1.93","1.93","Crystal structure of human PDK2 complexed with an allosteric inhibitor compound 8c","MAGSHHHHHHGMASMTGGQQMGRSGDDDDKALLKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQ","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","1","6LIL"
"6LIM",,"X-RAY DIFFRACTION",2.28,46.11,"EVAPORATION",7,"10mg/ml, 2.8-3.8M sodium formate, glycerol 10%",289,,,"6LIM",15.19,"1.75909502055","1.75909502055","BRD4-BD1 bound with compound 40","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6LIM"
"6LIN",,"X-RAY DIFFRACTION",2.35,47.73,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Lithium sulfate monohydrate, 0.1M Bis-Tris pH 6.5, 25% w/v Polyethylene glycol 3350",293,"10.1016/j.bbrc.2020.04.102",,"6LIN",188.14,"2.67","2.67","Crystal structure of human PDK2 complexed with GM10030","MAGSHHHHHHGMASMTGGQQMGRSGDDDDKALLKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQ","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","1","6LIN"
"6LIO",,"X-RAY DIFFRACTION",2.37,48.21,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Ammonium sulfate, 0.1M Bis-Tris pH 6.5, 25% Polyethylene glycol 3350",293,"10.1016/j.bbrc.2020.04.102","EH3","6LIO",94.63,"1.76","1.76","Crystal structure of human PDK2 complexed with GM67520","MAGSHHHHHHGMASMTGGQQMGRSGDDDDKALLKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVRLANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIRNRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGSTNPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVYVPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKIERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYLKALSTDSVERLPVYNKSAWRHYQTIQ","Homo sapiens","PDK2, PDHK2","[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial","1","6LIO"
"6LJE",,"X-RAY DIFFRACTION",2.03,44.03,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350, ammonium sulphate, calcium chloride, magnesium chloride",293,"10.1007/s10974-019-09571-5",,"6LJE",22.78,"1.4","1.4","Crystal structure of gelsolin G3 domain (calcium and magnesium condition)","LAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWR","Homo sapiens","GSN","Gelsolin","1","6LJE"
"6LJF",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350, ammonium sulphate, calcium chloride",293,"10.1007/s10974-019-09571-5",,"6LJF",22.78,"1.5","1.5","Crystal structure of gelsolin G3 domain (calcium condition)","LAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWR","Homo sapiens","GSN","Gelsolin","1","6LJF"
"6LJP",,"X-RAY DIFFRACTION",1.93,36.27,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1016/j.bbagen.2020.129755",,"6LJP",16.88,"2","2","Crystal structure of human galectin-16","GSHMSFLTVPYKLPVSLSVGSCVIIKGTLIDSSINEPQLQVDFYTEMNEDSEIAFHLRVHLGRRVVMNSREFGIWMLEENLHYVPFEDGKPFDLRIYVCLNEYEVKVNGEYIYAFVHRIPPSYVKMIQVWRDVSLDSVLVNNGRR","Homo sapiens","LGALS16","Galectin-16","1","6LJP"
"6LJQ",,"X-RAY DIFFRACTION",1.89,34.91,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1016/j.bbagen.2020.129755",,"6LJQ",17.18,"1.49","1.49","human galectin-16 R55N","GSHMSFLTVPYKLPVSLSVGSCVIIKGTLIDSSINEPQLQVDFYTEMNEDSEIAFHLNVHLGRRVVMNSREFGIWMLEENLHYVPFEDGKPFDLRIYVCLNEYEVKVNGEYIYAFVHRIPPSYVKMIQVWRDVSLDSVLVNNGRR","Homo sapiens","LGALS16","Galectin-16","1","6LJQ"
"6LJR",,"X-RAY DIFFRACTION",1.9,35.15,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1016/j.bbagen.2020.129755",,"6LJR",17.19,"2","2","human galectin-16 R55N/H57R","GSHMSFLTVPYKLPVSLSVGSCVIIKGTLIDSSINEPQLQVDFYTEMNEDSEIAFHLNVRLGRRVVMNSREFGIWMLEENLHYVPFEDGKPFDLRIYVCLNEYEVKVNGEYIYAFVHRIPPSYVKMIQVWRDVSLDSVLVNNGRR","Homo sapiens","LGALS16","Galectin-16","1","6LJR"
"6LJS",,"X-RAY DIFFRACTION",1.93,36.31,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH6.5",293,"10.1021/acs.jmedchem.9b02107","EHR","6LJS",17.26,"1.75","1.75","Crystal structure of human FABP4 in complex with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","6LJS"
"6LJT",,"X-RAY DIFFRACTION",1.94,36.49,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH 6.5",293,"10.1021/acs.jmedchem.9b02107","EH6","6LJT",17.3,"1.45","1.45","Crystal structure of human FABP4 in complex with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","6LJT"
"6LJU",,"X-RAY DIFFRACTION",1.94,36.63,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH 6.5",293,"10.1021/acs.jmedchem.9b02107","EHU","6LJU",17.33,"1.5","1.5","Crystal structure of human FABP4 in complex with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","6LJU"
"6LJV",,"X-RAY DIFFRACTION",1.96,37.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH 6.5",293,"10.1021/acs.jmedchem.9b02107","EHC","6LJV",17.28,"1.401","1.401","Crystal structure of human FABP4 in complex with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","6LJV"
"6LJW",,"X-RAY DIFFRACTION",1.94,36.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH 6.5",293,"10.1021/acs.jmedchem.9b02107",,"6LJW",17.19,"1.4","1.4","Crystal structure of human FABP4 in complex with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","6LJW"
"6LJX",,"X-RAY DIFFRACTION",1.94,36.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.4 M trisodium citrate, PH 7.5",293,"10.1021/acs.jmedchem.9b02107","EHO","6LJX",17.09,"1.75","1.75","Crystal structure of human FABP4 in complex with a novel inhibitor","MGSSHHHHHHSSGLVPRGSHMADAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","6LJX"
"6LK0",,"X-RAY DIFFRACTION",2.79,56.03,"VAPOR DIFFUSION, SITTING DROP",,"100mM Bicine/Sodium hydroxide pH 9.0; 10%(v/v) MPD_(+/-)-2-Methyl-2,4-pentanediol",277.15,"10.1158/0008-5472.CAN-18-3987",,"6LK0",48.69,"2.6","2.6","Crystal structure of human wild type TRIP13","SMDEAVGDLKQALPCVAESPTVHVEVHQRGSSTAKKEDINLSVRKLLNRHNIVFGDYTWTEFDEPFLTRNVQSVSIIDTELKVKDSQPIDLSACTVALHIFQLNEDGPSSENLEEETENIIAANHWVLPAAEFHGLWDSLVYDVEVKSHLLDYVMTTLLFSDKNVNSNLITWNRVVLLHGPPGTGKTSLCKALAQKLTIRLSSRYRYGQLIEINSHSLFSKWFSESGKLVTKMFQKIQDLIDDKDALVFVLIDEVESLTAARNACRAGTEPSDAIRVVNAVLTQIDQIKRHSNVVILTTSNITEKIDVAFVDRADIKQYIGPPSAAAIFKIYLSCLEELMKCQIIYPRQQLLTLRELEMIGFIENNVSKLSLLLNDISRKSEGLSGRVLRKLPFLAHALYVQAPTVTIEGFLQALSLAVDKQFEERKKLAAYI","Homo sapiens","TRIP13, PCH2","Pachytene checkpoint protein 2 homolog","1","6LK0"
"6LK5",,"X-RAY DIFFRACTION",1.57,21.42,"VAPOR DIFFUSION, HANGING DROP",,"5%(v/v) 2-Methyl-2,4-pentanediol,
0.1M HEPES(pH7.5), 
10%(w/v) PEG 10000",293,"10.1038/s41419-021-03859-6",,"6LK5",54.62,"2.5","2.5","MLKL mutant - T357ES358D","MENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQMLRRDNEKIEASLRRLEINMKEIKETLRQYLPPKCMQEIPQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQEDMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","6LK5"
"6LK6",,"X-RAY DIFFRACTION",2.56,52.03,"VAPOR DIFFUSION, HANGING DROP",,"14%(w/v) PEG 6000, 
5% EG, 
0.1M HEPES(pH7.5)",293,"10.1038/s41419-021-03859-6",,"6LK6",33.59,"2.41","2.41","MLKL mutant - T357AS358A","YLPPKCMQEIPQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQAAMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","6LK6"
"6LKM",,"X-RAY DIFFRACTION",2.68,54.07,"VAPOR DIFFUSION, HANGING DROP",,"Sodium acetate buffer, PEG3350, Lithium sulfate",300,,,"6LKM",154.41,"2.55","2.55","Crystal structure of Ribonucleotide reductase R1 subunit, RRM1 in complex with 5-chloro-N-((1S,2R)-2-(6-fluoro-2,3-dimethylphenyl)-1-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)propyl)-4-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-sulfonamide","GAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTR","Homo sapiens","RRM1, RR1","Ribonucleoside-diphosphate reductase large subunit","1","6LKM"
"6LLC",,"X-RAY DIFFRACTION",3.11,60.4,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M Lithium Sulfate,1.8M Ammonium Sulfate,0.1M Imidazole",293,"10.1186/s13045-020-00979-y",,"6LLC",381.77,"2.501","2.501","Discovery of A Dual Inhibitor of NQO1 and GSTP1 for Treating Malignant Glioblastoma","VGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDITGKLKDPANFQYPAESVLAYKEGHLSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGDMNVILWPIQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIWDETPLYFAPSSLFDLNFQAGFLMKKEVQDEEKNKKFGLSVGHHLGKSIPTDNQIKARK","Homo sapiens","NQO1, DIA4, NMOR1","NAD(P)H dehydrogenase [quinone] 1","1","6LLC"
"6LLE","2.9","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abb0147",,"6LLE",118.37,"2.9",,"CryoEM structure of SERCA2b WT in E1-2Ca2+-AMPPCP state.","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYSTDTNFSDMFWS","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","6LLE"
"6LLX",,"X-RAY DIFFRACTION",2.71,54.64,"VAPOR DIFFUSION, SITTING DROP",,"0.1M MES PH5.8 ,30% PEG6000 ,10mM DTT",293,"10.1186/s13045-020-00979-y",,"6LLX",48.79,"1.581","1.581","Discovery of A Dual Inhibitor of NQO1 and GSTP1 for Treating Malignant Glioblastoma","SHMASMPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","6LLX"
"6LLY","2.8","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abb0147",,"6LLY",117.86,"2.8",,"CryoEM structure of SERCA2b WT in E2-BeF3- state","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYSTDTNFSDMFWS","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","6LLY"
"6LMS",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa619",,"6LMS",11.6,,,"Solution NMR structure cold shock domain of YB1 from Homo sapiens","MHHHHHHSSGLVPRGSDKKVIATKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAA","Homo sapiens","YBX1, NSEP1, YB1","Y-box-binding protein 1","1","6LMS"
"6LMU","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.aba8105",,"6LMU",407.07,"3.4",,"Cryo-EM structure of the human CALHM2","MAALIAENFRFLSLFFKSKDVMIFNGLVALGTVGSQELFSVVAFHCPCSPARNYLYGLAAIGVPALVLFIIGIILNNHTWNLVAECQHRRTKNCSAAPTFLLLSSILGRAAVAPVTWSVISLLRGEAYVCALSEFVDPSSLTAREEHFPSAHATEILARFPCKENPDNLSDFREEVSRRLRYESQLFGWLLIGVVAILVFLTKCLKHYCSPLSYRQEAYWAQYRANEDQLFQRTAEVHSRVLAANNVRRFFGFVALNKDDEELIANFPVEGTQPRPQWNAITGVYLYRENQGLPLYSRLHKWAQGLAGNGAAPDNVEMALLPSENLYFQ","Homo sapiens","CALHM2, FAM26B","Calcium homeostasis modulator protein 2","1","6LMU"
"6LMY",,"X-RAY DIFFRACTION",2.5,50.82,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M imidazole, 0.4 M NaH2PO4, 1.6 M K2HPO4, 0.2 M NaCl",293,"10.3390/ijms21207515",,"6LMY",17.87,"1.5","1.5","Crystal structure of DUSP22 mutant_C88S/S93A","GPMGNGMNKILPGLYIGNFKDARDAEQLSKNKVTHILSVHDSARPMLEGVKYLCIPAADSPSQNLTRHFKESIKFIHECRLRGESCLVHSLAGVARSVTLVIAYIMTVTDFGWEDALHTVRAGRSCANPNVGFQRQLQEFEKHEVHQYRQWLKEEYG","Homo sapiens","DUSP22, JSP1, LMWDSP2, MKPX","Dual specificity protein phosphatase 22","1","6LMY"
"6LN1",,"X-RAY DIFFRACTION",3.02,59.21,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Bis-Tris, 17% PEG 1500, 30% ethylene glycol",277,"10.1002/ctm2.494",,"6LN1",81.48,"2.699","2.699","A natural inhibitor of DYRK1A for treatment of diabetes mellitus","VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKRFEYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6LN1"
"6LN5","2.8","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abb0147",,"6LN5",117.04,"2.8",,"CryoEM structure of SERCA2b T1032stop in E1-2Ca2+-AMPPCP (class1)","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYS","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","6LN5"
"6LN6","2.9","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abb0147",,"6LN6",117.04,"2.9",,"CryoEM structure of SERCA2b T1032stop in E1-2Ca2+-AMPPCP (class2)","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYS","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","6LN6"
"6LN7","2.8","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abb0147",,"6LN7",117.04,"2.8",,"CryoEM structure of SERCA2b T1032stop in E1-2Ca2+-AMPPCP (class3)","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYS","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","6LN7"
"6LN8","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abb0147",,"6LN8",116.52,"3.1",,"CryoEM structure of SERCA2b T1032stop in E2-BeF3- state (class1)","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYS","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","6LN8"
"6LN9","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.abb0147",,"6LN9",116.52,"3.4",,"CryoEM structure of SERCA2b T1032stop in E2-BeF3- state (class2)","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYS","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","6LN9"
"6LNI","2.702","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-020-0441-5",,"6LNI",229.96,"2.702",,"Cryo-EM structure of amyloid fibril formed by full-length human prion protein","MKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSS","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","6LNI"
"6LNZ",,"SOLUTION NMR",,,,,,,"10.1002/anie.202104624",,"6LNZ",7.47,,,"NMR solution structure of VEGF G-quadruplex bound a non-planar cyclometalated-carbene platinum(II) complex","CGGGGCGGGCCTTGGGCGGGGT","Homo sapiens",,"DNA (5'-D(*CP*GP*GP*GP*GP*CP*GP*GP*GP*CP*CP*TP*TP*GP*GP*GP*CP*GP*GP*GP*GP*T)-3')","1","6LNZ"
"6LO9",,"X-RAY DIFFRACTION",2.3,46.47,"VAPOR DIFFUSION, HANGING DROP",,"8% PEG4000, 0.4M NaCl, 0.1M PIPES, pH6.5",298,,,"6LO9",32.6,"1.8600494706","1.8600494706","Crystal structure of RORgammat with ligand C46D bound","HHHHHHLVPRGSPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6LO9"
"6LOA",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION, HANGING DROP",,"PEG4000(6%),0.4M sodium chloride , 0.1M PIPES, pH6.5",298,,,"6LOA",32.56,"2.50003303865","2.50003303865","Crystal structure of RORgammat with ligand C46D bound","HHHHHHLVPRGSPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6LOA"
"6LOB",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",,"8% PEG 4000, 0.4M NaCl, 0.1M PIPES pH6.5",298,,,"6LOB",32.5,"2.40006662577","2.40006662577","Crystal structure of RORgammat with ligand C46D bound","HHHHHHLVPRGSPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6LOB"
"6LOC",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION, HANGING DROP",,"8% PEG4000, 0.4M NaCl, 0.1M PIPES pH6.5",298,,,"6LOC",32.57,"2.20014861503","2.20014861503","Crystal structure of RORgammat with ligand C46D bound","HHHHHHLVPRGSPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6LOC"
"6LOG",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION, HANGING DROP",7.9,"0.2M Magnesium acetate tetrahydrate pH 7.9, 20% PEG 3350",283,"10.3390/ijms21051689",,"6LOG",7.83,"2.55","2.55","Crystal structure of human CCL5-12AAA14 mutant","MSPYSSDTTPCCAAAIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS","Homo sapiens","CCL5, D17S136E, SCYA5","C-C motif chemokine 5","1","6LOG"
"6LOH",,"X-RAY DIFFRACTION",4.13,70.23,"VAPOR DIFFUSION",6.4,"0.1M Sodium phosphate pH 6.4, 0.2M Potassium chloride, 2.25M Sodium  chloride",289,,,"6LOH",135.08,"3.207","3.207","Crystal structure of the catalytic domain of human ubiquitin ligase AREL1","HHHHHHENLYFQGSETFQDKVNFFQRELRQVHMKRPHSKVTLKVSRHALLESSLKATRNFSISDWSKNFEVVFQDEEALDWGGPRREWFELICKALFDTTNQLFTRFSDNNQALVHPNPNRPAHLRLKMYEFAGRLVGKCLYESSLGGAYKQLVRARFTRSFLAQIIGLRMHYKYFETDDPEFYKSKVCFILNNDMSEMELVFAEEKYNKSGQLDKVVELMTGGAQTPVTNANKIFYLNLLAQYRLASQVKEEVEHFLKGLNELVPENLLAIFDENELELLMCGTGDISVSDFKAHAVVVGGSWHFREKVMRWFWTVVSSLTQEELARLLQFTTGSSQLPPGGFAALCPSFQIIAAPTHSTLPTAHTCFNQLCLPTYDSYEEVHRMLQL","Homo sapiens","AREL1, KIAA0317","Apoptosis-resistant E3 ubiquitin protein ligase 1","1","6LOH"
"6LOT",,"X-RAY DIFFRACTION",2.64,53.39,"VAPOR DIFFUSION, HANGING DROP",6.7,"0.1 M PIPES, 30% PEG 3,350, 0.2 M Li2SO4",293,"10.3390/ijms21207515",,"6LOT",17.91,"1.69","1.69","Crystal structure of DUSP22 mutant_N128D","GPMGNGMNKILPGLYIGNFKDARDAEQLSKNKVTHILSVHDSARPMLEGVKYLCIPAADSPSQNLTRHFKESIKFIHECRLRGESCLVHCLAGVSRSVTLVIAYIMTVTDFGWEDALHTVRAGRSCANPDVGFQRQLQEFEKHEVHQYRQWLKEEYG","Homo sapiens","DUSP22, JSP1, LMWDSP2, MKPX","Dual specificity protein phosphatase 22","1","6LOT"
"6LOU",,"X-RAY DIFFRACTION",2.59,52.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.05 M arginine, 0.05 M glutamic acid, 0.4 M NaH2PO4, 1.6 M K2HPO4, 0.2 M NaCl",293,"10.3390/ijms21207515",,"6LOU",17.92,"1.5301","1.5301","Crystal structure of DUSP22 mutant_C88S/S93N","GPMGNGMNKILPGLYIGNFKDARDAEQLSKNKVTHILSVHDSARPMLEGVKYLCIPAADSPSQNLTRHFKESIKFIHECRLRGESCLVHSLAGVNRSVTLVIAYIMTVTDFGWEDALHTVRAGRSCANPNVGFQRQLQEFEKHEVHQYRQWLKEEYG","Homo sapiens","DUSP22, JSP1, LMWDSP2, MKPX","Dual specificity protein phosphatase 22","1","6LOU"
"6LOX",,"X-RAY DIFFRACTION",2.6,52.77,"EVAPORATION",8.7,"PEG 6000",289,"10.1021/acs.jmedchem.0c02044",,"6LOX",236.95,"3.2","3.2","Crystal Structure of human glutaminase with macrocyclic inhibitor","GLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKSHHHHHH","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","6LOX"
"6LP6",,"X-RAY DIFFRACTION",3.67,66.49,"VAPOR DIFFUSION, HANGING DROP",,"hepes pH4.6
2M AMMONIUM SULPHATE
30%Glycerol",293,"10.1021/acs.jmedchem.0c00512","B6U","6LP6",41.56,"1.795","1.795","Crystal structure of human DHODH in complex with inhibitor 1214","ATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6LP6"
"6LP7",,"X-RAY DIFFRACTION",3.68,66.56,"VAPOR DIFFUSION, HANGING DROP",,"hepes pH4.6
2M AMMONIUM SULPHATE
30%Glycerol",293,"10.1021/acs.jmedchem.0c00512","B6R","6LP7",41.29,"1.802","1.802","Crystal structure of human DHODH in complex with inhibitor 0944","ATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6LP7"
"6LP8",,"X-RAY DIFFRACTION",3.65,66.28,"VAPOR DIFFUSION, HANGING DROP",,"hepes pH4.6
2M AMMONIUM SULPHATE
30%Glycerol",293,"10.1021/acs.jmedchem.0c00512","B6O","6LP8",41.55,"1.79","1.79","Crystal structure of human DHODH in complex with inhibitor 1243","ATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6LP8"
"6LPF",,"X-RAY DIFFRACTION",2.84,56.63,"EVAPORATION",,"20% (w/v) PEG 6000, 100 mM Tris-cl, pH 8.0, and 200 mM Lithium chloride",289,"10.1093/nar/gkaa189",,"6LPF",251.75,"2.49","2.49","The crystal structure of human cytoplasmic LRS","MGHHHHHHHHHHSSGHIEGRHMMAERKGTAKVDFLKKIEKEIQQKWDTERVFEVNASNLEKQTSKGKYFVTFPYPYMNGRLHLGHTFSLSKCEFAVGYQRLKGKCCLFPFGLHCTGMPIKACADKLKREIELYGCPPDFPDEEEEEEETSVKTEDIIIKDKAKGKKSKAAAKAGSSKYQWGIMKSLGLSDEEIVKFSEAEHWLDYFPPLAIQDLKRMGLKVDWRRSFITTDVNPYYDSFVRWQFLTLRERNKIKFGKRYTIYSPKDGQPCMDHDRQTGEGVGPQEYTLLKLKVLEPYPSKLSGLKGKNIFLVAATLRPETMFGQTNCWVRPDMKYIGFETVNGDIFICTQKAARNMSYQGFTKDNGVVPVVKELMGEEILGASLSAPLTSYKVIYVLPMLTIKEDKGTGVVTSVPSDSPDDIAALRDLKKKQALRAKYGIRDDMVLPFEPVPVIEIPGFGNLSAVTICDELKIQSQNDREKLAEAKEKIYLKGFYEGIMLVDGFKGQKVQDVKKTIQKKMIDAGDALIYMEPEKQVMSRSSDECVVALCDQWYLDYGEENWKKQTSQCLKNLETFCEETRRNFEATLGWLQEHACSRTYGLGTHLPWDEQWLIESLSDSTIYMAFYTVAHLLQGGNLHGQAESPLGIRPQQMTKEVWDYVFFKEAPFPKTQIAKEKLDQLKQEFEFWYPVDLRVSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVRANGHLLLNSEKMSKSTGNFLTLTQAIDKFSADGMRLALADAGDTVEDANFVEAMADAGILRLYTWVEWVKEMVANWDSLRSGPASTFNDRVFASELNAGIIKTDQNYEKMMFKEALKTGFFEFQAAKDKYRELAVEGMHRELVFRFIEVQTLLLAPFCPHLCEHIWTLLGKPDSIMNASWPVAGPVNEVLIHSSQYLMEVTHDLRLRLKNYMMPAKGKKTDKQPLQKPSHCTIYVAKNYPPWQHTTLSVLRKHFEANNGKLPDNKVIASELGSMPELKKYMKKVMPFVAMIKENLEKMGPRILDLQLEFDEKAVLMENIVYLTNSLELEHIEVKFASEAEDKIREDCCPGKPLNVFRIEPGVSVS","Homo sapiens","LARS, KIAA1352, LARS1","Leucine--tRNA ligase, cytoplasmic","1","6LPF"
"6LPN",,"X-RAY DIFFRACTION",2.19,43.76,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BIS-TRIS, pH 6.5, 25% (w/v) PEG 3350",289,"10.1038/s41421-020-00227-0",,"6LPN",106.24,"2.206","2.206","Crystal structure of human D-2-hydroxyglutarate dehydrogenase in apo form","GPGSRYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQAHHHHHH","Homo sapiens","D2HGDH, D2HGD","D-2-hydroxyglutarate dehydrogenase, mitochondrial","1","6LPN"
"6LPP",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BIS-TRIS, pH 6.5, 25% (w/v) PEG 3350",289,"10.1038/s41421-020-00227-0",,"6LPP",107.31,"2.65","2.65","Crystal structure of human D-2-hydroxyglutarate dehydrogenase in complex with D-2-hydroxyglutarate (D-2-HG)","GPGSRYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQAHHHHHH","Homo sapiens","D2HGDH, D2HGD","D-2-hydroxyglutarate dehydrogenase, mitochondrial","1","6LPP"
"6LPQ",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BIS-TRIS, pH 6.5, 25% (w/v) PEG 3350",289,"10.1038/s41421-020-00227-0",,"6LPQ",106.64,"2.8","2.8","Crystal structure of human D-2-hydroxyglutarate dehydrogenase in complex with D-malate (D-MAL)","GPGSRYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQAHHHHHH","Homo sapiens","D2HGDH, D2HGD","D-2-hydroxyglutarate dehydrogenase, mitochondrial","1","6LPQ"
"6LPT",,"X-RAY DIFFRACTION",2.23,44.77,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BIS-TRIS, pH 6.5, 25% (w/v) PEG 3350",289,"10.1038/s41421-020-00227-0",,"6LPT",106.55,"2.621","2.621","Crystal structure of human D-2-hydroxyglutarate dehydrogenase in complex with D-lactate (D-LAC)","GPGSRYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQAHHHHHH","Homo sapiens","D2HGDH, D2HGD","D-2-hydroxyglutarate dehydrogenase, mitochondrial","1","6LPT"
"6LPU",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BIS-TRIS, pH 6.5, 25% (w/v) PEG 3350",289,"10.1038/s41421-020-00227-0",,"6LPU",106.66,"2.923","2.923","Crystal structure of human D-2-hydroxyglutarate dehydrogenase in complex with L-2-hydroxyglutarate (L-2-HG)","GPGSRYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQAHHHHHH","Homo sapiens","D2HGDH, D2HGD","D-2-hydroxyglutarate dehydrogenase, mitochondrial","1","6LPU"
"6LPX",,"X-RAY DIFFRACTION",2.22,44.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BIS-TRIS, pH 6.5, 25% (w/v) PEG 3350",289,"10.1038/s41421-020-00227-0",,"6LPX",106.66,"2.8","2.8","Crystal structure of human D-2-hydroxyglutarate dehydrogenase in complex with 2-oxoglutarate (2-OG)","GPGSRYPVRRLPFSTVSKQDLAAFERIVPGGVVTDPEALQAPNVDWLRTLRGCSKVLLRPRTSEEVSHILRHCHERNLAVNPQGGNTGMVGGSVPVFDEIILSTARMNRVLSFHSVSGILVCQAGCVLEELSRYVEERDFIMPLDLGAKGSCHIGGNVATNAGGLRFLRYGSLHGTVLGLEVVLADGTVLDCLTSLRKDNTGYDLKQLFIGSEGTLGIITTVSILCPPKPRAVNVAFLGCPGFAEVLQTFSTCKGMLGEILSAFEFMDAVCMQLVGRHLHLASPVQESPFYVLIETSGSNAGHDAEKLGHFLEHALGSGLVTDGTMATDQRKVKMLWALRERITEALSRDGYVYKYDLSLPVERLYDIVTDLRARLGPHAKHVVGYGHLGDGNLHLNVTAEAFSPSLLAALEPHVYEWTAGQQGSVSAEHGVGFRKRDVLGYSKPPGALQLMQQLKALLDPKGILNPYKTLPSQAHHHHHH","Homo sapiens","D2HGDH, D2HGD","D-2-hydroxyglutarate dehydrogenase, mitochondrial","1","6LPX"
"6LQA","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1002/anie.202102196",,"6LQA",234.06,"3.3",,"voltage-gated sodium channel Nav1.5 with quinidine","MASWSHPQFEKGGGARGGSGGGSWSHPQFEKGFDYKDDDDKGTMANFLLPRGTSSFRRFTRESLAAIEKRMAEKQARGSTTLQESREGLPEEEAPRPQLDLQASKKLPDLYGNPPQELIGEPLEDLDPFYSTQKTFIVLNKGKTIFRFSATNALYVLSPFHPIRRAAVKILVHSLFNMLIMCTILTNCVFMAQHDPPPWTKYVEYTFTAIYTFESLVKILARGFCLHAFTFLRDPWNWLDFSVIIMAYTTEFVDLGNVSALRTFRVLRALKTISVISGLKTIVGALIQSVKKLADVMVLTVFCLSVFALIGLQLFMGNLRHKCVRNFTALNGTNGSVEADGLVWESLDLYLSDPENYLLKNGTSDVLLCGNSSDAGTCPEGYRCLKAGENPDHGYTSFDSFAWAFLALFRLMTQDCWERLYQQTLRSAGKIYMIFFMLVIFLGSFYLVNLILAVVAMAYEEQNQATIAETEEKEKRFQEAMEMLKKEHEALTIRGVDTVSRSSLEMSPLAPVNSHERRSKRRKRMSSGTEECGEDRLPKSDSEDGPRAMNHLSLTRGLSRTSMKPRSSRGSIFTFRRRDLGSEADFADDENSTAGESESHHTSLLVPWPLRRTSAQGQPSPGTSAPGHALHGKKNSTVDCNGVVSLLGAGDPEATSPGSHLLRPVMLEHPPDTTTPSEEPGGPQMLTSQAPCVDGFEEPGARQRALSAVSVLTSALEELEESRHKCPPCWNRLAQRYLIWECCPLWMSIKQGVKLVVMDPFTDLTITMCIVLNTLFMALEHYNMTSEFEEMLQVGNLVFTGIFTAEMTFKIIALDPYYYFQQGWNIFDSIIVILSLMELGLSRMSNLSVLRSFRLLRVFKLAKSWPTLNTLIKIIGNSVGALGNLTLVLAIIVFIFAVVGMQLFGKNYSELRDSDSGLLPRWHMMDFFHAFLIIFRILCGEWIETMWDCMEVSGQSLCLLVFLLVMVIGNLVVLNLFLALLLSSFSADNLTAPDEDREMNNLQLALARIQRGLRFVKRTTWDFCCGLLRQRPQKPAALAAQGQLPSCIATPYSPPPPETEKVPPTRKETRFEEGEQPGQGTPGDPEPVCVPIAVAESDTDDQEEDEENSLGTEEESSKQQESQPVSGGPEAPPDSRTWSQVSATASSEAEASASQADWRQQWKAEPQAPGCGETPEDSCSEGSTADMTNTAELLEQIPDLGQDVKDPEDCFTEGCVRRCPCCAVDTTQAPGKVWWRLRKTCYHIVEHSWFETFIIFMILLSSGALAFEDIYLEERKTIKVLLEYADKMFTYVFVLEMLLKWVAYGFKKYFTNAWCWLDFLIVDVSLVSLVANTLGFAEMGPIKSLRTLRALRPLRALSRFEGMRVVVNALVGAIPSIMNVLLVCLIFWLIFSIMGVNLFAGKFGRCINQTEGDLPLNYTIVNNKSQCESLNLTGELYWTKVKVNFDNVGAGYLALLQVATFKGWMDIMYAAVDSRGYEEQPQWEYNLYMYIYFVIFIIFGSFFTLNLFIGVIIDNFNQQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPLNKYQGFIFDIVTKQAFDVTIMFLICLNMVTMMVETDDQSPEKINILAKINLLFVAIFTGECIVKLAALRHYYFTNSWNIFDFVVVILSIVGTVLSDIIQKYFFSPTLFRVIRLARIGRILRLIRGAKGIRTLLFALMMSLPALFNIGLLLFLVMFIYSIFGMANFAYVKWEAGIDDMFNFQTFANSMLCLFQITTSAGWDGLLSPILNTGPPYCDPTLPNSNGSRGDCGSPAVGILFFTTYIIISFLIVVNMYIAIILENFSVATEESTEPLSEDDFDMFYEIWEKFDPEATQFIEYSVLSDFADALSEPLRIAKPNQISLINMDLPMVSGDRIHCMDILFAFTKRVLGESGEMDALKIQMEEKFMAANPSKISYEPITTTLRRKHEEVSAMVIQRAFRRHLLQRSLKHASFLFRQQAGSGLSEEDAPEREGLIAYVMSENFSRPLGPPSSSSISSTSFPPSYDSVTRATSDNLQVRGSDYSHSEDLADFPPSPDRDRESIV","Homo sapiens","SCN5A","Sodium channel protein type 5 subunit alpha","1","6LQA"
"6LQX",,"X-RAY DIFFRACTION",2.14,42.65,"VAPOR DIFFUSION, SITTING DROP",4.7,"0.2 M Sodium phosphate monobasic 
monohydrate;20% w/v Polyethylene glycol 3,350;Ph 4.7",298,,,"6LQX",55.66,"2.46","2.46","Crystal structure of the CBP bromodomain in complex with small molecule LC-CPin7","KKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSL","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6LQX"
"6LR0","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-0302-0",,"6LR0",146.56,"3.5",,"structure of human bile salt exporter ABCB11","MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQLFRFSSSTDIWLMFVGSLCAFLHGIAQPGVLLIFGTMTDVFIDYDVELQELQIPGKACVNNTIVWTNSSLNQNMTNGTRCGLLNIESEMIKFASYYAGIAVAVLITGYIQICFWVIAAARQIQKMRKFYFRRIMRMEIGWFDCNSVGELNTRFSDDINKINDAIADQMALFIQRMTSTICGFLLGFFRGWKLTLVIISVSPLIGIGAATIGLSVSKFTDYELKAYAKAGVVADEVISSMRTVAAFGGEKREVERYEKNLVFAQRWGIRKGIVMGFFTGFVWCLIFLCYALAFWYGSTLVLDEGEYTPGTLVQIFLSVIVGALNLGNASPCLEAFATGRAAATSIFETIDRKPIIDCMSEDGYKLDRIKGEIEFHNVTFHYPSRPEVKILNDLNMVIKPGEMTALVGPSGAGKSTALQLIQRFYDPCEGMVTVDGHDIRSLNIQWLRDQIGIVEQEPVLFSTTIAENIRYGREDATMEDIVQAAKEANAYNFIMDLPQQFDTLVGEGGGQMSGGQKQRVAIARALIRNPKILLLDMATSALDNESEAMVQEVLSKIQHGHTIISVAHRLSTVRAADTIIGFEHGTAVERGTHEELLERKGVYFTLVTLQSQGNQALNEEDIKDATEDDMLARTFSRGSYQDSLRASIRQRSKSQLSYLVHEPPLAVVDHKSTYEEDRKDKDIPVQEEVEPAPVRRILKFSAPEWPYMLVGSVGAAVNGTVTPLYAFLFSQILGTFSIPDKEEQRSQINGVCLLFVAMGCVSLFTQFLQGYAFAKSGELLTKRLRKFGFRAMLGQDIAWFDDLRNSPGALTTRLATDASQVQGAAGSQIGMIVNSFTNVTVAMIIAFSFSWKLSLVILCFFPFLALSGATQTRMLTGFASRDKQALEMVGQITNEALSNIRTVAGIGKERRFIEALETELEKPFKTAIQKANIYGFCFAFAQCIMFIANSASYRYGGYLISNEGLHFSYVFRVISAVVLSATALGRAFSYTPSYAKAKISAARFFQLLDRQPPISVYNTAGEKWDNFQGKIDFVDCKFTYPSRPDSQVLNGLSVSISPGQTLAFVGSSGCGKSTSIQLLERFYDPDQGKVMIDGHDSKKVNVQFLRSNIGIVSQEPVLFACSIMDNIKYGDNTKEIPMERVIAAAKQAQLHDFVMSLPEKYETNVGSQGSQLSRGEKQRIAIARAIVRDPKILLLDEATSALDTESEKTVQVALDKAREGRTCIVIAHRLSTIQNADIIAVMAQGVVIEKGTHEELMAQKGAYYKLVTTGSPIS","Homo sapiens","ABCB11, BSEP","Bile salt export pump","1","6LR0"
"6LR2",,"SOLUTION NMR",,,,,,,,,"6LR2",16.14,,,"SOLUTION STRUCTURE OF THE YTH DOMAIN IN YTH DOMAIN-2 CONTAINING PROTEIN 2","GSSGSSGVRYFIMKSSNLRNLEISQQKGIWSTTPSNERKLNRAFWESSIVYLVFSVQGSGHFQGFSRMSSEIGREKSQDWGSAGLGGVFKVEWIRKESLPFQFAHHLLNPWNDNKKVQISRDGQELEPQVGEQLLQLWERL","Homo sapiens","YTHDC2","YTH domain containing protein 2 (YTHDC2)","1","6LR2"
"6LR6",,"X-RAY DIFFRACTION",2.9,57.58,"EVAPORATION",,"20% (w/v) PEG 6000, 100 mM Tris-Cl, pH 8.0, and 200 mM Lithium chloride",289,"10.1093/nar/gkaa189",,"6LR6",252.43,"3.009","3.009","The crystal structure of human cytoplasmic LRS","MGHHHHHHHHHHSSGHIEGRHMMAERKGTAKVDFLKKIEKEIQQKWDTERVFEVNASNLEKQTSKGKYFVTFPYPYMNGRLHLGHTFSLSKCEFAVGYQRLKGKCCLFPFGLHCTGMPIKACADKLKREIELYGCPPDFPDEEEEEEETSVKTEDIIIKDKAKGKKSKAAAKAGSSKYQWGIMKSLGLSDEEIVKFSEAEHWLDYFPPLAIQDLKRMGLKVDWRRSFITTDVNPYYDSFVRWQFLTLRERNKIKFGKRYTIYSPKDGQPCMDHDRQTGEGVGPQEYTLLKLKVLEPYPSKLSGLKGKNIFLVAATLRPETMFGQTNCWVRPDMKYIGFETVNGDIFICTQKAARNMSYQGFTKDNGVVPVVKELMGEEILGASLSAPLTSYKVIYVLPMLTIKEDKGTGVVTSVPSDSPDDIAALRDLKKKQALRAKYGIRDDMVLPFEPVPVIEIPGFGNLSAVTICDELKIQSQNDREKLAEAKEKIYLKGFYEGIMLVDGFKGQKVQDVKKTIQKKMIDAGDALIYMEPEKQVMSRSSDECVVALCDQWYLDYGEENWKKQTSQCLKNLETFCEETRRNFEATLGWLQEHACSRTYGLGTHLPWDEQWLIESLSDSTIYMAFYTVAHLLQGGNLHGQAESPLGIRPQQMTKEVWDYVFFKEAPFPKTQIAKEKLDQLKQEFEFWYPVDLRVSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVRANGHLLLNSEKMSKSTGNFLTLTQAIDKFSADGMRLALADAGDTVEDANFVEAMADAGILRLYTWVEWVKEMVANWDSLRSGPASTFNDRVFASELNAGIIKTDQNYEKMMFKEALKTGFFEFQAAKDKYRELAVEGMHRELVFRFIEVQTLLLAPFCPHLCEHIWTLLGKPDSIMNASWPVAGPVNEVLIHSSQYLMEVTHDLRLRLKNYMMPAKGKKTDKQPLQKPSHCTIYVAKNYPPWQHTTLSVLRKHFEANNGKLPDNKVIASELGSMPELKKYMKKVMPFVAMIKENLEKMGPRILDLQLEFDEKAVLMENIVYLTNSLELEHIEVKFASEAEDKIREDCCPGKPLNVFRIEPGVSVS","Homo sapiens","LARS, KIAA1352, LARS1","Leucine--tRNA ligase, cytoplasmic","1","6LR6"
"6LR9",,"X-RAY DIFFRACTION",2.6,52.71,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Tris-HCl (pH 8.5)
200 mM MgCl2
25% PEG4000",277,"10.1107/S2059798320014990",,"6LR9",28.94,"2.196","2.196","HSP90 in complex with Debio0932","MHHHHHHSSGVDLGTENLYFQSNADQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6LR9"
"6LRC",,"X-RAY DIFFRACTION",2.21,44.25,"VAPOR DIFFUSION, HANGING DROP",,"18-20% V/V PEG 3350, 0.2M AMMONIUM CITRATE (PH 7)",277,"10.1021/acs.jcim.0c00171","KHM","6LRC",86.41,"1.831","1.831","Human cGAS catalytic domain bound with the inhibitor PF-06928215","DAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6LRC"
"6LRE",,"X-RAY DIFFRACTION",2.38,48.43,"VAPOR DIFFUSION, HANGING DROP",,"18-20% V/V PEG 3350, 0.2M AMMONIUM CITRATE (PH 7)",277,"10.1021/acs.jcim.0c00171",,"6LRE",86.22,"2.65","2.65","Human cGAS catalytic domain bound with compound 3","DAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6LRE"
"6LRI",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, HANGING DROP",,"18-20% V/V PEG 3350, 0.2M AMMONIUM CITRATE (PH 7)",277,"10.1021/acs.jcim.0c00171",,"6LRI",86.28,"2.5","2.5","Human cGAS catalytic domain bound with compound 17","DAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6LRI"
"6LRJ",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, HANGING DROP",,"18-20% V/V PEG 3350, 0.2M AMMONIUM CITRATE (PH 7)",277,"10.1021/acs.jcim.0c00171",,"6LRJ",86.28,"3","3","Human cGAS catalytic domain bound with compound 23","DAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6LRJ"
"6LRK",,"X-RAY DIFFRACTION",2.26,45.68,"VAPOR DIFFUSION, HANGING DROP",,"18-20% V/V PEG 3350, 0.2M AMMONIUM CITRATE (PH 7)",277,"10.1021/acs.jcim.0c00171",,"6LRK",86.24,"2.25","2.25","Human cGAS catalytic domain bound with compound 40","DAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6LRK"
"6LRL",,"X-RAY DIFFRACTION",2.46,50.04,"VAPOR DIFFUSION, HANGING DROP",,"18-20% V/V PEG 3350, 0.2M AMMONIUM CITRATE (PH 7)",277,"10.1021/acs.jcim.0c00171",,"6LRL",85.95,"2.655","2.655","Human cGAS catalytic domain bound with compound s2","DAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6LRL"
"6LRM",,"X-RAY DIFFRACTION",2.38,48.25,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, pH 7.0, 0.2 M MgCl2, 10% isopropanol, 30% EG, 18% PEG3350",277,"10.1016/j.jare.2021.02.006",,"6LRM",82.73,"1.45","1.45","Crystal structure of PDE4D catalytic domain in complex with arctigenin","MGSSHHHHHHSSGLVPRGSHMTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQS","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6LRM"
"6LRQ","3.49","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-0299-4",,"6LRQ",87.04,"3.49",,"Cryo-EM structure of A53T alpha-synuclein amyloid fibril","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVTTVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6LRQ"
"6LS5",,"X-RAY DIFFRACTION",2.64,53.37,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.05 M Tris (pH 6.8), 10% (v/v) polyethylene glycol 8000",291,"10.1021/acs.jmedchem.0c00699",,"6LS5",156.82,"2.031","2.031","Structure of human liver FBPase complexed with covalent allosteric inhibitor","MSYYHHHHHHEGVRTMADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, hCG_1640493, FBP","Fructose-1,6-bisphosphatase 1","1","6LS5"
"6LSZ",,"X-RAY DIFFRACTION",2.57,52.16,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Tris-HCl (pH 8.5)
200 mM MgCl2
25% PEG4000",287,,,"6LSZ",28.77,"1.992","1.992","HSP 90 in complex with Ganetespib","MHHHHHHSSGVDLGTENLYFQSNADQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6LSZ"
"6LT8",,"X-RAY DIFFRACTION",2.59,52.51,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Tris-HCl (pH 8.5)
200 mM MgCl2
25% PEG4000",277,"10.1016/j.jsb.2021.107710",,"6LT8",28.98,"1.593","1.593","HSP90 in complex with KW-2478","MHHHHHHSSGVDLGTENLYFQSNADQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6LT8"
"6LTI",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Tris-HCl pH8.5
0.2M MgCl2
25% PEG4000",277,,,"6LTI",28.89,"1.588","1.588","HSP90 in complex with NVP-AUY922","MHHHHHHSSGVDLGTENLYFQSNADQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6LTI"
"6LTK",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Tris-HCl (pH 8.5)
200 mM MgCl2
25% PEG4000",277,"10.3389/fcell.2021.650106",,"6LTK",28.87,"2.141","2.141","HSP90 in complex with SNX-2112","MHHHHHHSSGVDLGTENLYFQSNADQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6LTK"
"6LTN","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-0313-x",,"6LTN",345.65,"3.1",,"cryo-EM structure of C-terminal truncated human Pannexin1","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMDVVDGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSCLEWSHPQFEK","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6LTN"
"6LTO","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-0313-x",,"6LTO",345.65,"3.1",,"cryo-EM structure of full length human Pannexin1","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMDVVDGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSCLEWSHPQFEK","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6LTO"
"6LU5",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Lithium sulfate monohydrate, 0.1 M Tris pH 8.5, 25% PEG 3350",289,,,"6LU5",13.16,"1.86527732574","1.86527732574","Crystal structure of BPTF-BRD with ligand DCBPin5 bound","LTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFK","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","6LU5"
"6LU6",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Lithium sulfate monohydrate, 0.1 M Tris pH 8.5, 25% PEG3350",289,,,"6LU6",13.45,"1.97006302049","1.97006302049","Crystal structure of BPTF-BRD with ligand DCBPin5-2 bound","VLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKA","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","6LU6"
"6LUB",,"X-RAY DIFFRACTION",3.35,63.32,"VAPOR DIFFUSION",7,"1.0 M Succinic Acid, 1.0 %(w/v) Polyethylene glycol monomethyl ether 2000, 0.1 M HEPES",294,"10.1158/1535-7163.MCT-20-0229","EUX","6LUB",38,"2.315","2.315","Crystal Structure of EGFR(L858R/T790M/C797S) in complex with CH7233163","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6LUB"
"6LUD",,"X-RAY DIFFRACTION",3.33,63.04,"VAPOR DIFFUSION",7.7,"0.96 M Succinic Acid, 1.0 %(w/v) Polyethylene glycol monomethyl ether 2000, 0.1 M HEPES",294,"10.1158/1535-7163.MCT-20-0229",,"6LUD",37.83,"2.05","2.05","Crystal Structure of EGFR(L858R/T790M/C797S) in complex with Osimertinib","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6LUD"
"6LUJ",,"X-RAY DIFFRACTION",3.37,63.47,"VAPOR DIFFUSION",,"2.1M ammonium sulfatesulphate, 0.2M magnesium chloride hexahydrate",293,"10.1126/sciadv.abf2229",,"6LUJ",39.02,"1.12","1.12","Crystal structure of the SAMD1 SAM domain","SPVEWTVMDVVEYFTEAGFPEQATAFQEQEIDGKSLLLMQRTDVLTGLSIRLGPALKIYEHHIKVL","Homo sapiens","SAMD1","Atherin","1","6LUJ"
"6LUK",,"X-RAY DIFFRACTION",2.6,52.68,"VAPOR DIFFUSION",,"0.1M bis-tris (pH 7.5), 2.1M ammonium sulphate",293,"10.1126/sciadv.abf2229",,"6LUK",157.95,"2.054","2.054","Crystal structure of the SAMD1 SAM domain in another crystal form","SPVEWTVMDVVEYFTEAGFPEQATAFQEQEIDGKSLLLMQRTDVLTGLSIRLGPALKIYEHHIKVLQQG","Homo sapiens","SAMD1","Atherin","1","6LUK"
"6LUN",,"X-RAY DIFFRACTION",2.3,46.46,"VAPOR DIFFUSION, HANGING DROP",,"20% (w/v) PEG 6000, 100mM HEPES-NaOH pH7.0, 200mM NaCl",293,"10.1016/j.ijbiomac.2020.05.045",,"6LUN",94.68,"1.9","1.9","NN2101 Antibody Fab fragment","QVQLVESGGGVVQPGRSLRLSCAASGFTFSRYGMHWVRQAPGKGLEWVAVIWYDGTNKDYTDSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREDWAEAFDMWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"NN2101","1","6LUN"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"NN2101","2","6LUN"
"6LUU",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LUU",29.38,"1.2","1.2","apo- Carbonic Anhydrase II pH 7.8 0 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LUU"
"6LUV",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LUV",29.47,"1.2","1.2","apo- Carbonic Anhydrase II pH 7.8 20 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LUV"
"6LUW",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LUW",29.45,"1.2","1.2","Zn- Carbonic Anhydrase II pH 7.8 0 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LUW"
"6LUX",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LUX",29.53,"1.2","1.2","Zn- Carbonic Anhydrase II pH 7.8 20 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LUX"
"6LUY",,"X-RAY DIFFRACTION",2.08,40.89,"VAPOR DIFFUSION, HANGING DROP",11,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LUY",29.45,"1.2","1.2","Zn- Carbonic Anhydrase II pH 11.0 0 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LUY"
"6LUZ",,"X-RAY DIFFRACTION",2.1,41.42,"VAPOR DIFFUSION, HANGING DROP",11,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LUZ",29.53,"1.2","1.2","Zn- Carbonic Anhydrase II pH 11.0 20 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LUZ"
"6LV1",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV1",29.5,"1.2","1.2","Co- Carbonic Anhydrase II pH 7.8 0 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV1"
"6LV2",,"X-RAY DIFFRACTION",2.09,41.19,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV2",29.55,"1.2","1.2","Co- Carbonic Anhydrase II pH 7.8 20 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV2"
"6LV3",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, HANGING DROP",11,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV3",29.44,"1.2","1.2","Co- Carbonic Anhydrase II pH 11.0 0 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV3"
"6LV4",,"X-RAY DIFFRACTION",2.1,41.51,"VAPOR DIFFUSION, HANGING DROP",11,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV4",29.59,"1.2","1.2","Co- Carbonic Anhydrase II pH 11.0 20 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV4"
"6LV5",,"X-RAY DIFFRACTION",2.08,41.01,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV5",29.5,"1.2","1.2","Ni- Carbonic Anhydrase II pH 7.8 0 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV5"
"6LV6",,"X-RAY DIFFRACTION",2.1,41.29,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV6",29.6,"1.2","1.2","Ni- Carbonic Anhydrase II pH 7.8 20 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV6"
"6LV7",,"X-RAY DIFFRACTION",2.09,41.05,"VAPOR DIFFUSION, HANGING DROP",11,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV7",29.5,"1.2","1.2","Ni- Carbonic Anhydrase II pH 11.0 0 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV7"
"6LV8",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, HANGING DROP",11,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV8",29.6,"1.2","1.2","Ni- Carbonic Anhydrase II pH 11.0 20 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV8"
"6LV9",,"X-RAY DIFFRACTION",2.08,40.92,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LV9",29.51,"1.2","1.2","Cu- Carbonic Anhydrase II pH 7.8 0 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LV9"
"6LVA",,"X-RAY DIFFRACTION",2.1,41.45,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate, 50 mM Tris-HCl",293,"10.1038/s41467-020-18425-5",,"6LVA",29.55,"1.2","1.2","Cu- Carbonic Anhydrase II pH 7.8 20 atm CO2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6LVA"
"6LVK",,"X-RAY DIFFRACTION",2.75,55.24,"VAPOR DIFFUSION, SITTING DROP",8.5,"Tris, Ammonium sulfate, PEG 8000",296,"10.1016/j.bmc.2020.115453","EVC","6LVK",73.35,"2.29","2.29","Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative","GSHMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","6LVK"
"6LVL",,"X-RAY DIFFRACTION",2.75,55.28,"VAPOR DIFFUSION, SITTING DROP",8.5,"Tris, Ammonium sulfate, PEG 8000",296,"10.1016/j.bmc.2020.115453",,"6LVL",73.16,"2.98","2.98","Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative","GSHMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","6LVL"
"6LVM",,"X-RAY DIFFRACTION",2.27,45.79,"VAPOR DIFFUSION, SITTING DROP",5,"Citric Acid, PEG 8000",296,"10.1016/j.bmc.2020.115453",,"6LVM",36.41,"2.53","2.53","Crystal structure of FGFR3 in complex with pyrimidine derivative","GSHMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDE","Homo sapiens","FGFR3, JTK4","Fibroblast growth factor receptor 3","1","6LVM"
"6LVQ",,"X-RAY DIFFRACTION",1.91,35.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 mM MnCl2, 0.1 mM VO4, 25% PEG 4000",293,"10.3390/ijms21207515",,"6LVQ",17.93,"1.38","1.38","Crystal structure of DUSP22_VO4","GPMGNGMNKILPGLYIGNFKDARDAEQLSKNKVTHILSVHDSARPMLEGVKYLCIPAADSPSQNLTRHFKESIKFIHECRLRGESCLVHCLAGVSRSVTLVIAYIMTVTDFGWEDALHTVRAGRSCANPNVGFQRQLQEFEKHEVHQYRQWLKEEYG","Homo sapiens","DUSP22, JSP1, LMWDSP2, MKPX","Dual specificity protein phosphatase 22","1","6LVQ"
"6LVS",,"X-RAY DIFFRACTION",2.08,40.87,"VAPOR DIFFUSION, SITTING DROP",,"0.2M HcooNa, 0.1M BICINE, 20% PEGmme 5000",295.15,,,"6LVS",285.9,"2.73","2.73","USP14 catalytic domain mutant C114S","HHHHHHSSGLVPRGSHMTEEQLASAMELPCGLTNLGNTSYMNATVQCIRSVPELKDALKRYAGALRASGEMASAQYITAALRDLFDSMDKTSSSIPPIILLQFLHMAFPQFAEKGEQGQYLQQDANECWIQMMRVLQQKLEAIEDDSSAATPSKKKSLIDQFFGVEFETTMKCTESEEEEVTKGKENQLQLSCFINQEVKYLFTGLKLRLQEEITKQSPTLQRNALYIKSSKISRLPAYLTIQMVRFFYKEKESVNAKVLKDVKFPLMLDMYELCTPELQEKMVSFRSKFKDLEDKKVNQQPNTSDKKSSPQKEVKYEPFSFADDIGSNNCGYYDLQAVLTHQGRSSSSGHYVSWVKRKQDEWIKFDDDKVSIVTPEDILRLSGGGDWHIAYVLLYGPRRVEIMEEESEQ","Homo sapiens","USP14, TGT","Ubiquitin carboxyl-terminal hydrolase 14","1","6LVS"
"6LW2",,"X-RAY DIFFRACTION",2.71,54.66,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Ammonium acetate, 0.1M HEPES, 20% PEG 3350, pH 7.0",291,"10.1021/acs.jmedchem.0c00726","EW0","6LW2",149.55,"2.4","2.4","The N-arylsulfonyl-indole-2-carboxamide-based inhibitors against fructose-1,6-bisphosphatase","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ","Homo sapiens","FBP1, FBP","Fructose-1,6-bisphosphatase 1","1","6LW2"
"6LX4",,"X-RAY DIFFRACTION",3,59.02,"VAPOR DIFFUSION",,"0.1 M Tris (pH 8.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LX4",62.99,"2.13","2.13","X-ray structure of human PPARalpha ligand binding domain-fenofibric acid co-crystals obtained by delipidation and co-crystallization","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LX4"
"6LX5",,"X-RAY DIFFRACTION",3.02,59.25,"VAPOR DIFFUSION",,"0.1 M HEPES (pH 7.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LX5",62.96,"1.87","1.87","X-ray structure of human PPARalpha ligand binding domain-ciprofibrate co-crystals obtained by delipidation and co-crystallization","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LX5"
"6LX6",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION",,"0.1 M HEPES (pH 7.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LX6",31.2,"1.3","1.3","X-ray structure of human PPARalpha ligand binding domain-palmitic acid co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LX6"
"6LX7",,"X-RAY DIFFRACTION",2.26,45.69,"VAPOR DIFFUSION",,"0.1 M Tris (pH 8.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LX7",31.23,"1.41","1.41","X-ray structure of human PPARalpha ligand binding domain-stearic acid co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LX7"
"6LX8",,"X-RAY DIFFRACTION",2.27,45.92,"VAPOR DIFFUSION",,"0.1 M HEPES (pH 7.0), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LX8",31.23,"1.54","1.54","X-ray structure of human PPARalpha ligand binding domain-oleic acid co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LX8"
"6LX9",,"X-RAY DIFFRACTION",2.26,45.53,"VAPOR DIFFUSION",,"0.1 M HEPES (pH 7.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LX9",31.25,"1.4","1.4","X-ray structure of human PPARalpha ligand binding domain-arachidonic acid co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LX9"
"6LXA",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION",,"0.1M HEPES (pH 7.5), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LXA",31.25,"1.23","1.23","X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA) co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LXA"
"6LXB",,"X-RAY DIFFRACTION",2.32,47.02,"VAPOR DIFFUSION",,"0.1 M Bis-Tris(pH 6.5), 25 %(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LXB",31.3,"2.36","2.36","X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by soaking","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LXB"
"6LXC",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION",,"0.1M Tris (pH 8.5), 25%(w/v) PEG3350",277,"10.1016/j.isci.2020.101727",,"6LXC",31.3,"2.03","2.03","X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by delipidation and cross-seeding","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","6LXC"
"6LXY",,"X-RAY DIFFRACTION",2.45,49.73,"VAPOR DIFFUSION",,"Ammonium sulphate",293,"10.1021/acsmedchemlett.0c00082","EXF","6LXY",138.79,"2.19","2.19","IRAK4 in complex with inhibitor","GAMGVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6LXY"
"6LZB",,"X-RAY DIFFRACTION",2.42,49.13,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.1M Bistris pH-6.2, 19% PEG 3350, 5% Glycerol",298,"10.1016/j.bioorg.2021.105185",,"6LZB",37.67,"1.29","1.29","crystal structure of Human Methionine aminopeptidase (HsMetAP1b) in complex with AN-P2-5H-06","MGSSHHHHHHSSGLVPRGSHMLEDPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","6LZB"
"6LZC",,"X-RAY DIFFRACTION",2.42,49.12,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.1M Bistris pH-6.2, 19% PEG 3350, 5% Glycerol",298,"10.1016/j.bioorg.2021.105185",,"6LZC",37.64,"1.35","1.35","crystal structure of Human Methionine aminopeptidase (HsMetAP1b) in complex with KV-P2-4H-05","MGSSHHHHHHSSGLVPRGSHMLEDPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLFHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","6LZC"
"6LZL",,"X-RAY DIFFRACTION",3.63,66.14,"VAPOR DIFFUSION, HANGING DROP",4.8,"HEPES pH 7.7, NaCl, 20% Glycerol, EDTA, UDAO, DDAO",293,,,"6LZL",40.55,"1.98","1.98","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with Piperine","TGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6LZL"
"6LZP",,"SOLUTION NMR",,,,,,,"10.3390/ijms21072452",,"6LZP",10.08,,,"The solution structure of N-terminal elongated hSNF5 RPT1 domain","GHDPAVIHENASQPEVLVPIRLDMEIDGQKLRDAFTWNMNEKLMTPEMFSEILCDDLDLNPLTFVPAIASAIRQQIESYPTDSILEDQS","Homo sapiens","SMARCB1, BAF47, INI1, SNF5L1","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1","1","6LZP"
"6LZZ",,"X-RAY DIFFRACTION",4.71,73.87,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES (pH 7.5), 2.5M Na formate, 5% xylitol",277,,,"6LZZ",77.1,"2.40003752238","2.40003752238","Crystal structure of the PDE9 catalytic domain in complex with inhibitor 4a","KYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","6LZZ"
"6M02","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-0298-5",,"6M02",336.66,"3.2",,"cryo-EM structure of human Pannexin 1 channel","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMDVVDGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSC","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6M02"
"6M04","4.36","ELECTRON MICROSCOPY",,,,,,,"10.1038/s42003-020-0951-z",,"6M04",595.87,"4.36",,"Structure of the human homo-hexameric LRRC8D channel at 4.36 Angstroms","MFTLAEVASLNDIQPTYRILKPWWDVFMDYLAVVMLMVAIFAGTMQLTKDQVVCLPVLPSPVNSKAHTPPGNAEVTTNIPKMEAATNQDQDGRTTNDISFGTSAVTPDIPLRATYPRTDFALPNQEAKKEKKDPTGRKTNLDFQQYVFINQMCYHLALPWYSKYFPYLALIHTIILMVSSNFWFKYPKTCSKVEHFVSILGKCFESPWTTKALSETACEDSEENKQRITGAQTLPKHVSTSSDEGSPSASTPMINKTGFKFSAEKPVIEVPSMTILDKKDGEQAKALFEKVRKFRAHVEDSDLIYKLYVVQTVIKTAKFIFILCYTANFVNAISFEHVCKPKVEHLIGYEVFECTHNMAYMLKKLLISYISIICVYGFICLYTLFWLFRIPLKEYSFEKVREESSFSDIPDVKNDFAFLLHMVDQYDQLYSKRFGVFLSEVSENKLREISLNHEWTFEKLRQHISRNAQDKQELHLFMLSGVPDAVFDLTDLDVLKLELIPEAKIPAKISQMTNLQELHLCHCPAKVEQTAFSFLRDHLRCLHVKFTDVAEIPAWVYLLKNLRELYLIGNLNSENNKMIGLESLRELRHLKILHVKSNLTKVPSNITDVAPHLTKLVIHNDGTKLLVLNSLKKMMNVAELELQNCELERIPHAIFSLSNLQELDLKSNNIRTIEEIISFQHLKRLTCLKLWHNKIVTIPPSITHVKNLESLYFSNNKLESLPVAVFSLQKLRCLDVSYNNISMIPIEIGLLQNLQHLHITGNKVDILPKQLFKCIKLRTLNLGQNCITSLPEKVGQLSQLTQLELKGNCFDRLPAQLGQCRMLKKSGLVVEDHLFDTLPLEVKEALNQDINIPFANGIGTENLYFQ","Homo sapiens","LRRC8D, LRRC5, UNQ213/PRO239","Volume-regulated anion channel subunit LRRC8D","1","6M04"
"6M05",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkab028",,"6M05",5.59,,,"Trimolecular G-quadruplex","GTTAGG","Homo sapiens",,"DNA (5'-D(*GP*TP*TP*AP*GP*G)-3')","1","6M05"
"6M06",,"X-RAY DIFFRACTION",2.5,50.77,"VAPOR DIFFUSION, HANGING DROP",6.6,"0.1 M MOPS pH 6.6, 0.4 M Li2SO4, 22.5-27% (w/v) (NH4)2SO4, 1 M Na-Ac, 1.4 % 1,4-butanediol",293,"10.1021/acs.jmedchem.0c00372",,"6M06",84.94,"2.1","2.1","Crystal structure of Lp-PLA2 in complex with a novel covalent inhibitor","TKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINT","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","6M06"
"6M07",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MOPS pH 6.6, 0.4 M Li2SO4, 22.5-27% (w/v) (NH4)2SO4, 1 M Na-Ac, 1.4 % 1,4-butanediol",293,"10.1021/acs.jmedchem.0c00372",,"6M07",85.37,"2.64","2.64","Crystal structure of Lp-PLA2 in complex with a novel covalent inhibitor","TKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNI","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","6M07"
"6M08",,"X-RAY DIFFRACTION",2.47,50.15,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MOPS pH 6.6, 0.4 M Li2SO4, 22.5-27% (w/v) (NH4)2SO4, 1 M Na-Ac, 1.4 % 1,4-butanediol",293,"10.1021/acs.jmedchem.0c00372",,"6M08",85.07,"2.19","2.19","Crystal structure of Lp-PLA2 in complex with a novel covalent inhibitor.","TKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINT","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","6M08"
"6M0B",,"SOLUTION NMR",,,,,,,"10.1021/acs.jpcb.0c03163",,"6M0B",2.59,,,"Solution NMR structures of DNA minidumbbell formed by 5'-CTTG CGTG-3'.","CTTGCGTG","Homo sapiens",,"DNA (5'-D(*CP*TP*TP*GP*CP*GP*TP*G)-3')","1","6M0B"
"6M0C",,"SOLUTION NMR",,,,,,,"10.1021/acs.jpcb.0c03163",,"6M0C",2.58,,,"Solution NMR Structures of DNA minidumbbell formed by 5'-CTTG CATG-3'.","CTTGCATG","Homo sapiens",,"DNA (5'-D(*CP*TP*TP*GP*CP*AP*TP*G)-3')","1","6M0C"
"6M0Y",,"SOLUTION NMR",,,,,,,,,"6M0Y",1.63,,,"KR-12 analog derived from human LL-37","KRIVKRIKKWLR","Homo sapiens",,"LYS-ARG-ILE-VAL-LYS-ARG-ILE-LYS-LYS-TRP-LEU-ARG","1","6M0Y"
"6M14",,"X-RAY DIFFRACTION",2.64,53.34,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES pH 6.5, 0.2 M ammonium sulfate,22% PEG 5000",295,"10.1016/j.bbagen.2022.130099",,"6M14",48.33,"1.88001831059","1.88001831059","Crystal Structure of the BARD1 BRCT Mutant","GPLVLIGSGLSSEQQKMLSELAVILKAKKYTEFDSTVTHVVVPGDAVQSTLKCMLGILNGCWILKFEWVKACLRRKVCEQEEKYEIPEGPRRSRLNREQLLPKLFDGCYFYLWGTFKHHPKDNLIKLLTAGGGQILSRKPKPDSDVTQTINTVAYHARPDSDQRFCTQYIIYEDLCNYHPERVRQGKVWKAPSSWFIDCVMSFELLPLDS","Homo sapiens","BARD1","BRCA1-associated RING domain protein 1","1","6M14"
"6M1B",,"X-RAY DIFFRACTION",2.19,43.82,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, ammonium acetate, glycerol, Phosphate buffer",293,"10.1080/13506129.2020.1813097",,"6M1B",12.25,"1.88","1.88","A new V27M variant of beta 2 microglobulin induced amyloidosis in a patient with long-term hemodialysis","MIQRTPKIQVYSRHPAENGKSNFLNCYMSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","6M1B"
"6M1K",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Tris (hydroxymethyl)aminomethane hydrochloride, pH 7.0, 20% (v/v) PEG 1000",289,"10.1016/j.ejmech.2020.112279",,"6M1K",81.45,"2.255","2.255","USP7 in complex with a novel inhibitor","KKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQK","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","6M1K"
"6M1U",,"X-RAY DIFFRACTION",2.62,52.97,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Tris-HCl, pH 7.4, 20% (w/v) PEG3350, 200 mM sodium citrate, 4% (w/v) formamide and 5 mM dextran sulfate sodium salt.",293,"10.1093/nar/gkaa227",,"6M1U",19.18,"2.791","2.791","Crystal structure of the vertebrate conserved region (VCR) of human METTL16","MKPITFVVLASVMKELSLKASPLRSETAEGIVVVTTWIEKILTDLKVQHKRVPCGKEEVSLFLTAIENSWIHLRRKKRERVRQLREVPRAPEDVIQALEEKKGVAGQYLFKCLINVKKEVDDALVEMHWVEGQNRDLMNQLCTYIRNQIFRLVAVNLEHHHHHH","Homo sapiens","METTL16, METT10D","RNA N6-adenosine-methyltransferase METTL16,RNA N6-adenosine-methyltransferase METTL16","1","6M1U"
,,,,,,,,,,,,,,,,,"Homo sapiens","METTL16, METT10D"
"6M1Y","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-00437-x",,"6M1Y",251.41,"3.2",,"The overall structure of KCC3","MADYKDDDDKSGRMPHFTVTKVEDPEEGAAASISQEPSLADIKARIQDSDEPDLSQNSITGEHSQLLDDGHKKARNAYLNNSNYEEGDEYFDKNLALFEEEMDTRPKVSSLLNRMANYTNLTQGAKEHEEAENITEGKKKPTKTPQMGTFMGVYLPCLQNIFGVILFLRLTWVVGTAGVLQAFAIVLICCCCTMLTAISMSAIATNGVVPAGGSYFMISRALGPEFGGAVGLCFYLGTTFAAAMYILGAIEIFLVYIVPRAAIFHSDDALKESAAMLNNMRVYGTAFLVLMVLVVFIGVRYVNKFASLFLACVIVSILAIYAGAIKSSFAPPHFPVCMLGNRTLSSRHIDVCSKTKEINNMTVPSKLWGFFCNSSQFFNATCDEYFVHNNVTSIQGIPGLASGIITENLWSNYLPKGEIIEKPSAKSSDVLGSLNHEYVLVDITTSFTLLVGIFFPSVTGIMAGSNRSGDLKDAQKSIPIGTILAILTTSFVYLSNVVLFGACIEGVVLRDKFGDAVKGNLVVGTLSWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHSKANGEPTWALLLTAAIAELGILIASLDLVAPILSMFFLMCYLFVNLACALQTLLRTPNWRPRFRYYHWALSFMGMSICLALMFISSWYYAIVAMVIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARFALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKHPRLLTFASQLKAGKGLTIVGSVIVGNFLENYGEALAAEQTIKHLMEAEKVKGFCQLVVAAKLREGISHLIQSCGLGGMKHNTVVMGWPNGWRQSEDARAWKTFIGTVRVTTAAHLALLVAKNISFFPSNVEQFSEGNIDVWWIVHDGGMLMLLPFLLKQHKVWRKCSIRIFTVAQLEDNSIQMKKDLATFLYHLRIEAEVEVVEMHDSDISAYTYERTLMMEQRSQMLRHMRLSKTERDREAQLVKDRNSMLRLTSIGSDEDEETETYQEKVHMTWTKDKYMASRGQKAKSMEGFQDLLNMRPDQSNVRRMHTAVKLNEVIVNKSHEAKLVLLNMPGPPRNPEGDENYMEFLEVLTEGLERVLLVRGGGSEVITIYS","Homo sapiens","KCC3, SLC12A6","Solute carrier family 12 member 6","1","6M1Y"
"6M22","2.7","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-00437-x",,"6M22",251.89,"2.7",,"KCC3 bound with DIOA","MADYKDDDDKSGRMPHFTVTKVEDPEEGAAASISQEPSLADIKARIQDSDEPDLSQNSITGEHSQLLDDGHKKARNAYLNNSNYEEGDEYFDKNLALFEEEMDTRPKVSSLLNRMANYTNLTQGAKEHEEAENITEGKKKPTKTPQMGTFMGVYLPCLQNIFGVILFLRLTWVVGTAGVLQAFAIVLICCCCTMLTAISMSAIATNGVVPAGGSYFMISRALGPEFGGAVGLCFYLGTTFAAAMYILGAIEIFLVYIVPRAAIFHSDDALKESAAMLNNMRVYGTAFLVLMVLVVFIGVRYVNKFASLFLACVIVSILAIYAGAIKSSFAPPHFPVCMLGNRTLSSRHIDVCSKTKEINNMTVPSKLWGFFCNSSQFFNATCDEYFVHNNVTSIQGIPGLASGIITENLWSNYLPKGEIIEKPSAKSSDVLGSLNHEYVLVDITTSFTLLVGIFFPSVTGIMAGSNRSGDLKDAQKSIPIGTILAILTTSFVYLSNVVLFGACIEGVVLRDKFGDAVKGNLVVGTLSWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAIAKDNIIPFLRVFGHSKANGEPTWALLLTAAIAELGILIASLDLVAPILSMFFLMCYLFVNLACALQTLLRTPNWRPRFRYYHWALSFMGMSICLALMFISSWYYAIVAMVIAGMIYKYIEYQGAEKEWGDGIRGLSLSAARFALLRLEEGPPHTKNWRPQLLVLLKLDEDLHVKHPRLLTFASQLKAGKGLTIVGSVIVGNFLENYGEALAAEQTIKHLMEAEKVKGFCQLVVAAKLREGISHLIQSCGLGGMKHNTVVMGWPNGWRQSEDARAWKTFIGTVRVTTAAHLALLVAKNISFFPSNVEQFSEGNIDVWWIVHDGGMLMLLPFLLKQHKVWRKCSIRIFTVAQLEDNSIQMKKDLATFLYHLRIEAEVEVVEMHDSDISAYTYERTLMMEQRSQMLRHMRLSKTERDREAQLVKDRNSMLRLTSIGSDEDEETETYQEKVHMTWTKDKYMASRGQKAKSMEGFQDLLNMRPDQSNVRRMHTAVKLNEVIVNKSHEAKLVLLNMPGPPRNPEGDENYMEFLEVLTEGLERVLLVRGGGSEVITIYS","Homo sapiens","KCC3, SLC12A6","Solute carrier family 12 member 6","1","6M22"
"6M23","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-00437-x",,"6M23",253.73,"3.2",,"Overall structure of KCC2","MADYKDDDDKSGRMLNNLTDCEDGDGGANPGDGNPKESSPFINSTDTEKGKEYDGKNMALFEEEMDTSPMVSSLLSGLANYTNLPQGSREHEEAENNEGGKKKPVQAPRMGTFMGVYLPCLQNIFGVILFLRLTWVVGIAGIMESFCMVFICCSCTMLTAISMSAIATNGVVPAGGSYYMISRSLGPEFGGAVGLCFYLGTTFAGAMYILGTIEILLAYLFPAMAIFKAEDASGEAAAMLNNMRVYGTCVLTCMATVVFVGVKYVNKFALVFLGCVILSILAIYAGVIKSAFDPPNFPICLLGNRTLSRHGFDVCAKLAWEGNETVTTRLWGLFCSSRFLNATCDEYFTRNNVTEIQGIPGAASGLIKENLWSSYLTKGVIVERSGMTSVGLADGTPIDMDHPYVFSDMTSYFTLLVGIYFPSVTGIMAGSNRSGDLRDAQKSIPTGTILAIATTSAVYISSVVLFGACIEGVVLRDKFGEAVNGNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAISRDGIVPFLQVFGHGKANGEPTWALLLTACICEIGILIASLDEVAPILSMFFLMCYMFVNLACAVQTLLRTPNWRPRFRYYHWTLSFLGMSLCLALMFICSWYYALVAMLIAGLIYKYIEYRGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLVRVDQDQNVVHPQLLSLTSQLKAGKGLTIVGSVLEGTFLENHPQAQRAEESIRRLMEAEKVKGFCQVVISSNLRDGVSHLIQSGGLGGLQHNTVLVGWPRNWRQKEDHQTWRNFIELVRETTAGHLALLVTKNVSMFPGNPERFSEGSIDVWWIVHDGGMLMLLPFLLRHHKVWRKCKMRIFTVAQMDDNSIQMKKDLTTFLYHLRITAEVEVVEMHESDISAYTYEKTLVMEQRSQILKQMHLTKNEREREIQSITDESRGSIRRKNPANTRLRLNVPEETAGDSEEKPEEEVQLIHDQSAPSCPSSSPSPGEEPEGEGETDPEKVHLTWTKDKSVAEKNKGPSPVSSEGIKDFFSMKPEWENLNQSNVRRMHTAVRLNEVIVKKSRDAKLVLLNMPGPPRNRNGDENYMEFLEVLTEHLDRVMLVRGGGREVITIYS","Homo sapiens","KCC2, SLC12A5, KIAA1176","Solute carrier family 12 member 5","1","6M23"
"6M2B",,"X-RAY DIFFRACTION",3.69,66.63,"VAPOR DIFFUSION, HANGING DROP",4.8,"0.1M acetate, 40mM UDAO, 20.8mM N,N-dimethyldecylamine-N-oxide (DDAO), 2mM DHO, 1.6-1.8M ammonium sulfate, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"6M2B",43.62,"1.76","1.76","Crystal structure of human dihydroorotate dehydrogenase (DHODH) with S416","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6M2B"
"6M2D",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.4 M Lithium sulfate monohydrate, 0.1 M BIS-TRIS pH 6.5, 25% w/v Polyethylene glycol 3350",291,"10.1111/febs.16360",,"6M2D",38.87,"1.795","1.795","MUL1-RING domain","GSLKSACVVCLSSFKSCVFLECGHVCSCTECYRALPEPKKCPICRQAITRVIPLYNS","Homo sapiens","MUL1, C1orf166, GIDE, MAPL, MULAN, RNF218","Mitochondrial ubiquitin ligase activator of NFKB 1","1","6M2D"
"6M3G",,"X-RAY DIFFRACTION",2.24,45.03,"VAPOR DIFFUSION",,"0.1 M Tris-pH 8.1, 0.2 M potassium acetate, 20% w/v Polyethylene glycol (PEG) 3350",300,"10.1038/s41467-021-21302-4",,"6M3G",39.5,"1.57","1.57","Crystal structure of human HPF1","MVGGGGKRRPGGEGPQCEKTTDVKKSKFCEADVSSDLRKEVENHYKLSLPEDFYHFWKFCEELDPEKPSDSLSASLGLQLVGPYDILAGKHKTKKKSTGLNFNLHWRFYYDPPEFQTIIIGDNKTQYHMGYFRDSPDEFPVYVGINEAKKNCIIVPNGDNVFAAVKLFLTKKLREITDKKKINLLKNIDEKLTEAARELGYSLEQRTVKMKQRDKKVVTKTFHGAGLVVPVDKNDVGYRELPETDADLKRICKTIVEAASDEERLKAFAPIQEMMTFVQFANDECDYGMGLELGMDLFCYGSHYFHKVAGQLLPLAYNLLKRNLFAEIIEEHLANRSQENIDQLAA","Homo sapiens","HPF1, C4orf27","Histone PARylation factor 1","1","6M3G"
"6M4I",,"X-RAY DIFFRACTION",2.44,49.65,"VAPOR DIFFUSION, SITTING DROP",,"Tris-HCl (pH 7.5), PEG 3350, PIPES-NaOH (pH 6.8), NaCl, MgCl2, EGTA-NaOH, TCEP, sucrose, CENP-E, CIBA",277,,,"6M4I",80.5,"1.9","1.9","Structure of CENP-E motor domain at 1.9 angstrom resolution","MNHKVHMAEEGAVAVCVRVRPLNSREESLGETAQVYWKTDNNVIYQVDGSKSFNFDRVFHGNETTKNVYEEIAAPIIDSAIQGYNGTIFAYGQTASGKTYTMMGSEDHLGVIPRAIHDIFQKIKKFPDREFLLRVSYMEIYNETITDLLCGTQKMKPLIIREDVNRNVYVADLTEEVVYTSEMALKWITKGEKSRHYGETKMNQRSSRSHTIFRMILESREKGEPSNCEGSVKVSHLNLVDLAGSERAAQTGAAGVRLKEGCNINRSLFILGQVIKKLSDGQVGGFINYRDSKLTRILQNSLGGNPKTRIICTITPVSFDETLTALQFASTAKYMKNTPYVNEVSGSHHHHHH","Homo sapiens","CENPE","Centromere-associated protein E","1","6M4I"
"6M4R",,"X-RAY DIFFRACTION",2.08,41,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,,,"6M4R",133.14,"2.49","2.49","Structure of Human Serum Albumin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6M4R"
"6M52","2.6","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.pbiomolbio.2020.07.009",,"6M52",510.47,"2.6",,"Human apo ferritin frozen on TEM grid with amorphous carbon supporting film","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6M52"
"6M54","2.4","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.pbiomolbio.2020.07.009",,"6M54",510.47,"2.4",,"Human apo ferritin frozen on TEM grid with Amorphous nickel titanium alloy supporting film","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6M54"
"6M5D",,"X-RAY DIFFRACTION",5.05,75.64,"VAPOR DIFFUSION, HANGING DROP",5.25,"PEG400 potassium phosphate",293,"10.1021/acs.jmedchem.0c01578",,"6M5D",66.06,"2.6","2.6","Human serum albumin (apo form)","KSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPQRNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAA","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6M5D"
"6M5O",,"X-RAY DIFFRACTION",3.43,64.14,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris hydrochloride pH 8.5, 8% (w/v) polyethylene glycol 8000",293,"10.1016/j.isci.2021.102036",,"6M5O",113.62,"2.30000663987","2.30000663987","Co-crystal structure of human serine hydroxymethyltransferase 2 in complex with Pyridoxal 5'-phosphate (PLP) and glycodeoxycholic acid","MGSSHHHHHHSSGLVPRGSGQLVRMAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","1","6M5O"
"6M5W",,"X-RAY DIFFRACTION",7.1,82.69,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M potassium chloride, 0.05 M HEPES pH 7.5, and 35% (v/v) pentaerythritol propoxylate (5/4 PO/OH)",293,"10.1016/j.isci.2021.102036",,"6M5W",56.04,"3.1","3.1","Co-crystal structure of human serine hydroxymethyltransferase 1 in complex with Pyridoxal 5'-phosphate (PLP) and glycodeoxycholic acid","MGSSHHHHHHSSGLVPRGSHMTMPVNGAHKDADLWSSHDKMLAQPLKDSDVEVYNIIKKESNRQRVGLELIASENFASRAVLEALGSCLNNKYSEGYPGQRYYGGTEFIDELETLCQKRALQAYKLDPQCWGVNVQPYSGSPANFAVYTALVEPHGRIMGLDLPDGGHLTHGFMTDKKKISATSIFFESMPYKVNPDTGYINYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHISGLVAAGVVPSPFEHCHVVTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLINSAVFPGLQGGPHNHAIAGVAVALKQAMTLEFKVYQHQVVANCRALSEALTELGYKIVTGGSDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCPGDRSALRPSGLRLGTPALTSRGLLEKDFQKVAHFIHRGIELTLQIQSDTGVRATLKEFKERLAGDKYQAAVQALREEVESFASLFPLPGLPDF","Homo sapiens","SHMT1","Serine hydroxymethyltransferase, cytosolic","1","6M5W"
"6M5Y",,"X-RAY DIFFRACTION",2.08,40.8,"VAPOR DIFFUSION, SITTING DROP",,"20%(w/v) PEG3350, 200 mM Ammonium citrate dibasic",293.15,"10.1093/glycob/cwab101",,"6M5Y",30.07,"1.38","1.38","Structure of human galectin-1 tandem-repeat mutant with lactose","MASGLVASNLNLKPGESLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVSNSKDGGAWGTEQREAVFPFQPGSVAEVSITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKSVAFDGSSASGLVASNLNLKPGESLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVSNSKDGGAWGTEQREAVFPFQPGSVAEVSITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKSVAFD","Homo sapiens","LGALS1","Galectin-1,Galectin-1","1","6M5Y"
,,,,,,,,,,,,,,,,,"Homo sapiens","LGALS1"
"6M61",,"X-RAY DIFFRACTION",2.79,55.97,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M zinc acetate dihydrate, 0.1 M Sodium acetate trihydrate, pH 4.6, 12% w/v polyethylene glycol (PEG) 4000",289.15,,,"6M61",148.08,"1.82449538629","1.82449538629","Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) with inhibitor heptelidic acid","FMGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","6M61"
"6M66","4.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-0310-0",,"6M66",348.35,"4.1",,"The Cryo-EM Structure of Human Pannexin 1","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMDVVDGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSCGSGSHHHHHHHHHH","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6M66"
"6M67","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-0310-0",,"6M67",348.54,"3.6",,"The Cryo-EM Structure of Human Pannexin 1 with D376E/D379E Mutation","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMEVVEGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSCGSGSHHHHHHHHHH","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6M67"
"6M68","4.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-020-0310-0",,"6M68",348.54,"4.6",,"The Cryo-EM Structure of Human Pannexin 1 in the Presence of CBX","MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMEVVEGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSCGSGSHHHHHHHHHH","Homo sapiens","PANX1, MRS1, UNQ2529/PRO6028","Pannexin-1","1","6M68"
"6M6E",,"SOLUTION NMR",,,,,,,"10.15252/embr.202051352",,"6M6E",14.09,,,"Solution structure of the core domain of Fibroblast growth factor 21 (FGF21)","GQVRQRYLYTDDAQQTEAHLEIREDGTVGGAADQSPESLLQLKALKPGVIQILGVKTSRFLCQRPDGALYGSLHFDPEACSFRELLLEDGYNVYQSEAHGLPLHLPGNKSPHRDPAPRGPARFLPLPG","Homo sapiens","FGF21, UNQ3115/PRO10196","Fibroblast growth factor 21","1","6M6E"
"6M6F",,"SOLUTION NMR",,,,,,,"10.15252/embr.202051352",,"6M6F",14.1,,,"Solution structure of disulfide bond mutaion of the core domain of Fibroblast growth factor 21 (FGF21)","GQVRQRYLYTSGPHGLSSCHLEIREDGTVGCAADQSPESLLQLKALKPGVIQILGVKTSRFLCQRPDGALYGSLHFDPEACSFRELLLEDGYNVYQSEAHGLPLHLPGNKSPHRDPAPRGPARFLPLPG","Homo sapiens","FGF21, UNQ3115/PRO10196","Fibroblast growth factor 21","1","6M6F"
"6M6J",,"SOLUTION NMR",,,,,,,"10.1039/d0cc03774e",,"6M6J",2.77,,,"NMR solution structure of a DNA minidumbbell containing an abasic bulge between two CTTG repeats","CTTGNCTTG","Homo sapiens",,"DNA (5'-D(*CP*TP*TP*GP*(3DR)P*CP*TP*TP*G)-3')","1","6M6J"
"6M6K",,"SOLUTION NMR",,,,,,,"10.1039/d0cc03774e",,"6M6K",2.74,,,"NMR solution structure of a DNA minidumbbell containing an abasic bulge between two CCTG repeats","CCTGNCCTG","Homo sapiens",,"DNA (5'-D(*CP*TP*TP*GP*(3DR)P*CP*TP*TP*G)-3')","1","6M6K"
"6M6O",,"SOLUTION NMR",,,,,,,"10.1016/j.bbrc.2022.05.086",,"6M6O",21.59,,,"NMR SOLUTION STRUCTURE OF A C-FLIPs","MGRSDSAEVIHQVEEALDTDEKEMLLFLCRDVAIDVVPPNVRDLLDILRERGKLSVGDLAELLYRVRRFDLLKRILKMDRKAVETHLLRNPHLVSDYRVLMAEIGEDLDKSDVSSLIGLMKDYMGRGKISKEKSFLDLVVELEKLNLVAPDQLDLLEKCLKNIHRIDLKTKIQKYKQLEHHHHHH","Homo sapiens","CFLAR, CASH, CASP8AP1, CLARP, MRIT","CASP8 and FADD-like apoptosis regulator","1","6M6O"
"6M7H",,"X-RAY DIFFRACTION",2.43,49.48,"VAPOR DIFFUSION, HANGING DROP",,"bis tris ph 6.5, peg 3350",289,"10.1016/j.ceca.2019.102063",,"6M7H",18.63,"1.6","1.6","Structure of calmodulin with KN93","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin-1","1","6M7H"
"6M7X",,"X-RAY DIFFRACTION",3.35,63.29,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M imidazole (pH 7.0), 12% PEG 20,000",293,"10.1074/jbc.RA118.006214","JD7","6M7X",113.03,"2.095","2.095","Structure of human CYP11B1 in complex with fadrozole","MAKKTSSVPRTVLPFEAMPRRPGNRWLRLLQIWREQGYEDLHLEVHQTFQELGPIFRYDLGGAGMVCVMLPEDVEKLQQVDSLHPHRMSLEPWVAYRQHRGHKCGVFLLNGPEWRFNRLRLNPEVLSPNAVQRFLPMVDAVARDFSQALKKKVLQNARGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFMPRSLSRWTSPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFSRPQQYTSIVAELLLNAELSPDAIKANSMELTAGSVDTTVFPLLMTLFELARNPNVQQALRQESLAAAASISEHPQKATTELPLLRAALKETLRLYPVGLFLERVASSDLVLQNYHIPAGTLVRVFLYSLGRNPALFPRPERYNPQRWLDIRGSGRNFYHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHLQVETLTQEDIKMVYSFILRPSMFPLLTFRAINHHHH","Homo sapiens","CYP11B1, S11BH","Cytochrome P450 11B1, mitochondrial","1","6M7X"
"6M80",,"X-RAY DIFFRACTION",1.79,31.32,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.1 M Tris-HCl, 0.01 M Li2SO4 monohydrate, 30% (w/v) PEG4000",277,"10.1039/c9sc02211b",,"6M80",6.76,"1.1","1.1","Collagen peptide containing aza-proline and aza-glycine","PPGPPGXPGPRXPPGPPGPPGPPGX","Homo sapiens",,"Collagen peptide containing aza-proline and aza-glycine","1","6M80"
"6M88",,"X-RAY DIFFRACTION",2.17,43.24,"VAPOR DIFFUSION, HANGING DROP",6,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol at 298K. To obtain complex structure, the apo crystal was further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM HEPES, pH 7.5 at 298K in the presence of 2 mM myricetin for 3 days.",298,"10.1021/acs.jmedchem.8b01593","MYC","6M88",30.15,"1.9","1.9","Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with myricetin","GSFTSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","6M88"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"6M89",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, HANGING DROP",6,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol at 298K. To obtain complex structure, the apo crystal was further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM HEPES, pH 7.5 at 298K in the presence of 2 mM quercetin for 3 days.",298,"10.1021/acs.jmedchem.8b01593","QUE","6M89",30.13,"1.85","1.85","Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with quercetin","GSFTSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","6M89"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"6M8A",,"X-RAY DIFFRACTION",2.37,43.7,"VAPOR DIFFUSION, HANGING DROP",6,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol at 298K. To obtain complex structure, the apo crystal was further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM HEPES, pH 7.5 at 298K in the presence of 2 mM luteolin for 3 days.",298,"10.1021/acs.jmedchem.8b01593","LU2","6M8A",30.11,"1.75","1.75","Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with luteolin","GSFTSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","6M8A"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"6M8B",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION, HANGING DROP",6,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol at 298K. To obtain complex structure, the apo crystal was further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM HEPES, pH 7.5 at 298K in the presence of 10 mM kaempferol for 3 days.",298,"10.1021/acs.jmedchem.8b01593","KMP","6M8B",30.11,"1.8","1.8","Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with kaempferol","GSFTSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","6M8B"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"6M8C",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, HANGING DROP",6,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol at 298K. To obtain complex structure, the apo crystal was further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM HEPES, pH 7.5 at 298K in the presence of 10 mM isorhamnetin for 3 days.",298,"10.1021/acs.jmedchem.8b01593","IRH","6M8C",30.14,"1.8","1.8","Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with isorhamnetin","GSFTSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","6M8C"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"6M8D",,"X-RAY DIFFRACTION",2.36,43.44,"VAPOR DIFFUSION, HANGING DROP",6,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol at 298K. To obtain complex structure, the apo crystal was further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM HEPES, pH 7.5 at 298K in the presence of 10 mM diosmetin for 3 days.",298,"10.1021/acs.jmedchem.8b01593","J8D","6M8D",30.13,"2","2","Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with diosmetin","GSFTSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","6M8D"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"6M8E",,"X-RAY DIFFRACTION",2.22,44.59,"VAPOR DIFFUSION, HANGING DROP",6,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol at 298K. To obtain complex structure, the apo crystal was further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM HEPES, pH 7.5 at 298K in the presence of 10 mM rhametine for 3 days.",298,"10.1021/acs.jmedchem.8b01593","J8G","6M8E",30.14,"2","2","Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with rhamnetin","GSFTSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","6M8E"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"6M8P",,"X-RAY DIFFRACTION",4.69,73.75,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.3M Ammonium sulfate, 100mM MES",293,"10.1038/s41467-021-25564-w","P52","6M8P",2338.35,"3.31","3.31","Human ERAP1 bound to phosphinic pseudotripeptide inhibitor DG013","QSTEASPKRHHHHHHHHHHSDENLYFQGTPFPWNKIRLPEYVIPVHYDLLIHANLTTLTFWGTTKVEITASQPTSTIILHSHHLQISRATLRKGAGERLSEEPLQVLEHPRQEQIALLAPEPLLVGLPYTVVIHYAGNLSETFHGFYKSTYRTKEGELRILASTQFEPTAARMAFPCFDEPAFKASFSIKIRREPRHLAISNMPLVKSVTVAEGLIEDHFDVTVKMSTYLVAFIISDFESVSKITKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDAEKSSASSKLGITMTVAHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEFVSVSVTHPELKVGDYFFGKCFDAMEVDALNSSHPVSTPVENPAQIREMFDDVSYDKGACILNMLREYLSADAFKSGIVQYLQKHSYKNTKNEDLWDSMASIGGGGVDVKTMMNTWTLQKGFPLITITVRGRNVHMKQEHYMKGSDGAPDTGYLWHVPLTFITSKSDMVHRFLLKTKTDVLILPEEVEWIKFNVGMNGYYIVHYEDDGWDSLTGLLKGTHTAVSSNDRASLINNAFQLVSIGKLSIEKALDLSLYLKHETEIMPVFQGLNELIPMYKLMEKRDMNEVETQFKAFLIRLLRDLIDKQTWTDEGSVSERMLRSQLLLLACVHNYQPCVQRAEGYFRKWKESNGNLSLPVDVTLAVFAVGAQSTEGWDFLYSKYQFSLSSTEKSQIEFALCRTQNKEKLQWLLDESFKGDKIKTQEFPQILTLIGRNPVGYPLAWQFLRKNWNKLVQKFELGSSSIAHMVMGTTNQFSTRTRLEEVKGFFSSLKENGSQLRCVQQTIETIEENIGWMDKNFDKIRVWLQSEKLER","Homo sapiens","ERAP1, APPILS, ARTS1, KIAA0525, UNQ584/PRO1154","Endoplasmic reticulum aminopeptidase 1","1","6M8P"
"6M8Q",,"X-RAY DIFFRACTION",2.67,54,"VAPOR DIFFUSION, SITTING DROP",7,"Reservoir solution: 100 mM Tris HCl pH 7.0; 0.4 M NaH2PO4; 1.466 K2HPO; 0.2 M NaCl
10 mg/mL 
Protein solution: CPSF3 protein in; 20 mM Hepes pH 7.7; 150 mM NaCl; 5 % glycerol; 1 mM DTT; 0.5 mM NVP-LTM531
Co-crystallization Protocol: 50 nL of protein mixed with 50 nL of reservoir solution. Crystals grew within 1 day with tetragonal bipyramidal habitus and reached a maximum size of 50 micrometers after 3 days.
Cryo-protection Protocol: supplemented reservoir solution with 10 and 20% glycerol, respectively, and subsequently added both solution within 5 min. Crystals incubate for another 5 min before harvesting.",294,"10.1038/s41589-019-0424-1",,"6M8Q",110.23,"2.49","2.49","Cleavage and Polyadenylation Specificity Factor Subunit 3 (CPSF3) in complex with NVP-LTM531","GSSHHHHHHSSGLVPRGSHMSAIPAEESDQLLIRPLGAGQEVGRSCIILEFKGRKIMLDCGIHPGLEGMDALPYIDLIDPAEIDLLLISHFHLDHCGALPWFLQKTSFKGRTFMTHATKAIYRWLLSDYVKVSNISADDMLYTETDLEESMDKIETINFHEVKEVAGIKFWCYHAGHVLGAAMFMIEIAGVKLLYTGDFSRQEDRHLMAAEIPNIKPDILIIESTYGTHIHEKREEREARFCNTVHDIVNRGGRGLIPVFALGRAQELLLILDEYWQNHPELHDIPIYYASSLAKKCMAVYQTYVNAMNDKIRKQININNPFVFKHISNLKSMDHFDDIGPSVVMASPGMMQSGLSRELFESWCTDKRNGVIIAGYCVEGTLAKHIMSEPEEITTMSGQKLPLKMSVDYISFSAHTDYQQTSEFIRALKPPHVILVHGEQNEMARLKAALIREYEDNDEVHIEVHNPRNTEAVTLNFR","Homo sapiens","CPSF3, CPSF73","Cleavage and polyadenylation specificity factor subunit 3","1","6M8Q"
"6M8Z",,"X-RAY DIFFRACTION",2.87,57.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"500 nL of protein in 50 mM Tris pH 8.0 and 500 mM NaCl were mixed with 500nL of 0.1M Bis-tris pH 5.5, 0.1M KSCN, and 29% PEG MME 2000",298,"10.1016/j.bbrc.2018.08.190",,"6M8Z",20.32,"1.83","1.83","Crystal structure of human DJ-1 without a modification on Cys-106","GAMASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6M8Z"
"6M95",,"X-RAY DIFFRACTION",2.01,38.66,"VAPOR DIFFUSION, SITTING DROP",7.4,"16.% PEG 3350, 0.06M MES, 0.04M MES_Na",277.15,"10.1002/cmdc.201900129","J8S","6M95",45.04,"1.8","1.8","Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridine-2-one based p38 MAP Kinase Inhibitors by scaffold hopping: compound 1","MSYYHHHHHHDYDIPTTENLYFQGAMGSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6M95"
"6M9H",,"X-RAY DIFFRACTION",2.19,43.95,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,,,"6M9H",33.61,"1.79","1.79","JAK2 JH2 in complex with diaminopyrimidine JAK040","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6M9H"
"6M9L",,"X-RAY DIFFRACTION",2.03,39.54,"VAPOR DIFFUSION, SITTING DROP",7.4,"24.% PEG MME 5000, 0.1M MES_Na",277.2,"10.1002/cmdc.201900129","J9G","6M9L",45.06,"2.45","2.45","Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridine-2-one based p38 MAP Kinase Inhibitors by scaffold hopping - compound 10","MSYYHHHHHHDYDIPTTENLYFQGAMGSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6M9L"
"6M9W",,"X-RAY DIFFRACTION",2.55,51.71,"VAPOR DIFFUSION, SITTING DROP",8.2,"0.056 M NaPO4.H2O, 1.344 M K2PO4, pH 8.2",293,"10.1038/s41598-019-46846-w",,"6M9W",19.7,"1.5","1.5","Structure of Mg-free KRAS4b (2-169) bound to GDP with the switch-I in fully open conformation","GGTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6M9W"
"6MA6",,"X-RAY DIFFRACTION",2.23,44.83,"MICROBATCH",7,"PEG 3350, sodium malonate",298,"10.1021/acs.biochem.8b01221","MYT","6MA6",56.75,"2.182","2.182","Human CYP3A4 bound to an inhibitor metyrapone","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6MA6"
"6MA7",,"X-RAY DIFFRACTION",2.21,44.31,"MICROBATCH",7,"PEG3350, sodium malonate",298,"10.1021/acs.biochem.8b01221","TPF","6MA7",56.82,"2.09","2.09","Human CYP3A4 bound to an inhibitor fluconazole","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRTDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6MA7"
"6MA8",,"X-RAY DIFFRACTION",2.27,45.92,"MICROBATCH",7,"PEG 3350, sodium malonate",298,"10.1021/acs.biochem.8b01221","PMF","6MA8",57.25,"1.83","1.83","Human CYP3A4 bound to PMSF","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6MA8"
"6MAL",,"X-RAY DIFFRACTION",2.11,41.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"Magnesium Chloride, HEPES pH 7.5, PEG 400",293,"10.1038/s41598-018-34615-0",,"6MAL",35.51,"2.6","2.6","Structure of human Nocturnin C-terminal domain","GPPPRFQRDFVDLRTDCPSTHPPIRVMQWNILAQALGEGKDNFVQCPVEALKWEERKCLILEEILAYQPDILCLQEVDHYFDTFQPLLSRLGYQGTFFPKPWSPCLDVEHNNGPDGCALFFLQNRFKLVNSANIRLTAMTLKTNQVAIAQTLECKESGRQFCIAVTHLKARTGWERFRSAQGCDLLQNLQNITQGAKIPLIVCGDFNAEPTEEVYKHFASSSLNLNSAYKLLSADGQSEPPYTTWKIRTSGECRHTLDYIWYSKHALNVRSALDLLTEEQIGPNRLPSFNYPSDHLSLVCDFSFTEESDGLS","Homo sapiens","NOCT, CCR4, CCRN4L, NOC","Nocturnin","1","6MAL"
"6MAU",,"X-RAY DIFFRACTION",2.6,52.64,"VAPOR DIFFUSION, HANGING DROP",8.2,"1.4 M Sodium/Potassium Phosphate pH 8.2",276,"10.1016/j.bmcl.2019.03.014",,"6MAU",15.95,"2.11","2.11","Crystal structure of human BRD4(1) in complex with CN210 (compound 19)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6MAU"
"6MBI",,"X-RAY DIFFRACTION",2.56,51.93,"VAPOR DIFFUSION, HANGING DROP",8.5,"4 M NaCl, 0.1 Tris (pH 8.5)",293,"10.1038/s41467-019-09355-y",,"6MBI",15.13,"2.834","2.834","Crystal Structure of SNX15 PX domain in domain swapped conformation form 2","GSMSRQAKDDFLRHYTVSDPRTHPKGYTEYKVTAQFISKKDPEDVKEVVVWKRYSDFRKLHGDLAYTHRNLFRRLEEFPAFPRAQVFGRFEASVIEERRKGAEDLLRFTVHIPALNNSPQLKEFFRGG","Homo sapiens","SNX15","Sorting nexin-15","1","6MBI"
"6MBM",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0220656",,"6MBM",1.97,,,"HS02 - Intragenic antimicrobial peptides derived from the protein unconventional myosin 1h","KWAVRIIRKFIKGFIS","Homo sapiens","MYO1H","Unconventional myosin-Ih peptide","1","6MBM"
"6MBO",,"X-RAY DIFFRACTION",3.05,59.63,"VAPOR DIFFUSION, SITTING DROP",5.5,"15% PEG 4000, 20% isopropanol and 100mM citrate (pH 5.5)",292,"10.1021/acs.jmedchem.8b02008","SAH","6MBO",64.72,"1.591","1.591","GLP Methyltransferase with Inhibitor EML741-P212121 Crystal Form","VERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Histone-lysine N-methyltransferase EHMT1","1","6MBO"
"6MBP",,"X-RAY DIFFRACTION",3.21,61.63,"VAPOR DIFFUSION, SITTING DROP",5.5,"15% PEG 4000, 20% isopropanol and 100mM citrate (pH 5.5)",292,"10.1021/acs.jmedchem.8b02008","SAH","6MBP",63.55,"1.947","1.947","GLP Methyltransferase with Inhibitor EML741- P3121 Crystal Form","VERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Histone-lysine N-methyltransferase EHMT1","1","6MBP"
"6MBQ",,"X-RAY DIFFRACTION",1.81,32.01,"VAPOR DIFFUSION, SITTING DROP",8,"200 mM Ammonium Fluoride, 20% PEG 3350",293,"10.1038/s41598-019-46846-w",,"6MBQ",19.47,"1.35","1.35","Crystal structure of Mg-free wild-type KRAS (2-166) bound to GMPPNP in the state 1 conformation","GGTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKH","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6MBQ"
"6MBT",,"X-RAY DIFFRACTION",1.98,38.03,"VAPOR DIFFUSION, SITTING DROP",4.5,"6% 2-Propanol, 0.1 M Na acetate pH 4.5,
26% PEG MME 550",293,"10.1038/s41598-019-46846-w",,"6MBT",39.59,"1.45","1.45","Crystal structure of wild-type KRAS bound to GDP and Mg (Space group C2)","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6MBT"
"6MBU",,"X-RAY DIFFRACTION",2.23,44.92,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M MgCl2, 0.1 M TRIS HCl pH 8.5,
30% PEG 4K",293,"10.1038/s41598-019-46846-w",,"6MBU",39.94,"1.45","1.45","Crystal structure of wild-type KRAS (1-169) bound to GDP and Mg (Space group P3)","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6MBU"
"6MBV",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M NaCitrate, 50 mM Tris",298,"10.1107/S2053230X18018344",,"6MBV",29.21,"1.695","1.695","Carbonic Anhydrase II in complex with Nicotinic Acid","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6MBV"
"6MBW",,"X-RAY DIFFRACTION",2.72,54.76,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000",293,"10.1038/s41467-019-10422-7",,"6MBW",131.24,"3.29","3.29","Structure of Transcription Factor","STGSAMSQKHLQINQTFEELRLVTQDTENELKKLQQTQEYFIIQYQESLRIQAQFGPLAQLSPQERLSRETALQQKQVSLEAWLQREAQTLQQYRVELAEKHQKTLQLLRKQQTIILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEIIWQNRQQIRRAEHLCQQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQPPQVLKTQTKFAATVRLLVGGKLNVHMNPPQVKATIISEQQAKSLLKNENTRNDYSGEILNNCCVMEYHQATGTLSAHFRNMSLKRIKRSDRRGAESVTEEKFTILFESQFSVGGNELVFQVKTLSLPVVVIVHGSQDNNATATVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLFNNSSSHLEDYSGLSVSWSQFNRENLPGRNYTFWQWFDGVMEVLKKHLKPHWNDGAILGFVNKQQAHDLLINKPDGTFLLRFSDSEIGGITIAWKFDSQERMFWNLMPFTTRDFSIRSLADRLGDLNYLIYVFPDRPKDEVYSKYYTPVPCESATAKAVDGYVKPQ","Homo sapiens","STAT5B","Signal transducer and activator of transcription 5B","1","6MBW"
"6MBY",,"X-RAY DIFFRACTION",2.1,41.48,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M NaCitrate, 50 mM Tris",298,"10.1107/S2053230X18018344","FER","6MBY",29.36,"1.496","1.496","Carbonic Anhydrase II in complex with Ferulic Acid","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6MBY"
"6MBZ",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000",293,"10.1038/s41467-019-10422-7",,"6MBZ",131.29,"3.21","3.21","Structure of Transcription Factor","STGSAMSQKHLQINQTFEELRLVTQDTENELKKLQQTQEYFIIQYQESLRIQAQFGPLAQLSPQERLSRETALQQKQVSLEAWLQREAQTLQQYRVELAEKHQKTLQLLRKQQTIILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEIIWQNRQQIRRAEHLCQQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQPPQVLKTQTKFAATVRLLVGGKLNVHMNPPQVKATIISEQQAKSLLKNENTRNDYSGEILNNCCVMEYHQATGTLSAHFRNMSLKRIKRSDRRGAESVTEEKFTILFESQFSVGGNELVFQVKTLSLPVVVIVHGSQDNNATATVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLFNNSSSHLEDYSGLSVSWSQFNRENLPGRNYTFWQWFDGVMEVLKKHLKPHWNDGAILGFVNKQQAHDLLINKPDGTFLLRFSDSEIGGITIAWKFDSQERMFWHLMPFTTRDFSIRSLADRLGDLNYLIYVFPDRPKDEVYSKYYTPVPCESATAKAVDGYVKPQ","Homo sapiens","STAT5B","Signal transducer and activator of transcription 5B","1","6MBZ"
"6MC1",,"X-RAY DIFFRACTION",3.4,63.84,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG 3350, 200 mM ammonium acetate, 100 mM HEPES",277,"10.1126/scisignal.aba3043",,"6MC1",107.72,"2.7","2.7","Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((9-(methylthio)-5,6-dihydrothieno[3,4-h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor","GSHMAELTPILPFLFLGNEQDAQDLDTMQRLNIGYVINVTTHLPLYHYEKGLFNYKRLPATDSNKQNLRQYFEEAFEFIEEAHQCGKGLLIHCQAGVSRSATIVIAYLMKHTRMTMTDAYKFVKGKRPIISPNLNFMGQLLEFEEDLNNGVT","Homo sapiens","DUSP10, MKP5","Dual specificity protein phosphatase 10","1","6MC1"
"6MCI",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-06591-6",,"6MCI",18.36,,,"Solution structure of 7SK stem-loop 1","GGGAUCUGUCACCCCAUUGAUCGCCGAGAGGCUGAUCUGGXUGGXUAGGCGGGUCCC","Homo sapiens",,"7SK RNA","1","6MCI"
"6MCK",,"X-RAY DIFFRACTION",3.33,63.01,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M sodium citrate, pH 4.5, 250 mM Tri-sodium citrate and 15 % PEG3350",289,"10.1124/mol.118.114256",,"6MCK",811.03,"3.77","3.77","p97 D1D2 with CB5083 bound","MRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYGRSHHHHHH","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","6MCK"
"6MCU",,"X-RAY DIFFRACTION",2.27,45.73,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000, ammonium sulfate, sodium acetate",298,"10.1021/jacs.9b04664",,"6MCU",189.85,"2.572","2.572","Crystal structure of the holo retinal-bound domain-swapped dimer Q108K:T51D:A28H mutant of human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFHTRKIAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6MCU"
"6MCV",,"X-RAY DIFFRACTION",2.3,46.63,"EVAPORATION",,"4000 PEG, Ammonium acetate, Sodium acetate",298,"10.1021/jacs.9b04664",,"6MCV",187.74,"3.3","3.3","Crystal Structure of Holo Retinal-Bound Domain-Swapped Dimer of Wild Type Human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6MCV"
"6MCZ",,"X-RAY DIFFRACTION",2.67,53.95,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M MOPS, pH 7.4
0.8M Sodium Citrate",293,"10.7554/eLife.43320","ACD","6MCZ",63.51,"2.1","2.1","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Arachidonic Acid","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6MCZ"
"6MD0",,"X-RAY DIFFRACTION",2.68,54.07,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M MOPS, pH 7.4
0.8M Sodium Citrate",293,"10.7554/eLife.43320","OLA","6MD0",63.46,"1.95","1.95","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Oleic Acid","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6MD0"
"6MD1",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M MOPS, pH 7.4
0.8M Sodium Citrate",293,"10.7554/eLife.43320","GW9, OLA","6MD1",63.74,"2.2","2.2","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Oleic acid","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6MD1"
"6MD2",,"X-RAY DIFFRACTION",2.67,53.99,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M MOPS, pH 7.4
0.8M SODIUM CITRATE",293,"10.7554/eLife.43320","GW9, ACD","6MD2",64.06,"2.2","2.2","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Arachidonic acid","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6MD2"
"6MD4",,"X-RAY DIFFRACTION",2.65,53.51,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M MOPS, pH 7.4
0.8M SODIUM CITRATE",293,"10.7554/eLife.43320","BRL, OLA","6MD4",63.54,"2.24","2.24","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Rosiglitazone and Oleic acid","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6MD4"
"6MD7",,"X-RAY DIFFRACTION",2.26,45.67,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acs.jmedchem.8b01726","JE1","6MD7",122.51,"1.96","1.96","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrimidinone 7","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6MD7"
"6MD9",,"X-RAY DIFFRACTION",2.28,46.01,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acs.jmedchem.8b01725",,"6MD9",121.74,"2.12","2.12","NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR Isoxazolo-pyridinone 3","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6MD9"
"6MDA",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acs.jmedchem.8b01725",,"6MDA",121.68,"2.21","2.21","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyridine 4","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6MDA"
"6MDB",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acs.jmedchem.8b01726","JE4","6MDB",121.77,"2.34","2.34","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyrimidinone 5","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6MDB"
"6MDC",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acs.jmedchem.8b01725","JEA","6MDC",122.11,"2.14","2.14","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyrimidinone 1 SHP389","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6MDC"
"6MDD",,"X-RAY DIFFRACTION",2.3,46.53,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acs.jmedchem.8b01725","JE7","6MDD",121.48,"2.05","2.05","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Imidazo-pyridine 24","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6MDD"
"6MDW",,"X-RAY DIFFRACTION",2.1,42.63,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M sodium citrate tribasic dihydrate at pH 5.5, 14% (w/v) PEG8000, and 10 mM ATP",293.15,"10.1016/j.celrep.2019.02.082",,"6MDW",23.52,"1.5","1.5","Mechanism of protease dependent DPC repair","GPGRPQESLSLVDASWELVDPTPDLQALFVQFNDQFFWGQLEAVEVKWSVRMTLCAGICSYEGKGGMCSIRLSEPLLKLRPRKDLVETLLHEMIHAYLFVTNNDKDREGHGPEFCKHMHRINSLTGANITVYHTFHDEVDEYRRHWWRCNGPCQHRPPYYGYVKRATNREPSAHDYWWAEHQKTCGGTYIKIKE","Homo sapiens","SPRTN, C1orf124, DVC1, UNQ1880/PRO4323","SprT-like domain-containing protein Spartan","1","6MDW"
"6MED",,"X-RAY DIFFRACTION",3.15,60.91,"VAPOR DIFFUSION, SITTING DROP",6.3,"2.0M ammonium sulfate, 0.3M sodium chloride, and 0.1M sodium cacodylate pH 6.3",298,"10.1016/j.chom.2018.10.009",,"6MED",146.99,"2.04","2.04","Crystal structure of broadly neutralizing antibody HEPC3","QVQLVQSGAEVKKPGSSVKVSCKASGGTLNSYEITWVRQAPGQGLEWMGGITPIFETTYAQKFQGRVTITADESTSTTYMELSSLRPEDTAVYYCARDGVRYCGGGRCYNWFDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"antibody HEPC3 Heavy Chain","1","6MED"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRAGQNINNYLNWYQQKPGKAPKVLIYAASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHSTVRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"antibody HEPC3 Light Chain","2","6MED"
"6MEE",,"X-RAY DIFFRACTION",2.5,50.86,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2 M ammonium acetate, 0.1M BIS-Tris pH5.5, and 25% PEG 3,350",298,"10.1016/j.chom.2018.10.009",,"6MEE",97.71,"1.36","1.36","Crystal structure of broadly neutralizing antibody HEPC74","QVQLVQSGAEVKKPGSSVKVSCTTSGGTYINYAISWVRQAPGQGLEWVGGMSPISNTPKYAQKFQGRVTITADESTSTTYMELSSLRPEDTAVYYCARDLLKYCGGGNCHSLLVDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"antibody HEPC74 Heavy Chain","1","6MEE"
,,,,,,,,,,,,,,,,"DIVMTQSPSTLSASVGDRVTISCRASQSISSWLAWYQQKPGRAPKLLIYKASSLETGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQHYNTYLFTFGPGTKVDLKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"antibody HEPC74 Light Chain","2","6MEE"
"6MEF",,"X-RAY DIFFRACTION",5.08,75.76,"VAPOR DIFFUSION, SITTING DROP",6.6,"0.2 M zinc acetate dihydrate pH 6.6, 11 % Sucrose, and 20% PEG 3,350",298,"10.1016/j.chom.2018.10.009",,"6MEF",48.84,"2.9","2.9","Crystal structure of broadly neutralizing antibody AR3C","QVQLEQSGAEVKKPGSSVKVSCETSGGTFDNYALNWVRQAPGQGLEWIGGVVPLFGTTRNAQKFQGRVTISDDKSTGTGHMELRSLRSEDTAVYYCVRSVTPRYCGGGFCYGEFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"antibody AR3C Heavy Chain","1","6MEF"
,,,,,,,,,,,,,,,,"EIELTQSPATLSVSPGERATLSCRASQSVSSNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTVSRLEPEDSAVYFCQQYYRSPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"antibody AR3C Light Chain","2","6MEF"
"6MEG",,"X-RAY DIFFRACTION",2.29,46.36,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris pH 8.0, 30% PEG 2,000",298,"10.1016/j.chom.2018.10.009",,"6MEG",47.62,"1.41","1.41","Crystal structure of human monoclonal antibody HEPC46","QVQLVQSGAEVKKPGASVKVSCKASGYIFTSHGISWVRQAPGQGLEWMGWISVYNGYTNYAQNLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYFCARASQIRGVDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"antibody HEPC46 Heavy Chain","1","6MEG"
,,,,,,,,,,,,,,,,"QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQFPGTAPKLLIYGNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGPWVFGGGTQVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"antibody HEPC46 Light Chain","2","6MEG"
"6MEP",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein at 32.5 mg/mL (in 20 mM Tris pH 8.0, 500 mM NaCl, 2mM BME) was incubated overnight with inhibitor at 2.5 mM final concentration, and then was mixed 1:1 with crystallization solution (27-33% (v/v) Peg 400, 200 mM MgCl2, 100 mM Tris pH 8.5).",285.2,"10.1021/jacs.9b08660",,"6MEP",73.27,"2.893","2.893","Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC3437","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","6MEP"
"6MEQ",,"X-RAY DIFFRACTION",2.97,58.6,"VAPOR DIFFUSION, SITTING DROP",7,"50 mM HEPES pH7, 10% PEG 5000MME, 4% ethylene glycol",293,"10.1073/pnas.1821063116",,"6MEQ",46.3,"2.9","2.9","PcdhgB3 EC1-4 in 50 mM HEPES","EPIRYAIPEELDRGSLVGNLAKDLGFGVGDLPTRNLRVIAEKKFFTVSPENGNLLVSDRIDREEICGKKSTCVLEFEMVAEKPLNFFHVTVLIQDINDNPPTFSQNITELEISELALTGATFALESAQDPDVGVNSLQQYYLSPDPHFSLIQKENLDGSRYPELVLKAPLDREEQPHHHLVLTAVDGGEPSRSCTTQIRVIVADANDNPPVFTQDMYRVNVAENLPAGSSVLKVMAIDMDEGINAEIIYAFINIGKEVRQLFKLDSKTGELTTIGELDFEERDSYTIGVEAKDGGHHTAYCKVQIDISDENDNAPEITLASESQHIQEDAELGTAVALIKTHDLDSGFNGEILCQLKGNFPFKIVQDTKNTYRLVTDGALDREQIPEYNVTITATDKGNPPLSSSKTITLHILDAA","Homo sapiens","PCDHGB3","Protocadherin gamma-B3","1","6MEQ"
"6MER",,"X-RAY DIFFRACTION",2.96,58.4,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM Tris pH 7, 10% PEG 5000MME, 4% ethylene glycol",293,"10.1073/pnas.1821063116",,"6MER",46.3,"3","3","PcdhgB3 EC1-4 in 50 mM HEPES","EPIRYAIPEELDRGSLVGNLAKDLGFGVGDLPTRNLRVIAEKKFFTVSPENGNLLVSDRIDREEICGKKSTCVLEFEMVAEKPLNFFHVTVLIQDINDNPPTFSQNITELEISELALTGATFALESAQDPDVGVNSLQQYYLSPDPHFSLIQKENLDGSRYPELVLKAPLDREEQPHHHLVLTAVDGGEPSRSCTTQIRVIVADANDNPPVFTQDMYRVNVAENLPAGSSVLKVMAIDMDEGINAEIIYAFINIGKEVRQLFKLDSKTGELTTIGELDFEERDSYTIGVEAKDGGHHTAYCKVQIDISDENDNAPEITLASESQHIQEDAELGTAVALIKTHDLDSGFNGEILCQLKGNFPFKIVQDTKNTYRLVTDGALDREQIPEYNVTITATDKGNPPLSSSKTITLHILDAA","Homo sapiens","PCDHGB3","Protocadherin gamma-B3","1","6MER"
"6MEV",,"X-RAY DIFFRACTION",3.33,63.01,"VAPOR DIFFUSION, SITTING DROP",,"0.1M sodium citrate pH 5.6
1.0M ammonium phosphate monobasic",281.15,"10.7554/eLife.53930",,"6MEV",322.92,"2.6","2.6","Structure of JMJD6 bound to Mono-Methyl Arginine.","MNHKSKKRIREAKRSARPELKDSLDWTRHNYYESFSLSPAAVADNVERADALQLSVEEFVERYERPYKPVVLLNAQEGWSAQEKWTLERLKRKYRNQKFKCGEDNDGYSVKMKMKYYIEYMESTRDDSPLYIFDSSYGEHPKRRKLLEDYKVPKFFTDDLFQYAGEKRRPPYRWFVMGPPRSGTGIHIDPLGTSAWNALVQGHKRWCLFPTSTPRELIKVTRDEGGNQQDEAITWFNVIYPRTQLPTWPPEFKPLEILQKPGETVFVPGGWWHVVLNLDTTIAITQNFASSTNFPVVWHKTVRGRPKLSRKWYRILKQEHPELAVLADSVDLQESTGIASD","Homo sapiens","JMJD6, KIAA0585, PTDSR, PSR","Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6","1","6MEV"
"6MF2",,"X-RAY DIFFRACTION",4.68,78.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"8-10% PEG8000, 0.1 M imidazole, 100-300 mM sodium chloride",277,"10.1111/jth.14621",,"6MF2",175.84,"3.6093641312","3.6093641312","Improved Model of Human Coagulation Factor VIII","SATRRYYLGAVELSWDYMQSDLGELPVDARFPPRVPKSFPFNTSVVYKKTLFVEFTDHLFNIAKPRPPWMGLLGPTIQAEVYDTVVITLKNMASHPVSLHAVGVSYWKASEGAEYDDQTSQREKEDDKVFPGGSHTYVWQVLKENGPMASDPLCLTYSYLSHVDLVKDLNSGLIGALLVCREGSLAKEKTQTLHKFILLFAVFDEGKSWHSETKNSLMQDRDAASARAWPKMHTVNGYVNRSLPGLIGCHRKSVYWHVIGMGTTPEVHSIFLEGHTFLVRNHRQASLEISPITFLTAQTLLMDLGQFLLFCHISSHQHDGMEAYVKVDSCPEEPQLRMKNNEEAEDYDDDLTDSEMDVVRFDDDNSPSFIQIRSVAKKHPKTWVHYIAAEEEDWDYAPLVLAPDDRSYKSQYLNNGPQRIGRKYKKVRFMAYTDETFKTREAIQHESGILGPLLYGEVGDTLLIIFKNQASRPYNIYPHGITDVRPLYSRRLPKGVKHLKDFPILPGEIFKYKWTVTVEDGPTKSDPRCLTRYYSSFVNMERDLASGLIGPLLICYKESVDQRGNQIMSDKRNVILFSVFDENRSWYLTENIQRFLPNPAGVQLEDPEFQASNIMHSINGYVFDSLQLSVCLHEVAYWYILSIGAQTDFLSVFFSGYTFKHKMVYEDTLTLFPFSGETVFMSMENPGLWILGCHNSDFRNRGMTALLKVSSCDKNTGDYYEDSYEDISAYLLSKNNAIEPRSDPLAWDNHYGTQIPKEEWKSQEKSPEKTAFKKKDTILSLNACESNHAIAAINEGQNKPEIEVTWAKQGRTERLCSQNPPVLKRHQREITRTTLQSDQEEIDYDDTISVEMKKEDFDIYDEDENQSPRSFQKKTRHYFIAAVERLWDYGMSSSPHVLRNRAQSGSVPQFKKVVFQEFTDGSFTQPLYRGELNEHLGLLGPYIRAEVEDNIMVTFRNQASRPYSFYSSLISYEEDQRQGAEPRKNFVKPNETKTYFWKVQHHMAPTKDEFDCKAWAYFSDVDLEKDVHSGLIGPLLVCHTNTLNPAHGRQVTVQEFALFFTIFDETKSWYFTENMERNCRAPCNIQMEDPTFKENYRFHAINGYIMDTLPGLVMAQDQRIRWYLLSMGSNENIHSIHFSGHVFTVRKKEEYKMALYNLYPGVFETVEMLPSKAGIWRVECLIGEHLHAGMSTLFLVYSNKCQTPLGMASGHIRDFQITASGQYGQWAPKLARLHYSGSINAWSTKEPFSWIKVDLLAPMIIHGIKTQGARQKFSSLYISQFIIMYSLDGKKWQTYRGNSTGTLMVFFGNVDSSGIKHNIFNPPIIARYIRLHPTHYSIRSTLRMELMGCDLNSCSMPLGMESKAISDAQITASSYFTNMFATWSPSKARLHLQGRSNAWRPQVNNPKEWLQVDFQKTMKVTGVTTQGVKSLLTSMYVKEFLISSSQDGHQWTLFFQNGKVKVFQGNQDSFTPVVNSLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQDLY","Homo sapiens","F8, F8C","Coagulation factor VIII","1","6MF2"
,,,,,,,,,,,,,,,,,"Homo sapiens","F8, F8C"
"6MFA",,"X-RAY DIFFRACTION",2.08,40.72,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M MES pH 5.5, 7% PEG 6000",293,,,"6MFA",40.04,"1.754","1.754","Fragment of human fibronectin containing the 4th-7th type III domains","GSGRSDTVPSPRDLQFVEVTDVKVTIMWTPPESAVTGYRVDVIPVNLPGEHGQRLPISRNTFAEVTGLSPGVTYYFKVFAVSHGRESKPLTAQQTTKLDAPTNLQFVNETDSTVLVRWTPPRAQITGYRLTVGLTRRGQPRQYNVGPSVSKYPLRNLQPASEYTVSLVAIKGNQESPKATGVFTTLQPGSSIPPYNTEVTETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQERDAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGNSLEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPISDTIIPAVP","Homo sapiens","FN1, FN","Fibronectin","1","6MFA"
"6MFJ",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3000
100 mM HEPES pH 7.5
200 mM sodium chloride",294,"10.1128/JVI.01120-19",,"6MFJ",95.98,"2.62","2.62","Crystal structure of the ADCC potent antibody DH677.3 Fab elicited in the RV305 vaccine trial.","QVQLVQSGAEVQKPGASVKVSCKASGYTFASYDINWVRQATGQGLEWMGWMNPKTGNTGYAQKFQGRVTLTRNTSISTAYMELTSLRSEDTAVYYCATYRIIAAVGYRYFQYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK","Homo sapiens",,"DH677.3 Fab heavy chain","1","6MFJ"
,,,,,,,,,,,,,,,,"DIQLTQSPSSLSASVGDSVTITCRASQGFGNYLAWYQQRPGKVPEVLIYAATTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPFTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"DH677.3 Fab light chain","2","6MFJ"
"6MFO",,"X-RAY DIFFRACTION",2.97,58.62,"VAPOR DIFFUSION, SITTING DROP",7.7,"0.1 M HEPES pH 7.7, 66% MPD, 4% Glycerol",277,"10.1073/pnas.1920444117",,"6MFO",43.27,"3.15","3.15","Crystal Structure of Human Protocadherin-15 EC1-3 G16D N369D Q370N","MQYDDDWQYEDCKLARDGPPATIVAIDEESRNGTILVDNMLIKGTAGGPDPTIELSLKDNVDYWVLMDPVKQMLFLNSTGRVLDRDPPMNIHSIVVQVQCINKKVGTIIYHEVRIVVRDRNDNSPTFKHESYYATVNELTPVGTTIFTGFSGDNGATDIDDGPNGQIEYVIQYNPDDPTSNDTFEIPLMLTGNIVLRKRLNYEDKTRYFVIIQANDRAQNLNERRTTTTTLTVDVLDGDDLGPMFLPCVLVPNTRDCRPLTYQAAIPELRTPEELNPIIVTPPIQAIDQDRNIQPPSDRPGILYSILVGTPEDYPRFFHMHPRTAELSLLEPVNRDFHQKFDLVIKAEQDNGHPLPAFAGLHIEILDENDNLEHHHHHH","Homo sapiens","PCDH15, USH1F","Protocadherin-15","1","6MFO"
"6MFQ",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION, HANGING DROP",5,"Crystals were obtained in conditions containing 4% tacsimate pH 5 (v/v) and 25% PEG 3350 (w/v). The concentrated PMS2 G207E protein (7 mg/mL) was combined with 0.1ul of an additive (0.1 M calcium chloride dehydrate) prior to the addition of crystallization reagent in a 1:1 ratio.",289.15,"10.1002/humu.23708",,"6MFQ",82,"2.6","2.6","Crystal structure of a PMS2 variant","GSHMMERAESSSTEPAKAIKPIDRKSVHQICSGQVVLSLSTAVKELVENSLDAGATNIDLKLKDYGVDLIEVSDNGCGVEEENFEGLTLKHHTSKIQEFADLTQVETFGFRGEALSSLCALSDVTISTCHASAKVGTRLMFDHNGKIIQKTPYPRPRGTTVSVQQLFSTLPVRHKEFQRNIKKEYAKMVQVLHAYCIISAGIRVSCTNQLEQGKRQPVVCTGGSPSIKENIGSVFGQKQLQSLIPFVQLPPSDSVCEEYGLSCSDALHNLFYISGFISQCTHGVGRSSTDRQFFFINRRPCDPAKVCRLVNEVYHMYNRHQYPFVVLNISVDSECVDINVTPDKRQILLQEEKLLLAVLKTSLIGMFDS","Homo sapiens","PMS2, PMSL2","Mismatch repair endonuclease PMS2","1","6MFQ"
"6MFT",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, HANGING DROP",5,"0.09M MgCl2, 0.09M Na Citrate  pH 5.0, 13.5% PEG 4K, 0.1M LiCl2",293,"10.7554/eLife.37688",,"6MFT",180.02,"2.315","2.315","Crystal structure of glycosylated 426c HIV-1 gp120 core G459C in complex with glVRC01 A60C heavy chain","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYCQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGKNSDYNWDFQHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHHHHHH","Homo sapiens",,"Heavy Chain glVRC01","1","6MFT"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYEFFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light chain glVRC01","2","6MFT"
,,,,,,,,,,,,,,,,"VWKEAKTTLFCASDAKAYEKECHNVWATHACVPTDPNPQEVVLENVTENFNMWKNDMVDQMQEDVISIWDQCLKPCVKLTNTSTLTQACPKVTFDPIPIHYCAPAGYAILKCNNKTFNGKGPCNNVSTVQCTHGIKPVVSTQLLLNGSLAEEEIVIRSKNLSDNAKIIIVQLNKSVEIVCTRPNNGGSGSGGDIRQAYCNISGRNWSEAVNQVKKKLKEHFPHKNISFQSSSGGDLEITTHSFNCGGEFFYCNTSGLFNDTISNATIMLPCRIKQIINMWQEVGKAIYAPPIKGNITCKSDITGLLLLRDGCNTTNNTEIFRPGGGDMRDNWRSELYKYKVVEIKPL","Homo sapiens",,"Gp120","3","6MFT"
"6MG4",,"X-RAY DIFFRACTION",2.71,54.54,"VAPOR DIFFUSION, SITTING DROP",,"Crystals of JTO-FL were grown via sitting-drop vapor diffusion using a crystallization buffer consisting of 20% PEG 3350 and 0.2 M NH4H2PO4 at 23 degrees C. Both diamond-shaped and plate-shaped crystals were generated in the same drop using these conditions, but only the plate-shaped crystals produced usable diffraction data. Crystals were harvested and immediately flash cooled in liquid nitrogen.",296,"10.1073/pnas.1817567116",,"6MG4",46.86,"1.75","1.75","Structure of full-length human lambda-6A light chain JTO","MNFMLNQPHSVSESPGKTVTISCTRSSGNIDSNYVQWYQQRPGSAPITVIYEDNQRPSGVPDRFAGSIDRSSNSASLTISGLKTEDEADYYCQSYDARNVVFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"JTO light chain","1","6MG4"
"6MG5",,"X-RAY DIFFRACTION",2.77,55.57,"VAPOR DIFFUSION, SITTING DROP",,"Crystals of JTO-FL were grown via sitting-drop vapor diffusion using a crystallization buffer consisting of 20% PEG 3350 and 0.2 M NH4H2PO4 at 23 degrees C. Both diamond-shaped and plate-shaped crystals were generated in the same drop using these conditions, but only the plate-shaped crystals produced usable diffraction data. To generate JTO-FL:ligand complexes, crystals of apo JTO-FL were soaked with a tenfold molar excess of ligand for 10 days. Crystals were harvested and immediately flash cooled in liquid nitrogen.",296,"10.1073/pnas.1817567116","6ZW","6MG5",47.28,"1.8","1.8","Structure of full-length human lambda-6A light chain JTO in complex with coumarin 1","MNFMLNQPHSVSESPGKTVTISCTRSSGNIDSNYVQWYQQRPGSAPITVIYEDNQRPSGVPDRFAGSIDRSSNSASLTISGLKTEDEADYYCQSYDARNVVFGGGTRLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Light chain JTO","1","6MG5"
"6MG9",,"SOLUTION NMR",,,,,,,"10.1002/pro.3578",,"6MG9",11.11,,,"Human Obscurin Ig57 Domain","MAPEVTILEPLQDVQLSEGQDASFQCRLSRASGQEARWALGGVPLQANEMNDITVEQGTLHLLTLHKVTLEDAGTVSFHVGTCSSEAQLKVTAGLEHHHHHH","Homo sapiens","OBSCN, KIAA1556, KIAA1639","Obscurin","1","6MG9"
"6MGA",,"X-RAY DIFFRACTION",4.7,73.81,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Magnesium Chloride, 0.05 M Tris HCl pH 8.5, 30% PEG 550 MME",277,"10.1038/s42003-019-0586-0",,"6MGA",50.81,"3.15","3.15","Crystal Structure of Human Protocadherin-1 EC1-4 with glycosylation","TRVVYKVPEEQPPNTLIGSLAADYGFPDVGHLYKLEVGAPYLRVDGKTGDIFTTETSIDREGLRECQNQLPGDPCILEFEVSITDLVQNGSPRLLEGQIEVQDINDNTPNFASPVITLAIPENTNIGSLFPIPLASDRDAGPNGVASYELQAGPEAQELFGLQVAEDQEEKQPQLIVMGNLDRERWDSYDLTIKVQDGGSPPRASSALLRVTVLDTNDNAPKFERPSYEAELSENSPIGHSVIQVKANDSDQGANAEIEYTFHQAPEVVRRLLRLDRNTGLITVQGPVDREDLSTLRFSVLAKDRGTNPKSARAQVVVTVKDMNDNAPTIEIRGIGLVTHQDGMANISEDVAEETAVALVQVSDRDEGENAAVTCVVAGDVPFQLRQASETGSDSKKKYFLQTTTPLDYEKVKDYTIEIVAVDSGNPPLSSTNSLKVQVVDVNDNATDPPVGGHHHHHH","Homo sapiens","PCDH1","Protocadherin-1","1","6MGA"
"6MGE",,"X-RAY DIFFRACTION",3.27,62.4,"VAPOR DIFFUSION, HANGING DROP",8.5,"8% w/v PEG 8000, 100mM Tris 8.5",295,"10.1038/s41467-018-07136-7",,"6MGE",66.38,"2.95","2.95","Structure of human 4-1BBL","ARASPGSAASPRLREGPELSPDDPAGLLDLRQGMFAQLVAQNVLLIDGPLSWYSDPGLAGVSLTGGLSYKEDTKELVVAKAGVYYVFFQLELRRVVAGEGSGSVSLALHLQPLRSAAGAAALALTVDLPPASSEARNSAFGFQGRLLHLSAGQRLGVHLHTEARARHAWQLTQGATVLGLFRVTPEIPAGLPSPRSEGSHHHHHHHH","Homo sapiens","TNFSF9","Tumor necrosis factor ligand superfamily member 9","1","6MGE"
"6MH1",,"X-RAY DIFFRACTION",2.3,46.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM HU-10",291,"10.1021/acs.jmedchem.8b01248","JQP","6MH1",31.27,"1.6","1.6","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH HU-10, A 1,4,5-Trisubstituted Imidazole Analogue","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6MH1"
"6MH2",,"X-RAY DIFFRACTION",2.42,49.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"200 mM ammonium acetate, 100 mM Bis-Tris, pH 5.5, 25% v/v PEG3350",293,"10.1021/acs.biochem.9b00037",,"6MH2",96.37,"2.8","2.8","Structure of Herceptin Fab without antigen","DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Herceptin Fab arm light chain","1","6MH2"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCGSHHHHHH","Homo sapiens",,"Herceptin Fab arm heavy chain","2","6MH2"
"6MH7",,"X-RAY DIFFRACTION",2.29,46.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 mg/mL BRD4, 5 mM HEPES, pH 7.5, 50 mM sodium chloride, 0.5 mM DTT, 50 mM Tris, pH 8.5, 0.1 M ammonium sulfate, 12.5% PEG3350, 10% DMSO, 1 mM SKT-68",291,"10.1021/acs.jmedchem.8b01248","JQY","6MH7",31.41,"1.74","1.74","Crystal structure of the first bromodomain of human BRD4 in complex with SKT-68, a 1,4,5-trisubstituted imidazole analogue","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6MH7"
"6MHB",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION, SITTING DROP",,"100 mM MES pH 6.5, 25% PEG-3350, 3% methanol",277,"10.1021/acs.jmedchem.8b01960",,"6MHB",169.61,"2.75","2.75","Glutathione S-Transferase Omega 1 bound to covalent inhibitor 18","SNAMSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","6MHB"
"6MHC",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, SITTING DROP",,"100 mM MES pH 6.5, 30% PEG-3350, 3% (+/-)-2-methyl-2,4-pentanediol",289,"10.1021/acs.jmedchem.8b01960",,"6MHC",57.11,"2","2","Glutathione S-Transferase Omega 1 bound to covalent inhibitor 37","SNAMSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","6MHC"
"6MHD",,"X-RAY DIFFRACTION",2.11,41.57,"VAPOR DIFFUSION, SITTING DROP",,"100 mM MES pH 6.5, 30% PEG-3350, 4% acetone",289,"10.1021/acs.jmedchem.8b01960",,"6MHD",56.91,"2.16","2.16","Glutathione S-Transferase Omega 1 bound to covalent inhibitor 44","SNAMSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","6MHD"
"6MHM",,"X-RAY DIFFRACTION",2.66,53.71,"VAPOR DIFFUSION, HANGING DROP",4.3,"0.2 M sodium-phosphate-citrate, pH 4.3, 0.275 M lithium sulfate, and 18% polyethylene glycol 1000",298,"10.1021/acs.jmedchem.8b01723",,"6MHM",92.45,"2.743","2.743","Crystal structure of human acid ceramidase in covalent complex with carmofur","DRHHHHHHKLQHAPPWTEDCRKSTYPPSGPTYRGAVPWYTINLDLPPYKRWHELMLDKAPMLKVIVNSLKNMINTFVPSGKVMQVVDEKLPGLLGNFPGPFEEEMKGIAAVTDIPLGEIISFNIFYELFTI","Homo sapiens","ASAH1, ASAH, HSD-33, HSD33","Acid ceramidase subunit alpha","1","6MHM"
,,,,,,,,,,,,,,,,"CTSIVAEDKKGHLIHGRNMDFGVFLGWNINNDTWVITEQLKPLTVNLDFQRNNKTVFKASSFAGYVGMLTGFKPGLFSLTLNERFSINGGYLGILEWILGKKDAMWIGFLTRTVLENSTSYEEAKNLLTKTKILAPAYFILGGNQSGEGCVITRDRKESLDVYELDAKQGRWYVVQTNYDRWKHPFFLDDRRTPAKMCLNRTSQENISFETMYDVLSTKPVLNKLTVYTTLIDVTKGQFETYLRDCPDPCIGW","Homo sapiens","ASAH1, ASAH, HSD-33, HSD33","Acid ceramidase subunit beta","2","6MHM"
"6MHO","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-07117-w",,"6MHO",379.44,"3.4",,"Structure of the human TRPV3 channel in the apo conformation","MEKAHPKEMVPLMGKRVAAPSGNPAILPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGKTCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGPAAAVDYKDDDDKAHHHHHHHHHH","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6MHO"
"6MHS","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-07117-w",,"6MHS",379.44,"3.2",,"Structure of the human TRPV3 channel in a putative sensitized conformation","MEKAHPKEMVPLMGKRVAAPSGNPAILPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGKTCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGPAAAVDYKDDDDKAHHHHHHHHHH","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6MHS"
"6MHV","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-07117-w",,"6MHV",379.44,"3.5",,"Structure of human TRPV3 in the presence of 2-APB in C4 symmetry","MEKAHPKEMVPLMGKRVAAPSGNPAILPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGKTCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGPAAAVDYKDDDDKAHHHHHHHHHH","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6MHV"
"6MHW","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-07117-w",,"6MHW",379.44,"4",,"Structure of human TRPV3 in the presence of 2-APB in C2 symmetry (1)","MEKAHPKEMVPLMGKRVAAPSGNPAILPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGKTCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGPAAAVDYKDDDDKAHHHHHHHHHH","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6MHW"
"6MHX","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-07117-w",,"6MHX",379.44,"4",,"Structure of human TRPV3 in the presence of 2-APB in C2 symmetry (2)","MEKAHPKEMVPLMGKRVAAPSGNPAILPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNCDDMDSPQSPQDDVTETPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGKTCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGPAAAVDYKDDDDKAHHHHHHHHHH","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6MHX"
"6MI4",,"X-RAY DIFFRACTION",2.39,48.5,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris pH 8.0, 5.8% PGA-LM, 5.45% PEG 20,000 mother liquor in MRC2 96 well sitting drop plates.",298,"10.1038/s41598-019-39588-2",,"6MI4",29.51,"2.50009425402","2.50009425402","Structure of the I65M mutant of NEMO(51-112) with N- and C-terminal coiled-coil adaptors.","GSWSVKELEDKNEELLSEIAHLKNEVARLKKLLQRCLAANQELRDAMRQSNQILRERAEELLHFQASQREEKEFLMSKFQEARKLVERLGLEKLELEDKNEELLSEIAHLKNEVARLKKLVGER","Homo sapiens","IKBKG, FIP3, NEMO","NF-kB ESSENTIAL MODULATOR","1","6MI4"
"6MIE",,"SOLUTION NMR",,,,,,,"10.7554/eLife.53901",,"6MIE",18.18,,,"Solution NMR structure of the KCNQ1 voltage-sensing domain","MGHHHHHHGVLARTHVQGRVYNFLERPTGWKCFVYHFAVFLIVLVCLIFSVLSTIEQYAALATGTLFWMEIVLVVFFGTEYVVRLWSAGCRSKYVGLWGRLRFARKPISIIDLIVVVASMVVLCVGSKGQVFATSAIRGIRFLQILRMLHVDRQGGTWR","Homo sapiens","KCNQ1, KCNA8, KCNA9, KVLQT1","Potassium voltage-gated channel subfamily KQT member 1","1","6MIE"
"6MIF",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-06906-7",,"6MIF",9.13,,,"Lim5 domain of PINCH1 protein","GSGDVCFHCNRVIEGDVVSALNKAWCVNCFACSTCNTKLTLKNKFVEFDMKPVCKKCYEKFPLELKKRLKKLAETLGRK","Homo sapiens","LIMS1, PINCH, PINCH1","LIM and senescent cell antigen-like-containing domain protein 1","1","6MIF"
"6MIU",,"X-RAY DIFFRACTION",2.24,45.19,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M BICINE, pH 8.0, 20% PEG 6000",291,"10.1038/s41467-018-06878-8",,"6MIU",12.52,"1.9","1.9","Crystal structure of p62 ZZ domain in complex with Arg-Glu peptide","RELGSNMVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSP","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1, Arg-Glu peptide chimera","1","6MIU"
,,,,,,,,,,,,,,,,,"Homo sapiens","SQSTM1, ORCA, OSIL"
"6MIW",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, SITTING DROP",6.5,"Molecular Dimensions Morpheus HT condition D3",293,,,"6MIW",10.71,"2","2","WWE domain of human HUWE1","GQSNSNNWRWFDDRSGRWCSYSASNNSTIDSAWKSGETSVRFTAGRRRYTVQFTTMVQVNEETGNRRPVMLTLLRVPRLNKNSKNSNGQEL","Homo sapiens","HUWE1, KIAA0312, KIAA1578, UREB1, HSPC272","E3 ubiquitin-protein ligase HUWE1","1","6MIW"
"6MIX","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aav4809",,"6MIX",685.66,"3.6",,"Human TRPM2 ion channel in apo state","MEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSKLSDAGKVVCQCGYTHEQHLEEATKPHTFQGTQWDPKKHVQEMPTDAFGDIVFTGLSQKVKKYVRVSQDTPSSVIYHLMTQHWGLDVPNLLISVTGGAKNFNMKPRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSYKEGELITIGVATWGTVHRREGLIHPTGSFPAEYILDEDGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTRLEKFISEQTKERGGVAIKIPIVCVVLEGGPGTLHTIDNATTNGTPCVVVEGSGRVADVIAQVANLPVSDITISLIQQKLSVFFQEMFETFTESRIVEWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFMDEWQWKPSDLHPTMTAALISNKPEFVKLFLENGVQLKEFVTWDTLLYLYENLDPSCLFHSKLQKVLVEDPERPACAPAAPRLQMHHVAQVLRELLGDFTQPLYPRPRHNDRLRLLLPVPHVKLNVQGVSLRSLYKRSSGHVTFTMDPIRDLLIWAIVQNRRELAGIIWAQSQDCIAAALACSKILKELSKEEEDTDSSEEMLALAEEYEHRAIGVFTECYRKDEERAQKLLTRVSEAWGKTTCLQLALEAKDMKFVSHGGIQAFLTKVWWGQLSVDNGLWRVTLCMLAFPLLLTGLISFREKRLQDVGTPAARARAFFTAPVVVFHLNILSYFAFLCLFAYVLMVDFQPVPSWCECAIYLWLFSLVCEEMRQLFYDPDECGLMKKAALYFSDFWNKLDVGAILLFVAGLTCRLIPATLYPGRVILSLDFILFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNERRVDWLFRGAVYHSYLTIFGQIPGYIDGVNFNPEHCSPNGTDPYKPKCPESDATQQRPAFPEWLTVLLLCLYLLFTNILLLNLLIAMFNYTFQQVQEHTDQIWKFQRHDLIEEYHGRPAAPPPFILLSHLQLFIKRVVLKTPAKRHKQLKNKLEKNEEAALLSWEIYLKENYLQNRQFQQKQRPEQKIEDISNKVDAMVDLLDLDPLKRSGSMEQRLASLEEQVAQTAQALHWIVRTLRASGFSSEADVPTLASQKAAEEPDAEPGGRKKTEEPGDSYHVNARHLLYPNCPVTRFPVPNEKVPWETEFLIYDPPFYTAERKDAAAMDPMGDTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPLNPMGRTGLRGRGSLSCFGPNHTLYPMVTRWRRNEDGAICRKSIKKMLEVLVVKLPLSEHWALPGGSREPGEMLPRKLKRILRQEHWPSFENLLKCGMEVYKGYMDDPRNTDNAWIETVAVSVHFQDQNDVELNRLNSNLHACDSGASIRWQVVDRRIPLYANHKTLLQKAAAEFGAHY","Homo sapiens","TRPM2, EREG1, KNP3, LTRPC2, TRPC7","Transient receptor potential cation channel subfamily M member 2","1","6MIX"
"6MIZ","6.1","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aav4809",,"6MIZ",685.66,"6.1",,"Human TRPM2 ion channel in an ADPR-bound state","MEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSKLSDAGKVVCQCGYTHEQHLEEATKPHTFQGTQWDPKKHVQEMPTDAFGDIVFTGLSQKVKKYVRVSQDTPSSVIYHLMTQHWGLDVPNLLISVTGGAKNFNMKPRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSYKEGELITIGVATWGTVHRREGLIHPTGSFPAEYILDEDGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTRLEKFISEQTKERGGVAIKIPIVCVVLEGGPGTLHTIDNATTNGTPCVVVEGSGRVADVIAQVANLPVSDITISLIQQKLSVFFQEMFETFTESRIVEWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFMDEWQWKPSDLHPTMTAALISNKPEFVKLFLENGVQLKEFVTWDTLLYLYENLDPSCLFHSKLQKVLVEDPERPACAPAAPRLQMHHVAQVLRELLGDFTQPLYPRPRHNDRLRLLLPVPHVKLNVQGVSLRSLYKRSSGHVTFTMDPIRDLLIWAIVQNRRELAGIIWAQSQDCIAAALACSKILKELSKEEEDTDSSEEMLALAEEYEHRAIGVFTECYRKDEERAQKLLTRVSEAWGKTTCLQLALEAKDMKFVSHGGIQAFLTKVWWGQLSVDNGLWRVTLCMLAFPLLLTGLISFREKRLQDVGTPAARARAFFTAPVVVFHLNILSYFAFLCLFAYVLMVDFQPVPSWCECAIYLWLFSLVCEEMRQLFYDPDECGLMKKAALYFSDFWNKLDVGAILLFVAGLTCRLIPATLYPGRVILSLDFILFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNERRVDWLFRGAVYHSYLTIFGQIPGYIDGVNFNPEHCSPNGTDPYKPKCPESDATQQRPAFPEWLTVLLLCLYLLFTNILLLNLLIAMFNYTFQQVQEHTDQIWKFQRHDLIEEYHGRPAAPPPFILLSHLQLFIKRVVLKTPAKRHKQLKNKLEKNEEAALLSWEIYLKENYLQNRQFQQKQRPEQKIEDISNKVDAMVDLLDLDPLKRSGSMEQRLASLEEQVAQTAQALHWIVRTLRASGFSSEADVPTLASQKAAEEPDAEPGGRKKTEEPGDSYHVNARHLLYPNCPVTRFPVPNEKVPWETEFLIYDPPFYTAERKDAAAMDPMGDTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPLNPMGRTGLRGRGSLSCFGPNHTLYPMVTRWRRNEDGAICRKSIKKMLEVLVVKLPLSEHWALPGGSREPGEMLPRKLKRILRQEHWPSFENLLKCGMEVYKGYMDDPRNTDNAWIETVAVSVHFQDQNDVELNRLNSNLHACDSGASIRWQVVDRRIPLYANHKTLLQKAAAEFGAHY","Homo sapiens","TRPM2, EREG1, KNP3, LTRPC2, TRPC7","Transient receptor potential cation channel subfamily M member 2","1","6MIZ"
"6MJ2","6.36","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aav4809",,"6MJ2",685.83,"6.36",,"Human TRPM2 ion channel in a calcium- and ADPR-bound state","MEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSKLSDAGKVVCQCGYTHEQHLEEATKPHTFQGTQWDPKKHVQEMPTDAFGDIVFTGLSQKVKKYVRVSQDTPSSVIYHLMTQHWGLDVPNLLISVTGGAKNFNMKPRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSYKEGELITIGVATWGTVHRREGLIHPTGSFPAEYILDEDGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTRLEKFISEQTKERGGVAIKIPIVCVVLEGGPGTLHTIDNATTNGTPCVVVEGSGRVADVIAQVANLPVSDITISLIQQKLSVFFQEMFETFTESRIVEWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFMDEWQWKPSDLHPTMTAALISNKPEFVKLFLENGVQLKEFVTWDTLLYLYENLDPSCLFHSKLQKVLVEDPERPACAPAAPRLQMHHVAQVLRELLGDFTQPLYPRPRHNDRLRLLLPVPHVKLNVQGVSLRSLYKRSSGHVTFTMDPIRDLLIWAIVQNRRELAGIIWAQSQDCIAAALACSKILKELSKEEEDTDSSEEMLALAEEYEHRAIGVFTECYRKDEERAQKLLTRVSEAWGKTTCLQLALEAKDMKFVSHGGIQAFLTKVWWGQLSVDNGLWRVTLCMLAFPLLLTGLISFREKRLQDVGTPAARARAFFTAPVVVFHLNILSYFAFLCLFAYVLMVDFQPVPSWCECAIYLWLFSLVCEEMRQLFYDPDECGLMKKAALYFSDFWNKLDVGAILLFVAGLTCRLIPATLYPGRVILSLDFILFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNERRVDWLFRGAVYHSYLTIFGQIPGYIDGVNFNPEHCSPNGTDPYKPKCPESDATQQRPAFPEWLTVLLLCLYLLFTNILLLNLLIAMFNYTFQQVQEHTDQIWKFQRHDLIEEYHGRPAAPPPFILLSHLQLFIKRVVLKTPAKRHKQLKNKLEKNEEAALLSWEIYLKENYLQNRQFQQKQRPEQKIEDISNKVDAMVDLLDLDPLKRSGSMEQRLASLEEQVAQTAQALHWIVRTLRASGFSSEADVPTLASQKAAEEPDAEPGGRKKTEEPGDSYHVNARHLLYPNCPVTRFPVPNEKVPWETEFLIYDPPFYTAERKDAAAMDPMGDTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPLNPMGRTGLRGRGSLSCFGPNHTLYPMVTRWRRNEDGAICRKSIKKMLEVLVVKLPLSEHWALPGGSREPGEMLPRKLKRILRQEHWPSFENLLKCGMEVYKGYMDDPRNTDNAWIETVAVSVHFQDQNDVELNRLNSNLHACDSGASIRWQVVDRRIPLYANHKTLLQKAAAEFGAHY","Homo sapiens","TRPM2, EREG1, KNP3, LTRPC2, TRPC7","Transient receptor potential cation channel subfamily M member 2","1","6MJ2"
"6MJ5",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"protein 22 mg/mL

0.1M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515",,"6MJ5",104.86,"1.853","1.853","Crystal structure of Tdp1 catalytic domain in complex with compound XZ519","GEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6MJ5"
"6MJ7",,"X-RAY DIFFRACTION",1.87,34.34,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bicine (pH 9.0), 14% PEG 20K, 4% 1,4-Dioxane",291,"10.1038/s41467-018-06878-8",,"6MJ7",6.24,"1.412","1.412","Crystal structure of p62 ZZ domain in complex with free arginine","LGSNMVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSP","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","1","6MJ7"
"6MJM",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, ADA, Anapoe 20",297,"10.1074/jbc.RA119.007928",,"6MJM",55.76,"2.2","2.2","Substrate Free Cytochrome P450 3A5 (CYP3A5)","MALYGTRTHGLFKRLGIPGPTPLPLLGNVLSYRQGLWKFDTECYKKYGKMWGTYEGQLPVLAITDPDVIRTVLVKECYSVFTNRRSLGPVGFMKSAISLAEDEEWKRIRSLLSPTFTSGKLKEMFPIIAQYGDVLVRNLRREAEKGKPVTLKDIFGAYSMDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSLFPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSIIFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVVNETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFSKKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQGLLQPEKPIVLKVDSRDGHHHH","Homo sapiens","CYP3A5","Cytochrome P450 3A5","1","6MJM"
"6MJU",,"X-RAY DIFFRACTION",2.72,54.84,"VAPOR DIFFUSION, HANGING DROP",7,"0.064 M sodium citrate 7.0, 0.1 M HEPES, pH 7.0, 10% PEG5000MME",293,"10.1038/s41467-019-08620-4","JUM","6MJU",43.92,"2.45","2.45","human cGAS catalytic domain bound with the inhibitor G108","SILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDEEHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6MJU"
"6MJV",,"SOLUTION NMR",,,,,,,"10.1002/prot.25785",,"6MJV",3.74,,,"A consensus human beta defensin","KKCWNGGRCRKKCKENEKPIGYCRNGKKCCVN","Homo sapiens",,"Human beta-defensin","1","6MJV"
"6MJW",,"X-RAY DIFFRACTION",2.71,54.55,"VAPOR DIFFUSION, HANGING DROP",7,"0.064 M sodium citrate 7.0, 0.1 M HEPES, pH 7.0, 10% PEG5000MME",293,"10.1038/s41467-019-08620-4","JUJ","6MJW",43.94,"2.405","2.405","human cGAS catalytic domain bound with the inhibitor G150","SILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDEEHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6MJW"
"6MJX",,"X-RAY DIFFRACTION",2.23,44.73,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M Bicine 8.5, 10% PEG6000, final PH 9.0",293,"10.1038/s41467-019-08620-4",,"6MJX",44.23,"2.6","2.6","human cGAS catalytic domain bound with cGAMP","SILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDEEHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6MJX"
"6MK3",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 200 mM sodium chloride, 18-21% PEG4000",293,"10.1021/acs.jmedchem.8b01529",,"6MK3",32.35,"1.478","1.478","Crystallographic solvent mapping analysis of DMSO bound to APE1","GSHMASEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQAPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","6MK3"
"6MKK",,"X-RAY DIFFRACTION",2.34,47.42,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 200 mM sodium chloride, 18-21% PEG4000",293,"10.1021/acs.jmedchem.8b01529",,"6MKK",32.3,"1.442","1.442","Crystallographic solvent mapping analysis of DMSO/Mg bound to APE1","GSHMASEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQAPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","6MKK"
"6MKM",,"X-RAY DIFFRACTION",2.24,45.06,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 200 mM sodium chloride, 18-21% PEG4000",293,"10.1021/acs.jmedchem.8b01529",,"6MKM",32.41,"1.673","1.673","Crystallographic solvent mapping analysis of DMSO/Tris bound to APE1","GSHMASEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQAPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","6MKM"
"6MKO",,"X-RAY DIFFRACTION",2.26,45.61,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 200 mM sodium chloride, 18-21% PEG4000",293,"10.1021/acs.jmedchem.8b01529",,"6MKO",32.2,"2.09","2.09","Crystallographic solvent mapping analysis of glycerol bound to APE1","GSHMASEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQAPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","6MKO"
"6MKV",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, Sodium acetate, Ammonium acetate",293,"10.1021/jacs.9b04664",,"6MKV",64.12,"2.107","2.107","Crystal structure of Retinal-bound holo Q108K:K40L:T51W domain-swapped dimer of human cellular retinol binding protein 2","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKWKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6MKV"
"6MKY",,"X-RAY DIFFRACTION",3.03,59.42,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium sulfate, 0.01 M Cadmium chloride hemi(pentahydrate), 0.1 M HEPES 7.5, 25 % v/v PEG Smear Medium (12.5%w/v PEG 3350
12.5%w/v PEG 4000
12.5%w/v PEG 2000
12.5%w/v PEG 5000 MME)",298,"10.1107/S2053230X18016503",,"6MKY",61.79,"2.9","2.9","Human SDS22","VKTLCLRQNLIKCIENLEELQSLRELDLYDNQIKKIENLEALTELEILDISFNLLRNIEGVDKLTRLKKLFLVNNKISKIENLSNLHQLQMLELGSNRIRAIENIDTLTNLESLFLGKNKITKLQNLDALTNLTVLSMQSNRLTKIEGLQNLVNLRELYLSHNGIEVIEGLENNNKLTMLDIASNRIKKIENISHLTELQEFWMNDNLLESWSDLDELKGARSLETVYLERNPLQKDPQYRRKVMLALPSVRQIDATFVRF","Homo sapiens","PPP1R7, SDS22","Protein phosphatase 1 regulatory subunit 7","1","6MKY"
"6MLB",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, ammonium acetate, sodium acetate",298,"10.1021/jacs.9b04664",,"6MLB",63.75,"2.15","2.15","Crystal structure of the holo retinal-bound domain-swapped dimer Q108K:K40L:T51F mutant of human cellular retinol binding protein II","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKFKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6MLB"
"6MM1",,"X-RAY DIFFRACTION",2.5,50.73,"VAPOR DIFFUSION, SITTING DROP",,"0.2M potassium sodium tartrate
18% PEG 3350
0.1M HEPES, pH 8.0",277,,,"6MM1",60.98,"1.9","1.9","Structure of the cysteine-rich region from human EHMT2","GSGFEELPLCSCRMEAPKIDRISERAGHKCMATESVDGELSGCNAAILKRETMRPSSRVALMVLCETHRARMVKHHCCPGCGYFCTAGTFLECHPDFRVAHRFHKACVSQLNGMVFCPHCGEDASEAQEVTIPRGD","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","6MM1"
"6MN6",,"X-RAY DIFFRACTION",3.49,64.78,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris, pH 8.5; 0.5 M succinic acid, pH 7.0",293,"10.1016/j.str.2019.11.016",,"6MN6",82.94,"3.36","3.36","Crystal structure of the cytosolic domain of human CNNM3","GPLGSDPYSDLSKGVLRCRTVEDVLTPLEDCFMLDASTVLDFGVLASIMQSGHTRIPVYEEERSNIVDMLYLKDLAFVDPEDCTPLSTITRFYNHPLHFVFNDTKLDAVLEEFKRGKSHLAIVQKVNNEGEGDPFYEVLGLVTLEDVIEEIIRSEILDESEDYRDTVVKRKPASLMAPLKRKEEFSLFKVSDDEYKVTISPQLLLATQRFLSREVDVFSPLRISEKVLLHLLKHPSVNQEVRFDESNRLATHHYLYQRSQPVDYFILILQGRVEVEIGKEGLKFENGAFTYYGVSALTVPSSVHQSPVSSLQPIRHDLQPDPGDGTHSSAYCPDYTVRALSDLQLIKVTRLQYLNALLATRAQNL","Homo sapiens","CNNM3, ACDP3","Metal transporter CNNM3","1","6MN6"
"6MNC",,"X-RAY DIFFRACTION",2.01,38.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"MgCl2, PEG3350, Glycerol",295,"10.1111/febs.14784","J3Z","6MNC",70.35,"2.4","2.4","CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 COMPLEXED WITH ESTRONE","MARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVRMLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHLSLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGGAGPGAEDEAGRGAVGDPELGDPPAAPQ","Homo sapiens","HSD17B1, E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1","Estradiol 17-beta-dehydrogenase 1","1","6MNC"
"6MNE",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, HANGING DROP",7.6,"KH2PO4, PEG8000",300,"10.1111/febs.14784","J3Z","6MNE",72.1,"1.86","1.86","CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 COMPLEXED WITH ESTRONE AND NADP+","MARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVRMLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHLSLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGGAGPGAEDEAGRGAVGDPELGDPPAAPQ","Homo sapiens","HSD17B1, E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1","Estradiol 17-beta-dehydrogenase 1","1","6MNE"
"6MNF",,"X-RAY DIFFRACTION",3.38,63.56,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG 4000, 0.2M imidazole malate",295,"10.1073/pnas.0505763102",,"6MNF",95.5,"2.758","2.758","Anti-HIV-1 Fab 2G12 + Man8 re-refinement","DVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"Fab 2G12, light chain","1","6MNF"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Fab 2g12, heavy chain","2","6MNF"
"6MNH",,"X-RAY DIFFRACTION",2.04,39.78,"VAPOR DIFFUSION, SITTING DROP",8.5,"31% PEG 4K, 200mM calcium chloride, 100mM bis tris propane pH 8.5",281,"10.1021/acsmedchemlett.8b00488",,"6MNH",32.94,"1.73","1.73","ULK1 Unc-51 like autophagy activating kinase in complex with inhibitor BTC","SLGGTETVGKFEFSRKDLIGHGAFAVVFKGRHREKHDLEVAVKCINKKNLAKSQTLLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHAMRTLSEDTIRLFLQQIAGAMRLLHSKGIIHRDLKPQNILLSNPAGRRANPNSIRVKIADFGFARYLQSNMMAATLCGSPMYMAPEVIMAQHYDGKADLWSIGTIVYQCLTGKAPFQAASPQDLRLFYEKNKTLVPTIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFLDASPSVRKSPPV","Homo sapiens","ULK1, KIAA0722","Serine/threonine-protein kinase ULK1","1","6MNH"
"6MNX",,"X-RAY DIFFRACTION",2.27,45.93,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MMT, 24% PEG 6000 and 1% 1,2-butanediol, pH 6.5",293,"10.1158/0008-5472.CAN-20-0448",,"6MNX",118.98,"2.2","2.2","Structural basis of impaired hydrolysis in KRAS Q61H mutant","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6MNX"
"6MO6",,"X-RAY DIFFRACTION",2.98,58.79,"VAPOR DIFFUSION, HANGING DROP",4.6,"500 uL reservoir of 20% (w/v) glycerol, 0.1 M sodium acetate trihydrate pH 4.6, 0.3-0.5 M ammonium acetate, 7-10% (w/v) PEG 4,000, 0.1% (w/v) 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), 310 uM decylubiquinone (DCQ; stock in 10% (w/v) DHPC) and 10 mM sodium thiosulfate pentahydrate. To the coverslip; apply 1 uL aliquot of 10.66% (w/v) 1-Oleoyl-rac-glycerol (monoolein; stock in ethanol) and air dry for 3 minutes. Add 1uL enzyme followed by 1uL reservoir condition (no mixing).",298,"10.1016/j.str.2019.03.002",,"6MO6",191.54,"2.59","2.59","Crystal structure of the selenomethionine-substituted human sulfide:quinone oxidoreductase","MNHYEVLVLGGGSGGITMAARMKRKVGAENVAIVEPSERHFYQPIWTLVGAGAKQLSSSGRPTASVIPSGVEWIKARVTELNPDKNCIHTDDDEKISYRYLIIALGIQLDYEKIKGLPEGFAHPKIGSNYSVKTVEKTWKALQDFKEGNAIFTFPNTPVKCAGAPQKIMYLSEAYFRKTGKRSKANIIFNTSLGAIFGVKKYADALQEIIQERNLTVNYKKNLIEVRADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLKTSPVADAAGWVDVDKETLQHRRYPNVFGIGDCTNLPTSKTAAAVAAQSGILDRTISVIMKNQTPTKKYDGYTSCPLVTGYNRVILAEFDYKAEPLETFPFDQSKERLSMYLMKADLMPFLYWNMMLRGYWGGPAFLRKLFHLGMSLEHH","Homo sapiens","SQOR, SQRDL, CGI-44","Sulfide:quinone oxidoreductase, mitochondrial","1","6MO6"
"6MO7",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, HANGING DROP",,"33% PEG 3350
150mM ammonium sulfate
100mM HEPES pH 7.5",293,"10.1016/j.bmc.2018.11.020",,"6MO7",45.92,"1.85","1.85","N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methylisoxazol-5-yl)methyl)acetamide inhibitor","SMKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKN","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6MO7"
"6MO8",,"X-RAY DIFFRACTION",2.45,49.73,"VAPOR DIFFUSION, HANGING DROP",,"29% PEG 3350
225 mM ammonium sulfate
100mM HEPES pH 7.5",293,"10.1016/j.bmc.2018.11.020",,"6MO8",45.8,"1.8","1.8","N-terminal bromodomain of human BRD2 in complex with 4,4'-(quinoline-5,7-diyl)bis(3,5-dimethylisoxazole) inhibitor","SMKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKN","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6MO8"
"6MO9",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG 3350
175mM ammonium sulfate
100mM HEPES pH8.2",293,"10.1016/j.bmc.2018.11.020",,"6MO9",45.86,"1.801","1.801","N-terminal bromodomain of human BRD2 in complex with N-cyclopentyl-7-(3,5-dimethylisoxazol-4-yl)quinoline-5-sulfonamide inhibitor","SMKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKN","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6MO9"
"6MOA",,"X-RAY DIFFRACTION",2.35,47.73,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG 1000
100mM NaTris-HCl pH 8.4",293,"10.1016/j.bmc.2018.11.020","JW4","6MOA",13.46,"1.271","1.271","C-terminal bromodomain of human BRD2 in complex with 4-(2-cyclopropyl-7-(6-methylquinolin-5-yl)-1H-benzo[d]imidazol-5-yl)-3,5-dimethylisoxazole inhibitor","LSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6MOA"
"6MOB",,"X-RAY DIFFRACTION",3.34,63.2,"VAPOR DIFFUSION, SITTING DROP",,"12 mg/mL Kit1 protein in 20 mM Tris pH 8.0, 0.25 M sodium chloride, 5 mM imidazole, 5 mM DTT, 1 mM EDTA, crystallant: 2.5 M ammonium nitrate, 0.1 M sodium acetate, pH 4.6, 5-fold molar excess DP2976, Crystal ID 204905d1",289,"10.1016/j.ccell.2019.04.006",,"6MOB",36.67,"1.8","1.8","Crystal structure of KIT1 in complex with DP2976 via co-crystallization","NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","6MOB"
,,,,,,,,,,,,,,,,,"Homo sapiens","KIT, SCFR"
"6MOM",,"X-RAY DIFFRACTION",2.57,52.2,"VAPOR DIFFUSION, SITTING DROP",8,"9.5 mg/ml IRAK4 (CID100300, Batch BOS047020B) in 20 mM Tris-HCl, pH 8.0, 1 mM DTT, with 1 mM BSI107659 (NCGC00371481) in DMSO, crystallization condition: Microlytic screen MCSG1, E10: 0.2 M ammonium tartrate dibasic, 20% PEG3350, cryoprotectant: 20% ethylene glycol with 1 mM compound, tray 286446 e10, puck: xvc2-1",289,"10.1126/scitranslmed.aaw8828","JX4","6MOM",138.08,"2.1","2.1","Crystal structure of human Interleukin-1 receptor associated Kinase 4 (IRAK 4, CID 100300) in complex with compound NCC00371481 (BSI 107591)","GSVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6MOM"
"6MOP",,"X-RAY DIFFRACTION",3.23,61.92,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3350, DL-malic acid",277,"10.1021/jacs.8b12493",,"6MOP",15.88,"1.9","1.9","Crystal Structure of the All-trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121E Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.9 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MOP"
"6MOQ",,"X-RAY DIFFRACTION",3.1,60.36,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, sodium Malonate",277,"10.1021/jacs.8b12493",,"6MOQ",15.94,"2.198","2.198","Crystal Structure of the All-trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121W Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 2.2 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIWTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MOQ"
"6MOR",,"X-RAY DIFFRACTION",3.16,61.09,"VAPOR DIFFUSION",,"PEG 3350, Sodium Malonate",277,"10.1021/jacs.8b12493",,"6MOR",15.91,"1.79","1.79","Crystal Structure of the All-Trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121Y Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.79 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIYTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MOR"
"6MOV",,"X-RAY DIFFRACTION",3.24,62.05,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, DL-malic acid",277,"10.1021/jacs.8b12493",,"6MOV",15.88,"1.752","1.752","Crystal Structure of the All-trans Retinal bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121Q Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.75 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIQTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MOV"
"6MOW",,"X-RAY DIFFRACTION",3.13,60.74,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, Sodium Malonate",277,,,"6MOW",15.59,"2.354","2.354","Crystal Structure of the apo R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121Q mutant of Human Cellular Retinoic Acid Binding Protein II at 2.3 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIQTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MOW"
"6MOX",,"X-RAY DIFFRACTION",3.16,61.13,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, BTP, Sodium Fluoride",277,"10.1021/jacs.8b12493",,"6MOX",15.84,"2.18","2.18","Crystal Structure of the All-trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Q:R59Y:L121E Human Cellular Retinoic Acid Binding Protein II Mutant in the Dark at 2.18 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKQAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MOX"
"6MOZ",,"X-RAY DIFFRACTION",3.24,62,"VAPOR DIFFUSION, HANGING DROP",7,"HEPES pH 7.5, monobasic sodium phosphate and monobasic potassium phosphate",298,"10.1016/j.bioorg.2019.02.025","JXA","6MOZ",113.45,"2.1","2.1","Structure of acid-beta-glucosidase in complex with an aromatic pyrrolidine iminosugar inhibitor","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6MOZ"
"6MP4",,"X-RAY DIFFRACTION",3,58.96,"VAPOR DIFFUSION, HANGING DROP",6.8,"1.4 M sodium malonate
0.1 M Bis Tris HCl",293,,,"6MP4",135.53,"2.502","2.502","Human liver FABP1 bound to tetrahydrocannabinol","MHHHHHHSSGVDLGTENLYFQSMSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRI","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","6MP4"
"6MP5",,"X-RAY DIFFRACTION",3.07,59.91,"VAPOR DIFFUSION, HANGING DROP",4.6,"14% (w/v) PEG 4000, 10% (w/v) glycerol, 0.1M sodium acetate trihydrate pH 4.6, 0.5M ammonium acetate + 0.1% (w/v) 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC). Apply 1uL protein then 1uL condition (no mixing) to coverslip and seal.",298,"10.1016/j.str.2019.03.002",,"6MP5",188.4,"2.99","2.99","Crystal structure of native human sulfide:quinone oxidoreductase","MNHYEVLVLGGGSGGITMAARMKRKVGAENVAIVEPSERHFYQPIWTLVGAGAKQLSSSGRPTASVIPSGVEWIKARVTELNPDKNCIHTDDDEKISYRYLIIALGIQLDYEKIKGLPEGFAHPKIGSNYSVKTVEKTWKALQDFKEGNAIFTFPNTPVKCAGAPQKIMYLSEAYFRKTGKRSKANIIFNTSLGAIFGVKKYADALQEIIQERNLTVNYKKNLIEVRADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLKTSPVADAAGWVDVDKETLQHRRYPNVFGIGDCTNLPTSKTAAAVAAQSGILDRTISVIMKNQTPTKKYDGYTSCPLVTGYNRVILAEFDYKAEPLETFPFDQSKERLSMYLMKADLMPFLYWNMMLRGYWGGPAFLRKLFHLGMSLEH","Homo sapiens","SQOR, SQRDL, CGI-44","Sulfide:quinone oxidoreductase, mitochondrial","1","6MP5"
"6MP6","3.54","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.48120",,"6MP6",170.58,"3.54",,"Cryo-EM structure of the human neutral amino acid transporter ASCT2","MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIVFGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFARLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLMMKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVTATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSCTVLNVEGDALGAGLLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESVM","Homo sapiens","SLC1A5, ASCT2, M7V1, RDR, RDRC","Neutral amino acid transporter B(0)","1","6MP6"
"6MPB","3.84","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.48120",,"6MPB",171.02,"3.84",,"Cryo-EM structure of the human neutral amino acid transporter ASCT2","MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIVFGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFARLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLMMKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVTATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSCTVLNVEGDALGAGLLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESVM","Homo sapiens","SLC1A5, ASCT2, M7V1, RDR, RDRC","Neutral amino acid transporter B(0)","1","6MPB"
"6MPK",,"X-RAY DIFFRACTION",3.15,60.96,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, D-Malic acid",277,"10.1021/jacs.8b12493",,"6MPK",16.16,"1.58","1.58","Crystal Structure of the 13-cis Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121E:A32Y Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.58 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIYVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MPK"
"6MQ3",,"X-RAY DIFFRACTION",4.11,70.04,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES pH 6.5, 5% Tacsimate pH 7, 10% 1,4-Dioxane, 14% PEGGMME 5000",298,"10.1038/s41589-019-0271-0",,"6MQ3",227.85,"3.56914708689","3.56914708689","Structure of Cysteine-free Human Insulin-Degrading Enzyme in complex with Substrate-selective Macrocycle Inhibitor 63","MNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLQHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","6MQ3"
"6MQ5",,"X-RAY DIFFRACTION",2.01,33.52,"VAPOR DIFFUSION, HANGING DROP",6.5,"equal volume of 10 mg/ml hCLASP1 TOG1 and well solution containing 30% PEG600, 100mM MES, pH 6.5, 10% glycerol were mixed together and equilibrated over 1 ml of well solution, crystals that were originally crystallized in 1.5 M sodium malonate, pH 6.25, 18C, were used for microseeding",291,"10.1371/journal.pone.0219823",,"6MQ5",58.03,"2.146","2.146","Structure of human CLASP1 TOG1","MEPRMESCLAQVLQKDVGKRLQVGQELIDYFSDKQKSADLEHDQTMLDKLVDGLATSWVNSSNYKVVLLGMDILSALVTRLQDRFKAQIGTVLPSLIDRLGDAKDSVREQDQTLLLKIMDQAANPQYVWDRMLGGFKHKNFRTREGICLCLIATLNASGAQTLTLSKIVPHICNLLGDPNSQVRDAAINSLVEIYRHVGERVRADLSKKGLPQSRLNVIFTKFDEVQKSGNMIQSANDKNFDDEDSVDGNRPSSASS","Homo sapiens","CLASP1, KIAA0622, MAST1","CLIP-associating protein 1","1","6MQ5"
"6MQ6",,"X-RAY DIFFRACTION",3.01,59.1,"MICROBATCH",10,"100 mM sodium thiosulfate, 100 mM CAPS, pH 10.0, 200 mM sodium chloride, 20% w/v PEG8000",277,"10.1021/jacs.8b07994","H7P","6MQ6",97.16,"3.05","3.05","Mapping the binding trajectory of a suicide inhibitor in human indoleamine 2,3-dioxygenase 1","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6MQ6"
"6MQ7",,"X-RAY DIFFRACTION",2.27,45.72,"VAPOR DIFFUSION, HANGING DROP",8.25,"equal volume of 10 mg/ml hCLASP1 TOG2 and well solution containing 22% PEG3350, 200mM Sodium citrate, pH 8.25 were mixed together and equilibrated over 1 ml of well solution., VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,"10.1371/journal.pone.0219823",,"6MQ7",61.49,"1.78","1.78","Crystal structure of CLASP1 TOG2 domain at 1.78A resolution","GSHMGSKSSAAKEGAGAVDEEDFIKAFDDVPVVQIYSSRDLEESINKIREILSDDKHDWEQRVNALKKIRSLLLAGAAEYDNFFQHLRLLDGAFKLSAKDLRSQVVREACITLGHLSSVLGNKFDHGAEAIMPTIFNLIPNSAKIMATSGVVAVRLIIRHTHIPRLIPVITSNCTSKSVAVRRRCFEFLDLLLQEWQTHSLERHISVLAETIKKGIHDADSEARIEARKCYWGFHSHFSREAEHLYHTLESSYQKALQSHLKNSDSIVSLPQS","Homo sapiens","CLASP1, KIAA0622, MAST1","CLIP-associating protein 1","1","6MQ7"
"6MQ9",,"X-RAY DIFFRACTION",2.06,40.42,"VAPOR DIFFUSION, SITTING DROP",8.5,"10% w/v PEG 8000, 20% v/v ethylene glycol,  0.1 M bicine/Trizma base pH 8.5, 20mM of each: 1,6-hexanediol, 1-butanol, (RS)-1,2-propanediol, 2-propanol, 1,4-butanediol, 1,3-propanediol",291,"10.1107/S2052252520002973",,"6MQ9",138.57,"1.86","1.86","Crystal Structure of GTPase Domain of Human Septin 12 in complex with GMPPNP","MGSSHHHHHHSSGLVPRGSHMGFEFNIMVVGQSGLGKSTMVNTLFKSKVWKSNPPGLGVPTPQTLQLHSLTHVIEEKGVKLKLTVTDTPGFGDQINNDNCWDPILGYINEQYEQYLQEEILITRQRHIPDTRVHCCVYFVPPTGHCLRPLDIEFLQRLCRTVNVVPVIARADSLTMEEREAFRRRIQQNLRTHCIDVYPQMCFDEDINDKILNSKLRDRIPFAVVGADQEHLVNGRCVLGRKTKWGIIEVENMAHCEFPLLRDLLIRSHLQDLKDITHNIHYENYRVIRLNESHL","Homo sapiens","SEPT12, SEPTIN12","Septin-12","1","6MQ9"
"6MQB",,"X-RAY DIFFRACTION",2.1,41.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"10% w/v PEG 8000, 20% v/v ethylene glycol,  0.1 M MES/imidazole pH 6.5 and 20mM of each: sodium formate, ammonium acetate, trisodium citrate, sodium potassium l-tartrate, sodium oxamate",291,"10.1107/S2052252520002973",,"6MQB",34.64,"2.12","2.12","Crystal Structure of GTPase Domain of Human Septin 12 in complex with GMPPNP in Space Group C2221","MGSSHHHHHHSSGLVPRGSHMGFEFNIMVVGQSGLGKSTMVNTLFKSKVWKSNPPGLGVPTPQTLQLHSLTHVIEEKGVKLKLTVTDTPGFGDQINNDNCWDPILGYINEQYEQYLQEEILITRQRHIPDTRVHCCVYFVPPTGHCLRPLDIEFLQRLCRTVNVVPVIARADSLTMEEREAFRRRIQQNLRTHCIDVYPQMCFDEDINDKILNSKLRDRIPFAVVGADQEHLVNGRCVLGRKTKWGIIEVENMAHCEFPLLRDLLIRSHLQDLKDITHNIHYENYRVIRLNESHL","Homo sapiens","SEPT12, SEPTIN12","Septin-12","1","6MQB"
"6MQG",,"X-RAY DIFFRACTION",2.56,51.94,"VAPOR DIFFUSION, HANGING DROP",8.2,"1.8 M Na/K Phosphate, pH 8.2",293,"10.1074/jbc.RA119.009131",,"6MQG",19.51,"1.5","1.5","Crystal structure of KRAS V14I-GDP demonstrating open switch 1 conformation - Form 1","EYKLVVVGAGGIGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6MQG"
"6MQI",,"X-RAY DIFFRACTION",3.22,61.85,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, DL-malic acid",277,"10.1021/jacs.8b12493",,"6MQI",15.88,"1.87","1.87","Crystal Structure of the All-trans Retinal bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121Q mutant of Human Cellular Retinoic Acid Binding Protein II Irradiated with 400 nm Laser for 5 minutes at 1.87 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIQTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MQI"
"6MQJ",,"X-RAY DIFFRACTION",3.23,61.9,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, DL-malic acid",277,"10.1021/jacs.8b12493",,"6MQJ",15.88,"2.125","2.125","Crystal Structure of the All-Trans Retinal bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121Q mutant of Human Cellular Retinoic Acid Binding Protein II Irradiated with 532 nm Laser for 10 minutes at 2.1 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIQTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MQJ"
"6MQK",,"X-RAY DIFFRACTION",1.98,37.78,"VAPOR DIFFUSION, SITTING DROP",8.5,"12.5% w/v PEG 1000, 12.5% w/v PEG 3350, 12.5% v/v MPD, 0.1 M bicine/Trizma base pH 8.5, 30mM magnesium chloride, 30mM calcium chloride",291,"10.1107/S2052252520002973",,"6MQK",138.25,"2.19","2.19","Crystal Structure of GTPase Domain of Human Septin 12 in complex with GDP","MGSSHHHHHHSSGLVPRGSHMGFEFNIMVVGQSGLGKSTMVNTLFKSKVWKSNPPGLGVPTPQTLQLHSLTHVIEEKGVKLKLTVTDTPGFGDQINNDNCWDPILGYINEQYEQYLQEEILITRQRHIPDTRVHCCVYFVPPTGHCLRPLDIEFLQRLCRTVNVVPVIARADSLTMEEREAFRRRIQQNLRTHCIDVYPQMCFDEDINDKILNSKLRDRIPFAVVGADQEHLVNGRCVLGRKTKWGIIEVENMAHCEFPLLRDLLIRSHLQDLKDITHNIHYENYRVIRLNESHL","Homo sapiens","SEPT12, SEPTIN12","Septin-12","1","6MQK"
"6MQL",,"X-RAY DIFFRACTION",2.21,44.47,"VAPOR DIFFUSION, SITTING DROP",8.5,"10% w/v PEG 4000, 20% v/v glycerol, 0.1 M bicine/Trizma base pH 8.5, 30mM of each: diethyleneglycol, triethyleneglycol, tetraethyleneglycol, pentaethyleneglycol",291,,,"6MQL",34.59,"2.17","2.17","Crystal Structure of GTPase Domain of Human Septin 12 Mutant T89M","MGSSHHHHHHSSGLVPRGSHMGFEFNIMVVGQSGLGKSTMVNTLFKSKVWKSNPPGLGVPTPQMLQLHSLTHVIEEKGVKLKLTVTDTPGFGDQINNDNCWDPILGYINEQYEQYLQEEILITRQRHIPDTRVHCCVYFVPPTGHCLRPLDIEFLQRLCRTVNVVPVIARADSLTMEEREAFRRRIQQNLRTHCIDVYPQMCFDEDINDKILNSKLRDRIPFAVVGADQEHLVNGRCVLGRKTKWGIIEVENMAHCEFPLLRDLLIRSHLQDLKDITHNIHYENYRVIRLNESHL","Homo sapiens","SEPT12, SEPTIN12","Septin-12","1","6MQL"
"6MQN",,"X-RAY DIFFRACTION",2.05,39.87,"VAPOR DIFFUSION, HANGING DROP",8.2,"1.8M Na/K Phosphate pH 8.2",293,"10.1074/jbc.RA119.009131",,"6MQN",59.19,"1.6","1.6","Crystal structure of KRAS V14I-GDP demonstrating disorder switch 1 conformation - Form 2","MTEYKLVVVGAGGIGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6MQN"
"6MQT",,"X-RAY DIFFRACTION",2.12,41.87,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Sodium acetate trihydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% w/v Polyethylene glycol 4,000",293,,,"6MQT",155.55,"1.498","1.498","HRAS G12S in complex with GDP","AMTEYKLVVVGASGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","6MQT"
"6MQW",,"X-RAY DIFFRACTION",3.18,61.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3350, DL-malic acid",277,"10.1021/jacs.8b12493",,"6MQW",15.88,"2.09","2.09","Crystal Structure of All-trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121E Human Cellular Retinoic Acid Binding Protein II Irradiated with 400 nm laser (30 seconds) and subsequently dark adapted (10 minutes) at 2.1 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MQW"
"6MQX",,"X-RAY DIFFRACTION",3.17,61.16,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, DL-malic acid",277,"10.1021/jacs.8b12493",,"6MQX",16.06,"2.01","2.01","Crystal Structure of All-trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121E Human Cellular Retinoic Acid Binding Protein II Irradiated with 400 nm Laser (30 seconds) and Subsequently Dark Adapted (25 minutes) at 2.0 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MQX"
"6MQY",,"X-RAY DIFFRACTION",3.15,60.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3350, D-Malic acid",277,"10.1021/jacs.8b12493",,"6MQY",16.16,"1.9","1.9","Crystal Structure of the 13-cis Product of All-trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121E Mutant of Human Cellular Retinoic Acid Binding Protein II Irradiated with 400 nm Laser (30 seconds) at 1.9 Angstrom","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MQY"
"6MQZ",,"X-RAY DIFFRACTION",3.14,60.85,"EVAPORATION, RECRYSTALLIZATION",6.5,"PEG 3350, DL-malic acid",277,"10.1021/jacs.8b12493",,"6MQZ",15.97,"2.07","2.07","Crystal Structure of the 13-cis Product of the All-trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121E Mutant of Human Cellular Retinoic Acid Binding Protein II Irradiated with 400 nm Laser (5 minutes) at 2.07 Angstrom","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MQZ"
"6MR0",,"X-RAY DIFFRACTION",3.16,61.05,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, BTP, Sodium Fluoride",277,"10.1021/jacs.8b12493",,"6MR0",15.84,"2.649","2.649","Crystal Structure of the All-trans Retinal Bound R111K:Y134F:T54V:R132Q:P39Q:R59Y:L121E Human Cellular Retinoic Acid Binding Protein II Mutant After 5 Minutes UV irradiation at 2.6 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKQAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6MR0"
"6MS9",,"X-RAY DIFFRACTION",2.04,39.83,"VAPOR DIFFUSION, HANGING DROP",8.2,"1.8 M Na/K-phosphate pH 8.3",293,"10.1002/bdr2.1647",,"6MS9",59.19,"1.49","1.49","GDP-bound KRAS P34R mutant","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6MS9"
"6MSA",,"X-RAY DIFFRACTION",2.1,41.48,"VAPOR DIFFUSION",,"5% Tascimate pH7.0, 100mM HEPES pH7, 10% PMME5000",277,"10.1016/j.bmcl.2018.12.029","JY4","6MSA",77.15,"2.06","2.06","Novel, potent, selective and brain penetrant phosphodiesterase 10A inhibitors","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6MSA"
"6MSC",,"X-RAY DIFFRACTION",2.15,42.71,"VAPOR DIFFUSION",,"5% Tascimate pH7.0, 100mM HEPES pH7, 10% PMME5000",277,"10.1016/j.bmcl.2018.12.029","JY7","6MSC",77.55,"2.36","2.36","Novel, potent, selective and brain penetrant phosphodiesterase 10A inhibitors","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWIS","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","6MSC"
"6MSM","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1815287115",,"6MSM",176.07,"3.2",,"Phosphorylated, ATP-bound human cystic fibrosis transmembrane conductance regulator (CFTR)","XXXXXXXXXXXXXXXXX","Homo sapiens","CFTR, ABCC7","Piece of Molecule-1","2","6MSM"
,,,,,,,,,,,,,,,,"MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDQPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRLSNSLEVLFQ","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","6MSM"
"6MST","2.7","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-09033-z",,"6MST",89.77,"2.7",,"Cryo-EM structure of human AA amyloid fibril","SFFSFLGEAFDGARDMWRAYSDMREANYIGSDKYFHARGNYDAAKRGPGGVWAAEAISDARENIQR","Homo sapiens","SAA1","Serum amyloid A-1 protein","1","6MST"
"6MSV",,"X-RAY DIFFRACTION",2.48,50.44,"VAPOR DIFFUSION, HANGING DROP",,"2.0 M Ammonium Sulfate",293,,,"6MSV",116.58,"2.4","2.4","Structure of the 6th type III domain from human fibronectin","GSGLQPGSSIPPYNTEVTETTIVITWTPAPRIGFKLGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLRDGQERDAPIVNKVVTP","Homo sapiens","FN1, FN","Fibronectin","1","6MSV"
"6MSY",,"X-RAY DIFFRACTION",3.1,60.37,"VAPOR DIFFUSION, SITTING DROP",6.6,"27% Peg 4000, 0.05M sodium acetate",295,"10.1073/pnas.0505763102",,"6MSY",47.9,"1.999","1.999","Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement","DVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"Fab 2G12, light chain","1","6MSY"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS","Homo sapiens",,"Fab 2g12, heavy chain","2","6MSY"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6MT0",,"X-RAY DIFFRACTION",3.4,63.84,"VAPOR DIFFUSION, HANGING DROP",8,"1.0M LiCl, 0.1M TRIS pH8.0, 20% PEG6K",277,"10.1021/acs.jmedchem.8b01733",,"6MT0",33.65,"2.2","2.2","Crystal structure of human Pim-1 kinase in complex with a quinazolinone-pyrrolodihydropyrrolone inhibitor","MAHHHHHHDEVDGPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6MT0"
"6MTA",,"X-RAY DIFFRACTION",1.93,41.33,"VAPOR DIFFUSION, HANGING DROP",8.2,"1.8 M Na/K-phosphate pH 8.2-8.5",293,"10.1002/bdr2.1647",,"6MTA",59.64,"2.15","2.15","KRAS P34R mutant structure in complex with GTP analogue","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDRTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6MTA"
"6MTR",,"X-RAY DIFFRACTION",2.86,57.04,"VAPOR DIFFUSION, HANGING DROP",5.6,"34% PEG 4000, 0.2M Ammonium Acetate, 0.1M Na Citrate 5.6",293,"10.1016/j.immuni.2019.02.008",,"6MTR",47.26,"1.798","1.798","Crystal structure of VRC43.01 Fab","QVQLQESGPGLVKATGTLSLNCAVSGASISSSNWWNWVRQSPGKGLEWIGEIYHSGTVTYNPSLKTRVTISVDKSRNQFSLKLTSVTAADTAKYYCAKRWDSSGWFSRHSYDYAVDVWGRGTTVIVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Antibody VRC43.01 Fab heavy chain","1","6MTR"
,,,,,,,,,,,,,,,,"QTVVTQEPSLTVSPGGTVTLTCASSAGAVTSGHCPSWFQQKPGQVPRALIYCTNNRQSWTPARFSGSLRGGKAALTLSGVQPDDEGDYYCLVQYSGVWVFGGGTKLTVLSQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Antibody VRC43.01 Fab light chain","2","6MTR"
"6MTS",,"X-RAY DIFFRACTION",3.02,59.28,"VAPOR DIFFUSION, HANGING DROP",7.4,"40% PEG 400, 8% PEG8K, 0.1M HEPES 7.4",293,"10.1016/j.immuni.2019.02.008",,"6MTS",47.48,"2.437","2.437","Crystal structure of VRC43.03 Fab","QVQLQESGPGLMKPSGTLFLTCAVSGASISSSNWWNWVRQPPGKGLEWIGEIYHDGSVSRNPFLQSRITMSVDKSKNQFSLKLTSVTAADTAVYYCAKRWDSSGWITRHTYDYGVDVWGRGTSVFVASASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Antibody VRC43.03 Fab heavy chain","1","6MTS"
,,,,,,,,,,,,,,,,"QTVVTQEPSLTVSPGGTVTLTCASSAGAVTSDFSPNWFLQKPGQVPRSLIYNTDKRHSWTPARFSGSLIGGKAALTLSGAQPDDEGDYYCLVHYRGAWVFGGGTRLTVLSQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Antibody VRC43.03 Fab light chain","2","6MTS"
"6MTW",,"X-RAY DIFFRACTION",2.57,52.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM sodium cacodylate pH 5.6, 6% isopropanol, 250 mM zinc acetate, 2 mM 1-hydroxy-2-azelaoyl-sn-glycero-3-phosphocholine",277,"10.1021/acs.biochem.8b01124",,"6MTW",87.72,"1.999","1.999","Lysosomal Phospholipase A2 in complex with Zinc","GAGRHPPVVLVPGDLGNQLEAKLDKPTVVHYLCSKKTESYFTIWLNLELLLPVIIDCWIDNIRLVYNKTSRATQFPDGVDVRVPGFGKTFSLEFLDPSKSSVGSYFHTMVESLVGWGYTRGEDVRGAPYDWRRAPNENGPYFLALREMIEEMYQLYGGPVVLVAHSMGNMYTLYFLQRQPQAWKDKYIRAFVSLGAPWGGVAKTLRVLASGDNNRIPVIGPLKIREQQRSAVSTSWLLPYNYTWSPEKVFVQTPTINYTLRDYRKFFQDIGFEDGWLMRQDTEGLVEATMPPGVQLHCLYGTGVPTPDSFYYESFPDRDPKICFGDGDGTVNLKSALQCQAWQSRQEHQVLLQELPGSEHIEMLANATTLAYLKRVLLGP","Homo sapiens","PLA2G15, LYPLA3, UNQ341/PRO540","Group XV phospholipase A2","1","6MTW"
"6MU3",,"X-RAY DIFFRACTION",2.65,53.52,"VAPOR DIFFUSION, SITTING DROP",6.6,"20% Peg 4000, 0.2M sodium tartrate",295,"10.1073/pnas.0505763102",,"6MU3",95.69,"2.327","2.327","Anti-HIV-1 Fab 2G12 + Man7 re-refinement","DVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"Fab 2G12, light chain","1","6MU3"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS","Homo sapiens",,"Fab 2G12, heavy chain","2","6MU3"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6MUB",,"X-RAY DIFFRACTION",2.68,54.13,"VAPOR DIFFUSION, SITTING DROP",6.8,"1.6M sodium/potassium phosphate",295,"10.1073/pnas.0505763102",,"6MUB",96.22,"2.503","2.503","Anti-HIV-1 Fab 2G12 + Man5 re-refinement","DVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"Fab 2G12, light chain","1","6MUB"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Fab 2G12, heavy chain","2","6MUB"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6MV1",,"X-RAY DIFFRACTION",2.61,52.9,"VAPOR DIFFUSION, SITTING DROP",7,"10% (w/v) PEG 6000, 0.1 M Hepes, 0.2 M NDSB-201",291,"10.1107/S205979831900754X",,"6MV1",43.57,"2.15","2.15","2.15A resolution structure of the CS-b5R domains of human Ncb5or (NAD+ form)","MGHHHHHHMGPSYPSYDWFQTDSLVTIAIYTKQKDINLDSIIVDHQNDSFRAETIIKDCLYLIHIGLSHEVQEDFSVRVVESVGKIEIVLQKKENTSWDFLGHPLKNHNSLIPRKDTGLYYRKCQLISKEDVTHDTRLFCLMLPPSTHLQVPIGQHVYLKLPITGTEIVKPYTPVSGSLLSEFKEPVLPNNKYIYFLIKIYPTGLFTPELDRLQIGDFVSVSSPEGNFKISKFQELEDLFLLAAGTGFTPMVKILNYALTDIPSLRKVKLMFFNKTEDDIIWRSQLEKLAFKDKRLDVEFVLSAPISEWNGKQGHISPALLSEFLKRNLDKSKVLVCICGPVPFTEQGVRLLHDLNFSKNEIHSFTA","Homo sapiens","CYB5R4, NCB5OR","Cytochrome b5 reductase 4","1","6MV1"
"6MV2",,"X-RAY DIFFRACTION",2.63,53.19,"VAPOR DIFFUSION, SITTING DROP",7,"10% (w/v) PEG 6000, 0.1 M Hepes, 0.3 M NDSB-195",291,"10.1107/S205979831900754X",,"6MV2",43.65,"2.05","2.05","2.05A resolution structure of the CS-b5R domains of human Ncb5or (NADP+ form)","MGHHHHHHMGPSYPSYDWFQTDSLVTIAIYTKQKDINLDSIIVDHQNDSFRAETIIKDCLYLIHIGLSHEVQEDFSVRVVESVGKIEIVLQKKENTSWDFLGHPLKNHNSLIPRKDTGLYYRKCQLISKEDVTHDTRLFCLMLPPSTHLQVPIGQHVYLKLPITGTEIVKPYTPVSGSLLSEFKEPVLPNNKYIYFLIKIYPTGLFTPELDRLQIGDFVSVSSPEGNFKISKFQELEDLFLLAAGTGFTPMVKILNYALTDIPSLRKVKLMFFNKTEDDIIWRSQLEKLAFKDKRLDVEFVLSAPISEWNGKQGHISPALLSEFLKRNLDKSKVLVCICGPVPFTEQGVRLLHDLNFSKNEIHSFTA","Homo sapiens","CYB5R4, NCB5OR","Cytochrome b5 reductase 4","1","6MV2"
"6MV4",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG4000, 1 M NaCl, 0.2 M Ammonium Sulfate, 5 mM Calcium Chloride",293,"10.1111/jth.14401",,"6MV4",33.18,"1.37","1.37","CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR IXa","VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT","Homo sapiens","F9","Coagulation factor IX","1","6MV4"
,,,,,,,,,,,,,,,,"MTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQ","Homo sapiens","F9","Coagulation factor IX","2","6MV4"
"6MV6",,"X-RAY DIFFRACTION",2.06,40.39,"VAPOR DIFFUSION",,"Peg 4000, 50mM Sodium phosphate",280,"10.1021/acs.biochem.9b00888",,"6MV6",14.75,"1.5","1.5","Crystal structure of RNAse 6","AKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLHDSFQNVAAVCDLLSIVCKNRRHNCHQSSKPVNMTDCRLTSGKYPQCRYSAAAQYKFFIVACDPPQKSDPPYKLVPVHLDSIL","Homo sapiens","RNASE6, RNS6","Ribonuclease K6","1","6MV6"
"6MV7",,"X-RAY DIFFRACTION",1.78,30.71,"VAPOR DIFFUSION",,"PEG 4000, 50mM Sodium phosphate",298,"10.1021/acs.biochem.9b00888",,"6MV7",15.15,"2.59","2.59","Crystal structure of RNAse 6","MWPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLHDSFQNVAAVCDLLSIVCKNRRHNCHQSSKPVNMTDCRLTSGKYPQCRYSAAAQYKFFIVACDPPQKSDPPYKLVPVHLDSIL","Homo sapiens","RNASE6, RNS6","Ribonuclease K6","1","6MV7"
"6MV8",,"X-RAY DIFFRACTION",2.2,44.05,"VAPOR DIFFUSION",,"30%PEG3350
0.1M HEPES",292,,,"6MV8",152.06,"1.95","1.95","LDHA structure in complex with inhibitor 14","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6MV8"
"6MVA",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION",,"30% PEG 3350 
0.1M HEPES",292,,,"6MVA",152.23,"2.02","2.02","LDHA structure in complex with inhibitor 14","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6MVA"
"6MVD",,"X-RAY DIFFRACTION",3.93,68.74,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.25 M lithium sulfate, 0.1 M Tris pH 8.5, and 16% PEG 3350",293,"10.7554/eLife.41604",,"6MVD",90.38,"3.1","3.1","Crystal structure of Lecithin:cholesterol acyltransferase (LCAT) in complex with isopropyl dodec-11-enylfluorophosphonate (IDFP) and a small molecule activator","HTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAHHHHHH","Homo sapiens","LCAT","Phosphatidylcholine-sterol acyltransferase","1","6MVD"
"6MW7",,"X-RAY DIFFRACTION",2.97,58.57,"VAPOR DIFFUSION, SITTING DROP",,"25 mM Bis Tris Propane pH 6.8, 50mM Ammonium sulfate, 5% glycerol, 7.5% PEG 8000, 5mM DTT",293,"10.1038/s42003-019-0499-y",,"6MW7",263.23,"2.194","2.194","Crystal structure of ATPase module of SMCHD1 bound to ATP","GSAAAGHRTVYLFDRREKESELGDRPLQVGERSDYAGFRACVCQTLGISPEEKFVITTTSRKEITCDNFDETVKDGVTLYLLQSVNQLLLTATKERIDFLPHYDTLVKSGMYEYYASEGQNPLPFALAALIDNSLSATSRNIGVRRIQIKLLFDETQGKPAVAVIDNGRGMTSKQLNNWAVYRLSKFTRQGDFESDHSGYVRPVPVPRSLNSDISYFGVGGKQAVFFVGQSARMISKPADSQDVHELVLSKEDFEKKEKNKEAIYSGYIRNRKPSDSVHITNDDERFLHHLIIEEKEKDSFTAVVITGVQPEHIQYLKNYFHLWTRQLAHIYHYYIHGPKGNEIRTSKEVEPFNNIDIEISMFEKGKVPKIVNLREIQDDMQTLYVNTAADSFEFKAHVEGDGVVEGIIRYHPFLYDRETYPDDPCFPSKLKDEDDEDDCFILEKAARGKRPIFECFWNGRLIPYTSVEDFDWCTPPKKRGLAPIECYNRISGALFTNDKFQVSTNKLTFMDLELKLKDKNTLFTRILNGQEQRMKIDREFALWLKDCHEKYDKQIKFTLFK","Homo sapiens","SMCHD1, KIAA0650","Structural maintenance of chromosomes flexible hinge domain-containing protein 1","1","6MW7"
"6MWE",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",4.6,"JCSG+ screen e4: 1.26M ammonium sulphate: 200mM lithium sulphate, 100mM Tris pH 8.5: cryo: 25% EG in 3 steps",290,"10.1158/1535-7163.MCT-17-0241",,"6MWE",74,"2.05","2.05","CRYSTAL STRUCTURE OF TIE2 IN COMPLEX WITH DECIPERA COMPOUND DP1919","KNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA","Homo sapiens","TEK, TIE2, VMCM, VMCM1","Angiopoietin-1 receptor","1","6MWE"
"6MX0",,"X-RAY DIFFRACTION",2.01,38.68,"VAPOR DIFFUSION",8,"31.0 v/v PEG 400, 0.1 M Tris hydrochloride, 0.2 M calcium chloride",277,"10.1021/acsmedchemlett.8b00466",,"6MX0",43.1,"1.73","1.73","Crystal structure of human STING apoprotein (G230A, H232R, R293Q)","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTADRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCQTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","6MX0"
"6MX3",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION",,"33.0 v/v PEG 400
0.1 M Tris hydrochloride pH 8.0
0.2 M calcium chloride",277,"10.1021/acsmedchemlett.8b00466",,"6MX3",43.96,"1.362","1.362","Crystal structure of human STING (G230A, H232R, R293Q) in complex with Compound 1","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTADRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCQTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","6MX3"
"6MX8",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS HCl pH 8.5, 19-27% PEG 3350, 2 mM TCEP",277,"10.1021/acs.jmedchem.6b00306","6GY","6MX8",35.07,"1.96","1.96","Crystal structure of anaplastic lymphoma kinase (ALK) bound by Brigatinib","PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","6MX8"
"6MXE",,"X-RAY DIFFRACTION",1.97,37.44,"VAPOR DIFFUSION",8,"0.2 M CaCl2
29.0 v/v PEG 400
0.1 M TRIS
0.002 M DTT",277,"10.1021/acsmedchemlett.8b00466",,"6MXE",44.18,"2.47","2.47","Crystal structure of human STING (G230A, H232R, R293Q) in complex with Compound 18","SVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTADRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCQTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEV","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","6MXE"
"6MXQ",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2020.01.001",,"6MXQ",15.52,,,"Solution structure of a c-JUN 5' UTR stem-loop associated with specialized cap-dependent translation initiation","GGCAGUAUAGUCCGAACUGCAACUUCGGUUCACCUUCUCUCUAACUGCC","Homo sapiens",,"RNA C-JUN TL","1","6MXQ"
"6MXX",,"X-RAY DIFFRACTION",3.57,65.55,"VAPOR DIFFUSION, HANGING DROP",7,"1 M sodium formate; 0.1 M Bis-Tris propane, pH 7.0",293,,"K6P","6MXX",143.43,"2.298","2.298","Structure of 53BP1 tandem Tudor domains in complex with small molecule UNC2991","GHMNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLG","Homo sapiens","TP53BP1","TP53-binding protein 1","1","6MXX"
"6MXY",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M sodium citrate tribasic, pH 5.6; 1M ammonium phosphate monobasic",295,,"K6M","6MXY",28.67,"1.624","1.624","Structure of 53BP1 tandem Tudor domains in complex with small molecule UNC3351","GHMNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLG","Homo sapiens","TP53BP1","TP53-binding protein 1","1","6MXY"
"6MXZ",,"X-RAY DIFFRACTION",3.61,65.96,"VAPOR DIFFUSION, HANGING DROP",7,"2 M sodium formate; 0.1 M bis-tris propane, pH 7.0",295,,"K6S","6MXZ",141.15,"2.5","2.5","Structure of 53BP1 Tudor domains in complex with small molecule UNC3474","GHMNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSEDEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLG","Homo sapiens","TP53BP1","TP53-binding protein 1","1","6MXZ"
"6MY0",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.5 M sodium/potassium phosphate, pH 6.0",295,,,"6MY0",27.82,"2.2","2.2","Structure of 53BP1 Tandem Tudor domains with E1549P and D1550N mutations","GHMNSFVGLRVVAKWSSNGYFYSGKITRDVGAGKYKLLFDDGYECDVLGKDILLCDPIPLDTEVTALSPNEYFSAGVVKGHRKESGELYYSIEKEGQRKWYKRMAVILSLEQGNRLREQYGLG","Homo sapiens","TP53BP1","TP53-binding protein 1","1","6MY0"
"6MYF",,"X-RAY DIFFRACTION",1.93,36.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Citric acid pH 3.5, 25% (w/v) PEG 3350",291,"10.1083/jcb.201811114",,"6MYF",9.9,"1.6","1.6","Crystal structure of free human Scribble PDZ1 domain","GAMGEELTLTILRQTGGLGISIAGGKGSTPYKGDDEGIFISRVSEEGPAARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAVQMRVWRER","Homo sapiens","SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL","Protein scribble homolog","1","6MYF"
"6MYZ",,"X-RAY DIFFRACTION",2.47,50.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",291,,,"6MYZ",104.83,"1.661","1.661","Crystal structure of Tdp1 catalytic domain in complex with compound XZ520","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6MYZ"
"6MZ0",,"X-RAY DIFFRACTION",2.43,49.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",291,,,"6MZ0",104.75,"1.969","1.969","Crystal structure of Tdp1 catalytic domain in complex with compound XZ530","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6MZ0"
"6MZQ",,"X-RAY DIFFRACTION",2.26,45.46,"VAPOR DIFFUSION, HANGING DROP",,"MPEG 5000, sodium cacodylate, ammonium sulfate",291,"10.1002/cmdc.201800719","TZ0","6MZQ",71.54,"2","2","TAS-120 in reversible binding mode with FGFR1","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6MZQ"
"6MZW",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION, HANGING DROP",,"MPEG 5000, ammonium sulfate, sodium cacodylate",291,"10.1002/cmdc.201800719","TZ0","6MZW",71.7,"2.2","2.2","TAS-120 covalent complex with FGFR1","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6MZW"
"6N0B",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, SITTING DROP",,"10% w/v PEG 4000, 20% v/v glycerol, 0.1 M MOPS/HEPES-Na pH 7.5, and 20mM of each sodium formate, ammonium acetate, trisodium citrate,  sodium potassium
l-tartrate, sodium oxamate",291,"10.1016/j.jsb.2019.04.015",,"6N0B",132.8,"1.739","1.739","Structure of GTPase Domain of Human Septin 7 at High Resolution","MGSSHHHHHHSQDPGFEFTLMVVGESGLGKSTLINSLFLTDLYSPEYPGPSHRIKKTVQVEQSKVLIKEGGVQLLLTIVDTPGFGDAVDNSNCWQPVIDYIDSKFEDYLNAESRVNRRQMPDNRVQCCLYFIAPSGHGLKPLDIEFMKRLHEKVNIIPLIAKADTLTPEECQQFKKQIMKEIQEHKIKIYEFPETDDEEENKLVKKIKDRLPLAVVGSNTIIEVNGKRVRGRQYPWGVAEVENGEHCDFTILRNMLIRTHMQDLKDVTNNVHYENYRSRKLAAVT","Homo sapiens","SEPT7, CDC10, SEPTIN7","Septin-7","1","6N0B"
"6N0D",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",291,,,"6N0D",104.75,"1.453","1.453","Crystal structure of Tdp1 catalytic domain in complex with compound XZ575","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6N0D"
"6N0J",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes, pH 7.5, 8% Ethylene Glycol, 20% PEG 8000",298,,,"6N0J",34.06,"1.79","1.79","The complex of CCG-222740 bound to pirin","MRGSHHHHHHGSGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","PIR","Pirin","1","6N0J"
"6N0K",,"X-RAY DIFFRACTION",2.27,45.91,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes pH 7.5, 8% Ethylene Glycol, 20% PEG 8000",295,,,"6N0K",34.21,"1.46","1.46","The complex of CCG-257081 bound to pirin","MRGSHHHHHHGSGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","PIR","Pirin","1","6N0K"
"6N0M",,"X-RAY DIFFRACTION",4.38,71.9,"VAPOR DIFFUSION, HANGING DROP",,"1.35M Na malonate pH 6.5, 0.1M Mes pH 6.0",295,"10.1038/s41598-019-40693-5",,"6N0M",238.2,"3.3","3.3","CRYSTAL STRUCTURE OF SESTRIN2 IN COMPLEX WITH NV-0005138","GLEALMSSGRVDNLAVVMGLHPDYFTSFWRLHYLLLHTDGPLASSWRHYIAIMAAARHQCSYLVGSHMAEFLQTGGDPEWLLGLHRAPEKLRKLSEINKLLAHRPWLITKEHIQALLKTGEHTWSLAELIQALVLLTHCHSLSSFVFGCGILPEGDADGSPAPQAPTPPSEQSSPPSRDPLNNSGGFESARDVEALMERMQQLQESLLRDEGTSQEEMESRFELEKSESLLVTPSADILEPSPHPDMLCFVEDPTFGYEDFTRRGAQAPPTFRAQDYTWEDHGYSLIQRLYPEGGQLLDEKFQAAYSLTYNTIAMHSGVDTSVLRRAIWNYIHCVFGIRYDDYDYGEVNQLLERNLKVYIKTVACYPEKTTRRMYNLFWRHFRHSEKVHVNLLLLEARMQAALLYALRAITRYMT","Homo sapiens","SESN2, Hi95, SEST2","Sestrin-2","1","6N0M"
"6N0N",,"X-RAY DIFFRACTION",2.55,51.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",291,,,"6N0N",105.08,"1.477","1.477","Crystal structure of Tdp1 catalytic domain in complex with compound XZ574","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6N0N"
"6N0O",,"X-RAY DIFFRACTION",2.44,49.53,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",291,,,"6N0O",104.92,"1.943","1.943","Crystal structure of Tdp1 catalytic domain in complex with compound XZ523","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6N0O"
"6N0P",,"X-RAY DIFFRACTION",2.95,58.37,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris ph 7.7, 12% PEG8000, and 100 mM NaCl",291,"10.1021/acs.jmedchem.9b00161","K81","6N0P",63.28,"2.37","2.37","BRAF in complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (LXH254)","DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6N0P"
"6N0Q",,"X-RAY DIFFRACTION",3.09,60.17,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris pH 8.3, 15% PEG8000, and 25% glycerol",291,"10.1021/acs.jmedchem.9b00161","K7S","6N0Q",64.68,"2.04","2.04","BRAF in complex with N-(4-methyl-3-(1-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)phenyl)-3-(trifluoromethyl)benzamide.","GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6N0Q"
"6N0R",,"X-RAY DIFFRACTION",2.45,49.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",291,,,"6N0R",104.97,"1.544","1.544","Crystal structure of Tdp1 catalytic domain in complex with compound XZ572","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6N0R"
"6N12",,"X-RAY DIFFRACTION",3.16,61.05,"VAPOR DIFFUSION, SITTING DROP",8.5,"10% w/v PEG 8000, 20% v/v ethylene glycol 0.03 M of each CaCl2 and MgCl2, 0.1 M bicine/Trizma base pH 8.5",291,"10.1016/j.jsb.2019.04.015",,"6N12",66.45,"2.23","2.23","Structure of GTPase Domain of Human Septin 7 at High Resolution","MGSSHHHHHHSQDPGFEFTLMVVGESGLGKSTLINSLFLTDLYSPEYPGPSHRIKKTVQVEQSKVLIKEGGVQLLLTIVDTPGFGDAVDNSNCWQPVIDYIDSKFEDYLNAESRVNRRQMPDNRVQCCLYFIAPSGHGLKPLDIEFMKRLHEKVNIIPLIAKADTLTPEECQQFKKQIMKEIQEHKIKIYEFPETDDEEENKLVKKIKDRLPLAVVGSNTIIEVNGKRVRGRQYPWGVAEVENGEHCDFTILRNMLIRTHMQDLKDVTNNVHYENYRSRKLAAVT","Homo sapiens","SEPT7, CDC10, SEPTIN7","Septin-7","1","6N12"
"6N17",,"X-RAY DIFFRACTION",2.46,49.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",291,"10.1093/nar/gkz515","K8Y","6N17",105.2,"1.639","1.639","Crystal structure of Tdp1 catalytic domain in complex with compound XZ577","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6N17"
"6N19",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5, 10% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",291,"10.1093/nar/gkz515","K8V","6N19",105.03,"1.501","1.501","Crystal structure of Tdp1 catalytic domain in complex with compound XZ578","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6N19"
"6N1G",,"X-RAY DIFFRACTION",3.63,66.16,"VAPOR DIFFUSION, SITTING DROP",7,"30% w/v polyethylene glycol 400, 100 mM MOPS pH 7.0, 100 mM NaCl.",291,"10.3389/fphys.2020.00728",,"6N1G",165.5,"3.995","3.995","Crystal structure of Aquaglyceroporin AQP7","MVQASGHRRSTRGSKMVSWSVIAKIQEILQRKMVREFLAEFMSTYVMMVFGLGSVAHMVLNKKYGSYLGVNLGFGFGVTMGVHVAGRISGAHMNAAVTFANCALGRVPWRKFPVYVLGQFLGSFLAAATIYSLFYTAILHFSGGQLMVTGPVATAGIFATYLPDHMTLWRGFLNEAWLTGMLQLCLFAITDQENNPALPGTEALVIGILVVIIGVSLGMNTGYAINPSRDLPPRIFTFIAGWGKQVFSNGENWWWVPVVAPLLGAYLGGIIYLVFIGSTIPREPLKLEDSVAYEDHGITVLPKMGSHEPTISPLTPVSVSPANRSSVHPAPPLHESMALEHFGGSLEVLFQGPAAYPYDVPDYAAAHHHHHHHHHH","Homo sapiens","AQP7, AQP7L, AQP9","Aquaporin-7","1","6N1G"
"6N1H","3.17","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1810524115",,"6N1H",156.4,"3.17",,"Cryo-EM structure of ASC-CARD filament","LHFIDQHRAALIARVTNVEWLLDALYGKVLTDEQYQAVRAEPTNPSKMRKLFSFTPAWNWTCKDLLLQALRESQSYLVEDLER","Homo sapiens","PYCARD, ASC, CARD5, TMS1","Apoptosis-associated speck-like protein containing a CARD","1","6N1H"
"6N1I","3.58","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1810524115",,"6N1I",159.8,"3.58",,"Cryo-EM structure of NLRC4-CARD filament","MNFIKDNSRALIQRMGMTVIKQITDDLFVWNVLNREEVNIICCEKVEQDAARGIIHMILKKGSESCNLFLKSLKEWNYPLFQDLN","Homo sapiens","NLRC4, CARD12, CLAN, CLAN1, IPAF, UNQ6189/PRO20215","NLR family CARD domain-containing protein 4","1","6N1I"
"6N1K",,"X-RAY DIFFRACTION",2.75,55.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"hPAH C29S was obtained from of the 6His-SUMO fusion using a sodium phosphate buffer. Crystals were grown from C29S (16 mg/mL) in 2 mM Tris-HCl pH 7.4, mixed with reservoir solutions in a protein:reservoir ratio equal to 1:1.25 and equilibrated using hanging drop vapor diffusion. The 1 mL reservoir solution initially contained 16% PEG 3350, 100 mM bis-tris-propane pH 7.5 and 200 mM sodium sulfate. Crystals appeared at 295K within one day in the dark.",295,"10.1074/jbc.RA119.008294",,"6N1K",207.49,"3.057","3.057","Full-length human phenylalanine hydroxylase (PAH) in the resting state","STAVLENPGLGRKLSDFGQETSYIEDNSNQNGAISLIFSLKEEVGALAKVLRLFEENDVNLTHIESRPSRLKKDEYEFFTHLDKRSLPALTNIIKILRHDIGATVHELSRDKKKDTVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVLDNTQQLKILADSINSEIGILCSALQKIK","Homo sapiens","PAH","Phenylalanine-4-hydroxylase","1","6N1K"
"6N29",,"X-RAY DIFFRACTION",3.74,67.13,"VAPOR DIFFUSION, HANGING DROP",,"5.5% (w/v) PEG8000, 10% (w/v) PEG1000, 0.2 M calcium acetate and 0.1 M Tris-acetate, pH 8.5",297,"10.1182/blood-2018-10-876300",,"6N29",108.1,"2.5","2.5","Crystal structure of monomeric von Willebrand Factor D`D3 assembly","SLSCRPPMVKLVCPADNLRAEGLECTKTCQNYDLECMSMGCVSGCLCPPGMVRHENRCVALERCPCFHQGKEYAPGETVKIGCNTCVCRDRKWNCTDHVCDATCSTIGMAHYLTFDGLKYLFPGECQYVLVQDYCGSNPGTFRILVGNKGCSHPSVKCKKRVTILVEGGEIELFDGEVNVKRPMKDETHFEVVESGRYIILLLGKALSVVWDRHLSISVVLKQTYQEKVCGLCGNFDGIQNNDLTSSNLQVEEDPVDFGNSWKVSSQCADTRKVPLDSSPATCHNNIMKQTMVDSSCRILTSDVFQDCNKLVDPEPYLDVCIYDTCSCESIGDCAAFCDTIAAYAHVCAQHGKVVTWRTATLCPQSCEERNLRENGYEAEWRYNSCAPACQVTCQHPEPLACPVQCVEGCHAHCPPGKILDELLQTCVDPEDCPVCEVAGRRFASGKKVTLNPSDPEHCQICHCDVVNLTCEACQEPGGLVPR","Homo sapiens","VWF, F8VWF","von Willebrand factor","1","6N29"
"6N2J",,"X-RAY DIFFRACTION",2.4,48.66,"VAPOR DIFFUSION, HANGING DROP",5,"0.1M Na Citrate, pH 5.0
29% PEG8000
0.2M Amm Acetate",277,"10.1021/acsmedchemlett.8b00382",,"6N2J",20.22,"1.8","1.8","Tetrahydropyridopyrimidines as Covalent Inhibitors of KRAS-G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6N2J"
"6N2K",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1M Na Citrate, pH 4.2
25% PEG 8000
0.2M Amm Acetate",277,"10.1021/acsmedchemlett.8b00382",,"6N2K",20.34,"1.72","1.72","Tetrahydropyridopyrimidines as Covalent Inhibitors of KRAS-G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6N2K"
"6N2M",,"SOLUTION NMR",,,,,,,"10.1038/s41467-019-10953-z",,"6N2M",32.36,,,"NMR solution structure of the homodimeric, autoinhibited state of the CARD9 CARD and first coiled-coil","GSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGKEPARVFSMIIDASGESGLTQLLMTEVMKLQKKVQDLTALLSSKDD","Homo sapiens","CARD9","Caspase recruitment domain-containing protein 9","1","6N2M"
"6N2P","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-10953-z",,"6N2P",173.52,"4",,"Helical assembly of the CARD9 CARD","GSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGKEPARVFSMIEDASGESGLTQLLMTEVMKLQKKVQDLTALLSSKDDFIKELRVKDS","Homo sapiens","CARD9","Caspase recruitment domain-containing protein 9","1","6N2P"
"6N2U",,"X-RAY DIFFRACTION",1.83,32.61,"VAPOR DIFFUSION, HANGING DROP",,"2.4 M Ammonium Phosphate dibasic, 0.1 M Tris HCl pH 8.5",293,,,"6N2U",11.12,"1.254","1.254","IL-8 Structure from Bacterial Expression Source","MTSKLAVALLAAFLISAALCEGAVLPRSAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS","Homo sapiens","CXCL8, IL8","Interleukin-8","1","6N2U"
"6N2W",,"X-RAY DIFFRACTION",2.34,47.44,"VAPOR DIFFUSION, SITTING DROP",6,"8-10% Tacsimate",293,"10.1038/s41589-020-0544-7",,"6N2W",159.29,"2.71","2.71","The structure of Stable-5-Lipoxygenase bound to NDGA","MGSSHHHHHHSSGLVPRGSHMPSYTVTVATGSQEHAGTDDYIYLSLVGSAGCSEKHLLDKGSFERGAVDSYDVTVDEELGEIQLVRIEKRKYGSNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGANPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWASWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNENLQLPYYYLSPDRIPNSVAI","Homo sapiens","ALOX5, LOG5","Arachidonate 5-lipoxygenase","1","6N2W"
"6N2X",,"X-RAY DIFFRACTION",3.9,68.48,"VAPOR DIFFUSION, SITTING DROP",7,"25% Peg 400, 0.2M imidazole malate",295,"10.1126/science.1083182",,"6N2X",97.95,"3","3","Anti-HIV-1 Fab 2G12 + Man9 re-refinement","DVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"Fab 2G12 light chain","1","6N2X"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Fab 2G12 heavy chain","2","6N2X"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6N31",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG 3350, 0.2M magnesium chloride, 0.1M Hepes",293,,,"6N31",78.6,"2.6","2.6","WD repeats of human WDR12","MHHHHHHSSGRENLYFQGTAPQPEQCMFHDDWISSIKGAEEWILTGSYDKTSRIWSLEGKSIMTIVGHTDVVKDVAWVKKDSLSCLLLSASMDQTILLWEWNVERNKVKALHCCRGHAGSVDSIAVDGSGTKFCSGSWDKMLKIWSTVPTDEEDEMEESTNRPRKKQKTEQLGLTRTPIVTLSGHMEAVSSVLWSDAEEICSASWDHTIRVWDVGSGSLKSTLTGNKVFNCISYSPLCKRLASGSTDRHIRLWDPRTKDGSLVSLSLTSHTGWVTSVKWSPTHEQQLISGSLDNIVKLWDTRSCKAPLYDLAAHEDKVLSVDWTDTGLLLSGGADNKLYSYRYSPTTSHVG","Homo sapiens","WDR12","Ribosome biogenesis protein WDR12","1","6N31"
"6N32",,"X-RAY DIFFRACTION",3.28,62.5,"VAPOR DIFFUSION, SITTING DROP",6,"1.05M ammonium sulfate, 18% Peg 6000, 0.1M imidazole malate",298,"10.1126/science.1083182",,"6N32",94.84,"2.2","2.2","Anti-HIV-1 Fab 2G12 re-refinement","DVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"Fab 2G12 light chain","1","6N32"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS","Homo sapiens",,"Fab 2G12 heavy chain","2","6N32"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6N33",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG8K, 0.2M MGCL2 AND 0.1M TRIS, PH 7.5",277,"10.1038/s41467-019-11674-z",,"6N33",39.04,"2.25","2.25","Crystal structure of fms kinase domain with a small molecular inhibitor, PLX5622","MKKGHHHHHHGQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCTYGDLLNFLRRKAEAMLGPSLSPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDSVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQITSFLQEQAQEDRR","Homo sapiens","CSF1R, FMS","Macrophage colony-stimulating factor 1 receptor","1","6N33"
"6N34",,"X-RAY DIFFRACTION",2.27,45.92,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Ammonium sulfate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350",293.15,"10.1073/pnas.1818012115",,"6N34",33.17,"2.8","2.8","Crystal structure of the BTB domain of Human NS1-BP","MIPNGYLMFEDENFIESSVAKLNALRKSGQFCDVRLQVCGHEMLAHRAVLACCSPYLFEIFNSDSDPHGISHVKFDDLNPEAVEVLLNYAYTAQLKADKELVKDVYSAAKKLKMDRVKQVCGDYLLSRMDVTSCISYLEHHHHHH","Homo sapiens","IVNS1ABP, ARA3, FLARA3, KIAA0850, KLHL39, NS1, NS1BP, HSPC068","Influenza virus NS1A-binding protein","1","6N34"
"6N35",,"X-RAY DIFFRACTION",3.45,64.36,"VAPOR DIFFUSION, SITTING DROP",7,"2M Sodium/Potassium Phosphate",298,"10.1126/science.1083182",,"6N35",94.92,"1.747","1.747","Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement","DVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"Fab 2G12 light chain","1","6N35"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"Fab 2G12 heavy chain","2","6N35"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6N37","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0248-4",,"6N37",52.08,"3.8",,"SegA-sym, conformation of TDP-43 low complexity domain segment A sym","MNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQ","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","6N37"
"6N3B","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0248-4",,"6N3B",52.08,"3.8",,"SegA-asym, conformation of TDP-43 low complexity domain segment A asym","MNFGAFSINPAMMAAAQAALQSSWGMMGMLASQQNQSGPSGNNQNQGNMQ","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","6N3B"
"6N3C","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0248-4",,"6N3C",88.1,"3.3",,"SegB, conformation of TDP-43 low complexity domain segment A","QGGFGNSRGGGAGLGNNQGSNMGGGMNFGEFSINPAMMAAAQAALQ","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","6N3C"
"6N3D",,"X-RAY DIFFRACTION",2.01,38.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 8000, 0.4 M MgCl2, 0.1 M TRIS",277.15,"10.1074/jbc.RA118.006764",,"6N3D",11.58,"1.13","1.13","Structure of HIV Tat-specific factor 1 U2AF Homology Motif (APO-State)","GSMRHERVVIIKNMFHPMDFEDDPLVLNEIREDLRVECSKFGQIRKLLLFDRHPDGVASVSFRDPEEADYCIQTLDGRWFGGRQITAQAWDGTTDY","Homo sapiens","HTATSF1","HIV Tat-specific factor 1","1","6N3D"
"6N3G",,"X-RAY DIFFRACTION",3.09,60.14,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, Ethanol, Water, 1 M Tris",294,,"SAH","6N3G",51.31,"2.43","2.43","Crystal structure of histone lysine methyltransferase SmyD2 in complex with polyethylene glycol","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLEFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","6N3G"
"6N3H",,"X-RAY DIFFRACTION",2.93,58.02,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris pH 8.5, 3.0 M NaCl",293,"10.1073/pnas.1818012115",,"6N3H",73.47,"2.6","2.6","Crystal structure of Kelch domain of the human NS1 binding protein","MNSPQSSPTSTPKLSKSLSFEMQQDELIEKPMSPMQYARSGLGTAEMNGKLIAAGGYNREECLRTVECYNPHTDHWSFLAPMRTPRARFQMAVLMGQLYVVGGSNGHSDDLSCGEMYDSNIDDWIPVPELRTNRCNAGVCALNGKLYIVGGSDPYGQKGLKNCDVFDPVTKLWTSCAPLNIRRHQSAVCELGGYLYIIGGAESWNCLNTVERYNPENNTWTLIAPMNVARRGAGVAVLNGKLFVCGGFDGSHAISCVEMYDPTRNEWKMMGNMTSPRSNAGIATVGNTIYAVGGFDGNEFLNTVEVYNLESNEWSPYTKIFQFLEHHHHHH","Homo sapiens","IVNS1ABP, ARA3, FLARA3, KIAA0850, KLHL39, NS1, NS1BP, HSPC068","Influenza virus NS1A-binding protein","1","6N3H"
"6N3L",,"X-RAY DIFFRACTION",2.22,39.8,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris 8.5, 24% PEG3350, 450 mM NaFormate, 1% hexanediol",293,"10.1021/acsmedchemlett.9b00400",,"6N3L",76.64,"2.61","2.61","Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents","MHHHHHHENLYFQGGSSETQRQFSRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIENGCHESEPSVTTEAVHYLYIQMEYCEASTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRNLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLAGMVGAALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHE","Homo sapiens","EIF2AK4, GCN2, KIAA1338","eIF-2-alpha kinase GCN2,eIF-2-alpha kinase GCN2","1","6N3L"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK4, GCN2, KIAA1338"
"6N3N",,"X-RAY DIFFRACTION",2.59,52.47,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Na Citrate pH 5.6, 10% PEG 5K MME, 0.7 M LiCl, 3% Ethylene Glycol",293,"10.1021/acsmedchemlett.9b00400",,"6N3N",36.7,"3.01","3.01","Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents","GGSSETQRQFSRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIENGCHESEPSVTTEAVHYLYIQMEYCEASTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRNLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLEGMVGEALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHE","Homo sapiens","EIF2AK4, GCN2, KIAA1338","eIF-2-alpha kinase GCN2,eIF-2-alpha kinase GCN2","1","6N3N"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK4, GCN2, KIAA1338"
"6N3O",,"X-RAY DIFFRACTION",2.65,53.64,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Na Citrate pH 5.6, 8% PEG 6K, 0.7 M LiCl, 1% Ethylene Glycol",293,"10.1021/acsmedchemlett.9b00400","KA7","6N3O",36.66,"2.4","2.4","Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents","GGSSETQRQFSRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIENGCHESEPSVTTEAVHYLYIQMEYCEASTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRNLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLEGMVGEALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHE","Homo sapiens","EIF2AK4, GCN2, KIAA1338","eIF-2-alpha kinase GCN2","1","6N3O"
,,,,,,,,,,,,,,,,,"Homo sapiens","EIF2AK4, GCN2, KIAA1338"
"6N3V",,"X-RAY DIFFRACTION",2.04,39.67,"VAPOR DIFFUSION",6.3,"100 mM MES, 35% PEG 8000",293,"10.1021/acschemneuro.9b00432","KB7","6N3V",28.58,"1.45","1.45","Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound 5'-O-[1-Ethyl]Carbamoyl Guanosine","SNAMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6N3V"
"6N3W",,"X-RAY DIFFRACTION",2.03,39.5,"VAPOR DIFFUSION",6.3,"100 mM MES, 35% PEG 8000",293,"10.1021/acschemneuro.9b00432","KBJ","6N3W",28.62,"1.75","1.75","Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound 5'-O-[3-Phenyl-1-Ethyl]Carbamoyl Guanosine","SNAMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6N3W"
"6N3X",,"X-RAY DIFFRACTION",2.05,39.88,"VAPOR DIFFUSION",6.3,"100 mM MES, 35% PEG 8000",293,"10.1021/acschemneuro.9b00432","KBD","6N3X",28.77,"1.1","1.1","Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound 5'-O-[1-Benzyl]Carbamoyl Guanosine","SNAMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6N3X"
"6N3Y",,"X-RAY DIFFRACTION",2.05,39.88,"VAPOR DIFFUSION",6.3,"100 mM MES, 35% PEG 8000",293,"10.1021/acschemneuro.9b00432","HHJ","6N3Y",28.73,"1.8","1.8","Human Histidine Triad Nucleotide Binding Protein 1 (Hint1) with Bound 5'-O-[(3-Indolyl)-1-Ethyl]Carbamoyl Guanosine","SNAMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6N3Y"
"6N42",,"X-RAY DIFFRACTION",3.71,66.89,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1021/acs.biochem.9b00006",,"6N42",23.87,"2.199","2.199","Crystal structure of cysteine-bound ferrous form of the crosslinked human cysteine dioxygenase in the anaerobic condition","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLYSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6N42"
"6N43",,"X-RAY DIFFRACTION",3.97,68.99,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1021/acs.biochem.9b00006",,"6N43",23.44,"2.289","2.289","Crystal structure of cysteine, nitric oxide-bound ferrous form of the crosslinked human cysteine dioxygenase in the anaerobic condition","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLYSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6N43"
"6N46",,"X-RAY DIFFRACTION",3.16,61.12,"VAPOR DIFFUSION, SITTING DROP",8.5,"22.5% (w/v) PEG2000
3% (w/v) dextran sulfate sodium salt
0.1M bicine (pH 8.5)
24 uM nonaethylene glycol monododecyl ether (C12E9)
8% (w/v) glycerol",281,"10.1038/s41467-019-12619-2",,"6N46",230.54,"3.708","3.708","Crystal structure of the cryptic polo box domain of a human activated Plk4","MGSSHHHHHHSSGLVPRGSHMGYQNRTLRSITSPLVAHRLKPIRQKTKKAVVSILDSEEVCVELVKEYASQEYVKEVLQISSDGNTITIYYPNGGRGFPLADRPPSPTDNISRYSFDNLPEKYWRKYQYASRFVQLVREKEPKIEYFDRYAKCILMENSPGADFEVWFYDGVKIHKTEDFIQVIEKTGKSYTLKSESEVNSLKEEIKMYMDHANEGHRICLALESIISEEERKTRSAPFFPIIIGRKPG","Homo sapiens","PLK4, SAK, STK18","Serine/threonine-protein kinase PLK4","1","6N46"
"6N4E",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, SITTING DROP",8.5,"18% Peg6K, 0.05 M tris pH 8.5, 5% glycerol, 10 mM DTT, 1% 1,4
Dioxane",295,"10.1016/j.bmc.2019.02.017","KCD","6N4E",24.11,"1.65","1.65","hPGDS complexed with a quinoline-3-carboxamide","GMPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","6N4E"
"6N4P",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium citrate dibasic, 30% PEG3350",291,,,"6N4P",1.62,"1.851","1.851","RQEFEV, crystal structure of the N-terminal segment RQEFEV from protein tau","RQEFEV","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6N4P"
"6N4T",,"X-RAY DIFFRACTION",2.33,47.32,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris, pH 8.2 - 8.7, 18 % - 22 % PEG800, 200 mM MgCl2",,"10.1016/j.chembiol.2019.09.004",,"6N4T",27.64,"1.945","1.945","Crystal structure of Matriptase1 in complex with a peptidomimetic benzothiazole","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","Suppressor of tumorigenicity 14 protein","1","6N4T"
"6N4X",,"X-RAY DIFFRACTION",4.76,74.16,"VAPOR DIFFUSION, SITTING DROP",6.5,"15% PEG 3350, 0.2M Na Cacodylate pH 6.5",293,"10.1038/s41586-019-0881-4",,"6N4X",198.37,"4","4","Metabotropic Glutamate Receptor 5 Apo Form Ligand Binding Domain","MKTIIALSYIFCLVFADYKDDDDAAAQSSERRVVAHMPGDIIIGALFSVHHQPTVDKVHERKCGAVREQYGIQRVEAMLHTLERINSDPTLLPNITLGCEIRDSCWHSAVALEQSIEFIRDSLISSEEEEGLVRCVDGSSSSFRSKKPIVGVIGPGSSSVAIQVQNLLQLFNIPQIAYSATSMDLSDKTLFKYFMRVVPSDAQQARAMVDIVKRYNWTYVSAVHTEGNYGESGMEAFKDMSAKEGICIAHSYKIYSNAGEQSFDKLLKKLTSHLPKARVVACFCEGMTVRGLLMAMRRLGLAGEFLLLGSDGWADRYDVTDGYQREAVGGITIKLQSPDVKWFDDYYLKLRPETNHRNPWFQEFWQHRFQCRLEGFPQENSKYNKTCNSSLTLKTHHVQDSKMGFVINAIYSMAYGLHNMQMSLCPGYAGLCDAMKPIDGRKLLESLMKTNFTGVSGDTILFDENGDSPGRYEIMNFKEMGKDYFDYINVGSWDNGELKMDDDEVWSKKSNIIRSVCSEPCEKGQIKVIRKGEVSCCWTCTPCKENEYVFDEYTCKACQLGSWPTDDLTGCDLIPVQYLRWGDPEPIAAVVFACLGLLATLFVTVVFIIYRDTPVVKSSSRELCYIILAGICLGYLCTFCLIAKPKQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACAQLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKSSSAASRSSSLVNLHHHHHH","Homo sapiens","GRM5, GPRC1E, MGLUR5","Metabotropic glutamate receptor 5","1","6N4X"
"6N52","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-0881-4",,"6N52",196.24,"4",,"Metabotropic Glutamate Receptor 5 Apo Form","MKTIIALSYIFCLVFADYKDDDDAAAQSSERRVVAHMPGDIIIGALFSVHHQPTVDKVHERKCGAVREQYGIQRVEAMLHTLERINSDPTLLPNITLGCEIRDSCWHSAVALEQSIEFIRDSLISSEEEEGLVRCVDGSSSSFRSKKPIVGVIGPGSSSVAIQVQNLLQLFNIPQIAYSATSMDLSDKTLFKYFMRVVPSDAQQARAMVDIVKRYNWTYVSAVHTEGNYGESGMEAFKDMSAKEGICIAHSYKIYSNAGEQSFDKLLKKLTSHLPKARVVACFCEGMTVRGLLMAMRRLGLAGEFLLLGSDGWADRYDVTDGYQREAVGGITIKLQSPDVKWFDDYYLKLRPETNHRNPWFQEFWQHRFQCRLEGFPQENSKYNKTCNSSLTLKTHHVQDSKMGFVINAIYSMAYGLHNMQMSLCPGYAGLCDAMKPIDGRKLLESLMKTNFTGVSGDTILFDENGDSPGRYEIMNFKEMGKDYFDYINVGSWDNGELKMDDDEVWSKKSNIIRSVCSEPCEKGQIKVIRKGEVSCCWTCTPCKENEYVFDEYTCKACQLGSWPTDDLTGCDLIPVQYLRWGDPEPIAAVVFACLGLLATLFVTVVFIIYRDTPVVKSSSRELCYIILAGICLGYLCTFCLIAKPKQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACAQLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKSSSAASRSSSLVNL","Homo sapiens","GRM5, GPRC1E, MGLUR5","Metabotropic glutamate receptor 5","1","6N52"
"6N53",,"X-RAY DIFFRACTION",3.49,64.72,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Na/K phosphate, 22% PEG 3350",298,"10.1038/s41592-019-0726-y",,"6N53",58.44,"2.7","2.7","Crystal structure of human uridine-cytidine kinase 2 complexed with 2'-azidouridine monophosphate","GPLGSMAGDSEQTLQNHQQPNGGEPFLIGVSGGTASGKSSVCAKIVQLLGQNEVDYRQKQVVILSQDSFYRVLTSEQKAKALKGQFNFDHPDAFDNELILKTLKEITEGKTVQIPVYDFVSHSRKEETVTVYPADVVLFEGILAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDISERGRDLEQILSQYITFVKPAFEEFCLPTKKYADVIIPRGADNLVAINLIVQHIQDILNGGPSKRQTNGCLNGYTPSRK","Homo sapiens","UCK2, UMPK","Uridine-cytidine kinase 2","1","6N53"
"6N54",,"X-RAY DIFFRACTION",3.47,64.51,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Na/K phosphate, 20% PEG 3350",298,"10.1038/s41592-019-0726-y",,"6N54",58.62,"2.424","2.424","Crystal structure of human uridine-cytidine kinase 2 complexed with 2'-azidocytidine monophosphate","GPLGSMAGDSEQTLQNHQQPNGGEPFLIGVSGGTASGKSSVCAKIVQLLGQNEVDYRQKQVVILSQDSFYRVLTSEQKAKALKGQFNFDHPDAFDNELILKTLKEITEGKTVQIPVYDFVSHSRKEETVTVYPADVVLFEGILAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDISERGRDLEQILSQYITFVKPAFEEFCLPTKKYADVIIPRGADNLVAINLIVQHIQDILNGGPSKRQTNGCLNGYTPSRK","Homo sapiens","UCK2, UMPK","Uridine-cytidine kinase 2","1","6N54"
"6N55",,"X-RAY DIFFRACTION",2.66,53.79,"VAPOR DIFFUSION, HANGING DROP",,"50 mM BIS-TRIS pH 6.5, 25 mM ammonium sulfate, 32% pentaerythritol ethoxylate (15/4 EO/OH)",298,"10.1038/s41592-019-0726-y",,"6N55",232.22,"3.085","3.085","Crystal structure of human uridine-cytidine kinase 2 complexed with 2'-azidouridine","GPLGSMAGDSEQTLQNHQQPNGGEPFLIGVSGGTASGKSSVCAKIVQLLGQNEVDYRQKQVVILSQDSFYRVLTSEQKAKALKGQFNFDHPDAFDNELILKTLKEITEGKTVQIPVYDFVSHSRKEETVTVYPADVVLFEGILAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDISERGRDLEQILSQYITFVKPAFEEFCLPTKKYADVIIPRGADNLVAINLIVQHIQDILNGGPSKRQTNGCLNGYTPSRK","Homo sapiens","UCK2, UMPK","Uridine-cytidine kinase 2","1","6N55"
"6N5C",,"X-RAY DIFFRACTION",2.71,54.65,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM AMPPNP, 2 mM CdCl2, Soaking with 2mM 5PCF2-Am-InsP5 under pH 5.2 for 3 days , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c9md00163h",,"6N5C",39.4,"1.95","1.95","Crystal structure of the catalytic domain of PPIP5K2 in complex with AMPPNP and 5-PCF2Am-InsP5","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2","1","6N5C"
"6N5K",,"X-RAY DIFFRACTION",5.31,76.82,"VAPOR DIFFUSION, HANGING DROP",7.4,"Magnesium chloride, Cyclic di-AMP, Potassium Chloride, HEPEs",297,,,"6N5K",42.06,"3.098","3.098","Structure of Human pir-miRNA-449c Apical Loop and One-base-pair Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCAUGAUUUGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGAG","Homo sapiens",,"RNA (125-MER)","1","6N5K"
"6N5N",,"X-RAY DIFFRACTION",5.37,77.1,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.9 M (NH4)2SO4, 0.2 M Li2SO4, and 0.1 M HEPES pH 7.4",297,,,"6N5N",42.19,"2.951","2.951","Structure of Human pir-miRNA-208a Apical Loop and One-base-pair Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCGAUGCUCGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGAG","Homo sapiens",,"RNA (125-MER)","1","6N5N"
"6N5O",,"X-RAY DIFFRACTION",5.37,77.11,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.9 M (NH4)2SO4, 0.2 M Li2SO4, and 0.1 M HEPES pH 7.4",297,,,"6N5O",42.46,"2.708","2.708","Structure of Human pir-miRNA-202 Apical Loop and One-base-pair Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCGAUCUGGCGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGAG","Homo sapiens",,"RNA (126-MER)","1","6N5O"
"6N5P",,"X-RAY DIFFRACTION",5.34,76.96,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.89 M (NH4)2SO4, 0.214 M Li2SO4, and 0.1 M HEPES pH 7.4",297,,,"6N5P",42.73,"2.991","2.991","Structure of Human pir-miRNA-340 Apical Loop and One-base-pair Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCAUGUCGUUUGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGAG","Homo sapiens",,"RNA (127-MER)","1","6N5P"
"6N5Q",,"X-RAY DIFFRACTION",5.25,76.59,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.63 M (NH4)2SO4, 0.272 M Li2SO4, and 0.1 M HEPES pH 7.4",297,,,"6N5Q",43.09,"2.946","2.946","Structure of Human pir-miRNA-378a Apical Loop and One-base-pair Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCACCUAGAAAUGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGAG","Homo sapiens",,"RNA (128-MER)","1","6N5Q"
"6N5S",,"X-RAY DIFFRACTION",5.46,77.47,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.9 M (NH4)2SO4, 0.2 M Li2SO4, and 0.1 M HEPES pH 7.4",297,,,"6N5S",41.86,"2.802","2.802","Structure of Human pir-miRNA-320b-2 Apical Loop and One-base-pair Stem Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCAAAGUUGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGA","Homo sapiens",,"RNA (123-MER)","1","6N5S"
"6N5T",,"X-RAY DIFFRACTION",5.26,76.6,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.7 M (NH4)2SO4, 0.2 M Li2SO4, and 0.1 M HEPES pH 7.4",297,,,"6N5T",42.46,"2.787","2.787","Structure of Human pir-miRNA-378a Apical Loop Fused to the YdaO Riboswitch Scaffold","GGUUGCCGAAUCCCCUAGAAAGGUACGGAGGAACCGCUUUUUGGGGUUAAUCUGCAGUGAAGCUGCAGUAGGGAUACCUUCUGUCCCGCACCCGACAGCUAACUCCGGAGGCAAUAAAGGAAGGAG","Homo sapiens",,"RNA (126-MER)","1","6N5T"
"6N65",,"X-RAY DIFFRACTION",1.92,35.87,"VAPOR DIFFUSION, SITTING DROP",7,"0.08 M sodium chloride, 0.012 M potassium chloride, 0.02 magnesium chloride hexahydrate, 0.04 M sodium cacodylate trihydrate pH 7.0, 35% MPD, 0.012 M spermine tetrahydrochloride.",293,"10.1093/nar/gkaa262",,"6N65",14.17,"1.6","1.6","KRAS G-quadruplex G16T mutant.","AGGGCGGTGTGGGAATAGGGAA","Homo sapiens",,"KRAS G-quadruplex G16T mutant","1","6N65"
"6N6O",,"X-RAY DIFFRACTION",2.9,57.67,"VAPOR DIFFUSION, SITTING DROP",8.5,"100mM Tris pH 8.5, 300mM Sodium Acetate, 8% PEG 20k, 8% PEG 500 MME",277,"10.1021/acs.jmedchem.8b01869",,"6N6O",33.78,"2.6","2.6","Crystal structure of the human TTK in complex with an inhibitor","SHNECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTLE","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","6N6O"
"6N77",,"X-RAY DIFFRACTION",2.48,50.43,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000",277,"10.1016/j.bmcl.2019.04.008","KEJ","6N77",70.35,"1.64","1.64","Structure of the human JAK1 kinase domain with compound 15","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6N77"
"6N78",,"X-RAY DIFFRACTION",2.43,49.29,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000",277,"10.1016/j.bmcl.2019.04.008","KEP","6N78",35.26,"1.83","1.83","Structure of the human JAK1 kinase domain with compound 21","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6N78"
"6N79",,"X-RAY DIFFRACTION",2.34,47.45,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000",277,"10.1016/j.bmcl.2019.04.008","KES","6N79",35.24,"2.27","2.27","Structure of the human JAK1 kinase domain with compound 20","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6N79"
"6N7A",,"X-RAY DIFFRACTION",2.38,48.38,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000",277,"10.1016/j.bmcl.2019.04.008","KEV","6N7A",70.85,"1.33","1.33","Structure of the human JAK1 kinase domain with compound 39","GSGDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6N7A"
"6N7B",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000",277,"10.1016/j.bmcl.2019.04.008","KEY","6N7B",35.31,"1.81","1.81","Structure of the human JAK1 kinase domain with compound 38","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6N7B"
"6N7C",,"X-RAY DIFFRACTION",2.43,49.37,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000",277,"10.1016/j.bmcl.2019.04.008","KF1","6N7C",70.35,"1.69","1.69","Structure of the human JAK1 kinase domain with compound 56","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6N7C"
"6N7D",,"X-RAY DIFFRACTION",2.34,47.47,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES pH 5-6 and 25-35% PEG 6000",277,"10.1016/j.bmcl.2019.04.008","KF4","6N7D",35.21,"1.78","1.78","Structure of the human JAK1 kinase domain with compound 54","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6N7D"
"6N7E",,"X-RAY DIFFRACTION",5.03,75.53,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris, pH 6.5, 0.5 M magnesium formate, 5 mM AMP-PNP",295,"10.1016/j.str.2019.11.016",,"6N7E",165.43,"3.5","3.5","Crystal structure of the cytosolic domain of human CNNM2 in complex with AMP-PNP and Mg2+","MKEELNIIQGALELRTKTVEDVMTPLRDCFMITGEAILDFNTMSEIMESGYTRIPVFEGERSNIVDLLFVKDLAFVDPDDCTPLKTITKFYNHPLHFVFNDTKLDAMLEEFKKGKSHLAIVQRVNNEGEGDPFYEVLGIVTLEDVIEEIIKSEILDETDLYTDNRTKKKVAHRERKQDFSAFKQTDSEMKVKISPQLLLAMHRFLATEVEAFSPSQMSEKILLRLLKHPNVIQELKYDEKNKKAPEYYLYQRNKPVDYFVLILQGKVEVEAGKEGMKFEASAFSYYGVMALTASPVIDAVTPTLGSSNNQLNSSLLQVYIPDYSVRALSDLQFVKISRQQYQNALMLEHHHHHH","Homo sapiens","CNNM2, ACDP2","Metal transporter CNNM2,Metal transporter CNNM2","1","6N7E"
,,,,,,,,,,,,,,,,,"Homo sapiens","CNNM2, ACDP2"
"6N7U",,"X-RAY DIFFRACTION",2.91,57.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"80 mM sodium citrate tribasic/hydrochloric acid, pH 5.6, 20% PEG300, 200 mM ammonium sulfate, 10% glycerol",298,"10.1038/s41467-019-09732-7",,"6N7U",48.4,"2.03","2.03","apo-BDBV223 Fab","QVQLQQWGAGLLKPSETLSLTCAVYGGSFTTTYWNWIRQPPGKGLEWIGEVNYSGNANYNPSLKGRVAISVDTSKNQFSLRLNSVTAADTAIYYCTSRIRSHIAYSWKGDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTRA","Homo sapiens",,"BDBV223 antibody heavy chain","1","6N7U"
,,,,,,,,,,,,,,,,"EIVMTQSPGTLSLSPGERATLSCRASQSVPRNYIGWFQQKPGQAPRLLIYGASSRAAGFPDRFSGSGSGTDFTLTITRLEPEDFAMYYCHQYDRLPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGEC","Homo sapiens",,"BDBV223 antibody light chain","2","6N7U"
"6N7Y",,"X-RAY DIFFRACTION",2.77,55.62,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.6 M Ammonium phosphate, 20% glycerol, 0.08 M TrisHCl",295,"10.1021/acs.jmedchem.9b01104","KFA","6N7Y",43.76,"2","2","Crystal structure of human FPPS in complex with an allosteric inhibitor MIT-01-102","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","6N7Y"
"6N7Z",,"X-RAY DIFFRACTION",2.67,53.97,"VAPOR DIFFUSION, HANGING DROP",,"0.08 M TrisHCl pH 8.5, 1.6 M Ammonium phosphate, 20% (v/v) glycerol",295,"10.1021/acs.jmedchem.9b01104","KF7","6N7Z",43.7,"2.55","2.55","Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","6N7Z"
"6N82",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.36M tri-sodium citrate
15% (v/v) glycerol",295,"10.1021/acs.jmedchem.9b01104","YF7","6N82",44.57,"2","2","Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","6N82"
"6N83",,"X-RAY DIFFRACTION",2.74,55.16,"VAPOR DIFFUSION, SITTING DROP",,"0.08 M TrisHCl ph 8.5, 1.6 M Ammonium phosphate, 20% (v/v) glycerol",295,"10.1021/acs.jmedchem.9b01104","YL6","6N83",43.79,"2","2","Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","6N83"
"6N8C",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1821216116",,"6N8C",10.97,,,"Structure of the Huntingtin tetramer/dimer mixture determined by paramagnetic NMR","ATLEKLMKAFESLKSFQQQQQQQ","Homo sapiens","HTT, HD, IT15","Huntingtin","1","6N8C"
"6N8G",,"X-RAY DIFFRACTION",2.72,54.83,"VAPOR DIFFUSION, HANGING DROP",,"1.6-1.7 M Sodium Malonate,  pH 7.0,  100-150 mM Sodium acetate,  10 mM DTT",296,,,"6N8G",136.31,"2","2","IRAK4 bound to benzoxazole compound","RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6N8G"
"6N8P",,"X-RAY DIFFRACTION",2.7,54.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"19.8 % PEG 3350, 0.29 M Na2SO4, 0.1 M bis-tris propane pH 7.5, 3% methanol",295.15,"10.1073/pnas.1821514116",,"6N8P",109.31,"3.193","3.193","Crystal structure of the human cell polarity protein Lethal Giant Larvae 2 (Lgl2). Unphosphorylated, crystal form 1.","MRERLKRDLFQFNKTVEHGFPHQPSALGYSPSLRILAIGTRSGAIKLYGAPGVEFMGLHQENNAVTQIHLLPGQCQLVTLLDDNSLHLWSLKVKGGASELQEDESFTLRGPPGAAPSATQITVVLPHSSCELLYLGTESGNVFVVQLPAFRALEDRTISSDAVLQRLPEEARHRRVFEMVEALQEHPRDPNQILIGYSRGLVVIWDLQGSRVLYHFLSSQQLENIWWQRDGRLLVSCHSDGSYCQWPVSSEAQQPEPLRSLVPYGPFPCKAITRILWLTTRQGLPFTIFQGGMPRASYGDRHCISVIHDGQQTAFDFTSRVIGFTVLTEADPAATFDDPYALVVLAEEELVVIDLQTAGWPPVQLPYLASLHCSAITCSHHVSNIPLKLWERIIAAGSRQNAHFSTMEWPIDGGTSLTPAPPQRDLLLTGHEDGTVRFWDASGVCLRLLYKLSTVRVFLTDTDPNENFSAQGEDEWPPLRKVGSFDPYSDDPRLGIQKIFLCKYSGYLAVAGTAGQVLVLELNDEAAEQAVEQVEADLLQDQEGYRWKGHERLAARSGPVRFEPGFQPFVLVQCQPPAVVTSLALHSEWRLVAFGTSHGFGLFDHQQRRQVFVKCTLHPSDQLALEGPLSRVKSLKKSLRQSFRRMRRSRVSSRKRHPAGPPGEAQEGSAKAERPGLQNMELAPVQRKIEARSAEDSFTGFVRTLYFADTYLKDSSRHCPSLWAGTNGGTIYAFSLRVPPAERRMDEPVRAEQAKEIQLMHRAPVVGILVLDGHSVPLPEPLEVAHDLSKSPDMQGSHQLLVVSEEQFKVFTLPKVSAKLKLKLTALEGSRVRRVSVAHFGSRRAEDYGEHHLAVLTNLGDIQVVSLPLLKPQVRYSCIRREDVSGIASCVFTKYGQGFYLISPSEFERFSLSTKWLVEPRCLVDSAETKNHRPGNGAGPKKAPSRARNSGTQSDGEEKQPGLVMEREFTTASENLYFQ","Homo sapiens","LLGL2","Lethal(2) giant larvae protein homolog 2","1","6N8P"
"6N8Q",,"X-RAY DIFFRACTION",2.31,46.77,"VAPOR DIFFUSION, SITTING DROP",6,"18-21 % PEG 2000 MME, 80-100 mM SPG pH 6.0",295.15,"10.1073/pnas.1821514116",,"6N8Q",109.4,"2.2","2.2","Crystal structure of the human cell polarity protein Lethal Giant Larvae 2 (Lgl2). Unphosphorylated, crystal form 2.","MRERLKRDLFQFNKTVEHGFPHQPSALGYSPSLRILAIGTRSGAIKLYGAPGVEFMGLHQENNAVTQIHLLPGQCQLVTLLDDNSLHLWSLKVKGGASELQEDESFTLRGPPGAAPSATQITVVLPHSSCELLYLGTESGNVFVVQLPAFRALEDRTISSDAVLQRLPEEARHRRVFEMVEALQEHPRDPNQILIGYSRGLVVIWDLQGSRVLYHFLSSQQLENIWWQRDGRLLVSCHSDGSYCQWPVSSEAQQPEPLRSLVPYGPFPCKAITRILWLTTRQGLPFTIFQGGMPRASYGDRHCISVIHDGQQTAFDFTSRVIGFTVLTEADPAATFDDPYALVVLAEEELVVIDLQTAGWPPVQLPYLASLHCSAITCSHHVSNIPLKLWERIIAAGSRQNAHFSTMEWPIDGGTSLTPAPPQRDLLLTGHEDGTVRFWDASGVCLRLLYKLSTVRVFLTDTDPNENFSAQGEDEWPPLRKVGSFDPYSDDPRLGIQKIFLCKYSGYLAVAGTAGQVLVLELNDEAAEQAVEQVEADLLQDQEGYRWKGHERLAARSGPVRFEPGFQPFVLVQCQPPAVVTSLALHSEWRLVAFGTSHGFGLFDHQQRRQVFVKCTLHPSDQLALEGPLSRVKSLKKSLRQSFRRMRRSRVSSRKRHPAGPPGEAQEGSAKAERPGLQNMELAPVQRKIEARSAEDSFTGFVRTLYFADTYLKDSSRHCPSLWAGTNGGTIYAFSLRVPPAERRMDEPVRAEQAKEIQLMHRAPVVGILVLDGHSVPLPEPLEVAHDLSKSPDMQGSHQLLVVSEEQFKVFTLPKVSAKLKLKLTALEGSRVRRVSVAHFGSRRAEDYGEHHLAVLTNLGDIQVVSLPLLKPQVRYSCIRREDVSGIASCVFTKYGQGFYLISPSEFERFSLSTKWLVEPRCLVDSAETKNHRPGNGAGPKKAPSRARNSGTQSDGEEKQPGLVMEREFTTASENLYFQ","Homo sapiens","LLGL2","Lethal(2) giant larvae protein homolog 2","1","6N8Q"
"6N8R",,"X-RAY DIFFRACTION",2.28,46.14,"VAPOR DIFFUSION, SITTING DROP",8,"25% PEG 1500, 100 mM SPG pH 8.0",295.15,"10.1073/pnas.1821514116",,"6N8R",109.4,"1.91","1.91","Crystal structure of the human cell polarity protein Lethal Giant Larvae 2 (Lgl2). aPKC phosphorylated, crystal form 2.","MRERLKRDLFQFNKTVEHGFPHQPSALGYSPSLRILAIGTRSGAIKLYGAPGVEFMGLHQENNAVTQIHLLPGQCQLVTLLDDNSLHLWSLKVKGGASELQEDESFTLRGPPGAAPSATQITVVLPHSSCELLYLGTESGNVFVVQLPAFRALEDRTISSDAVLQRLPEEARHRRVFEMVEALQEHPRDPNQILIGYSRGLVVIWDLQGSRVLYHFLSSQQLENIWWQRDGRLLVSCHSDGSYCQWPVSSEAQQPEPLRSLVPYGPFPCKAITRILWLTTRQGLPFTIFQGGMPRASYGDRHCISVIHDGQQTAFDFTSRVIGFTVLTEADPAATFDDPYALVVLAEEELVVIDLQTAGWPPVQLPYLASLHCSAITCSHHVSNIPLKLWERIIAAGSRQNAHFSTMEWPIDGGTSLTPAPPQRDLLLTGHEDGTVRFWDASGVCLRLLYKLSTVRVFLTDTDPNENFSAQGEDEWPPLRKVGSFDPYSDDPRLGIQKIFLCKYSGYLAVAGTAGQVLVLELNDEAAEQAVEQVEADLLQDQEGYRWKGHERLAARSGPVRFEPGFQPFVLVQCQPPAVVTSLALHSEWRLVAFGTSHGFGLFDHQQRRQVFVKCTLHPSDQLALEGPLSRVKSLKKSLRQSFRRMRRSRVSSRKRHPAGPPGEAQEGSAKAERPGLQNMELAPVQRKIEARSAEDSFTGFVRTLYFADTYLKDSSRHCPSLWAGTNGGTIYAFSLRVPPAERRMDEPVRAEQAKEIQLMHRAPVVGILVLDGHSVPLPEPLEVAHDLSKSPDMQGSHQLLVVSEEQFKVFTLPKVSAKLKLKLTALEGSRVRRVSVAHFGSRRAEDYGEHHLAVLTNLGDIQVVSLPLLKPQVRYSCIRREDVSGIASCVFTKYGQGFYLISPSEFERFSLSTKWLVEPRCLVDSAETKNHRPGNGAGPKKAPSRARNSGTQSDGEEKQPGLVMEREFTTASENLYFQ","Homo sapiens","LLGL2","Lethal(2) giant larvae protein homolog 2","1","6N8R"
"6N8S",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.4 M ammonium sulfate, 100 mM Hepes pH 7.5, 150 mM NaCl, 1.07% 1,6-hexanediol",295.15,"10.1073/pnas.1821514116",,"6N8S",218.55,"3.9","3.9","Crystal structure of the human cell polarity protein Lethal Giant Larvae 2 (Lgl2). aPKC phosphorylated, crystal form 3.","MRERLKRDLFQFNKTVEHGFPHQPSALGYSPSLRILAIGTRSGAIKLYGAPGVEFMGLHQENNAVTQIHLLPGQCQLVTLLDDNSLHLWSLKVKGGASELQEDESFTLRGPPGAAPSATQITVVLPHSSCELLYLGTESGNVFVVQLPAFRALEDRTISSDAVLQRLPEEARHRRVFEMVEALQEHPRDPNQILIGYSRGLVVIWDLQGSRVLYHFLSSQQLENIWWQRDGRLLVSCHSDGSYCQWPVSSEAQQPEPLRSLVPYGPFPCKAITRILWLTTRQGLPFTIFQGGMPRASYGDRHCISVIHDGQQTAFDFTSRVIGFTVLTEADPAATFDDPYALVVLAEEELVVIDLQTAGWPPVQLPYLASLHCSAITCSHHVSNIPLKLWERIIAAGSRQNAHFSTMEWPIDGGTSLTPAPPQRDLLLTGHEDGTVRFWDASGVCLRLLYKLSTVRVFLTDTDPNENFSAQGEDEWPPLRKVGSFDPYSDDPRLGIQKIFLCKYSGYLAVAGTAGQVLVLELNDEAAEQAVEQVEADLLQDQEGYRWKGHERLAARSGPVRFEPGFQPFVLVQCQPPAVVTSLALHSEWRLVAFGTSHGFGLFDHQQRRQVFVKCTLHPSDQLALEGPLSRVKSLKKSLRQSFRRMRRSRVSSRKRHPAGPPGEAQEGSAKAERPGLQNMELAPVQRKIEARSAEDSFTGFVRTLYFADTYLKDSSRHCPSLWAGTNGGTIYAFSLRVPPAERRMDEPVRAEQAKEIQLMHRAPVVGILVLDGHSVPLPEPLEVAHDLSKSPDMQGSHQLLVVSEEQFKVFTLPKVSAKLKLKLTALEGSRVRRVSVAHFGSRRAEDYGEHHLAVLTNLGDIQVVSLPLLKPQVRYSCIRREDVSGIASCVFTKYGQGFYLISPSEFERFSLSTKWLVEPRCLVDSAETKNHRPGNGAGPKKAPSRARNSGTQSDGEEKQPGLVMEREFTTASENLYFQ","Homo sapiens","LLGL2","Lethal(2) giant larvae protein homolog 2","1","6N8S"
"6N8W",,"X-RAY DIFFRACTION",2.32,46.97,"VAPOR DIFFUSION, HANGING DROP",8.5,"Tris-HCl pH 8.5, MgCl2, PEG 4000, Glycerol",296,"10.1002/prot.25750",,"6N8W",115.53,"3.0922814017","3.0922814017","Structure of Unliganded Hsp90-Beta N-Terminal Domain","MGSSHHHHHHSSGLVPRGSHMPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLEKEREKEISDDEAE","Homo sapiens","HSP90AB1, HSP90B, HSPC2, HSPCB","Heat shock protein HSP 90-beta","1","6N8W"
"6N8X",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na Cacodylate pH 6.5, MgCl2, PEG 2000 MME. Incubate with PU-11-trans prior to setup.",277,"10.1002/prot.25750","KFY","6N8X",29.14,"1.49484474369","1.49484474369","Hsp90-alpha bound to PU-11-trans","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6N8X"
"6N8Y",,"X-RAY DIFFRACTION",2.72,54.82,"VAPOR DIFFUSION, HANGING DROP",6.5,"MES pH 6.5, MgCl2, PEG 2000 MME. Incubate with PU-11-trans prior to setup.",277,"10.1002/prot.25750","KFY","6N8Y",27.34,"1.55390799533","1.55390799533","Hsp90-beta bound to PU-11-trans","MGSSHHHHHHSSGLVPRGSHMPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLEKER","Homo sapiens","HSP90AB1, HSP90B, HSPC2, HSPCB","Heat shock protein HSP 90-beta","1","6N8Y"
"6N9O",,"X-RAY DIFFRACTION",2.37,48.13,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 0.1M Bis-Tris pH 5.5, 200 mM NaCl, and 10 mM DTT",277,"10.1016/j.immuni.2019.04.017",,"6N9O",211.98,"3.5","3.5","Crystal structure of human GSDMD","SMGSAFERVVRRVVQELDHGGEFIPVTSLQSSTGFQPYCLVVRKPSSSWFWKPRYKCVNLSIKDILEPDAAEPDVQRGRSFHFYDAMDGQIQGSVELAAPGQAKIAGGAAVSDSSSTSMNVYSLSVDPNTWQTLLHERHLRQPEHKVLQQLRSRGDNVYVVTEVLQTQKEVEVTRTHKREGSGRFSLPGATCLQGEGQGHLSQKKTVTIPSGSTLAFRVAQLVIDSDLDVLLFPDKKQRTFQPPATGHKRSTSEGAWPQLPSGLSMMRCLHNFLTDGVPAELAFTEDFQGLRAEVETISKELELLDRELCQLLLEGLEGVLRDQLALRALEEALEQGQSLGPVEPLDGPAGAVLECLVLSSGMLVPELAIPVVYLLGALTMLSETQHKLLAEALESQTLLGPLELVGSLLEQSAPWQERSTMSLPPGLLGNSWGEGAPAWVLLDECGLELGEDTPHVCWEPQAQGRMCALYASLALLSGLSQEPH","Homo sapiens","GSDMD, DFNA5L, GSDMDC1, FKSG10","Gasdermin-D","1","6N9O"
"6N9P",,"X-RAY DIFFRACTION",2.26,45.62,"VAPOR DIFFUSION",7.5,"20% PEG 3350, 0.1 M Bis Tris Propane pH 7.5, 0.2 M Sodium acetate trihydrate",294,"10.1002/cmdc.201800714",,"6N9P",32.02,"2.23","2.23","Discovery of affinity-based probes for Btk occupancy assay","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6N9P"
"6NAD",,"X-RAY DIFFRACTION",3.05,59.64,"VAPOR DIFFUSION",,"1.35M NaFormate, 0.1M Hepes pH7, 3%MPD",293,"10.1016/j.bmcl.2019.04.021","KHY","6NAD",57.87,"2.90197076582","2.90197076582","Identification and biological evaluation of tertiary ALCOHOL-based inverse agonists of RORgt","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6NAD"
"6NAO",,"X-RAY DIFFRACTION",2.51,51.03,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN WAS CONCENTRATED TO 6 MG/ML,
AND THEN MIXED AT A 2:1 RATIO WITH PEG 3350 (18-20% V/V), 0.2 M
 AMMONIUM CITRATE (PH 7) IN A SITTING DROP WELL AT 277 K.
 CRYOPROTECTANT WAS MADE USING MOTHER LIQUOR AT A FINAL
 CONCENTRATION OF 23% PEG 3350., VAPOR DIFFUSION, SITTING DROP",277.15,"10.1371/journal.pone.0184843","KHM","6NAO",85.7,"3.23","3.23","Discovery of a high affinity inhibitor of cGAS","GASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","CYCLIC GMP-AMP SYNTHASE","1","6NAO"
"6NB5",,"X-RAY DIFFRACTION",2.41,48.93,"VAPOR DIFFUSION",7,"30 % (v/v) Jeffamine ED-2001 pH 7.0 and 0.1 M HEPES pH 7.0",293,"10.1016/j.cell.2018.12.028",,"6NB5",94.12,"3","3","Crystal structure of anti- MERS-CoV human neutralizing LCA60 antibody Fab fragment","EVQLLESGGGLVKPGGSLRLSCEASGLTFSNVWMSWVRQAPGKGLEWVGRIKRKSEGATTDYGAPVKGRFTLSRDDSKNTVYLQMNSLKIDDTAVYYCSTLTRGGDVWSSSYYFDYWGQGALVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"LCA60 antigen-binding (Fab) fragment, heavy chain","1","6NB5"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTGTSSDVGTYDLVSWYQQHPGKSPKLMIYADIKRPSGVSHRFSGSKSGNTASLTISGLQSADEADYYCCLYAGSSTSVIFGGGTKVTGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"LCA60 antigen-binding (Fab) fragment, light chain","2","6NB5"
"6NB8",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION",7,"3.5 M sodium formate",293,"10.1016/j.cell.2018.12.028",,"6NB8",48.97,"1.5","1.5","Crystal structure of anti- SARS-CoV human neutralizing S230 antibody Fab fragment","QAQLVESGGALVQPGRSLRLSCAASGFTFRNYAMHWVRQAPATGLQWLAVITSDGRNKFYADSVKGRFTISREDSKNTLYLQMDSLRGEDTAVYYCVTQRDNSRDYFPHYFHDMDVWGQGTTVAVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"S230 antigen-binding (Fab) fragment, heavy chain","1","6NB8"
,,,,,,,,,,,,,,,,"DVVLTQSPLSLPVTLGQPASISCRSSQSLVYSDGDTYLNWFQQRPGQSPRRLIYQVSNRDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGSHWPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"S230 antigen-binding (Fab) fragment, light chain","2","6NB8"
"6NB9",,"ELECTRON CRYSTALLOGRAPHY",1.51,18.76,"BATCH",7.6,"0.05M Tris-HCl, 0.15M NaCl, 1% DMSO",310,"10.1038/s41467-019-11183-z",,"6NB9",1.49,"1.05","1.05","Amyloid-Beta (20-34) with L-isoaspartate 23","FAEDVGSNKGAIIGL","Homo sapiens","APP, A4, AD1","Amyloid-beta A4 protein","1","6NB9"
"6NBA",,"X-RAY DIFFRACTION",2.35,47.77,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.03 M sodium nitrate
0.03 M sodium phosphate dibasic
0.03 M ammonium sulfate
12.5% (v/v) Methyl-2,4-pentanediol (MPD)
12.5% (v/v)  PEG 1000 
12.5% (w/v) PEG 3350
0.1 M Tris-BICINE buffer (pH 8.5)",293,"10.1074/jbc.RA119.009047",,"6NBA",178.27,"2.495","2.495","Crystal structure of Human Cystathionine gamma lyase with S-3-Carboxpropyl-L-Cysteine","MQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFEYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNRYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAESLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSG","Homo sapiens","CTH","Cystathionine gamma-lyase","1","6NBA"
"6NCF",,"X-RAY DIFFRACTION",2.56,51.99,"VAPOR DIFFUSION, HANGING DROP",6,"8-12% Tacsimate pH 6.0",295,"10.1038/s41589-020-0544-7",,"6NCF",318.48,"2.871","2.871","The structure of Stable-5-Lipoxygenase bound to AKBA","MGSSHHHHHHSSGLVPRGSHMPSYTVTVATGSQEHAGTDDYIYLSLVGSAGCSEKHLLDKGSFERGAVDSYDVTVDEELGEIQLVRIEKRKYGSNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGANPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWASWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNENLQLPYYYLSPDRIPNSVAI","Homo sapiens","ALOX5, LOG5","Arachidonate 5-lipoxygenase","1","6NCF"
"6NCG",,"X-RAY DIFFRACTION",2.15,42.71,"VAPOR DIFFUSION",6,"27.5% PEG3350; 200 mM LiSO4; 0.1M SBG (each Sodium-tartrate + Bis-Tris + Glycylglycine) pH 6.0",293,,,"6NCG",74.43,"2.45","2.45","Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to pyridin-benzenesulfonamide inhibitor","SMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFSTKGQSINVH","Homo sapiens","VRK2","Serine/threonine-protein kinase VRK2","1","6NCG"
"6NCN",,"X-RAY DIFFRACTION",2.13,42.23,"VAPOR DIFFUSION, SITTING DROP",,"20% w/v Polyethylene glycol monomethyl ether mesylate 5,000; 0.1M Bis-Tris buffer at pH6.5",296,"10.1021/acs.jmedchem.9b00178","KJM","6NCN",21.73,"1.82","1.82","Fragment-based Discovery of an apoE4 Stabilizer","GSSHHHHHHSSGLVPRGSHMKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVRGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAG","Homo sapiens","APOE","Apolipoprotein E","1","6NCN"
"6NCO",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, SITTING DROP",,"20% w/v Polyethylene glycol monomethyl ether mesylate 5,000; 0.1M Bis-Tris buffer at pH6.5",296,"10.1021/acs.jmedchem.9b00178","KQP","6NCO",21.87,"1.707","1.707","Fragment-based Discovery of an apoE4 Stabilizer","GSSHHHHHHSSGLVPRGSHMKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVRGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAG","Homo sapiens","APOE","Apolipoprotein E","1","6NCO"
"6NCQ",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-HCl (pH 8,5), 35-40% (v/v) MPD",293,"10.1107/S2053230X19006599",,"6NCQ",30.09,"1.9","1.9","The dimerization domain of human SFPQ in space group C2221","GAMEGFKANLSLLRRPGEKTYTQRCRLFVGNLPADITEDEFKRLFAKYGEPGEVFINKGKGFGFIKLESRALAEIAKAELDDTPMRGRQLRVRFATHAAALSVRNLSPYVSNELLEEAFSQFGPIERAVVIVDDRGRSTGKGIVEFASKPAARKAFERCSEGVFLLTTTPRPVIVEPLEQLDDEDGLPEKLAQKNPMYQKERETPPRFAQHGTFEYEYSQRWKSLDEMEKQQREQVEKNMKDAKDKLESEMEDAYHEHQANLL","Homo sapiens","SFPQ, PSF","Splicing factor, proline- and glutamine-rich","1","6NCQ"
"6NCU",,"X-RAY DIFFRACTION",2.71,54.64,"VAPOR DIFFUSION, SITTING DROP",,"JCSG Core I (Qiagen) screen, condition 92: 0.1M Citric acid pH 2.5, 20%MPD",277,"10.1073/pnas.1819672116",,"6NCU",34.63,"3.5","3.5","Interleukin-37 residues 53-206- dimer","KNLNPKKFSIHDQDHKVLVLDSGNLIAVPDKNYIRPEIFFALASSLSSASAEKGSPILLGVSKGEFCLYCDKDKGQSHPSLQLKKEKLMKLAAQKESARRPFIFYRAQVGSWNMLESAAHPGWFICTSCNCNEPVGVTDKFENRKHIEFSFQPV","Homo sapiens","IL37, FIL1Z, IL1F7, IL1H4, IL1RP1","Interleukin-37","1","6NCU"
"6NCV","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1817221116",,"6NCV",250.56,"3.7",,"Cryo-EM structure of NLRP6 PYD filament","MDQPEAPCSSTGPRLAVARELLLAALEELSQEQLKRFRHKLRDVGPDGRSIPWGRLERADAVDLAEQLAQFYGPEPALEVARKTLKRADARDVAAQLQERRLQRLG","Homo sapiens","NLRP6, NALP6, PYPAF5","NACHT, LRR and PYD domains-containing protein 6","1","6NCV"
"6ND0","3.5","ELECTRON MICROSCOPY",,,,,,,,,"6ND0",397.03,"3.5",,"human BK channel reconstituted into liposomes","LKTSNSIKLVNLLSIFISTWLTAAGFIHLVENSGDPWENFQNNQALTYWECVYLLMVTMSTVGYGDVYAKTTLGRLFMVFFILGGLAMFASYVPEIIELIGNRKKYGGSYSAVSGRKHIVVCGHITLESVSNFLKDFLHKDRDDVNVEIVFLHNISPNLELEALFKRHFTQVEFYQGSVLNPHDLARVKIESADACLILANKYCADPDAEDASNIMRVISIKNYHPKIRIITQMLQYHNKAHLLNIPSWNWKEGDDAICLAELKLGFIAQSCLAQGLSTMLANLFSMRSFIKIEEDTWQKYYLEGVSNEMYTEYLSSAFVGLSFPTVCELCFVKLKLLMIAIEYKSANRESRILINPGNHLKIQEGTLGFFIASDAKEVKRAFFYCKACHDDITDPKRIKKCGCKRPKMSIYKRMRRACCFDCGRSERDCSCMSGRVRGNVDTLERAFPLSSVSVNDCSTSFRAFEDEQPSTLSPKKKQRNGGMRNSPNTSPKLMRHDPLLIPGNDQIDNMDSNVKKYDSTGMFHWCAPKEIEKVILTRSEAAMTVLSGHVVVCIFGDVSSALIGLRNLVMPLRASNFHYHELKHIVFVGSIEYLKREWETLHNFPKVSILPGTPLSRADLRAVNINLCDMCVILSANQNNIDDTSLQDKECILASLNIKSMQFDDSIGVLQANSQGFTPPGMDRSSPDNSPVHGMLRQPSITTGVNIPIITELVNDTNVQFLDQDDDDDPDTELYLTQPFACGTAFAVSVLDSLMSATYFNDNILTLIRTLVTGGATPELEALIAEENALRGGYSTPQTLANRDRCRVAQLALLDGPFADLGDGGCYGDLFCKALKTYNMLCFGIYRLRDAHLSTPSQCTKRYVITNPPYEFELVPTDLIFCL","Homo sapiens","KCNMA1, KCNMA, SLO","Calcium-activated potassium channel subunit alpha-1","1","6ND0"
"6NE5",,"X-RAY DIFFRACTION",2.27,45.85,"EVAPORATION",7,"PEG 3350, MgCl2, Bis-Tris6.5",291,"10.1021/acs.jmedchem.8b01991","KJP","6NE5",74.99,"1.85","1.85","Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors that Demonstrate in vivo Activity in Mouse Xenograft Models of Human Cancer","GADELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGI","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6NE5"
"6NE7",,"X-RAY DIFFRACTION",2.92,57.8,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.2-2.6M Na FORMATE,
0.1M CITRATE pH 5.5",299,"10.1074/jbc.RA119.007682",,"6NE7",36.32,"1.99","1.99","Structure of G810A mutant of RET protein tyrosine kinase domain.","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYASLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","Proto-oncogene tyrosine-protein kinase receptor Ret","1","6NE7"
"6NEA",,"X-RAY DIFFRACTION",4.32,71.51,"VAPOR DIFFUSION, SITTING DROP",7,"15 to 21% PEG 3350, 0.17 - 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acsmedchemlett.9b00021",,"6NEA",121.75,"2.419","2.419","Human Acetylcholinesterase in complex with reactivator, HLo7","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6NEA"
"6NEB",,"SOLUTION NMR",,,,,,,"10.1021/acsomega.8b03580",,"6NEB",8.56,,,"MYC Promoter G-Quadruplex with 1:6:1 loop length","TTGGGGAGGGTTTTAAGGGTGGGGAAT","Homo sapiens",,"DNA (27-MER)","1","6NEB"
"6NEC",,"X-RAY DIFFRACTION",2.23,44.95,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.6 M Na FORMATE
0.1M Na CITRATE PH5.5",297,"10.1074/jbc.RA119.007682","XIN","6NEC",72.59,"1.87","1.87","STRUCTURE OF RET PROTEIN TYROSINE KINASE DOMAIN IN COMPLEX WITH NINTEDANIB","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","Proto-oncogene tyrosine-protein kinase receptor Ret","1","6NEC"
"6NEW",,"X-RAY DIFFRACTION",2.25,45.24,"VAPOR DIFFUSION, HANGING DROP",7.3,"16-22% (v/v) Ethylene Glycol, 0.1M TRIS pH 7.3, and 15% (w/v) Polyethylene Glycol 8000",294,,,"6NEW",49.81,"2.5","2.5","Apo structure of the activated truncation of Vav1","MGKHHHHHHENLYFQGDEIYEDLMRSEPVSMPPKMTEYDKRCCCLREIQQTEEKYTDTLGSIQQHFLKPLQRFLKPQDIEIIFINIEDLLRVHTHFLKEMKEALGTPGAANLYQVFIKYKERFLVYGRYCSQVESASKHLDRVAAAREDVQMKLEECSQRANNGRFTLRDLLMVPMQRVLKYHLLLQELVKHTQEAMEKENLRLALDAMRDLAQCVNEVKRDNETLRQITNFQLSIENLDQSLAHYGRPKIDGELKITSVERRSKMDRYAFLLDKALLICKRRGDSYDLKDFVNLHSFQVRDDSSGDRDNKKWSHMFLLIEDQGAQGYELFFKTRELKKKWMEQFEMAISNIYPENATANGHDFQMFSFEETTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVPPCGRHGQDFPGTM","Homo sapiens","VAV1, VAV","Proto-oncogene vav","1","6NEW"
"6NF0",,"X-RAY DIFFRACTION",2.14,42.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"Co-crystals were grown using the hanging drop vapor diffusion method by mixing the crystallization complex 1:1 with reservoir solution (100 mM HEPES pH 7.5, 10% (v/v) Isopropanol, 50 mM Sodium Acetate, and 12% (w/v) PEG 4,000)",293,"10.1038/s41467-019-10125-z",,"6NF0",36.28,"2.7","2.7","Nocturnin with bound NADPH substrate","GPPPRFQRDFVDLRTDCPSTHPPIRVMQWNILAQALGEGKDNFVQCPVEALKWEERKCLILEEILAYQPDILCLQEVDHYFDTFQPLLSRLGYQGTFFPKPWSPCLDVEHNNGPDGCALFFLQNRFKLVNSANIRLTAMTLKTNQVAIAQTLECKESGRQFCIAVTHLKARTGWERFRSAQGCDLLQNLQNITQGAKIPLIVCGDFNAEPTEEVYKHFASSSLNLNSAYKLLSADGQSEPPYTTWKIRTSGECRHTLDYIWYSKHALNVRSALDLLTEEQIGPNRLPSFNYPSDHLSLVCDFSFTEESDGLS","Homo sapiens","NOCT, CCR4, CCRN4L, NOC","Nocturnin","1","6NF0"
"6NF1",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, HANGING DROP",7.3,"16-22% (v/v) Ethylene Glycol, 0.1M TRIS pH 7.3, and 15% (w/v) Polyethylene Glycol 8000.",294,,,"6NF1",68.17,"2.6","2.6","Vav1 inhibited by an allosteric inhibitor: Vav1 inhibitors block GEF activity","GSGSELWRQCTHWLIQCRVLPPSHRVTWDGAQVCELAQALRDGVLLCQLLNNLLPHAINLREVNLRPQMSQFLCLKNIRTFLSTCCEKFGLKRSELFEAFDLFDVQDFGKVIYTLSALSWTPIAQNRGIMPFPTEEESVGDEDIYSGLSDQIDDTVEEDEDLYDCVENEEAEGDEIYEDLMRSEPVSMPPKMTEYDKRCCCLREIQQTEEKYTDTLGSIQQHFLKPLQRFLKPQDIEIIFINIEDLLRVHTHFLKEMKEALGTPGAANLYQVFIKYKERFLVYGRYCSQVESASKHLDRVAAAREDVQMKLEECSQRANNGRFTLRDLLMVPMQRVLKYHLLLQELVKHTQEAMEKENLRLALDAMRDLAQCVNEVKRDNETLRQITNFQLSIENLDQSLAHYGRPKIDGELKITSVERRSKMDRYAFLLDKALLICKRRGDSYDLKDFVNLHSFQVRDDSSGDRDNKKWSHMFLLIEDQGAQGYELFFKTRELKKKWMEQFEMAISNIYPENATANGHDFQMFSFEETTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVPPCGRHGQDFPGTM","Homo sapiens","VAV1, VAV","Proto-oncogene vav","1","6NF1"
"6NF3",,"X-RAY DIFFRACTION",1.74,29.51,"VAPOR DIFFUSION",6.5,"The crystals were grown by sitting drop vapor diffusion in Cryschem plates using 0.6 ml reservoirs of 16% to 18% 2-methyl-2,4-pentanediol (MPD) containing o.1 M sodium acetate and 0.25% octyl-beta-s-1-thioglucopyanoside. The drops were equal volumes, generally 6 ul each, of the reservoir and an 8 mg/ml solution of protein dissolved in .02 M ammonium bicarbonate.",298,"10.1194/jlr.M089441",,"6NF3",18.69,"2.33","2.33","Structure of the Monoclinic-3 (Monocln-3) Crystal Form of Human Apolipoprotein C1","MRLFLSLPVLVVVLSIVLEGPAPAQGTPDVSSALDKLKEFGNTLEDKARELISRIKQSELSAKMREWFSETFQKVKEKLKIDS","Homo sapiens","APOC1","Apolipoprotein C-I","1","6NF3"
"6NFA",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, HANGING DROP",7.3,"16-22% v/v ethylene glycol, 0.1 M Tris, pH 7.3, 15% w/v PEG8000",294,,,"6NFA",50.17,"2.7","2.7","Vav1 inhibited by an allosteric inhibitor: Vav1 inhibitors block GEF activity","MGKHHHHHHENLYFQGDEIYEDLMRSEPVSMPPKMTEYDKRCCCLREIQQTEEKYTDTLGSIQQHFLKPLQRFLKPQDIEIIFINIEDLLRVHTHFLKEMKEALGTPGAANLYQVFIKYKERFLVYGRYCSQVESASKHLDRVAAAREDVQMKLEECSQRANNGRFTLRDLLMVPMQRVLKYHLLLQELVKHTQEAMEKENLRLALDAMRDLAQCVNEVKRDNETLRQITNFQLSIENLDQSLAHYGRPKIDGELKITSVERRSKMDRYAFLLDKALLICKRRGDSYDLKDFVNLHSFQVRDDSSGDRDNKKWSHMFLLIEDQGAQGYELFFKTRELKKKWMEQFEMAISNIYPENATANGHDFQMFSFEETTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRVPPCGRHGQDFPGTM","Homo sapiens","VAV1, VAV","Proto-oncogene vav","1","6NFA"
"6NFG",,"X-RAY DIFFRACTION",2.44,49.59,"VAPOR DIFFUSION, SITTING DROP",7,"PROTEIN WAS CONCENTRATED TO 6 MG/ML,
AND THEN MIXED AT A 2:1 RATIO WITH PEG 3350 (18-20% V/V), 0.2 M
 AMMONIUM CITRATE (PH 7) IN A SITTING DROP WELL AT 277 K.
 CRYOPROTECTANT WAS MADE USING MOTHER LIQUOR AT A FINAL
 CONCENTRATION OF 23% PEG 3350, VAPOR DIFFUSION, SITTING DROP,
 TEMPERATURE 277K",277.15,,"KKP","6NFG",85.48,"2.76","2.76","CYCLIC GMP-AMP SYNTHASE in complex with compound 16 inhibitor: 7-hydroxy-N-methyl-5-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide","GASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","CYCLIC GMP-AMP SYNTHASE","1","6NFG"
"6NFH",,"X-RAY DIFFRACTION",2.27,45.85,"VAPOR DIFFUSION, SITTING DROP",6.5,"31% w/v PEG5000 MME, 0.1 M MES, pH 6.5, 0.1 M ammonium sulfate",277,"10.1021/acs.jcim.8b00941",,"6NFH",32.46,"1.4","1.4","BTK in complex with inhibitor 8-(2,3-dihydro-1H-inden-5-yl)-2-({4-[(2S)-3-(dimethylamino)-2-hydroxypropoxy]phenyl}amino)-5,8-dihydropteridine-6,7-dione","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6NFH"
"6NFI",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"31% w/v PEG5000 MME, 0.1 M MES, pH 6.5, 0.1 M ammonium sulfate",277,"10.1021/acs.jcim.8b00941",,"6NFI",31.97,"2.41","2.41","BTK in complex with inhibitor N-(3-{[(2,6-dimethylphenyl)methyl]amino}-7-methoxyindeno[1,2-c]pyrazol-6-yl)methanesulfonamide","YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6NFI"
"6NFK",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, SITTING DROP",,"Sodium Iodide, PEG3350",293,,,"6NFK",23.16,"1.86","1.86","Crystal Structure of the Cancer Genomic DNA Mutator APOBEC3B with loop 7 from APOBEC3G bound to iodide","MEILRYLMDPDTFTSNFNNDPLVLRRRQTYLCYEVERLDNGTSVKMDQHMGFLCNESGRHAQLRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIKAARIYDDQGRCQEALQMLRDAGAQVSIMTYDEFEYCWDTFVYRQGCPFQPWDGLEEHSQALSGRLRAILQLEHHHHHH","Homo sapiens","APOBEC3B, APOBEC3G, MDS019","DNA dC->dU-editing enzyme APOBEC-3B","1","6NFK"
"6NFL",,"X-RAY DIFFRACTION",2.24,45,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350",293,,,"6NFL",23.26,"1.731","1.731","Crystal Structure of the Cancer Genomic DNA Mutator APOBEC3B with loop 7 from APOBEC3G complexed with 2-HP","MEILRYLMDPDTFTSNFNNDPLVLRRRQTYLCYEVERLDNGTSVKMDQHMGFLCNESGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIKAARIYDDQGRCQEALQMLRDAGAQVSIMTYDEFEYCWDTFVYRQGCPFQPWDGLEEHSQALSGRLRAILQLEHHHHHH","Homo sapiens","APOBEC3B","DNA dC->dU-editing enzyme APOBEC-3B","1","6NFL"
"6NFM",,"X-RAY DIFFRACTION",2.08,40.73,"VAPOR DIFFUSION, SITTING DROP",,"LiCl, HEPES,PEG3350",293,,,"6NFM",22.88,"2.53","2.53","Crystal Structure of the Cancer Genomic DNA Mutator APOBEC3B with loop 7 from APOBEC3G","MEILRYLMDPDTFTSNFNNDPLVLRRRQTYLCYEVERLDNGTSVKMDQHMGFLCNESGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIKAARIYDDQGRCQEALQMLRDAGAQVSIMTYDEFEYCWDTFVYRQGCPFQPWDGLEEHSQALSGRLRAILQLEHHHHHH","Homo sapiens","APOBEC3B","DNA dC->dU-editing enzyme APOBEC-3B","1","6NFM"
"6NFO",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, SITTING DROP",,"PROTEIN WAS CONCENTRATED TO 6 MG/ML,
AND THEN MIXED AT A 2:1 RATIO WITH PEG 3350 (18-20% V/V), 0.2 M
 AMMONIUM CITRATE (PH 7) IN A SITTING DROP WELL AT 277 K.
 CRYOPROTECTANT WAS MADE USING MOTHER LIQUOR AT A FINAL
 CONCENTRATION OF 23% PEG 3350, VAPOR DIFFUSION, SITTING DROP",277,,"KKM","6NFO",85.57,"2.93","2.93","CYCLIC GMP-AMP SYNTHASE in complex with compound 20 inhibitor: 7-hydroxy-N-[(2S)-1-hydroxypropan-2-yl]-5-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide","GASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","CYCLIC GMP-AMP SYNTHASE","1","6NFO"
"6NFT",,"X-RAY DIFFRACTION",2.87,57.17,"VAPOR DIFFUSION, SITTING DROP",,"2 M sodium/potassium phosphate pH 7.0, 1.1% DMSO (v/v), 25% ethylene glycol (v/v)",298,"10.1021/acs.jmedchem.9b00988",,"6NFT",27.8,"1.65","1.65","Structure of USP5 zinc-finger ubiquitin binding domain co-crystallized with (4-oxoquinazolin-3(4H)-yl)acetic acid","GGEVRQVSKHAFSLKQLDNPARIPPCGWKCSKCDMRENLWLNLTDGSILCGRRYFDGSGGNNHAVEHYRETGYPLAVKLGTITPDGADVYSYDEDDMVLDPSLAEHLSHFGIDMLKMQKTD","Homo sapiens","USP5, ISOT","Ubiquitin carboxyl-terminal hydrolase 5","1","6NFT"
"6NFY",,"X-RAY DIFFRACTION",3.4,63.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"300 nl protein (16 mg/ml) plus 300 nl reservoir solution (4.19 M NaCl, 0.1 M HEPES, pH 6.5) and incubated at 25 C",294.15,"10.1074/jbc.AC119.007466","B49","6NFY",67.6,"2.17","2.17","Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.","GSNRDPRDHYDLLQRLGGGTYGEVFKARDKVSGDLVALKMVKMEPDDDVSTLQKEILILKTCRHANIVAYHGSYLWLQKLWICMEFCGAGSLQDIYQVTGSLSELQISYVCREVLQGLAYLHSQKKIHRDIKGANILINDAGEVRLADFGISAQIGATLARRLSFIGTPYWMAPEVAAVALKGGYNELCDIWSLGITAIELAELQPPLFDVHPLRVLFLMTKSGYQPPRLKEKGKWSAAFHNFIKVTLTKSPKKRPSATKMLSHQLVSQPGLNRGLILDLLDKLKNPGKGPSIGDIEDEE","Homo sapiens","MAP4K1, HPK1","Mitogen-activated protein kinase kinase kinase kinase 1","1","6NFY"
"6NFZ",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M ammonium fluoride, 20% PEG 3350, 100nl well + 100nl protein @ 22mg/ml",286.15,"10.1074/jbc.AC119.007466","B49","6NFZ",69.99,"2.966","2.966","Crystal structure of diphosphorylated HPK1 kinase domain in complex with sunitinib in the active state.","GSMDVVDPDIFNRDPRDHYDLLQRLGGGTYGEVFKARDKVSGDLVALKMVKMEPDDDVSTLQKEILILKTCRHANIVAYHGSYLWLQKLWICMEFCGAGSLQDIYQVTGSLSELQISYVCREVLQGLAYLHSQKKIHRDIKGANILINDAGEVRLADFGISAQIGATLARRLSFIGTPYWMAPEVAAVALKGGYNELCDIWSLGITAIELAELQPPLFDVHPLRVLFLMTKSGYQPPRLKEKGKWSAAFHNFIKVTLTKSPKKRPSATKMLSHQLVSQPGLNRGLILDLLDKLKNPGKGPSIGDIEDEE","Homo sapiens","MAP4K1, HPK1","Mitogen-activated protein kinase kinase kinase kinase 1","1","6NFZ"
"6NG0",,"X-RAY DIFFRACTION",2.58,52.41,"VAPOR DIFFUSION, SITTING DROP",8,"200 nl protein (15 mg/ml) plus 300 nl reservoir solution (0.1 M tris, pH 8.0, 17.5 % 1,6-Hexanediol, 10 mM magnesium sulfate, 24 mM Barium acetate)",286.15,"10.1074/jbc.AC119.007466","B49","6NG0",69.81,"2.05","2.05","Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with sunitinib in the inactive state.","GSMDVVDPDIFNRDPRDHYDLLQRLGGGTYGEVFKARDKVSGDLVALKMVKMEPDDDVSTLQKEILILKTCRHANIVAYHGSYLWLQKLWICMEFCGAGSLQDIYQVTGSLSELQISYVCREVLQGLAYLHSQKKIHRDIKGANILINDAGEVRLADFGISAQIGAELARRLEFIGTPYWMAPEVAAVALKGGYNELCDIWSLGITAIELAELQPPLFDVHPLRVLFLMTKSGYQPPRLKEKGKWSAAFHNFIKVTLTKSPKKRPSATKMLSHQLVSQPGLNRGLILDLLDKLKNPGKGPSIGDIEDEE","Homo sapiens","MAP4K1, HPK1","Mitogen-activated protein kinase kinase kinase kinase 1","1","6NG0"
"6NG1",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KLY","6NG1",99.94,"2.15","2.15","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-fluoro-5-(3-(methylamino)prop-1-yn-1-yl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NG1"
"6NG2",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KM7","6NG2",99.97,"1.93","1.93","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-(3-(dimethylamino)prop-1-yn-1-yl)-5-fluorophenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NG2"
"6NG4",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KMA","6NG4",100.28,"1.776","1.776","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with (R)-6-(3-fluoro-5-(2-(pyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NG4"
"6NG5",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KMD","6NG5",100.22,"1.96","1.96","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with (R)-6-(3-fluoro-5-(2-(1-methylpyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NG5"
"6NG6",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KL4","6NG6",100.1,"2.044","2.044","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with (S)-6-(3-fluoro-5-(2-(pyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NG6"
"6NG7",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KLD","6NG7",100.07,"2","2","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-fluoro-5-(2-((2R,4S)-4-fluoro-1-methylpyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NG7"
"6NG8",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KL1","6NG8",100.02,"1.9","1.9","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(5-(3-(dimethylamino)propyl)-2,3-difluorophenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NG8"
"6NG9",,"X-RAY DIFFRACTION",2.08,40.73,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Sodium Formate, 0.1 M Tris, pH8.5 and 30% (W/V) PEG4000",277,"10.1016/j.str.2019.05.010",,"6NG9",26.36,"1.954","1.954","Crystal structure of human CD160","MINITSSASQEGTRLNLICTVWHKKEEAEGFVVFLCKDRSGDCSPETSLKQLRLKRDPGIDGVGEISSQLMFTISQVTPLHSGTYQCCARSQKSGIRLQGHFFSILFTETGNYTVTGLK","Homo sapiens","CD160, BY55","CD160 antigen","1","6NG9"
"6NGA",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KL7","6NGA",100.02,"1.98","1.98","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-(3-(dimethylamino)propyl)-2,6-difluorophenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NGA"
"6NGB",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KMJ","6NGB",100.02,"1.9","1.9","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-(3-(dimethylamino)propyl)-2,5-difluorophenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NGB"
"6NGC",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KMM","6NGC",100.05,"1.998","1.998","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-(3-(dimethylamino)propyl)-2,5,6-trifluorophenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NGC"
"6NGD",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KMS","6NGD",100.42,"1.8","1.8","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(5-(3-(dimethylamino)propyl)-2,3,4-trifluorophenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NGD"
"6NGE",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KMV","6NGE",100.07,"2.102","2.102","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(2,3-difluoro-5-(3-(methylamino)prop-1-yn-1-yl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NGE"
"6NGF",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KN4","6NGF",100.16,"1.993","1.993","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with (R)-6-(2,3-difluoro-5-(2-(1-methylpyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NGF"
"6NGG",,"X-RAY DIFFRACTION",2.12,41.86,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Sodium Formate, 0.1 M Tris, pH8.5 and 30% (W/V) PEG4000",277,"10.1016/j.str.2019.05.010",,"6NGG",26.42,"1.95","1.95","Crystal structure of human CD160 V58M mutant","MINITSSASQEGTRLNLICTVWHKKEEAEGFVMFLCKDRSGDCSPETSLKQLRLKRDPGIDGVGEISSQLMFTISQVTPLHSGTYQCCARSQKSGIRLQGHFFSILFTETGNYTVTGLK","Homo sapiens","CD160, BY55","CD160 antigen","1","6NGG"
"6NGH",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KPJ","6NGH",100.16,"2","2","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with (S)-6-(2,3-difluoro-5-(2-(1-methylpyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NGH"
"6NGI",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KND","6NGI",100.38,"1.8","1.8","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with (S)-6-(2,3-difluoro-5-(2-(4-methylmorpholin-3-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NGI"
"6NH1",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS, 0.2-0.3M MG ACETATE, 0.1M GdCl3, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NH1",205.52,"2.216","2.216","Structure of human endothelial nitric oxide synthase heme domain in complex with 6-(3-fluoro-5-(3-(methylamino)prop-1-yn-1-yl)phenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NH1"
"6NH2",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NH2",205.63,"2.29","2.29","Structure of human endothelial nitric oxide synthase heme domain in complex with (R)-6-(3-fluoro-5-(2-(pyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NH2"
"6NH3",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NH3",205.7,"2.01","2.01","Structure of human endothelial nitric oxide synthase heme domain in complex with (S)-6-(3-fluoro-5-(2-(pyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NH3"
"6NH4",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NH4",205.53,"2.27","2.27","Structure of human endothelial nitric oxide synthase heme domain in complex with 6-(3-fluoro-5-(2-((2R,4S)-4-fluoropyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NH4"
"6NH5",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NH5",205.87,"1.959","1.959","Structure of human endothelial nitric oxide synthase heme domain in complex with 6-(3-fluoro-5-(2-((2R,4S)-4-fluoro-1-methylpyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NH5"
"6NH6",,"X-RAY DIFFRACTION",2.69,55.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NH6",205.95,"2.189","2.189","Structure of the human endothelial nitric oxide synthase heme domain in complex with 6-(3-(3-(dimethylamino)propyl)-2,6-difluorophenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NH6"
"6NH7",,"X-RAY DIFFRACTION",2.38,48.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NH7",103.49,"1.9","1.9","Structure of human endothelial nitric oxide synthase heme domain in complex with 6-(3-(3-(dimethylamino)propyl)-2,5,6-trifluorophenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NH7"
"6NH8",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NH8",205.61,"1.8","1.8","Structure of human endothelial nitric oxide synthase heme domain in complex with 6-(5-(3-(dimethylamino)propyl)-2,3,4-trifluorophenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NH8"
"6NH9",,"X-RAY DIFFRACTION",2.13,42.16,"VAPOR DIFFUSION, HANGING DROP",10.5,"30% v/v PEG 400
0.1M CAPS",291,,,"6NH9",30.36,"1.85","1.85","Crystal structure of a human calcium/calmodulin dependent serine protein kinase (CASK) PDZ domain","MGRVRLVQFQKNTDEPMGITLKMNELNHCIVARIMHGGMIHRQGTLHVGDEIREINGISVANQTVEQLQKMLREMRGSITFKIVPSYR","Homo sapiens","CASK, LIN2","Peripheral plasma membrane protein CASK","1","6NH9"
"6NHB",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KNS","6NHB",100.43,"2.03","2.03","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(5-(2-((2S,4R)-4-ethoxy-1-methylpyrrolidin-2-yl)ethyl)-2,3-difluorophenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NHB"
"6NHC",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032","KNV","6NHC",100.32,"2.16","2.16","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with (S)-6-(2,3-difluoro-5-(2-(1-methylazetidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6NHC"
"6NHF",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.8b02032",,"6NHF",205.58,"1.83","1.83","Structure of human endothelial nitric oxide synthase heme domain in complex with (S)-6-(2,3-difluoro-5-(2-(1-methylazetidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Endothelial nitric oxide synthase splice variant eNOS13A","1","6NHF"
"6NHK",,"X-RAY DIFFRACTION",2.98,58.76,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.17 M Ammonium Acetate, 0.085 M Sodium Citrate:HCl pH 5.6, 25.5% (w/v) PEG 4000, 15% (v/v) Glycerol",293,"10.1021/acs.jpcb.9b00071",,"6NHK",83.67,"2.777","2.777","Mortalin nucleotide binding domain in the ADP-bound state","GAMGSKGAVVGIDLGTTNSCVAVMEGKQAKVLENAEGARTTPSVVAFTADGERLVGMPAKRQAVTNPNNTFYATKRLIGRRYDDPEVQKDIKNVPFKIVRASNGDAWVEAHGKLYSPSQIGAFVLMKMKETAENYLGHTAKNAVITVPAYFNDSQRQATKDAGQISGLNVLRVINEPTAAALAYGLDKSEDKVIAVYDLGGGTFDISILEIQKGVFEVKSTNGDTFLGGEDFDQALLRHIVKEFKRETGVDLTKDNMALQRVREAAEKAKCELSSSVQTDINLPYLTMDSSGPKHLNMKLTRAQFEGIVTDLIRRTIAPCQKAMQDAEVSKSDIGEVILVGGMTRMPKVQQTVQDLFGRAPSKAVNPDEAVAIGAAIQGGVLA","Homo sapiens","HSPA9, GRP75, HSPA9B, mt-HSP70","Stress-70 protein, mitochondrial","1","6NHK"
"6NHW",,"SOLUTION NMR",,,,,,,"10.1016/j.cell.2019.02.001",,"6NHW",22.35,,,"Structure of the transmembrane domain of the Death Receptor 5 - Dimer of Trimer","MPGSLSGIIIGVTVAAVVLIVAVFVCKSLLWKKVLP","Homo sapiens","TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186","Tumor necrosis factor receptor superfamily member 10B","1","6NHW"
"6NHY",,"SOLUTION NMR",,,,,,,"10.1016/j.cell.2019.02.001",,"6NHY",11.5,,,"Structure of the transmembrane domain of the Death Receptor 5 mutant (G217Y) - Trimer Only","MPGSLSGIIIYVTVAAVVLIVAVFVCKSLLWKKVLP","Homo sapiens","TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186","Tumor necrosis factor receptor superfamily member 10B","1","6NHY"
"6NJ2",,"X-RAY DIFFRACTION",2.42,49.08,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M AMMONIUM SULFATE, 30% PEG 4000,
 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K",278,"10.1021/acsami.9b12746","SO4","6NJ2",61.08,"1.5","1.5","thermostable carbonic anhydrase II variant with tetrazine 2.0 at site 186","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSANPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPXSLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPTQPLKNRQIKASFKHHHHHH","Homo sapiens","CA2","Carbonic anhydrase 2","1","6NJ2"
"6NJ3",,"X-RAY DIFFRACTION",2.01,38.78,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M AMMONIUM ACETATE, 0.1 M SODIUM
 ACETATE TRIHYDRATE PH 4.6, 30% PEG 4000, VAPOR DIFFUSION,
 HANGING DROP, TEMPERATURE 278K",278,"10.1021/acsami.9b12746","ACT","6NJ3",30.37,"1.01","1.01","Thermostable variant of human carbonic anhydrase with ordered tetrazine 2.0 at site 233","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSANPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGXGEPEEPMVDNWRPTQPLKNRQIKASFKHHHHHH","Homo sapiens","CA2","Carbonic anhydrase 2","1","6NJ3"
"6NJ4",,"X-RAY DIFFRACTION",1.97,37.67,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M SODIUM CHLORIDE, 0.1 M TRIS PH
 8.5, 25% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE
 278K",278,"10.1021/acsami.9b12746",,"6NJ4",30.31,"1.3","1.3","Thermostable variant of human carbonic anhydrase with disordered tetrazine 2.0 reacted with strained trans-cyclooctene at site 233","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSANPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGXGEPEEPMVDNWRPTQPLKNRQIKASFKHHHHHH","Homo sapiens","CA2","Carbonic anhydrase 2","1","6NJ4"
"6NJ5",,"X-RAY DIFFRACTION",1.98,37.9,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M SODIUM CHLORIDE, 0.1 M TRIS PH
 8.5, 25% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE
 278K",278,"10.1021/acsami.9b12746",,"6NJ5",30.31,"1.25","1.25","Thermostable variant of human carbonic anhydrase II with disordered tetrazine 2.0 at site 233","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSANPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGXGEPEEPMVDNWRPTQPLKNRQIKASFKHHHHHH","Homo sapiens","CA2","Carbonic anhydrase 2","1","6NJ5"
"6NJ6",,"X-RAY DIFFRACTION",2.5,50.8,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M AMMONIUM SULFATE, 30% PEG 4000,
 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K",278,"10.1021/acsami.9b12746","SO4","6NJ6",61.62,"1.6","1.6","Thermostable variant of human carbonic anhydrase with tetrazine 2.0 at site 186 reacted with sTCO in crystallo","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSANPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPXSLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPTQPLKNRQIKASFKHHHHHH","Homo sapiens","CA2","Carbonic anhydrase 2","1","6NJ6"
"6NJ7",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, HANGING DROP",6.5,"THE 4 UL DROP CONTAINED 2 UL PROTEIN
 (25 MM TRIS, PH 8.0, 250 MM NACL, 4 MM CHAPS, 10 MG/ML PROTEIN)
 AND 2 UL WELL SOLUTION (100 MM MES, PH 6.5, 20 PEG 4000), VAPOR
 DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1021/acs.jmedchem.9b00187",,"6NJ7",132.68,"2.6","2.6","11-BETA DEHYDROGENASE ISOZYME 1 IN COMPLEX WITH COLLETOIC ACID","MKHQHQHQHQHQHQQPLQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","6NJ7"
"6NJA",,"X-RAY DIFFRACTION",2.78,55.79,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.2-2.6M Na FORMATE, 0.1m Na CITRATE pH5.5",295,"10.1074/jbc.RA119.007682",,"6NJA",36.1,"1.92","1.92","Structure of WT RET protein tyrosine kinase domain at 1.92A resolution.","GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","Proto-oncogene tyrosine-protein kinase receptor Ret","1","6NJA"
"6NJE",,"X-RAY DIFFRACTION",1.81,31.94,"VAPOR DIFFUSION",8.5,"3.2 M NaCl, 0.1 M Tris",291,,,"6NJE",42.71,"2.2","2.2","Crystal structure of the motor domain of human kinesin family member 22","MHHHHHHSSGRENLYFQGPPARVRVAVRLRPFVDGTAGASDPPCVRGMDSCSLEIANWRNHQETLKYQFDAFYGERSTQQDIYAGSVQPILRHLLEGQNASVLAYGPTGAGKTHTMLGSPEQPGVIPRALMDLLQLTREEGAEGRPWALSVTMSYLEIYQEKVLDLLDPASGDLVIREDCRGNILIPGLSQKPISSFADFERHFLPASRNRTVGATRLNQRSSRSHAVLLVKVDQRERLAPFRQREGKLYLIDLAGSEDNRRTGNKGLRLKESGAINTSLFVLGKVVDALNQGLPRVPYRDSKLTRLLQDSLGGSAHSILIANIAPERRFYLDTVSALNFAARSKEVINRPFTNESLQPHALGPVKLSQKELLGPPEAK","Homo sapiens","KIF22, KID, KNSL4","Kinesin-like protein KIF22","1","6NJE"
"6NJH",,"X-RAY DIFFRACTION",2.15,42.89,"VAPOR DIFFUSION, SITTING DROP",6.5,"4.6MG/ML VCID7620 + 0.5MM T-048-1
 1MM DTT, 0.1MM ZNCL2, 0.1MM MGCL2 (BATCH 1214013) AGAINST
 SPARSE MATRIX CONDITION MORPHEUS C4, 12.5% W/V PEG1,000 ,
 12.5% W/V PEG3,350 , 12.5% W/V MPD , 0.03M NPS (SODIUM
 NITRATE, DISODIUM HYDROGEN PHOSPHATE, AMMONIUM SULFATE), 0.1M
 MES/IMIDAZOLE PH 6.5, CRYO-PROTECTED - DIRECT (QYM9-2), VAPOR
 DIFFUSION, SITTING DROP, TEMPERATURE 289K",289,"10.1021/acs.jmedchem.9b00193",,"6NJH",172.25,"2.15","2.15","Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-48","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAPAPPLDEQNRDSQGNQVSEFISNTFLDENLYFQ","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6NJH"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDE4D, DPDE3"
"6NJI",,"X-RAY DIFFRACTION",2.44,49.66,"VAPOR DIFFUSION, SITTING DROP",7.14,"5.0MG/ML VCID7620 + 0.5MM T-049
 1MM DTT, 0.1MM ZNCL2, 0.1MM MGCL2 (BATCH 1214023) AGAINST
 OPTIMIZATION MATRIX BASED ON CONDITION MORPHEUS C8, 47.47%V/V
 OF 2X MORPHEUS-PPT4 (FINAL = 11.8% W/V PEG1,000 , 11.8% W/V
 PEG3,350 , 11.8% W/V MPD), 0.03M NPS (SODIUM NITRATE, DISODIUM
 HYDROGEN PHOSPHATE, AMMONIUM SULFATE), 0.1M HEPES PH 7.14,
 CRYO-PROTECTED - DIRECT (ZQV4-6); TRAY ID 236552B5, VAPOR
 DIFFUSION, SITTING DROP, TEMPERATURE 289K",289,"10.1021/acs.jmedchem.9b00193",,"6NJI",86.08,"2.45","2.45","Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-49","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAPAPPLDEQNRDSQGNQVSEFISNTFLDENLYFQ","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6NJI"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDE4D, DPDE3"
"6NJJ",,"X-RAY DIFFRACTION",2.14,42.65,"VAPOR DIFFUSION, SITTING DROP",6.3,"8.8MG/ML VCID7620 + 0.5MM BPN-
 014770 (EBSI4045) IN A PROTEIN SOLUTION CONTAINING 10MM HEPES
 PH 7.5, 100MM NACL, 1MM DTT, 0.1MM ZNCL2, 0.1MM MGCL2 (BATCH
 1214057) AGAINST OPTIMIZATION SCREEN TET_MPC8_JCH7 (OPT SCREEN
 BASED ON MORPHEUS C8 AND JCSG H7); 6.25% W/V PEG1,000, 20.91%
 W/V PEG3350, 6.25% W/V MPD, 0.2M AMMONIUM SULFATE, 0.1MM BIS-
 TRIS PH 6.3, CRYO-PROTECTED - 20% ETHYLENE GLYCOL, CRYSTAL
 TRACKING ID 247599D11 (WEV9-9), PH 6.30, VAPOR DIFFUSION,
 SITTING DROP, TEMPERATURE 289K",298,"10.1021/acs.jmedchem.9b00193",,"6NJJ",173.35,"2.3","2.3","Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with BPN14770","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAPAPPLDEQNRDSQGNQVSEFISNTFLDENLYFQ","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6NJJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDE4D, DPDE3"
"6NJS",,"X-RAY DIFFRACTION",2.83,56.48,"VAPOR DIFFUSION, SITTING DROP",,"10% peg 3350, 100-150 mM ammonium nitrate",277.15,"10.1016/j.ccell.2019.10.002",,"6NJS",65.25,"2.7","2.7","Stat3 Core in complex with compound SD36","GQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCR","Homo sapiens","STAT3, APRF","Signal transducer and activator of transcription 3","1","6NJS"
"6NK4",,"ELECTRON CRYSTALLOGRAPHY",2.54,51.58,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M lithium citrate, 20% PEG3350",291,"10.1073/pnas.2014139118",,"6NK4",1.09,"1.994","1.994","KVQIINKKL, crystal structure of a tau protein fragment","KVQIINKKL","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6NK4"
"6NL3",,"SOLUTION NMR",,,,,,,"10.1016/j.celrep.2019.11.054",,"6NL3",9.59,,,"Solution structure of human Coa6","GSMAAPSMKERQVCWGARDEYWKCLDENLEDASQCKKLRSSFESSCPQQWIKYFDKRRDYLKFKEKFEAGQFEPSETTAKS","Homo sapiens","COA6, C1orf31","Cytochrome c oxidase assembly factor 6 homolog","1","6NL3"
"6NLH",,"X-RAY DIFFRACTION",2.13,42.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"31% PEG 3350, 50 mM Potassium Bromide, Tris pH7.5",277,"10.1016/j.bbadis.2019.05.002",,"6NLH",210.99,"2.199","2.199","Structure of human triose phosphate isomerase R189A","RKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLAGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","Triosephosphate isomerase","1","6NLH"
"6NLO",,"X-RAY DIFFRACTION",2.34,47.47,"VAPOR DIFFUSION, SITTING DROP",,"2.1-2.4M Ammonium Sulfate
0.1M HEPES pH 6.8-8.2",277.15,,,"6NLO",25.34,"2.85021981416","2.85021981416","Human ABCC6 NBD1 H812A in Apo state","SAAGKDCITIHSATFAWSQESPPCLHRINLTVPQGCLLAVVGPVGAGKSSLLSALLGELSKVEGFVSIEGAVAYVPQEAWVQNTSVVENVCFGQELDPPWLERVLEACALQPDVDSFPEGIHTSIGEQGMNLSGGQKQRLSLARAVYRKAAVYLLDDPLAALDAHVGQHVFNQVIGPGGLLQGTTRILVTAALHILPQADWIIVLANGAIAEMGSYQELLQRKGALVCLLDQARQPGD","Homo sapiens","ABCC6, ARA, MRP6","Multidrug resistance-associated protein 6","1","6NLO"
"6NLQ",,"X-RAY DIFFRACTION",1.98,38,"EVAPORATION",7,"0.1 M Tris-HCl, 100 mM calcium chloride, 18% PEG3350",298,"10.1038/s41467-020-14725-y",,"6NLQ",47.23,"1.15","1.15","Human Mitochondrial Alanyl-tRNA Synthetase C-terminal domain","ELLERHSKGPLIVDTVSAESLSVLVKVVRQLCEQAPSTSVLLLSPQPMGKVLCACQVAQGAMPTFTAEAWALAVCSHMGGKAWGSRVVAQGTGSTTDLEAALSIAQTYALSQL","Homo sapiens","AARS2, AARSL, KIAA1270","Alanine--tRNA ligase, mitochondrial","1","6NLQ"
"6NLV",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium citrate, 50 mM Tris HCl, pH 7.8",298,"10.1021/acs.jmedchem.0c02077",,"6NLV",29.34,"1.794","1.794","Selective inhibition of carbonic anhydrase IX activity, using compound SLC-149, displays limited anticancer effects in breast cancer cell lines","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6NLV"
"6NLY",,"X-RAY DIFFRACTION",2.69,54.26,"EVAPORATION",8.5,"0.1 M Tris-HCl, 40% PEG200",298,"10.1038/s41467-020-14725-y",,"6NLY",83.27,"2.307","2.307","Fragment of human mitochondrial Alanyl-tRNA Synthetase C-Ala domain","AATERLSLGSRDVAEALRLSKDIGRLIEAVETAVMPQWQRRELLATVKMLQRRANTAIRKLQMGQAAKKTQELLERHSKGPLIVDTVSAESLSVLVKVVRQLCEQAPSTSVLLLSPQPMGKVLCACQVAQGAMPTFTAEAWALAVCSHMGGKAWGSRVVAQGTGSTTDLEAALSIAQTYALSQLLEHHHHHH","Homo sapiens","AARS2, AARSL, KIAA1270","Alanine--tRNA ligase, mitochondrial","1","6NLY"
"6NM0",,"X-RAY DIFFRACTION",2.13,42.31,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium citrate, 50 mM Tris-HCl, pH 7.8",298,"10.1021/acs.jmedchem.0c02077",,"6NM0",29.52,"1.44","1.44","Selective inhibition of carbonic anhydrase IX activity, using compound SLC-149, displays limited anticancer effects in breast cancer cell lines","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6NM0"
"6NM4",,"X-RAY DIFFRACTION",2.38,48.3,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis-Tris, pH 6.0, 0.2 M ammonium acetate, 24.5% PEG3350",291,"10.1038/s41467-019-13652-x",,"6NM4",45.46,"2.58","2.58","Crystal structure of SAM-bound PRDM9 in complex with MRK-740 inhibitor","SEPQDDDYLYCEMCQNFFIDSCAAHGPPTFVKDSAVDKGHPNRSALSLPPGLRIGPSGIPQAGLGVWNEASDLPLGLHFGPYEGRITEDEEAANNGYSWLITKGRNCYEYVDGKDKSWANWMRYVNCARDDEEQNLVAFQYHRQIFYRTCRVIRPGCELLVWYGDEYGQELGIKWGSKWKKELMAGREPKP","Homo sapiens","PRDM9, PFM6","Histone-lysine N-methyltransferase PRDM9","1","6NM4"
"6NM7",,"X-RAY DIFFRACTION",2.21,44.44,"VAPOR DIFFUSION, SITTING DROP",,"0.056 M NaH2PO4, 1.344 M K2HPO4",291,"10.1016/j.bmcl.2019.01.028",,"6NM7",29.85,"2.426","2.426","PD-L1 IgV domain bound to fragment","MAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKTQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALEHHHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6NM7"
"6NM8",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, SITTING DROP",8.5,"29% PEG 4000, 0.28 M NaCl, 0.01 M Tris",291,"10.1016/j.bmcl.2019.01.028","KSD","6NM8",30.06,"2.792","2.792","IgV-V76T BMS compound 105","MAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKTQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALEHHHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6NM8"
"6NMB",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.03 M sodium nitrate, 0.03 M sodium phosphate, 0.03 M ammonium sulfate, 0.1 M Tris bicine, 25% v/v PEG500, 10% v/v PEG20000",293,"10.1182/bloodadvances.2018025429","AMH","6NMB",128.91,"2.3","2.3","Tranexamic Acid is an Active Site Inhibitor of Urokinase Plasminogen Activator","HHHHHHENLYFQSLKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6NMB"
"6NMQ",,"X-RAY DIFFRACTION",3.2,61.56,"VAPOR DIFFUSION, SITTING DROP",,"2M AMMONIUM SULFATE/100MM IMIDAZOLE, 100 MM MAGNESIUM SULFATE/10% (V/V) GLYCEROL, pH 6.50, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/acsomega.9b00199","KU1","6NMQ",24.23,"1.58","1.58","Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase 2 (PHD2) in Complex with the Carboxamide Analog JNJ43058171","RPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFD","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6NMQ"
"6NMW",,"X-RAY DIFFRACTION",2.22,44.71,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Na citrate, 3.2 M NaCl",298,"10.1371/journal.pone.0215140",,"6NMW",8.08,"1.199","1.199","Crystal structure of the human Lyn SH3 domain","EQGDIVVALYPYDGIHPDDLSFKKGEKMKVLEEHGEWWKAKSLLTKKEGFIPSNYVAKLNTLEHHHHHH","Homo sapiens","LYN, JTK8","Tyrosine-protein kinase Lyn","1","6NMW"
"6NN4",,"X-RAY DIFFRACTION",2.96,58.42,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium citrate dibasic, 20% PEG3350",298,"10.1107/S2053230X19007209",,"6NN4",236.72,"2.15","2.15","The structure of human liver pyruvate kinase, hLPYK-D499N, in complex with Fru-1,6-BP","MEGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVNRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","Pyruvate kinase PKLR","1","6NN4"
"6NN5",,"X-RAY DIFFRACTION",2.95,58.27,"VAPOR DIFFUSION, HANGING DROP",,"0.325 M ammonium citrate dibasic, 16% PEG3350",298,"10.1107/S2053230X19007209",,"6NN5",235.79,"2.256","2.256","The structure of human liver pyruvate kinase, hLPYK-W527H","MEGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGHRPGSGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","Pyruvate kinase PKLR","1","6NN5"
"6NN7",,"X-RAY DIFFRACTION",2.51,50.91,"VAPOR DIFFUSION, HANGING DROP",6,"0.2 M ammonium citrate, pH 6.0, 24% PEG3350",298,"10.1107/S2053230X19007209",,"6NN7",470.22,"2.32","2.32","The structure of human liver pyruvate kinase, hLPYK-GGG","MEGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRGGGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","Pyruvate kinase PKLR","1","6NN7"
"6NN8",,"X-RAY DIFFRACTION",2.49,50.58,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium citrate, pH 5.6, 16% PEG3350",298,"10.1107/S2053230X19007209",,"6NN8",471.39,"2.416","2.416","The structure of human liver pyruvate kinase, hLPYK-S531E","MEGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGEGYTNIMRVLSIS","Homo sapiens","PKLR, PK1, PKL","Pyruvate kinase PKLR","1","6NN8"
"6NNA",,"X-RAY DIFFRACTION",2.26,45.48,"VAPOR DIFFUSION, HANGING DROP",7.6,"0.19 M ammonium sulfate, 5 mM sodium cacodylate,pH7.6 and 27 % w/v PEG 3350",291,"10.1016/j.bmcl.2019.02.012",,"6NNA",147.01,"2.26","2.26","Human Fatty Acid Synthase Psi/KR Tri-Domain with NADPH and Compound 22","QQVPILEKFCFTPHTEEGCLSERAALQEELQLCKGLVQALQTKVTQQGLKMVVPGLDGAQIPRDPSQQELPRLLSAACRLQLNGNLQLELAQVLAQERPKLPEDPLLSGLLDSPALKACLDTAVENMPSLKMKVVEVLAGHGHLYSRIPGLLSPHPLLQLSYTATDRHPQALEAAQAELQQHDVAQGQWDPADPAPSALGSADLLVCNCAVAALGDPASALSNMVAALREGGFLLLHTLLRGHPLGDIVAFLTSTEPQYGQGILSQDAWESLFSRVSLRLVGLKKSFYGSTLFLCRRPTPQDSPIFLPVDDTSFRWVESLKGILADEDSARPVWLKAINCATSGVVGLVNCLRREPGGNRLRCVLLSNLSSTSHVPEVDPGSAELQKVLQGDLVMNVYRDGAWGAFRHFLLEEDKGSKTFCPAHKSYIIAGGLGGFGLELAQWLIQRGVQKLVLTSRSGIRTGYQAKQVRRWRRQGVQVQVSTSNISSLEGARGLIAEAAQLGPVGGVFNLAVVLRDGLLENQTPEFFQDVCKPKYSGTLNLDRVTREACPELDYFVVFSSVSCGRGNAGQSNYGFANSAMERICEKRRHEGLPGLAVQWGAIGDVGILVETMSTNDTIVSGTLPQRMASCLEVLDLFLNQPHMVLSSFVLAEKHHHHHH","Homo sapiens","FASN, FAS","Fatty acid synthase,Fatty acid synthase","1","6NNA"
,,,,,,,,,,,,,,,,,"Homo sapiens","FASN, FAS"
"6NNX",,"X-RAY DIFFRACTION",3.19,61.43,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Sodium Malonate",298,,,"6NNX",15.88,"1.87","1.87","Crystal Structure of the All-Trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121M Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.87 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIMTMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6NNX"
"6NNY",,"X-RAY DIFFRACTION",3.1,60.37,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Tacsimate",277,,,"6NNY",15.85,"1.668","1.668","Crystal Structure of the All-Trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39E:R59Y:L121E Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.67 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKEAVEIKQEGDTFYIKVSTTVYTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6NNY"
"6NO8",,"X-RAY DIFFRACTION",3.44,64.2,"EVAPORATION",8.5,"of 0.1 M Tris 8.5, 0.1-0.3M LiSO4, and 29-33% PEG 4000",292,,"KUY","6NO8",32.06,"2.377","2.377","PIM1 in complex with Cpd9 ((R)-5-amino-N-(3-(4-aminoazepan-1-yl)-1H-pyrazol-4-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide)","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6NO8"
"6NO9",,"X-RAY DIFFRACTION",3.45,64.36,"EVAPORATION",8.5,"0.1 M Tris 8.5, 0.1-0.3M LiSO4, and 29-33% PEG 4000",292,"10.1021/acs.jmedchem.8b01857","KUV","6NO9",32.27,"1.712","1.712","PIM1 in complex with Cpd16 (5-amino-N-(5-((4R,5R)-4-amino-5-fluoroazepan-1-yl)-1-methyl-1H-pyrazol-4-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide)","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6NO9"
"6NOA",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2020.01.001",,"6NOA",17.63,,,"Solution Structure of the RNA element that recruits eIF3 to the 5'-UTR of c-Jun and regulates specialized translation initiation (apical loop)","GGCAGUAUAGUCCGAACUGCAAAUCUUAUUUUCUUUUCACCUUCUCUCUAACUGCC","Homo sapiens",,"C-JUN SL1","1","6NOA"
"6NOE",,"X-RAY DIFFRACTION",3.23,61.94,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350,Sodium Malonate",277,,,"6NOE",15.88,"1.969","1.969","Crystal Structure of the All-Trans Retinal-Bound R111K:Y134F:T54V:R132Q:P39Y:R59Y:L121E:I63D Mutant of Human Cellular Retinoic Acid Binding Protein II in the Dark at 1.97 Angstrom Resolution","PNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKYAVEIKQEGDTFYIKVSTTVYTTEDNFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTKELTNDGELIETMTADDVVCTQVFVRE","Homo sapiens","CRABP2","Cellular retinoic acid-binding protein 2","1","6NOE"
"6NOJ",,"X-RAY DIFFRACTION",2.28,46.03,"EVAPORATION",,"0.056 M sodium phosphate monobasic, 1.344 M potassium phosphate dibasic",291,"10.1016/j.bmcl.2019.01.028",,"6NOJ",29.34,"2.33","2.33","PD-L1 IgV domain V76T with fragment","AFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKTQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALHHHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6NOJ"
"6NOS",,"X-RAY DIFFRACTION",2.33,47.27,"EVAPORATION",,"0.056 M sodium phosphate monobasic, 1.344 M potassium phosphate dibasic",291,"10.1016/j.bmcl.2019.01.028",,"6NOS",29.36,"2.701","2.701","PD-L1 IgV domain V76T with fragment","AFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKTQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALHHHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6NOS"
"6NOU",,"X-RAY DIFFRACTION",2.32,46.94,"VAPOR DIFFUSION, SITTING DROP",7,"2800mM Sodium Acetate pH 7",294,"10.1080/19420862.2019.1624463",,"6NOU",27.99,"1.914","1.914","An scFv derived from ixekizumab","QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQCLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSSQPDGGSGGSGGGSGGSKADYEKHKVDIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGCGTKLEIK","Homo sapiens",,"scFv derived from ixekizumab","1","6NOU"
"6NOV",,"X-RAY DIFFRACTION",2.69,54.28,"VAPOR DIFFUSION, SITTING DROP",6.5,"28% PEG 5000 MME/100 mM MES (pH 6.5)/200 mM ammonium phosphate",294,"10.1080/19420862.2019.1624463",,"6NOV",97.34,"2.14","2.14","A Fab derived from ixekizumab","QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTH","Homo sapiens",,"Fab Heavy Chain","1","6NOV"
,,,,,,,,,,,,,,,,"DIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab Light Chain","2","6NOV"
"6NOW",,"X-RAY DIFFRACTION",5.08,75.81,"EVAPORATION",7,"0.1 M imidazole, 2 M sodium chloride",298,"10.1038/s41467-020-14725-y",,"6NOW",44.03,"4.099","4.099","Human Mitochondrial Alanyl-tRNA Synthetase C-Ala domain","GEQAQQARELGQSLAQEVKAATERLSLGSRDVAERLRLSKDIGRLIEAVETSVMPQWQRRELLATVKMLQRRANTAIRKLQMGQAAKKTQELLERHSKGPLIVDTVSAESLSVLVKVVRQLCEQAPSTSVLLLSPQPMGKVLCACQVAQGAMPTFTAEAWALAVCSHMGGKAWGSRVVAQGTGSTTDLEAALSIAQTYALSQLL","Homo sapiens","AARS2, AARSL, KIAA1270","Alanine--tRNA ligase, mitochondrial","1","6NOW"
"6NP9",,"X-RAY DIFFRACTION",2.13,42.15,"EVAPORATION",,"Ammonium Sulfate",291,"10.1016/j.bmcl.2019.01.028",,"6NP9",14.73,"1.27","1.27","PD-L1 IgV domain V76T with fragment","AFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKTQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALHEHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6NP9"
"6NPE",,"X-RAY DIFFRACTION",2.96,58.42,"VAPOR DIFFUSION",,"20 mM Tris-HCl [pH 8.0]
 100 mM NaCl
3 mM DTT, and 5% (v/v) glycerol.

1-3 % PEG300,
2M AmSO4
Cryo: 20% glycerol",277,"10.1021/acs.jmedchem.8b01872","STI, KWD","6NPE",71.83,"2.15","2.15","C-abl Kinase domain with the activator(cmpd6), 2-cyano-N-(4-(3,4-dichlorophenyl)thiazol-2-yl)acetamide","MHHHHHHENLYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6NPE"
"6NPN",,"X-RAY DIFFRACTION",2.59,52.47,"VAPOR DIFFUSION, SITTING DROP",6,"27.5% PEG 3350, 20 mM Li2SO4, 0.1M SBG, pH 6.0",293,,,"6NPN",167.98,"2.2","2.2","Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine-3-hydroxyindazole inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6NPN"
"6NPT",,"X-RAY DIFFRACTION",2.57,52.25,"VAPOR DIFFUSION, HANGING DROP",,"The protein at a concentration of 10 mg/ml was mixed with 2mM of the ligand (diluted from 100 mM DMSO stock solution) for 1 hour on ice and crystallized at 4 deg C (hanging drop) from:
0.10 M KH2PO4/ 0.10 M NaH2PO4/ 0.10 M MES/NaOH pH 6.00 and 1.90 M NaCl (cryo: 25% glycerol in reservoir), or
18.00 % (w/v) PEG 3350, 0.20 M CaCl2, 0.10 M, MES pH=6.50 (cryo: direct).",277.15,"10.1021/acschembio.9b00126","KWY","6NPT",35.22,"2.19","2.19","TRK-A IN COMPLEX WITH LIGAND 1","IENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6NPT"
"6NPU",,"X-RAY DIFFRACTION",2.99,58.84,"VAPOR DIFFUSION",,"1 - 3 % PEG 400
2M AmSO4
0.1 HEPES pH 7.5
cryo: 20% Glycerol",277,"10.1021/acs.jmedchem.8b01872","STI, KWV","6NPU",71.64,"2.33","2.33","C-abl Kinase domain with the activator(cmpd29), N-(1-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)acetamide","MHHHHHHENLYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6NPU"
"6NPV",,"X-RAY DIFFRACTION",2.97,58.56,"VAPOR DIFFUSION",,"1 - 3 % PEG 400
0.1 HEPES pH 7.5
2M AmSO4",277,"10.1021/acs.jmedchem.8b01872","STI, KWP","6NPV",72.05,"1.86","1.86","C-abl Kinase domain with the activator(cmpd51), N-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-dihydro-1H-pyrazol-3-yl)isonicotinamide","MHHHHHHENLYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6NPV"
"6NQ0","3.7","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.45222",,"6NQ0",172.84,"3.7",,"Cryo-EM structure of human TPC2 channel in the ligand-bound open state","GSLEMAEPQAESEPAAGGARGGGGDWPAGLTTYRSIQVGPGAAARWDLCIDQAVVFIEDAIQYRSINHRVDASSMWLYRRYYSNVCQRTLSFTIFLILFLAFIETPSSLTSTADVRYRAAPWEPPCGLTESVEVLCLLVFAADLSVKGYLFGWAHFQKNLWLLGYLVVLVVSLVDWTVSLSLVCHEPLRIRRLLRPFFLLQNSSMMKKTLKCIRWSLPEMASVGLLLAIHLCLFTMFGMLLFAGGKQDDGQDRERLTYFQNLPESLTSLLVLLTTANNPDVMIPAYSKNRAYAIFFIVFTVIGSLFLMNLLTAIIYSQFRGYLMKSLQTSLFRRRLGTRAAFEVLSSMVGEGGAFPQAVGVKPQNLLQVLQKVQLDSSHKQAMMEKVRSYGSVLLSAEEFQKLFNELDRSVVKEHPPRPEYQSPFLQSAQFLFGHYYFDYLGNLIALANLVSICVFLVLDADVLPAERDDFILGILNCVFIVYYLLEMLLKVFALGLRGYLSYPSNVFDGLLTVVLLVLEISTLAVYRLPHPGWRPEMVGLLSLWDMTRMLNMLIVFRFLRIIPSMKPMAVVASTVLGLVQNMRAFGGILVVVYYVFAIIGINLFRGVIVALPGNSSLAPANGSAPCGSFEQLEYWANNFDDFAAALVTLWNLMVVNNWQVFLDAYRRYSGPWSKIYFVLWWLVSSVIWVNLFLALILENFLHKWDPRSHLQPLAGTPEATYQMTVELLFRDILEEPEEDELTERLSQHPHLWLCR","Homo sapiens","TPCN2, TPC2","Two pore calcium channel protein 2","1","6NQ0"
"6NQ1","3.5","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.45222",,"6NQ1",171.34,"3.5",,"Cryo-EM structure of human TPC2 channel in the apo state","GSLEMAEPQAESEPAAGGARGGGGDWPAGLTTYRSIQVGPGAAARWDLCIDQAVVFIEDAIQYRSINHRVDASSMWLYRRYYSNVCQRTLSFTIFLILFLAFIETPSSLTSTADVRYRAAPWEPPCGLTESVEVLCLLVFAADLSVKGYLFGWAHFQKNLWLLGYLVVLVVSLVDWTVSLSLVCHEPLRIRRLLRPFFLLQNSSMMKKTLKCIRWSLPEMASVGLLLAIHLCLFTMFGMLLFAGGKQDDGQDRERLTYFQNLPESLTSLLVLLTTANNPDVMIPAYSKNRAYAIFFIVFTVIGSLFLMNLLTAIIYSQFRGYLMKSLQTSLFRRRLGTRAAFEVLSSMVGEGGAFPQAVGVKPQNLLQVLQKVQLDSSHKQAMMEKVRSYGSVLLSAEEFQKLFNELDRSVVKEHPPRPEYQSPFLQSAQFLFGHYYFDYLGNLIALANLVSICVFLVLDADVLPAERDDFILGILNCVFIVYYLLEMLLKVFALGLRGYLSYPSNVFDGLLTVVLLVLEISTLAVYRLPHPGWRPEMVGLLSLWDMTRMLNMLIVFRFLRIIPSMKPMAVVASTVLGLVQNMRAFGGILVVVYYVFAIIGINLFRGVIVALPGNSSLAPANGSAPCGSFEQLEYWANNFDDFAAALVTLWNLMVVNNWQVFLDAYRRYSGPWSKIYFVLWWLVSSVIWVNLFLALILENFLHKWDPRSHLQPLAGTPEATYQMTVELLFRDILEEPEEDELTERLSQHPHLWLCR","Homo sapiens","TPCN2, TPC2","Two pore calcium channel protein 2","1","6NQ1"
"6NQ2","3.4","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.45222",,"6NQ2",172.84,"3.4",,"Cryo-EM structure of human TPC2 channel in the ligand-bound closed state","GSLEMAEPQAESEPAAGGARGGGGDWPAGLTTYRSIQVGPGAAARWDLCIDQAVVFIEDAIQYRSINHRVDASSMWLYRRYYSNVCQRTLSFTIFLILFLAFIETPSSLTSTADVRYRAAPWEPPCGLTESVEVLCLLVFAADLSVKGYLFGWAHFQKNLWLLGYLVVLVVSLVDWTVSLSLVCHEPLRIRRLLRPFFLLQNSSMMKKTLKCIRWSLPEMASVGLLLAIHLCLFTMFGMLLFAGGKQDDGQDRERLTYFQNLPESLTSLLVLLTTANNPDVMIPAYSKNRAYAIFFIVFTVIGSLFLMNLLTAIIYSQFRGYLMKSLQTSLFRRRLGTRAAFEVLSSMVGEGGAFPQAVGVKPQNLLQVLQKVQLDSSHKQAMMEKVRSYGSVLLSAEEFQKLFNELDRSVVKEHPPRPEYQSPFLQSAQFLFGHYYFDYLGNLIALANLVSICVFLVLDADVLPAERDDFILGILNCVFIVYYLLEMLLKVFALGLRGYLSYPSNVFDGLLTVVLLVLEISTLAVYRLPHPGWRPEMVGLLSLWDMTRMLNMLIVFRFLRIIPSMKPMAVVASTVLGLVQNMRAFGGILVVVYYVFAIIGINLFRGVIVALPGNSSLAPANGSAPCGSFEQLEYWANNFDDFAAALVTLWNLMVVNNWQVFLDAYRRYSGPWSKIYFVLWWLVSSVIWVNLFLALILENFLHKWDPRSHLQPLAGTPEATYQMTVELLFRDILEEPEEDELTERLSQHPHLWLCR","Homo sapiens","TPCN2, TPC2","Two pore calcium channel protein 2","1","6NQ2"
"6NQM",,"X-RAY DIFFRACTION",3.78,67.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3350 8%, 0.1 M Ammonium citrate pH6.5",296,"10.3389/fimmu.2019.01351",,"6NQM",74.09,"2.9","2.9","Crystal structure of Human LSD1","GVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFL","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","6NQM"
"6NQT",,"X-RAY DIFFRACTION",2.45,49.84,"VAPOR DIFFUSION, SITTING DROP",,"PEG",293,"10.1016/j.molcel.2020.03.030",,"6NQT",392.72,"3.05","3.05","GalNac-T2 soaked with UDP-sugar","MRRRSRMLLCFAFLWVLGIAYYMYSGGGSALAGGAGGGAGRKEDWNEIDPIKKKDLHHSNGEEKAQSMETLPPGKVRWPDFNQEAYVGGTMVRSGQDPYARNKFNQVESDKLRMDRAIPDTRHDQCQRKQWRVDLPATSVVITFHNEARSALLRTVVSVLKKSPPHLIKEIILVDDYSNDPEDGALLGKIEKVRVLRNDRREGLMRSRVRGADAAQAKVLTFLDSHCECNEHWLEPLLERVAEDRTRVVSPIADVINMDNFQYVGASADLKGGFDWNLVFKWDYMTPEQRRSRQGNPVAPIKTPMIAGGAFVMDKFYFEELGKYDMMMDVWGGENLEISFRVWQCGGSLEIIPCSRVGHVFRKQHPYTFPGGSGTVFARNTRRAAEVWMDEYKNFYYAAVPSARNVPYGNIQSRLELRKKLSCKPFKWYLENVYPELRVPDHQDIAFGALQQGTNCLDTLGHFADGVVGVYECHNAGGNQEWALTKEKSVKHMDLCLTVVDRAPGSLIKLQGCRENDSRQKWEQIEGNSKLRHVGSNLCLDSRTAKSGGLSVEVCGPALSQQWKFTLNLQQ","Homo sapiens","GALNT2","Polypeptide N-acetylgalactosaminyltransferase 2","1","6NQT"
"6NQU",,"X-RAY DIFFRACTION",3.71,66.87,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350 6%, 0.1M Ammonium citrate pH7.0",296,"10.3389/fimmu.2019.01351",,"6NQU",74.23,"2.7","2.7","Human LSD1 in complex with GSK2879552","GVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFL","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","6NQU"
"6NR0",,"X-RAY DIFFRACTION",2.49,55.04,"VAPOR DIFFUSION, HANGING DROP",5,"Mixed solution of 0.44 mM protein (in buffer of 20 mM Tris/HCl pH 7.5, 160 mM NaCl) 2.5 mM NAD+, 2.5 mM Glucose-TM-1beta with an equal volume of well solution of 2 M (NH4)2SO4, 80 mM Na Acetate/HCl pH 5.0",293,"10.1021/acschembio.9b00384",,"6NR0",75.38,"2.45","2.45","SIRT2(56-356) with covalent intermediate between mechanism-based inhibitor Glucose-TM-1beta and 1'-SH ADP-ribose","MDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","6NR0"
"6NR5",,"X-RAY DIFFRACTION",3.85,68.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 3350 95, 0.1M Ammonium citrate pH6.5",296,"10.3389/fimmu.2019.01351",,"6NR5",74.2,"2.9","2.9","Human LSD1 in complex with Phenelzine sulfate","GVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFL","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","6NR5"
"6NRF",,"X-RAY DIFFRACTION",2.51,51.02,"EVAPORATION",7.5,"~20% PEG 3350, 0.2 M ammonium sulfate or sodium citrate, 100 mM Hepes pH 7.5",298,"10.1021/acs.jmedchem.8b01709","KYV","6NRF",30.84,"2","2","Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT103","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFGSGSGSGGDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTS","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6NRF"
"6NRG",,"X-RAY DIFFRACTION",2.5,50.73,"EVAPORATION",7.5,"~20% PEG 3350, 0.2 M ammonium sulfate or sodium citrate, 100 mM Hepes pH 7.5",298,"10.1021/acs.jmedchem.8b01709","KYY","6NRG",31.07,"1.7","1.7","Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT57","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFGSGSGSGGDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTS","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6NRG"
"6NRH",,"X-RAY DIFFRACTION",2.51,51.04,"EVAPORATION",7.5,"~20% PEG 3350, 0.2 M ammonium sulfate or sodium citrate, 100 mM Hepes pH 7.5",298,"10.1021/acs.jmedchem.8b01709","KYP","6NRH",31.1,"1.5","1.5","Crystal Structure of human PARP-1 ART domain bound inhibitor UTT63","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFGSGSGSGGDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTS","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6NRH"
"6NRI",,"X-RAY DIFFRACTION",2.54,51.55,"EVAPORATION",7.5,"~20% PEG 3350, 0.2 M ammonium sulfate or sodium citrate, 100 mM Hepes pH 7.5",298,"10.1021/acs.jmedchem.8b01709","KYM","6NRI",30.76,"2.2","2.2","Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT83","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFGSGSGSGGDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTS","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6NRI"
"6NRJ",,"X-RAY DIFFRACTION",2.56,51.92,"EVAPORATION",7.5,"~20% PEG 3350, 0.2 M ammonium sulfate or sodium citrate, 100 mM Hepes pH 7.5",298,"10.1021/acs.jmedchem.8b01709","KYJ","6NRJ",31.09,"1.65","1.65","Crystal Structure of human PARP-1 ART domain bound to inhibitor UTT93","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFGSGSGSGGDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTS","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6NRJ"
"6NRY",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, SITTING DROP",5.5,"25mM Bis-Tris, 20% PEG3350",277,,,"6NRY",32.92,"2.184","2.184","Crystal structure of human caspase-4","GSMEAGPPESGESTDALKLCPHEEFLRLCKERAEEIYPIKERNNRTRLALIICNTEFDHLPPRNGADFDITGMKELLEGLDYSVDVEENLTARDMESALRAFATRPEHKSSDSTFLVLMSHGILEGICGTVHDEKKPDVLLYDTIFQIFNNRNCLSLKDKPKVIIVQAARGANRGELWVRDSPASLEVASSQSSENLEEDAVYKTHVEKDFIAFCSSTPHNVSWRDSTMGSIFITQLITCFQKYSWCCHLEEVFRKVQQSFETPRAKAQMPTIERLSMTRYFYLFPGN","Homo sapiens","CASP4, ICH2","Caspase-4","1","6NRY"
"6NSL",,"X-RAY DIFFRACTION",1.92,36.13,"VAPOR DIFFUSION, HANGING DROP",,"200 mM ammonium sulfate, and 100 mM sodium cacodylate buffer, pH 6.5, 30%(W/V) PEG 5000 (Methyl Ether)",293,"10.1021/acsmedchemlett.9b00035","KZJ","6NSL",72.17,"2.15","2.15","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound-6c AKA 6-((1-(4-CYANOPHENY L)-2-OXO-1,2-DIHYDRO-3-PYRIDINYL)AMINO)-N-CYCLOPROPYL-8-(M ETHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBOXAMIDE","MGSSHHHHHHSSGETVRFQGHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6NSL"
"6NSP",,"X-RAY DIFFRACTION",2.66,53.87,"VAPOR DIFFUSION, HANGING DROP",,"0.1M KH2PO4/ 0.1M NaH2PO4/ 0.1M MES/NaOH pH 6.0 and 1.9M NaCl (cryo: 25% glycerol in reservoir), or 18% (w/v) PEG 3350, 0.2M CaCl2, 0.1M, MES pH = 6.50 (cryo: direct).",277,"10.1021/acschembio.9b00126","L0P","6NSP",34.13,"2.31","2.31","TRK-A IN COMPLEX WITH LIGAND 9","ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6NSP"
"6NSQ",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, SITTING DROP",7,"25% PEG 3350, 0.1M Bis-Tris Propane pH 7.75, 0.2M Sodium Malonate",277,"10.1021/acsmedchemlett.9b00194",,"6NSQ",65.41,"3.05","3.05","Crystal structure of BRAF kinase domain bound to the inhibitor 2l","GAMDRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6NSQ"
"6NSS",,"X-RAY DIFFRACTION",2.54,51.61,"VAPOR DIFFUSION, HANGING DROP",,"0.10M KH2PO4/ 0.10M NaH2PO4/ 0.1M MES/NaOH pH = 6.00 and 1.9M NaCl (cryo: 25% glycerol in reservoir), or 18% (w/v) PEG 3350, 0.2M CaCl2, 0.10M, MES pH = 6.50 (cryo: direct).",277,"10.1021/acschembio.9b00126","L0M","6NSS",35.8,"1.97","1.97","TRK-A IN COMPLEX WITH LIGAND 6","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6NSS"
"6NT2",,"X-RAY DIFFRACTION",3.17,61.24,"VAPOR DIFFUSION, HANGING DROP",6.5,"SAH and inhibitor were added to PRMT1 to a final concentration of 1.5mM each (3% DMSO). The complex was incubated at 4deg C before crystallization. 1uL protein-ligand complex was mixed with 1 uL of reservoir solution containing 0.3M sodium formate, 0.1M HEPES, 8% PEG 10,000, pH 6.5, and 0.2 uL 30% sodium dextran sulfate Mr=5,000). The droplets were incubated against 500uL reservoir solution for 1-2 days before crystals were observed.",291,"10.1016/j.ccell.2019.05.014","SAH","6NT2",175.32,"2.48","2.48","type 1 PRMT in complex with the inhibitor GSK3368715","MAAAEAANCIMENFVATLANGMSLQPPLEEVSCGQAESSEKPNAEDMTSKDYYFDSYAHFGIHEEMLKDEVRTLTYRNSMFHNRHLFKDKVVLDVGSGTGILCMFAAKAGARKVIGIECSSISDYAVKIVKANKLDHVVTIIKGKVEEVELPVEKVDIIISEWMGYCLFYESMLNTVLYARDKWLAPDGLIFPDRATLYVTAIEDRQYKDYKIHWWENVYGFDMSCIKDVAIKEPLVDVVDPKQLVTNACLIKEVDIYTVKVEDLTFTSPFCLQVKRNDYVHALVAYFNIEFTRCHKRTGFSTSPESPYTHWKQTVFYMEDYLTVKTGEEIFGTIGMRPNAKNNRDLDFTIDLDFKGQLCELSCSTDYRMR","Homo sapiens","PRMT1, HMT2, HRMT1L2, IR1B4","Protein arginine N-methyltransferase 1","1","6NT2"
"6NT5","4.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-0998-5",,"6NT5",85.97,"4.1",,"Cryo-EM structure of full-length human STING in the apo state","MPHSSLHPSIPCPRGHGAQKAALVLLSACLVTLWGLGEPPEHTLRYLVLHLASLQLGLLLNGVCSLAEELRHIHSRYRGSYWRTVRACLGCPLRRGALLLLSIYFYYSLPNAVGPPFTWMLALLGLSQALNILLGLKGLAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFSLEVLFQ","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6NT5"
"6NTG",,"X-RAY DIFFRACTION",4.32,71.55,"VAPOR DIFFUSION, SITTING DROP",7,"15-21% PEG 3350 and 0.17- 0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"6NTG",122.04,"2.652","2.652","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by A-234 in Complex with Reactivator, HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6NTG"
"6NTH",,"X-RAY DIFFRACTION",4.39,72,"VAPOR DIFFUSION, SITTING DROP",7,"15-21% polyethylene glycol 3350 (PEG) and 0.17- 0.21M potassium nitrate",295,,,"6NTH",121.46,"2.421","2.421","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by (S) Stereoisomer of A-232","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6NTH"
"6NTK",,"X-RAY DIFFRACTION",4.35,71.73,"VAPOR DIFFUSION, SITTING DROP",7,"15-21% polyethylene glycol 3350 (PEG) and 0.17- 0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"6NTK",121.29,"2.406","2.406","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by A-232","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6NTK"
"6NTL",,"X-RAY DIFFRACTION",4.33,71.6,"VAPOR DIFFUSION, SITTING DROP",7,"15-21% polyethylene glycol 3350 (PEG) and 0.17- 0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"6NTL",121.33,"2.25","2.25","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by A-234","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6NTL"
"6NTM",,"X-RAY DIFFRACTION",4.37,71.84,"VAPOR DIFFUSION, SITTING DROP",7,"15-21% polyethylene glycol 3350 (PEG) and 0.17- 0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"6NTM",121.82,"2.552","2.552","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by A-232 in Complex with the Reactivator, HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6NTM"
"6NTN",,"X-RAY DIFFRACTION",4.28,71.28,"VAPOR DIFFUSION, SITTING DROP",7,"15-21% polyethylene glycol 3350 (PEG) and 0.17- 0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"6NTN",121.79,"2.697","2.697","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by A-230 in Complex with the Reactivator, HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6NTN"
"6NTO",,"X-RAY DIFFRACTION",4.28,71.28,"VAPOR DIFFUSION, SITTING DROP",7,"15-21% polyethylene glycol 3350 (PEG) and 0.17- 0.21M potassium nitrate with DMSO, glycerol, and ethylene glycol in a 1:1:1 ratio; pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"6NTO",121.84,"2.052","2.052","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by A-230","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6NTO"
"6NTU",,"X-RAY DIFFRACTION",2.8,56,"EVAPORATION",5.6,"~20% PEG 3350, 0.2 M ammonium sulfate, 10% DMSO (plus 20% sucrose in cryo), 100 mM sodium citrate pH 5.6",298,"10.1126/science.aax6367",,"6NTU",31.42,"1.8","1.8","Crystal Structure of human PARP-1 ART domain bound to inhibitor UKTT-15","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFGSGSGSGGDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTS","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6NTU"
"6NTY",,"X-RAY DIFFRACTION",1.6,25,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.4 M ammonium phosphate dibasic, 0.1 M Tris",291,"10.1002/prot.25836",,"6NTY",21.37,"2.1","2.1","2.1 A resolution structure of the Musashi-2 (Msi2) RNA recognition motif 1 (RRM1) domain","SNAGKMFIGGLSWQTSPDSLRDYFSKFGEIRECMVMRDPTTKRSRGFGFVTFADPASVDKVLGQPHHELDSKTIDPKVAFPRRAQPKMVTRTKK","Homo sapiens","MSI2","RNA-binding protein Musashi homolog 2","1","6NTY"
"6NU1",,"X-RAY DIFFRACTION",2.42,49.25,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M SODIUM THIOCYANATE, 100 mM BIS-TRIS PROPANE, 16-20% PEG 3350, 0.2 M NDSB-221",293,"10.1021/acs.biochem.9b00349",,"6NU1",243.13,"2.25","2.25","Crystal Structure of Human PKM2 in Complex with L-cysteine","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6NU1"
"6NU5",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M SODIUM THIOCYANATE, 100 mM BIS-TRIS PROPANE, 16-20% PEG 3350",291,"10.1021/acs.biochem.9b00349",,"6NU5",121.88,"1.6","1.6","Pyruvate Kinase M2 Mutant - S437Y in Complex with L-cysteine","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRYAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6NU5"
"6NUB",,"X-RAY DIFFRACTION",2.41,48.87,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M SODIUM THIOCYANATE, 100 mM BIS-TRIS PROPANE, 16-20% PEG 3350",291,"10.1021/acs.biochem.9b00349",,"6NUB",121.98,"1.7","1.7","Pyruvate Kinase M2 Mutant - S437Y in Complex with L-serine","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRYAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6NUB"
"6NUG",,"SOLUTION NMR",,,,,,,,,"6NUG",2.59,,,"hGRNA4-28_3s","CDMEVSCPDGYTCCRLQSGAWGCC","Homo sapiens","GRN","Granulin-4","1","6NUG"
"6NUI",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA119.009251",,"6NUI",21.89,,,"Human Guanylate Kinase","HMSGPRPVVLSGPSGAGKSTLLKRLLQEHSGIFGFSVSHTTRNPRPGEENGKDYYFVTREVMQRDIAAGDFIEHAEFSGNLYGTSKVAVQAVQAMNRICVLDVDLQGVRNIKATDLRPIYISVQPPSLHVLEQRLRQRNTETEESLVKRLAAAQADMESSKEPGLFDVVIINDSLDQAYAELKEALSEEIKKAQRTGA","Homo sapiens","GUK1, GMK, GMPK","Guanylate kinase","1","6NUI"
"6NUQ",,"X-RAY DIFFRACTION",2.84,56.66,"VAPOR DIFFUSION",,"10% peg 3350, 150mM Ammonium Nitrate",277,"10.1016/j.ccell.2019.10.002",,"6NUQ",65.25,"3.15","3.15","Stat3 Core in complex with compound SI109","GQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCR","Homo sapiens","STAT3, APRF","Signal transducer and activator of transcription 3","1","6NUQ"
"6NV7",,"X-RAY DIFFRACTION",3.19,61.4,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M MgSO4
0.1 M sodium citrate
12-14 % PEG4000",295,"10.1021/acs.biochem.9b00714","L3J","6NV7",132.07,"2.132","2.132","BACE1 in complex with a macrocyclic inhibitor","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6NV7"
"6NV9",,"X-RAY DIFFRACTION",3.2,61.53,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M MgSO4
0.1 M Na citrate
14-20 % PEG 4000",293,"10.1021/acs.biochem.9b00714","L3M","6NV9",132.45,"2.13","2.13","BACE1 in complex with a macrocyclic inhibitor","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6NV9"
"6NVB",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.2M lithium sulfate, 0.1M sodium acetate, 22% PEG 8000
cryoprotectant = 1:1 glycerol : mother liquor",293,"10.1107/S2053230X19009610",,"6NVB",96.8,"1.636","1.636","Crystal structure of the inhibitor-free form of the serine protease kallikrein-4","IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISIASQCPTAGNSCLVSGWGLLANGRMPTVLQCVNVSVVSEEVCSKLYDPLYHPSMFCAGGGQDQKDSCNGDSGGPLICNGYLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKTVQAS","Homo sapiens","KLK4, EMSP1, PRSS17, PSTS","Kallikrein-4","1","6NVB"
"6NVG",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, HANGING DROP",4.5,"100mM Bis-tris pH4.5, 200mM Lithium sulphate, 16% PEG 3350",291,"10.1021/acsmedchemlett.9b00196",,"6NVG",34.7,"1.99","1.99","FGFR4 complex with N-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide","MVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSHHHHHH","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6NVG"
"6NVH",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, HANGING DROP",,"100mM Bis-tris pH 4.5, 200mM lithium sulphate, 12% PEG3350",291,"10.1021/acsmedchemlett.9b00196",,"6NVH",34.55,"1.9","1.9","FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide","MVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSHHHHHH","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6NVH"
"6NVI",,"X-RAY DIFFRACTION",2.73,55,"VAPOR DIFFUSION, HANGING DROP",4.5,"100mM bis-tris pH 4.5, 200mM lithium sulfate, 16% PEG 3350",291,"10.1021/acsmedchemlett.9b00196",,"6NVI",34.49,"2.117","2.117","FGFR4 complex with N-(3-chloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-5-fluorophenyl)acrylamide","MVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSHHHHHH","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6NVI"
"6NVJ",,"X-RAY DIFFRACTION",2.67,53.91,"VAPOR DIFFUSION, HANGING DROP",4.5,"100mM Bis-tris pH 4.5, 200mM Lithium sulphate, 16% PEG 3350",291,"10.1021/acsmedchemlett.9b00196",,"6NVJ",34.75,"2.3","2.3","FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-fluorophenyl)acrylamide","MVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSHHHHHH","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6NVJ"
"6NVK",,"X-RAY DIFFRACTION",2.71,54.58,"VAPOR DIFFUSION, SITTING DROP",4.5,"100mM Bis-tris pH4.5, 200mM Lithium sulfate, 16% PEG 3350",277,"10.1021/acsmedchemlett.9b00196",,"6NVK",34.66,"2.3","2.3","FGFR4 complex with BLU-554, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide","MVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSHHHHHH","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","6NVK"
"6NVL",,"X-RAY DIFFRACTION",2.61,52.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"90 mM NPS salt mixture (30 mM sodium nitrate, 30 mM sodium phosphate dibasic, 30 mM ammonium sulfatesulfate), 100 mM HEPES/MOPS pH 7.5, and 50% v/v of a precipitant mixture of 40% v/v PEG 500 MME and 20 % w/v PEG 20,000",291,"10.1021/acsmedchemlett.9b00196",,"6NVL",143.12,"2.7","2.7","FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6NVL"
"6NW2",,"X-RAY DIFFRACTION",1.96,37.23,"VAPOR DIFFUSION",,"0.1M Bis Tris Propane pH 6.5, 0.2M Sodium Iodide, 20% PEG3350",277,"10.1016/j.bmcl.2019.04.014","L4Y","6NW2",71.56,"2","2","Structure of human RIPK1 kinase domain in complex with compound 11","MHHHHHHGENLYFQGSMQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6NW2"
"6NW3",,"X-RAY DIFFRACTION",3.08,60.01,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M MgSO4
0.1 M Na citrate
14-20 % PEG4000",298,"10.1021/acs.biochem.9b00714","L4J","6NW3",132.6,"2.352","2.352","BACE1 in complex with a macrocyclic inhibitor","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6NW3"
"6NWP","2.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-1026-5",,"6NWP",275.52,"2.3",,"Chronic traumatic encephalopathy Type I Tau filament","MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6NWP"
"6NWQ","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-1026-5",,"6NWQ",275.52,"3.4",,"Chronic traumatic encephalopathy Type II Tau filament","MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6NWQ"
"6NWS",,"X-RAY DIFFRACTION",2.47,50.16,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1 M sodium phosphate, pH 7.4, 0.5-0.7 M sodium chloride, 4-6% PEG4000, 3% DMSO",295,"10.7554/eLife.47172",,"6NWS",30.58,"2.44","2.44","RORgamma Ligand Binding Domain","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6NWS"
"6NWT",,"X-RAY DIFFRACTION",3.27,62.35,"VAPOR DIFFUSION, SITTING DROP",8,"100-250 mM ammonium sulfate, 10-25% PEG3350, 100 mM Tris, pH 8.0",295,"10.7554/eLife.47172","L7P","6NWT",58.01,"2.35","2.35","RORgamma Ligand Binding Domain","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGN","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6NWT"
"6NWU",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1 M sodium phosphate, pH 7.4, 0.5-0.7 M sodium chloride, 4-6% PEG4000, 3% DMSO",295,"10.7554/eLife.47172",,"6NWU",30.59,"3.2","3.2","RORgamma Ligand Binding Domain","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6NWU"
"6NWV",,"X-RAY DIFFRACTION",2.16,43.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES sodium pH 7.5; 0.4 M Potassium sodium tartrate tetrahydrate.",298,,,"6NWV",36.05,"1.601","1.601","Insulin Lispro Analog","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","6NWV"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin Lispro B chain","2","6NWV"
"6NX4",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2019.05.019",,"6NX4",18.89,,,"Structure of the C-terminal Helical Repeat Domain of Eukaryotic Elongation Factor 2 Kinase (eEF-2K)","SHMGELEAIVGLGLMYSQLPHHILADVSLKETEENKTKGFDYLLKAAEAGDRQSMILVARAFDSGQNLSPDRCQDWLEALHWYNTALEMTDCDEGGEYDGMQDEPRYMMLAREAEMLFTGGYGLEKDPQRSGDLYTQAAEAAMEAMKGRLANQYYQKAEEAWAQMEE","Homo sapiens","EEF2K","Eukaryotic elongation factor 2 kinase","1","6NX4"
"6NXL",,"X-RAY DIFFRACTION",2.39,48.52,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Sodium Acetate pH 4.6, 0.02 M Calcium Chloride, 30% MPD, 0.1M Potassium Sodium Tartrate Tetrahydrate and 56mg/mL protein co-sized Ubv and APC2 WHB (735-C)",277.15,"10.1073/pnas.1902889116",,"6NXL",71.17,"2.803","2.803","Ubiquitin binding variants","GSGGSGMQIFVDTVQWKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESALILLLTLR","Homo sapiens","UBB","Polyubiquitin-B","1","6NXL"
"6NY4",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, HANGING DROP",5.8,"30% PEG3350, 200 mM magnesium chloride, 100 mM Bis-Tris, pH 5.8",293,"10.1021/acsmedchemlett.8b00508","Z3A","6NY4",33.59,"2.33","2.33","Crystal structure of JAK3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor","GPASQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6NY4"
"6NYH",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION",,"0.1 M Bis Tris Propane buffer (pH 6.5), 0.2 M sodium iodide, 20% PEG3350",277,"10.1038/s41418-019-0347-0","L8D","6NYH",68.85,"2.1","2.1","Structure of human RIPK1 kinase domain in complex with GNE684","GSMQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6NYH"
"6NZE",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM ammonium sulfate, and 100 mM HEPES buffer, pH 7.5, 30%(W/V) PEG 5000 (Methyl Ether)",293,"10.1021/acs.jmedchem.9b00443","L8Y","6NZE",72.14,"1.96","1.96","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE","MGSSHHHHHHSSGETVRFQGHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6NZE"
"6NZF",,"X-RAY DIFFRACTION",2.27,45.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM ammonium sulfate, and 100 mM HEPES buffer, pH 7.5, 30%(W/V) PEG 5000 (Methyl Ether)",293,"10.1021/acs.jmedchem.9b00443","L91","6NZF",72.12,"2.39","2.39","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE","MGSSHHHHHHSSGETVRFQGHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6NZF"
"6NZH",,"X-RAY DIFFRACTION",2.21,44.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM ammonium sulfate, and 100 mM HEPES buffer, pH 7.5, 30%(W/V) PEG 5000 (Methyl Ether)",293,"10.1021/acs.jmedchem.9b00443",,"6NZH",71.78,"2.73","2.73","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_40 AKA 6-cyclopropaneamido-4-[(2-methanesulfonylphenyl)amino]-N-methylpyridine-3-carboxamide","MGSSHHHHHHSSGETVRFQGHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6NZH"
"6NZM",,"X-RAY DIFFRACTION",2.21,44.38,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Ammonium Tartrate, 20% PEG3350",298,"10.1016/j.bmc.2019.05.021","L9S","6NZM",66.04,"1.72","1.72","Brutons tyrosine kinase in complex with compound 50.","GSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6NZM"
"6NZN",,"SOLID-STATE NMR",,,,,,,"10.1038/s41594-019-0238-6",,"6NZN",55.79,,,"Dimer-of-dimer amyloid fibril structure of glucagon","HSQGTFTSDYSKYLDSRRAQDFVQWLMNT","Homo sapiens","GCG","Glucagon","1","6NZN"
"6NZP",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM ammonium sulfate, and 100 mM Cacodylate buffer, pH 7.5, 30%(W/V) PEG 5000 (Methyl Ether)",293,"10.1021/acs.jmedchem.9b00444","LB7","6NZP",71.88,"2.35","2.35","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE","MGSSHHHHHHSSGETVRFQGHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6NZP"
"6NZQ",,"X-RAY DIFFRACTION",2.34,47.37,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM ammonium sulfate, and 100 mM Sodium Cacodylate, pH 6.5, 30%(W/V) PEG 5000 (Methyl Ether)",293,"10.1021/acs.jmedchem.9b00444","LB4","6NZQ",72.03,"2.11","2.11","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_29 AKA 6-[(5-FLUORO-4-METH YLPYRIDIN-2-YL)AMINO]-4-({2-METHOXY-3-[(PYRIDIN-2-YLMETHYL )CARBAMOYL]PHENYL}AMINO)-N-METHYLPYRIDINE-3-CARBOXAMIDE","MGSSHHHHHHSSGETVRFQGHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6NZQ"
"6NZR",,"X-RAY DIFFRACTION",2.29,46.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM ammonium sulfate, and 100 mM Sodium Cacodylate, pH 6.5, 30%(W/V) PEG 5000 (Methyl Ether)",293,"10.1021/acs.jmedchem.9b00444",,"6NZR",71.96,"2.56","2.56","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide","MGSSHHHHHHSSGETVRFQGHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRSEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6NZR"
"6O0H","3.67","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-019-1094-6",,"6O0H",494.67,"3.67",,"Cryo-EM structure of human ATP-citrate lyase in complex with inhibitor NDI-091143","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSMKLAAALEHHHHHHHH","Homo sapiens","ACLY","ATP-citrate synthase","1","6O0H"
"6O0Q",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis Tris propane pH 6.5, 0.2 M potassium thiocyanate, 11% PEG3350",293,"10.1126/science.aax1911",,"6O0Q",33.04,"1.8","1.8","Crystal structure of the TIR domain from human SARM1 in complex with ribose","SNADTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQ","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6O0Q"
"6O0R",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis Tris propane pH 6.5, 0.2 M potassium thiocyanate, 11% PEG3350",293,"10.1126/science.aax1911",,"6O0R",32.85,"1.8","1.8","Crystal structure of the TIR domain from human SARM1 in complex with glycerol","SNADTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQ","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6O0R"
"6O0S",,"X-RAY DIFFRACTION",2.74,55.05,"VAPOR DIFFUSION, HANGING DROP",,"10.7% w/v PEG 4000, 21.4% v/v glycerol, 30 mM MgCl2 and 0.1 M bicine/Trizma base pH 8.0",293,"10.1126/science.aax1911",,"6O0S",162.37,"2.7","2.7","Crystal structure of the tandem SAM domains from human SARM1","MHHHHHHSSGVDLGTENLYFQSNAVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTEFKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILTAAREMLHSPLPCTGGKPSGDT","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6O0S"
"6O0T",,"X-RAY DIFFRACTION",2.69,54.34,"VAPOR DIFFUSION, HANGING DROP",,"17% PEG 8000, 20% ethylene glycol, 0.2 M sodium formate, 0.2 M ammonium acetate, 0.2 M trisodium citrate, 0.2 M sodium potassium L-tartrate, 10 mM DTT and 0.1 M Tris pH 7.9",293,"10.1126/science.aax1911",,"6O0T",164.79,"2.8","2.8","Crystal structure of selenomethionine labelled tandem SAM domains (L446M:L505M:L523M mutant) from human SARM1","MHHHHHHSSGVDLGTENLYFQSNAVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRMTEEELQTDLGMKSGITRKRFFRELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGMVSCGLDRSLLHRVSEQQMLEDCGIHLGVHRARILTAAREMLHSPLPCTGGKPSGDT","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6O0T"
"6O0U",,"X-RAY DIFFRACTION",2.05,40.06,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES pH 7.5, 0.2 M MgCl2, 25% PEG3350",293,"10.1126/science.aax1911",,"6O0U",32.53,"3.03","3.03","Crystal structure of the TIR domain H685A mutant from human SARM1","SNADTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAGKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSAEYQEATIEKIIRFLQ","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6O0U"
"6O0V",,"X-RAY DIFFRACTION",2.28,45.97,"VAPOR DIFFUSION, HANGING DROP",,"0.1 MES pH 6.0, 0.2 M MgCl2, 20% PEG3350; or 0.1 MES pH 6.0, 1 M LiCl, 20% PEG6000",293,"10.1126/science.aax1911",,"6O0V",65.8,"2.07","2.07","Crystal structure of the TIR domain G601P mutant from human SARM1, crystal form 2","SNADTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAPKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQ","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6O0V"
"6O17",,"X-RAY DIFFRACTION",3.41,63.93,"BATCH MODE",,"PEG 6000 30%",298,,,"6O17",5.72,"1.58","1.58","Recombinant Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin chain A","1","6O17"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","Insulin chain B","2","6O17"
"6O1B",,"X-RAY DIFFRACTION",2.03,39.32,"VAPOR DIFFUSION, HANGING DROP",,"0.1 MES pH 6.0, 0.2 M MgCl2, 20% PEG3350; or 0.1 MES pH 6.0, 1 M LiCl, 20% PEG6000",293,"10.1126/science.aax1911",,"6O1B",16.57,"1.67","1.67","Crystal structure of the TIR domain G601P mutant from human SARM1, crystal form 1","SNADTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEAPKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGFEWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQ","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6O1B"
"6O1E",,"X-RAY DIFFRACTION",3.03,59.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 10 % w/v PEG8000 and 8 % v/v ethylene glycol",296,"10.1073/pnas.1819524116",,"6O1E",52.97,"2.41","2.41","The crystal structure of human MORC3 ATPase-CW in complex with AMPPNP","MAAQPPRGIRLSALCPKFLHTNSTSHTWPFSAVAELIDNAYDPDVNAKQIWIDKTVINDHICLTFTDNGNGMTSDKLHKMLSFGFSDKVTMNGHVPVGLYGNGFKSGSMRLGKDAIVFTKNGESMSVGLLSQTYLEVIKAEHVVVPIVAFNKHRQMINLAESKASLAAILEHSLFSTEQKLLAELDAIIGKKGTRIIIWNLRSYKNATEFDFEKDKYDIRIPEDLDEITGKKGYKKQERMDQIAPESDYSLRAYCSILYLKPRMQIILRGQKVKTQLVSKSLAYIERDVYRPKFLSKTVRITFGFNCRNKDHYGIMMYHRNRLIKAYEKVGCQLRANNMGVGVVGIIECNFLKPTHNKQDFDYTNEYRLTITALGEKLNDYWNEMKVKKNTEYPLNLPVEDIQKRPDQTWVQCDACLKWRKLPDGMDQLPEKWYCSNNPDPQFRNCEVPEEPEDE","Homo sapiens","MORC3, KIAA0136, NXP2, ZCWCC3","MORC family CW-type zinc finger protein 3","1","6O1E"
"6O1G",,"X-RAY DIFFRACTION",3.03,59.37,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes pH 7.5 0.1 M Sodium Citrate 25 % PEG 3350",296,"10.1016/j.jsb.2019.03.001","7SD","6O1G",72.31,"2.2","2.2","Full length human plasma kallikrein with inhibitor","MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA","Homo sapiens","KLKB1, KLK3","Plasma kallikrein","1","6O1G"
"6O1Q",,"SOLUTION NMR",,,,,,,"10.1021/acschembio.9b00582",,"6O1Q",13.68,,,"The N-terminal domain of NPHP1 folds into an antiparallel three-stranded coiled coil","GPMAMLARRQRDPLQALRRRNQELKQQVDSLLSESQLKEALEPNKRQHIYQRCIQLKQAIDENKNALQKLSKADESAPVANYNQRKEEEHTLLDKLTQQLQGLAVTISRENITEVGAPT","Homo sapiens","NPHP1, NPH1","Nephrocystin-1","1","6O1Q"
"6O1S",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG 3350, 0.2M potassium dihydrogen phosphate",296,"10.1016/j.jsb.2019.03.001","7SD","6O1S",30,"1.7","1.7","Structure of human plasma kallikrein protease domain with inhibitor","NTGDNSVCTTKTSTRIVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA","Homo sapiens","KLKB1, KLK3","Plasma kallikrein","1","6O1S"
"6O2L",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz1015",,"6O2L",7.82,,,"NMR structure of the 2:1 complex of a carbazole derivative BMVC bound to c-MYC G-quadruplex","TGAGGGTGGGTAGGGTGGGTAA","Homo sapiens",,"DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3')","1","6O2L"
"6O2U",,"X-RAY DIFFRACTION",2.06,40.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BisTris, pH 6.5, 18-20% PEG 5000 MME",293,"10.1016/j.jmb.2019.05.008",,"6O2U",31.03,"1.8","1.8","Crystal structure of the SARAF luminal domain","GWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECKTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFASFSDYYYK","Homo sapiens","SARAF, TMEM66, XTP3, HSPC035, NPD003, PSEC0019, UNQ1967/PRO4499","Store-operated calcium entry-associated regulatory factor","1","6O2U"
"6O2V",,"X-RAY DIFFRACTION",1.86,33.82,"VAPOR DIFFUSION, HANGING DROP",4.4,"0.1M sodium acetate, pH 4.2-4.6 and 1.2-1.6M sodium formate",293,"10.1016/j.jmb.2019.05.008",,"6O2V",31.18,"1.58","1.58","Crystal structure of the SARAF luminal domain Cys-lock mutant monomer","GWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECCTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFCSFSDYYYK","Homo sapiens","SARAF, TMEM66, XTP3, HSPC035, NPD003, PSEC0019, UNQ1967/PRO4499","Store-operated calcium entry-associated regulatory factor","1","6O2V"
"6O2W",,"X-RAY DIFFRACTION",1.88,34.43,"VAPOR DIFFUSION, HANGING DROP",,"3-5% glycerol or ethylene glycol",293,"10.1016/j.jmb.2019.05.008",,"6O2W",31.14,"2.101","2.101","Crystal structure of the SARAF luminal domain Cys-lock mutant dimer","GWNDPDRMLLRDVKALTLHYDRYTTSRRLDPIPQLKCVGGTAGCDSYTPKVIQCQNKGWDGYDVQWECCTDLDIAYKFGKTVVSCEGYESSEDQYVLRGSCGLEYNLDYTELGLQKLKESGKQHGFCSFSDYYYK","Homo sapiens","SARAF, TMEM66, XTP3, HSPC035, NPD003, PSEC0019, UNQ1967/PRO4499","Store-operated calcium entry-associated regulatory factor","1","6O2W"
"6O2Y",,"X-RAY DIFFRACTION",2.58,52.31,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG MME 5000, 0.1 M Bicine pH 8.5, and 0.2 M Sodium formate.",293,"10.1021/acs.jmedchem.9b00362","LJY","6O2Y",147.86,"2.8","2.8","Crystal structure of IDH1 R132H mutant in complex with compound 24","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLELEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6O2Y"
"6O2Z",,"X-RAY DIFFRACTION",2.67,54,"VAPOR DIFFUSION, SITTING DROP",,"1.8 M Tri-ammonium citrate pH 6.5",293,"10.1021/acs.jmedchem.9b00362","LJV","6O2Z",98.59,"2.5","2.5","Crystal structure of IDH1 R132H mutant in complex with compound 32","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6O2Z"
"6O31",,"X-RAY DIFFRACTION",2.05,40.07,"VAPOR DIFFUSION, SITTING DROP",7.2,"50mM Sodium Chloride, 5% Glycerol, 1mM EDTA, 15-18% PEG5000-MME",295,"10.1681/ASN.2019101032",,"6O31",26.71,"1.51","1.51","CRYSTAL STRUCTURE OF THE ACTIN-BINDING DOMAIN OF HUMAN ALPHA-ACTININ-4","GGAMDPEFAWEKQQRKTFTAWCNSHLRKAGTQIENIDEDFRDGLKLMLLLEVISGERLPKPERGKMRVHKINNVNKALDFIASKGVKLVSIGAEEIVDGNAKMTLGMIWTIILRFAIQDISVEETSAKEGLLLWCQRKTAPYKNVNVQNFHISWKDGLAFNALIHRHRPELIEYDKLRKDDPVTNLNNAFEVAEKYLDIPKMLDAEDIVNTARPDEKAIMTYVSSFYHAFSGAL","Homo sapiens","ACTN4","Alpha-actinin-4","1","6O31"
"6O36",,"X-RAY DIFFRACTION",3.07,59.93,"VAPOR DIFFUSION, HANGING DROP",8.2,"1.6-1.8 M sodium/potassium phosphate, pH 8.2",293,"10.1002/bdr2.1647",,"6O36",59.34,"2","2","Crystal structure of human KRAS P34R mutant in complex with GNP","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDRTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6O36"
"6O3D",,"X-RAY DIFFRACTION",2.54,51.1,"VAPOR DIFFUSION, SITTING DROP",4.6,"Reservoir: 20% PEG 4000, 20% glycerol, 0.08 M sodium acetate pH 4.6, 0.16 M ammonium sulfate",293,"10.1038/s41467-019-12973-1",,"6O3D",48.23,"1.402","1.402","Crystal structure of the unbound Fab fragment of the human HIV-1 neutralizing antibody PGZL1.","DVVMTQSPGTLSLSPGERATLSCRASQSVSGGALAWYQQKPGQAPRLLIYDTSSRPTGVPGRFSGSGSGTDFSLTISRLEPEDFAVYYCQQYGTSQSTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PGZL1 FAB LIGHT CHAIN","1","6O3D"
,,,,,,,,,,,,,,,,"EVQLVQSGGEVKRPGSSVTVSCKATGGTFSTLAFNWVRQAPGQGPEWMGGIVPLFSIVNYGQKFQGRLTIRADKSTTTVFLDLSGLTSADTATYYCAREGEGWFGKPLRAFEFWGQGTVITVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"PGZL1 FAB HEAVY CHAIN","2","6O3D"
"6O3I",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis Tris propane pH 6.5, 20% PEG 3350, 0.2 M potassium thiocyanate",293,"10.1021/acs.jmedchem.9b00662","LKP","6O3I",96.69,"2.69","2.69","Crystal Structure of Human IDO1 bound to navoximod (NLG-919)","MHHHHHHGENLYFQGSAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGNS","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6O3I"
"6O3K",,"X-RAY DIFFRACTION",2.34,47.1,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir: 30% PEG 2000 MME, 0.1 M sodium acetate pH 4.6, 0.2 M ammonium sulfate",293.15,"10.1038/s41467-019-12973-1",,"6O3K",48.43,"1.451","1.451","Crystal structure of the unbound Fab fragment of the human HIV-1 neutralizing antibody PGZL1.H4K3","EIVLTQSPGTFALSPGERATLSCRASQSVSGGALAWYQQKAGQAPRLLIYGTSGRATGVPGRFSGSGSETDFSLTISRLEPEDFAVYYCQQYGTSQSTFGQGTRLETRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PGZL1.H4K3 light chain","1","6O3K"
,,,,,,,,,,,,,,,,"KVQLVQSGAELKKPWSSVRVSCKASGGSFSSYAFNWVRQAPGQRLEWLGGIVPLVSSTNYAQRFRGRVTISADRSTSTVYLEMTGLTSADTAVYFCAREGEGWFGRPLRAFEFWGQGTLVTVSTASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"PGZL1.H4K3 heavy chain","2","6O3K"
"6O3U",,"X-RAY DIFFRACTION",4.6,73,"VAPOR DIFFUSION, SITTING DROP",5.83,"1.44 M ammonium sulfate, 0.01M cobalt chloride, 0.1 M MES pH 5.83",293.15,"10.1038/s41467-019-12973-1",,"6O3U",195.2,"3.105","3.105","Crystal structure of the Fab fragment of the human HIV-1 neutralizing antibody PGZL1.H4K3 in complex with 06:0 PA","EIVLTQSPGTFALSPGERATLSCRASQSVSGGALAWYQQKAGQAPRLLIYGTSGRATGVPGRFSGSGSETDFSLTISRLEPEDFAVYYCQQYGTSQSTFGQGTRLETRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PGZL1.H4K3 light chain","1","6O3U"
,,,,,,,,,,,,,,,,"KVQLVQSGAELKKPWSSVRVSCKASGGSFSSYAFNWVRQAPGQRLEWLGGIVPLVSSTNYAQRFRGRVTISADRSTSTVYLEMTGLTSADTAVYFCAREGEGWFGRPLRAFEFWGQGTLVTVSTASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"PGZL1.H4K3 heavy chain","2","6O3U"
"6O3Z",,"X-RAY DIFFRACTION",2.33,47.27,"VAPOR DIFFUSION, SITTING DROP",5,"20% PEG3350, 100 mM sodium citrate",298,"10.1021/acsmedchemlett.9b00649",,"6O3Z",32.04,"2.4","2.4","Crystal structure of RORgt with 3-cyano-N-(3-{[(3S)-4-(cyclopentanecarbonyl)-3-methylpiperazin-1-yl]methyl}-5-fluoro-2-methylphenyl)benzamide (compound 1)","GSHMTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERMQIFQHLHPIVVQAAFPPLYKELFSTGGSGDHKIIHRLLQEG","Homo sapiens","RORC, NR1F3, RORG, RZRG","RAR-related orphan receptor C isoform a variant","1","6O3Z"
"6O46",,"X-RAY DIFFRACTION",3.1,60.27,"VAPOR DIFFUSION, HANGING DROP",,"1.8-2.0 M sodium/potassium phosphate, pH 8.0-8.4",293,"10.1002/bdr2.1647",,"6O46",59.51,"1.9","1.9","Crystal structure of human KRAS P34R mutant in complex with GNP and Phosphate","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDRTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6O46"
"6O47",,"X-RAY DIFFRACTION",2.87,57.19,"VAPOR DIFFUSION, HANGING DROP",7,"0.064 M sodium citrate 7.0, 0.1 M HEPES, pH 7.0, 10% PEG5000MME",293,"10.1073/pnas.1905013116",,"6O47",44.77,"2.196","2.196","human cGAS core domain (K427E/K428E) bound with RU-521","SILVRRDAAPGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDEEHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","CGAS, C6orf150, MB21D1","Cyclic GMP-AMP synthase","1","6O47"
"6O4B",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, SITTING DROP",6.8,"0.1 M MgCl2, 0.1 M sodium acetate trihydrate, 20% (w/v) PEG 4000, and 0.1 M Tris pH 6.8",293,"10.1111/febs.14997",,"6O4B",453.34,"1.85","1.85","Structure of ALDH7A1 mutant W175G complexed with NAD","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGGNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4B"
"6O4C",,"X-RAY DIFFRACTION",2.27,45.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M MgCl2, 0.1 M sodium acetate trihydrate, 20% (w/v) PEG 4000, and 0.1 M Tris pH 7.5",293,"10.1111/febs.14997",,"6O4C",453.55,"1.7","1.7","Structure of ALDH7A1 mutant W175A complexed with NAD","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGANNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4C"
"6O4D",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.1 M MgCl2, 0.1 M Tris pH 7.2, 0.1 M sodium acetate trihydrate, 20% (w/v) PEG 4000",293,"10.1111/febs.14997",,"6O4D",447.52,"1.88","1.88","Structure of ALDH7A1 mutant W175A complexed with L-pipecolic acid","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGANNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","2","6O4D"
,,,,,,,,,,,,,,,,"GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGANNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","3","6O4D"
,,,,,,,,,,,,,,,,"GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGANNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4D"
"6O4E",,"X-RAY DIFFRACTION",2.24,45.11,"VAPOR DIFFUSION, SITTING DROP",6.7,"0.1 M MgCl2, 0.1 M sodium acetate trihydrate, 20% (w/v) PEG 4000, and 0.1 M Tris pH 6.7",293,"10.1111/febs.14997",,"6O4E",452.02,"1.75","1.75","Structure of ALDH7A1 mutant N167S complexed with NAD","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFSFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4E"
"6O4F",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, SITTING DROP",6.7,"0.1 M MgCl2, 0.1 M sodium acetate trihydrate, 20% (w/v) PEG 4000, and 0.1 M Tris pH 6.7",293,"10.1111/febs.14997",,"6O4F",445.42,"1.9","1.9","Structure of ALDH7A1 mutant N167S complexed with alpha-aminoadipate","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFSFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4F"
"6O4G",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, SITTING DROP",6,"0.2 M MgCl2, 25% (w/v) PEG 3350, and 0.1 M Bis-Tris",293,"10.1111/febs.14997",,"6O4G",445.53,"2.05","2.05","Structure of ALDH7A1 mutant P169S complexed with alpha-aminoadipate","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFSVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4G"
"6O4H",,"X-RAY DIFFRACTION",2.24,45.11,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.2 M MgCl2, 25% (w/v) PEG 3350, and 0.1 M Bis-Tris pH 5.8",293,"10.1111/febs.14997",,"6O4H",450.62,"2.05","2.05","Structure of ALDH7A1 mutant A171V complexed with NAD","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVVVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4H"
"6O4I",,"X-RAY DIFFRACTION",2.2,43.97,"VAPOR DIFFUSION, SITTING DROP",5.4,"0.2 M MgCl2, 0.1 M Bis-Tris pH 5.4, and 25% (w/v) PEG 3350",293,"10.1002/jimd.12184",,"6O4I",447.13,"1.75","1.75","Structure of ALDH7A1 mutant E399D complexed with alpha-aminoadipate","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTDTFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4I"
"6O4J","1.402","ELECTRON CRYSTALLOGRAPHY",1.43,,"UNSPECIFIED",,,,"10.7554/eLife.46924",,"6O4J",2.47,"1.402, 1.402","1.402","Amyloid Beta KLVFFAENVGS 16-26 D23N Iowa mutation","XKLVFFAENVGSX","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6O4J"
"6O4K",,"X-RAY DIFFRACTION",2.18,43.61,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.2 M MgCl2, 21% (w/v) PEG 3350, and 0.1 M Bis-Tris pH 6.2",293,"10.1002/jimd.12184",,"6O4K",450.79,"2.06","2.06","Structure of ALDH7A1 mutant E399Q complexed with NAD","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTQTFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4K"
"6O4L",,"X-RAY DIFFRACTION",2.03,39.47,"VAPOR DIFFUSION, SITTING DROP",5.7,"0.2 M MgCl2, 21% (w/v) PEG 3350, and 0.1 M Bis-Tris pH 5.7",293,"10.1002/jimd.12184",,"6O4L",225.4,"1.85","1.85","Structure of ALDH7A1 mutant E399D complexed with NAD","GHMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTDTFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ","Homo sapiens","ALDH7A1, ATQ1","Alpha-aminoadipic semialdehyde dehydrogenase","1","6O4L"
"6O4O",,"X-RAY DIFFRACTION",1.94,36.63,"VAPOR DIFFUSION, HANGING DROP",9,"18% PEG 3350, 0.1 M Bis-Tris propane pH 9, 0.2 M ammonium sulphate, 0.05 M praseodymium chloride, seeded",293,"10.1074/jbc.RA119.012351",,"6O4O",18.4,"1.62","1.62","The structure of human interleukin 11","GSPDPRAELDSTVLLTRSLLADTRQLAAQLRDKFPADGDHNLDSLPTLAMSAGALGALQLPGVLTRLRADLLSYLRHVQWLRRAGGSSLKTLEPELGTLQARLDRLLRRLQLLMSRLALPQPPPDPPAPPLAPPSSAWGGIRAAHAILGGLHLTLDWAVRGLLLLKTRL","Homo sapiens","IL11","Interleukin-11","1","6O4O"
"6O4P",,"X-RAY DIFFRACTION",3,58.95,"VAPOR DIFFUSION, SITTING DROP",8,"1.6 M Ammonium sulfate, 0.02 M NaCl, 67 mM NDSB-195, 0.1 M HEPES pH 8.0",293,"10.1074/jbc.RA119.012351",,"6O4P",78.87,"3.429","3.429","The crystal structure of the interleukin 11 alpha receptor","SSPCPQAWGPPGVQYGQPGRSVKLCCPGVTAGDPVSWFRDGEPKLLQGPDSGLGHELVLAQADSTDEGTYICQTLDGALGGTVTLQLGYPPARPVVSCQAADYENFSCTWSPSQISGLPTRYLTSYRKKTVLGADSQRRSPSTGPWPCPQDPLGAARCVVHGAEFWSQYRINVTEVNPLGASTRLLDVSLQSILRPDPPQGLRVESVPGYPRRLRASWTYPASWPSQPHFLLKFRLQYRPAQHPAWSTVEPAGLEEVITDAVAGLPHAVRVSARDFLDAGTWSTWSPEAWGTPSTGTIPKEIPAWGQLHTQPEVEPQVDSPAPPRPSLQPHPRLLDHRDSVHHHHHHHH","Homo sapiens","IL11RA","Interleukin-11 receptor subunit alpha","1","6O4P"
"6O4U",,"X-RAY DIFFRACTION",1.89,35.01,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris pH 8.0,
3% Methanol,
30-42.5% PEG6K",277,,,"6O4U",36.61,"1.7","1.7","Co-crystal structure of Mcl1 with inhibitor","DELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6O4U"
"6O4W",,"X-RAY DIFFRACTION",4.82,74.46,"VAPOR DIFFUSION, SITTING DROP",,"10 mM sodium citrate, 100 mM HEPES, pH 7, and 6-8 % PEG6000 or PEG3350",283,"10.1016/j.cbi.2019.06.011","E20","6O4W",122.14,"2.35","2.35","Binary complex of native hAChE with Donepezil","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6O4W"
"6O4X",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"10 mM sodium citrate, 100 mM HEPES, pH 7, and 6-8 % PEG6000 or PEG3350",283,"10.1016/j.cbi.2019.06.011",,"6O4X",121.49,"2.3","2.3","Binary complex of native hAChE with 9-aminoacridine","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6O4X"
"6O50",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"10 mM sodium citrate, 100 mM HEPES, pH 7, and 6-8 % PEG6000 or PEG3350",283,"10.1016/j.cbi.2019.06.011","EBW","6O50",121.82,"2.352","2.352","Binary complex of native hAChE with BW284c51","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6O50"
"6O52",,"X-RAY DIFFRACTION",4.99,75.34,"VAPOR DIFFUSION, SITTING DROP",,"10 mM sodium citrate, 100 mM HEPES, pH 7, and 6-8 % PEG6000 or PEG3350",283,"10.1016/j.cbi.2019.06.011","EBW","6O52",121.39,"3.2","3.2","Room temperature structure of binary complex of native hAChE with BW284c51","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6O52"
"6O5D",,"X-RAY DIFFRACTION",3.25,62.2,"VAPOR DIFFUSION, HANGING DROP",4.5,"HosaA.18070.a at 10 mg/ml. 1.3M Ammonium sulfate, 0.2M Lithium sulfate, 50mM sodium chloride, 0.1M sodium acetate, pH 4.5. Cryoprotection 15% glycerol., VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1016/j.yjsbx.2019.100008",,"6O5D",61.04,"2.4","2.4","PYOCHELIN","SDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","6O5D"
"6O5E",,"X-RAY DIFFRACTION",2.04,39.71,"VAPOR DIFFUSION, SITTING DROP",6.5,"1 uL protein solution + 1 uL precipitate solution [0.09 M imidazole/MES, pH 6.5, 27 mM sodium nitrate, 27 mM sodium phosphate dibasic, 27 mM ammonium sulfate, 11.25% v/v MPD, 11.25% w/v PEG1000, 11.25% w/v PEG3350, 3% w/v D-(+)-trehalose]",293,"10.1126/sciadv.aax5068",,"6O5E",47.45,"1.9","1.9","Crystal structure of the Vitronectin hemopexin-like domain","MELCSGKPFDAFTDLKNGSLFAFRGQYSYELDEKAVRPGYPKLIRDVWGIEGPIDAAFTRINSQGKTYLFKGSQYWRFEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGRERVYFFKGKQYWEYQFQRTSAGTRQPQFISRDWHGVPGQVDAAMAGRISVFFFSGDKYYRVNLRTRRVDTVDPPYPRSIAQYWLGCPA","Homo sapiens","VTN","Vitronectin","1","6O5E"
,,,,,,,,,,,,,,,,,"Homo sapiens","VTN"
,,,,,,,,,,,,,,,,,"Homo sapiens","VTN"
"6O5G",,"X-RAY DIFFRACTION",2.47,50.17,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris pH 8.5, 0.2 M MgCl2, 20% PEG 8000",293,"10.1073/pnas.1818547116","LMJ","6O5G",17.8,"1.89","1.89","Calmodulin in complex with isomalbrancheamide D","SNAMADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin-1","1","6O5G"
"6O5H",,"X-RAY DIFFRACTION",2.29,46.26,"VAPOR DIFFUSION, SITTING DROP",,"50 - 80 mM magnesium formate dihydrate and 24% - 29% PEG3350",295.15,"10.1021/acs.jmedchem.9b00663",,"6O5H",208.11,"2.84","2.84","The effect of modifier structure on the activation of leukotriene A4 hydrolase aminopeptidase activity.","IVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","6O5H"
"6O5I",,"X-RAY DIFFRACTION",2.32,47.05,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M lithium sulfate, 0.1 M HEPES, pH 7.5, 25% (w/v) PEG-3,350.",277,"10.1172/JCI129126","LMY","6O5I",56.03,"1.24025624626","1.24025624626","Menin in complex with MI-3454","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","6O5I"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
"6O5R",,"X-RAY DIFFRACTION",4.96,75.22,"VAPOR DIFFUSION, SITTING DROP",,"10 mM sodium citrate, 100 mM HEPES, pH 7, and 6-8 % PEG6000",283,"10.1074/jbc.RA119.008725",,"6O5R",121.2,"2.8","2.8","Room temperature structure of binary complex of native hAChE with oxime reactivator RS-170B","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6O5R"
"6O5S",,"X-RAY DIFFRACTION",5.03,75.54,"VAPOR DIFFUSION, SITTING DROP",7,"10 mM sodium citrate, 100 mM HEPES, pH 7, and 6-8 % PEG6000",283,"10.1074/jbc.RA119.008725",,"6O5S",121.62,"2.801","2.801","Room temperature structure of VX-phosphonylated hAChE in complex with oxime reactivator RS-170B","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6O5S"
"6O5V",,"X-RAY DIFFRACTION",4.9,74.89,"VAPOR DIFFUSION, SITTING DROP",,"10 mM sodium citrate, 100 mM HEPES, pH 7, and 6-8 % PEG6000",283,"10.1074/jbc.RA119.008725",,"6O5V",121.62,"2.152","2.152","Binary complex of native hAChE with oxime reactivator RS-170B","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6O5V"
"6O5Y",,"X-RAY DIFFRACTION",3.36,63.44,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M potassium phosphate dibasic, 20% PEG3350, 10% glycerol, 1 mM hexadecyltrimethylammonium bromide",277,"10.1124/dmd.119.089607",,"6O5Y",226.77,"3.17","3.17","Structure of Human Cytochrome P450 1A1 with 5-amino-N-(5-((4R,5R)-4-amino-5-fluoroazepan-1-yl)-1-methyl-1H-pyrazol-4-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide)","MAKKTSSKGLKNPPGPWGWPLIGHMLTLGKNPHLALSRMSQQYGDVLQIRIGSTPVVVLSGLDTIRQALVRQGDDFKGRPDLYTFTLISNGQSMSFSPDSGPVWAARRRLAQNGLKSFSIASDPASSTSCYLEEHVSKEAEVLISTLQELMAGPGHFNPYRYVVVSVTNVICAICFGRRYDHNHQELLSLVNLNNNFGEVVGSGNPADFIPILRYLPNPSLNAFKDLNEKFYSFMQKMVKEHYKTFEKGHIRDITDSLIEHCQEKQLDENANVQLSDEKIINIVLDLFGAGFDTVTTAISWSLMYLVMNPRVQRKIQEELDTVIGRSRRPRLSDRSHLPYMEAFILETFRHSSFVPFTIPHSTTRDTSLKGFYIPKGRCVFVNQWQINHDQKLWVNPSEFLPERFLTPDGAIDKVLSEKVIIFGMGKRKCIGETIARWEVFLFLAILLQRVEFSVPLGVKVDMTPIYGLTMKHACCEHFQMQLRSHHHHHH","Homo sapiens","CYP1A1","Cytochrome P450 1A1","1","6O5Y"
"6O5Z",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, SITTING DROP",7.88,"0.18 M magnesium chloride, 26.8% (w/v) PEG 3350, 0.1 M sodium HEPES pH 7.88",293,"10.1021/acschembio.0c00482",,"6O5Z",66.36,"2.285","2.285","Crystal Structure of the human MLKL pseudokinase domain bound to compound 2","GAMGSQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQTSMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","6O5Z"
"6O66",,"X-RAY DIFFRACTION",4.85,74.63,"VAPOR DIFFUSION, SITTING DROP",,"10 mM sodium citrate, 100 mM HEPES, pH 7, and 6-8 % PEG6000",283,"10.1074/jbc.RA119.008725",,"6O66",122.26,"2.452","2.452","Structure of VX-phosphonylated hAChE in complex with oxime reactivator RS-170B","GPLEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLD","Homo sapiens","ACHE","Acetylcholinesterase","1","6O66"
"6O67",,"X-RAY DIFFRACTION",2.56,52.03,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.8M SODIUM CITRATE, 100mM MOPS, pH 7.6",293,"10.1073/pnas.1909016116","LO7","6O67",63.43,"2.52","2.52","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Mitoglitazone","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6O67"
"6O68",,"X-RAY DIFFRACTION",2.52,51.25,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.8M SODIUM CITRATE, 100mM MOPS, pH 7.6",293,"10.1073/pnas.1909016116",,"6O68",63.23,"2.78","2.78","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Ciglitazone","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6O68"
"6O69",,"X-RAY DIFFRACTION",3.12,60.59,"VAPOR DIFFUSION, HANGING DROP",6,"0.46-0.96 M sodium citrate, pH 6.0-7.5",295,"10.1002/pro.3625",,"6O69",60.04,"2.081","2.081","Crystal Structure of Double Mutant L380R/F535K of Human Acetylcholinesterase","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVRHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRKLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6O69"
"6O6F",,"X-RAY DIFFRACTION",2.33,47.13,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris pH 8.0,
3% Methanol,
30-42.5% PEG6000",277,"10.1158/2159-8290.CD-18-0387","LOD","6O6F",36.67,"1.6","1.6","Co-crystal structure of Mcl1 with inhibitor","GSDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6O6F"
"6O6G",,"X-RAY DIFFRACTION",2.3,46.48,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris, pH 8.0,
3% Methanol,
30-42.5% PEG 6000",277,"10.1158/2159-8290.CD-18-0387","LOJ","6O6G",18.2,"2.4","2.4","Co-crystal structure of Mcl1 with inhibitor","DELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6O6G"
"6O6W",,"SOLUTION NMR",,,,,,,"10.1038/s41467-019-13577-5",,"6O6W",16.29,,,"Solution structure of human myeloid-derived growth factor","GSKGTVSEPTTVAFDVRPGGVVHSFSHNVGPGDKYTCMFTYASQGGTNEQWQMSLGTSEDHQHFTCTIWRPQGKSYLYFTQFKAEVRGAEIEYAMAYSKAAFERESDVPLKTEEFEVTKTAVAHRPGAFKAELSKLVIVAKASRTEL","Homo sapiens","MYDGF, C19orf10","Myeloid-derived growth factor","1","6O6W"
"6O76",,"X-RAY DIFFRACTION",2.64,53.38,"VAPOR DIFFUSION, HANGING DROP",7,"0.29 mM potassium sodium tartrate tetrahydrate, 18% PEG3350",293,"10.1073/pnas.1908288116",,"6O76",115.05,"2.787","2.787","Human cytosolic Histidyl-tRNA synthetase (HisRS) with WHEP domain","MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPKGTRDYSPRQMAVREKVFDVIIRCFKRHGAEVIDTPVFELKETLMGKYGEDSKLIYDLKDQGGELLSLRYDLTVPFARYLAMNKLTNIKRYHIAKVYRRDNPAMTRGRYREFYQCDFDIAGNFDPMIPDAECLKIMCEILSSLQIGDFLVKVNDRRILDGMFAICGVSDSKFRTICSSVDKLDKVSWEEVKNEMVGEKGLAPEVADRIGDYVQQHGGVSLVEQLLQDPKLSQNKQALEGLGDLKLLFEYLTLFGIDDKISFDLSLARGLDYYTGVIYEAVLLQTPAQAGEEPLGVGSVAAGGRYDGLVGMFDPKGRKVPCVGLSIGVERIFSIVEQRLEALEEKIRTTETQVLVASAQKKLLEERLKLVSELWDAGIKAELLYKKNPKLLNQLQYCEEAGIPLVAIIGEQELKDGVIKLRSVTSREEVDVRREDLVEEIKRRTGQPLCIC","Homo sapiens","HARS, HRS, HARS1","Histidine--tRNA ligase, cytoplasmic","1","6O76"
"6O89",,"X-RAY DIFFRACTION",2.6,52.61,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG3350, 0.18M sodium phosphate monobasic",294,,,"6O89",75.99,"2.09","2.09","Anti-CD28xCD3 CODV Fab","DIVMTQTPLSLSVTPGQPASISCKSSQSLVHNNANTYLSWYLQKPGQSPQSLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCGQGTQYPFTFGSGTKVEIKGQPKAAPDIQMTQSPSSLSASVGDRVTITCQASQNIYVWLNWYQQKPGKAPKLLIYKASNLHTGVPSRFSGSGSGTDFTLTISSLQPEDIATYYCQQGQTYPYTFGQGTKLEIKTKGPSRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Anti-CD28xCD3 CODV-Fab Light chain","2","6O89"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVVKPGASVKVSCKASGYTFTSYYIHWVRQAPGQGLEWIGSIYPGNVNTNYAQKFQGRATLTVDTSISTAYMELSRLRSDDTAVYYCTRSHYGLDWNFDVWGKGTTVTVSSSQVQLVESGGGVVQPGRSLRLSCAASGFTFTKAWMHWVRQAPGKQLEWVAQIKDKSNSYATYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCRGVYYALSPFDYWGQGTLVTVSSRTASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTHHHHHH","Homo sapiens",,"Anti-CD28xCD3 CODV-Fab Heavy chain","1","6O89"
"6O8I",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION",,"Unkown",298,"10.1021/acs.jmedchem.9b00167",,"6O8I",31.8,"1.42","1.42","BTK In Complex With Inhibitor","GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6O8I"
"6O8U",,"X-RAY DIFFRACTION",2.65,53.53,"VAPOR DIFFUSION",,"2.3M-2.7M ammonium sulfate, 0.1M HEPES Na pH 7.0-7.3",292,"10.1021/acs.jmedchem.9b00439","LS7","6O8U",139.03,"1.8","1.8","Crystal structure of IRAK4 in complex with compound 23","SVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTASGNS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6O8U"
"6O94",,"X-RAY DIFFRACTION",2.78,55.75,"VAPOR DIFFUSION",,"2.6-2.9 M Ammonium Sulfate, Hepes",277,"10.1021/acs.jmedchem.9b00439","LRS","6O94",146.72,"1.98","1.98","Structure of the IRAK4 kinase domain with compound 17","MHHHHHHGENLYFQGSVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTASGNS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6O94"
"6O95",,"X-RAY DIFFRACTION",2.51,51,"VAPOR DIFFUSION",,"2.6-2.9 M Ammonium Sulfate, Hepes",,"10.1021/acs.jmedchem.9b00439","LSV","6O95",146.61,"1.77","1.77","Structure of the IRAK4 kinase domain with compound 41","MHHHHHHGENLYFQGSVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTASGNS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6O95"
"6O98",,"X-RAY DIFFRACTION",2.84,56.65,"VAPOR DIFFUSION, HANGING DROP",,"unspecified",,"10.1021/acsmedchemlett.9b00010","L8A","6O98",62.67,"2.29","2.29","Crystal structure of RAR-related orphan receptor C in complex with a phenyl (3-phenylpyrrolidin-3-yl)sulfone inhibitor","MGSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFST","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6O98"
"6O9D",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION",,"2.6-2.9 M Ammonium Sulfate, Hepes",277,"10.1021/acs.jmedchem.9b00439","LTY","6O9D",146.29,"2.51","2.51","Structure of the IRAK4 kinase domain with compound 5","MHHHHHHGENLYFQGSVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTASGNS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6O9D"
"6O9O",,"X-RAY DIFFRACTION",2.22,44.53,"VAPOR DIFFUSION, SITTING DROP",,"Libro 24 well sitting drop tray.
Reservoir solution: 10% PEG 3350, 0.2M MgOAc
Drops composed of 2ul protein + 2 ul reservoir.
Frozen seed stock added to ensure nucleation.

Crystals should grow overnight at 22C and fully mature within 3 days
Apo crystals were soaked with inhibitor as follows:
1ul 100mM compound + 1ul well buffer
 Add 0.3ul to the drop
 Incubate at room temperature",295,,,"6O9O",50.97,"1.586","1.586","Crystal Structure of SMYD3 with Potent and Selective Isoxazole Amide Inhibitor 1","GSFTMEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","6O9O"
"6O9X",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% (w/v) PEG 3350, 0.1 M PCTP pH 7.5 and 0.15 M MgCl2",295,"10.1038/s41467-019-13508-4","M0S","6O9X",61.55,"1.7","1.7","Structure of human PARG complexed with JA2-4","GPHMSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6O9X"
"6O9Y",,"X-RAY DIFFRACTION",2.26,45.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.05 M PCTP pH 7.5, 0.1 M NaCl, 0.15 M MgCl2",295,"10.1038/s41467-019-13508-4",,"6O9Y",61.55,"2","2","Structure of human PARG complexed with JA2-8","GPHMSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6O9Y"
"6OA0",,"X-RAY DIFFRACTION",2.27,45.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.05 M PCTP pH 7.5, 0.1 M NaCl, 0.15 M MgCl2",295,"10.1038/s41467-019-13508-4",,"6OA0",61.49,"2","2","Structure of human PARG complexed with JA2-9","GPHMSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6OA0"
"6OA1",,"X-RAY DIFFRACTION",2.24,45.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.05 M PCTP pH 7.5, 0.1 M NaCl, 0.15 M MgCl2",295,"10.1038/s41467-019-13508-4","M0P","6OA1",61.55,"1.8","1.8","Structure of human PARG complexed with JA2120","GPHMSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6OA1"
"6OA3",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.05 M PCTP pH 7.5, 0.1 M NaCl, 0.15 M MgCl2",295,"10.1038/s41467-019-13508-4","M0M","6OA3",61.57,"1.9","1.9","Structure of human PARG complexed with JA2131","GPHMSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6OA3"
"6OA6",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION, SITTING DROP",7.2,"50mM Sodium Chloride, 5% Glycerol, 1mM EDTA, 15 - 18% PEG5000-MME",295,"10.1681/ASN.2019101032",,"6OA6",26.83,"1.37","1.37","CRYSTAL STRUCTURE OF THE ACTIN-BINDING DOMAIN OF HUMAN ALPHA-ACTININ-4","GGAMDPEFAWEKQQRKTFTAWCNSHLRKAGTQIENIDEDFRDGLKLMLLLEVISGERLPKPERGKMRVHKINNVNKALDFIASKGVKLVSIGAEEIVDGNAKMTLGMIWTIILRFAIQDIDVEETSAKEGLLLWCQRKTAPYKNVNVQNFHISWKDGLAFNALIHRHRPELIEYDKLRKDDPVTNLNNAFEVAEKYLDIPKMLDAEDIVNTARPDEKAIMTYVSSFYHAFSGAL","Homo sapiens","ACTN4","Alpha-actinin-4","1","6OA6"
"6OAC",,"X-RAY DIFFRACTION",2.62,53.01,"VAPOR DIFFUSION, HANGING DROP",9.5,"8% PEG6000, 0.6M Na Formate, 0.1M CHES pH 9.5, 5mM TCEP",290,"10.1021/acs.jmedchem.9b00525",,"6OAC",110.61,"3.15","3.15","PQR530 [(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine] bound to the PI3Ka catalytic subunit p110alpha","AGTMVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHH","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","6OAC"
"6OAE",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, SITTING DROP",4.4,"0.1M Sodium Acetate pH 4.4, 0.7M Calcium Chloride",277,,,"6OAE",24.64,"1.9","1.9","Crystal Structure of Human Mucin-like Protocadherin EC1-2","MQAQYCSVNKDIFEVEENTNVTEPLVDIHVPEGQEVTLGALSTPFAFRIQGNQLFLNVTPDYEEKSLLEAQLLCQSGGTLVTQLRVFVSVLDVNDNAPEFPFKTKEIRVEEDTKVNSTVIPETQLQAEDRDKDDILFYTLQEMTAGASDYFSLVSVNRPALRLDRPLDFYERPNMTFWLLVRDTPGENVEPSHTATATLVLNVVPADLEHHHHHH","Homo sapiens","MUPCDH, CDHR5, MUCDHL, UNQ2781/PRO7168","Mucin-like protocadherin","1","6OAE"
"6OAG",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.075 M HEPES, 0.6 M potassium phosphate, 0.6 M sodium phosphate, 25% glycerol",295,"10.1021/acs.jmedchem.9b01104","M2Y","6OAG",44.16,"2.3","2.3","Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02-82","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","6OAG"
"6OAH",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.075 M HEPES, 0.6 M potassium phosphate, 0.6 M sodium phosphate, 25% glycerol",295,"10.1021/acs.jmedchem.9b01104","M2V","6OAH",44.25,"2.2","2.2","Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02-78","MGSSHHHHHHSSGRENLYFQGHMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","6OAH"
"6OAK",,"X-RAY DIFFRACTION",2.43,49.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M PCTP, pH 7.5, 0.2 M (NH3)2SO4, 17%  PEG3350",295,"10.1038/s41467-019-13508-4","M0M","6OAK",61.57,"1.7","1.7","Structure of human PARG complexed with JA2131","SPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLKQKMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTEKKPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6OAK"
"6OAL",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M PCTP, pH 7.5, 0.2 M (NH3)2SO4, 17% PEG3350",295,"10.1038/s41467-019-13508-4","M0P","6OAL",61.55,"1.6","1.6","Structure of human PARG complexed with JA2120","SPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLKQKMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTEKKPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","Poly(ADP-ribose) glycohydrolase","1","6OAL"
"6OAV",,"X-RAY DIFFRACTION",2.31,46.85,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M TRIS, PH 8.0 0.2M SODIUM ACETATE, 0.001 M TCEP, 12-24% PEG 4,000",277.15,"10.1021/acs.jmedchem.0c00192",,"6OAV",33.44,"1.939","1.939","JAK2 JH2 in complex with JAK146","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6OAV"
"6OB6",,"X-RAY DIFFRACTION",2.44,49.62,"LIPIDIC CUBIC PHASE",8,"30% PEG 500 MME, 0.1M magnesium chloride hexahydrate, 0.1M Tris-HCl pH 8.0",298,"10.1038/s41594-019-0245-7","NBM","6OB6",98.57,"2.9","2.9","Human equilibrative nucleoside transporter-1, S-(4-nitrobenzyl)-6-thioinosine bound, merohedrally twinned","MATTSHQPQDRYKAVWLIFFMLGLGTLLPWNFFMTATQYFTNRLDMSQNVSLVTAELSKDAQASAAPAAPLPERNSLSAIFNNVMTLCAMLPLLLFTYLNSFLHQRIPQSVRILGSLVAILLVFLITAILVKVQLDALPFFVITMIKIVLINSFGAILQGSLFGLAGLFPASYTAAIMSGQGLAGFFASVAMICAIASGSELSESAFGYFITACAVIILTIICYLGLPRLEFYRYYQQLKLEGPTNESHSIKAILKKISVLAFSVCFIFTITIGMFPAVTVEVKSSIAGSSTWERYFIPVSCFLTFNIFDWLGRSLTAVFMWPGKDSRWLPSLVLARLVFVPLLLLCNIKPRRYLTVVFEHDAWFIFFMAAFAFSNGYLASLCMCFGPKKVKPAEAETAGAIMAFFLCLGLALGAVFSFLFRAIVGTELLQVDTNSLEVLFQ","Homo sapiens","SLC29A1, ENT1","Equilibrative nucleoside transporter 1","1","6OB6"
"6OB7",,"X-RAY DIFFRACTION",2.49,50.59,"LIPIDIC CUBIC PHASE",9,"50% PEG 400, 0.5 M NaCl, 0.1 M glycine pH 9.0",298,"10.1038/s41594-019-0245-7","8DZ","6OB7",55.89,"2.3","2.3","Human equilibrative nucleoside transporter-1, dilazep bound","MATTSHQPQDRYKAVWLIFFMLGLGTLLPWNFFMTATQYFTNRLDMSQNVSLVTAELSKDAQASAAPAAPLPERNSLSAIFNNVMTLCAMLPLLLFTYLNSFLHQRIPQSVRILGSLVAILLVFLITAILVKVQLDALPFFVITMIKIVLINSFGAILQGSLFGLAGLFPASYTAAIMSGQGLAGFFASVAMICAIASGSELSESAFGYFITACAVIILTIICYLGLPRLEFYRYYQQLKLEGPTNESHSIKAILKKISVLAFSVCFIFTITIGMFPAVTVEVKSSIAGSSTWERYFIPVSCFLTFNIFDWLGRSLTAVFMWPGKDSRWLPSLVLARLVFVPLLLLCNIKPRRYLTVVFEHDAWFIFFMAAFAFSNGYLASLCMCFGPKKVKPAEAETAGAIMAFFLCLGLALGAVFSFLFRAIVGTELLQVDTNSLEVLFQ","Homo sapiens","SLC29A1, ENT1","Equilibrative nucleoside transporter 1","1","6OB7"
"6OBB",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M TRIS, PH 8.0 0.2M SODIUM ACETATE, 0.001 M TCEP, 12-24% PEG 4,000",277.15,"10.1021/acs.jmedchem.0c00192",,"6OBB",33.49,"1.904","1.904","JAK2 JH2 in complex with JAK170","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6OBB"
"6OBF",,"X-RAY DIFFRACTION",2.17,43.23,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M TRIS, PH 8.0 0.2M SODIUM ACETATE, 0.001 M TCEP, 12-24% PEG 4,000",277.15,"10.1021/acs.jmedchem.0c00192",,"6OBF",33.66,"1.71","1.71","JAK2 JH2 in complex with JAK179","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6OBF"
"6OBL",,"X-RAY DIFFRACTION",2.17,43.33,"VAPOR DIFFUSION, HANGING DROP",,"0.1M TRIS, PH 8.0 0.2M SODIUM ACETATE, 0.001 M TCEP, 12-24% PEG 4,000",277.15,"10.1021/acs.jmedchem.0c00192",,"6OBL",33.51,"2.061","2.061","JAK2 JH2 in complex with JAK168","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6OBL"
"6OBS",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, HANGING DROP",6,"20% PEG6000, 1 M lithium chloride, 0.1 M MES, pH 6.0",289,"10.1073/pnas.1908718116",,"6OBS",68.76,"1.803","1.803","PP1 Y134K","GHMGSLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIKGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAD","Homo sapiens","PPP1CA, PPP1A","Serine/threonine-protein phosphatase PP1-alpha catalytic subunit","1","6OBS"
"6OBX",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM sodium cacodylate, 52-58% MPD",293,"10.1039/c9sc02610j",,"6OBX",57.03,"1.3","1.3","Montbretin A analogue M10-MbA in complex with Human pancreatic alpha-amylase","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","6OBX"
"6OBZ",,"X-RAY DIFFRACTION",2.33,47.27,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M tri-sodium citrate
20% (w/v) PEG3350",277.15,"10.1016/j.cell.2019.04.011",,"6OBZ",97.32,"1.73","1.73","Crystal structure of FluA-20 Fab","QVQLEESGPGLVKPSETLSLTCSVSGVSVTSDIYYWTWIRQPPGKGLEWIGYIFYNGDTNYNPSLKSRVTMSIDTSKNEFSLRLTSVTAADTAVYFCARGTEDLGYCSSGSCPNHWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"Heavy chain of FluA-20 Fab","1","6OBZ"
,,,,,,,,,,,,,,,,"DIVMTQSPSSLSASIGDRVTITCRPSQNIRSFLNWFQHKPGKAPKLLIYAASNLQSGVPSRFSGSGSGTEFTLTIRSLQPEDFATYYCQQSYNTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light chain of FluA-20 Fab, Immunoglobulin light chain","2","6OBZ"
"6OC0",,"X-RAY DIFFRACTION",3.72,66.92,"VAPOR DIFFUSION, HANGING DROP",4.5,"Ammonium sulfate, glycerol, DHO, DDAO, OSU-03012",293,"10.1016/j.chembiol.2019.10.012",,"6OC0",41.49,"1.4","1.4","Crystal structure of human DHODH with OSU-03012","HMMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6OC0"
"6OC1",,"X-RAY DIFFRACTION",3.05,59.67,"VAPOR DIFFUSION, HANGING DROP",8.2,"Sodium Phosphate",293,"10.1016/j.chembiol.2019.10.012",,"6OC1",41.39,"2.7","2.7","Crystal structure of human DHODH with TAK-632","HMMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6OC1"
"6OC9",,"SOLID-STATE NMR",,,,,,,"10.1073/pnas.1818530116",,"6OC9",44.16,,,"S8 phosphorylated beta amyloid 40 fibrils","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV","Homo sapiens","APP, A4, AD1","Amyloid-beta precursor protein","1","6OC9"
"6OCC",,"X-RAY DIFFRACTION",2.23,44.93,"VAPOR DIFFUSION, HANGING DROP",,"0.1M TRIS, PH 8.0 0.2M SODIUM ACETATE, 0.001 M TCEP, 12-24% PEG 4,000",277.15,"10.1021/acs.jmedchem.0c00192",,"6OCC",33.7,"2.03","2.03","JAK2 JH2 in complex with JAK190","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6OCC"
"6OCN",,"X-RAY DIFFRACTION",2.07,40.53,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM sodium cacodylate, 52-58% MPD",293,"10.1039/c9sc02610j",,"6OCN",56.85,"1.147","1.147","Montbretin A analogue M06-MbA in complex with Human pancreatic alpha-amylase","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","6OCN"
"6OCQ",,"X-RAY DIFFRACTION",2.07,40.53,"VAPOR DIFFUSION, HANGING DROP",7.5,"24 % PEG 4000, 0.1 M ammonium acetate, 0.1 M HEPES pH 7.5",277,"10.1021/acs.jmedchem.9b00318",,"6OCQ",69.88,"2.793","2.793","Crystal structure of RIP1 kinase in complex with a pyrrolidine","MDYKDDDDKMQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6OCQ"
"6OCR",,"X-RAY DIFFRACTION",2.31,46.73,"EVAPORATION",7,"20% ethanol, 0.1 M Tris, pH 7.0",293.15,"10.1073/pnas.1903024116",,"6OCR",200.49,"2.28","2.28","Crystal structure of human KCTD16 T1 domain","SFPEVVELNVGGQVYFTRHSTLISIPHSLLWKMFSPKRDTANDLAKDSKGRFFIDRDGFLFRYILDYLRDRQVVLPDHFPEKGRLKREAEYFQLPDLVKLLTPDEIKQSPDEF","Homo sapiens","KCTD16, KIAA1317","BTB/POZ domain-containing protein KCTD16","1","6OCR"
"6OCT",,"X-RAY DIFFRACTION",2.69,54.26,"EVAPORATION",6,"6% PEG 6000
2% glycerol 
0.1 M sodium cacodylate trihydrate pH 6.0",293.15,"10.1073/pnas.1903024116",,"6OCT",133.66,"2.8","2.8","Crystal structure of human KCTD16 T1 domain","SFPEVVELNVGGQVYFTRHSTLISIPHSLLWKMFSPKRDTANDLAKDSKGRFFIDRDGFLFRYILDYLRDRQVVLPDHFPEKGRLKREAEYFQLPDLVKLLTPDEIKQSPDEF","Homo sapiens","KCTD16, KIAA1317","BTB/POZ domain-containing protein KCTD16","1","6OCT"
"6OD6",,"X-RAY DIFFRACTION",2.54,56.15,"VAPOR DIFFUSION",6.25,"17% PEG-4000, 0.1M MES",293,"10.1021/acsmedchemlett.9b00181","M7D","6OD6",145.59,"2","2","Structure of BACE-1 in complex with Ligand 13","MHHHHHHTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGTTGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6OD6"
"6ODA",,"X-RAY DIFFRACTION",2.69,54.19,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.1M MES pH5.3, 5% PEG6000, 0.06M Gly-Gly-Gly, 4mM TCEP",291,,,"6ODA",139.42,"2.88","2.88","Crystal structure of HDAC8 in complex with compound 2","MHHHHHHSSGVDLGTENLYFQSNAMEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","6ODA"
"6ODB",,"X-RAY DIFFRACTION",2.69,54.29,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.1M MES pH5.3, 5% PEG6000, 0.12M Gly-Gly-Gly, 2mM TCEP",291,,,"6ODB",139.85,"2.7","2.7","Crystal structure of HDAC8 in complex with compound 3","MHHHHHHSSGVDLGTENLYFQSNAMEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","6ODB"
"6ODC",,"X-RAY DIFFRACTION",2.67,53.96,"VAPOR DIFFUSION, HANGING DROP",5.3,"0.1M MES pH5.3, 5% PEG6000, 0.14 M Gly-Gly-Gly, 2mM TCEP",291,,,"6ODC",139.64,"2.8","2.8","Crystal structure of HDAC8 in complex with compound 30","MHHHHHHSSGVDLGTENLYFQSNAMEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","6ODC"
"6ODG",,"X-RAY DIFFRACTION",1.32,6.48,"BATCH MODE",,"3.3 mg/mL SVQIVY, 0.667 M DL-malic acid, pH 7.0, 8% w/v PEG3350",291,"10.1074/jbc.RA119.009688",,"6ODG",1.42,"1","1","SVQIVY, Crystal Structure of a tau protein fragment","SVQIVY","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6ODG"
"6ODH",,"X-RAY DIFFRACTION",,35.15,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG 3350 and 100 mM ammonium sulfate",277,,,"6ODH",59.94,"2.3","2.3","BH3 domain swapped dimer of a BAK fragment","MGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLEENLYFQ","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","6ODH"
"6ODZ",,"X-RAY DIFFRACTION",2.09,41.21,"VAPOR DIFFUSION, SITTING DROP",,"200 nL 7 mg/mL protein + 200 nL reservoir (50 mM Tris, pH 8.0-8.2, 2.5-2.8 M ammonium sulfate)",281,"10.1016/j.ejmech.2019.05.058","M8J","6ODZ",30.18,"1.3","1.3","Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6ODZ"
"6OE0",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION, SITTING DROP",,"200 nL 7 mg/mL protein + 200 nL reservoir (50 mM Tris, pH 8.0-8.2, 2.5-2.8 M ammonium sulfate)",281,"10.1016/j.ejmech.2019.05.058","M8S","6OE0",29.84,"1.3","1.3","Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OE0"
"6OE1",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, SITTING DROP",,"200 nL 7 mg/mL protein + 200 nL reservoir (50 mM Tris, pH 8.0-8.2, 2.5-2.8 M ammonium sulfate)",281,"10.1016/j.ejmech.2019.05.058","SO4, M8V","6OE1",29.92,"1.45","1.45","Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OE1"
"6OED",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEG 4000
0.1 M MES pH 5.5
0.15 M ammonium sulfate",294,"10.1128/mBio.00208-20",,"6OED",142.35,"2.461","2.461","CRYSTAL STRUCTURE OF THE RV144 C1-C2 SPECIFIC ANTIBODY CH55 FAB","QVQLVQSGAEVKKPGASVKVSCKASGYIFISYFMHWVRQAPGQGLEWMGIINPSSGDTRYAQKFQGRVTMTRDTSTNTVYMELSSLRSDDTAVYYCARRPGGLERHNWLDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"CH55 Fab heavy chain","1","6OED"
,,,,,,,,,,,,,,,,"EIVMTQSPATLSVSPGERATLSCRASQSISSNLAWYQQKPGQAPRLLIYGASTRATGTPARFSGSGSGTEFTLTISSLQSEDFASYYCQQYNNWPAITFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CH55 Fab light chain","2","6OED"
"6OEU","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-018-0308-7",,"6OEU",163.41,"3.5, 3.5",,"Structure of human Patched1","MASAGNAAEPQDRGGGGSGCIGAPGRPAGGGRRRRTGGLRRAAAPDRDYLHRPSYCDAAFALEQISKGKATGRKAPLWLRAKFQRLLFKLGCYIQKNCGKFLVVGLLIFGAFAVGLKAANLETNVEELWVEVGGRVSRELNYTRQKIGEEAMFNPQLMIQTPKEEGANVLTTEALLQHLDSALQASRVHVYMYNRQWKLEHLCYKSGELITETGYMDQIIEYLYPCLIITPLDCFWEGAKLQSGTAYLLGKPPLRWTNFDPLEFLEELKKINYQVDSWEEMLNKAEVGHGYMDRPCLNPADPDCPATAPNKNSTKPLDMALVLNGGCHGLSRKYMHWQEELIVGGTVKNSTGKLVSAHALQTMFQLMTPKQMYEHFKGYEYVSHINWNEDKAAAILEAWQRTYVEVVHQSVAQNSTQKVLSFTTTTLDDILKSFSDVSVIRVASGYLLMLAYACLTMLRWDCSKSQGAVGLAGVLLVALSVAAGLGLCSLIGISFNAATTQVLPFLALGVGVDDVFLLAHAFSETGQNKRIPFEDRTGECLKRTGASVALTSISNVTAFFMAALIPIPALRAFSLQAAVVVVFNFAMVLLIFPAILSMDLYRREDRRLDIFCCFTSPCVSRVIQVEPQAYTDTHDNTRYSPPPPYSSHSFAHETQITMQSTVQLRTEYDPHTHVYYTTAEPRSEISVQPVTVTQDTLSCQSPESTSSTRDLLSQFSDSSLHCLEPPCTKWTLSSFAEKHYAPFLLKPKAKVVVIFLFLGLLGVSLYGTTRVRDGLDLTDIVPRETREYDFIAAQFKYFSFYNMYIVTQKADYPNIQHLLYDLHRSFSNVKYVMLEENKQLPKMWLHYFRDWLQGLQDAFDSDWETGKIMPNNYKNGSDDGVLAYKLLVQTGSRDKPIDISQLTKQRLVDADGIINPSAFYIYLTAWVSNDPVAYAASQANIRPHRPEWVHDKADYMPETRLRIPAAEPIEYAQFPFYLNGLRDTSDFVEAIEKVRTICSNYTSLGLSSYPNGYPFLFWEQYIGLRHWLLLFISVVLACTFLVCAVFLLNPWTAGIIVMVLALMTVELFGMMGLIGIKLSAVPVVILIASVGIGVEFTVHVALAFLTAIGDKNRRAVLALEHMFAPVLDGAVSTLLGVLMLAGSEFDFIVRYFFAVLAILTILGVLNGLVLLPVLLSFFGPYPEVSPANGLNRLPTPSPEPPPSVVRFAMPPGHTHSGSDSSDSEYSSQTTVSGLSEELRHYEAQQGAGGPAHQVIVEATENPVFAHSTVVHPESRHHPPSNPRQQPHLDSGSLPPGRQGQQPRRDPPREGLWPPPYRPRRDAFEISTEGHSGPSNRARWGPRGARSHNPRNPASTAMGSSVPGYCQPITTVTASASVTVAVHPPPVPGPGRNPRGGLCPGYPETDHGLFEDPHVPFHVRCERRDSKVEVIELQDVECEERPRGSSSNDYKDDDDK","Homo sapiens","PTCH1, PTCH","Protein patched homolog 1","1","6OEU"
"6OF8",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",,"17 mg/mL mutant hub in 25 mM Tris, 150 mM KCl, 10% (v/v) glycerol, 2 mM DTT, 1 mM TCEP, pH 8.0 was mixed 1:1 with 235 mM K3Citrate, 15% (w/v) PEG 3350, pH 8.0",293,"10.1002/pro.3614",,"6OF8",109.33,"2.1","2.1","Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CamKII-alpha hub domain","GPHMVRKQEIIKVNQQLIEAISNGDFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHNTMLNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQHVHMHRSGAPSV","Homo sapiens","CAMK2A, CAMKA, KIAA0968","Calcium/calmodulin-dependent protein kinase type II subunit alpha","1","6OF8"
"6OFB",,"X-RAY DIFFRACTION",3.51,64.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8 M AMMONIUM SULFATE, 30% MPD, 15%
 GLYCEROL, 85 MM HEPES",288,"10.1038/s41467-019-13845-4",,"6OFB",161.71,"2.84","2.84","Crystal structure of human glutamine-dependent NAD+ synthetase complexed with NaAD+, AMP, pyrophosphate, and Mg2+","SMGRKVTVATCALNQWALDFEGNLQRILKSIEIAKNRGARYRLGPELEICGYGCWDHYYESDTLLHSFQVLAALLESPVTQDIICDVGMPVMHRNVRYNCRVIFLNRKILLIRPKMALANEGNYRELRWFTPWSRSRHTEEYFLPRMIQDLTKQETVPFGDAVLVTWDTCIGSEICEELWTPHSPHIDMGLDGVEIITNASGSHHVLRKANTRVDLVTMVTSKNGGIYLLANQKGCDGDRLYYDGCAMIAMNGSVFAQGSQFSLDDVEVLTATLDLEDVRSYRAEISSRNLAASRASPYPRVKVDFALSCHEDLLAPISEPIEWKYHSPEEEISLGPACWLWDFLRRSQQAGFLLPLSGGVDSAATACLIYSMCCQVCEAVRSGNEEVLADVRTIVNQISYTPQDPRDLCGRILTTCYMASKNSSQETCTRARELAQQIGSHHISLNIDPAVKAVMGIFSLVTGKSPLFAAHGGSSRENLALQNVQARIRMVLAYLFAQLSLWSRGVHGGLLVLGSANVDESLLGYLTKYDCSSADINPIGGISKTDLRAFVQFCIQRFQLPALQSILLAPATAELEPLADGQVSQTDEEDMGMTYAELSVYGKLRKVAKMGPYSMFCKLLGMWRHICTPRQVADKVKRFFSKYSMNRHKMTTLTPAYHAENYSPEDNRFDLRPFLYNTSWPWQFRCIENQVLQLERAEPQSLDGVD","Homo sapiens","NADSYN1","Glutamine-dependent NAD(+) synthetase","1","6OFB"
"6OFP",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, HANGING DROP",8.05,"0.1 M Tris, pH 8.05, 26% tert-Butanol, 40 mM CaCl2, 60 mM 1,6-Hexanediol",293,"10.1021/acs.jpclett.9b01865",,"6OFP",21.88,"2.006","2.006","Structure of the C-terminal cargo binding domain of human Bicaudal D2","GSHMYENEKAMVTETMMKLRNELKALKEDAATFSSLRAMFATRCDEYITQLDEMQRQLAAAEDEKKTLNSLLRMAIQQKLALTQRLELLELDHE","Homo sapiens","BICD2, KIAA0699","Protein bicaudal D homolog 2","1","6OFP"
"6OFZ",,"X-RAY DIFFRACTION",2.1,40.4,"VAPOR DIFFUSION, SITTING DROP",5.9,"100 mM Bis-Tris pH5.9, 32% PEG3350,
54.6 mM Ammonium Sulfate",295,"10.1021/acs.biochem.0c00035",,"6OFZ",34.39,"1.85","1.85","Crystal structure of human WDR5","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6OFZ"
"6OHD",,"X-RAY DIFFRACTION",2.04,48.9,"VAPOR DIFFUSION, SITTING DROP",,"20.% PEG 3350, 0.1M MES_Na",277,"10.1002/cmdc.201900373","MKP","6OHD",45.08,"2.5","2.5","P38 in complex with T-3220137","MSYYHHHHHHDYDIPTTENLYFQGAMGSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6OHD"
"6OHM",,"X-RAY DIFFRACTION",2.09,41.22,"VAPOR DIFFUSION, SITTING DROP",6.7,"0.2M ammonium sulfate, 20% PEG3350, 0.1M bis-tris pH 6.7",298,"10.1038/s41589-019-0458-4",,"6OHM",147.32,"1.895","1.895","Structure of tungstate bound human Phospholipase D2 catalytic domain","SSYRQARWWAQEITELAQGPGRDFLQLHRHDSYAPPRPGTLARWFVNGAGYFAAVADAILRAQEEIFITDWWLSPEVYLKRPAHSDDWRLDIMLKRKAEEGVRVSILLFKEVELALGINSGYSKRALMLLHPNIKVMRHPDQVTLWAHHEKLLVVDQVVAFLGGLDLAYGRWDDLHYRLTDLGDSSESAASQPPTPRPDSPATPDLSHNQFFWLGKDYSNLITKDWVQLDRPFEDFIDRETTPRMPWRDVGVVVHGLPARDLARHFIQRWNFTKTTKAKYKTPTYPYLLPKSTSTANQLPFTLPGGQCTTVQVLRSVDRWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRTVLNKVGDEIVDRILKAHKQGWCYRVYVLLPLLPGFEGDISTGGGNSIQAILHFTYRTLCRGEYSILHRLKAAMGTAWRDYISICGLRTHGELGGHPVSELIYIHSKVLIADDRTVIIGSANINDRSLLGKRDSELAVLIEDTETEPSLMNGAEYQAGRFALSLRKHCFGVILGANTRPDLDLRDPICDDFFQLWQDMAESNANIYEQIFRCLPSNATRSLRTLREYVAVEPLATVSPPLARSELTQVQGHLVHFPLKFLEDESLLPPLGSKEGMIPLEVWT","Homo sapiens","PLD2","Phospholipase D2","1","6OHM"
"6OHO",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, SITTING DROP",6.7,"0.2M ammonium sulfate, 20% PEG3350, 0.1M bis-tris pH 6.7",298,"10.1038/s41589-019-0458-4",,"6OHO",148.22,"2","2","Structure of human Phospholipase D2 catalytic domain","SSYRQARWWAQEITELAQGPGRDFLQLHRHDSYAPPRPGTLARWFVNGAGYFAAVADAILRAQEEIFITDWWLSPEVYLKRPAHSDDWRLDIMLKRKAEEGVRVSILLFKEVELALGINSGYSKRALMLLHPNIKVMRHPDQVTLWAHHEKLLVVDQVVAFLGGLDLAYGRWDDLHYRLTDLGDSSESAASQPPTPRPDSPATPDLSHNQFFWLGKDYSNLITKDWVQLDRPFEDFIDRETTPRMPWRDVGVVVHGLPARDLARHFIQRWNFTKTTKAKYKTPTYPYLLPKSTSTANQLPFTLPGGQCTTVQVLRSVDRWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRTVLNKVGDEIVDRILKAHKQGWCYRVYVLLPLLPGFEGDISTGGGNSIQAILHFTYRTLCRGEYSILHRLKAAMGTAWRDYISICGLRTHGELGGHPVSELIYIHSKVLIADDRTVIIGSANINDRSLLGKRDSELAVLIEDTETEPSLMNGAEYQAGRFALSLRKHCFGVILGANTRPDLDLRDPICDDFFQLWQDMAESNANIYEQIFRCLPSNATRSLRTLREYVAVEPLATVSPPLARSELTQVQGHLVHFPLKFLEDESLLPPLGSKEGMIPLEVWT","Homo sapiens","PLD2","Phospholipase D2","1","6OHO"
"6OHP",,"X-RAY DIFFRACTION",2.28,46.16,"VAPOR DIFFUSION, SITTING DROP",,"0.2M ammonium tartrate di-basic, 22% PEG 3350",298,"10.1038/s41589-019-0458-4",,"6OHP",294.13,"2.6","2.6","Structure of compound 1 (halopemide) bound human Phospholipase D2 catalytic domain","SSYRQARWWAQEITELAQGPGRDFLQLHRHDSYAPPRPGTLARWFVNGAGYFAAVADAILRAQEEIFITDWWLSPEVYLKRPAHSDDWRLDIMLKRKAEEGVRVSILLFKEVELALGINSGYSKRALMLLHPNIKVMRHPDQVTLWAHHEKLLVVDQVVAFLGGLDLAYGRWDDLHYRLTDLGDSSESAASQPPTPRPDSPATPDLSHNQFFWLGKDYSNLITKDWVQLDRPFEDFIDRETTPRMPWRDVGVVVHGLPARDLARHFIQRWNFTKTTKAKYKTPTYPYLLPKSTSTANQLPFTLPGGQCTTVQVLRSVDRWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRTVLNKVGDEIVDRILKAHKQGWCYRVYVLLPLLPGFEGDISTGGGNSIQAILHFTYRTLCRGEYSILHRLKAAMGTAWRDYISICGLRTHGELGGHPVSELIYIHSKVLIADDRTVIIGSANINDRSLLGKRDSELAVLIEDTETEPSLMNGAEYQAGRFALSLRKHCFGVILGANTRPDLDLRDPICDDFFQLWQDMAESNANIYEQIFRCLPSNATRSLRTLREYVAVEPLATVSPPLARSELTQVQGHLVHFPLKFLEDESLLPPLGSKEGMIPLEVWT","Homo sapiens","PLD2","Phospholipase D2","1","6OHP"
"6OHQ",,"X-RAY DIFFRACTION",2.01,38.71,"VAPOR DIFFUSION, SITTING DROP",,"0.2M ammonium sulfate, 20% PEG3350, 0.1M bis-tris pH 6.7",298,"10.1038/s41589-019-0458-4",,"6OHQ",148.79,"2.694","2.694","Structure of compound 4 bound human Phospholipase D2 catalytic domain","SSYRQARWWAQEITELAQGPGRDFLQLHRHDSYAPPRPGTLARWFVNGAGYFAAVADAILRAQEEIFITDWWLSPEVYLKRPAHSDDWRLDIMLKRKAEEGVRVSILLFKEVELALGINSGYSKRALMLLHPNIKVMRHPDQVTLWAHHEKLLVVDQVVAFLGGLDLAYGRWDDLHYRLTDLGDSSESAASQPPTPRPDSPATPDLSHNQFFWLGKDYSNLITKDWVQLDRPFEDFIDRETTPRMPWRDVGVVVHGLPARDLARHFIQRWNFTKTTKAKYKTPTYPYLLPKSTSTANQLPFTLPGGQCTTVQVLRSVDRWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRTVLNKVGDEIVDRILKAHKQGWCYRVYVLLPLLPGFEGDISTGGGNSIQAILHFTYRTLCRGEYSILHRLKAAMGTAWRDYISICGLRTHGELGGHPVSELIYIHSKVLIADDRTVIIGSANINDRSLLGKRDSELAVLIEDTETEPSLMNGAEYQAGRFALSLRKHCFGVILGANTRPDLDLRDPICDDFFQLWQDMAESNANIYEQIFRCLPSNATRSLRTLREYVAVEPLATVSPPLARSELTQVQGHLVHFPLKFLEDESLLPPLGSKEGMIPLEVWT","Homo sapiens","PLD2","Phospholipase D2","1","6OHQ"
"6OHR",,"X-RAY DIFFRACTION",2.22,44.67,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.1M Tris-HCl pH 8.8, 2.81M sodium acetate pH 7.6, 0.04-0.05M glycine pH 9.5, 0.3-0.5 M NaCl",298,"10.1038/s41589-019-0458-4",,"6OHR",446.59,"3.2","3.2","Structure of compound 5 bound human Phospholipase D1 catalytic domain","GNSYRHARWWGGAIEEFIQKHGTNFLKDHRFGSYAAIQENALAKWYVNAKGYFEDVANAMEEANEEIFITDWWLSPEIFLKRPVVEGNRWRLDCILKRKAQQGVRIFIMLYKEVELALGINSEYTKRTLMRLHPNIKVMRHPDHVSSTVYLWAHHEKLVIIDQSVAFVGGIDLAYGRWDDNEHRLTDVGSGSGSGSGSGSGSGSGSGSGSHGETRFWHGKDYCNFVFKDWVQLDKPFADFIDRYSTPRMPWHDIASAVHGKAARDVARHFIQRWNFTKIMKSKYRSLSYPFLLPKSQTTAHELRYQVPGSVHANVQLLRSAADWSAGIKYHEESIHAAYVHVIENSRHYIYIENQFFISCADDKVVFNKIGDAIAQRILKAHRENQKYRVYVVIPLLPGFEGDISTGGGNALQAIMHFNYRTMCRGENSILGQLKAELGNQWINYISFCGLRTHAELEGNLVTELIYVHSKLLIADDNTVIIGSANINDRSMLGKRDSEMAVIVQDTETVPSVMDGKEYQAGRFARGLRLQCFRVVLGYLDDPSEDIQDPVSDKFFKEVWVSTAARNATIYDKVFRCLPNDEVHNLIQLRDFINKPVLAKEDPIRAEEELKKIRGFLVQFPFYFLSEESLLPSVGTKEAIVPMEVWT","Homo sapiens","PLD1","Phospholipase D1, chimeric constuct","1","6OHR"
,,,,,,,,,,,,,,,,,"Homo sapiens","PLD1"
"6OHS",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, SITTING DROP",,"0.08M sodium cacodylate pH 7.0, 22% PEG 8000, 0.1M calcium acetate",298,"10.1038/s41589-019-0458-4","JY","6OHS",293.34,"3.2","3.2","Structure of compound 3 (ML299) bound human Phospholipase D2 catalytic domain","SSYRQARWWAQEITELAQGPGRDFLQLHRHDSYAPPRPGTLARWFVNGAGYFAAVADAILRAQEEIFITDWWLSPEVYLKRPAHSDDWRLDIMLKRKAEEGVRVSILLFKEVELALGINSGYSKRALMLLHPNIKVMRHPDQVTLWAHHEKLLVVDQVVAFLGGLDLAYGRWDDLHYRLTDLGDSSESAASQPPTPRPDSPATPDLSHNQFFWLGKDYSNLITKDWVQLDRPFEDFIDRETTPRMPWRDVGVVVHGLPARDLARHFIQRWNFTKTTKAKYKTPTYPYLLPKSTSTANQLPFTLPGGQCTTVQVLRSVDRWSAGTLENSILNAYLHTIRESQHFLYIENQFFISCSDGRTVLNKVGDEIVDRILKAHKQGWCYRVYVLLPLLPGFEGDISTGGGNSIQAILHFTYRTLCRGEYSILHRLKAAMGTAWRDYISICGLRTHGELGGHPVSELIYIHSKVLIADDRTVIIGSANINDRSLLGKRDSELAVLIEDTETEPSLMNGAEYQAGRFALSLRKHCFGVILGANTRPDLDLRDPICDDFFQLWQDMAESNANIYEQIFRCLPSNATRSLRTLREYVAVEPLATVSPPLARSELTQVQGHLVHFPLKFLEDESLLPPLGSKEGMIPLEVWT","Homo sapiens","PLD2","Phospholipase D2","1","6OHS"
"6OHT",,"X-RAY DIFFRACTION",3.88,68.33,"VAPOR DIFFUSION, HANGING DROP",,"Hepes, peg 600",293.15,"10.1038/s41467-019-10279-w",,"6OHT",83.85,"3.2","3.2","Structure of EBP and U18666A","MWSHPQFEKTTNAGPLHPYWPQHLRLDNFVPNDRPTWHILAGLFSVTGVLVVTTWLLSGRAAVVPLGTWRRLSLCWFAVCGFIHLVIEGWFVLYYEDLLGDQAFLSQLWKEYAKGDSRYILGDNFTVCMETITACLWGPLSLWVVIAFLRQHPLRFILQLVVSVGQIYGDVLYFLTEHRDGFQHGELGHPLYFWFYFVFMNALWLVLPGVLVLDAVKHLTHAQSTLDAKATKAKSKKN","Homo sapiens","EBP","3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase","1","6OHT"
"6OHU",,"X-RAY DIFFRACTION",3.86,68.17,"VAPOR DIFFUSION, HANGING DROP",,"Hepes, peg 600",293.15,"10.1038/s41467-019-10279-w","CTX","6OHU",83.38,"3.526","3.526","Structure of EBP and tamoxifen","MWSHPQFEKTTNAGPLHPYWPQHLRLDNFVPNDRPTWHILAGLFSVTGVLVVTTWLLSGRAAVVPLGTWRRLSLCWFAVCGFIHLVIEGWFVLYYEDLLGDQAFLSQLWKEYAKGDSRYILGDNFTVCMETITACLWGPLSLWVVIAFLRQHPLRFILQLVVSVGQIYGDVLYFLTEHRDGFQHGELGHPLYFWFYFVFMNALWLVLPGVLVLDAVKHLTHAQSTLDAKATKAKSKKN","Homo sapiens","EBP","3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase","1","6OHU"
"6OI0",,"X-RAY DIFFRACTION",2.1,40.4,"VAPOR DIFFUSION, SITTING DROP",5.9,"100 mM Bis-Tris pH 5.9; 32% PEG3350, 54.6 mM Ammonium Sulfate, 0.66 mM L-arginine",295,"10.1021/acs.biochem.0c00035",,"6OI0",35.13,"1.92","1.92","Crystal structure of human WDR5 in complex with L-arginine","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6OI0"
"6OI1",,"X-RAY DIFFRACTION",2.1,40,"VAPOR DIFFUSION, SITTING DROP",5.9,"100mM Bis-Tris pH 5.9, 32% PEG3350,
54.6 mM Ammonium Sulfate, 0.66 mM monomethyl L-arginine",295,"10.1021/acs.biochem.0c00035",,"6OI1",34.86,"1.68","1.68","Crystal structure of human WDR5 in complex with monomethyl L-arginine","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6OI1"
"6OI2",,"X-RAY DIFFRACTION",2.1,40,"VAPOR DIFFUSION, SITTING DROP",5.9,"100 mM Bis-Tris pH5.9, 32% PEG3350,
54.6 mM Ammonium Sulfate, 0.66 mM symmetric dimethyl-L-arginine",295,"10.1021/acs.biochem.0c00035",,"6OI2",35.16,"1.68","1.68","Crystal structure of human WDR5 in complex with symmetric dimethyl-L-arginine","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6OI2"
"6OI5",,"X-RAY DIFFRACTION",3.08,60.1,"VAPOR DIFFUSION, HANGING DROP",7,"30% PEG 400, 0.1M ADA pH 7.0, 0.35M lithium sulfate",293.15,"10.1016/j.chembiol.2019.09.010",,"6OI5",95.58,"2.811","2.811","Crystal structure of human Sulfide Quinone Oxidoreductase","MNHYEVLVLGGGSGGITMAARMKRKVGAENVAIVEPSERHFYQPIWTLVGAGAKQLSSSGRPTASVIPSGVEWIKARVTELNPDKNCIHTDDDEKISYRYLIIALGIQLDYEKIKGLPEGFAHPKIGSNYSVKTVEKTWKALQDFKEGNAIFTFPNTPVKCAGAPQKIMYLSEAYFRKTGKRSKANIIFNTSLGAIFGVKKYADALQEIIQERNLTVNYKKNLIEVRADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLKTSPVADAAGWVDVDKETLQHRRYPNVFGIGDCTNLPTSKTAAAVAAQSGILDRTISVIMKNQTPTKKYDGYTSCPLVTGYNRVILAEFDYKAEPLETFPFDQSKERLSMYLMKADLMPFLYWNMMLRGYWGGPAFLRKLFHLGMSLEHHHHHH","Homo sapiens","SQOR, SQRDL, CGI-44","Sulfide:quinone oxidoreductase, mitochondrial","1","6OI5"
"6OI6",,"X-RAY DIFFRACTION",3.11,60.48,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium tartrate dibasic, 20% PEG 3350",293.15,"10.1016/j.chembiol.2019.09.010",,"6OI6",96.08,"2.56","2.56","Crystal structure of human Sulfide Quinone Oxidoreductase in complex with coenzyme Q (sulfide soaked)","MNHYEVLVLGGGSGGITMAARMKRKVGAENVAIVEPSERHFYQPIWTLVGAGAKQLSSSGRPTASVIPSGVEWIKARVTELNPDKNCIHTDDDEKISYRYLIIALGIQLDYEKIKGLPEGFAHPKIGSNYSVKTVEKTWKALQDFKEGNAIFTFPNTPVKCAGAPQKIMYLSEAYFRKTGKRSKANIIFNTSLGAIFGVKKYADALQEIIQERNLTVNYKKNLIEVRADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLKTSPVADAAGWVDVDKETLQHRRYPNVFGIGDCTNLPTSKTAAAVAAQSGILDRTISVIMKNQTPTKKYDGYTSCPLVTGYNRVILAEFDYKAEPLETFPFDQSKERLSMYLMKADLMPFLYWNMMLRGYWGGPAFLRKLFHLGMSLEHHHHHH","Homo sapiens","SQOR, SQRDL, CGI-44","Sulfide:quinone oxidoreductase, mitochondrial","1","6OI6"
"6OIA",,"X-RAY DIFFRACTION",2.7,54.44,"VAPOR DIFFUSION, HANGING DROP",,"10% PEG 6000, 200 mM NaCl, 2.5 % Glycerol",298,"10.1021/jacs.9b03254",,"6OIA",135.98,"1.777","1.777","(1S,3S)-3-amino-4-(perfluoropropan-2-ylidene)cyclopentane-1-carboxylic acid hydrochloride, a potent inhibitor of ornithine aminotransferase","GPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF","Homo sapiens","OAT","Ornithine aminotransferase, mitochondrial","1","6OIA"
"6OIB",,"X-RAY DIFFRACTION",3.11,60.5,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium tartrate dibasic, 20% PEG 3350",293.15,"10.1016/j.chembiol.2019.09.010",,"6OIB",96.5,"2.03","2.03","Crystal structure of human Sulfide Quinone Oxidoreductase in complex with coenzyme Q","MNHYEVLVLGGGSGGITMAARMKRKVGAENVAIVEPSERHFYQPIWTLVGAGAKQLSSSGRPTASVIPSGVEWIKARVTELNPDKNCIHTDDDEKISYRYLIIALGIQLDYEKIKGLPEGFAHPKIGSNYSVKTVEKTWKALQDFKEGNAIFTFPNTPVKCAGAPQKIMYLSEAYFRKTGKRSKANIIFNTSLGAIFGVKKYADALQEIIQERNLTVNYKKNLIEVRADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLKTSPVADAAGWVDVDKETLQHRRYPNVFGIGDCTNLPTSKTAAAVAAQSGILDRTISVIMKNQTPTKKYDGYTSCPLVTGYNRVILAEFDYKAEPLETFPFDQSKERLSMYLMKADLMPFLYWNMMLRGYWGGPAFLRKLFHLGMSLEHHHHHH","Homo sapiens","SQOR, SQRDL, CGI-44","Sulfide:quinone oxidoreductase, mitochondrial","1","6OIB"
"6OIC",,"X-RAY DIFFRACTION",2.89,57.39,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium tartrate dibasic, 20% PEG 3350",293.15,"10.1016/j.chembiol.2019.09.010",,"6OIC",96.59,"2.21","2.21","Crystal structure of human Sulfide Quinone Oxidoreductase in complex with coenzyme Q (sulfite soaked)","MNHYEVLVLGGGSGGITMAARMKRKVGAENVAIVEPSERHFYQPIWTLVGAGAKQLSSSGRPTASVIPSGVEWIKARVTELNPDKNCIHTDDDEKISYRYLIIALGIQLDYEKIKGLPEGFAHPKIGSNYSVKTVEKTWKALQDFKEGNAIFTFPNTPVKCAGAPQKIMYLSEAYFRKTGKRSKANIIFNTSLGAIFGVKKYADALQEIIQERNLTVNYKKNLIEVRADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLKTSPVADAAGWVDVDKETLQHRRYPNVFGIGDCTNLPTSKTAAAVAAQSGILDRTISVIMKNQTPTKKYDGYTSCPLVTGYNRVILAEFDYKAEPLETFPFDQSKERLSMYLMKADLMPFLYWNMMLRGYWGGPAFLRKLFHLGMSLEHHHHHH","Homo sapiens","SQOR, SQRDL, CGI-44","Sulfide:quinone oxidoreductase, mitochondrial","1","6OIC"
"6OIF","4.4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-11194-w",,"6OIF",827.44,"4.4",,"Cryo-EM structure of human TorsinA filament","GQKRSLSREALQKDLDDNLFGQHLAKKIILNAVFGFINNPKPKKPLTLSLHGWTGTGKNFVSKIIAENIYEGGLNSDYVHLFVATLHFPHASNITLYKDQLQLWIRGNVSACARSIFIFDEMDKMHAGLIDAIKPFLDYYDLVDGVSYQKAMFIFLSNAGAERITDVALDFWRSGKQREDIKLKDIEHALSVSVFNNKNSGFWHSSLIDRNLIDYFVPFLPLEYKHLKMCIRVEMQSRGYEIDEDIVSRVAEEMTFFPKEERVFSDKGCKTVFTKLDYYYDD","Homo sapiens","TOR1A, DQ2, DYT1, TA, TORA","Torsin-1A","1","6OIF"
"6OIL",,"X-RAY DIFFRACTION",1.85,33.48,"VAPOR DIFFUSION, SITTING DROP",,"18% PEG3350, 0.075M NaBr, 0.05M HAT buffer(combination of HEPES (7.5), ADA (6.5), and TrisHCl (8.0))",293,"10.1016/j.celrep.2019.07.073",,"6OIL",19.49,"1.85","1.85","Crystal structure of human VISTA extracellular domain","FKVATPYSLYVCPEGQNVTLTCRLLGPVDKGHDVTFYKTWYRSSRGEVQTCSERRPIRQLTFQDLHLHHGGHQAAQTSHDLAQRHGLESASDHHGNFSITMRNLTLLDSGLYCCLVVEIRHHHSEHRVHGAMELQVQTGKDAPSNCVVYPSSSQESEQITAAHHHHHH","Homo sapiens","VSIR, C10orf54, SISP1, VISTA, PP2135, UNQ730/PRO1412","V-type immunoglobulin domain-containing suppressor of T-cell activation","1","6OIL"
"6OIM",,"X-RAY DIFFRACTION",1.87,34.19,"VAPOR DIFFUSION, SITTING DROP",6.5,"1mM MgCl2, 0.1M MES pH6.5, 30% PEG4000",293,"10.1038/s41586-019-1694-1",,"6OIM",22.07,"1.65","1.65","Crystal Structure of human KRAS G12C covalently bound to AMG 510","MKHHHHHHHDEVDGMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6OIM"
"6OIN",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION",7,"20% PEG 3350, 2% Tacsimate pH 7.0, 0.1 M HEPES pH 7.0",292,"10.1021/acs.jmedchem.9b00665",,"6OIN",32.64,"1.7","1.7","Crystal structure of MYST acetyltransferase domain in complex with inhibitor CTX-124143","VKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6OIN"
"6OIO",,"X-RAY DIFFRACTION",2.51,50.97,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 2% Tacsimate pH 7.0, 0.1 M HEPES pH 7.0",292,"10.1021/acs.jmedchem.9b00665",,"6OIO",32.56,"1.7","1.7","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 60","VKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6OIO"
"6OIP",,"X-RAY DIFFRACTION",2.51,51,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2 M K/Na Tartrate",292,"10.1021/acs.jmedchem.9b00665",,"6OIP",32.75,"1.8","1.8","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 34","VKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6OIP"
"6OIQ",,"X-RAY DIFFRACTION",2.52,51.27,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 2% Tacsimate pH 7.0, 0.1 M HEPES pH 7.0",292,"10.1021/acs.jmedchem.9b00665",,"6OIQ",32.67,"1.75","1.75","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 63","VKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6OIQ"
"6OIR",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG 3350, 2% Tacsimate pH 7.0, 0.1 M HEPES pH 7.0",292,"10.1021/acs.jmedchem.9b00665",,"6OIR",32.67,"2.03","2.03","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 62","VKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6OIR"
"6OIZ",,"ELECTRON CRYSTALLOGRAPHY",1.5,18.21,,,,,"10.1038/s41467-019-11183-z",,"6OIZ",1.49,"1.1","1.1","Amyloid-Beta (20-34) wild type","FAEDVGSNKGAIIGL","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","6OIZ"
"6OJE",,"X-RAY DIFFRACTION",2.15,42.88,"MICROBATCH",6.5,"100mM KSCN, 25% PEGMME 2000, 0.1M BisTris pH 6.5",298,,,"6OJE",48.01,"1.95","1.95","Dimeric structure of LRRK2 GTPase domain","MGSSHHHHHHSQDPAVPYNRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEKQRKACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQLVVG","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6OJE"
"6OJF",,"X-RAY DIFFRACTION",2.13,42.21,"MICROBATCH",6.5,"100mM KSCN, 25% PEGMME 2000, 0.1M BisTris pH 6.5",298,,,"6OJF",47.77,"1.6","1.6","Dimeric structure of LRRK2 GTPase domain","MGSSHHHHHHSQDPAVPYNRMKLMIVGNTGSGKTTLLQQLMKTKKSDLGMQSATVGIDVKDWPIQIRDKRKRDLVLNVWDFAGREEFYSTHPHFMTQRALYLAVYDLSKGQAEVDAMKPWLFNIKARASSSPVILVGTHLDVSDEAQRAACMSKITKELLNKRGFPAIRDYHFVNATEESDALAKLRKTIINESLNFKIRDQLVVG","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6OJF"
"6OJU",,"X-RAY DIFFRACTION",2.39,48.5,"VAPOR DIFFUSION, SITTING DROP",5,"Well solution 0.1 M Na Acetate, 1.55 M Na formate
Seed Solution (diluted 50:1) 0.2 M MgCl2, 20 % PEG 3350 
Drop ratio 3:2:1 Enzyme mix/well solution/ seed solution",295.15,"10.1002/1873-3468.13474",,"6OJU",135.64,"2.884","2.884","Crystal structure of human thymidylate synthase Delta (7-29) in complex with dUMP and 2-amino-4-oxo-4,7-dihydro-pyrrolo[2,3-d]pyrimidine-methyl-phenyl-D-glutamic acid","MPVAGSELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase,Thymidylate synthase","1","6OJU"
,,,,,,,,,,,,,,,,,"Homo sapiens","TYMS, TS, OK/SW-cl.29"
"6OJV",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, SITTING DROP",6.5,"Well solution 5% PEG 8000, 40% MPD, and 0.1M Na cacodylate
Drop ratio 1:1 Enzyme mix/well solution",295.15,"10.1002/1873-3468.13474",,"6OJV",135.64,"2.593","2.593","Crystal structure of human thymidylate synthase delta(7-29) in complex with dUMP and 2-amino-4-oxo-4,7-dihydro-pyrrolo[2,3-d]pyrimidine-methyl-phenyl-L-glutamic acid","MPVAGSELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase,Thymidylate synthase","1","6OJV"
,,,,,,,,,,,,,,,,,"Homo sapiens","TYMS, TS, OK/SW-cl.29"
"6OKQ",,"X-RAY DIFFRACTION",7,82.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, pH 7.5, 1.8 M sodium formate",293,"10.1016/j.immuni.2019.04.014",,"6OKQ",147.79,"3.2","3.2","Crystal structure of the SF12 Fab","IDLTQSPRTLSLSAGERATLLCRASQSVSNVALAWYQHKPGQAPRLLLHEASTRATGIPDRFIGSGSGRDFTLTITSLEPEDFAVYYCQLSGRRLGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"SF12 Fab Light Chain,SF12 Fab Light Chain","2","6OKQ"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"QVQLQESGPGLVKPSETLSVTCRVSGGSLDLYYWSWIRQPPGKGLQWIGFVYFDGSYGDYDPSLRSRVTISADMSKNQISLRLKSVTPADTAVYYCARLGPGGIFDRWTGHYGDKWLDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHHHHHH","Homo sapiens",,"SF12 Fab Heavy Chain,SF12 Fab Heavy Chain","1","6OKQ"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6OL4",,"X-RAY DIFFRACTION",3.37,63.53,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470",,"6OL4",34.72,"2.15","2.15","Protein Tyrosine Phosphatase 1B (1-301), F182A mutant, apo state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDAGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHE","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6OL4"
"6OLQ",,"X-RAY DIFFRACTION",3.41,63.94,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470",,"6OLQ",34.9,"2.1","2.1","Protein Tyrosine Phosphatase 1B (1-301), P188A mutant, apo state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESAASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6OLQ"
"6OLV",,"X-RAY DIFFRACTION",3.41,63.93,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470",,"6OLV",34.78,"2.1","2.1","Protein Tyrosine Phosphatase 1B (1-301), P185A mutant, apo state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVAESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHE","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6OLV"
"6OLX",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION, HANGING DROP",6.5,"100mM Na Cacodylate pH 6.5
160 mM MgCl2
6% PEG 2000 monomethyl ether",277,"10.1002/prot.25750","KFY","6OLX",29.13,"1.43760580022","1.43760580022","Hsp90-alpha S52A bound to PU-11-trans","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6OLX"
"6OML",,"X-RAY DIFFRACTION",3.38,63.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"50mM Ammonium Sulfate, 100mM Bis-Tris pH 6.5, 30% Pentaerythritol Ethoxylate",293,"10.1126/scitranslmed.aar4953",,"6OML",25,"2.7","2.7","Human BMP chimera BV261","KSSCKRHPLYVDFSDVGWNDWIVAPPGYHAFYCDGECSFPLNAHMNATNHAIVQTLVHLMNPEYVPKPCCAPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR","Homo sapiens","BMP2, BMP2A","Bone morphogenetic protein 2 and Bone morphogenetic protein 6","1","6OML"
"6OMN",,"X-RAY DIFFRACTION",2.79,55.9,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TrisHCl pH 8.5, 100mM NaCl, 12% MPD",293,"10.1126/scitranslmed.aar4953",,"6OMN",52.44,"2.68","2.68","Glycosylated BMP2 homodimer","RKRLKSSCKRHPLYVDFSDVGWNDWIVAPPGYHAFYCHGECPFPLADHLNSTNHAIVQTLVNSVNSKIPKACCVPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR","Homo sapiens","BMP2, BMP2A","Bone morphogenetic protein 2","1","6OMN"
"6OMO",,"X-RAY DIFFRACTION",4.89,74.87,"VAPOR DIFFUSION, HANGING DROP",,"100mM Tris HCl 8.0, 15% MPD",293,"10.1126/scitranslmed.aar4953",,"6OMO",24.77,"2.8","2.8","Human BMP6 homodimer","TACRKHELYVSFQDLGWQDWIIAPKGYAANYCDGECSFPLNAHMNATNHAIVQTLVHLMNPEYVPKPCCAPTKLNAISVLYFDDNSNVILKKYRNMVVRACGCH","Homo sapiens","BMP6, VGR","Bone morphogenetic protein 6","1","6OMO"
"6OMU",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.1 M Bis Tris Propane pH 7.5, 0.2 M Sodium acetate trihydrate",295,"10.1021/acs.jmedchem.9b00794","MZJ","6OMU",32.06,"1.41","1.41","Structure of human Bruton's Tyrosine Kinase in complex with Evobrutinib","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6OMU"
"6OMY",,"X-RAY DIFFRACTION",3.36,63.39,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470",,"6OMY",34.75,"2.1","2.1","Protein Tyrosine Phosphatase 1B (1-301), P180A mutant, apo state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWADFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6OMY"
"6ON5",,"X-RAY DIFFRACTION",2.17,43.27,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Bis-Tris-HCl",298,"10.1021/jacs.9b04664",,"6ON5",31.32,"1.638","1.638","Crystal Structure of the Zn-bound Domain-Swapped Dimer Q108K:T51D:A28C:L36C:F57H Mutant of Human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFCTRKIAVRCTQTKVIDQDGDNFKDKTTSTHRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6ON5"
"6ON7",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, HANGING DROP",,"PEG4000, ammonium acetate",298,"10.1021/jacs.9b04664",,"6ON7",31.27,"1.981","1.981","Crystal Structure of Apo Domain-Swapped Dimer Q108K:T51D:A28C:L36C Mutant of Human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFCTRKIAVRCTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6ON7"
"6ON8",,"X-RAY DIFFRACTION",2.29,46.2,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris:HCl, PEG 3350",298,"10.1021/jacs.9b04664",,"6ON8",15.63,"2.395","2.395","Crystal Structure of the Reduced Form of Apo Domain-Swapped Dimer Q108K:T51D:A28C:L36C:F57H Mutant of Human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFCTRKIAVRCTQTKVIDQDGDNFKDKTTSTHRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6ON8"
"6ONY",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.665 M Ammonium Tartrate, 0.095 M Tris pH 8.5",290,"10.1038/s41586-020-1930-8",,"6ONY",30.88,"1.98","1.98","BRD2_Bromodomain1 complex with inhibitor 744","GSHMGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKN","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6ONY"
"6OO9",,"X-RAY DIFFRACTION",2.42,49.13,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 3350",298,"10.3390/ijms20174245",,"6OO9",57.07,"2.25","2.25","Human CYP3A4 bound to a drug mibefradil","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6OO9"
"6OOA",,"X-RAY DIFFRACTION",2.19,43.76,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 3350",298,"10.3390/ijms20174245",,"6OOA",56.95,"2.52","2.52","Human CYP3A4 bound to a drug substrate","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6OOA"
"6OOB",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 3350",298,"10.3390/ijms20174245",,"6OOB",56.75,"2.202","2.202","Human CYP3A4 bound to a suicide substrate","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6OOB"
"6OOY",,"X-RAY DIFFRACTION",1.97,37.55,"VAPOR DIFFUSION, SITTING DROP",8,"13% MPD, 13% PEG 1000, 13% PEG 3350, 0.1M HEPES, PH 8.0,VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K",289,"10.1038/s41467-019-13616-1","A7M","6OOY",52.5,"2.5","2.5","Asymmetric hTNF-alpha","VRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6OOY"
"6OOZ",,"X-RAY DIFFRACTION",1.95,36.9,"VAPOR DIFFUSION, SITTING DROP",8,"10% PEG 2000, 15% PEG 3350, 3% XYLITOL, 0.1 M HEPES, PH 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K",289,"10.1038/s41467-019-13616-1",,"6OOZ",52.49,"2.8","2.8","Asymmetric hTNF-alpha","VRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6OOZ"
"6OP0",,"X-RAY DIFFRACTION",2,38.8,"VAPOR DIFFUSION, SITTING DROP",8,"23.2% PEG 3350, 5% MPD, 100 MM TRIS, PH 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K",289,"10.1038/s41467-019-13616-1",,"6OP0",52.8,"2.55","2.55","Asymmetric hTNF-alpha","SVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6OP0"
"6OP9",,"X-RAY DIFFRACTION",3.08,60.06,"VAPOR DIFFUSION, HANGING DROP",6.7,"10% PEG 20000, 0.1M MES, pH 6.7",298,"10.1016/j.celrep.2021.110291","DB8","6OP9",37.47,"2.501","2.501","HER3 pseudokinase domain bound to bosutinib","KRAMRRYLERGESIEPLDPSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLE","Homo sapiens","ERBB3, HER3","Receptor tyrosine-protein kinase erbB-3","1","6OP9"
"6OPG",,"X-RAY DIFFRACTION",2.99,58.81,"VAPOR DIFFUSION, HANGING DROP",8.8,"36% PEG3350, 0.1 M Tris pH 8.8
10mg/mL protein.",293,"10.1073/pnas.1906824116",,"6OPG",41.69,"2.9","2.9","phosphorylated ERK2 with AMP-PNP","SGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6OPG"
"6OPH",,"X-RAY DIFFRACTION",2.99,58.8,"VAPOR DIFFUSION, HANGING DROP",9,"36% PEG3350, 100mM bicine pH 9.0",293,"10.1073/pnas.1906824116","6QB","6OPH",41.57,"2.4","2.4","phosphorylated ERK2 with GDC-0994","SGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6OPH"
"6OPI",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, HANGING DROP",7.2,"20% (w/v) PEG3350, 100 mM Na cacodylate pH 7.2, 600 mM NaCl, 10 mM MnCl2",293,"10.1073/pnas.1906824116","N0V","6OPI",41.8,"3","3","phosphorylated ERK2 with SCH-CPD336","SGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6OPI"
"6OPL",,"X-RAY DIFFRACTION",2.95,58.34,"VAPOR DIFFUSION, SITTING DROP",6.5,"mother liquor: 0.1 M MES monohydrate, 12% w/v PEG20000, 1 M sodium chloride",277,,,"6OPL",22.79,"1.37","1.37","Human biliverdin IX beta reductase Q14R mutant: NADP complex","MAVKKIAIFGATGRTGLTTLAQAVQAGYEVTVLVRDSSRLPSEGPRPAHVVVGDVLQAADVDKTVAGQDAVIVLLGTRNDLSPTTVMSEGARNIVAAMKAHGVDKVVACTSAFLLWDPTKVPPRLQAVTDDHIRMHKVLRESGLKYVAVMPPHIGDQPLTGAYTVTLDGRGPSRVISKHDLGHFMLRCLTTDEYDGHSTYPSHQY","Homo sapiens","BLVRB, FLR","Flavin reductase (NADPH)","1","6OPL"
"6OQ1",,"X-RAY DIFFRACTION",2.09,41.01,"VAPOR DIFFUSION, SITTING DROP",6.5,"bis-tris, sodium chloride, PEG 3350",295,"10.1016/j.str.2019.10.008",,"6OQ1",51.81,"2.2","2.2","Crystal Structure of Branched K11/K48-Linked Tri-Ubiquitin","MQIFVKTLTGRTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGCQLEDGRTLSDYNIQRESTLHLVLRLRGG","Homo sapiens","UBB","Ubiquitin","1","6OQ1"
,,,,,,,,,,,,,,,,"MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGRQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Ubiquitin","2","6OQ1"
,,,,,,,,,,,,,,,,"MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGD","Homo sapiens","UBB","Ubiquitin","3","6OQ1"
"6OQ2",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2019.10.008",,"6OQ2",25.96,,,"NMR Structure of Branched K11/K48-Linked Tri-Ubiquitin","MQIFVKTLTGRTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGRQLEDGRTLSDYNIQRESTLHLVLRLRGG","Homo sapiens","UBB","Ubiquitin","1","6OQ2"
,,,,,,,,,,,,,,,,"MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGRQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Ubiquitin","2","6OQ2"
,,,,,,,,,,,,,,,,"MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGD","Homo sapiens","UBB","Ubiquitin","3","6OQ2"
"6OQB",,"X-RAY DIFFRACTION",2.32,47.08,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris, pH 8.0
3% Methanol
30%-42.5% PEG6000",277,"10.1158/2159-8290.CD-18-0387","N0J","6OQB",18.52,"1.6","1.6","Co-crystal structure of Mcl1 with inhibitor 10","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6OQB"
"6OQC",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris, pH 8.0
3% Methanol
30%-42.5% PEG6000",277,"10.1158/2159-8290.CD-18-0387","N0S","6OQC",37.01,"1.8","1.8","Crystal structure of Mcl1 with inhibitor 9","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6OQC"
"6OQD",,"X-RAY DIFFRACTION",2.3,46.49,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris, pH 8.0
3% Methanol
30%-42.5% PEG 6000",277,"10.1158/2159-8290.CD-18-0387","N0M","6OQD",18.51,"1.48","1.48","Crystal structure of Mcl1 with inhibitor 8","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6OQD"
"6OQI",,"X-RAY DIFFRACTION",2.03,39.45,"EVAPORATION",7.5,"10-12% PEG 4K, 50 mM Hepes pH7.5, 50 mM Ammonia Acetate",292,"10.1016/j.bmcl.2019.06.021",,"6OQI",34.56,"2","2","CDK2 in complex with Cpd14 (5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl)-N-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine)","FMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6OQI"
"6OQL",,"X-RAY DIFFRACTION",2.35,47.63,"EVAPORATION",6,"13-17% PEG 3350, 80 mM NH4NO3, 100 mM MES pH 6.0",292,"10.1016/j.bmcl.2019.06.021",,"6OQL",33.51,"2.707","2.707","CDK6 in complex with Cpd13 (R)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl)-N-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine","QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ","Homo sapiens","CDK6, CDKN6","Cyclin-dependent kinase 6","1","6OQL"
"6OQM",,"X-RAY DIFFRACTION",1.78,31.01,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium sulfate, 0.1 M sodium cacodylate pH 5.5, 0.01 M magnesium chloride",291,,,"6OQM",15.55,"2.2","2.2","crystal structure of the MSH6 PWWP domain","MHHHHHHSSGRENLYFQGSCDFSPGDLVWAKMEGYPWWPCLVYNHPFDGTFIREKGKSVRVHVQFFDDSPTRGWVSKRLLKPYTGSKSKEAQKGGHFYSAKPEILRAMQRADEALNKDKIKRLELAVCDE","Homo sapiens","MSH6, GTBP","DNA mismatch repair protein Msh6","1","6OQM"
"6OQN",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris, pH 8.0
3% Methanol
30%-42.5% PEG 6000",277,"10.1158/2159-8290.CD-18-0387","N0P","6OQN",36.88,"1.7","1.7","Crystal structure of Mcl1 with inhibitor 7","EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6OQN"
"6OQO",,"X-RAY DIFFRACTION",2.63,53.22,"EVAPORATION",7.5,"17 % w/v PEG 3,350, 100 mM HEPES, pH 7.5, 200 mM NaCl, 20 mM L-Glutathione",292,"10.1016/j.bmcl.2019.06.021",,"6OQO",33.53,"1.977","1.977","CDK6 in complex with Cpd24 N-(5-(6-ethyl-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-2-yl)-5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl)pyrimidin-2-amine","QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ","Homo sapiens","CDK6, CDKN6","Cyclin-dependent kinase 6","1","6OQO"
"6ORR",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION",6.8,"100 mM HEPES pH 6.8, 2 M ammonium sulfate",293,"10.1021/acs.jmedchem.9b01238","N37","6ORR",128.36,"2.25","2.25","Co-crystal structure of human NicotinamideN-Methyltransferase (NNMT) in complex with High-Affinity Alkynyl Bisubstrate Inhibitor NS1","MGSSHHHHHHSSGLVPRGSMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT, hCG_39357","NNMT protein","1","6ORR"
"6OS4",,"X-RAY DIFFRACTION",2.44,49.68,"VAPOR DIFFUSION, SITTING DROP",6.7,"0.2mM sodium acetate, 0.1mM cacodylate, 28% PEG 8000",293,"10.1126/scisignal.aaz0344",,"6OS4",17.22,"2.05","2.05","Calmodulin in complex with farnesyl cysteine methyl ester","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin-1","1","6OS4"
"6OSJ","2.8","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.jmb.2019.07.001",,"6OSJ",144.76,"2.8",,"Cryo-EM structure of the N-terminally acetylated full length alpha-synuclein fibrils (Ac1-140)","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6OSJ"
"6OSL","3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.jmb.2019.07.001",,"6OSL",144.76,"3",,"Cryo-EM structure of the N-terminally acetylated C-terminal Alpha-synuclein truncation Ac1-122","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6OSL"
"6OSM","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.jmb.2019.07.001",,"6OSM",144.76,"3.4",,"Cryo-EM structure of the N-terminally acetylated C-terminal Alpha-synuclein truncation Ac1-103","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6OSM"
"6OSN",,"X-RAY DIFFRACTION",1.68,26.61,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Li acetate
20% PEG 3350",294,"10.1074/jbc.RA120.012791",,"6OSN",11.02,"1.083","1.083","Potent and Selective Antitumor Antibody Targeting a Membrane-Proximal Epitope of ROR2","MGSHHHHHHLVPRGSHMHQCYNGSGMDYRGTASTTKSGHQCQPWALQHPHSHHLSSTDFPELGGGHAYCRNPGGQMEGPWCFTQNKNVRMELCDVPSC","Homo sapiens","ROR2, NTRKR2","Tyrosine-protein kinase transmembrane receptor ROR2","1","6OSN"
"6OSP",,"X-RAY DIFFRACTION",2.53,51.35,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 200mM Malic acid",293,"10.1016/j.chembiol.2020.02.003","N51","6OSP",91.71,"2.21","2.21","Crystal Structure Analysis of PIP4K2A","MHHHHHHSSGVDLGTENLYFQSMDPLLSVLMWGVNHSINELSHVQIPVMLMPDDFKAYSKIKVDNHLFNKENMPSHFKFKEYCPMVFRNLRERFGIDDQDFQNSLTRSAPLPNDSQARSGARFHTSYDKRYIIKTITSEDVAEMHNILKKYHQYIVECHGITLLPQFLGMYRLNVDGVEIYVIVTRNVFSHRLSVYRKYDLKGSTVAREASDKEKAKELPTLKDNDFINEGQKIYIDDNNKKVFLEKLKKDVEFLAQLKLMDYSLLVGIHDVERAEQEEVECEENDGEEEGESDGTHPVGTPPDSPGNTLNSSPPLAPGEFDPNIDVYGIKCHENSPRKEVYFMAIIDILTHYDAKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFLDFIGHIL","Homo sapiens","PIP4K2A, PIP5K2, PIP5K2A, PI5P4KA","Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha","1","6OSP"
"6OT2","4.1","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.47746",,"6OT2",337.78,"4.1",,"Structure of the TRPV3 K169A sensitized mutant in apo form at 4.1 A resolution","XXXXXXXXXXXXXXPSNPNSPSAQLAKEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGATCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGDYKDDDDKAHHHHHH","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3","1","6OT2"
,,,,,,,,,,,,,,,,,"Homo sapiens","TRPV3"
"6OT5","3.6","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.47746",,"6OT5",332.83,"3.6",,"Structure of the TRPV3 K169A sensitized mutant in the presence of 2-APB at 3.6 A resolution","XXXXXXXXXXXXEEQRRKKRRLKKRIFAAVSEGCVEELVELLVELQELCRRRHDEDVPDFLMHKLTASDTGATCLMKALLNINPNTKEIVRILLAFAEENDILGRFINAEYTEEAYEGQTALNIAIERRQGDIAALLIAAGADVNAHAKGAFFNPKYQHEGFYFGETPLALAACTNQPEIVQLLMEHEQTDITSRDSRGNNILHALVTVAEDFKTQNDFVKRMYDMILLRSGNWELETTRNNDGLTPLQLAAKMGKAEILKYILSREIKEKRLRSLSRKFTDWAYGPVSSSLYDLTNVDTTTDNSVLEITVYNTNIDNRHEMLTLEPLHTLLHMKWKKFAKHMFFLSFCFYFFYNITLTLVSYYRPREEEAIPHPLALTHKMGWLQLLGRMFVLIWAMCISVKEGIAIFLLRPSDLQSILSDAWFHFVFFIQAVLVILSVFLYLFAYKEYLACLVLAMALGWANMLYYTRGFQSMGMYSVMIQKVILHDVLKFLFVYIVFLLGFGVALASLIEKCPKDNKDCSSYGSFSDAVLELFKLTIGLGDLNIQQNSKYPILFLFLLITYVILTFVLLLNMLIALMGETVENVSKESERIWRLQRARTILEFEKMLPEWLRSRFRMGELCKVAEDDFRLCLRINEVKWTEWKTHVSFLNEDPGPVRRTDFNKIQDSSRNNSKTTLNAFEEVEEFPETSVVDAGLEVLFQGDYKDDDDKAHHHHHH","Homo sapiens","TRPV3","Transient receptor potential cation channel subfamily V member 3,Transient receptor potential cation channel subfamily V member 3","1","6OT5"
,,,,,,,,,,,,,,,,,"Homo sapiens","TRPV3"
"6OTI",,"X-RAY DIFFRACTION",2.16,43.08,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Sodium Citrate, 50mM Tris-HCL, pH 7.8",298,,,"6OTI",29.35,"2","2","Carbonic Anhydrase IX mimic complexed with ureic benzene sulfonamide MB9-561B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OTI"
"6OTK",,"X-RAY DIFFRACTION",2.13,42.27,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Sodium Citrate, 50mM Tris-HCl, pH 7.8",298,,,"6OTK",29.31,"1.123","1.123","Carbonic Anhydrase IX mimic complexed with ureido benzene sulfonamide MB10-596B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OTK"
"6OTM",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Sodium Citrate, 50mM Tris-HCl, pH 7.8",298,,,"6OTM",29.43,"1.307","1.307","Carbonic Anhydrase IX mimic complexed with ureic benzene sulfonamide MB10-586B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OTM"
"6OTN",,"X-RAY DIFFRACTION",2.96,58.45,"VAPOR DIFFUSION, HANGING DROP",6.5,"Crystals were grown in hanging drops by mixing purified N_82AA_Tpm3.1 at 20 mg/ml with an equal volume of reservoir solution (0.1 M BisTris pH 6.5, 0.2 M Li2SO4, 12% polyethylene glycol 3350)",293,"10.1038/s41598-019-47592-9",,"6OTN",37.24,"2.4","2.4","Crystal Structure of an N-terminal Fragment of Cancer Associated Tropomyosin 3.1 (Tpm3.1)","ASAGITTIEAVKRKIQVLQQQADDAEERAERLQREVEGERRAREQAEAEVASLNRRIQLVEEELDRAQERLATALQKLEEC","Homo sapiens","TPM3","Tropomyosin alpha-3 chain","1","6OTN"
"6OTO",,"X-RAY DIFFRACTION",2.04,39.82,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Sodium Citrate, 50mM Tris Hal, pH7.8",298,,,"6OTO",29.85,"1.496","1.496","Carbonic Anhydrase II complexed with ureic benzene sulfonamide MB9-561B","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OTO"
"6OTP",,"X-RAY DIFFRACTION",2.06,40.28,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate, 50mM Tris-JCl, pH 7.8",298,,,"6OTP",29.33,"1.466","1.466","Carbonic Anhydrase II complexed with ureic benzene sulfonamide MB10-586B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OTP"
"6OTQ",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate, 50mM Tris-HCl, pH 7.8",298,,,"6OTQ",29.46,"1.467","1.467","Carbonic Anhydrase II complexed with ureic benzene sulfonamide MB10-596B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OTQ"
"6OU0",,"X-RAY DIFFRACTION",1.86,34.02,"VAPOR DIFFUSION, HANGING DROP",7.2,"15% PEG 3350, 0.2 M Bis Tris pH 6, 0.2 M Magnesium formate",277,"10.1074/jbc.RA119.009419",,"6OU0",31.22,"1.799","1.799","Crystal Structure of the D380A/D478S Variant of the Myocilin Olfactomedin Domain","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIALAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMISYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","6OU0"
"6OU1",,"X-RAY DIFFRACTION",1.87,34.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2 M Bis Tris pH 6.0, 0.1 M Magnesium formate",298,"10.1074/jbc.RA119.009419",,"6OU1",63.02,"1.878","1.878","Crystal Structure of the Computationally-derived 21-Variant of the Myocilin Olfactomedin Domain","LKESPSGYLRSGEGDTGCGELVWVGEPVTLRTAETITGKYGVWMRDPKPVYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYNGSLYFQGAGSRTVIRYDLKTETVKAEKEIPGAGYHGQYPYSWGGYTDIDLAVDENGLWVIYSTNQAKGNIVLSKLNPETLEVEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTNTGTSKYLDIPFKNRYKYNSMIDYNPLERKLFAWDNGHMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","6OU1"
"6OU2",,"X-RAY DIFFRACTION",1.86,34.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2M Bis Tris pH 6.0, 0.3 M Magnesium formate",298,"10.1074/jbc.RA119.009419",,"6OU2",31.31,"1.963","1.963","Crystal Structure of the D478N Variant of the Myocilin Olfactomedin Domain","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMINYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","6OU2"
"6OU3",,"X-RAY DIFFRACTION",1.88,34.71,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2 M Bis Tris pH 6.0, 0.4 M Magnesium formate",277,"10.1074/jbc.RA119.009419",,"6OU3",31.38,"1.796","1.796","Crystal Structure of the D478S Variant of the Myocilin Olfactomedin Domain","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVANAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMISYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","6OU3"
"6OUB",,"X-RAY DIFFRACTION",2.09,41.02,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate, 50mM Tris-HCl, pH7.8",298,,,"6OUB",29.79,"1.418","1.418","Carbonic Anhydrase II complexed with benzene sulfonamide MB11-694B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUB"
"6OUD",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate, 50mM Tris Hal, pH 7.8",298,,,"6OUD",29.6,"1.256","1.256","Carbonic Anhydrase IX mimic complexed with benzene sulfonamide MB11-694B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUD"
"6OUE",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate, 50mM Tris HCl, pH 7.8",298,,,"6OUE",29.66,"1.415","1.415","Carbonic Anhydrase II complexed with benzene sulfonamide MB11-707A","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUE"
"6OUF",,"X-RAY DIFFRACTION",2.11,41.68,"VAPOR DIFFUSION, HANGING DROP",,"1.6M sodium citrate, 50mM Tris HCl, pH 7.8",298,,,"6OUF",29.58,"1.358","1.358","Carbonic Anhydrase IX mimic complexed with benzene sulfonamide MB11-707A","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUF"
"6OUH",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION, HANGING DROP",,"1.6M sodium citrate, 50mM Tris HCl, pH 7.8",298,,,"6OUH",29.76,"1.449","1.449","Carbonic Anhydrase II mimic complexed with benzene sulfonamide MB11-710A","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUH"
"6OUI",,"X-RAY DIFFRACTION",2.15,42.86,"VAPOR DIFFUSION, HANGING DROP",,"1.6M sodium citrate, 50mM Tris HCl, pH 7.8",298,,,"6OUI",30.01,"1.528","1.528","Carbonic Anhydrase IX mimic complexed with benzene sulfonamide MB11-710A","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUI"
"6OUJ",,"X-RAY DIFFRACTION",2.09,41.22,"VAPOR DIFFUSION, HANGING DROP",,"1.6M sodium citrate, 50mM Tris HCl, pH 7.8",298,,,"6OUJ",29.53,"1.466","1.466","Carbonic Anhydrase II complexed with benzene sulfonamide MB11-689A","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUJ"
"6OUK",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION, HANGING DROP",,"1.6M sodium citrate, 50mM Tris HCl, pH 7.8",298,,,"6OUK",29.64,"1.498","1.498","Carbonic Anhydrase II complexed with benzene sulfonamide MB10-580B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUK"
"6OUM",,"X-RAY DIFFRACTION",2.09,41.28,"VAPOR DIFFUSION, HANGING DROP",,"1.6M sodium citrate, 50mM Tris HCl, pH 7.8",298,,,"6OUM",29.23,"1.559","1.559","Carbonic Anhydrase IX mimic complexed with benzene sulfonamide MB10-580B","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6OUM"
"6OVA",,"X-RAY DIFFRACTION",2.5,50.74,"VAPOR DIFFUSION, SITTING DROP",6,"15% PEG 5000 MME, and 100 mM Sodium Citrate (pH 6.0)",293,"10.1016/j.bmcl.2020.126963","N9G","6OVA",35.24,"2.5","2.5","Crystal Structure of TYK2 with novel pyrrolidinone inhibitor","MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYHHHHHH","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6OVA"
"6OVC",,"SOLUTION NMR",,,,,,,"10.1158/2159-8290.CD-18-0387",,"6OVC",19.41,,,"hMcl1 inhibitor complex","MEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESSIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGHHHHHH","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6OVC"
"6OVG",,"X-RAY DIFFRACTION",2.32,46.93,"VAPOR DIFFUSION, SITTING DROP",,"30% isopropanol, 150mM sodium citrate  100mM sodium cocadylate pH 6.5",277,"10.1073/pnas.1917362117",,"6OVG",365.92,"2.719","2.719","L-Methionine Depletion with an Engineered Human Enzyme Disrupts Prostate Cancer Metabolism","MGGHHHHHHGGQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFIYSRLGNPTRNCLEKAVAALDGAKYCLAFASGMAATVTITHLLKAGDQIICMDDVYGGTNAYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMERHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCGGMVTFYIKGTLQHAEIFLKNLKLFTLAVSLGGFESLAELPASMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGSHS","Homo sapiens","CTH","Cystathionine gamma-lyase","1","6OVG"
"6OWC",,"X-RAY DIFFRACTION",2.26,45.46,"VAPOR DIFFUSION, SITTING DROP",,"40% PEG 1000, 60 mM NaCl, 0.1 M TAPS pH 9.0",293,,,"6OWC",59.88,"1.85","1.85","Mutant estrogen receptor alpha (ERa) Y537S covalently bound to H3B-6545.","GIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLSDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6OWC"
"6OWH",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 3350, 2% Tacsimate pH 7.0, 0.1 M HEPES pH 7.0",292,"10.1021/acs.jmedchem.9b02071",,"6OWH",32.89,"2","2","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 92","VKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6OWH"
"6OWI",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG3350, 2% Tacsimate pH 7.0, 0.1 M HEPES pH 7.0",292,"10.1021/acs.jmedchem.9b02071",,"6OWI",32.59,"1.75","1.75","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 85","VKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6OWI"
"6OWJ",,"X-RAY DIFFRACTION",2.15,42.67,"VAPOR DIFFUSION, HANGING DROP",,"14% PEG4000, 0.2 M calcium chloride, 0.1 M MES, pH 6.0",293,"10.1093/nar/gkaa076",,"6OWJ",60.25,"1.94","1.94","Zn-mediated polymerization of human SFPQ","GAMEGFKANLSLLRRPGEKTYTQRCRLFVGNLPADITEDEFKRLFAKYGEPGEVFINKGKGFGFIKLESRALAEIAKAELDDTPMRGRQLRVRFATHAAALSVRNLSPYVSNELLEEAFSQFGPIERAVVIVDDRGRSTGKGIVEFASKPAARKAFERCSEGVFLLTTTPRPVIVEPLEQLDDEDGLPEKLAQKNPMYQKERETPPRFAQHGTFEYEYSQRWKSLDEMEKQQREQVEKNMKDAKDKLESEMEDAYHEHQANLL","Homo sapiens","SFPQ, PSF","Splicing factor, proline- and glutamine-rich","1","6OWJ"
"6OWV",,"X-RAY DIFFRACTION",2.32,46.89,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, lithium sulfate",298,"10.1038/s41594-020-0510-9",,"6OWV",46.05,"1.88","1.88","Crystal structure of a Human Cardiac Calsequestrin Filament","GHMASRAEEGLNFPTYDGKDRVVSLSEKNFKQVLKKYDLLCLYYHEPVSSDKVTQKQFQLKEIVLELVAQVLEHKAIGFVMVDAKKEAKLAKKLGFDEEGSLYILKGDRTIEFDGEFAADVLVEFLLDLIEDPVEIISSKLEVQAFERIEDYIKLIGFFKSEDSEYYKAFEEAAEHFQPYIKFFATFDKGVAKKLSLKMNEVDFYEPFMDEPIAIPNKPYTEEELVEFVKEHQRPTLRRLRPEEMFETWEDDLNGIHIVAFAEKSDPDGYEFLEILKQVARDNTDNPDLSILWIDPDDFPLLVAYWEKTFKIDLFRPQIGVVNVTDADSVWMEIPDDDDLPTAEELEDWIEDVLSGKINTEDDDEDDDDDDNSDEEDNDDSDDDDDE","Homo sapiens","CASQ2","Calsequestrin-2","1","6OWV"
"6OWW",,"X-RAY DIFFRACTION",2.2,44.19,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, lithium sulfate",298,"10.1038/s41594-020-0510-9",,"6OWW",371.13,"3.84","3.84","Crystal structure of a Human Cardiac Calsequestrin Filament Complexed with Ytterbium","GHMASRAEEGLNFPTYDGKDRVVSLSEKNFKQVLKKYDLLCLYYHEPVSSDKVTQKQFQLKEIVLELVAQVLEHKAIGFVMVDAKKEAKLAKKLGFDEEGSLYILKGDRTIEFDGEFAADVLVEFLLDLIEDPVEIISSKLEVQAFERIEDYIKLIGFFKSEDSEYYKAFEEAAEHFQPYIKFFATFDKGVAKKLSLKMNEVDFYEPFMDEPIAIPNKPYTEEELVEFVKEHQRPTLRRLRPEEMFETWEDDLNGIHIVAFAEKSDPDGYEFLEILKQVARDNTDNPDLSILWIDPDDFPLLVAYWEKTFKIDLFRPQIGVVNVTDADSVWMEIPDDDDLPTAEELEDWIEDVLSGKINTEDDDEDDDDDDNSDEEDNDDSDDDDDE","Homo sapiens","CASQ2","Calsequestrin-2","1","6OWW"
"6OXB",,"X-RAY DIFFRACTION",2.33,47.13,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris HCl pH 8.0
18% sucrose
1.9 M Ammonium sulfate",292,,,"6OXB",125.24,"1.86","1.86","First bromo-adjacent homology (BAH) domain of human Polybromo-1 (PBRM1)","GSSSGAAGLSGLHRTYSQDCSFKNSMYHVGDYVYVEPAEANLQPHIVCIERLWEDSAGEKWLYGCWFYRPNETFHLATRKFLEKEVFKSDYYNKVPVSKILGKCVVMFVKEYFKLCPENFRDEDVFVCESRYSAKTKSFKKIKLWTMPISSVRFVPRDVPLPVVRVASVFANADGNS","Homo sapiens","PBRM1, BAF180, PB1","Protein polybromo-1","1","6OXB"
"6OY8",,"X-RAY DIFFRACTION",2.74,55.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,"10.1016/j.chembiol.2020.05.001",,"6OY8",37.52,"1.53","1.53","Crystal structure of Y99G mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYGDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6OY8"
"6OYB",,"X-RAY DIFFRACTION",2.74,55.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,"10.1016/j.chembiol.2020.05.001",,"6OYB",37.79,"1.53","1.53","Crystal structure of H62G mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLGSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6OYB"
"6OYE",,"X-RAY DIFFRACTION",2.72,54.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,"10.1016/j.chembiol.2020.05.001",,"6OYE",37.91,"1.53","1.53","Crystal structure of Y99F mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYFDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6OYE"
"6OYG",,"X-RAY DIFFRACTION",2.72,54.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,"10.1016/j.chembiol.2020.05.001",,"6OYG",37.72,"1.55","1.55","Crystal structure of H62F mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLFSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6OYG"
"6OYT",,"X-RAY DIFFRACTION",2.37,48.02,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Na Acetate pH 5.5, 2% PEG4K and 30% polyacrylic acid.",298,"10.1021/acs.jmedchem.9b01206","NJV","6OYT",129.12,"2.824","2.824","ASK1 kinase domain in complex with GS-4997","MESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKHHHHHH","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","6OYT"
"6OYW",,"X-RAY DIFFRACTION",2.81,56.28,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M BisTRIS pH 5.5, 0.2M MgCl2, 10mM Na cholate and 12% PEG3350",298,"10.1021/acs.jmedchem.9b01206",,"6OYW",133.68,"2.603","2.603","ASK1 kinase domain in complex with Compound 11","GRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTEEFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","6OYW"
"6OZE",,"X-RAY DIFFRACTION",2.84,56.71,"VAPOR DIFFUSION, HANGING DROP",,"3.6 M sodium acetate",293,"10.1016/j.molcel.2019.06.046",,"6OZE",27.51,"1.5","1.5","Crystal structure of the catalytic domain of human Endonuclease V (C140S/C225S/C226A/C228S)","PPEETLSLWKREQARLKAHVVDRDTEAWQRDPAFSGLQRVGGVDVSFVAGDSVRACASLVVLSFPELEVVYEESRMVSLTAPYVSGFLAFREVPFLLELVQQLREKEPGLMPQVLLVDGNGVLHHRGFGVASHLGVLTDLPCVGVAKKLLQVDGLANNALHKEKIRLLQTRGDSFPLLGDSGTVLGMALRSHDRSTRPLYISVGHRMSLEAAVRLTSACSRFRIPEPVRQADICSREHIRKSLGLP","Homo sapiens","ENDOV","Endonuclease V","1","6OZE"
"6P05",,"X-RAY DIFFRACTION",2.43,49.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"16-18% PEG 4000, 0.1M Tris-HCl pH 8.5, 0.2M LiSO4",277,"10.1021/acs.jmedchem.0c00456","YF2","6P05",15.86,"1.54","1.54","Bromodomain-containing protein 4 (BRD4) bromodomain 1 (BD1) complexed with compound 27","LENPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6P05"
"6P0I",,"X-RAY DIFFRACTION",2.39,43.91,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M Calcium Acetate pH 5.5, 18-22% PEG3350.",293,"10.1073/pnas.1913654117",,"6P0I",22.47,"1.18","1.18","Crystal structure of GDP-bound human RalA in a covalent complex with aryl sulfonyl fluoride compounds.","MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARLEHHHHHH","Homo sapiens","RALA, RAL","Ras-related protein Ral-A","1","6P0I"
"6P0J",,"X-RAY DIFFRACTION",2.21,44.23,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M calcium acetate, pH 5.5, 18-22% PEG3350",293,"10.1073/pnas.1913654117",,"6P0J",21.79,"1.31","1.31","Crystal structure of GDP-bound human RalA","MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARLEHHHHHH","Homo sapiens","RALA, RAL","Ras-related protein Ral-A","1","6P0J"
"6P0K",,"X-RAY DIFFRACTION",2.39,48.52,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M Calcium Acetate pH 5.5 18-22% PEG3350",293,"10.1073/pnas.1913654117",,"6P0K",22.17,"1.49","1.49","Crystal structure of GDP-bound human RalA in a covalent complex with aryl sulfonyl fluoride compounds.","MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARLEHHHHHH","Homo sapiens","RALA, RAL","Ras-related protein Ral-A","1","6P0K"
"6P0L",,"X-RAY DIFFRACTION",2.31,46.68,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M Calcium Acetate pH 5.5 18-20% PEG3350",293,"10.1073/pnas.1913654117",,"6P0L",22.13,"1.3","1.3","Crystal structure of GDP-bound human RalA in a covalent complex with aryl sulfonyl fluoride compounds.","MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARLEHHHHHH","Homo sapiens","RALA, RAL","Ras-related protein Ral-A","1","6P0L"
"6P0M",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M Calcium Acetate pH 5.5 18-22% PEG3350",293,"10.1073/pnas.1913654117",,"6P0M",22.17,"1.5","1.5","Crystal structure of GDP-bound human RalA in a covalent complex with aryl sulfonyl fluoride compounds.","MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARLEHHHHHH","Homo sapiens","RALA, RAL","Ras-related protein Ral-A","1","6P0M"
"6P0N",,"X-RAY DIFFRACTION",2.39,48.55,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M Calcium Acetate pH 5.5, 18-22% PEG3350",293,"10.1073/pnas.1913654117",,"6P0N",22.19,"1.63","1.63","Crystal structure of GDP-bound human RalA in a covalent complex with aryl sulfonyl fluoride compounds.","MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARLEHHHHHH","Homo sapiens","RALA, RAL","Ras-related protein Ral-A","1","6P0N"
"6P0O",,"X-RAY DIFFRACTION",2.22,44.61,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M Calcium Acetate pH 5.5 18-22% PEG3350",293,"10.1073/pnas.1913654117",,"6P0O",21.79,"1.54","1.54","Crystal structure of GDP-bound human RalA","MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARLEHHHHHH","Homo sapiens","RALA, RAL","Ras-related protein Ral-A","1","6P0O"
"6P0P",,"X-RAY DIFFRACTION",2.38,48.3,"VAPOR DIFFUSION, SITTING DROP",4.6,"1.9 mg/mL protein incubated with compound for 30 minutes on ice prior to setup with 30% PEG1500, 0.1 M sodium acetate, pH 4.6, 0.2 M ammonium sulfate",298,"10.1021/acs.jmedchem.9b01689",,"6P0P",62.63,"2.55","2.55","Human beta-tryptase co-crystal structure with 5-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-2-(3'-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-[1,1'-biphenyl]-3-yl)-2-hydroxy-2H-1,3,2-benzodioxaborol-2-uide","MLNLLLLALPVLASRAYAAPAPGQALQRVGIVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPSAB1, TPS1, TPS2, TPSB1","Tryptase alpha/beta-1","1","6P0P"
"6P0Q",,"X-RAY DIFFRACTION",2.25,45.32,"VAPOR DIFFUSION, SITTING DROP",4.6,"2.5M NH4SO4, 0.1M NaOAc pH4.6",291,,,"6P0Q",22.54,"1.72","1.72","Crystal Structure of Ubiquitin-like Domain of Human WDR12","MAQLQTRFYTDNKKYAVDDVPFSIPAASEIADLSNIINKLLKDKNEFHKHVEFDFLIKGQFLRMPLDKHMEMENISSEEVVEIEYVEAENLYFQ","Homo sapiens","WDR12","Ribosome biogenesis protein WDR12","1","6P0Q"
"6P0R",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2M NH4Formate",291,,,"6P0R",69.36,"2.4","2.4","Methyltransferase domain of human suppressor of variegation 3-9 homolog 2 (SUV39H2) in complex with OTS186935 inhibitor","PKDNNKTLKPAIAEYIVKKAKQRIALQRWQDELNRRKNHKGMIFVENTVDLEGPPSDFYYINEYKPAPGISLVNEATFGCSCTDCFFQKCCPAEAGVLLAYNKNQQIKIPPGTPIYECNSRCQCGPDCPNRIVQKGTQYSLCIFRTSNGRGWGVKTLVKIKRMSFVMEYVGEVITSEEAERRGQFYDNKGITYLFDLDYESDEFTVDAARYGNVSHFVNHSCDPNLQVFNVFIDNLDTRLPRIALFSTRTINAGEELTFDYQMKGSGDISSDSIDHSPAKKRVRTVCKCGAVTCRGYLN","Homo sapiens","SUV39H2, KMT1B","Histone-lysine N-methyltransferase SUV39H2","1","6P0R"
"6P0Z",,"X-RAY DIFFRACTION",1.99,38.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM BS1 pH 6.5, 100mM AminoAcids, 30% PEG500MME_P20K",293,"10.1038/s41598-019-46846-w",,"6P0Z",39.41,"1.011","1.011","Crystal structure of N-acetylated KRAS (2-169) bound to GDP and Mg","TEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6P0Z"
"6P1D",,"X-RAY DIFFRACTION",2.07,40.47,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, 29% PEG 3350, 5.0 mM TCEP",298,"10.1021/acsmedchemlett.9b00381",,"6P1D",152.65,"2.4","2.4","Crystal structure of EGFR with mutant-selective dihydrodibenzodiazepinone allosteric inhibitor","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6P1D"
"6P1L",,"X-RAY DIFFRACTION",2.33,42.5,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris ,26% PEG 8000",298,"10.1021/acsmedchemlett.9b00381","9LL","6P1L",152.84,"2.8","2.8","Crystal structure of EGFR in complex with EAI045","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6P1L"
"6P2B",,"X-RAY DIFFRACTION",2.61,52.89,"VAPOR DIFFUSION, HANGING DROP",,"30% MPD, 100mM Imidazole, pH 7",277,"10.1021/acs.jmedchem.0c00012",,"6P2B",79.46,"2.3","2.3","Tethered PXR-LBD/SRC-1p bound to Garcinoic Acid","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGSGGSGGSSHSSLTERHKILHRLLQEGSPS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","6P2B"
"6P2J","3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2290-0",,"6P2J",141.55,"3",,"Dimeric structure of ACAT1","MADYKDDDDKSGPDEVDASGRMVGEEKMSLRNRLSKSRENPEEDEDQRNPAKESLETPSNGRIDIKQLIAKKIKLTAEAEELKPFFMKEVGSHFDDFVTNLIEKSASLDNGGCALTTFSVLEGEKNNHRAKDLRAPPEQGKIFIARRSLLDELLEVDHIRTIYHMFIALLILFILSTLVVDYIDEGRLVLEFSLLSYAFGKFPTVVWTWWIMFLSTFSVPYFLFQHWATGYSKSSHPLIRSLFHGFLFMIFQIGVLGFGPTYVVLAYTLPPASRFIIIFEQIRFVMKAHSFVRENVPRVLNSAKEKSSTVPIPTVNQYLYFLFAPTLIYRDSYPRNPTVRWGYVAMKFAQVFGCFFYVYYIFERLCAPLFRNIKQEPFSARVLVLCVFNSILPGVLILFLTFFAFLHCWLNAFAEMLRFGDRMFYKDWWNSTSYSNYYRTWNVVVHDWLYYYAYKDFLWFFSKRFKSAAMLAVFAVSAVVHEYALAVCLSFFYPVLFVLFMFFGMAFNFIVNDSRKKPIWNVLMWTSLFLGNGVLLCFYSQEWYARQHCPLKNPTFLDYVRPRSWTCRYVFLEGSDEVDAVEGSHHHHHHHHHH","Homo sapiens","SOAT1, ACACT, ACACT1, ACAT, ACAT1, SOAT, STAT","Sterol O-acyltransferase 1","1","6P2J"
"6P2P","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-2290-0",,"6P2P",283.11,"3.1",,"Tetrameric structure of ACAT1","MADYKDDDDKSGPDEVDASGRMVGEEKMSLRNRLSKSRENPEEDEDQRNPAKESLETPSNGRIDIKQLIAKKIKLTAEAEELKPFFMKEVGSHFDDFVTNLIEKSASLDNGGCALTTFSVLEGEKNNHRAKDLRAPPEQGKIFIARRSLLDELLEVDHIRTIYHMFIALLILFILSTLVVDYIDEGRLVLEFSLLSYAFGKFPTVVWTWWIMFLSTFSVPYFLFQHWATGYSKSSHPLIRSLFHGFLFMIFQIGVLGFGPTYVVLAYTLPPASRFIIIFEQIRFVMKAHSFVRENVPRVLNSAKEKSSTVPIPTVNQYLYFLFAPTLIYRDSYPRNPTVRWGYVAMKFAQVFGCFFYVYYIFERLCAPLFRNIKQEPFSARVLVLCVFNSILPGVLILFLTFFAFLHCWLNAFAEMLRFGDRMFYKDWWNSTSYSNYYRTWNVVVHDWLYYYAYKDFLWFFSKRFKSAAMLAVFAVSAVVHEYALAVCLSFFYPVLFVLFMFFGMAFNFIVNDSRKKPIWNVLMWTSLFLGNGVLLCFYSQEWYARQHCPLKNPTFLDYVRPRSWTCRYVFLEGSDEVDAVEGSHHHHHHHHHH","Homo sapiens","SOAT1, ACACT, ACACT1, ACAT, ACAT1, SOAT, STAT","Sterol O-acyltransferase 1","1","6P2P"
"6P2U",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, SITTING DROP",4.5,"30% w/v PEG8000, 100 mM sodium acetate, 200 mM lithium sulfate",298,"10.1002/1873-3468.13475",,"6P2U",42,"2","2","Structure of Mortalin-NBD with N6-propargyladenosine-5'-diphosphate","GAMGSKGAVVGIDLGTTNSCVAVMEGKQAKVLENAEGARTTPSVVAFTADGERLVGMPAKRQAVTNPNNTFYATKRLIGRRYDDPEVQKDIKNVPFKIVRASNGDAWVEAHGKLYSPSQIGAFVLMKMKETAENYLGHTAKNAVITVPAYFNDSQRQATKDAGQISGLNVLRVINEPTAAALAYGLDKSEDKVIAVYDLGGGTFDISILEIQKGVFEVKSTNGDTFLGGEDFDQALLRHIVKEFKRETGVDLTKDNMALQRVREAAEKAKCELSSSVQTDINLPYLTMDSSGPKHLNMKLTRAQFEGIVTDLIRRTIAPCQKAMQDAEVSKSDIGEVILVGGMTRMPKVQQTVQDLFGRAPSKAVNPDEAVAIGAAIQGGVLAGD","Homo sapiens","HSPA9, GRP75, HSPA9B, mt-HSP70","Stress-70 protein, mitochondrial","1","6P2U"
"6P38",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"PEG 2000, Trimethylamine N-oxide dihydrate, Tris pH 8.5",293,"10.1021/acsmedchemlett.9b00243",,"6P38",16.42,"2.8","2.8","Crystal Structure Analysis of TAF1 Bromodomain","SMDDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICTAKEAALEEAELESLD","Homo sapiens","TAF1, BA2R, CCG1, CCGS, TAF2A","Transcription initiation factor TFIID subunit 1","1","6P38"
"6P39",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"PEG1000, Tris pH 8.0",293,,,"6P39",16.48,"2.941","2.941","Crystal Structure Analysis of TAF1 Bromodomain","SMDDDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICTAKEAALEEAELESLD","Homo sapiens","TAF1, BA2R, CCG1, CCGS, TAF2A","Transcription initiation factor TFIID subunit 1","1","6P39"
"6P3A",,"X-RAY DIFFRACTION",3.95,68.84,"VAPOR DIFFUSION, SITTING DROP",,"PEG8000, Tris pH 8.0",293,,,"6P3A",32.89,"2.99","2.99","Crystal Structure Analysis of TAF1 Bromodomain","SMDDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICTAKEAALEEAELESLD","Homo sapiens","TAF1, BA2R, CCG1, CCGS, TAF2A","Transcription initiation factor TFIID subunit 1","1","6P3A"
"6P3D",,"X-RAY DIFFRACTION",2.7,54.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"2 M AMMONIUM SULFATE, 5% (V/V) 2
 -PROPANOL, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE
 291K",291,"10.1038/s41467-020-18123-2","0LI","6P3D",35.2,"2.11","2.11","The co-crystal structure of BRAF(V600E) with ponatinib","MGSSHHHHHHSSGLVPRGSKMDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6P3D"
"6P3P",,"X-RAY DIFFRACTION",1.99,38.22,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM Bicine pH 8.5, 35% PEG 1500 and 10% ethanol",277,"10.1016/j.bmcl.2019.06.008","NQJ","6P3P",18.44,"1.61","1.61","Crystal structure of Mcl-1 in complex with compound 65","SDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6P3P"
"6P3Q",,"X-RAY DIFFRACTION",2.71,54.68,"VAPOR DIFFUSION, HANGING DROP",6,"250 mM sodium phosphate, 12 % PEG 8000, 36 mM EDTA, 10 mM Calcium chloride, 0.4 mM H-E(EDANS)-KIEIVRKKPIFKKATV-K(DASBCYL)-OH",291,"10.1016/j.celrep.2019.12.077",,"6P3Q",82.73,"2.8","2.8","Calpain-5 (CAPN5) Protease Core (PC)","GSHMFSCVKPYEDQNYSALRRDCRRRKVLFEDPLFPATDDSLYYKGTPGPAVRWKRPKGICEDPRLFVDGISSHDLHQGQVGNCWFVAACSSLASRESLWQKVIPDWKEQEWDPEKPNAYAGIFHFHFWRFGEWVDVVIDDRLPTVNNQLIYCHSNSRNEFWCALVEKAYAKLAGCYQALDGGNTADALVDFTGGVSEPIDLTEGDFANDETKRNQLFERMLKVHSRGGLISASIKAVTAADMEARLACGLVKGHAYAVTDVRKVRLGHGLLAFFKSEKLDMIRLRNPWGEREWNGPWSDTSEEWQKVSKSEREKMGVTVQDDGEFWMTFEDVCRYFTDIIKCRVILENLYFQGHHHHH","Homo sapiens","CAPN5, NCL3","Calpain-5","1","6P3Q"
"6P4V",,"X-RAY DIFFRACTION",3.05,59.64,"VAPOR DIFFUSION, HANGING DROP",,"0.1M TRIS (8.0) AND 65% MPD, VAPOR
 DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1021/acs.jmedchem.9b01979","GC7","6P4V",84.22,"1.65","1.65","1.65 Angstrom ternary complex of Deoxyhypusine synthase with cofactor NAD and spermidine mimic inhibitor GC7","GGSMEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6P4V"
"6P4Z",,"X-RAY DIFFRACTION",1.85,33.39,"VAPOR DIFFUSION, SITTING DROP",,"18% (w/v) PEG 12,000 and 0.1 M HEPES pH 7.0",293,,,"6P4Z",11.95,"1.8","1.8","Structure of gadolinium-caged cobalt (III) insulin hexamer","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin chain A","1","6P4Z"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin chain B","2","6P4Z"
"6P5M",,"X-RAY DIFFRACTION",4.01,69.31,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.8 M trisodium citrate, 0.1 M citrate, pH 5.1",293,"10.1021/acs.jmedchem.9b01427",,"6P5M",185.5,"2.65","2.65","Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent","GAMGSPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR","Homo sapiens","ROCK2, KIAA0619","Rho-associated protein kinase 2","1","6P5M"
"6P5P",,"X-RAY DIFFRACTION",4.09,69.93,"VAPOR DIFFUSION, SITTING DROP",5.2,"0.8 M trisodium citrate, 0.1 M citrate, pH 5.2, Silver Bullets Bio B12 (0.025% thymidine-5'-triphosphate sodium salt, 0.025% alpha-ketoglutaric acid disodium salt, 0.025% 2-nitrophenyl beta-D-galactopyranoside, 0.025% cis-aconitic acid, 0.002 M HEPES sodium, pH 6.8)",293,"10.1021/acs.jmedchem.9b01427",,"6P5P",186.24,"3.3","3.3","Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent","GAMGSPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR","Homo sapiens","ROCK2, KIAA0619","Rho-associated protein kinase 2","1","6P5P"
"6P5S",,"X-RAY DIFFRACTION",2.84,56.7,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2 M KSCN",298,"10.1074/jbc.RA119.009725","3NG","6P5S",45.33,"2.194","2.194","HIPK2 kinase domain bound to CX-4945","MGSSHHHHHHSSGENLYFQGSNSEGDYQLVQHEVLCSMTNTYEVLEFLGRGTFGQVVKCWKRGTNEIVAIKILKNHPSYARQGQIEVSILARLSTESADDYNFVRAYECFQHKNHTCLVFEMLEQNLYDFLKQNKFSPLPLKYIRPVLQQVATALMKLKSLGLIHADLKPENIMLVDPSRQPYRVKVIDFGSASHVSKAVCSTYLQSRYYRAPEIILGLPFCEAIDMWSLGCVIAELFLGWPLYPGASEYDQIRYISQTQGLPAEYLLSAGTKTTRFFNRDTDSPYPLWRLKTPDDHEAETGIKSKEARKYIFNCLDDMAQVNMTTDLEGSDMLVEKADRREFIDLLKKMLTIDADKRITPIETLNHPFVTMTHLLDFPHSTHVKSCFQN","Homo sapiens","HIPK2","Homeodomain-interacting protein kinase 2","1","6P5S"
"6P68",,"X-RAY DIFFRACTION",3.28,62.54,"VAPOR DIFFUSION, HANGING DROP",6.5,"1:1 mix of protein + reservoir
Protein at ~15 mg/mL formulated in: 20mM Tris pH 8, 20mM NaCl, 2mM TCEP
Reservoir:
14-18% PEG 10K
0.3 M (NH4)2SO4
0.1 M MES pH 6.5
5% ethylene glycol",277,,,"6P68",107.07,"2.9","2.9","Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVECASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6P68"
"6P69",,"X-RAY DIFFRACTION",2.7,54.51,"VAPOR DIFFUSION, HANGING DROP",,"1:1 mix of protein + reservoir
Protein at ~15 mg/mL formulated in: 20mM Tris pH 8, 20mM NaCl, 2mM TCEP
Reservoir:
14-18% PEG 10K
0.3 M (NH4)2SO4
0.1 M MES pH 6.5
5% ethylene glycol",277,,"O21","6P69",71.91,"2.2","2.2","Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVECASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6P69"
"6P6B",,"SOLUTION NMR",,,,,,,"10.3390/ijms20133335",,"6P6B",10.45,,,"CS-Rosetta Model of PEA-15 Death Effector Domain","MAEYGTLLQDLTNNITLEDLEQLKSACKEDIPSEKSEEITTGSAWFSFLESHNKLDKDNLSYIEHIFEISRRPDLLTMVVDYRTRVLKIS","Homo sapiens","PEA15","Astrocytic phosphoprotein PEA-15","1","6P6B"
"6P6C",,"SOLUTION NMR",,,,,,,"10.3390/ijms20133335",,"6P6C",15.06,,,"CS-Rosetta Model of PEA-15 Death Effector Domain in the Complex with ERK2","MAEYGTLLQDLTNNITLEDLEQLKSACKEDIPSEKSEEITTGSAWFSFLESHNKLDKDNLSYIEHIFEISRRPDLLTMVVDYRTRVLKISEEDELDTKLTRIPSAKKYKDIIRQPSEEEIIKLAPPPKKA","Homo sapiens","PEA15","Astrocytic phosphoprotein PEA-15","1","6P6C"
"6P6D",,"X-RAY DIFFRACTION",2.71,54.58,"VAPOR DIFFUSION, SITTING DROP",7.5,"12 mg/mL protein, 20% w/v PEG 3350, 200 mM K Acetate",295,"10.3390/pharmaceutics11100546",,"6P6D",54.6,"2.31","2.31","HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT","DKTHTCPPCPAPELLGGPSCVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"IgG1 Fc fragment","1","6P6D"
"6P6G",,"X-RAY DIFFRACTION",2.22,44.53,"VAPOR DIFFUSION, HANGING DROP",,"Sitting Drop, Linbro tray, room temp, reservoir is 10% PEG 3350, 0.2M MgOAc ,
protein:reservoir is 1:1,
streak seed
soaking: 2ul 20%PEG 3350, 0.4M MgOAc added to 2ul protein, mix and add 0.3ul to drop, store at 295",295,"10.1021/acsmedchemlett.9b00493","LUP","6P6G",50.97,"1.59","1.59","Co-crystal Structure of human SMYD3 with Isoxazole Amides Inhibitors","GSFTMEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","6P6G"
"6P6K",,"X-RAY DIFFRACTION",2.14,42.55,"VAPOR DIFFUSION, HANGING DROP",,"apo crystals :  room temp, Linbro tray, hanging drop, 1+1, reservoir is 10% PEG 3350, 0.2M MgOAc
seeding:  scratch seed
Soaks:  2ul of 200mM compound in DMSO mixed with 2x well solution (20% PEG3350, 0.4M MgOAc)",295,"10.1021/acsmedchemlett.9b00493",,"6P6K",50.59,"1.55","1.55","Co-crystal Structure of human SMYD3 with Isoxazole Amides Inhibitors","GSFTMEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","6P6K"
"6P7F",,"X-RAY DIFFRACTION",3.86,68.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5, 1.6 M Ammonium sulfate, 10% dioxane",277.15,,,"6P7F",27.1,"2.85003990159","2.85003990159","Human ABCC6 NBD2 R1459D mutant in Apo state","AAQPPWPQGGQIEFRDFGLRYRPELPLAVQGVSFKIHAGEKVGIVGRTGAGKSSLASGLLRLQEAAEGGIWIDGVPIAHVGLHTLRSRISIIPQDPILFPGSLRMNLDLLQEHSDEAIWAALETVQLKALVASLPGQLQYKCADRGEDLSVGQKQLLCLARALLRKTQILILDEATAAVDPGTELQMQAMLGSWFAQCTVLLIAHDLRSVMDCARVLVMDKGQVAESGSPAQLLAQKGLFYRLAQESGLV","Homo sapiens","ABCC6, ARA, MRP6","Multidrug resistance-associated protein 6","1","6P7F"
"6P7G",,"X-RAY DIFFRACTION",2.64,53.38,"VAPOR DIFFUSION, SITTING DROP",9,"0.1 M CHES/NaOH, 1 M Sodium Citrate",291,"10.1038/s41467-020-18123-2",,"6P7G",137.47,"2.65","2.65","The co-crystal structure of BRAF(V600E) with PHI1","MGSSHHHHHHSSGLVPRGSKMDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6P7G"
"6P7I",,"X-RAY DIFFRACTION",2.58,52.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Sodium Malonate pH 7.0, 12% (w/v) PEG 3350",293,,,"6P7I",171.22,"2","2","Crystal structure of Human PRMT6 in complex with S-Adenosyl-L-Homocysteine and YS17-117 Compound","GMSQPKKRKLESGGGGEGGEGTEEEDGAEREAALERPRRTKRERDQLYYECYSDVSVHEEMIADRVRTDAYRLGILRNWAALRGKTVLDVGAGTGILSIFCAQAGARRVYAVEASAIWQQAREVVRFNGLEDRVHVLPGPVETVELPEQVDAIVSEWMGYGLLHESMLSSVLHARTKWLKEGGLLLPASAELFIVPISDQMLEWRLGFWSQVKQHYGVDMSCLEGFATRCLMGHSEIVVQGLSGEDVLARPQRFAQLELSRAGLEQELEAGVGGRFRCSCYGSAPMHGFAIWFQVTFPGGESEKPLVLSTSPFHPATHWKQALLYLNEPVQVEQDTDVSGEITLLPSRDNPRRLRVLLRYKVGDQEEKTKDFAMED","Homo sapiens","PRMT6, HRMT1L6","Protein arginine N-methyltransferase 6","1","6P7I"
"6P7J",,"X-RAY DIFFRACTION",2.03,39.42,"BATCH MODE",4.6,"Reservoir composition: 20% PEG3350, 300 mM NaAc pH 4.6",293,,,"6P7J",29.27,"3.501","3.501","Crystal structure of Latency Associated Peptide unbound to TGF-beta1","LSTCKTIDMELVKRKRIEAIRGQILSKLRLASPPSQGEVPPGPLPEAVLALYNSTRDRVAGESAEPEPEPEADYYAKEVTRVLMVETHNEIYDKFKQSTHSIYMFFNTSELREAVPEPVLLSRAELRLLRLKLKVEQHVELYQKYSNNSWRYLSNRLLAPSDSPEWLSFDVTGVVRQWLSRGGEIEGFRLSAHCSCDSRDNTLQVDINGFTTGRRGDLATIHGMNRPFLLLMATPLERAQHLQSSRHRAHHHHHH","Homo sapiens","TGFB1, TGFB","Transforming growth factor beta-1 proprotein","1","6P7J"
"6P7Z",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, HANGING DROP",,"Sitting drop, room temp, reservoir is 20%PEG 3350, 0.2M MgOAc
protein at 5mg/ml ratio to reservoir is 1:1, seed 
Soaking: 0.1ul of 200mM compound in DMSO added to drop for 72 hours before harvest",295,"10.1021/acsmedchemlett.9b00493",,"6P7Z",50.5,"1.19","1.19","Co-crystal Structure of human SMYD3 with Isoxazole Amides Inhibitors","GSFTMEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","6P7Z"
"6P8I",,"X-RAY DIFFRACTION",2.51,50.94,"VAPOR DIFFUSION, SITTING DROP",5.5,"100mM ammonium citrate dibasic, 20% PEG 3350",292.15,"10.1038/s42003-020-01211-w",,"6P8I",82.25,"2.54","2.54","N-terminal 5 domains of IGFIIR","AAGSTQAQAAPFPELCSYTWEAVDTKNNVLYKINICGSVDIVQCGPSSAVCMHDLKTRTYHSVGDSVLRSATRSLLEFNTTVSCDQQGTNHRVQSSIAFLCGKTLGTPEFVTATECVHYFEWRTTAACKKDIFKANKEVPCYVFDEELRKHDLNPLIKLSGAYLVDDSDPDTSLFINVCRDIDTLRDPGSQLRACPPGTAACLVRGHQAFDVGQPRDGLKLVRKDRLVLSYVREEAGKLDFCDGHSPAVTITFVCPSERREGTIPKLTAKSNCRYEIEWITEYACHRDYLESKTCSLSGEQQDVSIDLTPLAQSGGSSYISDGKEYLFYLNVCGETEIQFCNKKQAAVCQVKKSDTSQVKAAGRYHNQTLRYSDGDLTLIYFGGDECSSGFQRMSVINFECNKTAGNDGKGTPVFTGEVDCTYFFTWDTEYACVKEKEDLLCGATDGKKRYDLSALVRHAEPEQNWEAVDGSQTETEKKHFFINICHRVLQEGKARGCPEDAAVCAVDKNGSKNLGKFISSPMKEKGNIQLSYSDGDDCGHGKKIKTNITLVCKPGDLESAPVLRTSGEGGCFYEFEWHTAAACVLSKTEGENCTVFDSQAGFSFDLSPLTKKNGAYKVETKKYDFYINVCGPVSVSPCQPDSGACQVAKSDEKTWNLGLSNAKLSYYDGMIQLNYRGGTPYNNERHTPRATLITFLCDRDAGVGFPEYQEEDNSTYNFRWYTSYACPEEALVPL","Homo sapiens","IGF2R, MPRI","Cation-independent mannose-6-phosphate receptor","1","6P8I"
"6P8Q",,"X-RAY DIFFRACTION",2.11,41.73,"VAPOR DIFFUSION, HANGING DROP",5.5,"PEG 3350, Bis-Tris",298,"10.1021/acsmedchemlett.9b00381",,"6P8Q",153.07,"1.9","1.9","EGFR in complex with a dihydrodibenzodiazepinone allosteric inhibitor.","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6P8Q"
"6P8W",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M Calcium chloride, 0.1M MES pH6.5, 30% PEG4000",293,"10.1021/acsmedchemlett.9b00258",,"6P8W",44.05,"2.1","2.1","Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor.","MKHHHHHHHDEVDGMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6P8W"
"6P8X",,"X-RAY DIFFRACTION",2.01,38.87,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Calcium chloride, 20% PEG3350",293,"10.1021/acsmedchemlett.9b00258",,"6P8X",88.38,"2.11","2.11","Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor.","MKHHHHHHHDEVDGMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6P8X"
"6P8Y",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M Ammonium acetate, 0.1M Sodium citrate pH5.6, 32% PEG4000, 0.005M Magnesium chloride",293,"10.1021/acsmedchemlett.9b00258",,"6P8Y",44.12,"2.31","2.31","Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor.","MKHHHHHHHDEVDGMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6P8Y"
"6P8Z",,"X-RAY DIFFRACTION",1.87,34.12,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M Calcium chloride, 0.1M TRIS pH8.5, 20% PEG 4000",293,"10.1021/acsmedchemlett.9b00258",,"6P8Z",44.25,"1.65","1.65","Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor","MKHHHHHHHDEVDGMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6P8Z"
"6P9E",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, SITTING DROP",3.5,"3 M NaCl, 0.1 M Na3 Citrate, pH 3.5",296.15,"10.1038/s41598-019-45626-w","O6D","6P9E",17.51,"2","2","Crystal structure of IL-36gamma complexed to A-552","SMCKPITGTINDLNQQVWTLQGQNLVAVPRSDSVTPVTVAVITCKYPEALEQGRGDPIYLGIQNPEMCLYCEKVGEQPTLQLKEQKIMDLYGQPEPVKPFLFYRAKTGRTSTLESVAFPDWFIASSKRDQPIILTSELGKSYNTAFELNIND","Homo sapiens","IL36G, IL1E, IL1F9, IL1H1, IL1RP2, UNQ2456/PRO5737","Interleukin-36 gamma","1","6P9E"
"6P9G",,"X-RAY DIFFRACTION",3.73,67.05,"VAPOR DIFFUSION, SITTING DROP",6.8,"1.75 M ammonium sulfate, 0.2 M sodium acetate, 0.1 M sodium cacodylate, 1.1% v/v dimethyl sulfoxide, 25% v/v ethylene glycol",291,"10.1021/acs.jmedchem.9b00988",,"6P9G",13.82,"2.1","2.1","Structure of USP5 zinc-finger ubiquitin binding domain co-crystallized with 2-(4-oxoquinazolin-3(4H)-yl)propanoic acid","GGEVRQVSKHAFSLKQLDNPARIPPCGWKCSKCDMRENLWLNLTDGSILCGRRYFDGSGGNNHAVEHYRETGYPLAVKLGTITPDGADVYSYDEDDMVLDPSLAEHLSHFGIDMLKMQKTD","Homo sapiens","USP5, ISOT","Ubiquitin carboxyl-terminal hydrolase 5","1","6P9G"
"6P9I",,"X-RAY DIFFRACTION",2.44,49.68,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 200, 18% PEG 8000, 0.1 M Bis-tris propane pH 9.0",291.15,"10.1128/mBio.02473-19",,"6P9I",94.52,"2.4","2.4","crystal structure of human anti staphylococcus aureus antibody STAU-399 Fab","QVQLVQSGAEVKKPGSSLKVSCKVSGGNLRSYGISWVRQAPGQGLEWMGVIIPIFGTPTYAQKFQGRVTLAADDSNNIVFMELSSLRSEDTAVYYCARDWPSITVAVDATNYGMDVWGQGTLVTVSSASFKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"human anti staphylococcus aureus antibody STAU-399 Fab heavy chain","1","6P9I"
,,,,,,,,,,,,,,,,"QSALTQPRSVSGSPGQSVTISCTGTSNDVGYYDHVSWYQQHPGKAPKFIIYDVSKRPSGVPDRFSGSKSDNTASLTISGLQAEDEADYYCCSFAGSYTYVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"human anti staphylococcus aureus antibody STAU-399 Fab light chain","2","6P9I"
"6P9J",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M ammonium acetate, 0.1 M Bis-tris pH 5.5, 17% PEG 10,000",291.15,"10.1128/mBio.02473-19",,"6P9J",95.1,"2.2","2.2","crystal structure of human anti staphylococcus aureus antibody STAU-229 Fab","QSALTQPPSASGSPGQSVTISCTGSSNDVGDYNFVSWYQQHPGKPPKLMIYEVTKRPSGVPDRFFGSKSGNTASLTVSGLQADDEADYYCSSYAGGNSVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"human anti staphylococcus aureus antibody STAU-229 Fab light chain","2","6P9J"
,,,,,,,,,,,,,,,,"EVQLVQSGAEVKKPGATMKISCKVSGYPFTDYYMHWVQQAPGKGLEWMGLIDPEDGETNYAEKFQGRVTITADTSTDTVYMELSSLRSEDTAVYFCAKPHCSSRTCQRVSGYYFGMDVWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"human anti staphylococcus aureus antibody STAU-229 Fab heavy chain","1","6P9J"
"6P9U",,"X-RAY DIFFRACTION",2.77,55.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"10 mM ZnSO4, 100 mM MES and 25% PEG 550 MME",293,"10.1038/s41598-019-48839-1",,"6P9U",141.17,"3.3","3.3","Crystal structure of human thrombin mutant W215A","EADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","6P9U"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGEYLEDQVDPRLIDGK","Homo sapiens","F2","Prothrombin","2","6P9U"
"6P9V",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M KCl, 0.05M HEPES, 35% (v/v) Pentaeythritol propoxylate (5/4 PO/OH), PROTEIN BUFFER ADDITIVES: 0.002M ADP, 0.005M magnesium chloride, 0.010M metol -- [(S)-(-)-methioninol]",298,"10.1021/acschembio.9b00943",,"6P9V",46.38,"2.051","2.051","Crystal Structure of hMAT Mutant K289L","MGSSHHHHHHSSGLVPRGSHMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTLVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6P9V"
"6PAF",,"X-RAY DIFFRACTION",2.16,43.14,"VAPOR DIFFUSION, HANGING DROP",,"Sitting Drop, Linbro tray, room temp, reservoir is 10% PEG 3350, 0.2M MgOAc , protein:reservoir is 1:1, streak seed soaking: 2ul 20%PEG 3350, 0.4M MgOAc added to 2ul protein, mix and add 0.3ul to drop, store at 295",295,"10.1021/acsmedchemlett.9b00493",,"6PAF",50.77,"1.241","1.241","Co-crystal Structure of human SMYD3 with Isoxazole Amides Inhibitors","GSFTMEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","6PAF"
"6PAH",,"X-RAY DIFFRACTION",3.22,62,,6.8,"pH 6.8",,"10.1021/bi9815290",,"6PAH",35.95,"2.15","2.15","HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND L-DOPA (3,4-DIHYDROXYPHENYLALANINE) INHIBITOR","TVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVL","Homo sapiens","PAH","PHENYLALANINE 4-MONOOXYGENASE","1","6PAH"
"6PAX",,"X-RAY DIFFRACTION",2.93,58,,8,"pH 8.0",,"10.1101/gad.13.10.1263",,"6PAX",30.49,"2.5","2.5","CRYSTAL STRUCTURE OF THE HUMAN PAX-6 PAIRED DOMAIN-DNA COMPLEX REVEALS A GENERAL MODEL FOR PAX PROTEIN-DNA INTERACTIONS","AAGCATTTTCACGCATGAGTGCACAG",,,"26 NUCLEOTIDE DNA","1","6PAX"
,,,,,,,,,,,,,,,,"SHSGVNQLGGVFVNGRPLPDSTRQRIVELAHSGARPCDISRILQVSNGCVSKILGRYYATGSIRPRAIGGSKPRVATPEVVSKIAQYKQECPSIFAWEIRDRLLSEGVCTNDNIPSVSSINRVLRNLASEKQQ","Homo sapiens","PAX6, AN2","HOMEOBOX PROTEIN PAX-6","3","6PAX"
,,,,,,,,,,,,,,,,"TTCTGTGCACTCATGCGTGAAAATGC",,,"26 NUCLEOTIDE DNA","2","6PAX"
"6PAY",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG3350, 10% Tacsimate, pH 5.0",298,"10.1021/acs.biochem.9b00518","ICT","6PAY",188.81,"2.199","2.199","Structure of HsICDH1:Mg(II):ICT:NADPH(50%) complex reveals structural basis for observation of half-sites reactivity","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6PAY"
"6PBG",,"X-RAY DIFFRACTION",1.83,32.73,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2M di-Ammonium Tartrate",293,,,"6PBG",37.22,"1.72","1.72","Crystal structure of WD-repeat domain of human coatomer subunit Alpha (COPA)","GMLTKFETKSARVKGLSFHPKRPWILTSLHNGVIQLWDYRMCTLIDKFDEHDGPVRGIDFHKQQPLFVSGGDDYKIKVWNYKLRRCLFTLLGHLDYIRTTFFHHEYPWILSASDDQTIRVWNWQSRTCVCVLTGHNHYVMCAQFHPTEDLVVSASLDQTVRVWDISGLRKKNLSPGAVESDVRGITGVDLFGTTDAVVKHVLEGHDRGVNWAAFHPTMPLIVSGADDRQVKIWRMNESKAWEVDTCRGHYNNVSCAVFHPRQELILSNSEDKSIRVWDMSKRTGVQTFRRDHDRFWVLAAHPNLNLFAAGHDGGMIVFKLE","Homo sapiens","COPA","Coatomer subunit alpha","1","6PBG"
"6PCE",,"X-RAY DIFFRACTION",2.04,39.69,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES, pH 7.6, 29% (w/v) PEG 3350",293,"10.26508/lsa.201900458",,"6PCE",17.2,"1.65","1.65","Human Coa6","PSMKERQVCWGARDEYWKCLDENLEDASQCKKLRSSFESSCPQQWIKYFDKRRDYLKFKEKFEAGQFEPS","Homo sapiens","COA6, C1orf31","Cytochrome c oxidase assembly factor 6 homolog","1","6PCE"
"6PCF",,"X-RAY DIFFRACTION",2.64,53.44,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris, pH 5.7, 0.23 M MgCl2.6H2O, 29% (w/v) PEG 3350",293,"10.26508/lsa.201900458",,"6PCF",31.57,"2.2","2.2","Human Coa6: W59C mutant protein","APSMKERQVCCGARDEYWKCLDENLEDASQCKKLRSSFESSCPQQWIKYFDKRRDYLKFKEKFEA","Homo sapiens","COA6, C1orf31","Cytochrome c oxidase assembly factor 6 homolog","1","6PCF"
"6PCK",,"X-RAY DIFFRACTION",2.4,48.77,"VAPOR DIFFUSION, HANGING DROP",4.6,"12 - 18% PEG 8000, 150 - 300 mM LiSO4, 0.1 M sodium acetate, pH 4.6",290.15,"10.1073/pnas.1908875117",,"6PCK",17.95,"1.2","1.2","Crystal structure of human diphosphoinositol polyphosphate phosphohydrolase 1 in complex with 1-IP7","MMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6PCK"
"6PCL",,"X-RAY DIFFRACTION",2.47,50.25,"VAPOR DIFFUSION, HANGING DROP",4.6,"12 - 18% PEG 8000, 150 - 300 mM LiSO4, 0.1 M sodium acetate, pH 4.6",290.15,"10.1073/pnas.1908875117",,"6PCL",18,"1.3","1.3","Crystal structure of human diphosphoinositol polyphosphate phosphohydrolase 1 in complex with 5-IP7","MMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGIFENQERKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKIEDAIKVLQYHKPVQASYFETLRQGYS","Homo sapiens","NUDT3, DIPP, DIPP1","Diphosphoinositol polyphosphate phosphohydrolase 1","1","6PCL"
"6PD8",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PD8",32.57,"2.738","2.738","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 39","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PD8"
"6PD9",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PD9",32.59,"2.8","2.8","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 60","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PD9"
"6PDA",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PDA",32.7,"2.448","2.448","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 74","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PDA"
"6PDB",,"X-RAY DIFFRACTION",2.5,50.75,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PDB",32.7,"2.42","2.42","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 80","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PDB"
"6PDC",,"X-RAY DIFFRACTION",2.52,51.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PDC",32.67,"1.96","1.96","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 42","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PDC"
"6PDD",,"X-RAY DIFFRACTION",2.52,51.14,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PDD",32.68,"2.15","2.15","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 41","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PDD"
"6PDE",,"X-RAY DIFFRACTION",2.49,50.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PDE",32.68,"2.22","2.22","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 40","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PDE"
"6PDF",,"X-RAY DIFFRACTION",2.48,50.41,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PDF",32.69,"2.22","2.22","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 55","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PDF"
"6PDG",,"X-RAY DIFFRACTION",2.5,50.87,"VAPOR DIFFUSION, HANGING DROP",6.5,"27% PEG 3350, 0.2 M ammonium sulfate, 0.1 M bis-tris pH 6.5",292,"10.1021/acs.jmedchem.9b02071",,"6PDG",32.71,"1.919","1.919","Crystal structure of MYST acetyltransferase domain in complex with inhibitor 83","KYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPP","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6PDG"
"6PDJ",,"X-RAY DIFFRACTION",2.44,49.68,"VAPOR DIFFUSION, HANGING DROP",10.5,"1.5 M ammonium sulfate, 120 mM lithium chloride, 10 mM nickel(II) chloride, 100 mM CAPS pH 10.5",291,"10.1021/acsmedchemlett.9b00354","PTR","6PDJ",34.32,"1.81","1.81","Tyrosine-protein kinase LCK bound to Compound 11","GHMQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP","Homo sapiens","LCK","Tyrosine-protein kinase Lck","1","6PDJ"
"6PDM",,"X-RAY DIFFRACTION",2.19,43.96,"VAPOR DIFFUSION",,"20% PEG3350, 0.2M ammonium nitrate",293,,,"6PDM",80.49,"2.45","2.45","Crystal structure of Human Protein Arginine Methyltransferase 9 (PRMT9)","GAVKLNPDFSDAKENFYRVANWLVERWHFIMLNDTKRNTIYNAAIQKAVCLGSKSVLDIGAGTGILSMFAKKAGAHSVYACELSKTMYELACDVVAANKMEAGIKLLHTKSLDIEIPKHIPERVSLVVTETVDAGLFGEGIVESLIHAWEHLLLQPKTKGESANCEKYGKVIPASAVIFGMAVECAEIRRHHRVGIKDIAGIHLPTNVKFQSPAYSSVDTEETIEPYTTEKMSRVPGGYLALTECFEIMTVDFNNLQELKSLATKKPDKIGIPVIKEGILDAIMVWFVLQLDDEHSLSTSPSEETCWEQAVYPVQDLADYWIKPGDHVMMEVSCQDCYLRIQSISVLGLECEMDVAKSFTQNKDLLSLGNEAELCSALANLQTSKPDAVEQTCILESTEIALLNNIPYHEGFKMAMSKVLSSLTPEKLYQTMDTHCQNEMSSGTGQSNTVQNILEPFYVLDVSEGFSVLPVIAGTLGQVKPYSSVEKDQHRIALDLISEANHFPKETLEFWLRHVEDESAMLQRPKSDKLWSIIILDVIEPSGLIQQEIMEKAAISRCLLQSGGKIFPQYVLMFGLLVESQTLLEENAVQGTERTLGLNIAPFINQFQVPIRVFLDLSSLPCIPLSKPVELLRLDLMTPYLNTSNREVKVYVCKSGRLTAIPFWYHMYLDEEIRLDTSSEASHWKQAAVVLDNPIQVEMGEELVLSIQHHKSNVSITVKQ","Homo sapiens","PRMT9, PRMT10","Protein arginine N-methyltransferase 9","1","6PDM"
"6PDQ",,"X-RAY DIFFRACTION",2.04,39.69,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium acetate, pH 4.6, 0.1 M sodium acetate trihydrate, 30% PEG 4000",291,"10.1042/BCJ20190625",,"6PDQ",54.27,"1.83","1.83","Ancestral Effector Caspase 3/6/7","LDNSYKMNHKRRGLCLIINNKNFDRKTGMKTRNGTDKDAENLEKTFKSLGFEVKVYNDLTAEEMQETLQEVSKEDHSDSDCFVCVLLSHGEEGLVYGTDGKIEIQELTSLFKGDKCQSLVGKPKLFFIQACRGDELDSGVEV","Homo sapiens",,"Ancestral Effector Caspase-3/6/7","1","6PDQ"
,,,,,,,,,,,,,,,,"XDEVD","Homo sapiens",,"Ac-DEVD inhibitor","3","6PDQ"
,,,,,,,,,,,,,,,,"HKIPAEADFLIAYSTAPGYYSYRNTSNGSWFIQSLCEVLNKYGSELEIMEILTRVNHKVSLRSESSSNDPAFNGKKQMPCFASMLTKKLYFSP","Homo sapiens",,"Ancestral Effector Caspase-3/6/7","2","6PDQ"
"6PDV",,"X-RAY DIFFRACTION",2.09,41.21,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate, 50mM Tris",298,"10.1107/S2052252520000986","NO2","6PDV",29.58,"1.23","1.23","Cu-Carbonic Anhydrase II, A Nitrite Reductase","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6PDV"
"6PE6",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, SITTING DROP",5.6,"PEG 4000, ammonium acetate, citrate",291.15,"10.1126/scitranslmed.abf5965",,"6PE6",43,"1.6","1.6","PANK3 complex structure with compound PZ-3022","MGSSHHHHHHSSGLVPRGSPWFGMDIGGTLVKLSYFEPIDITAEEEQEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLFGRRGNLHFIRFPTQDLPTFIQMGRDKNFSTLQTVLCATGGGAYKFEKDFRTIGNLHLHKLDELDCLVKGLLYIDSVSFNGQAECYYFANASEPERCQKMPFNLDDPYPLLVVNIGSGVSILAVHSKDNYKRVTGTSLGGGTFLGLCSLLTGCESFEEALEMASKGDSTQADKLVRDIYGGDYERFGLPGWAVASSFGNMIYKEKRESVSKEDLARATLVTITNNIGSVARMCAVNEKINRVVFVGNFLRVNTLSMKLLAYALDYWSKGQLKALFLEHEGYFGAVGALLGLPNFSDD","Homo sapiens","PANK3","Pantothenate kinase 3","1","6PE6"
"6PE7",,"X-RAY DIFFRACTION",2.86,57.06,"VAPOR DIFFUSION",,"25% (w/v) PMME 550, 0.1M MES pH 6.5, 0.01M zinc sulfate",296.15,"10.1186/s12860-019-0213-4",,"6PE7",48.23,"1.74","1.74","Crystal Structure of ABBV-323 FAB","EVQLVESGGGLVKPGGSLRLSCAASGFTFSDYGMNWVRQAPGKGLEWIAYISSGRGNIYYADTVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARSWGYFDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTH","Homo sapiens",,"FAB Heavy Chain","1","6PE7"
,,,,,,,,,,,,,,,,"DIVMTQSPDSLAVSLGERATINCKSSQSLLNRGNQKNYLTWFQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYTYPLTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FAB Light chain","2","6PE7"
"6PEA",,"X-RAY DIFFRACTION",2.1,41.38,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate, 50mM Tris",298,"10.1107/S2052252520000986",,"6PEA",29.41,"1.36","1.36","High Resolution Apo Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6PEA"
"6PEB",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, SITTING DROP",8.8,"100 mM NaPO4, pH 8.8
34 % (w/v) PEG 3350
180 mM NaCl. Equal volumes (0.5 uL) of reservoir solution and protein. Compound was soaked overnight at 1 mM concentration in crystallization solution.",293,"10.1021/acsmedchemlett.9b00325","OE4","6PEB",229.62,"2.46","2.46","Crystal Structure of human NAMPT in complex with NVP-LTM976","NPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6PEB"
"6PEG",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, SITTING DROP",,"100microMolar 4048, 2M Ammonium sulfate, 4% isopropanol, 50 mM Tris pH 8.0, 12.5% Glycerol, 50mM sodium acetate

Protein 100mg/ml MIF in 50mM citrate pH 5, 50microMolar 4048",298,"10.1021/acsmedchemlett.9b00351",,"6PEG",38.59,"2","2","MIF with a allosteric inhibitor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6PEG"
"6PEH",,"X-RAY DIFFRACTION",3.01,59.2,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Imidazole pH 6.5, 16% PEG 3350, 10% MPD, 0.2M LiSO4",293,"10.1016/j.immuni.2019.10.008",,"6PEH",95.89,"2.296","2.296","Crystal structure of rabbit monoclonal anti-HIV antibody 1C2","QSLEESGGDLVKPGASLTLTCTASGFSFGWNDYMSWVRQAPGKGLEWIGCIYAGSTRSTYYANWAKGRLTISKTSSTAVTLQMTSLTAADTATYFCARGAVTYDGLGGAYLKHFNLWGPGTLVTVSSGQPKAPSVFPLAPCCGDTPSSTVTLGCLVKGYLPEPVTVTWNSGTLTNGVRTFPSVRQSSGLYSLSSVVSVTSSSQPVTCNVAHPATNTKVDKTVAPSTCSKHHHHHHHH","Homo sapiens",,"1C2 Fab Heavy Chain","1","6PEH"
,,,,,,,,,,,,,,,,"AIKMTQTPSSVSAAVGGTVTVNCRASEDIESYLAWYQQKPGQPPKLLIYDTSKLASGVPSRFKGSGSGTQFALTISGVQCDDAATYYCLYGYISSDRIDFGFGGGTELVVKGDPVAPSVLIFPPAADQVATGTVTIVCVANKYFPDVTVTWEVDGTTQTTGIENSKTPQNSADCTYNLSSTLTLTSTQYNSHKEYTCKVTQGTTSVVQSFNRGDC","Homo sapiens",,"1C2 Fab Light Chain","2","6PEH"
"6PEO","3.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0322-y",,"6PEO",72.33,"3.3",,"Cryo-EM structure of alpha-synuclein H50Q Narrow Fibril","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVQGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6PEO"
"6PES","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0322-y",,"6PES",144.66,"3.6",,"Cryo-EM structure of alpha-synuclein H50Q Wide Fibril","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVQGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6PES"
"6PET",,"X-RAY DIFFRACTION",1.94,36.52,"VAPOR DIFFUSION",,"25-35% PEG 3,350
0.1 M Bis-Tris (pH 6.1-6.5)
150-300 mM MgCl2",295,"10.1016/j.bmcl.2019.07.013",,"6PET",129.87,"2.203","2.203","Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha","MHHHHHHSSGVDLGTENLYFQSNAIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6PET"
"6PF2",,"X-RAY DIFFRACTION",3.03,59.43,"VAPOR DIFFUSION, HANGING DROP",8,"Crystals grew spontaneously at room temperature by mixing 1:1 ratio of 16 mg/ml protein in 100 mM NaCl, 10 mM HEPES pH 7.6, 0.1 mM TCEP with well solution containing 2.4 M ammonium phosphate pH 8.0, 100 mM HEPPS pH 8.0.",293,,,"6PF2",36.96,"2.17","2.17","Crystal Structure of Amino Acids 1220-1276 of Human Beta Cardiac Myosin Fused to Gp7 and Eb1","GGSGPLKPEEHEDILNKLLDPELAQSERTEALQQLRVNYGSFVSEYNDLTKEKSEFKLELDDVTSNMEQIIKAKANLEKMCRTLEDQMNEHRSKAEETQRSVNDLTSQVEDLEKERDFYFGKLRNIELICQENEGENDPVLQRIVDILYATDEGFVIPD","Homo sapiens","MAPRE1, MYH7, MYHCB","Myosin, heavy polypeptide 7, cardiac muscle, beta variant","1","6PF2"
"6PF3",,"X-RAY DIFFRACTION",2.49,50.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"Well solution 18 % PEG monomethyl ether 5000, 0.1 M Bis-Tris

Drop ratio 1:1 enzyme mix/well solution",295.15,"10.1016/j.ejmech.2019.111673",,"6PF3",135.74,"2.391","2.391","Crystal structure of human thymidylate synthase Delta (7-29) in complex with dUMP and 2-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-chlorobenzoic acid","MPVAGSELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","6PF3"
"6PF4",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"Well solution 28 % PEG 4000, 0.2 M lithium sulfate, 0.1 M Tris

Drop ratio 1:1 enzyme mix/well solution",295.15,"10.1016/j.ejmech.2019.111673",,"6PF4",135.66,"2.854","2.854","Crystal structure of human thymidylate synthase Delta (7-29) in complex with dUMP and 2-(2-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)phenyl)acetic acid","MPVAGSELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","6PF4"
"6PF5",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION, HANGING DROP",7,"Well solution 16 % PEG monomethyl ether 5000, 0.1 M Bis-Tris

Drop ratio 1:1 enzyme mix/ well solution",295.15,"10.1016/j.ejmech.2019.111673",,"6PF5",135.78,"2.39","2.39","Crystal structure of human thymidylate synthase Delta (7-29) in complex with dUMP and 2-(2-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-methoxyphenyl)acetic acid","MPVAGSELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","6PF5"
"6PF6",,"X-RAY DIFFRACTION",2.38,48.3,"VAPOR DIFFUSION, HANGING DROP",8,"Well solution 40 % PEG 400, 0.1 M Imidazole
Drop ratio 1:1 enzyme mix/well solution",295.15,"10.1016/j.ejmech.2019.111673",,"6PF6",134.88,"2.502","2.502","Crystal structure of TS-DHFR from Cryptosporidium hominis in complex with NADPH, FdUMP and 2-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)terephthalic acid","MPVAGSELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase,Thymidylate synthase","1","6PF6"
,,,,,,,,,,,,,,,,,"Homo sapiens","TYMS, TS, OK/SW-cl.29"
"6PFL",,"X-RAY DIFFRACTION",2.24,45.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.4M NaCitrate, and 0.1M Tris-HCL pH7.5",291,,,"6PFL",22.16,"2.1","2.1","Crystal structure of Human HUWE1 WWE domain in complex with ADPR","GQSNSNNWRWFDDRSGRWCSYSASNNSTIDSAWKSGETSVRFTAGRRRYTVQFTTMVQVNEETGNRRPVMLTLLRVPRLNKNSKNSNGQEL","Homo sapiens","HUWE1, KIAA0312, KIAA1578, UREB1, HSPC272","E3 ubiquitin-protein ligase HUWE1","1","6PFL"
"6PFM",,"X-RAY DIFFRACTION",2.67,53.97,"VAPOR DIFFUSION",,"25-35% PEG 3,350
0.1 M Bis-Tris (pH 6.1-6.5)
150-300 mM MgCl2",298,"10.1016/j.bmcl.2019.07.013","OGJ","6PFM",64.88,"2.84","2.84","Crystal structure of GDC-0927 bound to estrogen receptor alpha","MHHHHHHSSGVDLGTENLYFQSNAIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6PFM"
"6PFP",,"X-RAY DIFFRACTION",2.58,52.26,"VAPOR DIFFUSION, HANGING DROP",,"Crystals grew from 1:1 mixture of 18 mg/ml protein solution with 37% (w/v) 2-methyl-2,4-pentanediol (MPD), 80 mM magnesium sulfate, 100 mM sodium acetate. Protein solution contained 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.6, and 0.2 mM tris(2-carboxyethyl)phosphine (TCEP).",298,,,"6PFP",77.82,"2.2","2.2","Crystal Structure of Amino Acids 1473-1536 of Human Beta Cardiac Myosin Fused to Gp7 and Eb1","GGSGPLKPEEHEDILNKLLDPELAQSERTEALQQLRVNYGSFVSEYNDLTKEARSLSTELFKLKNAYEESLEHLETFKRENKNLQEEISDLTEQLGSSGKTIHELEKVRKQLEAEVEDLEKERDFYFGKLRNIELICQENEGENDPVLQRIVDILYATDEGFVIPD","Homo sapiens","MYH7, MYHCB","Myosin-7  fused to GP7 and EB1","1","6PFP"
,,,,,,,,,,,,,,,,,"Homo sapiens","MYH7, MYHCB"
"6PFW",,"X-RAY DIFFRACTION",3.32,62.99,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470",,"6PFW",34.8,"2.34","2.34","Protein Tyrosine Phosphatase 1B (1-301), T177A mutant, apo state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYATWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6PFW"
"6PG0",,"X-RAY DIFFRACTION",3.38,63.64,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470","VO4","6PG0",35.07,"2.1","2.1","Protein Tyrosine Phosphatase 1B (1-301), P188A mutant, vanadate bound state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESAASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6PG0"
"6PG3",,"X-RAY DIFFRACTION",2.28,46.14,"VAPOR DIFFUSION, SITTING DROP",,"0.182 M ammonium fluoride, 0.1 M sodium cacodylate (pH 5.79), 22.1 %w/v PEG8000",281,"10.1063/1.5122849","OHJ","6PG3",69.2,"2.04","2.04","WDR5delta23 bound to (2-butyl-1H-imidazol-4-yl)methanol","GSATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PG3"
"6PG4",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, SITTING DROP",,"0.114 M ammonium sulfate, 0.1 M bis-tris chloride (pH 6.11), 25.8 %w/v PEG8000",281,"10.1063/1.5122849","OHG","6PG4",33.94,"1.6","1.6","WDR5delta32 bound to (2-methyl-1H-imidazol-4-yl)methanol","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PG4"
"6PG5",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",,"0.215 M ammonium sulfate, 0.1 M sodium cacodylate (pH 7.06), 25.6 %w/v PEG8000",281,"10.1063/1.5122849","OHV","6PG5",34.13,"1.99","1.99","WDR5delta32 bound to benzyl (4-(5-(hydroxymethyl)-1H-imidazol-2-yl)butyl)carbamate","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PG5"
"6PG6",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, SITTING DROP",,"0.215 M ammonium sulfate, 0.1 M sodium cacodylate (pH 7.06), 25.6 %w/v PEG8000",281,"10.1063/1.5122849","OH7","6PG6",69.55,"1.68","1.68","WDR5delta23 bound to N-(4-(5-(hydroxymethyl)-1H-imidazol-2-yl)butyl)acetamide","GSATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PG6"
"6PG7",,"X-RAY DIFFRACTION",2.22,44.71,"VAPOR DIFFUSION, SITTING DROP",,"0.17 M ammonium sulfate, 0.1 bis-tris chloride (pH 6.3), 30.5 %w/v PEG4000",281,"10.1063/1.5122849","OH4","6PG7",33.89,"2.45","2.45","WDR5delta32 bound to (2-(3-methoxy-3-phenylpropyl)-1H-imidazol-4-yl)methanol","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PG7"
"6PG8",,"X-RAY DIFFRACTION",2.16,43.11,"VAPOR DIFFUSION, SITTING DROP",,"0.179 M ammonium sulfate, 0.1 M bis-tris chloride (pH 5.62), 28.6 %w/v PEG3350",281,"10.1063/1.5122849","OGY","6PG8",138.9,"1.67","1.67","WDR5delta23 bound to (2-(3-phenylpropyl)-1H-imidazol-4-yl)methanol","GSATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PG8"
"6PG9",,"X-RAY DIFFRACTION",2.31,46.78,"VAPOR DIFFUSION, SITTING DROP",,"0.182 M ammonium fluoride, 0.1 soidum cacodylate (pH 5.79), 22.1 %w/v PEG8000",281,"10.1063/1.5122849","OH1","6PG9",69.44,"1.75","1.75","WDR5delta23 bound to N-(4-(5-(hydroxymethyl)-1H-imidazol-2-yl)butyl)benzamide","GSATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PG9"
"6PGA",,"X-RAY DIFFRACTION",2.21,44.27,"VAPOR DIFFUSION, SITTING DROP",,"0.237 M ammonium sulfate, 0.1 M bis-tris chloride, 25.7 %w/v MPEG5000",281,"10.1063/1.5122849","OGM","6PGA",33.86,"2.45","2.45","WDR5delta32 bound to methyl (4-(4-(hydroxymethyl)-1H-imidazol-2-yl)butyl)carbamate","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PGA"
"6PGB",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, SITTING DROP",,"0.101 M ammonium sulfate, 0.1 M Bis-Tris chloride, pH 5.63, 25.8% w/v PEG4000",281,"10.1063/1.5122849","OJG","6PGB",34.11,"1.73","1.73","WDR5delta32 bound to N-(4-(5-(hydroxymethyl)-1H-imidazol-2-yl)butyl)-2-phenylacetamide","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PGB"
"6PGC",,"X-RAY DIFFRACTION",2.21,44.32,"VAPOR DIFFUSION, SITTING DROP",,"0.237 M ammonium sulfate, 0.1 M Bis-Tris chloride, pH 6.92, 25.7% w/v MPEG5000",281,"10.1063/1.5122849","OJJ","6PGC",34.05,"1.81","1.81","WDR5delta32 bound to methyl benzyl(4-(4-(hydroxymethyl)-1H-imidazol-2-yl)butyl)carbamate","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PGC"
"6PGD",,"X-RAY DIFFRACTION",2.21,44.28,"VAPOR DIFFUSION, SITTING DROP",,"0.233 M ammonium sulfate, 0.1 M Bis-Tris chloride, pH 6.02, 26% w/v PEG8000",281,"10.1063/1.5122849",,"6PGD",34.25,"1.5","1.5","WDR5delta32 bound to peptidomimetic","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PGD"
"6PGE",,"X-RAY DIFFRACTION",2.2,44.18,"VAPOR DIFFUSION, SITTING DROP",,"0.024 M ammonium sulfate, 0.1 M Bis-Tris chloride, pH 5.64, 26.3% w/v PEG4000",281,"10.1063/1.5122849","OJM","6PGE",33.99,"1.76","1.76","WDR5delta32 bound to ethyl 3-(4-(hydroxymethyl)-1H-imidazol-2-yl)propanoate","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PGE"
"6PGF",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION, SITTING DROP",,"0.16 M ammonium sulfate, 0.1 M Bis-Tris chloride, pH 6.1, 30.1% w/v PEG8000",281,"10.1063/1.5122849",,"6PGF",34.05,"1.54","1.54","WDR5delta32 bound to N-(4-(4-(hydroxymethyl)-1H-imidazol-2-yl)butyl)acrylamide","GSKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6PGF"
"6PGO",,"X-RAY DIFFRACTION",1.85,33.41,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M ammonium acetate, 0.1M sodium citrate pH5.6, 32% PEG 400, 5mM magnesium chloride",293,"10.1021/acs.jmedchem.9b01180",,"6PGO",43.99,"1.6","1.6","Crystal structure of human KRAS G12C covalently bound to a phthalazine inhibitor","MKHHHHHHHDEVDGMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6PGO"
"6PGP",,"X-RAY DIFFRACTION",1.86,33.74,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M calcium acetate, 25% PEG 3350",293,"10.1021/acs.jmedchem.9b01180",,"6PGP",44.22,"1.5","1.5","Crystal structure of human KRAS G12C covalently bound to a quinazolinone inhibitor","MKHHHHHHHDEVDGMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6PGP"
"6PGR",,"X-RAY DIFFRACTION",3.07,59.99,"VAPOR DIFFUSION, HANGING DROP",,"1.6M SODIUM/POTASSIUM PHOSPHATE (PH
 6.8), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",293,"10.1021/acs.jmedchem.9b01979","8XY","6PGR",83.17,"1.95","1.95","Cocomplex structure of Deoxyhypusine synthase with inhibitor 6-BROMO-N-(1H-INDOL-4-YL)-1-BENZOTHIOPHENE-2-CARBOXAMIDE","GGSMEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED","Homo sapiens","DHPS, DS","Deoxyhypusine synthase","1","6PGR"
"6PGT",,"X-RAY DIFFRACTION",3.35,63.24,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470","VO4","6PGT",35.06,"2.2","2.2","Protein Tyrosine Phosphatase 1B (1-301), T177A mutant, vanadate bound state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYATWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6PGT"
"6PGU",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION",,"20% MPD, 0.1 M Tris pH 8, 7.5% PEG-MME 5000",277,"10.1063/1.5119336","OK7","6PGU",76.19,"1.72","1.72","Crystal structure of the p300 acetyltransferase domain with allosteric inhibitor CPI-076 and CoA","GSKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWFKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKESGGSGSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQ","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","6PGU"
,,,,,,,,,,,,,,,,,"Homo sapiens","EP300, P300"
"6PGX",,"X-RAY DIFFRACTION",2.1,41.54,"VAPOR DIFFUSION, SITTING DROP",,"250 nL 7.5 mg/mL protein + 225 nL well solution (2.5-3.0 M ammonium sulfate, 100 mM Tris buffer, pH 8.0-8.5) + 25 nL microseeds",281,"10.1016/j.ejmech.2019.111586","OJ4","6PGX",31.3,"1.36","1.36","Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6PGX"
"6PHA",,"X-RAY DIFFRACTION",3.28,62.53,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470","VO4","6PHA",35.27,"2.299","2.299","Protein Tyrosine Phosphatase 1B (1-301), F182A mutant, vanadate bound state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDAGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6PHA"
"6PHG",,"X-RAY DIFFRACTION",2.29,46.38,"VAPOR DIFFUSION",,"0.1 M sodium acetate pH 4.5, 25 % (w/v) PEG 3350",293,"10.1038/s41467-019-11980-6",,"6PHG",48.42,"2","2","Predicted germline variant of human transmission blocking antibody 2544","EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVEYYYDSSGYYYDFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Germline 2544 Antibody Fab, Heavy Chain","1","6PHG"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Germline 2544 Antibody Fab, Light Chain","2","6PHG"
"6PHH",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION",,"0.1 M sodium cacodylate HCl, pH 6.5, 1.0 M sodium citrate tribasic",293,"10.1038/s41467-019-11980-6",,"6PHH",97.14,"2.4","2.4","Unliganded human transmission blocking antibody 2544","EVQLVESGGGLVQPGGSLRLSCVASGFTFSNYNMNWVRQAPGKGLEWLSYISSSSGTIYYADSVKGRFTISRDNAKNSMYLQMNSLRAEDTAVYYCVRVEYYYGSSGYYYDFDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"2544 Antibody Fab, Heavy Chain","1","6PHH"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEPASISCRSSQSLLHNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQTLQPFTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"2544 Antibody Fab, Light Chain","2","6PHH"
"6PHI",,"X-RAY DIFFRACTION",1.92,35.88,"VAPOR DIFFUSION, HANGING DROP",8,"2.5 M sodium chloride, 0.1 M imidazole, pH 8",293,,,"6PHI",3.56,"1.1","1.1","Crystal structure of native glucagon in space group I41 at 1.1 A resolution","HSQGTFTSDYSKYLDSRRAQDFVQWLMNT","Homo sapiens","GCG","Glucagon","1","6PHI"
"6PHJ",,"X-RAY DIFFRACTION",2.14,42.47,"VAPOR DIFFUSION, HANGING DROP",7,"1 M sodium/potassium tartrate, 0.2 M lithium sulfate, 0.1 M Tris, pH 7",293,,,"6PHJ",3.49,"1.99","1.99","Crystal structure of native glucagon in space group P213 at 1.99 A resolution","HSQGTFTSDYSKYLDSRRAQDFVQWLMNT","Homo sapiens","GCG","Glucagon","1","6PHJ"
"6PHK",,"X-RAY DIFFRACTION",1.79,31.38,"VAPOR DIFFUSION, HANGING DROP",6,"0.2 M lithium sulfate, 20% butanediol, 0.1 M MES, pH 6",293,,,"6PHK",3.49,"1.18","1.18","Crystal structure of glucagon analog with mono-stereoinversion at position 21 (D-Asp21) in space group I41 at 1.18 A resolution","HSQGTFTSDYSKYLDSRRAQDFVQWLMNT","Homo sapiens","GCG","Glucagon","1","6PHK"
"6PHL",,"X-RAY DIFFRACTION",2.19,43.74,"VAPOR DIFFUSION, HANGING DROP",5.5,"tri-sodium citrate, pH 5.5, 20% PEG3000",293,,,"6PHL",3.49,"1.443","1.443","Crystal structure of glucagon analog with mono-stereoinversion at position 23 (D-Val23) in space group I41 at 1.44 A resolution","HSQGTFTSDYSKYLDSRRAQDFVQWLMNT","Homo sapiens","GCG","Glucagon","1","6PHL"
"6PHM",,"X-RAY DIFFRACTION",1.71,33.52,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium sulfate, 20% PEG3350",293,,,"6PHM",3.58,"1.1","1.1","Crystal structure of glucagon analog fully composed of D-amino acids in space group I41 at 1.1 A resolution","HSQGTFTSDYSKYLDSRRAQDFVQWLMNT","Homo sapiens",,"D-glucagon","1","6PHM"
"6PHN",,"X-RAY DIFFRACTION",2.08,40.73,"VAPOR DIFFUSION, HANGING DROP",8,"2.5 M sodium chloride, 0.1 M imidazole, pH 8",293,,,"6PHN",3.51,"1.33","1.33","Crystal structure of glucagon analog composed of D-amino acids with mono-stereoinversion at position 23 (L-Val23) in space group I41 at 1.33 A resolution","HSQGTFTSDYSKYLDSRRAQDFVQWLMNT","Homo sapiens",,"D-glucagon L-Val23","1","6PHN"
"6PHO",,"X-RAY DIFFRACTION",1.8,31.78,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M tri-potassium citrate, 20% PEG3350",293,,,"6PHO",3.57,"1.42","1.42","Crystal structure of glucagon analog with selenomethionine substitutions at position 1 and 27 in space group I41 at 1.42 A resolution","MSQGTFTSDYSKYLDSRRAQDFVQWLMNT","Homo sapiens","GCG","Glucagon","1","6PHO"
"6PHP",,"X-RAY DIFFRACTION",1.82,32.27,"VAPOR DIFFUSION, HANGING DROP",,"Tacsimate, pH 4, 16% PEG3350, 0.1 M sodium acetate, pH 4.6",293,,,"6PHP",3.64,"1.65","1.65","Crystal structure of glucagon analog with 4-bromo-phenylalanine substitutions at position 6 and 22 in space group I41 at 1.65 A resolution","HSQGTYTSDYSKYLDSRRAQDYVQWLMNT","Homo sapiens","GCG","Glucagon","1","6PHP"
"6PHQ",,"X-RAY DIFFRACTION",2.02,35.41,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium chloride, 20% PEG3350",293,,,"6PHQ",3.29,"1.32","1.32","Crystal structure of glucagon analog fully composed of D-amino acids with 4-bromo-D-phenylalanine substitutions at position 6 and 22 in space group I41 at 1.1 A resolution","GTXTSDYSKYLDSRRAQDXVQWLMNT","Homo sapiens",,"D-glucagon D-BrPhe 6,22","1","6PHQ"
"6PHS",,"X-RAY DIFFRACTION",3.31,62.81,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470","VO4","6PHS",34.86,"2.129","2.129","Protein Tyrosine Phosphatase 1B (1-301), P185A mutant, vanadate bound state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVAESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6PHS"
"6PIM",,"X-RAY DIFFRACTION",3.38,63.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5, 20% PEG 4000, 0.6 M Sodium Chloride",277,"10.1038/s42003-019-0586-0",,"6PIM",26.63,"3.05","3.05","Crystal Structure of Human Protocadherin-1 EC3-4","MDTNDNAPKFERPSYEAELSENSPIGHSVIQVKANDSDQGANAEIEYTFHQAPEVVRRLLRLDRNTGLITVQGPVDREDLSTLRFSVLAKDRGTNPKSARAQVVVTVKDMNDNAPTIEIRGIGLVTHQDGMANISEDVAEETAVALVQVSDRDEGENAAVTCVVAGDVPFQLRQASETGSDSKKKYFLQTTTPLDYEKVKDYTIEIVAVDSGNPPLSSTNSLKVQVVDVNDNALEHHHHHH","Homo sapiens","PCDH1","Protocadherin-1","1","6PIM"
"6PJJ",,"X-RAY DIFFRACTION",2.59,52.46,"VAPOR DIFFUSION, SITTING DROP",,"0.1M HEPES pH 7.5, 0.1M Na/K phosphate, 15% PEG smear high, 10% etylene glycol",293,,,"6PJJ",166.74,"2.4","2.4","Human PRPF4B bound to benzothiophene inhibitor 224","SMDFKENPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARANQEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLLRHFYHKQHLCLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASHVADNDITPYLFSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQE","Homo sapiens","PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K","Serine/threonine-protein kinase PRP4 homolog","1","6PJJ"
"6PJV",,"X-RAY DIFFRACTION",3.64,66.21,"VAPOR DIFFUSION, HANGING DROP",7,"24% (w/v) polyethylene glycol 8000, 0.10 M TRIS pH 7.0, and 0.24 M MgCl2",277,"10.1107/S2059798319012890",,"6PJV",19.63,"1.43","1.43","Structure of Human Sonic Hedgehog in complex with Zinc and Magnesium","GFGKRRHPKKLTPLAYKQFIPNVAEKTLGASGRYEGKISRNSERFKELTPNYNPDIIFKDEENTGADRLMTQRCKDKLNALAISVMNQWPGVKLRVTEGWDEDGHHSEESLHYEGRAVDITTSDRDRSKYGMLARLAVEAGFDWVYYESKAHIHCSVKAENSVAAKSGG","Homo sapiens","SHH","Sonic hedgehog protein","1","6PJV"
"6PK4","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0352-5",,"6PK4",267,"3.5",,"cryoEM structure of the substrate-bound human CTP synthase 2 filament","MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS","Homo sapiens","CTPS2","CTP synthase 2","1","6PK4"
"6PK6",,"X-RAY DIFFRACTION",3.21,61.63,"VAPOR DIFFUSION, SITTING DROP",,"0.1M CAPSO pH 9.5, 20% PEG 8,000",293,,,"6PK6",41.45,"2.1","2.1","Human PRPF4B bound to benzothiophene inhibitor 329","SMDFKENPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARANQEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQE","Homo sapiens","PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K","Serine/threonine-protein kinase PRP4 homolog","1","6PK6"
"6PK7","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0352-5",,"6PK7",266.68,"3.1",,"cryoEM structure of the product-bound human CTP synthase 2 filament","MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS","Homo sapiens","CTPS2","CTP synthase 2","1","6PK7"
"6PK9",,"SOLUTION NMR",,,,,,,,,"6PK9",6.41,,,"Solution Structure of lncRNA (LINK-A) 20-nt Hexaloop Hairpin","GGAGGGUAGACUCGCUCUCC","Homo sapiens",,"RNA (5'-R(*GP*GP*AP*GP*GP*GP*UP*AP*GP*AP*CP*UP*CP*GP*CP*UP*CP*UP*CP*C)-3')","1","6PK9"
"6PKC",,"X-RAY DIFFRACTION",2.34,47.36,"VAPOR DIFFUSION, SITTING DROP",6,"14%(w/v) PEG3350
0.2M Potassium thiocyanate
0.1M MES pH=6.0
15%(v/v) Ethylene glycol",293,"10.1016/j.ccell.2019.11.001",,"6PKC",111,"1.9","1.9","Inhibition of Human Menin by VTP-50469","GSGLKTAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGEERPGEQSQGTQSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRITFQSEKMKGMKELLVATKINSSAIKLQLTAQS","Homo sapiens","MEN1, SCG2","Menin,Menin","1","6PKC"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
"6PKD",,"X-RAY DIFFRACTION",1.82,32.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 8000, MgCl2",289,"10.1107/S205979831901074X",,"6PKD",62.49,"1.9","1.9","Myocilin OLF mutant N428D/D478H","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVADAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIHYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","6PKD"
"6PKE",,"X-RAY DIFFRACTION",1.81,31.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 8000, MgCl2",289,"10.1107/S205979831901074X",,"6PKE",62.37,"1.88","1.88","Myocilin OLF mutant N428E/D478S","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVAEAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMISYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","6PKE"
"6PKF",,"X-RAY DIFFRACTION",1.91,35.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 3350, M Bis Tris pH 6, magnesium formate",289,"10.1107/S205979831901074X",,"6PKF",31.32,"1.484","1.484","Myocilin OLF mutant N428E/D478K","LKESPSGYLRSGEGDTGCGELVWVGEPLTLRTAETITGKYGVWMRDPKPTYPYTQETTWRIDTVGTDVRQVFEYDLISQFMQGYPSKVHILPRPLESTGAVVYSGSLYFQGAESRTVIRYELNTETVKAEKEIPGAGYHGQFPYSWGGYTDIDLAVDEAGLWVIYSTDEAKGAIVLSKLNPENLELEQTWETNIRKQSVAEAFIICGTLYTVSSYTSADATVNFAYDTGTGISKTLTIPFKNRYKYSSMIKYNPLEKKLFAWDNLNMVTYDIKLSKM","Homo sapiens","MYOC, GLC1A, TIGR","Myocilin","1","6PKF"
"6PL1",,"X-RAY DIFFRACTION",2.68,54.12,"VAPOR DIFFUSION, HANGING DROP",,"20mM Tris/HCl, pH=8.5, 50mM NaCl, 2mM DTT, 0.5mM PMSF",277.15,"10.1016/j.bmcl.2019.126680","OOJ","6PL1",35.92,"2.03","2.03","TRK-A IN COMPLEX WITH LIGAND 1B","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6PL1"
"6PL2",,"X-RAY DIFFRACTION",2.66,53.78,"VAPOR DIFFUSION, HANGING DROP",,"20mM Tris/HCl",277.15,"10.1016/j.bmcl.2019.126624",,"6PL2",35.88,"2.59","2.59","TRK-A IN COMPLEX WITH LIGAND 1a","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6PL2"
"6PL3",,"X-RAY DIFFRACTION",2.81,56.21,"VAPOR DIFFUSION, HANGING DROP",,"pH 8.5",277.15,"10.1016/j.bmcl.2019.126624",,"6PL3",35.79,"3","3","TRK-A IN COMPLEX WITH LIGAND 2a","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6PL3"
"6PL4",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, HANGING DROP",,"pH 8.5",277.15,,,"6PL4",35.91,"2.06","2.06","TRK-A IN COMPLEX WITH LIGAND 1","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6PL4"
"6PLF",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Bis-Tris pH 5.5 and a range of PEG 3350 (24% to 29%), using micro-seeding",297,"10.1016/j.bmcl.2019.07.011","ONV","6PLF",68.52,"1.7","1.7","Crystal structure of human PHGDH complexed with Compound 1","SMANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGV","Homo sapiens","PHGDH, PGDH3","D-3-phosphoglycerate dehydrogenase","1","6PLF"
"6PLG",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, SITTING DROP",7,"27% PEG mme 5000, 180 mM ammonium sulfate, 90 mM MES pH 6.5, 2% glycerol, and 20 mM DL-malic acid pH 7.0",297,"10.1016/j.bmcl.2019.07.011",,"6PLG",273.67,"2.93","2.93","Crystal structure of human PHGDH complexed with Compound 15","SMANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGV","Homo sapiens","PHGDH, PGDH3","D-3-phosphoglycerate dehydrogenase","1","6PLG"
"6PM8",,"X-RAY DIFFRACTION",3.38,63.66,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes,  0.2 M magnesium acetate and 15-20% polyethylene glycol 8000",277,"10.1021/jacs.9b04470","VO4","6PM8",34.95,"2.06","2.06","Protein Tyrosine Phosphatase 1B (1-301), P180A mutant, vanadate bound state","EMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWADFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6PM8"
"6PM9",,"X-RAY DIFFRACTION",3.12,60.61,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M K-Na-tartrate tetrahydrate, 20% (w/v) PEG 3350",293,"10.1021/acs.jmedchem.9b01090","OQ1","6PM9",250.69,"2.86","2.86","Crystal structure of the core catalytic domain of human O-GlcNAcase bound to MK-8719","GESELSSNPAASAGASLEPPAAPAPGEDNPAGAGGAAVAGAAGGARRFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSR","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase TIM-barrel domain","1","6PM9"
,,,,,,,,,,,,,,,,"MTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQPHHHHHHHH","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase stalk domain","2","6PM9"
"6PMA",,"X-RAY DIFFRACTION",2.69,54.26,"VAPOR DIFFUSION, HANGING DROP",,"0.10M KH2PO4/ 0.10M NaH2PO4/ 0.1M MES/NaOH pH = 6.00 and 1.9M NaCl (cryo: 25% glycerol in reservoir), or 18% (w/v) PEG 3350, 0.2M CaCl2, 0.10M, MES pH = 6.50 (cryo: direct).",277,"10.1039/c9md00554d",,"6PMA",35.91,"2.53","2.53","TRK-A IN COMPLEX WITH LIGAND","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6PMA"
"6PMB",,"X-RAY DIFFRACTION",2.7,54.5,"VAPOR DIFFUSION, HANGING DROP",,"0.10M KH2PO4/ 0.10M NaH2PO4/ 0.1M MES/NaOH pH = 6.00 and 1.9M NaCl (cryo: 25% glycerol in reservoir), or 18% (w/v) PEG 3350, 0.2M CaCl2, 0.10M, MES pH = 6.50 (cryo: direct)",277,"10.1039/c9md00554d",,"6PMB",35.78,"2.81","2.81","TRK-A IN COMPLEX WITH LIGAND 1a","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6PMB"
"6PMC",,"X-RAY DIFFRACTION",2.83,56.55,"VAPOR DIFFUSION, HANGING DROP",,"0.10M KH2PO4/ 0.10M NaH2PO4/ 0.1M MES/NaOH pH = 6.00 and 1.9M NaCl (cryo: 25% glycerol in reservoir), or 18% (w/v) PEG 3350, 0.2M CaCl2, 0.10M, MES pH = 6.50 (cryo: direct)",277,"10.1039/c9md00554d",,"6PMC",35.88,"2.19","2.19","TRK-A IN COMPLEX WITH LIGAND 1a","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6PMC"
"6PME",,"X-RAY DIFFRACTION",4.18,70.56,"VAPOR DIFFUSION, HANGING DROP",,"0.10M KH2PO4/ 0.10M NaH2PO4/ 0.1M MES/NaOH pH = 6.00 and 1.9M NaCl (cryo: 25% glycerol in reservoir), or 18% (w/v) PEG 3350, 0.2M CaCl2, 0.10M, MES pH = 6.50 (cryo: direct).",277,"10.1039/c9md00554d",,"6PME",108.16,"3","3","TRK-A IN COMPLEX WITH LIGAND","GLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6PME"
"6PMT",,"X-RAY DIFFRACTION",2.6,52.64,"VAPOR DIFFUSION, SITTING DROP",4.5,"100 mM sodium acetate, 20% (w/v) PEG 3000",298,,,"6PMT",42.05,"2.3","2.3","Structure of Mortalin-NBD with adenosine-5'-monophosphate and thiodiphosphate","GAMGSKGAVVGIDLGTTNSCVAVMEGKQAKVLENAEGARTTPSVVAFTADGERLVGMPAKRQAVTNPNNTFYATKRLIGRRYDDPEVQKDIKNVPFKIVRASNGDAWVEAHGKLYSPSQIGAFVLMKMKETAENYLGHTAKNAVITVPAYFNDSQRQATKDAGQISGLNVLRVINEPTAAALAYGLDKSEDKVIAVYDLGGGTFDISILEIQKGVFEVKSTNGDTFLGGEDFDQALLRHIVKEFKRETGVDLTKDNMALQRVREAAEKAKCELSSSVQTDINLPYLTMDSSGPKHLNMKLTRAQFEGIVTDLIRRTIAPCQKAMQDAEVSKSDIGEVILVGGMTRMPKVQQTVQDLFGRAPSKAVNPDEAVAIGAAIQGGVLAGD","Homo sapiens","HSPA9, GRP75, HSPA9B, mt-HSP70","Stress-70 protein, mitochondrial","1","6PMT"
"6PNA",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","M16","6PNA",100,"1.95","1.95","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(4-(2-Aminoethyl)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PNA"
"6PNB",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OSY","6PNB",100.06,"2.05","2.05","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(4-(Aminomethyl)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PNB"
"6PNC",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OUG","6PNC",99.88,"2.15","2.15","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(2-Aminoethyl)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PNC"
"6PND",,"X-RAY DIFFRACTION",2.74,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573",,"6PND",99.9,"2.4","2.4","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(2-Aminoethyl)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PND"
"6PNE",,"X-RAY DIFFRACTION",2.74,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573",,"6PNE",100.06,"2.1","2.1","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(5-(Aminomethyl)pyridin-3-yl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PNE"
"6PNF",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OSJ","6PNF",100.06,"2.1","2.1","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-ethoxyphenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PNF"
"6PNG",,"X-RAY DIFFRACTION",2.74,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OSG","6PNG",100.15,"1.775","1.775","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-propoxyphenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PNG"
"6PNH",,"X-RAY DIFFRACTION",2.74,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OSD","6PNH",100.15,"1.85","1.85","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-isopropoxyphenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PNH"
"6PNM",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION, HANGING DROP",,"1.7-2.2 M ammonium sulfate, 100 mM sodium citrate, 0.1 M sodium potassium tartrate, 0.75 mM zinc sulfate",277,"10.1021/acs.jmedchem.9b01391",,"6PNM",28.36,"1.82","1.82","Human GSTO1-1 complexed with 2-chloro-N-(4-chloro-3-(morpholinosulfonyl)phenyl)acetamide","SGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","6PNM"
"6PNN",,"X-RAY DIFFRACTION",2.41,48.97,"VAPOR DIFFUSION, HANGING DROP",,"1.7-2.2 M ammonium sulfate, 100 mM sodium citrate, 0.1 M sodium potassium tartrate, 0.75 mM zinc sulfate",277,"10.1021/acs.jmedchem.9b01391",,"6PNN",28.17,"2.1","2.1","Human GSTO1-1 complexed with 2-chloro-N-(4-chloro-3-(N-(2-methoxyethyl)-N-methylsulfamoyl)phenyl)acetamide","SGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","6PNN"
"6PNO",,"X-RAY DIFFRACTION",2.42,49.16,"VAPOR DIFFUSION, HANGING DROP",,"1.7-2.2 M ammonium sulfate, 100 mM sodium citrate, 0.1 M sodium potassium tartrate, 0.75 mM zinc sulfate",277,"10.1021/acs.jmedchem.9b01391",,"6PNO",28.23,"1.82","1.82","Human GSTO1-1 complexed with 2-chloro-N-(4-chloro-3-(N-isopropylsulfamoyl)phenyl)acetamide","SGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","6PNO"
"6PNX",,"X-RAY DIFFRACTION",2.57,56.68,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes, pH 7.5, and 1.8 M (NH4)2SO4",292,"10.1038/s41589-019-0455-7",,"6PNX",74.29,"2.199","2.199","Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction","MGSSHHHHHHSQDPTLANVSELELPADPKWELSRARLTLGKPLGEGAFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTSKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWMAPEALFDEVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDE","Homo sapiens","FGFR3, JTK4","Fibroblast growth factor receptor 3","1","6PNX"
"6PO5",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OUP","6PO5",100.32,"1.82","1.82","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-(cyclobutylmethoxy)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PO5"
"6PO7",,"X-RAY DIFFRACTION",2.75,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP

M",277,"10.1021/acs.jmedchem.9b01573","OU1","6PO7",100.29,"1.95","1.95","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-(cyclopropylmethoxy)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PO7"
"6PO8",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573",,"6PO8",100.14,"1.898","1.898","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 4-((4-(2-Amino-4-methylquinolin-7-yl)-2-(aminomethyl)phenoxy)methyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PO8"
"6PO9",,"X-RAY DIFFRACTION",2.74,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OS7","6PO9",100.37,"1.808","1.808","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-(pyridin-2-ylmethoxy)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6PO9"
"6POA",,"X-RAY DIFFRACTION",2.74,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OUS","6POA",100.46,"1.809","1.809","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-(pyridin-3-ylmethoxy)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6POA"
"6POB",,"X-RAY DIFFRACTION",2.75,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OUJ","6POB",100.38,"1.95","1.95","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-(thiazol-4-ylmethoxy)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6POB"
"6POC",,"X-RAY DIFFRACTION",2.75,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OU4","6POC",100.59,"1.998","1.998","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-(oxazol-4-ylmethoxy)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6POC"
"6POE","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0351-6",,"6POE",487.01,"3.5",,"Structure of ACLY in complex with CoA","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ATP-citrate synthase","1","6POE"
"6POF","4.3","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0351-6",,"6POF",483.94,"4.3",,"Structure of human ATP citrate lyase","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSM","Homo sapiens","ACLY","ATP-citrate synthase","1","6POF"
"6POJ",,"SOLID-STATE NMR",,,,,,,"10.1021/acs.jpcb.9b06430",,"6POJ",31.24,,,"STRUCTURAL REFINEMENT OF AQUAPORIN 1 VIA SSNMR","MASEFKKKLFWRAVVAEFLATTLFVFISIGSALGFKYPVGNNQTAVQDNVKVSLAFGLSIATLAQSVGHISGAHLNPAVTLGLLLSCQISIFRALMYIIAQCVGAIVATAILSGITSSLTGNSLGRNDLADGVNSGQGLGIEIIGTLQLVLCVLATTDRRRRDLGGSAPLAIGLSVALGHLLAIDYTGCGINPARSFGSAVITHNFSNHWIFWVGPFIGGALAVLIYDFILAPRSSDLTDRVKVWTSGQVEEYDLDADDINSRVEMKPKALEQKLISEEDLNSAVDHHHHHH","Homo sapiens","AQP1, CHIP28","Aquaporin-1","1","6POJ"
"6POK",,"X-RAY DIFFRACTION",2.64,53.47,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES, pH 7.5, 12% PEG 6,000",294,"10.1038/s41467-020-15211-1",,"6POK",22.59,"1.796","1.796","Crystal structure of the Robo3 FN2-3 domains","GQQGLAEVAVRLQEPIVLGPRTLQVSWTVDGPVQLVQGFRVSWRVAGPEGGSWTMLDLQSPSQQSTVLRGLPPGTQIQIKVQAQGQEGLGAESLSVTRSIPEEAPSGPPQGVAVALGGDGNSSITVSWEPPLPSQQNGVITEYQIWCLGNESRFHLNRSAAGWARSAMLRGLVPGLLYRTLVAAATSAGVGVPSAPVLVQLPSPPDLHHHHHH","Homo sapiens","ROBO3","Roundabout homolog 3","1","6POK"
"6POT",,"X-RAY DIFFRACTION",2.75,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OU7","6POT",100.38,"2.3","2.3","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-(3-(Aminomethyl)-4-(thiazol-5-ylmethoxy)phenyl)-4-methylquinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6POT"
"6POU",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","M16","6POU",308.9,"2.194","2.194","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(4-(2-Aminoethyl)phenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6POU"
"6POV",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OUG","6POV",205.98,"2.047","2.047","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(2-Aminoethyl)phenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6POV"
"6POW",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573",,"6POW",204.89,"2.15","2.15","Structure of human endotheial nitric oxide synthase heme domain in complex with 7-(5-(Aminomethyl)pyridin-3-yl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6POW"
"6POX",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OSJ","6POX",205.64,"2.197","2.197","Structure of human endothelialnitric oxide synthase heme domain in complex with 7-(3-(Aminomethyl)-4-ethoxyphenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6POX"
"6POY",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OSG","6POY",205.07,"2.3","2.3","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(Aminomethyl)-4-propoxyphenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6POY"
"6POZ",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OSD","6POZ",205.23,"2.2","2.2","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(Aminomethyl)-4-isopropoxyphenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6POZ"
"6PP0",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OUP","6PP0",205.59,"1.97","1.97","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(Aminomethyl)-4-(cyclobutylmethoxy)phenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6PP0"
"6PP1",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OU1","6PP1",205.72,"1.76","1.76","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(Aminomethyl)-4-(cyclopropylmethoxy)phenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6PP1"
"6PP2",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"0-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OUM","6PP2",205.46,"2.02","2.02","Structure of human endothelial nitric oxide synthase heme domain in complex with 4-((4-(2-Amino-4-methylquinolin-7-yl)-2-(aminomethyl)phenoxy)methyl)benzonitrile","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6PP2"
"6PP3",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OS7","6PP3",205.68,"1.95","1.95","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(Aminomethyl)-4-(pyridin-2-ylmethoxy)phenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6PP3"
"6PP4",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"10-12% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.9b01573","OUS","6PP4",204.9,"2.2","2.2","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-(3-(Aminomethyl)-4-(pyridin-3-ylmethoxy)phenyl)-4-methylquinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6PP4"
"6PPA",,"X-RAY DIFFRACTION",2.4,48.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"7.5 MG/ML BRD7, 25MM PHOSPHATE PH 6.9, 25MM AMMONIUM SULPHATE, 0.5MM DTT, 25MM BIS-TRIS PH6.5, 15% PENTAERYTHRYTOL ETHOXYLATE 15/4EO/OH",291,"10.1021/acs.jmedchem.9b01980",,"6PPA",14.61,"1.77","1.77","Crystal structure of the unliganded bromodomain of human BRD7","ESEVEQTPLQEALNQLMRQLQRKDPSAFFSFPVTDFIAPGYSMIIKHPMDFSTMKEKIKNNDYQSIEELKDNFKLMCTNAMIYNKPETIYYKAAKKLLHSGMKILSQERIQSLKQSIDFMADL","Homo sapiens","BRD7, BP75, CELTIX1","Bromodomain-containing protein 7","1","6PPA"
"6PQ3",,"X-RAY DIFFRACTION",2.02,39,"VAPOR DIFFUSION, SITTING DROP",,"200 mM lithium acetate and 2.2 M ammonium sulfate",293,"10.1074/jbc.RA119.011080",,"6PQ3",21.41,"1.75","1.75","Crystal structure of GDP-bound KRAS with ten residues long internal tandem duplication in the switch II region","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDQAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6PQ3"
"6PQ5",,"X-RAY DIFFRACTION",1.55,20.86,"VAPOR DIFFUSION, HANGING DROP",4,"35 mg/mL peptide in 1.92 M sodium malonate, pH 4.0",298,"10.1038/s41594-020-0403-y",,"6PQ5",1.07,"1.5","1.5","AGAAAA segment 113-118 from human prion","AGAAAA","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","6PQ5"
"6PQA",,"X-RAY DIFFRACTION",1.39,11.35,"VAPOR DIFFUSION, HANGING DROP",7,"10 mg/mL peptide in 2.4 M sodium malonate, pH 7.0",298,"10.1038/s41594-020-0403-y",,"6PQA",0.46,"1.46","1.46","GAVVGG segment 119-124 from human prion","GAVVGG","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","6PQA"
"6PQO","2.88","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.neuron.2019.11.023",,"6PQO",546.67,"2.88, 2.88",,"Cryo-EM structure of the human TRPA1 ion channel in complex with the covalent agonist JT010","MAKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIAEVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEPSNSLEVLFQGPAADYKDDDDKAHHHHHHHHHH","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6PQO"
"6PQP","3.06","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.neuron.2019.11.023",,"6PQP",545.68,"3.06, 3.06",,"Cryo-EM structure of the human TRPA1 ion channel in complex with the covalent agonist BITC","MAKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIAEVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEPSNSLEVLFQGPAADYKDDDDKAHHHHHHHHHH","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6PQP"
"6PQQ","2.81","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.neuron.2019.11.023",,"6PQQ",546.36,"2.81, 2.81",,"Cryo-EM structure of human TRPA1 C621S mutant in the apo state","MAKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELMEKITRDSSLEVLHEMDDYGNTPLHCAVEKNQIESVKFLLSRGANPNLRNFNMMAPLHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEHGYSRQLHINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGSVDIVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDNFGRNFLHLTVQQPYGLKNLRPEFMQMQQIKELVMDEDNDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYTQTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDECLKIFSHNSPGNKSPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALNAMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNSYLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFLLYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYLRNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIAEVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYPNKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISETEDDDSHCSFQDRFKKEQMEQRNSRWNTVLRAVKAKTHHLEPSNSLEVLFQGPAADYKDDDDKAHHHHHHHHHH","Homo sapiens","TRPA1, ANKTM1","Transient receptor potential cation channel subfamily A member 1","1","6PQQ"
"6PRT",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium nitrate, 35% PEG3350, 6% v/v ethylene glycol",277.15,"10.1016/j.bmc.2019.115157","OWA","6PRT",15.14,"1.3","1.3","Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 10 (methyl [(3R)-1-methyl-5-oxopyrrolidin-3-yl]acetate)","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6PRT"
"6PRX",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION",,"200 mM magnesium acetate tetrahydrate, 100 mM sodium cacodylate trihydrate pH6.5, 20% w/v polyethylene glycol 8,000",293,"10.1107/S2053230X19016480",,"6PRX",87.2,"3.25","3.25","oxidized Human Branched Chain Aminotransferase mutant C318A","MGGSHHHHHHGMASGSHMASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKTFTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRPWLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSLGVSQPRRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLVQQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQSLLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTACQVAPVHRILYKDRNLHIPTMENGPELILRFQKELKEIQYGIRAHEWMFPV","Homo sapiens","BCAT2, BCATM, BCT2, ECA40","Branched-chain-amino-acid aminotransferase, mitochondrial","1","6PRX"
"6PS9",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium nitrate, 35% PEG3350, 6% v/v ethylene glycol",277.15,"10.1016/j.bmc.2019.115157","Y17","6PS9",15.28,"1.21","1.21","Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 17 (5-{2-[(3R)-1-methyl-5-oxopyrrolidin-3-yl]ethyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one)","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6PS9"
"6PSB",,"X-RAY DIFFRACTION",2.16,43.17,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium nitrate, 35% PEG3350, 6% v/v ethylene glycol",277.15,"10.1016/j.bmc.2019.115157","Y18","6PSB",15.27,"1.59","1.59","Crystal structure of BRD4 bromodomain 1 with N-methylpyrrolidin-2-one (NMP) derivative 18 (5-{[(3R)-1-methyl-5-oxopyrrolidin-3-yl]methyl}-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one)","SNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6PSB"
"6PSJ",,"X-RAY DIFFRACTION",2.06,40.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, magnesium chloride",298,"10.7554/eLife.72512","29S","6PSJ",61.01,"1.8","1.8","Bazedoxifene in Complex with Y537S Estrogen Receptor Alpha Ligand Binding Domain","HHHHHHENLYFQSMALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLSDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6PSJ"
"6PT3",,"X-RAY DIFFRACTION",2.69,54.26,"LIPIDIC CUBIC PHASE",6,"32-35% PEG400, 100-110 mM potassium citrate tribasic monohydrate and 100 mM MES pH 6.0",293,"10.1126/sciadv.aax9115",,"6PT3",103.09,"3.3","3.3","Crystal structure of the active delta opioid receptor in complex with the small molecule agonist DPI-287","MKTIIALSYIFCLVFADYKDDDDAKLQTMHHHHHHHHHHENLYFQGGTTMADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLRSASSLALAIAITALYSAVCAVGLLGNVLVMFVIVRYTKMKTATNIYIFSLALAGALATSTLPFQSADYLMETWPFGELLCKAVLSIDYYSMFTSIFTLTMMCVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVVAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYINSSLNPVLYAFLDKNFKRCFRQLCRKPCG","Homo sapiens","OPRD1, OPRD","Delta opioid receptor","1","6PT3"
"6PU7",,"X-RAY DIFFRACTION",3.01,59.09,"VAPOR DIFFUSION",,"unavailable",293,"10.1021/acsmedchemlett.9b00344","OY4","6PU7",90.56,"2.43","2.43","Human IDO1 in complex with compound 17 (N-{2-[(4-{N-[(7S)-4-fluorobicyclo[4.2.0]octa-1,3,5-trien-7-yl]-N'-hydroxycarbamimidoyl}-1,2,5-oxadiazol-3-yl)sulfanyl]ethyl}acetamide)","MISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKE","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6PU7"
"6PUO","3.3","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.50175",,"6PUO",689.12,"3.3",,"Human TRPM2 in the apo state","GSGGRATMEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSKLSDAGKVVCQCGYTHEQHLEEATKPHTFQGTQWDPKKHVQEMPTDAFGDIVFTGLSQKVKKYVRVSQDTPSSVIYHLMTQHWGLDVPNLLISVTGGAKNFNMKPRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSYKEGELITIGVATWGTVHRREGLIHPTGSFPAEYILDEDGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTRLEKFISEQTKERGGVAIKIPIVCVVLEGGPGTLHTIDNATTNGTPCVVVEGSGRVADVIAQVANLPVSDITISLIQQKLSVFFQEMFETFTESRIVEWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFMDEWQWKPSDLHPTMTAALISNKPEFVKLFLENGVQLKEFVTWDTLLYLYENLDPSCLFHSKLQKVLVEDPERPACAPAAPRLQMHHVAQVLRELLGDFTQPLYPRPRHNDRLRLLLPVPHVKLNVQGVSLRSLYKRSSGHVTFTMDPIRDLLIWAIVQNRRELAGIIWAQSQDCIAAALACSKILKELSKEEEDTDSSEEMLALAEEYEHRAIGVFTECYRKDEERAQKLLTRVSEAWGKTTCLQLALEAKDMKFVSHGGIQAFLTKVWWGQLSVDNGLWRVTLCMLAFPLLLTGLISFREKRLQDVGTPAARARAFFTAPVVVFHLNILSYFAFLCLFAYVLMVDFQPVPSWCECAIYLWLFSLVCEEMRQLFYDPDECGLMKKAALYFSDFWNKLDVGAILLFVAGLTCRLIPATLYPGRVILSLDFILFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNERRVDWLFRGAVYHSYLTIFGQIPGYIDGVNFNPEHCSPNGTDPYKPKCPESDATQQRPAFPEWLTVLLLCLYLLFTNILLLNLLIAMFNYTFQQVQEHTDQIWKFQRHDLIEEYHGRPAAPPPFILLSHLQLFIKRVVLKTPAKRHKQLKNKLEKNEEAALLSWEIYLKENYLQNRQFQQKQRPEQKIEDISNKVDAMVDLLDLDPLKRSGSMEQRLASLEEQVAQTAQALHWIVRTLRASGFSSEADVPTLASQKAAEEPDAEPGGRKKTEEPGDSYHVNARHLLYPNCPVTRFPVPNEKVPWETEFLIYDPPFYTAERKDAAAMDPMGDTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPLNPMGRTGLRGRGSLSCFGPNHTLYPMVTRWRRNEDGAICRKSIKKMLEVLVVKLPLSEHWALPGGSREPGEMLPRKLKRILRQEHWPSFENLLKCGMEVYKGYMDDPRNTDNAWIETVAVSVHFQDQNDVELNRLNSNLHACDSGASIRWQVVDRRIPLYANHKTLLQKAAAEFGAHYFE","Homo sapiens","TRPM2, EREG1, KNP3, LTRPC2, TRPC7","Transient receptor potential cation channel subfamily M member 2","1","6PUO"
"6PUR","4.4","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.50175",,"6PUR",693.59,"4.4",,"Human TRPM2 bound to ADPR","GSGGRATMEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSKLSDAGKVVCQCGYTHEQHLEEATKPHTFQGTQWDPKKHVQEMPTDAFGDIVFTGLSQKVKKYVRVSQDTPSSVIYHLMTQHWGLDVPNLLISVTGGAKNFNMKPRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSYKEGELITIGVATWGTVHRREGLIHPTGSFPAEYILDEDGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTRLEKFISEQTKERGGVAIKIPIVCVVLEGGPGTLHTIDNATTNGTPCVVVEGSGRVADVIAQVANLPVSDITISLIQQKLSVFFQEMFETFTESRIVEWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFMDEWQWKPSDLHPTMTAALISNKPEFVKLFLENGVQLKEFVTWDTLLYLYENLDPSCLFHSKLQKVLVEDPERPACAPAAPRLQMHHVAQVLRELLGDFTQPLYPRPRHNDRLRLLLPVPHVKLNVQGVSLRSLYKRSSGHVTFTMDPIRDLLIWAIVQNRRELAGIIWAQSQDCIAAALACSKILKELSKEEEDTDSSEEMLALAEEYEHRAIGVFTECYRKDEERAQKLLTRVSEAWGKTTCLQLALEAKDMKFVSHGGIQAFLTKVWWGQLSVDNGLWRVTLCMLAFPLLLTGLISFREKRLQDVGTPAARARAFFTAPVVVFHLNILSYFAFLCLFAYVLMVDFQPVPSWCECAIYLWLFSLVCEEMRQLFYDPDECGLMKKAALYFSDFWNKLDVGAILLFVAGLTCRLIPATLYPGRVILSLDFILFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNERRVDWLFRGAVYHSYLTIFGQIPGYIDGVNFNPEHCSPNGTDPYKPKCPESDATQQRPAFPEWLTVLLLCLYLLFTNILLLNLLIAMFNYTFQQVQEHTDQIWKFQRHDLIEEYHGRPAAPPPFILLSHLQLFIKRVVLKTPAKRHKQLKNKLEKNEEAALLSWEIYLKENYLQNRQFQQKQRPEQKIEDISNKVDAMVDLLDLDPLKRSGSMEQRLASLEEQVAQTAQALHWIVRTLRASGFSSEADVPTLASQKAAEEPDAEPGGRKKTEEPGDSYHVNARHLLYPNCPVTRFPVPNEKVPWETEFLIYDPPFYTAERKDAAAMDPMGDTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPLNPMGRTGLRGRGSLSCFGPNHTLYPMVTRWRRNEDGAICRKSIKKMLEVLVVKLPLSEHWALPGGSREPGEMLPRKLKRILRQEHWPSFENLLKCGMEVYKGYMDDPRNTDNAWIETVAVSVHFQDQNDVELNRLNSNLHACDSGASIRWQVVDRRIPLYANHKTLLQKAAAEFGAHYFE","Homo sapiens","TRPM2, EREG1, KNP3, LTRPC2, TRPC7","Transient receptor potential cation channel subfamily M member 2","1","6PUR"
"6PUS","3.7","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.50175",,"6PUS",693.76,"3.7",,"Human TRPM2 bound to ADPR and calcium","GSGGRATMEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSKLSDAGKVVCQCGYTHEQHLEEATKPHTFQGTQWDPKKHVQEMPTDAFGDIVFTGLSQKVKKYVRVSQDTPSSVIYHLMTQHWGLDVPNLLISVTGGAKNFNMKPRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSYKEGELITIGVATWGTVHRREGLIHPTGSFPAEYILDEDGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTRLEKFISEQTKERGGVAIKIPIVCVVLEGGPGTLHTIDNATTNGTPCVVVEGSGRVADVIAQVANLPVSDITISLIQQKLSVFFQEMFETFTESRIVEWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFMDEWQWKPSDLHPTMTAALISNKPEFVKLFLENGVQLKEFVTWDTLLYLYENLDPSCLFHSKLQKVLVEDPERPACAPAAPRLQMHHVAQVLRELLGDFTQPLYPRPRHNDRLRLLLPVPHVKLNVQGVSLRSLYKRSSGHVTFTMDPIRDLLIWAIVQNRRELAGIIWAQSQDCIAAALACSKILKELSKEEEDTDSSEEMLALAEEYEHRAIGVFTECYRKDEERAQKLLTRVSEAWGKTTCLQLALEAKDMKFVSHGGIQAFLTKVWWGQLSVDNGLWRVTLCMLAFPLLLTGLISFREKRLQDVGTPAARARAFFTAPVVVFHLNILSYFAFLCLFAYVLMVDFQPVPSWCECAIYLWLFSLVCEEMRQLFYDPDECGLMKKAALYFSDFWNKLDVGAILLFVAGLTCRLIPATLYPGRVILSLDFILFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNERRVDWLFRGAVYHSYLTIFGQIPGYIDGVNFNPEHCSPNGTDPYKPKCPESDATQQRPAFPEWLTVLLLCLYLLFTNILLLNLLIAMFNYTFQQVQEHTDQIWKFQRHDLIEEYHGRPAAPPPFILLSHLQLFIKRVVLKTPAKRHKQLKNKLEKNEEAALLSWEIYLKENYLQNRQFQQKQRPEQKIEDISNKVDAMVDLLDLDPLKRSGSMEQRLASLEEQVAQTAQALHWIVRTLRASGFSSEADVPTLASQKAAEEPDAEPGGRKKTEEPGDSYHVNARHLLYPNCPVTRFPVPNEKVPWETEFLIYDPPFYTAERKDAAAMDPMGDTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPLNPMGRTGLRGRGSLSCFGPNHTLYPMVTRWRRNEDGAICRKSIKKMLEVLVVKLPLSEHWALPGGSREPGEMLPRKLKRILRQEHWPSFENLLKCGMEVYKGYMDDPRNTDNAWIETVAVSVHFQDQNDVELNRLNSNLHACDSGASIRWQVVDRRIPLYANHKTLLQKAAAEFGAHYFE","Homo sapiens","TRPM2, EREG1, KNP3, LTRPC2, TRPC7","Transient receptor potential cation channel subfamily M member 2","1","6PUS"
"6PUU","3.7","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.50175",,"6PUU",691.77,"3.7",,"Human TRPM2 bound to 8-Br-cADPR and calcium","GSGGRATMEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSKLSDAGKVVCQCGYTHEQHLEEATKPHTFQGTQWDPKKHVQEMPTDAFGDIVFTGLSQKVKKYVRVSQDTPSSVIYHLMTQHWGLDVPNLLISVTGGAKNFNMKPRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSYKEGELITIGVATWGTVHRREGLIHPTGSFPAEYILDEDGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTRLEKFISEQTKERGGVAIKIPIVCVVLEGGPGTLHTIDNATTNGTPCVVVEGSGRVADVIAQVANLPVSDITISLIQQKLSVFFQEMFETFTESRIVEWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFMDEWQWKPSDLHPTMTAALISNKPEFVKLFLENGVQLKEFVTWDTLLYLYENLDPSCLFHSKLQKVLVEDPERPACAPAAPRLQMHHVAQVLRELLGDFTQPLYPRPRHNDRLRLLLPVPHVKLNVQGVSLRSLYKRSSGHVTFTMDPIRDLLIWAIVQNRRELAGIIWAQSQDCIAAALACSKILKELSKEEEDTDSSEEMLALAEEYEHRAIGVFTECYRKDEERAQKLLTRVSEAWGKTTCLQLALEAKDMKFVSHGGIQAFLTKVWWGQLSVDNGLWRVTLCMLAFPLLLTGLISFREKRLQDVGTPAARARAFFTAPVVVFHLNILSYFAFLCLFAYVLMVDFQPVPSWCECAIYLWLFSLVCEEMRQLFYDPDECGLMKKAALYFSDFWNKLDVGAILLFVAGLTCRLIPATLYPGRVILSLDFILFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNERRVDWLFRGAVYHSYLTIFGQIPGYIDGVNFNPEHCSPNGTDPYKPKCPESDATQQRPAFPEWLTVLLLCLYLLFTNILLLNLLIAMFNYTFQQVQEHTDQIWKFQRHDLIEEYHGRPAAPPPFILLSHLQLFIKRVVLKTPAKRHKQLKNKLEKNEEAALLSWEIYLKENYLQNRQFQQKQRPEQKIEDISNKVDAMVDLLDLDPLKRSGSMEQRLASLEEQVAQTAQALHWIVRTLRASGFSSEADVPTLASQKAAEEPDAEPGGRKKTEEPGDSYHVNARHLLYPNCPVTRFPVPNEKVPWETEFLIYDPPFYTAERKDAAAMDPMGDTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPLNPMGRTGLRGRGSLSCFGPNHTLYPMVTRWRRNEDGAICRKSIKKMLEVLVVKLPLSEHWALPGGSREPGEMLPRKLKRILRQEHWPSFENLLKCGMEVYKGYMDDPRNTDNAWIETVAVSVHFQDQNDVELNRLNSNLHACDSGASIRWQVVDRRIPLYANHKTLLQKAAAEFGAHYFE","Homo sapiens","TRPM2, EREG1, KNP3, LTRPC2, TRPC7","Transient receptor potential cation channel subfamily M member 2","1","6PUU"
"6PUV",,"X-RAY DIFFRACTION",1.96,37.29,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 3000, 100mM Sodium citrate tribasic",291,"10.1021/acs.biochem.1c00009",,"6PUV",14.88,"1.2","1.2","Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin","SCPVNWVEHQDSCYWFSHSGMSWAEAEKYCQLKNAHLVVINSREEQNFVQKYLGSAYTWMGLSDPEGAWKWVDGTDYATGFQNWKPGQPDDWQGHGLGGGEDCAHFHPDGRWNDDVCQRPYHWVCEAGL","Homo sapiens","CLEC10A, CLECSF13, CLECSF14, HML","C-type lectin domain family 10 member A","1","6PUV"
"6PV0",,"SOLUTION NMR",,,,,,,"10.1002/pep2.24177",,"6PV0",3.8,,,"Backbone-modified variant of zinc finger 2 from the transcription factor Sp1 DNA binding domain: D-Pro in the metal-binding turn","RPFLCTWPGCGKRFTRSDELQRHKRTHTGEKX","Homo sapiens","SP1, TSFP1","Transcription factor Sp1","1","6PV0"
"6PV1",,"SOLUTION NMR",,,,,,,"10.1002/pep2.24177",,"6PV1",3.79,,,"Backbone-modified variant of zinc finger 2 from the transcription factor Sp1 DNA binding domain: Aib in the metal-binding turn","RPFLCTWAGCGKRFTRSDELQRHKRTHTGEKX","Homo sapiens","SP1, TSFP1","Transcription factor Sp1","1","6PV1"
"6PV2",,"SOLUTION NMR",,,,,,,"10.1002/pep2.24177",,"6PV2",3.76,,,"Backbone-modified variant of zinc finger 2 from the transcription factor Sp1 DNA binding domain: Orn in the metal-binding turn","RPFLCTWACGKRFTRSDELQRHKRTHTGEKX","Homo sapiens","SP1, TSFP1","Transcription factor Sp1","1","6PV2"
"6PV3",,"SOLUTION NMR",,,,,,,"10.1002/pep2.24177",,"6PV3",3.71,,,"Backbone-modified variant of zinc finger 2 from the transcription factor Sp1 DNA binding domain: altered helix, loop, turn, and sheet","PFXCTWAGCGKRFTRSDELQRHKRTHXGEKX","Homo sapiens","SP1, TSFP1","Transcription factor Sp1","1","6PV3"
"6PVE",,"X-RAY DIFFRACTION",2.42,49.22,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M bicine, pH 9.0, and 1.6 M ammonium sulfate",293,"10.1021/acs.jmedchem.9b01255","OZP","6PVE",127.98,"2.3","2.3","Structure of Nicotinamide N-Methyltransferase (NNMT) in complex with inhibitor LL319","MGSSHHHHHHSSGLVPRGSMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT, hCG_39357","NNMT protein","1","6PVE"
"6PVS",,"X-RAY DIFFRACTION",2.45,49.84,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M bicine, pH 9.0, and 1.6 M ammonium sulfate",293,"10.1021/acs.jmedchem.9b01255",,"6PVS",127.96,"2.575","2.575","Structure of Nicotinamide N-Methyltransferase (NNMT) in complex with inhibitor LL320","MGSSHHHHHHSSGLVPRGSMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT, hCG_39357","NNMT protein","1","6PVS"
"6PW3",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION",,"100 mM Hepes 7.5, 0.08 M NaCl,
36% PEG 3350",293,"10.1016/j.str.2019.10.006",,"6PW3",80.05,"2.34","2.34","LARP1 DM15 FYRE (F844Y, R847E) mutant bound to m7GpppG dinucleotide (capG)","GHSGGGGGGHMQHPSHELLKENGFTQHVYHKYRRRCLNERKRLGIGQSQEMNTLFRFWSYFLEDHFNKKMYEEFKQLALEDAKEGYRYGLECLFRYYSYGLEKKFRLDIFKDFQEETVKDYEAGQLYGLEKFWAFLKYSKAKNLDIDPKLQEYLGKFRRLED","Homo sapiens","LARP1, KIAA0731, LARP","La-related protein 1","1","6PW3"
"6PWZ",,"X-RAY DIFFRACTION",2.7,54.45,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris, pH 6.5, 25% pentaerythritol ethoxylate (15/4 EO/OH)",298,,,"6PWZ",229.2,"3","3","Crystal structure of human uridine-cytidine kinase 2 complexed with 2'-azidocytidine","MAGDSEQTLQNHQQPNGGEPFLIGVSGGTASGKSSVCAKIVQLLGQNEVDYRQKQVVILSQDSFYRVLTSEQKAKALKGQFNFDHPDAFDNELILKTLKEITEGKTVQIPVYDFVSHSRKEETVTVYPADVVLFEGILAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDISERGRDLEQILSQYITFVKPAFEEFCLPTKKYADVIIPRGADNLVAINLIVQHIQDILNGGPSKRQTNGCLNGYTPSRK","Homo sapiens","UCK2, UMPK","Uridine-cytidine kinase 2","1","6PWZ"
"6PX0",,"X-RAY DIFFRACTION",2.33,47.18,"VAPOR DIFFUSION, HANGING DROP",,"0.1  M Tris, 5-15 % PEG 8000
pH-7.5-8.5",291,"10.1074/jbc.RA119.010666",,"6PX0",19.21,"1.55","1.55","Crystal structure of the TPR domain of human aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1)","MGHHHHHHGNHEKMKAVPVLHGEGNRLFKLGRYEEASSKYQEAIICLRNLQTKEKPWEVQWLKLEKMINTLILNYCQCLLKKEEYYEVLEHTSDILRHHPGIVKAYYVRARAHAEVWNEAEAKADLQKVLELEPSMQKAVRRELRLLENRMAEKQ","Homo sapiens","AIPL1, AIPL2","Aryl-hydrocarbon-interacting protein-like 1","1","6PX0"
"6PX5",,"X-RAY DIFFRACTION",3.6,65.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"10 mM zinc sulfate, 100 mM MES, pH 6.5, 25% PEG 550 MME",293,"10.1038/s41598-019-48839-1",,"6PX5",47.75,"2.4","2.4","CRYSTAL STRUCTURE OF HUMAN MEIZOTHROMBIN DESF1 MUTANT S195A bound with PPACK","QCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","6PX5"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","6PX5"
"6PX9",,"X-RAY DIFFRACTION",2.78,55.74,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M imidazole, pH 8.0, 1.0 M sodium citrate",293,"10.1021/acschembio.0c00019",,"6PX9",187.59,"2.88","2.88","Crystal structure of procaspase-8 in complex with covalent small molecule inhibitor 63-R","SESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQFTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETASEEQPYLEMALSSPQTRYIPDEADFLLGMATVNNSVSYRNPAEGTWYIQSLCQSLRERSPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSDAAALEHHHHHH","Homo sapiens","CASP8, MCH5","Caspase-8","1","6PX9"
"6PXB",,"X-RAY DIFFRACTION",1.92,35.94,"VAPOR DIFFUSION, HANGING DROP",8,"21% PEG 10,000
0.1M Tris pH 8.0
0.2M Ammonium Acetate",293,"10.1371/journal.pone.0226113",,"6PXB",73.6,"1.747","1.747","N-Terminal SH2 domain of the p120RasGAP","GSTAPPTNQWYHGKLDRTIAEERLRQAGKSGSYLIRESDRRPGSFVLSFLSQMNVVNHFRIIAMSGDYYIGGRRFSSLSDLIGYYSHVSSLLKGEKLLYPVAPPEPVED","Homo sapiens","RASA1, GAP, RASA","Ras GTPase-activating protein 1","1","6PXB"
"6PXF",,"X-RAY DIFFRACTION",2.1,41.51,"VAPOR DIFFUSION",,"0.04 M Potassium phosphate monobasic, 16% w/v PEG8000, 20% v/v glycerol",295,,,"6PXF",25.01,"1.85","1.85","Structure of human Cathepsin K with an ectosteric inhibitor at 1.85 Angstrom resolution","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLAPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6PXF"
"6PXJ",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, HANGING DROP",,"200 mM Mg formate, 20% PEG 3350",295,"10.1038/s41598-019-54564-6",,"6PXJ",67.94,"1.7","1.7","Crystal structure of human thrombin mutant I16T","TVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","6PXJ"
,,,,,,,,,,,,,,,,"TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","6PXJ"
"6PXN",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",6,"0.3 M Ammonium sulfate
0.05 M Sodium Acetate
18% PEG 2000",295,"10.7554/eLife.52343",,"6PXN",95.19,"1.551","1.551","Human Casein Kinase 1 delta Tau mutant (R178C)","MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTACYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPVSGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6PXN"
"6PXO",,"X-RAY DIFFRACTION",2.24,45.05,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.15 M Succinic Acid
17% PEG 3350",295,"10.7554/eLife.52343",,"6PXO",68.41,"2","2","Human Casein Kinase 1 delta (anion-free crystallization conditions)","MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6PXO"
"6PXP",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION, HANGING DROP",6,"7.7 mg/mL Protein
0.05 M Sodium Acetate
0.35 M Ammonium Sulfate
17.5% PEG 3500",295,"10.7554/eLife.52343",,"6PXP",69.37,"2.35","2.35","Human Casein Kinase 1 delta Site 2 mutant (K171E)","MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENENLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6PXP"
"6PXQ",,"X-RAY DIFFRACTION",2.99,58.9,"VAPOR DIFFUSION, HANGING DROP",,"200 mM di-Na phosphate and 20% PEG 3350",295,"10.1038/s41598-019-54564-6",,"6PXQ",33.75,"2.8","2.8","Crystal structure of human thrombin mutant D194A","SGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","6PXQ"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGASGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","6PXQ"
"6PY1",,"X-RAY DIFFRACTION",2.92,57.91,"VAPOR DIFFUSION, SITTING DROP",7,"100mM Tris pH 6.0 - 7.0, 200mM Magnesium chloride, 2.0 - 2.8M sodium chloride",291,"10.1021/acs.biochem.1c00009",,"6PY1",15.68,"1.701","1.701","Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc","GTSCPVNWVEHQDSCYWFSHSGMSWAEAEKYCQLKNAHLVVINSREEQNFVQKYLGSAYTWMGLSDPEGAWKWVDGTDYATGFQNWKPGQPDDWQGHGLGGGEDCAHFHPDGRWNDDVCQRPYHWVCEAGLG","Homo sapiens","CLEC10A, CLECSF13, CLECSF14, HML","C-type lectin domain family 10 member A","1","6PY1"
"6PYA",,"X-RAY DIFFRACTION",2.58,52.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% Peg 3350, 0.2 M potassium thiocyanate, HEPES pH 7.5, 2.5 mM Calcium Chloride",295,"10.1074/jbc.RA119.011051","P57","6PYA",22.92,"1.71","1.71","Sex Hormone-binding globulin mutant E176K in complex with IPI","LRPVLPTQSAHDPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPALDGCLRRDSWLDKQAKISASAPTSLRSCDVESNPGIFLPPGTQAE","Homo sapiens","SHBG","Sex hormone-binding globulin","1","6PYA"
"6PYB",,"X-RAY DIFFRACTION",2.61,52.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 3350, Potassium thiocyanate",295,"10.1074/jbc.RA119.011051","P5G","6PYB",23,"1.8","1.8","Sex Hormone-binding globulin mutant E176K in complex with DVT","LRPVLPTQSAHDPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPALDGCLRRDSWLDKQAKISASAPTSLRSCDVESNPGIFLPPGTQAE","Homo sapiens","SHBG","Sex hormone-binding globulin","1","6PYB"
"6PYF",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 3350, potassium thiocyanate",295,"10.1074/jbc.RA119.011051","EST","6PYF",22.92,"1.73","1.73","Sex Hormone-binding globulin mutant E176K in complex with Estradiol","LRPVLPTQSAHDPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPALDGCLRRDSWLDKQAKISASAPTSLRSCDVESNPGIFLPPGTQAE","Homo sapiens","SHBG","Sex hormone-binding globulin","1","6PYF"
"6PYO",,"X-RAY DIFFRACTION",3.91,68.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M HEPES pH 7.5, 0.1 M CaCl2, 28% PEG 400",290,"10.1016/j.celrep.2019.12.059",,"6PYO",39.69,"2","2","Calcium Activated Chloride Channel Regulator 1 (CLCA1) VWA Domain","ETGIGQRIVCLVLDKSGSMATGNRLNRLNQAGQLFLLQTVELGSWVGMVTFDSAAHVQSELIQINSGSDRDTLAKRLPAAASGGTSICSGLRSAFTVIRKKYPTDGSEIVLLTDGEDNTISGCFNEVKQSGAIIHTVALGPSAAQELEELSKMTGGLQTYASDQVQNNGLIDAFGALSGTKHHHHHH","Homo sapiens","CLCA1, CACC1","cDNA FLJ56608, highly similar to Homo sapiens chloride channel, calcium activated, family member 1 (CLCA1), mRNA","1","6PYO"
"6PYP",,"X-RAY DIFFRACTION",2.07,40.68,"VAPOR DIFFUSION, HANGING DROP",7,"23% PEG 20000
175 mM KCl
0.1M Bis-Tris propane",287,"10.1021/acscatal.0c02757",,"6PYP",76.15,"1.95","1.95","Binary Complex of Human Glycerol 3-Phosphate Dehydrogenase, R269A mutant","MASKKVCIVGSGNWGSAIAKIVGGNAAQLAQFDPRVTMWVFEEDIGGKKLTEIINTQHENVKYLPGHKLPPNVVAVPDVVQAAEDADILIFVVPHQFIGKICDQLKGHLKANATGISLIKGVDEGPNGLKLISEVIGERLGIPMSVLMGANIASEVADEKFCETTIGCKDPAQGQLLKELMQTPNFRITVVQEVDTVEICGALKNVVAVGAGFCDGLGFGDNTKAAVIRLGLMEMIAFAKLFCSGPVSSATFLESCGVADLITTCYGGANRKVAEAFARTGKSIEQLEKELLNGQKLQGPETARELYSILQHKGLVDKFPLFMAVYKVCYEGQPVGEFIHCLQNHPEHM","Homo sapiens","GPD1","Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic","1","6PYP"
"6PYS",,"X-RAY DIFFRACTION",2.61,52.87,"VAPOR DIFFUSION",,"not available",293,"10.1016/j.bmcl.2019.08.004",,"6PYS",110.61,"2.19","2.19","Human PI3Kalpha in complex with Compound 2-10 ((3S)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2H-indol-2-one)","NREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGW","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","6PYS"
"6PYX",,"X-RAY DIFFRACTION",3.99,69.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M HEPES pH 7.5, 0.1 M CaCl2, 28% PEG 400",290,"10.1016/j.celrep.2019.12.059",,"6PYX",39.69,"2.6","2.6","Calcium Activated Chloride Channel Regulator 1 (CLCA1) VWA Domain","ETGIGQRIVCLVLDKSGSMATGNRLNRLNQAGQLFLLQTVELGSWVGMVTFDSAAHVQSELIQINSGSDRDTLAKRLPAAASGGTSICSGLRSAFTVIRKKYPTDGSEIVLLTDGEDNTISGCFNEVKQSGAIIHTVALGPSAAQELEELSKMTGGLQTYASDQVQNNGLIDAFGALSGTKHHHHHH","Homo sapiens","CLCA1, CACC1","cDNA FLJ56608, highly similar to Homo sapiens chloride channel, calcium activated, family member 1 (CLCA1), mRNA","1","6PYX"
"6PYY",,"X-RAY DIFFRACTION",2.7,54.4,"MICROBATCH",,"50 mM Sodium Citrate (pH 5.6), 
2% Tacsimate (pH 5.0)
5% PEG 3350",298,"10.1021/jacs.9b08871","H7S","6PYY",185.05,"2.4","2.4","Crystal Structure of human Tryptophan 2,3-dioxygenase in complex with PF-06840003 in Active Site and Exo site","MLPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEKVLNAQELQSETKGNKIHDEHLFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSVILKLLVQQFSILETMTALDFNDFREYLSPASGFQSLQFRLLENKIGVLQNMRVPYNRRHYRDNFKGEENELLLKSEQEKTLLELVEAWLERTPGLEPHGFNFWGKLEKNITRGLEEEFIRIQAKEESEEKEEQVAEFQKQKEVLLSLFDEKRHEHLLSKGERRLSYRALQGALMIYFYREEPRFQVPFQLLTSLMDIDSLMTKWRYNHVCMVHRMLGSKAGTGGSSGYHYLRSTVSDRYKVFVDLFNLSTYLIPRHWIPKMNPTIHKFLEHHHHHH","Homo sapiens","TDO2, TDO","Tryptophan 2,3-dioxygenase","1","6PYY"
"6PYZ",,"X-RAY DIFFRACTION",2.96,58.48,"MICROBATCH",,"50 mM Sodium Citrate (pH 5.6), 
2% Tacsimate (pH 5.0)
5% PEG 3350",298,"10.1021/jacs.9b08871","H7S","6PYZ",185,"2.02","2.02","Crystal Structure of human Tryptophan 2,3-dioxygenase in complex with PF-06840003 in Active Site","MLPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEKVLNAQELQSETKGNKIHDEHLFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSVILKLLVQQFSILETMTALDFNDFREYLSPASGFQSLQFRLLENKIGVLQNMRVPYNRRHYRDNFKGEENELLLKSEQEKTLLELVEAWLERTPGLEPHGFNFWGKLEKNITRGLEEEFIRIQAKEESEEKEEQVAEFQKQKEVLLSLFDEKRHEHLLSKGERRLSYRALQGALMIYFYREEPRFQVPFQLLTSLMDIDSLMTKWRYNHVCMVHRMLGSKAGTGGSSGYHYLRSTVSDRYKVFVDLFNLSTYLIPRHWIPKMNPTIHKFLEHHHHHH","Homo sapiens","TDO2, TDO","Tryptophan 2,3-dioxygenase","1","6PYZ"
"6PZ1",,"X-RAY DIFFRACTION",2.95,58.3,"MICROBATCH",10,"100 mM Sodium thiosulfate, 100 mM CAPS buffer pH 10.0, and 20% (w/v) PEG 8000",277,"10.1021/jacs.9b08871","AOJ","6PZ1",97.97,"2.65","2.65","Crystal Structure of human Indoleamine 2,3-Dioxygenase 1 in complex with PF-06840003 in Active Site and Si site","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6PZ1"
"6PZ4",,"X-RAY DIFFRACTION",3.05,59.63,"VAPOR DIFFUSION, HANGING DROP",6.6,"21% PEG 5000 MME, 190 mM Na citrate (pH 6.6), 190 mM ammonium iodide, 3% (v/v) DMSO",298,"10.1021/acs.jmedchem.9b01034","P6J","6PZ4",46.92,"1.85","1.85","co-crystal structure of BACE with inhibitor AM-6494","LPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6PZ4"
"6PZG",,"X-RAY DIFFRACTION",2.54,51.67,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1 M sodium citrate, pH 5.6, 40% PEG600",293,"10.1016/j.chom.2019.10.002",,"6PZG",48.14,"1.59","1.59","Crystal structure of human NA-80 Fab","DDIVMTQSPSSLSASVGDRVTISCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSASGTDFTLTISSLQPEDFATYYCQQSYSAPFTFGPGTKVDIERTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"NA-80 Fab light chain","1","6PZG"
,,,,,,,,,,,,,,,,"DQVQLVQSGAEVKRPGASVKVSCKASGYTFISYGISWVRQAPGQGLEWMGWISAYNGNTNYAQNLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARVIPGTAVDYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"NA-80 Fab heavy chain","2","6PZG"
"6PZH",,"X-RAY DIFFRACTION",2.49,50.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, pH 8.5, 40% ethanol, 0.02% magnium chloride",293,"10.1016/j.chom.2019.10.002",,"6PZH",96.42,"2.3","2.3","Crystal structure of human NA-22 Fab","DQSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWHQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQTEDEADYYCSSYTSSTTNVFGTGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"NA-22 Fab light chain","1","6PZH"
,,,,,,,,,,,,,,,,"DQVQLVESGGGVVQPGRSLRLSCAASGFTFNNYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDKRFITMILVGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"NA-22 Fab heavy chain","2","6PZH"
"6PZP",,"X-RAY DIFFRACTION",2.76,55.42,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M sodium formate, 20% w/v PEG3350",277,,,"6PZP",30.61,"1.94","1.94","Crystal structure of caspase-1 in complex with VX-765","AIKKAHIEKDFIAFCSSTPDNVSWRHPTMGSVFIGRLIEHMQEYACSCDVEEIFRKVRFSFEQPDGRAQMPTTERVTLTRCFYLFPGH","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","2","6PZP"
,,,,,,,,,,,,,,,,"NPAMPTSSGSEGNVKLCSLEEAQRIWKQKSAEIYPIMDKSSRTRLALIICNEEFDSIPRRTGAEVDITGMTMLLQNLGYSVDVKKNLTASDMTTELEAFAHRPEHKTSDSTFLVFMSHGIREGICGKKHSEQVPDILQLNAIFNMLNTKNCPSLKDKPKVIIIQACRGDSPGVVWFKD","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","1","6PZP"
"6PZT","3.46","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-020-14790-3",,"6PZT",263.34,"3.46",,"cryo-EM structure of human NKCC1","MEPRPTAPSSGAPGLAGVGETPSAAALAAARVELPGTAVPSVPEDAAPASRDGGGVRDEGPAAAGDGLGRPLGPTPSQSRFQVDLVSENAGRAAAAAAAAAAAAAAAGAGAGAKQTPADGEASGESEPAKGSEEAKGRFRVNFVDPAASSSAEDSLSDAAGVGVDGPNVSFQNGGDTVLSEGSSLHSGGGGGSGHHQHYYYDTHTNTYYLRTFGHNTMDAVPRIDHYRHTAAQLGEKLLRPSLAELHDELEKEPFEDGFANGEESTPTRDAVVTYTAESKGVVKFGWINGVLVRCMLNIWGVMLFIRLSWIVGQAGIGLSVLVIMMATVVTTITGLSTSAIATNGFVRGGRAYYLISRSLGPEFGGAIGLIFAFANAVAVAMYVVGFAETVVELLKEHSILMIDEINDIRIIGAITVVILLGISVAGMEWEAKAQIVLLVILLLAIGDFVIGTFIPLESKKPKGFFGYKSEIFNENFGPDFREEETFFSVFAIFFPAATGILAGANISGDLADPQSAIPKGTLLAILITTLVYVGIAVSVGSCVVRDATGNVNDTIVTELTNCTSAACKLNFDFSSCESSPCSYGLMNNFQVMSMVSGFTPLISAGIFSATLSSALASLVSAPKIFQALCKDNIYPAFQMFAKGYGKNNEPLRGYILTFLIALGFILIAELNVIAPIISNFFLASYALINFSVFHASLAKSPGWRPAFKYYNMWISLLGAILCCIVMFVINWWAALLTYVIVLGLYIYVTYKKPDVNWGSSTQALTYLNALQHSIRLSGVEDHVKNFRPQCLVMTGAPNSRPALLHLVHDFTKNVGLMICGHVHMGPRRQAMKEMSIDQAKYQRWLIKNKMKAFYAPVHADDLREGAQYLMQAAGLGRMKPNTLVLGFKKDWLQADMRDVDMYINLFHDAFDIQYGVVVIRLKEGLDISHLQGQEELLSSQEKSPGTKDVVVSVEYSKKSDLDTSKPLSEKPITHKVEEEDGKTATQPLLKKESKGPIVPLNVADQKLLEASTQFQKKQGKNTIDVWWLFDDGGLTLLIPYLLTTKKKWKDCKIRVFIGGKINRIDHDRRAMATLLSKFRIDFSDIMVLGDINTKPKKENIIAFEEIIEPYRLHEDDKEQDIADKMKEDEPWRITDNELELYKTKTYRQIRLNELLKEHSSTANIIVMSLPVARKGAVSSALYMAWLEALSKDLPPILLVRGNHQSVLTFYS","Homo sapiens","SLC12A2, NKCC1","Solute carrier family 12 member 2","1","6PZT"
"6Q0D",,"X-RAY DIFFRACTION",2.8,56.01,"VAPOR DIFFUSION, SITTING DROP",4.2,"5% (W/V) PEG 1000, 100 MM SODIUM PHOSPHATE DIBASIC/CITRIC ACID (PH 4.2) 40% (V/V) REAGENT",289,"10.1021/acs.jmedchem.0c00916","P8M","6Q0D",229.26,"2.05","2.05","CRYSTAL STRUCTURE OF LDHA IN COMPLEX WITH COMPOUND NCGC00384414-01 AT 2.05 A RESOLUTION","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6Q0D"
"6Q0Q",,"X-RAY DIFFRACTION",2.06,40.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"31% PEG 3100, 100 mM tris-HCl pH 7.5, 100 mM MgCl2, 8 mM 2-Mercaptoethanol",297,"10.1111/cbdd.13683","P8G","6Q0Q",16.47,"1.98601176315","1.98601176315","Crystal structure of Human galectin-3 CRD in complex with Methyl 3-O-(1-{3-O-[1-(b-D-galactopyranosyl)-1,2,3-triazol-4-yl]-methyl-b-D-galactopyranosyl}-1,2,3-triazol-4-yl)-methyl-b-D-galactopyranoside","GPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6Q0Q"
"6Q13",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, SITTING DROP",8,"10% (W/V) PEG 8000, 100 MM IMIDAZOLE (PH 8.0); 25% EG CRYOPROTECTANT",289,"10.1021/acs.jmedchem.0c00916","P8V","6Q13",153,"2","2","CRYSTAL STRUCTURE OF LDHA IN COMPLEX WITH COMPOUND NCGC00420737-09 AT 2.00 A RESOLUTION","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6Q13"
"6Q17",,"X-RAY DIFFRACTION",2.02,39.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"31% PEG 3100, 100 mM tris-HCl pH 7.5, 100 mM MgCl2, 8 mM 2-Mercaptoethanol",297,"10.1111/cbdd.13683","P8J","6Q17",16.27,"1.98","1.98","Crystal structure of Human galectin-3 CRD in complex with Methyl 3-O-[1-(b-D-galactopyranosyl)-1,2,3-triazol-4-yl]-methyl-b-D-galactopyranoside","GPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6Q17"
"6Q19",,"X-RAY DIFFRACTION",2.14,42.62,"VAPOR DIFFUSION, HANGING DROP",7,"1M sodium chloride, 30% (w/v) PEG 8000, 100 mM HEPES pH7.0",291.15,"10.1073/pnas.1915620116",,"6Q19",48.66,"1.58","1.58","Inferred intermediate (I-6) of the human antibody lineage 652","ASSSELTQDPAVSVALGQTVRITCQGDSLRGYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHPVVFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab lambda chain","1","6Q19"
,,,,,,,,,,,,,,,,"QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEISHGGYTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARAPPYCTSASCPDDYYYYYMDVWGKGTTVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"Fab heavy chain","2","6Q19"
"6Q1A",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, HANGING DROP",6,"200 mM zinc acetate, 10% (w/v) PEG 8000 100 mM MES pH 6.0",291.15,"10.1073/pnas.1915620116",,"6Q1A",49.07,"2.001","2.001","Inferred intermediate mutant (I-6V) of the human antibody lineage 652","ASSSELTQDPAVSVALGQTVRITCQGDSLRGYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHPVVFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab lambda chain","1","6Q1A"
,,,,,,,,,,,,,,,,"QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEISHGVYTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARAPPYCTSASCPDDYYYYYMDVWGKGTTVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"Fab heavy chain","2","6Q1A"
"6Q1E",,"X-RAY DIFFRACTION",2.37,48.16,"VAPOR DIFFUSION, HANGING DROP",5,"5% (v/v) PEG 400, 1.4M sodium citrate pH 5.0",291.15,"10.1073/pnas.1915620116",,"6Q1E",48.9,"2.5","2.5","Inferred precursor (UCA) of the human antibody lineage 652","ASQVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARAPPYCSSTSCPDDYYYYYMDVWGKGTTVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"Fab heavy chain","2","6Q1E"
,,,,,,,,,,,,,,,,"ASSSELTQDPAVSVALGQTVRITCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHPVVFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab lambda chain","1","6Q1E"
"6Q1G",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION, HANGING DROP",,"100mM Potassium thiocyanate, 30% (w/v) PEG 2000 MME",291.15,"10.1073/pnas.1915620116",,"6Q1G",49.22,"1.75","1.75","Human antibody H1244 of the human antibody lineage 652","ASSSELTQDPAVSVALGQTVRITCQGDSLRGYSASWYQLKPGQAPVLVIYGKNNRPSGIPDRFSGSTSGNRASLIITGTQAEDEADYYCNSRDTNGYRPVLFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"H1244 Fab lambda chain","1","6Q1G"
,,,,,,,,,,,,,,,,"ASQVQLQESGPGLVKPSGTLSLTCAISGGSISSSNWWTWVRQPPGKGLQWIGEIQHGGGTNYNPSLKSRATIFVDVSKNHFSLRLSSVTAADTAVYYCAKVPPYCTSASCPDDYYYHYMDVWGKGTTVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"H1244 Fab heavy chain","2","6Q1G"
"6Q1J",,"X-RAY DIFFRACTION",2.93,58.01,"VAPOR DIFFUSION, HANGING DROP",4,"100mM ammonium sulfate, 40% (v/v) PEG 400, 100mM sodium citrate pH 4.0",291.15,"10.1073/pnas.1915620116",,"6Q1J",48.45,"2.703","2.703","Antibody H2227 from the human antibody lineage 652","QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSQWWSWVRQPPGKGLEWIGEISHGVYTNYNPSLKSRVTISADKSQNQFSLNLSSVTAADTAVYYCARAPPYCSSASCPDDYYYFFLDVWGKGTTVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"Fab heavy chain","1","6Q1J"
,,,,,,,,,,,,,,,,"SSELTQDPAVSVALGQTVRITCQGDSLRGYYASWHQQKPGQAPVLVIYGKNNRPSGIPDRFSGSRSGNTASLTITGAQAEDEADYYCASRDSSGNHPVVFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab lambda light chain","2","6Q1J"
"6Q1K",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, HANGING DROP",8.5,"200mM sodium acetate, 30% (w/v) PEG 400, 100mM Tris-HCl pH 8.5",291.15,"10.1073/pnas.1915620116",,"6Q1K",48.75,"2.2","2.2","Inferred intermediate I-7 of the human antibody lineage 652","ASSSELTQDPAVSVALGQTVRITCQGDSLRGYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCNSRDSSGNHPVVFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab lambda light chain","2","6Q1K"
,,,,,,,,,,,,,,,,"QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHGGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARAPPYCTSASCPDDYYYYYMDVWGKGTTVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"Fab heavy chain","1","6Q1K"
"6Q1N",,"X-RAY DIFFRACTION",3.27,62.36,"VAPOR DIFFUSION, HANGING DROP",,"1.5 M (NH4)2SO4, 0.1 M Bis Tris (pH 4.9) containing 0.1 M CsCl",291.15,,,"6Q1N",116.14,"2.526","2.526","Glucocerebrosidase in complex with pharmacological chaperone IMX8","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6Q1N"
"6Q1P",,"X-RAY DIFFRACTION",3.27,62.42,"VAPOR DIFFUSION, HANGING DROP",,"1.5 M (NH4)2SO4, 0.1 M Bis Tris (pH 4.9) containing 0.1 M CsCl",291.15,,,"6Q1P",116.06,"2.796","2.796","Glucocerebrosidase in complex with pharmacological chaperone norIMX8","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6Q1P"
"6Q21",,"X-RAY DIFFRACTION",2.42,49.27,,,,,"10.1126/science.2406906",,"6Q21",80.25,"1.95","1.95","MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS OF PROTOONCOGENIC RAS PROTEINS","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKL","Homo sapiens","HRAS, HRAS1","C-H-RAS P21 PROTEIN CATALYTIC DOMAIN","1","6Q21"
"6Q2I",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkaa689",,"6Q2I",12.1,,,"Solution state NMR structures of the RNA recognition motif (RRM) domain of human CstF-64","GGSMAGLTVRDPAVDRSLRSVFVGNIPYEATEEQLKDIFSEVGPVVSFRLVYDRETGKPKGYGFCEYQDQETALSAMRNLNGREFSGRALRVDNAASEKNKEELKSLGTG","Homo sapiens","CSTF2","Cleavage stimulation factor subunit 2","1","6Q2I"
"6Q2T",,"X-RAY DIFFRACTION",2.68,54.02,"VAPOR DIFFUSION, HANGING DROP",7.4,"15 mM sodium cholate, 8% PEG3350, 0.2 M potassium formate, pH 7.4",289,"10.1021/acs.jmedchem.9b01485",,"6Q2T",108.51,"2.8","2.8","Human sterol 14a-demethylase (CYP51) in complex with the functionally irreversible inhibitor (R)-N-(1-(3-chloro-4'-fluoro-[1,1'-biphenyl]-4-yl)-2-(1H-imidazol-1-yl)ethyl)-4-(5-(3-fluoro-5-(5-fluoropyrimidin-4-yl)phenyl)-1,3,4-oxadiazol-2-yl)benzamide","GKLPPYIFSPIPFLGHAIAFGKSPIEFLENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSIIEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRRRDRAHREIKDIFYKAIQKRRQSQEKIDDILQTLLDATYKDGRPLTDDEVAGMLIGLLLAGQHTSSTTSAWMGFFLARDKTLQKKCYLEQKTVCGENLPPLTYDQLKDLNLLDRCIKETLRLRPPIMIMMRMARTPQTVAGYTIPPGHQVCVSPTVNQRLKDSWVERLDFNPDRYLQDNPASGEKFAYVPFGAGRHRCIGENFAYVQIKTIWSTMLRLYEFDLIDGYFPTVNYTTMIHTPENPVIRYKRRSK","Homo sapiens","CYP51A1, CYP51","Lanosterol 14-alpha demethylase","1","6Q2T"
"6Q2V",,"X-RAY DIFFRACTION",2.22,44.67,"VAPOR DIFFUSION, SITTING DROP",,"containing 0.2 M MgCl2, 0.1M Bis-Tris pH 5.5, 25%PEG 3350",295,,,"6Q2V",147.37,"2.594","2.594","Crystal structure of SPOC domain of human PHD-finger protein 3 (PHF3)","GAMGSTFLARLNFIWKGFINMPSVAKFVTKAYPVSGSPEYLTEDLPDSIQVGGRISPQTVWDYVEKIKASGTKEICVVRFTPVTEEDQISYTLLFAYFSSRKRYGVAANNMKQVKDMYLIPLGATDKIPHPLVPFDGPGLELHRPNLLLGLIIRQKLKRQHS","Homo sapiens","PHF3, KIAA0244","PHD finger protein 3","1","6Q2V"
"6Q2W",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MgCl2, 0.1M Mes pH 6, 8% w/v PEG 6000",277,"10.1016/j.bmcl.2019.05.015",,"6Q2W",52.97,"1.99","1.99","Crystal structure of human ROR gamma LBD in complex with a quinoline sulfonamide inverse agonist","LTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQ","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6Q2W"
"6Q37",,"X-RAY DIFFRACTION",3.27,62.42,"VAPOR DIFFUSION, HANGING DROP",7,"CRYSTALS IN CONDITION H3 FROM SILVER BULLET SCREEN (HAMPTON RESEARCH) USING TACSIMATE",293,"10.1021/acs.jmedchem.9b00931","HE8","6Q37",101.38,"2.211","2.211","Complex of Arginase 2 with Example 23","HSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREG","Homo sapiens","ARG2","Arginase-2, mitochondrial","1","6Q37"
"6Q39",,"X-RAY DIFFRACTION",3.27,62.42,"VAPOR DIFFUSION, HANGING DROP",7,"CRYSTALS IN CONDITION H3 FROM SILVER BULLET SCREEN (HAMPTON RESEARCH) USING TACSIMATE IN THE",293,"10.1021/acs.jmedchem.9b00931","HDQ","6Q39",101.61,"2.213","2.213","Complex of Arginase 2 with Example 49","HSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREG","Homo sapiens","ARG2","Arginase-2, mitochondrial","1","6Q39"
"6Q3B",,"X-RAY DIFFRACTION",2.15,42.69,"VAPOR DIFFUSION, SITTING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM     
 HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q3B",35.15,"1.11","1.11","CDK2 in complex with FragLite2","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q3B"
"6Q3C",,"X-RAY DIFFRACTION",1.97,37.5,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM        HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5.",293,"10.1021/acs.jmedchem.9b00304",,"6Q3C",35.1,"1.29","1.29","CDK2 in complex with FragLite1","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q3C"
"6Q3F",,"X-RAY DIFFRACTION",1.97,37.51,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM      HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5.",293,"10.1021/acs.jmedchem.9b00304",,"6Q3F",34.98,"1.18","1.18","CDK2 in complex with FragLite2","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q3F"
"6Q3M",,"X-RAY DIFFRACTION",3.53,65.12,"VAPOR DIFFUSION",,"0.12M Diethyleneglycol,
0.12M Triethylene-glycol, 
0.12M Tetraethyleneglycol, 
0.12M Pentaethyleneglycol,
20% v/v Ethylene glycol, 
10 % w/v PEG 8000,
Sodium HEPES, MOPS pH = 7.5",277,,,"6Q3M",116.28,"2.52","2.52","Structure of CHD4 PHD2 - tandem chromodomains","GPEDDHHMEFCRVCKDGGELLCCDTCPSSYHIHCLNPPLPEIPNGEWLCPRCTCPALKGKVQKILIWKWGQPPSPTPVPRPPDADPNTPSPKPLEGRPERQFFVKWQGMSYWHCSWVSELQLELHCQVMFRNYQRKNDMDEPPSGDFGGDEEKSRKRKNKDPKFAEMEERFYRYGIKPEWMMIHRILNHSVDKKGHVHYLIKWRDLPYDQASWESEDVEIQDYDLFKQSYWNHRELMR","Homo sapiens","CHD4","Chromodomain-helicase-DNA-binding protein 4","1","6Q3M"
"6Q3O",,"X-RAY DIFFRACTION",2.75,55.46,"VAPOR DIFFUSION, HANGING DROP",6.5,"Zn acetate 0.2 M, Na cacodylate 0.1 M, PEG 8000 18%, NaN3 3mM",293,,,"6Q3O",124.38,"2.23","2.23","PROTEIN-AROMATIC FOLDAMER COMPLEX CRYSTAL STRUCTURE","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6Q3O"
"6Q3P",,"X-RAY DIFFRACTION",1.96,37.38,"VAPOR DIFFUSION, SITTING DROP",7.8,"19% PEG monomethyl ether 2K, 0.1M Tris-HCl, pH 8.6",293.15,,,"6Q3P",13.42,"1.03","1.03","Atomic resolution crystal structure of an AAB collagen heterotrimer","GPPGPKGDPGPKGDPGPPGARGQAGVLGFPGPPGPPGPKGDKGDPGGYX","Homo sapiens",,"Leading Chain of the AAB Collagen Heterotrimer","1","6Q3P"
,,,,,,,,,,,,,,,,"XGPPGPKGDPGPKGDPGPPGARGQAGVLGFPGPPGPPGPKGDKGDPGGYX","Homo sapiens",,"Middle Chain of the AAB Collagen Heterotrimer","2","6Q3P"
,,,,,,,,,,,,,,,,"XGPKGPPGDKGPPGDPGPPGARGEPGNIGFPGPPGPKGPKGDPGDPGGY","Homo sapiens",,"Trailing Chain of the AAB Collagen Heterotrimer","3","6Q3P"
"6Q3V",,"X-RAY DIFFRACTION",2.27,45.76,"VAPOR DIFFUSION, SITTING DROP",,"Sodium malonate",277,,,"6Q3V",20.85,"1.882","1.882","Crystal structure of Human N4BP1 KH domains","GSDEFTAPAEKAELLEQSRGRIEGLFGVSLAVLGALGAEEPLPARIWLQLCGAQEAVHSAKEYIKGICEPELEERECYPKDMHCIFVGAESLFLKSLIQDTCADLCILDIGLLGIRGSAEAVVMARSHIQQFVKLFENKENLPSSQKESEVKREFKQFVEAHADNYTMDLLILPTSLKKELLTLTQGE","Homo sapiens","N4BP1, KIAA0615","NEDD4-binding protein 1","1","6Q3V"
"6Q3W",,"X-RAY DIFFRACTION",2.97,58.57,"VAPOR DIFFUSION",,"0.1 M MOPS/sodium HEPES pH 7.0-7.5, 40-50 % Morpheus Precipitant Mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1 M Morpheus Carboxylic acids mix (0.02M each of:sodium formate, ammonium acetate, sodium citrate tribasic dehydrate, sodium potassium tartrate tetrahydrate and sodium oxamate).",293,,,"6Q3W",170.11,"1.962","1.962","Structure of human galactokinase 1 bound with Ethyl 1-(2-pyrazinyl)-4-piperidinecarboxylate","AALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6Q3W"
"6Q3X",,"X-RAY DIFFRACTION",2.78,55.76,"VAPOR DIFFUSION",,"0.02M Sodium formate; 0.02M Ammonium acetate; 0.02M Sodium citrate tribasic dihydrate; 0.02M Sodium potassium tartrate tetrahydrate; 0.02M Sodium oxamate
0.1 M pH 7.5, Sodium HEPES; MOPS (acid) pH 7.5
12.5% v/v MPD; 12.5% PEG 1000; 12.5% w/v PEG 3350",298,"10.1021/acschembio.0c00498",,"6Q3X",86.35,"2.1","2.1","Structure of human galactokinase in complex with galactose and 2'-(benzo[d]oxazol-2-ylamino)-7',8'-dihydro-1'H-spiro[cyclohexane-1,4'-quinazolin]-5'(6'H)-one","HHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6Q3X"
"6Q3Y",,"X-RAY DIFFRACTION",2.14,42.61,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% pentaerythritol ethoxylate 15/4, 0.05 ammonium sulfate, 0.1M bis-tris pH6.5",293,"10.1021/acs.jmedchem.8b01947","HG5","6Q3Y",31.72,"1.2","1.2","Crystal structure of the first bromodomain of human BRD4 in complex with the inhibitor 16i","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6Q3Y"
"6Q3Z",,"X-RAY DIFFRACTION",2.11,41.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.2M ammonium sulfate, 0.1M bis-tris pH6.5",293,"10.1021/acs.jmedchem.8b01947","HG8","6Q3Z",31.7,"2","2","Crystal structure of the first bromodomain of human BRD4 in complex with the inhibitor 16k","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6Q3Z"
"6Q41",,"X-RAY DIFFRACTION",2.24,45.13,"VAPOR DIFFUSION, SITTING DROP",9.2,"50% Ethylene glycol, 0.1M Tris-HCl, 0.2 M MgCl2, pH 8.5",293.15,,,"6Q41",13.79,"1.03","1.03","Atomic resolution crystal structure of a BAA collagen heterotrimer","XGPKGDPGPKGDPGPPGPPGARGQAGVLGFPGPPGPKGDKGDPGPPGGYX","Homo sapiens",,"Middle and Trailing Chains of the BAA collagen heterotrimer","1","6Q41"
,,,,,,,,,,,,,,,,"XGPKGPPGDKGPPGDPGPPGARGEPGNIGFPGPPGPKGPKGDPGDPGGYX","Homo sapiens",,"Leading chain of the BAA collagen heterotrimer","2","6Q41"
"6Q42",,"X-RAY DIFFRACTION",1.95,36.77,"VAPOR DIFFUSION",8.5,"32% (w/v) PEG4K, 0.8M Lithium chloride, Tris-HCl",291,"10.1172/JCI131842",,"6Q42",28.46,"1.9","1.9","Crystal Structure of Human Pancreatic Phospholipase A2","AVWQFRKMIKCVIPGSDPFLEYNNYGCYCGLGGSGTPVDELDKCCQTHDNCYDQAKKLDSCKFLLDNPYTHTYSYSCSGSAITCSSKNKECEAFICNCDRNAAICFSKAPYNKAHKNLDTKKYCQS","Homo sapiens","PLA2G1B, PLA2, PLA2A, PPLA2","Phospholipase A2","1","6Q42"
"6Q43",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, SITTING DROP",8.6,"17% PEG 3350, 0.2M Sodium Nitrate",293.15,,,"6Q43",12.74,"1.16","1.16","Atomic resolution crystal structure of an ABA collagen heterotrimer","XGPPGPKGPKGDPGDPGPPGARGQAGVLGFPGPPGPKGPKGDPGDP","Homo sapiens",,"Trailing chain of the ABA collagen heterotrimer","3","6Q43"
,,,,,,,,,,,,,,,,"GPPGPKGPKGDPGDPGPPGARGQAGVLGFPGPPGPKGPKGDPGDPG","Homo sapiens",,"Leading Chain of the ABA collagen heterotrimer","1","6Q43"
,,,,,,,,,,,,,,,,"XGPPGPPGDKGDKGPPGPPGARGEPGNIGFPGPPGPPGDKGDKGPPG","Homo sapiens",,"Middle Chain of the ABA collagen heterotrimer","2","6Q43"
"6Q48",,"X-RAY DIFFRACTION",1.99,38.32,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM      
HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q48",35.06,"1.03","1.03","CDK2 in complex with FragLite7","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q48"
"6Q49",,"X-RAY DIFFRACTION",1.99,38.2,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q49",35.01,"1","1","CDK2 in complex with FragLite6","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q49"
"6Q4A",,"X-RAY DIFFRACTION",2.01,38.77,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4A",34.97,"1.13","1.13","CDK2 in complex with FragLite14","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CYCLIN-DEPENDENT KINASE 2","1","6Q4A"
"6Q4B",,"X-RAY DIFFRACTION",2,38.47,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4B",34.92,"1.12","1.12","CDK2 in complex with FragLite13","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4B"
"6Q4C",,"X-RAY DIFFRACTION",1.96,37.24,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4C",34.97,"1.73","1.73","CDK2 in complex with FragLite16","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4C"
"6Q4D",,"X-RAY DIFFRACTION",1.93,36.18,"VAPOR DIFFUSION, HANGING DROP",,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4D",36.23,"1.07","1.07","CDK2 in complex with FragLite31","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4D"
"6Q4E",,"X-RAY DIFFRACTION",1.99,38.29,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304","HH5","6Q4E",35.18,"1.06","1.06","CDK2 in complex with FragLite33","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4E"
"6Q4F",,"X-RAY DIFFRACTION",1.97,37.46,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4F",34.92,"1.21","1.21","CDK2 in complex with FragLite32","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4F"
"6Q4G",,"X-RAY DIFFRACTION",1.98,37.88,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304","HJK","6Q4G",35.03,"0.98","0.98","CDK2 in complex with FragLite37","GPLGSPEFMENFEKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4G"
"6Q4H",,"X-RAY DIFFRACTION",1.99,38.06,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4H",35.12,"1","1","CDK2 in complex with FragLite36","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4H"
"6Q4I",,"X-RAY DIFFRACTION",2,38.62,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4I",35.14,"1.11","1.11","CDK2 in complex with FragLite35","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFLVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4I"
"6Q4J",,"X-RAY DIFFRACTION",1.99,38.1,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4J",35.15,"1.05","1.05","CDK2 in complex with FragLite34","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4J"
"6Q4K",,"X-RAY DIFFRACTION",1.95,37.04,"VAPOR DIFFUSION, HANGING DROP",7.4,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1021/acs.jmedchem.9b00304",,"6Q4K",35.43,"1.06","1.06","CDK2 in complex with FragLite38","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6Q4K"
"6Q4M",,"X-RAY DIFFRACTION",3.19,61.38,"VAPOR DIFFUSION",,"1.45 M K2HPO4, 8 mM EDTA and 1% xylitol.",293,,,"6Q4M",81.84,"2.2","2.2","Crystal structure of the O-GlcNAc transferase Asn648Tyr mutation","GPGSCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTLKEMQDVQGALQCYTRAIQINPAFADAHSNLASIHKDSGNIPEAIASYRTALKLKPDFPDAYCNLAHCLQIVCDWTDYDERMKKLVSIVADQLEKNRLPSVHPHHSMLYPLSHGFRKAIAERHGNLCLDKINVLHKPPYEHPKDLKLSDGRLRVGYVSSDFGNHPTSHLMQSIPGMHNPDKFEVFCYALSPDDGTNFRVKVMAEANHFIDLSQIPCNGKAADRIHQDGIHILVNMNGYTKGARYELFALRPAPIQAMWLGYPGTSGALFMDYIITDQETSPAEVAEQYSEKLAYMPHTFFIGDHANMFPHLKKKAVIDFKSNGHIYDNRIVLNGIDLKAFLDSLPDVKIVKMKCPDGGDNADSSNTALNMPVIPMNTIAEAVIEMINRGQIQITINGFSISNGLATTQINNKAATGEEVPRTIIVTTRSQYGLPEDAIVYCNFNQLYKIDPSTLQMWANILKRVPNSVLWLLRFPAVGEPNIQQYAQNMGLPQNRIIFSPVAPKEEHVRRGQLADVCLDTPLCNGHTTGMDVLWAGTPMVTMPGETLASRVAASQLTCLGCLELIAKNRQEYEDIAVKLGTDLEYLKKVRGKVWKQRISSPLFNTKQYTMELERLYLQMWEHYAAGNKPDHMIKPVE","Homo sapiens","OGT","UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit","1","6Q4M"
"6Q4R",,"X-RAY DIFFRACTION",2.39,48.45,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM DL-malic acid, Bis-tris propane, pH 7.0, 25% PEG 1500",289,"10.1021/acsmedchemlett.9b00002",,"6Q4R",108.76,"1.6","1.6","High-resolution crystal structure of ERAP1 with bound phosphinic transition-state analogue inhibitor","MVFLPLKWSLATMSFLLSSLLALLTVSTPSWCQSTEASPKRSDGTPFPWNKIRLPEYVIPVHYDLLIHANLTTLTFWGTTKVEITASQPTSTIILHSHHLQISRATLRKGAGERLSEEPLQVLEHPRQEQIALLAPEPLLVGLPYTVVIHYAGNLSETFHGFYKSTYRTKEGELRILASTQFEPTAARMAFPCFDEPAFKASFSIKIRREPRHLAISNMPLVKSVTVAEGLIEDHFDVTVKMSTYLVAFIISDFESVSKITKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDAEKSSASSKLGITMTVAHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEFVSVSVTHPELKVGDYFFGKCFDAMEVDALNSSHPVSTPVENPAQIREMFDDVSYDKGACILNMLREYLSADAFKSGIVQYLQKHSYKNTKNEDLWDSMASIGSGGVDVKTMMNTWTLQKGFPLITITVRGRNVHMKQEHYMKGSDGAPDTGYLWHVPLTFITSKSDMVHRFLLKTKTDVLILPEEVEWIKFNVGMNGYYIVHYEDDGWDSLTGLLKGTHTAVSSNDRASLINNAFQLVSIGKLSIEKALDLSLYLKHETEIMPVFQGLNELIPMYKLMEKRDMNEVETQFKAFLIRLLRDLIDKQTWTDEGSVSERMLRSQLLLLACVHNYQPCVQRAEGYFRKWKESNGNLSLPVDVTLAVFAVGAQSTEGWDFLYSKYQFSLSSTEKSQIEFALCRTQNKEKLQWLLDESFKGDKIKTQEFPQILTLIGRNPVGYPLAWQFLRKNWNKLVQKFELGSSSIAHMVMGTTNQFSTRTRLEEVKGFFSSLKENGSQLRCVQQTIETIEENIGWMDKNFDKIRVWLQSEK","Homo sapiens","ERAP1, APPILS, ARTS1, KIAA0525, UNQ584/PRO1154","Endoplasmic reticulum aminopeptidase 1,Endoplasmic reticulum aminopeptidase 1","1","6Q4R"
,,,,,,,,,,,,,,,,,"Homo sapiens","ERAP1, APPILS, ARTS1, KIAA0525, UNQ584/PRO1154"
"6Q6F",,"X-RAY DIFFRACTION",2.74,55.09,"VAPOR DIFFUSION, SITTING DROP",,"0.2M di-ammonium citrate, 20% PEG 3350",277,"10.1038/s41375-019-0582-x",,"6Q6F",94.01,"3.3","3.3","Crystal structure of IDH1 R132H in complex with HMS101","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6Q6F"
"6Q6J",,"X-RAY DIFFRACTION",2.59,52.51,"VAPOR DIFFUSION, HANGING DROP",6.5,"Sodium cacodylate 0.1M pH6.5; CaCl2 0.3M; PEG 2000 20%; DMSO 4%",291,"10.1107/S2059798319006867",,"6Q6J",49.25,"1.985","1.985","Human phosphoserine phosphatase with substrate analogue homo-cysteic acid","SELRKLFYSADAVCFDVDSTVIREEGIDELAKICGVEDAVSEMTRRAMGGAVPFKAALTERLALIQPSREQVQRLIAEQPPHLTPGIRELVSRLQERNVQVFLISGGFRSIVEHVASKLNIPATNVFANRLKFYFNGEYAGFDETQPTAESGGKGKVIKLLKEKFHFKKIIMIGDGATDMEACPPADAFIGFGGNVIRQQVKDNAKWYITDFVELLGELE","Homo sapiens","PSPH","Phosphoserine phosphatase","1","6Q6J"
"6Q6K",,"X-RAY DIFFRACTION",3.28,62.47,"VAPOR DIFFUSION, HANGING DROP",4.6,"Ammonium sulfate, Gaunidine Hydrochloride, Potassium chloride and Sodium acetate (pH 4.6)",293,"10.1021/jacs.9b00056",,"6Q6K",117.57,"1.92","1.92","Crystal structure of recombinant human beta-glucocerebrosidase in complex with cyclophellitol activity based probe with Cy5 tag (ME569)","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6Q6K"
"6Q6L",,"X-RAY DIFFRACTION",3.25,62.13,"VAPOR DIFFUSION, HANGING DROP",4.6,"Ammonium sulfate, Guanidine Hydrochloride, Potassium Chloride, Sodium Acetate (pH 4.6)",293,"10.1021/jacs.9b00056",,"6Q6L",116.63,"1.81","1.81","Crystal structure of recombinant human beta-glucocerebrosidase in complex with adamantyl-cyclophellitol inhibitor (ME656)","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6Q6L"
"6Q6M",,"X-RAY DIFFRACTION",3.5,64.89,"VAPOR DIFFUSION, HANGING DROP",8.2,"0.5% PEG MME 5k (w/v), 0.6 M KNa Tartrate 0.1M TRIS",298,"10.1021/acs.jmedchem.9b01291","HJW","6Q6M",27.98,"2.35","2.35","RORCVAR2 (RORGT, 264-499) IN COMPLEX WITH COMPOUND 1: Identification of N-aryl imidazoles as potent and selective RORgt inhibitors","GPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLSKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFP","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6Q6M"
"6Q6N",,"X-RAY DIFFRACTION",3.25,62.15,"VAPOR DIFFUSION, HANGING DROP",4.6,"Ammonium sulfate, Gaunidine Hydrochloride, Potassium chloride, Sodium acetate (pH 4.6)",293,"10.1021/jacs.9b00056",,"6Q6N",116.12,"1.63","1.63","Crystal structure of recombinant human beta-glucocerebrosidase in complex with biphenyl-cyclophellitol inhibitor (ME655)","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","6Q6N"
"6Q6O",,"X-RAY DIFFRACTION",3.5,64.83,"VAPOR DIFFUSION, HANGING DROP",8.8,"0.5% PEG MME 5k (w/v), 0.74M KNa Tartrate 0.1M TRIS",298,"10.1021/acs.jmedchem.9b01291","HKE","6Q6O",28.82,"2.3","2.3","RORCVAR2 (RORGT, 264-499) IN COMPLEX WITH COMPOUND 2 AT 2.3A: Identification of N-aryl imidazoles as potent and selective RORgt inhibitors","GPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLSKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFP","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6Q6O"
"6Q6Q",,"X-RAY DIFFRACTION",2.53,51.43,"VAPOR DIFFUSION, HANGING DROP",5,"PEG3350, Sodium malonate",293,"10.1002/2211-5463.12617",,"6Q6Q",149.74,"3.10003770671","3.10003770671","Human aldehyde oxidase SNP G1269R","MDRASELLFYVNGRKVIEKNVDPETMLLPYLRKKLRLTGTKYGCGGGGCGACTVMISRYNPITKRIRHHPANACLIPICSLYGAAVTTVEGIGSTHTRIHPVQERIAKCHGTQCGFCTPGMVMSIYTLLRNHPEPTLDQLTDALGGNLCRCTGYRPIIDACKTFCKTSGCCQSKENGVCCLDQGINGLPEFEEGSKTSPKLFAEEEFLPLDPTQELIFPPELMIMAEKQSQRTRVFGSERMMWFSPVTLKELLEFKFKYPQAPVIMGNTSVGPEVKFKGVFHPVIISPDRIEELSVVNHAYNGLTLGAGLSLAQVKDILADVVQKLPEEKTQMYHALLKHLGTLAGSQIRNMASLGGHIISRHPDSDLNPILAVGNCTLNLLSKEGKRQIPLNEQFLSKCPNADLKPQEILVSVNIPYSRKWEFVSAFRQAQRQENALAIVNSGMRVFFGEGDGIIRELCISYGGVGPATICAKNSCQKLIGRHWNEQMLDIACRLILNEVSLLGSAPGGKVEFKRTLIISFLFKFYLEVSQILKKMDPVHYPSLADKYESALEDLHSKHHCSTLKYQNIGPKQHPEDPIGHPIMHLSGVKHATGEAIYCDDMPLVDQELFLTFVTSSRAHAKIVSIDLSEALSMPGVVDIMTAEHLSDVNSFCFFTEAEKFLATDKVFCVGQLVCAVLADSEVQAKRAAKRVKIVYQDLEPLILTIEESIQHNSSFKPERKLEYGNVDEAFKVVDQILEGEIHMGGQEHFYMETQSMLVVPKGEDQEMDVYVSTQFPKYIQDIVASTLKLPANKVMCHVRRVGGAFGGKVLKTGIIAAVTAFAANKHGRAVRCVLERGEDMLITGGRHPYLGKYKAGFMNDGRILALDMEHYSNAGASLDESLFVIEMGLLKMDNAYKFPNLRCRGWACRTNLPSNTAFRGFGFPQAALITESCITEVAAKCGLSPEKVRIINMYKEIDQTPYKQEINAKNLIQCWRECMAMSSYSLRKVAVEKFNAENYWKKKGLAMVPLKFPVGLGSRAAGQAAALVHIYLDGSVLVTHGGIEMGQGVHTKMIQVVSRELRMPMSNVHLRGTSTETVPNANISGGSVVADLNGLAVKDACQTLLKRLEPIISKNPKGTWKDWAQTAFDESINLSAVGYFRGYESDMNWEKGEGQPFEYFVYGAACSEVEIDCLTGDHKNIRTDIVMDVGCSINPAIDIGQIEGAFIQGMGLYTIEELNYSPQGILHTRGPDQYKIPAICDMPTELHIALLPPSQNSNTLYSSKGLRESGVFLGCSVFFAIHDAVSAARQERGLHGPLTLNSPLTPEKIRMACEDKFTKMIPRDEPGSYVPWNVPI","Homo sapiens","AOX1, AO","Aldehyde oxidase","1","6Q6Q"
"6Q7A",,"X-RAY DIFFRACTION",3.54,65.21,"VAPOR DIFFUSION, HANGING DROP",8.8,"0.5% PEG MME 5k (w/v), 0.4M KNa Tartrate, 0.1M TRIS",298,"10.1021/acs.jmedchem.9b01291","HKZ","6Q7A",28.01,"2.2","2.2","RORCVAR2 (RORGT, 264-499) IN COMPLEX WITH COMPOUND 4 AT 2.2A: Identification of N-aryl imidazoles as potent and selective RORgt inhibitors","GPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLSKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFP","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6Q7A"
"6Q7B",,"X-RAY DIFFRACTION",1.95,36.97,"VAPOR DIFFUSION, SITTING DROP",6.5,"37.5 % MPD_PEG1000_PEG3350 (Precipitant Mix 4 Morpheus), 100 mM Morpheus Amino Acids Mix, 100 mM Bis-Tris",291,,,"6Q7B",34.99,"1.009","1.009","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL09","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6Q7B"
"6Q7C",,"X-RAY DIFFRACTION",1.93,36.23,"VAPOR DIFFUSION, SITTING DROP",6,"37.5 % MPD_PEG1000_PEG3350, 100 mM Morpheus Amino Acids Mix, 100 mM Bis-Tris",291,,,"6Q7C",35,"1.049","1.049","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL11","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6Q7C"
"6Q7D",,"X-RAY DIFFRACTION",1.96,37.24,"VAPOR DIFFUSION, SITTING DROP",8.5,"30 % PEG 3350, 100 mM Morpheus Amino Acids Mix, 100 mM Morpheus Buffer System 3 (Tris/Bicine)",291,,,"6Q7D",35,"0.978","0.978","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL13","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6Q7D"
"6Q7E",,"X-RAY DIFFRACTION",1.97,37.47,"VAPOR DIFFUSION, SITTING DROP",8.5,"37.5% MPD_PEG1000_PEG3350, 100 mM Alanine, 100 mM Morpheus Buffer System 3  (Tris/Bicine)",291,,,"6Q7E",34.99,"1.059","1.059","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL14","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6Q7E"
"6Q7F",,"X-RAY DIFFRACTION",1.95,37.02,"VAPOR DIFFUSION, SITTING DROP",8.5,"37.5 % MPD_PEG1000_PEG3350, 125 mM Morpheus Carboxylic Acids Mix, 100 mM Morpheus Buffer System 3 (Tris/Bicine)",291,,,"6Q7F",34.99,"1.204","1.204","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL18","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6Q7F"
"6Q7G",,"X-RAY DIFFRACTION",1.97,37.53,"VAPOR DIFFUSION, SITTING DROP",8.5,"30 % PEG3350, 100 mM Morpheus Amino Acids Mix, 100 mM Morpheus Buffer System 3 (Tris/Bicine)",291,,,"6Q7G",34.99,"1.047","1.047","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATHA01","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6Q7G"
"6Q7H",,"X-RAY DIFFRACTION",3.46,64.42,"VAPOR DIFFUSION, HANGING DROP",8.4,"0.5% PEG MME 5k (w/v), 0.4M KNa Tartrate, 0.1M TRIS",298,"10.1021/acs.jmedchem.9b01291","HL8","6Q7H",28.62,"2.3","2.3","RORCVAR2 (RORGT, 264-499) IN COMPLEX WITH COMPOUND 9 AT 2.3A: Identification of N-aryl imidazoles as potent and selective RORgt inhibitors","GPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLSKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFP","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6Q7H"
"6Q7K",,"X-RAY DIFFRACTION",2.28,45.95,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
33% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6Q7K",42.73,"1.84","1.84","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6Q7K"
"6Q7S",,"X-RAY DIFFRACTION",2.27,45.85,"VAPOR DIFFUSION, HANGING DROP",7.2,"02M (NH4)2SO4
33% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6Q7S",42.84,"1.73","1.73","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6Q7S"
"6Q7T",,"X-RAY DIFFRACTION",2.25,45.37,"VAPOR DIFFUSION, SITTING DROP",7.2,"02M (NH4)2SO4
33% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6Q7T",42.82,"1.6","1.6","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6Q7T"
"6Q8F",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 16-20 % PEG 10K, 0.1 M ammonium acetate",293,"10.1073/pnas.1901214116",,"6Q8F",115.59,"1.9","1.9","Nterminal domain of human SMU1","MGSIEIESSDVIRLIMQYLKENSLHRALATLQEETTVSLNTVDSIESFVADINSGHWDTVLQAIQSLKLPDKTLIDLYEQVVLELIELRELGAARSLLRQTDPMIMLKQTQPERYIHLENLLARSYFDPREAYPDGSSKEKRRAAIAQALAGEVSVVPPSRLMALLGQALKWQQHQGLLPPGMTIDLFRGKAAVKDVEEEKFPTQLSRHIKFGQKSHVECARFSPDGQYLVTGSVDGFIEVWNFTTGKIRKDLKYQAQDNFMMMDDAVLCMCFSRDTEMLATGAQDGKIKVWKIQSGQCLRRFERAHSKGVTCLSFSKDSSQILSASFDQTIRIHGLKSGKTLKEFRGHSSFVNEATFTQDGHYIISASSDGTVKIWNMKTTECSNTFKSLGSTAGTDITVNSVILLPKNPEHFVVCNRSNTVVIMNMQGQIVRSFSSGKREGGDFVCCALSPRGEWIYCVGEDFVLYCFSTVTGKLERTLTVHEKDVIGIAHHPHQNLIATYSEDGLLKLWKP","Homo sapiens","SMU1","WD40 repeat-containing protein SMU1","1","6Q8F"
"6Q8J",,"X-RAY DIFFRACTION",3.12,60.52,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bis-Tris pH 6, 16-20 % PEG 10K, 0.2 M ammonium acetate",293,"10.1073/pnas.1901214116",,"6Q8J",23.42,"1.8","1.8","Nterminal domain of human SMU1 in complex with LSP641","MGSIEIESSDVIRLIMQYLKENSLHRALATLQEETTVSLNTVDSIESFVADINSGHWDTVLQAIQSLKLPDKTLIDLYEQVVLELIELRELGAARSLLRQTDPMIMLKQTQPERYIHLENLLARSYFDPREAYPDGSSKEKRRAAIAQALAGEVSVVPPSRLMALLGQALKWQQHQGLLPPGMTIDLFRGKAAVKDV","Homo sapiens","SMU1","WD40 repeat-containing protein SMU1","1","6Q8J"
"6Q8K",,"X-RAY DIFFRACTION",2.4,48.76,"VAPOR DIFFUSION, SITTING DROP",9,"255 PEG 6000. 0.1 M bicine pH 9.0",277,"10.1016/j.ejmech.2019.01.052","FG9","6Q8K",39.98,"2.29","2.29","CLK1 with bound pyridoquinazoline","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6Q8K"
"6Q8P",,"X-RAY DIFFRACTION",2.55,51.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"Protein solution: 7-8 mg/ml protein in 30 mM Hepes, pH 7.5, 300 mM NaCl, 50 mM arginine/glutamine mix 1:1, 0.5 mM TCEP, and 1% v/v glycerol.
Reservoir solution: 29% (v/v) 1,2 propanediol, 0.08 M Na/K phosphate. 
Crystals were soaked for 72 h in reservoir solution complemented with 1 mM compound and 20% ethylene glycol.",277,"10.1016/j.ejmech.2019.01.052",,"6Q8P",119.55,"3","3","Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6Q8P"
"6Q8Z",,"X-RAY DIFFRACTION",2.95,58.37,"VAPOR DIFFUSION",,"0.1M MOPS/sodium HEPES pH7-7.5, 40-50% Morpheus precipitant mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1M Morpheus carboxylic acids mix (0.02M each of: sodium formate, ammonium acetate, sodium citrate tribasic dihydrate, sodium oxamate and potassium sodium tartrate tetrahydrate",293,,,"6Q8Z",171.52,"2.4","2.4","Structure of human galactokinase 1 bound with N-(Cyclobutylmethyl)-1,5-dimethyl-1H-pyrazole-4-carboxamide","HAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6Q8Z"
"6Q90",,"X-RAY DIFFRACTION",2.96,58.51,"VAPOR DIFFUSION, SITTING DROP",,"0.1M MOPS/sodium HEPES, pH 7-7.5; 40-50% morpheus precipitant mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1M morpheus carboxylic acids mix (0.02M each of: sodium formate, ammonium acetate, sodium citrate tribasic dihydrate, sodium oxamate, potassium sodium tartrate tetrahydrate",293,,,"6Q90",170.92,"2.4","2.4","Structure of human galactokinase 1 bound with 1-(4-Methoxyphenyl)-3-(4-pyridinyl)urea","HAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6Q90"
"6Q91",,"X-RAY DIFFRACTION",2.96,58.52,"VAPOR DIFFUSION, SITTING DROP",,"0.1M MOPS/sodium HEPES, 40-50% Morpheus precipitant mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1M morpheus carboxylic acids mix (0.02M each of sodium formate, ammonium actetate, sodium citrate tribasic dihydrate, sodium oxamate, potassium sodium tartrate tetrahydrate",293,,,"6Q91",171.4,"2.4","2.4","Structure of human galactokinase 1 bound with 5-Chloro-N-isobutyl-2-methoxybenzamide","HAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6Q91"
"6Q92",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, HANGING DROP",4,"Crystals were generated from 22 % PEG 1500, 0.2 M MIB buffer pH 4.0 (sodium malonate, imidazole and boric acid in a 2:3:3 molar ratio). Crystals were equilibrated to soaking solution (22 % PEG 1500, 0.2 M MMT buffer pH 7.0 (DL-malic acid, MES, Tris base in a 1:2:2 molar ratio). Subsequently, crystals were gradually soaked for 13 days in soaking solution containing 15 mM ABH.",293,"10.1016/j.yjsbx.2019.100014",,"6Q92",74.55,"1.5","1.5","Crystal structure of human Arginase-1 at pH 7.0 in complex with ABH","MGSSHHHHHHSSGLVPRGSHMSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","6Q92"
"6Q94",,"X-RAY DIFFRACTION",3.45,64.32,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG3350, 0.2M ammonium acetate, 0.1M bis-tris pH 5.5",293,"10.1021/acscatal.9b00064",,"6Q94",331.71,"2.8","2.8","Crystal structure of human GDP-D-mannose 4,6-dehydratase (S156D) in complex with GDP-Man","SMRNVALITGITGQDGSYLAEFLLEKGYEVHGIVRRSSSFNTGRIEHLYKNPQAHIEGNMKLHYGDLTDSTCLVKIINEVKPTEIYNLGAQSHVKISFDLAEYTADVDGVGTLRLLDAVKTCGLINSVKFYQASTDELYGKVQEIPQKETTPFYPRSPYGAAKLYAYWIVVNFREAYNLFAVNGILFNHESPRRGANFVTRKISRSVAKIYLGQLECFSLGNLDAKRDWGHAKDYVEAMWLMLQNDEPEDFVIATGEVHSVREFVEKSFLHIGKTIVWEGKNENEVGRCKETGKVHVTVDLKYYRPTEVDFLQGDCTKAKQKLNWKPRVAFDELVREMVHADVELMRTNPNA","Homo sapiens","GMDS","GDP-mannose 4,6 dehydratase","1","6Q94"
"6Q96",,"X-RAY DIFFRACTION",3.51,64.96,"VAPOR DIFFUSION, HANGING DROP",,"2.2M AmSO4, 0.2M citrate",298,"10.1002/cmdc.201900201","HRE","6Q96",23.59,"1.8","1.8","HDM2 (17-111, WILD TYPE) COMPLEXED WITH COMPOUND 12 AT 1.8A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","6Q96"
"6Q9H",,"X-RAY DIFFRACTION",2.13,42.2,"VAPOR DIFFUSION, HANGING DROP",,"2.2M AmSO4, 0.2M NH4PO4",298,"10.1002/cmdc.201900201","HRH","6Q9H",11.57,"2","2","HDM2 (17-111, WILD TYPE) COMPLEXED WITH COMPOUND 11 AT 2.0A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","6Q9H"
"6Q9L",,"X-RAY DIFFRACTION",2.07,40.44,"VAPOR DIFFUSION, HANGING DROP",8,"2.7M AmSO4, 0.2M NaI, 0.2M NaCl, 0.2M TRIS",298,"10.1002/cmdc.201900201","HTZ","6Q9L",23.92,"1.13","1.13","HDM2 (17-111, WILDTYPE) COMPLEXED WITH COMPOUND 9 AT 1.13A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","6Q9L"
"6Q9O",,"X-RAY DIFFRACTION",1.91,35.72,"VAPOR DIFFUSION, HANGING DROP",8,"2.4M AmSO4, 0.1M NaCitrate, 0.2M NaCl, 0.1M TRIS",298,"10.1002/cmdc.201900201","HU8","6Q9O",23.45,"1.21","1.21","HDM2 (17-111, WILDTYPE) COMPLEXED WITH COMPOUND 10 AT 1.21A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","6Q9O"
"6Q9P",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, HANGING DROP",4,"Crystals were generated from 22 % PEG 1500, 0.2 M MIB buffer pH 4.0 (sodium malonate, imidazole and boric acid in a 2:3:3 molar ratio). Crystals were equilibrated to soaking solution (22 % PEG 1500, 0.2 M MMT buffer pH 9.0 (DL-malic acid, MES, Tris base in a 1:2:2 molar ratio). Subsequently, crystals were gradually soaked for 13 days in soaking solution containing 15 mM ABH.",293,"10.1016/j.yjsbx.2019.100014",,"6Q9P",74.55,"1.66","1.66","Crystal structure of human Arginase-1 at pH 9.0 in complex with ABH","MGSSHHHHHHSSGLVPRGSHMSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","6Q9P"
"6Q9Q",,"X-RAY DIFFRACTION",3.14,60.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.6M AmSO4, 4% w/v 18-crown-ether, 0.1M HEPES",298,"10.1002/cmdc.201900201","HUE","6Q9Q",49.42,"2.1","2.1","HDMX (14-111; C17S) COMPLEXED WITH COMPOUND 13 AT 2.1A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GPDSASRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","6Q9Q"
"6Q9R",,"X-RAY DIFFRACTION",3.19,61.5,"VAPOR DIFFUSION, SITTING DROP",8,"1.5 M ammonium sulfate, 15 % glycerol, 100 mM Tris-HCl",293,"10.1007/s00249-019-01409-9",,"6Q9R",173.26,"2.73","2.73","Crystal structure of the pathological N184K variant of calcium-free human gelsolin","MGSSHHHHHHSSGLVPRGSHMASATASRGASQAGAPQGRVPEARPNSMVVEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQRLFQVKGRRVVRATEVPVSWESFKNGDCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAELAA","Homo sapiens","GSN","Gelsolin","1","6Q9R"
"6Q9S",,"X-RAY DIFFRACTION",3.7,66.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.25M AmSO4, 6% w/v 18-crown-ether, 0.1M HEPES",298,"10.1002/cmdc.201900201","HRN","6Q9S",39.98,"2.4","2.4","HDMX (14-111; C17S) COMPLEXED WITH COMPOUND 14 AT 2.4A: Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GPDSASRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","6Q9S"
"6Q9T",,"X-RAY DIFFRACTION",2.52,51,"VAPOR DIFFUSION, HANGING DROP",5.7,"Ammonium sulfate 0.2 M, Sodium acetate 0.1 M pH 5.7, PEG 4000 14%, Sodium azide 3 mM",293,"10.1002/chem.201902942",,"6Q9T",32.49,"2.68","2.68","Protein-aromatic foldamer complex crystal structure","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6Q9T"
"6Q9U",,"X-RAY DIFFRACTION",2.57,52.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.3M AmSO4, 2% w/v 18-crown-ether, 0.1M HEPES",298,"10.1002/cmdc.201900201","HRE","6Q9U",12.03,"2.4","2.4","HDMX (14-111; C17S) COMPLEXED WITH COMPOUND 12 AT 2.4A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GPDSASRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","6Q9U"
"6Q9V",,"X-RAY DIFFRACTION",2.36,47.88,"VAPOR DIFFUSION, HANGING DROP",,"200mM NaCl, 100mM Cacodylate pH 7.4, 1.6M Ammonium Sulfate, 10% 2-Methyl-2,4-pentanediol",293,"10.1089/ars.2020.8037",,"6Q9V",35.54,"1.85","1.85","MSRB3","EFQSGSCRDKKNCKVVFSQQELRKRLTPLQYHVTQEKGTESAFEGEYTHHKDPGIYKCVVCGTPLFKSETKFDSGSGWPSFHDVINSEAITFTDDFSYGMHRVETSCSQCGAHLGHIFDDGPRPTGKRYCINSAALSFTPADSSGTAEGGSGVASPAQAD","Homo sapiens","MSRB3, UNQ1965/PRO4487","Methionine-R-sulfoxide reductase B3","1","6Q9V"
,,,,,,,,,,,,,,,,"SGSCRDKKNCKVVFSQQELRKRLTPLQYHVTQEKGTESAFEGEYTHHKDPGIYKCVVCGTPLFKSETKFDSGSGWPSFHDVINSEAITFTDDFSYGMHRVETSCSQCGAHLGHIFDDGPRPTGKRYCINSAALSFTPADSSGTAEGGSGVASPAQAD","Homo sapiens","MSRB3, UNQ1965/PRO4487","Methionine-R-sulfoxide reductase B3","2","6Q9V"
"6Q9W",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.25M AmSO4, 4% w/v 18-crown-ether, 0.1M HEPES",298,"10.1002/cmdc.201900201","HRT","6Q9W",24.73,"1.55","1.55","X-ray structure of compound 15 bound to HdmX: Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GPDSASRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","6Q9W"
"6Q9Y",,"X-RAY DIFFRACTION",2.05,39.94,"VAPOR DIFFUSION, HANGING DROP",6,"2.5M AmSO4, 0.1M KSCN, 1% v/v MPD, 0.1M MES",298,"10.1002/cmdc.201900201","HRQ","6Q9Y",23.07,"1.2","1.2","HDMX (14-111; C17S) COMPLEXED WITH COMPOUND 16 AT 1.20A; Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes","GPDSASRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","6Q9Y"
"6Q9Z",,"X-RAY DIFFRACTION",3.46,64.52,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.5 M ammonium sulfate, 20% glycerol, 100 mM Tris-HCl",293,"10.1007/s00249-019-01409-9",,"6Q9Z",171.61,"3.8","3.8","Crystal structure of the pathological G167R variant of calcium-free human gelsolin,","MGSSHHHHHHSSGLVPRGSHMASATASRGASQAGAPQGRVPEARPNSMVVEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQRLFQVKRRRVVRATEVPVSWESFNNGDCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAELAA","Homo sapiens","GSN","Gelsolin","1","6Q9Z"
"6QA0",,"X-RAY DIFFRACTION",2.68,54.19,"VAPOR DIFFUSION, HANGING DROP",,"200mM NaCl, 100mM Sodium Cacodylate pH 7.4, 1.6M Ammonium Sulfate, 20% Glycerol",293,"10.1089/ars.2020.8037",,"6QA0",32.11,"1.709","1.709","MSRB3 - AA 1-137","EFQSGSCRDKKNCKVVFSQQELRKRLTPLQYHVTQEKGTESAFEGEYTHHKDPGIYKCVVCGTPLFKSETKFDSGSGWPSFHDVINSEAITFTDDFSYGMHRVETSCSQCGAHLGHIFDDGPRPTGKRYCINSAALSFTPA","Homo sapiens","MSRB3, UNQ1965/PRO4487","Methionine-R-sulfoxide reductase B3","1","6QA0"
"6QA1",,"X-RAY DIFFRACTION",2.28,45.98,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
33% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6QA1",43.31,"1.58","1.58","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6QA1"
"6QA3",,"X-RAY DIFFRACTION",2.26,45.53,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
33% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6QA3",42.78,"1.57","1.57","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6QA3"
"6QA4",,"X-RAY DIFFRACTION",2.25,45.29,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
34% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6QA4",43.03,"1.6","1.6","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6QA4"
"6QA5",,"X-RAY DIFFRACTION",2.7,54.5,"VAPOR DIFFUSION, SITTING DROP",9,"0.1 M PCTP (Propionic acid, Cacodylate, Bis-tris propane) buffer pH 9.0 25 % w/v PEG 1500",277,,,"6QA5",49.84,"2.655","2.655","Aspartyl/Asparaginyl beta-hydroxylase (AspH) H679A in the apo form","KPKLLNKFDKTIKAELDAAEKLRKRGKIEEAVNAFKELVRKYPQSPRARYGKAQCEDDLAEKRRSNEVLRGAIETYQEVASLPDVPADLLKLSLKRRSDRQQFLGHMRGSLLTLQRLVQLFPNDTSLKNDLGVGYLLIGDNDNAKKVYEEVLSVTPNDGFAKVHYGFILKAQNKIAESIPYLKEGIESGDPGTDDGRFYFHLGDAMQRVGNKEAYKWYELGHKRGHFASVWQRSLYNVNGLKAQPWWTPKETGYTELVKSLERNWKLIRDEGLAVMDKAKGLFLPEDENLREKGDWSQFTLWQQGRRNENACKGAPKTCTLLEKFPETTGCRRGQIKYSIMHPGTHVWPATGPTNCRLRMHLGLVIPKEGCKIRCANETKTWEEGKVLIFDDSFEHEVWQDASSFRLIFIVDVWHPELTPQQRRSLPAI","Homo sapiens","ASPH, BAH","Aspartyl/asparaginyl beta-hydroxylase","1","6QA5"
"6QAA",,"X-RAY DIFFRACTION",3.12,60.56,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium Sulfate
MES pH 6.5",293,"10.1039/c9cc01330j","HUN","6QAA",66.69,"1.897","1.897","Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(2-cycloheptylethyl)-3-(1H-indol-3-yl)propanamide","MDSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6QAA"
"6QAB",,"X-RAY DIFFRACTION",3.06,59.76,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium Sulfate
MES pH 6.5",293,"10.1039/c9cc01330j","HUQ","6QAB",66.64,"2.49","2.49","Human Butyrylcholinesterase in complex with (S)-N-(1-((2-cycloheptylethyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-N,N-dimethylbutan-1-aminium","MDSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6QAB"
"6QAC",,"X-RAY DIFFRACTION",3.09,60.22,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium Sulfate
MES pH 6.5",293,"10.1039/c9cc01330j",,"6QAC",65.92,"2.771","2.771","Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(3-cycloheptylpropyl)-3-(1H-indol-3-yl)propanamide","MDSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6QAC"
"6QAD",,"X-RAY DIFFRACTION",3.14,60.85,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate
MES pH 6.5",293,"10.1039/c9cc01330j","HUZ","6QAD",66.64,"2.497","2.497","Human Butyrylcholinesterase in complex with ((S)-2-(butylamino)-N-(2-(4-(dimethylamino)cyclohexyl)ethyl)-3-(1H-indol-3-yl)propanamide","MDSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6QAD"
"6QAE",,"X-RAY DIFFRACTION",3.05,59.72,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate
MES pH 6.5",293,"10.1039/c9cc01330j","HUK","6QAE",66.08,"2.487","2.487","Human Butyrylcholinesterase in complex with (S)-N2-butyl-N1-(2-cycloheptylethyl)-3-(1H-indol-3-yl)-N1,N2-dimethylpropane-1,2-diamine","MDSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6QAE"
"6QAF",,"X-RAY DIFFRACTION",2.2,44.23,"VAPOR DIFFUSION, HANGING DROP",4,"Crystals were generated from 22.5 % PEG 1500, 0.2 M MIB buffer pH 4.0 (sodium malonate, imidazole and boric acid in a 2:3:3 molar ratio). Crystals were equilibrated to soaking solution (22.5 % PEG 1500, 0.2 M MMT buffer pH 9.0 (DL-malic acid, MES, Tris base in a 1:2:2 molar ratio). Subsequently, crystals were gradually soaked for 4 days in soaking solution containing 15 mM compound 3.",293,"10.1016/j.yjsbx.2019.100014",,"6QAF",74.77,"1.61","1.61","Crystal structure of human Arginase-1 at pH 9.0 in complex with CB-1158/INCB001158","MGSSHHHHHHSSGLVPRGSHMSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","6QAF"
"6QAG",,"X-RAY DIFFRACTION",2.23,44.94,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
34% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6QAG",42.98,"2.07","2.07","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6QAG"
"6QAH",,"X-RAY DIFFRACTION",2.29,46.38,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
34% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6QAH",42.79,"1.58","1.58","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6QAH"
"6QAK",,"X-RAY DIFFRACTION",2.32,46.88,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG 4K, sodium citrate pH 5.6,
2.5% isopropanol",292,"10.1042/BSR20190558",,"6QAK",443.86,"2.5","2.5","Structure of human ALDH9 in P21212 space group","MGSSHHHHHHSQDPMSTGTFVVSQPLNYRGGARVEPADASGTEKAFEPATGRVIATFTCSGEKEVNLAVQNAKAAFKIWSQKSGMERCRILLEAARIIREREDEIATMECINNGKSIFEARLDIDISWQCLEYYAGLAASMAGEHIQLPGGSFGYTRREPLGVCVGIGAWNYPFQIASWKSAPALACGNAMVFKPSPFTPVSALLLAEIYSEAGVPPGLFNVVQGGAATGQFLCQHPDVAKVSFTGSVPTGMKIMEMSAKGIKPVTLELGGKSPLIIFSDCDMNNAVKGALMANFLTQGQVCCNGTRVFVQKEILDKFTEEVVKQTQRIKIGDPLLEDTRMGPLINRPHLERVLGFVKVAKEQGAKVLCGGDIYVPEDPKLKDGYYMRPCVLTNCRDDMTCVKEEIFGPVMSILSFDTEAEVLERANDTTFGLAAGVFTRDIQRAHRVVAELQAGTCFINNYNVSPVELPFGGYKKSGFGRENGRVTIEYYSQLKTVCVEMGDVESAF","Homo sapiens","ALDH9A1, ALDH4, ALDH7, ALDH9","4-trimethylaminobutyraldehyde dehydrogenase","1","6QAK"
"6QAL",,"X-RAY DIFFRACTION",2.29,46.38,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
34% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6QAL",43.18,"1.57","1.57","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6QAL"
"6QAO",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, HANGING DROP",,"14% PEG 4K, 0.1 M sodium citrate pH 5.6",292,"10.1042/BSR20190558",,"6QAO",443.91,"2.89","2.89","Structure of human aldehyde dehydrogenase 9A1 in P21 space group","MGSSHHHHHHSQDPMSTGTFVVSQPLNYRGGARVEPADASGTEKAFEPATGRVIATFTCSGEKEVNLAVQNAKAAFKIWSQKSGMERCRILLEAARIIREREDEIATMECINNGKSIFEARLDIDISWQCLEYYAGLAASMAGEHIQLPGGSFGYTRREPLGVCVGIGAWNYPFQIASWKSAPALACGNAMVFKPSPFTPVSALLLAEIYSEAGVPPGLFNVVQGGAATGQFLCQHPDVAKVSFTGSVPTGMKIMEMSAKGIKPVTLELGGKSPLIIFSDCDMNNAVKGALMANFLTQGQVCCNGTRVFVQKEILDKFTEEVVKQTQRIKIGDPLLEDTRMGPLINRPHLERVLGFVKVAKEQGAKVLCGGDIYVPEDPKLKDGYYMRPCVLTNCRDDMTCVKEEIFGPVMSILSFDTEAEVLERANDTTFGLAAGVFTRDIQRAHRVVAELQAGTCFINNYNVSPVELPFGGYKKSGFGRENGRVTIEYYSQLKTVCVEMGDVESAF","Homo sapiens","ALDH9A1, ALDH4, ALDH7, ALDH9","4-trimethylaminobutyraldehyde dehydrogenase","1","6QAO"
"6QAP",,"X-RAY DIFFRACTION",2.51,50.91,"VAPOR DIFFUSION, HANGING DROP",,"14% PEG 4K, 0.1 M sodium citrate pH 5.6",292,"10.1042/BSR20190558",,"6QAP",223.44,"2.3","2.3","Structure of the human aldehyde dehydrogenase 9A1 in C2 space group","MGSSHHHHHHSQDPMSTGTFVVSQPLNYRGGARVEPADASGTEKAFEPATGRVIATFTCSGEKEVNLAVQNAKAAFKIWSQKSGMERCRILLEAARIIREREDEIATMECINNGKSIFEARLDIDISWQCLEYYAGLAASMAGEHIQLPGGSFGYTRREPLGVCVGIGAWNYPFQIASWKSAPALACGNAMVFKPSPFTPVSALLLAEIYSEAGVPPGLFNVVQGGAATGQFLCQHPDVAKVSFTGSVPTGMKIMEMSAKGIKPVTLELGGKSPLIIFSDCDMNNAVKGALMANFLTQGQVCCNGTRVFVQKEILDKFTEEVVKQTQRIKIGDPLLEDTRMGPLINRPHLERVLGFVKVAKEQGAKVLCGGDIYVPEDPKLKDGYYMRPCVLTNCRDDMTCVKEEIFGPVMSILSFDTEAEVLERANDTTFGLAAGVFTRDIQRAHRVVAELQAGTCFINNYNVSPVELPFGGYKKSGFGRENGRVTIEYYSQLKTVCVEMGDVESAF","Homo sapiens","ALDH9A1, ALDH4, ALDH7, ALDH9","4-trimethylaminobutyraldehyde dehydrogenase","1","6QAP"
"6QAQ",,"X-RAY DIFFRACTION",2.28,46.04,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
34% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6QAQ",43.16,"1.58","1.58","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6QAQ"
"6QAS",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION, SITTING DROP",5.6,"2.8 M Ammonium sulfate, 0.1 M citrate, pH 5.6",293.15,"10.1042/BCJ20190038",,"6QAS",68.94,"1.75","1.75","Crystal structure of ULK1 in complexed with PF-03814735","GGGSMEPGRGGTETVGKFEFSRKDLIGHGAFAVVFKGRHRAAHDLEVAVKCINKKNLAKSQTLLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHAMRTLSEDTIRLFLQQIAGAMRLLHSKGIIHRDLKPQNILLSNPAGRRANPNSIRVKIADFGFARYLQSNMMAATLCGSPMYMAPEVIMSQHYDGKADLWSIGTIVYQCLTGKAPFQASSPQDLRLFYEKNKTLVPTIPRETSAPLRQLLLALLQRNHKDRMDFDEFFHHPFLDASPS","Homo sapiens","ULK1, KIAA0722","Serine/threonine-protein kinase ULK1","1","6QAS"
"6QAT",,"X-RAY DIFFRACTION",2.16,43.03,"VAPOR DIFFUSION, SITTING DROP",,"27.5% PEG 3350, 0.1 M sodium citrate, pH 5.9, 0.15 M MgCl2, 0.1 M bis-tris, pH 5.75, 5% glycerol",293.15,"10.1042/BCJ20190038",,"6QAT",129.14,"2.77","2.77","Crystal structure of ULK2 in complexed with hesperadin","GGGSMEVVGDFEYSKRDLVGHGAFAVVFRGRHRQKTDWEVAIKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAADLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQANSPQDLRMFYEKNRSLMPSIPRETSPYLANLLLGLLQRNQKDRMDFEAFFSHPFLEQGPV","Homo sapiens","ULK2, KIAA0623","Serine/threonine-protein kinase ULK2","1","6QAT"
"6QAU",,"X-RAY DIFFRACTION",2.93,58.07,"VAPOR DIFFUSION, SITTING DROP",,"22.5% PEG 3350, 0.2 M sodium citrate, pH 5.9, 0.1 M bis-tris, pH 5.75, 5% glycerol",293.15,"10.1042/BCJ20190038","1FV","6QAU",97.38,"2.48","2.48","Crystal structure of ULK2 in complexed with MRT67307","GGGSMEVVGDFEYSKRDLVGHGAFAVVFRGRHRQKTDWEVAIKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAADLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQANSPQDLRMFYEKNRSLMPSIPRETSPYLANLLLGLLQRNQKDRMDFEAFFSHPFLEQGPV","Homo sapiens","ULK2, KIAA0623","Serine/threonine-protein kinase ULK2","1","6QAU"
"6QAV",,"X-RAY DIFFRACTION",2.16,43.15,"VAPOR DIFFUSION, SITTING DROP",,"37.5% PEG 3350, 0.1 M sodium citrate, pH 5.9, 0.15 M MgCl2, 0.1 M bis-tris, pH 5.5, 5% glycerol",293.15,"10.1042/BCJ20190038",,"6QAV",129.95,"2.05","2.05","Crystal structure of ULK2 in complexed with MRT68921","GGGSMEVVGDFEYSKRDLVGHGAFAVVFRGRHRQKTDWEVAIKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAADLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQANSPQDLRMFYEKNRSLMPSIPRETSPYLANLLLGLLQRNQKDRMDFEAFFSHPFLEQGPV","Homo sapiens","ULK2, KIAA0623","Serine/threonine-protein kinase ULK2","1","6QAV"
"6QAW",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4
34% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",293,"10.1016/j.drudis.2019.03.009",,"6QAW",42.96,"1.84","1.84","ERK2 mini-fragment binding","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6QAW"
"6QAX",,"SOLUTION NMR",,,,,,,"10.1002/psc.3161",,"6QAX",1.53,,,"P31-43","LGQQQPFPPQQPY","Homo sapiens",,"LEU-GLY-GLN-GLN-GLN-PRO-PHE-PRO-PRO-GLN-GLN-PRO-TYR","1","6QAX"
"6QB0",,"SOLUTION NMR",,,,,,,"10.1002/psc.3161",,"6QB0",1.5,,,"5675","LGQQQAFPPQQPY","Homo sapiens",,"LEU-GLY-GLN-GLN-GLN-ALA-PHE-PRO-PRO-GLN-GLN-PRO-TYR","1","6QB0"
"6QB1",,"SOLUTION NMR",,,,,,,"10.1002/psc.3161",,"6QB1",1.45,,,"5676","LGQQQPAPPQQPY","Homo sapiens",,"LEU-GLY-GLN-GLN-GLN-PRO-ALA-PRO-PRO-GLN-GLN-PRO-TYR","1","6QB1"
"6QB5",,"X-RAY DIFFRACTION",3,58.99,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Na/K Phosphate pH 6.0, 0.2 M NaCl, 34% PEG200",277,"10.26508/lsa.202000725",,"6QB5",158.54,"2.02","2.02","Crystal structure of the N-terminal region of human cohesin subunit STAG1","SMGGTLFEVVKLGKSAMQSVVDDWIESYKQDRDIALLDLINFFIQCSGCRGTVRIEMFRNMQNAEIIRKMTEEFDEDSGDYPLTMPGPQWKKFRSNFCEFIGVLIRQCQYSIIYDEYMMDTVISLLTGLSDSQVRAFRHTSTLAAMKLMTALVNVALNLSIHQDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDEIENMMNSIFKGIFVHRYRDAIAEIRAICIEEIGVWMKMYSDAFLNDSYLKYVGWTLHDRQGEVRLKCLKALQSLYTNRELFPKLELFTNRFKDRIVSMTLDKEYDVAVEAIRLVTLILHGSEEALSNEDCENVYHLV","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","6QB5"
"6QB7",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION, HANGING DROP",,"Mother liquor:
0.8M ammonium phosphate monobasic -- 0.8M ammonium phosphate dibasic

1:1 drops with protein in:
300 mM NaCl, 50 mM HEPES pH 7.5, 1 mM TCEP, 5 mM DTT",293,,,"6QB7",95.32,"2.23","2.23","Structure of the H1 domain of human KCTD16","SMEIKQSPDEFCHSDFEDASQGSDTRICPPSSLLPADRKWGFITVGYRGSCTLGREGQADAKFRRVPRILVCGRISLAKEVFGETLNESRDPDRAPERYTSRFYLKFKHLERAFDMLSECGFHMVACNSSVTASFINQYTDDKIWSSYTEYVFYREPSRWSPS","Homo sapiens","KCTD16, KIAA1317","BTB/POZ domain-containing protein KCTD16","1","6QB7"
"6QB9",,"X-RAY DIFFRACTION",2.22,44.58,"VAPOR DIFFUSION, SITTING DROP",,"1M K/Na tartrate, Hepes pH 7.5",293,"10.1107/S2059798319014116",,"6QB9",53.16,"1.85","1.85","Structure of an anti-Mcl1 scFv","QVTLKESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQVGATWAFDIWGQGTLVTVSSGGGGSGGGGSGGGGSAQSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNAWVFGGGTKLTVLGAAAENLYFQ","Homo sapiens",,"scFv55","1","6QB9"
"6QBC",,"X-RAY DIFFRACTION",2.72,54.73,"VAPOR DIFFUSION, SITTING DROP",,"1.8 M (NH4)2SO4 12% EtOH 0.1 M PCPT 8.5",293,"10.1107/S2059798319014116",,"6QBC",47.98,"1.56","1.56","structure of anti-Mcl1 Fab","QVTLKESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQVGATWAFDIWGQGTLVTVSAAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVPSSPRPSETVTCNVAHPASSTKVDKKIVPRDCAAAENLYFQ","Homo sapiens",,"Anti-Mcl1 Fab Heavy Chain","1","6QBC"
,,,,,,,,,,,,,,,,"QSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNAWVFGGGTKLTVLGESEGQPKSSPSVTLFPPSSEELETNKATLVCTITDFYPGVVTVDWKVDGTPVTQGMETTQPSKQSNNKYMASSYLTLTARAWERHSSYSCQVTHEGHTVEKSLSRADCS","Homo sapiens",,"Anti-Mcl1 Fab Light Chain","2","6QBC"
"6QBF",,"X-RAY DIFFRACTION",3.45,64.35,"VAPOR DIFFUSION, SITTING DROP",8,"1.3 M Ammonium sulfate, 19% glycerol, 100 mM Tris HCl",293,"10.1007/s00249-019-01409-9",,"6QBF",171.34,"3.499","3.499","Crystal structure of the pathological D187N variant of calcium-free human gelsolin.","MGSSHHHHHHSSGLVPRGSHMASATASRGASQAGAPQGRVPEARPNSMVVEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQRLFQVKGRRVVRATEVPVSWESFNNGNCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAELAA","Homo sapiens","GSN","Gelsolin","1","6QBF"
"6QBG",,"X-RAY DIFFRACTION",2.99,58.91,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350
0.2 M lithium sulphate 
0.1 M Bis-Tris pH 5.5",291.15,"10.1021/acs.jmedchem.9b01351","HVT","6QBG",39.12,"1.8","1.8","Crystal structure of human cathepsin D in complex with macrocyclic inhibitor 14","GPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQS","Homo sapiens","CTSD, CPSD","Cathepsin D","1","6QBG"
,,,,,,,,,,,,,,,,"GVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAAR","Homo sapiens","CTSD, CPSD","Cathepsin D","2","6QBG"
"6QBH",,"X-RAY DIFFRACTION",3,58.94,"VAPOR DIFFUSION, HANGING DROP",,"25 % PEG 3350
0.2 M lithium sulphate
0.1 M Bis-Tris Ph 5.5",291.15,"10.1021/acs.jmedchem.9b01351","S43","6QBH",38.38,"1.85","1.85","Crystal structure of human cathepsin D in complex with macrocyclic inhibitor 33","GPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQ","Homo sapiens","CTSD, CPSD","Cathepsin D","1","6QBH"
,,,,,,,,,,,,,,,,"GVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAAR","Homo sapiens","CTSD, CPSD","Cathepsin D","2","6QBH"
"6QBS",,"X-RAY DIFFRACTION",2.96,58.49,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M CaCl2, 20 % PEG-3350",295.15,"10.1021/jacs.8b11027",,"6QBS",48.12,"1.7","1.7","The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6QBS"
"6QCB",,"X-RAY DIFFRACTION",3.01,59.08,"VAPOR DIFFUSION, HANGING DROP",,"25 % PEG 3350
0.2 lithium sulphate
0.1 Bis-Tris pH 5.5",291.15,"10.1021/acs.jmedchem.9b01351","HWE","6QCB",38.91,"1.55","1.55","Crystal structure of human cathepsin D in complex with macrocyclic inhibitor 9","GPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQ","Homo sapiens","CTSD, CPSD","Cathepsin D","1","6QCB"
,,,,,,,,,,,,,,,,"GVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAAR","Homo sapiens","CTSD, CPSD","Cathepsin D","2","6QCB"
"6QCD",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION, HANGING DROP",5.7,"1.6 M (NH4)2SO4, 10% PEG 400, and Bis-Tris buffer pH 5.7",293,"10.1038/s41598-019-55654-1",,"6QCD",70.45,"1.84","1.84","Human Sirt6 in complex with ADP-ribose and the activator quercetin","GIDPFTADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRIN","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6QCD"
"6QCE",,"X-RAY DIFFRACTION",2.63,53.34,"VAPOR DIFFUSION, HANGING DROP",5.7,"1.6 M (NH4)2SO4, 10% PEG 400, and Bis-Tris buffer pH 5.7",293,"10.1038/s41598-019-55654-1",,"6QCE",70.55,"1.9","1.9","Human Sirt6 in complex with ADP-ribose and the activator isoquercetin","GIDPFTADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRIN","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6QCE"
"6QCH",,"X-RAY DIFFRACTION",2.63,53.2,"VAPOR DIFFUSION, HANGING DROP",5.7,"1.6 M (NH4)2SO4, 10% PEG 400, and Bis-Tris buffer pH 5.7",293,"10.1038/s41598-019-55654-1",,"6QCH",70.3,"2.1","2.1","Human Sirt6 in complex with ADP-ribose and the activator cyanidin","GIDPFTADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRIN","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6QCH"
"6QCI",,"X-RAY DIFFRACTION",1.87,34.19,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris, pH 8.0, 0.2 M lithium sulphate, PEG 4000",293,"10.1002/open.201900059",,"6QCI",49.96,"2.3","2.3","Structure of XIAP-BIR1 V86E mutant","MGSSHHHHHHSSGLVPQGSHMKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAVGRHRKESPNCRFINGFYLE","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","6QCI"
"6QCJ",,"X-RAY DIFFRACTION",2.67,53.92,"VAPOR DIFFUSION, HANGING DROP",5.7,"1.6 M (NH4)2SO4, 10% PEG 400, and Bis-Tris buffer pH 5.7",293,"10.1038/s41598-019-55654-1",,"6QCJ",70.13,"2.01","2.01","Human Sirt6 in complex with ADP-ribose and the inhibitor catechin gallate","GIDPFTADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRIN","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","6QCJ"
"6QCK",,"X-RAY DIFFRACTION",2.4,48.9,"VAPOR DIFFUSION, SITTING DROP",,"PEG 6000 20% Hepes 0.1M, DMSO 5%",291,"10.1016/j.jsbmb.2019.02.009",,"6QCK",29.9,"1.68","1.68","17beta-hydroxysteroid dehydrogenase 14 variant T205 in complex with FB262","GHMATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRATIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPSGS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6QCK"
"6QCN",,"X-RAY DIFFRACTION",2.66,53.73,"VAPOR DIFFUSION, HANGING DROP",5.8,"14% PEG 10,000, 0.1M ammonium acetate pH 5.8",293,"10.1038/s41598-019-55654-1",,"6QCN",70.53,"2.23","2.23","Human Sirt2 in complex with ADP-ribose and the inhibitor quercetin","HMKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","6QCN"
"6QCU",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION, SITTING DROP",,"0.15M LiSo4 monohydrate, 0.1M Citric Acid pH3.5, 18% PEG 6000, 5% Ethylen Glycol",293,,,"6QCU",47.37,"1.56","1.56","Crystal structure of a Fab portion of the anti EBOV 3T0331 antibody","EIVLTQSPATLSLSPGERATLSCRASQSVSTYLAWYQHQPGQAPRLLIYEASNRATGIPARFSGSGSGTEFTLTISSLEPEDVAVYYCQQRASWPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light chain","1","6QCU"
,,,,,,,,,,,,,,,,"EVQLLESGGGLVQPGGSLRLSCEASGFPLRDYAMSWVRQAPGRGLQWVSTIGGNDNAANYADSVKGRFTVSRDNSKSTIYLQMNSLRAEDTALYFCAKSVRLSRPSPFDLWGQGSLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"Heavy chain","2","6QCU"
"6QD5",,"X-RAY DIFFRACTION",4.12,70.14,"VAPOR DIFFUSION, SITTING DROP",8.5,"36% PEG400 -- 0.1M tris pH 8.5 -- 0.05M lithium sulfate -- 0.05M sodium sulfate",277,,,"6QD5",43.1,"2.398","2.398","X-ray Structure of the Human Urea Channel SLC14A1/UT1","MFPKALGYVTGDMKELANQLKDKPVVLQFIDWILRGISQVVFVNNPVSGILILVGLLVQNPWWALTGWLGTVVSTLMALLLSQDRSLIASGLYGYNATLVGVLMAVFSDKGDYFWWLLLPVCAMSMTCPIFSSALNSVLSKWDLPVFTLPFNMALSMYLSATGHYNPFFPAKLVIPITTAPQISWSDLSALELLKSIPVGVGQIYGCDNPWTGGIFLGAILLSSPLMCLHAAIGSLLGIAAGLSLSAPFENIYFGLWGFNSSLACIAMGGMFMALTWQTHLLALGCALFTAYLGVGMANFMAEVGLPACTWPFCLATLLFLIMTTKNSNIYKMPLSKVTYPEENRIFYLQAKKRMVESPLAENLYFQ","Homo sapiens","SLC14A1, HUT11, JK, RACH1, UT1, UTE","Urea transporter 1","1","6QD5"
"6QDU",,"X-RAY DIFFRACTION",2.61,52.83,"VAPOR DIFFUSION, SITTING DROP",,"0.19 M CaCl2, 5% v/v glycerol, 28 % PEG 400, 0.095 M HEPES, pH 7.1",277,"10.1016/j.chembiol.2020.02.010",,"6QDU",27.49,"1.632","1.632","Crystal structure of 14-3-3sigma in complex with a RapGef2 pT740 phosphopeptide inhibited by semi-synthetic fusicoccane FC-NCPC","GAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","6QDU"
"6QDZ",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, HANGING DROP",9,"PEG 3000, Calcium Chloride, CHES",293,,,"6QDZ",42.32,"1.73","1.73","P38 alpha complex with AR117045","GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6QDZ"
"6QE1",,"X-RAY DIFFRACTION",2.25,45.32,"VAPOR DIFFUSION, HANGING DROP",9,"PEG 3000, Calcium Chloride, CHES",293,,,"6QE1",42.32,"1.85","1.85","P38 alpha complex with AR117046","GSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6QE1"
"6QE3",,"X-RAY DIFFRACTION",2.53,51.31,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M MES, 20% PEG3350",293,"10.1107/S2059798319000214",,"6QE3",33.28,"1.75","1.75","Re-refinement of 6ESR human IBA57 at 1.75 A resolution","AGAAWACFRLDGRTLLRVRGPDAAPFLLGLLTNELPLPSPAAAGAPPAARAGYAHFLNVQGRTLYDVILYGLQEHSEVSGFLLECDSSVQGALQKHLALYRIRRKVTVEPHPELRVWAVLPSSPEACGAASLQERAGAAAILIRDPRTARMGWRLLTQDEGPALVPGGRLGDLWDYHQHRYLQGVPEGVRDLPPGVALPLESNLAFMNGVSFTKGCYIGQELTARTHHMGVIRKRLFPVRFLDPLPTSGITPGATVLTASGQTVGKFRAGQGNVGLALLWSEKIKGPLHIRASEGAQVALAASVPDWWP","Homo sapiens","IBA57, C1orf69","Putative transferase CAF17, mitochondrial","1","6QE3"
"6QE4",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES, 20% PEG 6000, PH 7.0,
 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1107/S2059798319000214",,"6QE4",37.2,"2.3","2.3","Re-refinement of 5OLI human IBA57-I3C","GLAHSSCSPGGDPTAGAAWACFRLDGRTLLRVRGPDAAPFLLGLLTNELPLPSPAAAGAPPAARAGYAHFLNVQGRTLYDVILYGLQEHSEVSGFLLECDSSVQGALQKHLALYRIRRKVTVEPHPELRVWAVLPSSPEACGAASLQERAGAAAILIRDPRTARMGWRLLTQDEGPALVPGGRLGDLWDYHQHRYLQGVPEGVRDLPPGVALPLESNLAFMNGVSFTKGCYIGQELTARTHHMGVIRKRLFPVRFLDPLPTSGITPGATVLTASGQTVGKFRAGQGNVGLALLWSEKIKGPLHIRASEGAQVALAASVPDWWPTVSK","Homo sapiens","IBA57, C1orf69","Putative transferase CAF17, mitochondrial","1","6QE4"
"6QEB",,"SOLID-STATE NMR",,,,,,,"10.1002/anie.201811714","AZM","6QEB",29.58,,,"Assessment of a large enzyme-drug complex by proton-detected solid-state NMR without deuteration","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6QEB"
"6QED",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, HANGING DROP",6,"20% METHANOL, 0.1 M CITRATE, PH 6.0",277,"10.1021/acs.jmedchem.9b00041","HZK","6QED",43.37,"1.8","1.8","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX; WITH AN INHIBITOR (S)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide","MGPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDYHHHHHH","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","6QED"
"6QEF",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, HANGING DROP",6,"20% METHANOL, 0.1 M CITRATE, PH 6.0",277,"10.1021/acs.jmedchem.9b00041","HZW","6QEF",43.35,"1.79","1.79","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR (S)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide","MGPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDYHHHHHH","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","6QEF"
"6QEG",,"X-RAY DIFFRACTION",2.63,53.31,"VAPOR DIFFUSION, HANGING DROP",6,"20% METHANOL, 0.1 M CITRATE, PH 6.0",277,"10.1021/acs.jmedchem.9b00041","K4K","6QEG",43,"2.08","2.08","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR 2-Oxo-1-phenyl-pyrrolidine-3-carboxylic acid (2-thiophen-2-yl-ethyl)-amide","MGPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDYHHHHHH","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","6QEG"
"6QEH",,"X-RAY DIFFRACTION",2.67,53.87,"VAPOR DIFFUSION, HANGING DROP",6,"20% METHANOL, 0.1 M CITRATE, PH 6.0,",277,"10.1021/acs.jmedchem.9b00041","HZQ","6QEH",42.85,"2.17","2.17","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR 5-Chloro-quinolin-8-ol","MGPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDYHHHHHH","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","6QEH"
"6QEI",,"X-RAY DIFFRACTION",2.66,53.74,"VAPOR DIFFUSION, HANGING DROP",,"20% METHANOL, 0.1 M CITRATE, PH 6.0,",277,"10.1021/acs.jmedchem.9b00041",,"6QEI",43.29,"1.8","1.8","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR 5,6-Difluoro-3-(2-isopropoxy-4-piperazin-1-yl-phenyl)-1H-indole-2-carboxylic acid amide","MGPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDYHHHHHH","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","6QEI"
"6QEJ",,"X-RAY DIFFRACTION",2.69,54.25,"VAPOR DIFFUSION, HANGING DROP",6,"20% METHANOL, 0.1 M CITRATE, PH 6.0,",277,"10.1021/acs.jmedchem.9b00041",,"6QEJ",43.07,"1.62","1.62","CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR Thiophene-2-sulfonic acid (4-fluoro-benzyl)-(4H-[1,2,4]triazol-3-ylmethyl)-amide","MGPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDYHHHHHH","Homo sapiens","METAP2, MNPEP, P67EIF2","Methionine aminopeptidase 2","1","6QEJ"
"6QEY",,"X-RAY DIFFRACTION",1.98,37.95,"VAPOR DIFFUSION, HANGING DROP",7,"51.4% PEG1000
150 mM MOPS pH 7.0
60 mM Sodium Iodide
4% acetonitrile",291,"10.1093/nar/gkz136",,"6QEY",19.94,"2.2","2.2","IMP1 KH1 and KH2 domains create a structural platform with unique RNA recognition and re-modelling properties","GAMVDIPLRLLVPTQYVGAIIGKEGATIRNITKQTQSKIDVHRKENAGAAEKAISVHSTPEGCSSACKMILEIMHKEAKDTKTADEVPLKILAHNNFVGRLIGKEGRNLKKVEQDTETKITISSLQDLTLYNPERTITVKGAIENCCRAEQEIMKKVREAYENDVAAMSLQSHLIPGLN","Homo sapiens","IGF2BP1, CRDBP, VICKZ1, ZBP1","Insulin-like growth factor 2 mRNA-binding protein 1","1","6QEY"
"6QF4",,"X-RAY DIFFRACTION",2.89,57.43,"BATCH MODE",7.5,"0.2M ammonium acetate, 20% PEG 3350, 50mM sodium/potassium tartrate, 0.8mM quercetin",295,"10.1107/S2052252519007395",,"6QF4",37.94,"2.495","2.495","X-Ray structure of human Serine/Threonine Kinase 17B (STK17B) aka DRAK2 in complex with ADP obtained by on-chip soaking","MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSS","Homo sapiens","STK17B, DRAK2","Serine/threonine-protein kinase 17B","1","6QF4"
"6QF5",,"X-RAY DIFFRACTION",3.48,64.67,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris pH 8.5, 0.1M sodium chloride, 0.1M magnesium chloride, 22-25% PEG 400, cadmium chloride",295,"10.1107/S2052252519007395",,"6QF5",101.28,"3.7","3.7","X-Ray structure of human Aquaporin 2 crystallized on a silicon chip","GSELRSIAFSRAVFAEFLATLLFVFFGLGSALNWPQALPSVLQIAMAFGLGIGTLVQALGHISGAHINPAVTVACLVGCHVSVLRAAFYVAAQLLGAVAGAALLHEITPADIRGDLAVNALSNSTTAGQAVTVELFLTLQLVLCIFASTDERRGENPGTPALSIGFSVALGHLLGIHYTGCSMNPARSLAPAVVTGKFDDHWVFWIGPLVGAILGSLLYNYVLFPPAKSLSERLAVLKGLEP","Homo sapiens","AQP2","Aquaporin-2","1","6QF5"
"6QF6",,"X-RAY DIFFRACTION",3.71,66.85,"VAPOR DIFFUSION, SITTING DROP",,"0.4 M Ammonium Sulphate, 25% PEG 3350, 0.1 M BIS-TRIS pH 5.9",293,,,"6QF6",102.03,"2.59","2.59","Structure of an E.coli expressed anti-Mcl1 scFv","GSQVTLKESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQVGATWAFDIWGQGTLVTVSSGGGGSGGGGSGGGGSAQSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNAWVFGGGTKLTVL","Homo sapiens",,"E.coli expressed scFv","1","6QF6"
"6QF8",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2019.03.005",,"6QF8",8.84,,,"Solution NMR ensemble for human ubiquitin at 298K compiled using the CoMAND method","AMGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","6QF8"
"6QF9",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG4k, 10% 2-propanol, 0.1M HEPES, pH 7.5",293,"10.1107/S2059798319014116",,"6QF9",52.86,"1.43","1.43","Structure of an anti-Mcl1 scFv","QVTLKESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQVGATWAFDIWGQGTLVTVSSGGGGSGGGGSGGGGSAQSVLTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNAWVFGGGTKLTVLGAAAENLYFQ","Homo sapiens",,"scFv","1","6QF9"
"6QFB",,"X-RAY DIFFRACTION",3.51,64.91,"VAPOR DIFFUSION, SITTING DROP",8.15,"17 % PEG 3350
0.2 M Na2HPO4 pH 8.15

Protein sample buffer",293,"10.1038/s41586-019-1095-5",,"6QFB",468.9,"3.25","3.25","Structure of the human ATP citrate lyase holoenzyme in complex with citrate, coenzyme A and Mg.ADP","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPMGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKEEMGIGGVLGLLWFQKRLPKYSCQFIEMCLMVTADHGPAVSGAHNTIICARAGKDLVSSLTSGLLTIGDRFGGALDAAAKMFSKAFDSGIIPMEFVNKMKKEGKLIMGIGHRVKSINNPDMRVQILKDYVRQHFPATPLLDYALEVEKITTSKKPNLILNVDGLIGVAFVDMLRNCGSFTREEADEYIDIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMSMGGSHHHHHH","Homo sapiens","ACLY","ATP-citrate synthase","1","6QFB"
"6QFE",,"X-RAY DIFFRACTION",2.97,58.59,"VAPOR DIFFUSION, SITTING DROP",5.6,"100mM Sodium Citrate pH 5.6, 20% PEG 4K, 5% Glycerol, 10% Iso-propanol",293,"10.1107/S2053230X19003169","J08","6QFE",52.52,"1.67","1.67","Crystal Structure of Human Kallikrein 5 in complex with GSK144","IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKVFRVRLGHYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSSHCPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQIDDTMFCAGDKAGRDSCQGDSGGPVVCNGSLQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETIQANS","Homo sapiens","KLK5, SCTE, UNQ570/PRO1132","Kallikrein-5","1","6QFE"
"6QFF",,"X-RAY DIFFRACTION",2.48,50.31,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1107/S2053230X19003169","J08","6QFF",49.47,"1.64","1.64","Crystal Structure of Human Kallikrein 6 in complex with GSK144","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQA","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6QFF"
"6QFG",,"X-RAY DIFFRACTION",2.44,49.64,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1107/S2053230X19003169","J08","6QFG",49.92,"1.68","1.68","Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK144","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNYPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6QFG"
"6QFH",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1107/S2053230X19003169","J08","6QFH",49.72,"1.65","1.65","Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK144.","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGDYPCGSKERPGVYTNVCRYTNWIQKTIQA","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6QFH"
"6QFL",,"X-RAY DIFFRACTION",2.78,55.73,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodiumcitrate
20 % PEG3350",277,"10.1021/acs.jmedchem.9b00472",,"6QFL",36.15,"2.2","2.2","Structure of the mitogen activated kinase kinase 7 active conformation","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6QFL"
"6QFQ",,"X-RAY DIFFRACTION",2.2,44.08,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M BisTRIS buffer pH 6.5, 20% PEGMME5K",292,"10.1021/acsomega.9b00611",,"6QFQ",20.37,"1.6","1.6","Structure of human Mcl-1 in complex with indole acid inhibitor","MHHHHHHLVPRGSEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6QFQ"
"6QFR",,"X-RAY DIFFRACTION",2.89,57.4,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodiumcitrate
20% PEG3350",277,"10.1021/acs.jmedchem.9b00472",,"6QFR",36.15,"2.3","2.3","Structure of the mitogen activated kinase kinase 7 dfg-out conformation","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6QFR"
"6QFT",,"X-RAY DIFFRACTION",2.38,48.38,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodiumcitrate
20% PEG3350",277,"10.1021/acs.jmedchem.9b00472",,"6QFT",36.55,"2.7","2.7","Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6QFT"
"6QFU",,"X-RAY DIFFRACTION",2.1,41.38,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.6 M ammonium sulfate, 50 mM Tris-H2SO4",293,"10.1021/acscatal.9b01006","SO4, J0K","6QFU",30.12,"1.8","1.8","Human carbonic anhydrase II with bound IrCp* complex (cofactor 7) to generate an artificial transfer hydrogenase (ATHase)","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6QFU"
"6QFV",,"X-RAY DIFFRACTION",2.16,43.06,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.6 M ammonium sulfate, 50 mM Tris-H2SO4",293,"10.1021/acscatal.9b01006","SO4, J0N","6QFV",30.2,"1.45","1.45","Human carbonic anhydrase II with bound IrCp* complex (cofactor 8) to generate an artificial transfer hydrogenase (ATHase)","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6QFV"
"6QFW",,"X-RAY DIFFRACTION",2.13,42.26,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.6 M ammonium sulfate, 50 mM Tris-H2SO4",293,"10.1021/acscatal.9b01006","SO4, JR8","6QFW",30.32,"1.2","1.2","Human carbonic anhydrase II with bound IrCp* complex (cofactor 9) to generate an artificial transfer hydrogenase (ATHase)","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6QFW"
"6QFX",,"X-RAY DIFFRACTION",2.15,42.69,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.6 M ammonium sulfate, 50 mM Tris-H2SO4",293,"10.1021/acscatal.9b01006","SO4, JR3","6QFX",30.24,"1.32","1.32","Human carbonic anhydrase II with bound IrCp* complex (cofactor 10) to generate an artificial transfer hydrogenase (ATHase)","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6QFX"
"6QG4",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodiumcitrate
0.2% PEG3350",277,"10.1021/acs.jmedchem.9b00472",,"6QG4",36.51,"2.3","2.3","Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1h","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6QG4"
"6QG7",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodiumcitrate
20% PEG3350",277,"10.1021/acs.jmedchem.9b00472",,"6QG7",36.55,"2.1","2.1","Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1k","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6QG7"
"6QGE",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION",7.5,"Hanging drop vapour diffusion: 28% (w/v) PEG 4000, Tris-HCl pH 7.5, 0.4 M NaSCN, 15 mM beta-mercaptoethanol. The drop volume was 2 microlitres and the protein solution:reservoir ratio was varied between 0.5:1, 1:1, and 2:1. The crystals were soaked in 10 mM of the ligand for 20 hours.",295,"10.1021/jacs.8b11099","J1E","6QGE",16.26,"1.16","1.16","Galectin-3C in complex with a pair of enantiomeric ligands: S enantiomer","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QGE"
"6QGF",,"X-RAY DIFFRACTION",2.08,40.92,"VAPOR DIFFUSION",7.5,"28% (w/v) PEG 4000, Tris-HCl pH 7.5, 0.4 M NaSCN, 15 mM beta-mercaptoethanol. Drop volume was 2 microlitres and the protein solution:reservoir ratio was varied between 0.5:1, 1:1, and 2:1. The crystals were soaked in 10 mM ligand for 7 hours.",295,"10.1021/jacs.8b11099","J0T","6QGF",16.26,"1.34","1.34","Galectin-3C in complex with a pair of enantiomeric ligands: R enantiomer","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QGF"
"6QGN",,"X-RAY DIFFRACTION",2.82,56.42,"VAPOR DIFFUSION, SITTING DROP",,"D1 Morpheus (Molecular Dimensions)
0.1 M  imidazole, 0.1 M MES monohydrate, 20% v/v PEG 500 MME, 10% w/v PEG 2000, 20 mM  1,6-Hexanediol,  20 mM 1-Butanol, 20 mM 1,2-Propanediol, 20 mM 2- Propanol, 20 mM 1,4-Butanediol, 20 mM 1,3-Propanediol, pH 6.5.",291,"10.1038/s41589-021-00753-2",,"6QGN",101.25,"2.099","2.099","Crystal structure of APT1 bound to 2-Bromopalmitate","GSRMSGNNMSTPLPAIVPAARKATAAVIFLHGLGDTGHGWAEAFAGIRSSHIKYICPHAPVRPVTLNMNVAMPSWFDIIGLSPDSQEDESGIKQAAENIKALIDQEVKNGIPSNRIILGGFSQGGALSLYTALTTQQKLAGVTALSCWLPLRASFPQGPIGGANRDISILQCHGDCDPLVPLMFGSLTVEKLKTLVNPANVTFKTYEGMMHSSCQQEMMDVKQFIDKLLPPID","Homo sapiens","LYPLA1, APT1, LPL1","Acyl-protein thioesterase 1","1","6QGN"
"6QGO",,"X-RAY DIFFRACTION",2.77,55.58,"VAPOR DIFFUSION, SITTING DROP",,"25% of of polyethylene glycol (PEG) 2000, 0.3 M sodium acetate, 0.1 M sodium cacodylate pH 6.5;",291,"10.1038/s41589-021-00753-2",,"6QGO",50.21,"2.599","2.599","Crystal structure of APT1 S119A mutant bound to palmitic acid.","GSRMCGNNMSTPLPAIVPAARKATAAVIFLHGLGDTGHGWAEAFAGIRSSHIKYICPHAPVRPVTLNMNVAMPSWFDIIGLSPDSQEDESGIKQAAENIKALIDQEVKNGIPSNRIILGGFAQGGALSLYTALTTQQKLAGVTALSCWLPLRASFPQGPIGGANRDISILQCHGDCDPLVPLMFGSLTVEKLKTLVNPANVTFKTYEGMMHSSCQQEMMDVKQFIDKLLPPID","Homo sapiens","LYPLA1, APT1, LPL1","Acyl-protein thioesterase 1","1","6QGO"
"6QGQ",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION, HANGING DROP",,"25% of of polyethylene glycol (PEG) 2000 MME, 0.3 M sodium acetate, 0.1 M sodium cacodylate pH 6.5;",291,"10.1038/s41589-021-00753-2",,"6QGQ",100.86,"2.601","2.601","Crystal structure of APT1 C2S mutant bound to palmitic acid.","GSRMSGNNMSTPLPAIVPAARKATAAVIFLHGLGDTGHGWAEAFAGIRSSHIKYICPHAPVRPVTLNMNVAMPSWFDIIGLSPDSQEDESGIKQAAENIKALIDQEVKNGIPSNRIILGGFSQGGALSLYTALTTQQKLAGVTALSCWLPLRASFPQGPIGGANRDISILQCHGDCDPLVPLMFGSLTVEKLKTLVNPANVTFKTYEGMMHSSCQQEMMDVKQFIDKLLPPID","Homo sapiens","LYPLA1, APT1, LPL1","Acyl-protein thioesterase 1","1","6QGQ"
,,,,,,,,,,,,,,,,"GSRMSGNNMSTPLPAIVPAARKATAAVIFLHGLGDTGHGWAEAFAGIRSSHIKYICPHAPVRPVTLNMNVAMPSWFDIIGLSPDSQEDESGIKQAAENIKALIDQEVKNGIPSNRIILGGFSQGGALSLYTALTTQQKLAGVTALSCWLPLRASFPQGPIGGANRDISILQCHGDCDPLVPLMFGSLTVEKLKTLVNPANVTFKTYEGMMHSSCQQEMMDVKQFIDKLLPPIDA","Homo sapiens","LYPLA1, APT1, LPL1","Acyl-protein thioesterase 1","2","6QGQ"
"6QGS",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, SITTING DROP",,"10% of polyethylene glycol (PEG) 8000, 0.2 M potassium bromide, 01.M sodium acetate at pH 5.5,10%w/v PEG1000",291,"10.1038/s41589-021-00753-2",,"6QGS",150.51,"2.755","2.755","Crystal structure of APT1 bound to palmitic acid.","GSRMCGNNMSTPLPAIVPAARKATAAVIFLHGLGDTGHGWAEAFAGIRSSHIKYICPHAPVRPVTLNMNVAMPSWFDIIGLSPDSQEDESGIKQAAENIKALIDQEVKNGIPSNRIILGGFSQGGALSLYTALTTQQKLAGVTALSCWLPLRASFPQGPIGGANRDISILQCHGDCDPLVPLMFGSLTVEKLKTLVNPANVTFKTYEGMMHSSCQQEMMDVKQFIDKLLPPID","Homo sapiens","LYPLA1, APT1, LPL1","Acyl-protein thioesterase 1","1","6QGS"
"6QGV",,"X-RAY DIFFRACTION",2.19,43.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.0 M Ammonium sulfate, 5% v/v 2-propanol",293,"10.1039/c8md00548f","J2H","6QGV",26.94,"1.4","1.4","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with a Spiro[4.5]decanone inhibitor (JPHM-2-167)","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGE","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","6QGV"
"6QH3",,"X-RAY DIFFRACTION",2.61,52.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M magnesium chloride, 0.1 M hepes pH 7.5, 25% PEG 3350",293,"10.1016/j.str.2019.05.008",,"6QH3",35.08,"2.9","2.9","Catalytic domain of the human ubiquitin-conjugating enzyme UBE2S C118M","MNSNVENLPPHIIRLVYKEVTTLTADPPDGIKVFPNEEDLTDLQVTIEGPEGTPYAGGLFRMKLLLGKDFPASPPKGYFLTKIFHPNVGANGEICVNVLKRDWTAELGIRHVLLTIKMLLIHPNPESALNEEAGRLLLENYEEYAARARLLTEIHG","Homo sapiens","UBE2S, E2EPF, OK/SW-cl.73","Ubiquitin-conjugating enzyme E2 S","1","6QH3"
"6QH4",,"X-RAY DIFFRACTION",2.04,39.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG4000, 10% 2-propanol and 0.1M HEPES pH 7.5",293,,,"6QH4",67.43,"1.922","1.922","Crystal structure of human Methylmalonyl-CoA epimerase (MCEE) p.Arg143Cys variant","MHHHHHHSSGVDLGTENLYFQSMLGRLNHVAIAVPDLEKAAAFYKNILGAQVSEAVPLPEHGVSVVFVNLGNTKMELLHPLGLDSPIAGFLQKNKAGGMHHICIEVDNINAAVMDLKKKKICSLSEEVKIGAHGKPVIFLHPKDCGGVLVELEQA","Homo sapiens","MCEE","Methylmalonyl-CoA epimerase, mitochondrial","1","6QH4"
"6QH9",,"X-RAY DIFFRACTION",2.55,51.73,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1016/j.bmcl.2019.01.020",,"6QH9",49.97,"2.27","2.27","Crystal Structure of Human Kallikrein 6 in complex with GSK3239861A","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6QH9"
"6QHA",,"X-RAY DIFFRACTION",2.47,50.24,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1016/j.bmcl.2019.01.020",,"6QHA",49.53,"1.82","1.82","Crystal Structure of Human Kallikrein 6 in complex with GSK3205388B","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6QHA"
"6QHB",,"X-RAY DIFFRACTION",2.46,50.08,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1016/j.bmcl.2019.01.020",,"6QHB",49.5,"1.84","1.84","Crystal Structure of Human Kallikrein 6 in complex with GSK578724A","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6QHB"
"6QHC",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, SITTING DROP",8.6,"100mM Tris-HCl pH 8.6, PEG 4000 18-28%",293,"10.1016/j.bmcl.2019.01.020",,"6QHC",49.52,"1.87","1.87","Crystal Structure of Human Kallikrein 6 in complex with GSK358180B","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","6QHC"
"6QHI",,"SOLUTION NMR",,,,,,,,,"6QHI",6.89,,,"TINA-conjugated antiparallel DNA triplex","TCCTCCT","Homo sapiens",,"DNA (5'-D(*(DT5)P*CP*CP*TP*CP*CP*(DT3)*(DA5)P*GP*GP*AP*GP*GP*(DA3)*(DT5)P*GP*GP*TP*GP*(TIN)P*GP*(DT3))-3')","1","6QHI"
,,,,,,,,,,,,,,,,"AGGAGGA","Homo sapiens",,"DNA (5'-D(*(DT5)P*CP*CP*TP*CP*CP*(DT3)*(DA5)P*GP*GP*AP*GP*GP*(DA3)*(DT5)P*GP*GP*TP*GP*(TIN)P*GP*(DT3))-3')","2","6QHI"
,,,,,,,,,,,,,,,,"TGGTGXGT","Homo sapiens",,"DNA (5'-D(*(DT5)P*CP*CP*TP*CP*CP*(DT3)*(DA5)P*GP*GP*AP*GP*GP*(DA3)*(DT5)P*GP*GP*TP*GP*(TIN)P*GP*(DT3))-3')","3","6QHI"
"6QHJ",,"X-RAY DIFFRACTION",2.38,48.35,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris pH 8.5
8 % (w/v) PEG 8000",291,"10.1186/s12860-019-0232-1",,"6QHJ",31.31,"1.25","1.25","High-resolution crystal structure of calcium- and sodium-bound mouse Olfactomedin-1 beta-propeller domain","GSACGKLTGISDPVTVKTSGSRFGSWMTDPLAPEGDNRVWYMDGYHNNRFVREYKSMVDFMNTDNFTSHRLPHPWSGTGQVVYNGSIYFNKFQSHIIIRFDLKTETILKTRSLDYAGYNNMYHYAWGGHSDIDLMVDENGLWAVYATNQNAGNIVISKLDPVSLQILQTWNTSYPKRSAGEAFIICGTLYVTNGYSGGTKVHYAYQTNASTYEYIDIPFQNKYSHISMLDYNPKDRALYAWNNGHQTLYNVTLFHAAAHHHHHH","Homo sapiens","OLFM1, NOE1, NOEL1","Noelin","1","6QHJ"
"6QHK",,"X-RAY DIFFRACTION",2.43,49.43,"VAPOR DIFFUSION, SITTING DROP",8.5,"1 mM TCEP, 11.74 mg/ml PAO, 0.2 M magnesium chloride, 0.1 M Tris pH 8.5, 30% PEG 4000",293,"10.1016/j.str.2019.05.008",,"6QHK",35.17,"1.96","1.96","PAO-linked dimer of the catalytic domain of the human ubiquitin-conjugating enzyme UBE2S","MNSNVENLPPHIIRLVYKEVTTLTADPPDGIKVFPNEEDLTDLQVTIEGPEGTPYAGGLFRMKLLLGKDFPASPPKGYFLTKIFHPNVGANGEICVNVLKRDWTAELGIRHVLLTIKCLLIHPNPESALNEEAGRLLLENYEEYAARARLLTEIHG","Homo sapiens","UBE2S, E2EPF, OK/SW-cl.73","Ubiquitin-conjugating enzyme E2 S","1","6QHK"
"6QHO",,"X-RAY DIFFRACTION",2.77,55.65,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M soidumcitrate
20% PEG3350",277,"10.1021/acs.jmedchem.9b00472",,"6QHO",36.42,"2.7","2.7","Dual specificity mitogen-activated protein kinase kinase 7 in complex with pyrazolopyrimidine 1a","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6QHO"
"6QHR",,"X-RAY DIFFRACTION",2.79,55.9,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Sodiumcitrate
20% PEG3350",277,"10.1021/acs.jmedchem.9b00472",,"6QHR",36.54,"2.52","2.52","Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1m","MGHHHHHHSAKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSG","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","6QHR"
"6QI4",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium cacodylate trihydrate pH 6.5, 0.2 M sodium acetate trihydrate, 30% (v/v) polyethylene glycol 8000",277.15,"10.1038/s41467-019-10627-w","FKW","6QI4",46.32,"1.78","1.78","NCS-1 bound to a ligand","MGKSNSKLKPEVVEELTRKTYFTEKEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPSIVQALSLYDGLV","Homo sapiens","NCS1, FLUP, FREQ","Neuronal calcium sensor 1","1","6QI4"
"6QIQ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",7.5,"5mM MgCl2 and 30% PEG 400",292,"10.1093/nar/gkz832",,"6QIQ",6.28,"2.519","2.519","Crystal structure of seleno-derivative CAG repeats with synthetic CMBL3a compound","GCAGCAGC","Homo sapiens",,"RNA (5'-R(*GP*CP*AP*G)-D(P*(CSL))-R(P*AP*GP*C)-3')","1","6QIQ"
"6QIR",,"X-RAY DIFFRACTION",3.7,66.75,"VAPOR DIFFUSION, SITTING DROP",6,"10mM MgCl2 and 1M Li2SO4",292,"10.1093/nar/gkz832",,"6QIR",12.26,"1.531","1.531","Crystal structure of CAG repeats with synthetic CMBL3a compound (model I)","GCAGCAGC","Homo sapiens",,"RNA (5'-R(*GP*CP*AP*GP*CP*AP*GP*C)-3')","1","6QIR"
"6QIS",,"X-RAY DIFFRACTION",3.38,63.64,"VAPOR DIFFUSION, SITTING DROP",6,"10mM MgCl2,  1M Li2SO4",292,"10.1093/nar/gkz832",,"6QIS",24.62,"1.99","1.99","Crystal structure of CAG repeats with synthetic CMBL3a compound (model II)","GCAGCAGC","Homo sapiens",,"RNA (5'-R(*GP*CP*AP*GP*CP*AP*GP*C)-3')","1","6QIS"
"6QIT",,"X-RAY DIFFRACTION",3.36,63.39,"VAPOR DIFFUSION, SITTING DROP",6,"20 mM magnesium acetate and 1.7 M ammonium sulfate",292,"10.1093/nar/gkz832",,"6QIT",12.26,"1.501","1.501","Crystal structure of CAG repeats with synthetic CMBL3b compound","GCAGCAGC","Homo sapiens",,"RNA (5'-R(*GP*CP*AP*GP*CP*AP*GP*C)-3')","1","6QIT"
"6QIV",,"X-RAY DIFFRACTION",2.63,53.2,"VAPOR DIFFUSION, SITTING DROP",7,"2 mM MgCl2, Tacsimate and 5 mM hexamine cobalt chloride",292,"10.1093/nar/gkz832",,"6QIV",3.08,"2.28","2.28","Crystal structure of seleno-derivative CAG repeats with synthetic CMBL4 compound","GCAGCAGC","Homo sapiens",,"RNA (5'-R(*GP*CP*AP*GP*CP*AP*GP*C)-3')","1","6QIV"
"6QJ5",,"X-RAY DIFFRACTION",2.44,49.55,"VAPOR DIFFUSION, SITTING DROP",8,"0.8M NaCitrate, 0.15M Tris",293,"10.1021/acs.jmedchem.0c01555","H8R","6QJ5",69.52,"2","2","X-ray structure of PPARgamma LBD with the ligand NV1380","MGSSHHHHHHSSGLVPRGSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6QJ5"
"6QJA",,"X-RAY DIFFRACTION",2.46,49.99,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Bis-Tris Propane, 0.2 M Magnesium Chloride, 28 % PEG 4000",277,"10.1016/j.str.2020.04.017",,"6QJA",71.34,"1.54","1.54","Organizational principles of the NuMA-Dynein interaction interface and implications for mitotic spindle functions","GPMGMTLHATRGAALLSWVNSLHVADPVEAVLQLQDCSIFIKIIDRIHGTEEGQQILKQPVSERLDFVCSFLQKNRKHPSSPECLVSAQKVLEGSELELAKMTMLLLYHSTMSSKSPRDWEQFEYKIQAELAVILKFVLDHEDGLNLNEDLENFLQK","Homo sapiens","NUMA1, NMP22, NUMA","Nuclear mitotic apparatus protein 1","1","6QJA"
"6QJD",,"X-RAY DIFFRACTION",2.3,46.59,"VAPOR DIFFUSION",6,"0.2 M ammonium sulphate, 30% PEG 4000",298,"10.1107/S2059798319001980",,"6QJD",40.31,"1.551","1.551","Crystal Structure of the truncated form of the third PDZ domain of PSD-95: residues 302-392","MGLGEEDIPREPRRIVIHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYK","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6QJD"
"6QJE",,"X-RAY DIFFRACTION",2.98,58.77,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MOPS/sodium HEPES pH 7.0-7.5, 40-50 % Morpheus Precipitant Mix 4 (50% mix = 12.5% MPD, 12.5% PEG1000, 12.5% PEG3350), 0.1 M Morpheus Carboxylic acids mix (0.02M each of:sodium formate, ammonium acetate, sodium citrate tribasic dehydrate, sodium potassium tartrate tetrahydrate and sodium oxamate).",293,,,"6QJE",171.26,"2.4","2.4","Structure of human galactokinase 1 bound with 4-{[2-(Methylsulfonyl)-1H-imidazol-1-yl]methyl}-1,3-thiazole","HAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6QJE"
"6QJF",,"X-RAY DIFFRACTION",1.91,35.65,"VAPOR DIFFUSION, SITTING DROP",8,"0.16 M ammonium dihydrogenphosphate, 50 mM Tris, 20 % glycerol",298,"10.1107/S2059798319001980",,"6QJF",44.52,"1.5","1.5","Crystal Structure of the third PDZ domain of PSD-95 protein D332P mutant: space group C121, structure 1","MGLGEEDIPREPRRIVIHRGSTGLGFNIVGGEPGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAK","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6QJF"
"6QJG",,"X-RAY DIFFRACTION",1.97,37.55,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES, 30 % PEG 8000",298,"10.1107/S2059798319001980",,"6QJG",44.52,"2.003","2.003","Crystal Structure of the third PDZ domain of PSD-95 protein D332P mutant: space group C121, structure 2","MGLGEEDIPREPRRIVIHRGSTGLGFNIVGGEPGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAK","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6QJG"
"6QJH","3.3","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.43584",,"6QJH",18.67,"3.3",,"Cryo-EM structure of heparin-induced 2N4R tau snake filaments","GGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHH","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6QJH"
"6QJI",,"X-RAY DIFFRACTION",1.89,35,"VAPOR DIFFUSION, SITTING DROP",6,"0.2 M AMMONIUM SULPHATE, 30% PEG 4000",298,"10.1107/S2059798319001980",,"6QJI",64.73,"1.5","1.5","Crystal Structure of the third PDZ domain of PSD-95 protein: space group P3112","EDIPREPRRIVIHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAK","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6QJI"
"6QJJ",,"X-RAY DIFFRACTION",1.79,31.17,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium sulphate, 30% PEG 4000",298,"10.1107/S2059798319001980",,"6QJJ",10.95,"1.7","1.7","Crystal Structure of the third PDZ domain of PSD-95 protein: space group P3221","EDIPREPRRIVIHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAK","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6QJJ"
"6QJK",,"X-RAY DIFFRACTION",2.03,39.44,"VAPOR DIFFUSION, SITTING DROP",,"0.17 M ammonium sulphate , 25.5% PEG 8000 , 15% Glycerol",298,"10.1107/S2059798319001980",,"6QJK",10.79,"1.046","1.046","Crystal Structure of the third PDZ domain of PSD-95 protein D332G mutant: space group P43","EDIPREPRRIVIHRGSTGLGFNIVGGEGGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAK","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6QJK"
"6QJL",,"X-RAY DIFFRACTION",1.89,35.01,"VAPOR DIFFUSION, SITTING DROP",,"0.17 M ammonium sulphate , 25.5% PEG 8000 , 15% Glycerol",298,"10.1107/S2059798319001980",,"6QJL",22.56,"1.043","1.043","Crystal Structure of the third PDZ domain of PSD-95 protein D332G mutant: space group P21","MGLGEEDIPREPRRIVIHRGSTGLGFNIVGGEGGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAK","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6QJL"
"6QJM","3.3","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.43584",,"6QJM",15.57,"3.3",,"Cryo-EM structure of heparin-induced 2N4R tau twister filaments","KVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSK","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6QJM"
"6QJN",,"X-RAY DIFFRACTION",1.93,36.28,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1 M sodium citrate, 20% 2-Propanol, 20% PEG 4000, 5% Glycerol",298,"10.1107/S2059798319001980",,"6QJN",22.18,"1.8","1.8","Crystal Structure of the third PDZ domain of PSD-95 protein D332G mutant: space group I4122","MGLGEEDIPREPRRIVIHRGSTGLGFNIVGGEGGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAK","Homo sapiens","DLG4, PSD95","Disks large homolog 4","1","6QJN"
"6QJP","3.5","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.43584",,"6QJP",15.57,"3.5",,"Cryo-EM structure of heparin-induced 2N4R tau jagged filaments","KVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSK","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6QJP"
"6QJQ","3.7","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.43584",,"6QJQ",17.83,"3.7",,"Cryo-EM structure of heparin-induced 2N3R tau filaments","GGKVQIVYKPVDLSKVTSKCGSLGNIHH","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6QJQ"
"6QJU",,"X-RAY DIFFRACTION",2.43,49.33,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.20 M KSCN, 0.1 M BTPop, 20% PEG3350, 10% EtGly, soaked with 14% DMSO containing 42mM 3-bromo-1H-imidazol-5-amine",277,,,"6QJU",29.75,"1.202","1.202","Crystal structure of human Bromodomain containing protein 3 (BRD3) in complex with 3-bromo-1H-indazol-5-amine","SMPEVSNPSKPGRKTNQLQYMQNVVVKTLWKHQFAWPFYQPVDAIKLNLPDYHKIIKNPMDMGTIKKRLENNYYWSASECMQDFNTMFTNCYIYNKPTDDIVLMAQALEKIFLQKVAQMPQEE","Homo sapiens","BRD3, KIAA0043, RING3L","Bromodomain-containing protein 3","1","6QJU"
"6QK9",,"X-RAY DIFFRACTION",1.84,33.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.06 M Divalents (0.3M Magnesium chloride hexahydrate, 0.3M Calcium chloride
dihydrate), 50% Precipitation mix 1 (40% v/v PEG 500 MME, 20 % w/v PEG 20000), 0.1 M MES pH 6.5",289,"10.1016/j.str.2019.06.008",,"6QK9",106.2,"2.231","2.231","A dimeric ubiquitin formed by a single amino acid substitution","GSGGSMQIFVKTLTVKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR","Homo sapiens","UBB","Polyubiquitin-B","1","6QK9"
"6QL1",,"X-RAY DIFFRACTION",2.06,40.24,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1038/s41598-019-49094-0","V50","6QL1",30.49,"1.42","1.42","Crystal structure of chimeric carbonic anhydrase VI with 4-[(4,6-dimethylpyrimidin-2-yl)thio]-2,3,5,6-tetrafluorobenzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDYGKAQQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLTECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6QL1"
"6QL2",,"X-RAY DIFFRACTION",2.05,40.01,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1038/s41598-019-49094-0","EZL","6QL2",30.19,"1.3","1.3","Crystal structure of chimeric carbonic anhydrase VI with ethoxzolamide.","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDYGKAQQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLTECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6QL2"
"6QL3",,"X-RAY DIFFRACTION",2.07,40.62,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1038/s41598-019-49094-0","V14","6QL3",30.65,"1.35","1.35","Crystal structure of chimeric carbonic anhydrase VI with 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDYGKAQQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLTECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6QL3"
"6QL8",,"X-RAY DIFFRACTION",2.87,57.2,"VAPOR DIFFUSION, HANGING DROP",6,"100mM ADA pH6.0, 500mM ammonium nitrate, 17% PEG 3350",291,,,"6QL8",24.68,"1.8","1.8","Cathepsin-K in complex with MIV-711","GRAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6QL8"
"6QLM",,"X-RAY DIFFRACTION",2.03,39.27,"VAPOR DIFFUSION, HANGING DROP",6.1,"25mM ADA pH6.1, 300mM NaCl & 20% PEG 5k.mme",291,,,"6QLM",48.76,"1.5","1.5","Cathepsin-K in complex with MIV-701","RAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6QLM"
"6QLN",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1002/cmdc.201900293","J5Q","6QLN",16.13,"1","1","Galectin-3C in complex with fluoroaryl triazole monothiogalactoside derivative 2","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QLN"
"6QLO",,"X-RAY DIFFRACTION",2.13,42.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1002/cmdc.201900293","J5E","6QLO",16.19,"1.18","1.18","Galectin-3C in complex with substituted fluoroaryltriazole monothiogalactoside derivative 1","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QLO"
"6QLP",,"X-RAY DIFFRACTION",2.07,40.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1002/cmdc.201900293","J3Q","6QLP",16.35,"1.081","1.081","Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative 3","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QLP"
"6QLQ",,"X-RAY DIFFRACTION",2.09,41.3,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1002/cmdc.201900293","J4E","6QLQ",16.27,"1.079","1.079","Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative 4","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QLQ"
"6QLR",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1002/cmdc.201900293","J4N","6QLR",16.19,"0.97","0.97","Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative 5","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QLR"
"6QLS",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1002/cmdc.201900293","HRK","6QLS",16.22,"1.047","1.047","Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative 6","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QLS"
"6QLT",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1002/cmdc.201900293","J5W","6QLT",16.24,"1.15","1.15","Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative-7","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QLT"
"6QLU",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1 M MgCl2, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",298,"10.1002/cmdc.201900293","J62","6QLU",16.18,"1.1","1.1","Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative-8","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6QLU"
"6QLW",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, HANGING DROP",6.1,"25mM ADA pH6.1, 250mM sodium nitrate and 20% PEG 5k.mme",291,,,"6QLW",97.34,"2","2","Cathepsin-K in complex with MIV-710","RAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6QLW"
"6QLX",,"X-RAY DIFFRACTION",2.92,57.87,"VAPOR DIFFUSION, HANGING DROP",6.1,"25mM ADA pH6.1, 400mM sodium chloride and 20% PEG 5k.mme",291,,,"6QLX",24.13,"2.1","2.1","Cathepsin-K in complex with fluoro-oxa-azabicyclo[3.3.0]octanyl containing inhibitor","RAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6QLX"
"6QLY",,"X-RAY DIFFRACTION",3.28,62.47,"VAPOR DIFFUSION, SITTING DROP",,"100mM Tris pH 8.5, 
20mM MgSO4, 
4% (w/v) ethylene glycol,
12% (w/v) 2-Methyl-2,4-pentanediol (MPD)",293,"10.1074/jbc.RA120.014349",,"6QLY",39.16,"2.5","2.5","IDOL FERM domain","GGMLCYVTRPDAVLMEVEVEAKANGEDCLNQVCRRLGIIEVDYFGLQFTGSKGESLWLNLRNRISQQMDGLAPYRLKLRVKFFVEPHLILQEQTRHIFFLHIKEALLAGHLLCSPEQAVELSALLAQTKFGDYNQNTAKYNYEELCAKELSSATLNSIVAKHKELEGTSQASAEYQVLQIVSAMENYGIEWHSVRDSEGQKLLIGVGPEGISICKDDFSPINRIAYPVVQMATQSGKNVYLTVTKESGNSIVLLFKMISTRAASGLYRAITETHAFYRCDTVTSAVMMQYSRDLKGHLASLFLNENINLGKKYVFDIKRTSKEVYDHARRALYNAGVVDLVSRNNQ","Homo sapiens","MYLIP, BZF1, IDOL, BM-023, PP5242","E3 ubiquitin-protein ligase MYLIP","1","6QLY"
"6QLZ",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, SITTING DROP",7,"100mM Hepes pH 7.0
10% (w/v) PEG 6000",293,"10.1074/jbc.RA120.014349",,"6QLZ",33.39,"2.343","2.343","IDOL F3ab subdomain","ENYGIEWHSVRDSEGQKLLIGVGPEGISICKDDFSPINRIAYPVVQMATQSGKNVYLTVTKESGNSIVLLFKMISTRAASGLYRAITETHAFYRCDTVTSA","Homo sapiens","MYLIP, BZF1, IDOL, BM-023, PP5242","E3 ubiquitin-protein ligase MYLIP","1","6QLZ"
"6QM0",,"X-RAY DIFFRACTION",2.06,40.35,"VAPOR DIFFUSION, HANGING DROP",6.1,"25mM ADA pH6.1, 250mM sodium nitrate and 20% PEG 5k.mme",291,,,"6QM0",48.67,"1.9","1.9","Cathepsin-K in complex with amino-oxaazabicyclo[3.3.0]octanyl containing inhibitor","RAPDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6QM0"
"6QMO",,"X-RAY DIFFRACTION",2.32,47.01,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2M magnesium formate",292.15,,,"6QMO",36.87,"1.87","1.87","Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289E and S308A mutations","GPMATVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAEAVNMEKFKKFAARKKWKQAVR","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","6QMO"
"6QMR",,"X-RAY DIFFRACTION",1.99,38.17,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG MME 2000, 0.1M sodium thiocyanate",293,"10.1021/acs.jmedchem.9b00271","J6T","6QMR",164.85,"2","2","Complement factor D in complex with the inhibitor (S)-2-(2-((3'-(1-amino-2-hydroxyethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)acetic acid","HSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6QMR"
"6QMT",,"X-RAY DIFFRACTION",1.71,28.2,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEGME 3350, 100 mM Bis-Tris pH 5.5",293,"10.1021/acs.jmedchem.9b00271","J7B","6QMT",54.92,"1.8","1.8","Complement factor D in complex with the inhibitor 2-(2-(3'-(aminomethyl)-[1,1'-biphenyl]-3-carboxamido)phenyl)acetic acid","HSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6QMT"
"6QMU",,"X-RAY DIFFRACTION",2.25,45.25,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.6 M ammonium sulfate",293,"10.1002/cbic.201900405",,"6QMU",44.02,"1.98","1.98","A tetrahedral boronic acid diester formed by a non-natural amino acid in the ligand pocket of an engineered lipocalin","QDSTSDLIPAPPLSKVPLQQNFQDNQFHGKWYVVGFAGNAILREDKDPQKMFATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKWVSQNREYFNITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDGSAWSHPQFEK","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","6QMU"
"6QN0",,"X-RAY DIFFRACTION",2.24,45.17,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M AMMONIUM ACETATE, 0.1M SODIUM CITRATE, PH 5.6, 31% PEG 4000, PROTEIN CONC. 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS DISSOLVED IN 100% DMSO)",294,"10.1016/j.ejmech.2019.111825",,"6QN0",121.4,"1.89","1.89","Three dimensional structure of human carbonic anhydrase XII in complex with benzenesulfonamide","ASKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6QN0"
"6QN2",,"X-RAY DIFFRACTION",3.46,64.47,"VAPOR DIFFUSION, SITTING DROP",4.5,"CRYSTALLIZATION CONDITIONS: 1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE)",294,"10.1016/j.ejmech.2019.111825",,"6QN2",114.75,"1.95","1.95","Three dimensional structure of human carbonic anhydrase IX in complex with benzenesulfonamide","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6QN2"
"6QN4",,"X-RAY DIFFRACTION",2.54,51.64,"VAPOR DIFFUSION, SITTING DROP",,"16% PEG 4000, 0.1 M Tris pH 8.5, 0.2 M sodium acetate",292.15,,,"6QN4",36.85,"2.5","2.5","Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289E and S308E mutations","GPMATVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAEAVNMEKFKKFAARKKWKQEVR","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","6QN4"
"6QN5",,"X-RAY DIFFRACTION",3.45,64.37,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE)",294,"10.1016/j.ejmech.2019.111825",,"6QN5",114.56,"1.96","1.96","Three dimensional structure of human carbonic anhydrase IX in complex with benzenesulfonamide","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6QN5"
"6QN6",,"X-RAY DIFFRACTION",3.43,64.16,"VAPOR DIFFUSION, SITTING DROP",4.5,"CRYSTALLIZATION CONDITIONS: 1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE)",294,"10.1016/j.ejmech.2019.111825",,"6QN6",114.66,"2.25","2.25","Three dimensional structure of human carbonic anhydrase IX in complex with benzenesulfonamide","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6QN6"
"6QNG",,"X-RAY DIFFRACTION",2.21,44.26,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M AMMONIUM ACETATE, 0.1M SODIUM CITRATE, PH 5.6, 31% PEG 4000, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS DISSOLVED IN 100% DMSO)",294,,"J95","6QNG",121.24,"1.67","1.67","Three dimensional structure of human carbonic anhydrase XII in complex with benzenesulfonamide","ASKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6QNG"
"6QNL",,"X-RAY DIFFRACTION",2.19,43.99,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M AMMONIUM ACETATE, 0.1M SODIUM CITRATE, PH 5.6, 31% PEG 4000, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS DISSOLVED IN 100% DMSO)",294,"10.1016/j.ejmech.2019.111825",,"6QNL",121.49,"1.53","1.53","Three dimensional structure of human carbonic anhydrase XII in complex with benzenesulfonamide","ASKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6QNL"
"6QNV",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, SITTING DROP",,"Morpheus 0.09M NPS, 0.1M Buffer System 3 pH = 8.5, 50% v/v Precipitant Mix 1",293.15,,,"6QNV",25.18,"1.4","1.4","Fibrinogen-like globe domain of Human Tenascin-C","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, HXB","Tenascin","1","6QNV"
"6QP5",,"X-RAY DIFFRACTION",2.14,42.57,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG4000 -- 0.2M lithium sulfate -- 0.1M tris pH 8.5",293,,,"6QP5",37.02,"1.9","1.9","Apo Human Calcium/Calmodulin-dependent kinase type 1D","SMSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQIRKNFAKSKWRQAFNATAVVRHMRKLHLGSSLD","Homo sapiens","CAMK1D, CAMKID","Calcium/calmodulin-dependent protein kinase type 1D","1","6QP5"
"6QPJ",,"X-RAY DIFFRACTION",2.15,42.82,"VAPOR DIFFUSION, SITTING DROP",,"20 mM MES pH 6.5
0.1M Magnesium sulfate
20 % PEG 3350",298,"10.1073/pnas.1905216116",,"6QPJ",18.31,"2.315","2.315","Human CLOCK PAS-A domain","MSNEEFTQLMLEALDGFFLAIMTDGSIIYVSESVTSLLEHLPSDLVDQSIFNFIPEGEHSEVYKILSTHLLESDSLTPEYLKSKNQLEFCCHMLRGTIDPKEPSTYEYVKFIGNFKSLNSVSSSAHNGFEGTIQRTHRPSYEDRVCFVATVRLATPQFIKE","Homo sapiens","CLOCK, BHLHE8, KIAA0334","Circadian locomoter output cycles protein kaput","1","6QPJ"
"6QPL",,"X-RAY DIFFRACTION",2.84,56.7,"VAPOR DIFFUSION, SITTING DROP",6,"60% MPD and 0.1 M SPG buffer pH 6.0",277,"10.1021/acs.jmedchem.9b00522","JC5","6QPL",26.5,"1.6","1.6","Crystal structure of Spindlin1 in complex with the inhibitor MS31","MPRRNIVGCRIQHGWKEGNGPVTQWKGTVLDQVPVNPSLYLIKYDGFDCVYGLELNKDERVSALEVLPDRVATSRISDAHLADTMIGKAVEHMFETEDGSKDEWRGMVLARAPVMNTWFYITYEKDPVLYMYQLLDDYKEGDLRIMPDSNDSPPAEREPGEVVDSLVGKQVEYAKEDGSKRTGMVIHQVEAKPSVYFIKFDDDFHIYVYDLVKTSAENLYFQ","Homo sapiens","SPIN1, OCR, SPIN","Spindlin-1","1","6QPL"
"6QRN",,"X-RAY DIFFRACTION",2.81,56.22,"VAPOR DIFFUSION, SITTING DROP",7.4,"PBS supplemented with 300 mM D-ribose. Cryoprotection: 25 % (w/v) PEG 400",293,"10.1126/science.aaw4295",,"6QRN",16.82,"1.4","1.4","Galectin-10 complexed with ribose","GHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6QRN"
"6QSB",,"X-RAY DIFFRACTION",2.77,55.66,"VAPOR DIFFUSION, SITTING DROP",,"10mM NaTetraBorate, 690-760mM NaCitrate",293,,,"6QSB",110.06,"1.99","1.99","Crystal Structure of Arg470His mutant of Human Prolidase with Mn ions","MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPHTVEEIEACMAGCDKAFTPFSGPK","Homo sapiens","PEPD, PRD","Xaa-Pro dipeptidase","1","6QSB"
"6QSC",,"X-RAY DIFFRACTION",2.77,55.53,"VAPOR DIFFUSION, SITTING DROP",,"10mM NaTetraBorate, 690-760mM NaCitrate",293,,,"6QSC",110.65,"1.569","1.569","Crystal Structure of Arg470His mutant of Human Prolidase with Mn ions and GlyPro ligand","MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECRVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPHTVEEIEACMAGCDKAFTPFSGPK","Homo sapiens","PEPD, PRD","Xaa-Pro dipeptidase","1","6QSC"
"6QST",,"X-RAY DIFFRACTION",2.78,55.8,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris propane pH 7.5, 0.02 M Sodium/potassium phosphate, 20% w/v PEG 3350",277,,,"6QST",58.68,"2.1","2.1","Structure of CREBBP bromodomain with compound 2 bound","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6QST"
"6QSW",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, SITTING DROP",,"2.0 M ammonium sulfate, 0.1 M sodium acetate (pH 4.6), 2 mM inhibitor",293,"10.1073/pnas.1820892116",,"6QSW",100.74,"1.64","1.64","Complement factor B protease domain in complex with the reversible inhibitor N-(2-bromo-4-methylnaphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine.","SLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGVVDVCKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFL","Homo sapiens","CFB, BF, BFD","Complement factor B","1","6QSW"
"6QSX",,"X-RAY DIFFRACTION",2.52,51.19,"VAPOR DIFFUSION, SITTING DROP",,"2.5 M ammonium sulfate, 0.1 mM sodium acetate (pH 4.6), 2 mM inhibitor",293,"10.1073/pnas.1820892116",,"6QSX",67.32,"1.77","1.77","Complement factor B protease domain in complex with the reversible inhibitor ((2S,4S)-1-((5,7-dimethyl-1H-indol-4-yl)methyl)-4-methoxypiperidin-2-yl)methanol.","SLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGVVDVCKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFL","Homo sapiens","CFB, BF, BFD","Complement factor B","1","6QSX"
"6QTY",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"24% PEG 3350, 200mM MgCl2, 100mM Bis-Tris (pH 6.5)",273,"10.1016/j.pep.2020.105742",,"6QTY",39.79,"1.65","1.65","Non-phosphorylated human CLK1 in complex with an indole inhibitor to 1.65 Ang","HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRRCKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6QTY"
"6QU2",,"X-RAY DIFFRACTION",3.23,61.89,"VAPOR DIFFUSION, SITTING DROP",8.75,"31% PEG 400, 0.25 M lithium sulfate and 0.1 M Tris, pH 8.75",277,,,"6QU2",171.99,"2.9","2.9","Crystal structure of DYRK1A complexed with FC162 inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6QU2"
"6QU7",,"X-RAY DIFFRACTION",3.67,66.45,"VAPOR DIFFUSION, HANGING DROP",,"2.3 M NH4SO4, 0.1 M Na-acetate, 30% Glycerol",293,"10.1038/s41375-019-0461-5",,"6QU7",41.29,"1.52","1.52","Crystal structure of human DHODH in complex with BAY 2402234","ATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6QU7"
"6QUT",,"X-RAY DIFFRACTION",3.45,64.37,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE)",294,"10.1016/j.ejmech.2019.111825",,"6QUT",112.87,"1.96","1.96","Three dimensional structure of human carbonic anhydrase IX in complex with benzenesulfonamide","WRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6QUT"
"6QUU",,"X-RAY DIFFRACTION",1.9,35.37,"VAPOR DIFFUSION",6.4,"52% MPD, 0.06M MES",277,"10.1002/chem.201902810",,"6QUU",44.15,"1.477","1.477","Crystal Structure of KRAS-G12D in complex with GMP-PCP","MHHHHHHSSGRENLYFQGMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6QUU"
"6QUV",,"X-RAY DIFFRACTION",2.1,41.45,"VAPOR DIFFUSION",6.4,"52% MPD, 0.06 M MES",277,"10.1002/chem.201902810","JJN","6QUV",40.21,"1.475","1.475","Crystal Structure of KRAS-G12D in complex with GMP-PCP and compound 15R","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6QUV"
"6QUW",,"X-RAY DIFFRACTION",2.1,41.48,"VAPOR DIFFUSION",6.4,"52% MPD, 0.06 M MES",277,"10.1002/chem.201902810",,"6QUW",40.08,"1.242","1.242","Crystal Structure of KRAS-G12D in Complex with Natural Product-Like Compound 9b","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6QUW"
"6QUX",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION",6.4,"52% MPD, 0.06 M MES",277,"10.1002/chem.201902810","JJN","6QUX",40.34,"1.62","1.62","Crystal Structure of KRAS-G12D in Complex with Natural Product-Like Compound 15","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6QUX"
"6QV6","3.63","ELECTRON MICROSCOPY",,,,,,,"10.1371/journal.pbio.3000218",,"6QV6",217.47,"3.63",,"CryoEM structure of the human ClC-1 chloride channel, membrane domain","MEQSRSQQRGGEQSWWGSDPQYQYMPFEHCTSYGLPSENGGLQHRLRKDAGPRHNVHPTQIYGHHKEQFSDREQDIGMPKKTGSSSTVDSKDEDHYSKCQDCIHRLGQVVRRKLGEDGIFLVLLGLLMALVSWSMDYVSAKSLQAYKWSYAQMQPSLPLQFLVWVTFPLVLILFSALFCHLISPQAVGSGIPEMKTILRGVVLKEYLTMKAFVAKVVALTAGLGSGIPVGKEGPFVHIASICAAVLSKFMSVFCGVYEQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFFAATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGLPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL","Homo sapiens","CLCN1, CLC1","Chloride channel protein 1","1","6QV6"
"6QVB","4.34","ELECTRON MICROSCOPY",,,,,,,"10.1371/journal.pbio.3000218",,"6QVB",217.47,"4.34",,"CryoEM structure of the human ClC-1 chloride channel, CBS state 3","MEQSRSQQRGGEQSWWGSDPQYQYMPFEHCTSYGLPSENGGLQHRLRKDAGPRHNVHPTQIYGHHKEQFSDREQDIGMPKKTGSSSTVDSKDEDHYSKCQDCIHRLGQVVRRKLGEDGIFLVLLGLLMALVSWSMDYVSAKSLQAYKWSYAQMQPSLPLQFLVWVTFPLVLILFSALFCHLISPQAVGSGIPEMKTILRGVVLKEYLTMKAFVAKVVALTAGLGSGIPVGKEGPFVHIASICAAVLSKFMSVFCGVYEQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFFAATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGLPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL","Homo sapiens","CLCN1, CLC1","Chloride channel protein 1","1","6QVB"
"6QVC","4","ELECTRON MICROSCOPY",,,,,,,"10.1371/journal.pbio.3000218",,"6QVC",217.47,"4",,"CryoEM structure of the human ClC-1 chloride channel, CBS state 1","MEQSRSQQRGGEQSWWGSDPQYQYMPFEHCTSYGLPSENGGLQHRLRKDAGPRHNVHPTQIYGHHKEQFSDREQDIGMPKKTGSSSTVDSKDEDHYSKCQDCIHRLGQVVRRKLGEDGIFLVLLGLLMALVSWSMDYVSAKSLQAYKWSYAQMQPSLPLQFLVWVTFPLVLILFSALFCHLISPQAVGSGIPEMKTILRGVVLKEYLTMKAFVAKVVALTAGLGSGIPVGKEGPFVHIASICAAVLSKFMSVFCGVYEQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFFAATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGLPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL","Homo sapiens","CLCN1, CLC1","Chloride channel protein 1","1","6QVC"
"6QVD","4.34","ELECTRON MICROSCOPY",,,,,,,"10.1371/journal.pbio.3000218",,"6QVD",217.47,"4.34",,"CryoEM structure of the human ClC-1 chloride channel, CBS state 2","MEQSRSQQRGGEQSWWGSDPQYQYMPFEHCTSYGLPSENGGLQHRLRKDAGPRHNVHPTQIYGHHKEQFSDREQDIGMPKKTGSSSTVDSKDEDHYSKCQDCIHRLGQVVRRKLGEDGIFLVLLGLLMALVSWSMDYVSAKSLQAYKWSYAQMQPSLPLQFLVWVTFPLVLILFSALFCHLISPQAVGSGIPEMKTILRGVVLKEYLTMKAFVAKVVALTAGLGSGIPVGKEGPFVHIASICAAVLSKFMSVFCGVYEQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFFAATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGLPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL","Homo sapiens","CLCN1, CLC1","Chloride channel protein 1","1","6QVD"
"6QVG",,"X-RAY DIFFRACTION",3.38,63.61,"VAPOR DIFFUSION",,"0.1 M Bis-tris pH 6.5, 28 % PEGMME2000",291,"10.1002/1873-3468.13455",,"6QVG",114.07,"2.32","2.32","Human SHMT2 in complex with lometrexol","MLYFSLFWAARPLQRCGQLVRMAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","1","6QVG"
"6QVL",,"X-RAY DIFFRACTION",3.46,64.45,"VAPOR DIFFUSION",,"0.2 M LiCl2, 0.1 M MES pH 6.0, 20 % PEG6000",291,"10.1002/1873-3468.13455",,"6QVL",113.48,"2.28","2.28","Human SHMT2 in complex with pemetrexed","MLYFSLFWAARPLQRCGQLVRMAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","1","6QVL"
"6QVO",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",,"0.1 M sodium acetate pH 3.5, 26 % PEG3350, 0.2 M LiSO4",293,"10.1074/jbc.RA120.012636",,"6QVO",92.22,"2.45","2.45","Crystal structure of human MTH1 in complex with N6-methyl-dAMP","MYWSNQITRRLGERVQGFMSGISPQQMGEPEGSWSGKNPGTMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6QVO"
"6QVS",,"X-RAY DIFFRACTION",3.31,62.84,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.1 M Ammonium Acetate, 8% (w/v) PEG 20.000",293,"10.1016/j.jsb.2020.107628",,"6QVS",63.91,"1.6","1.6","Unliganded structure of the human wild type Beta-galactoside alpha-2,6-sialyltransferase 1 (ST6Gal1)","GIKFSAEALRCHLRDHVNVSMVEVTDFPFNTSEWEGYLPKESIRTKAGPWGRCAVVSSAGSLKSSQLGREIDDHDAVLRFNGAPTANFQQDVGTKTTIRLMNSQLVTTEKRFLKDSLYNEGILIVWDPSVYHSDIPKWYQNPDYNFFNNYKTYRKLHPNQPFYILKPQMPWELWDILQEISPEEIQPNPPSSGMLGIIIMMTLCDQVDIYEFLPSKRKTDVCYYYQKFFDSACTMGAYHPLLYEKNLVKHLNQGTDEDIYLLGKATLPGFRTIHC","Homo sapiens","ST6GAL1, SIAT1","Beta-galactoside alpha-2,6-sialyltransferase 1","1","6QVS"
"6QVT",,"X-RAY DIFFRACTION",3.21,61.62,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris pH 5.5, 0.1 M Ammonium Acetate, 10% (w/v) PEG 6000",293,"10.1016/j.jsb.2020.107628",,"6QVT",65.05,"1.7","1.7","CMP-Sialic acid bound structure of the human wild type Beta-galactoside alpha-2,6-sialyltransferase 1 (ST6Gal1)","GIKFSAEALRCHLRDHVNVSMVEVTDFPFNTSEWEGYLPKESIRTKAGPWGRCAVVSSAGSLKSSQLGREIDDHDAVLRFNGAPTANFQQDVGTKTTIRLMNSQLVTTEKRFLKDSLYNEGILIVWDPSVYHSDIPKWYQNPDYNFFNNYKTYRKLHPNQPFYILKPQMPWELWDILQEISPEEIQPNPPSSGMLGIIIMMTLCDQVDIYEFLPSKRKTDVCYYYQKFFDSACTMGAYHPLLYEKNLVKHLNQGTDEDIYLLGKATLPGFRTIHC","Homo sapiens","ST6GAL1, SIAT1","Beta-galactoside alpha-2,6-sialyltransferase 1","1","6QVT"
"6QVU","4.2","ELECTRON MICROSCOPY",,,,,,,"10.1371/journal.pbio.3000218",,"6QVU",217.47,"4.2",,"CryoEM structure of the human ClC-1 chloride channel, low pH","MEQSRSQQRGGEQSWWGSDPQYQYMPFEHCTSYGLPSENGGLQHRLRKDAGPRHNVHPTQIYGHHKEQFSDREQDIGMPKKTGSSSTVDSKDEDHYSKCQDCIHRLGQVVRRKLGEDGIFLVLLGLLMALVSWSMDYVSAKSLQAYKWSYAQMQPSLPLQFLVWVTFPLVLILFSALFCHLISPQAVGSGIPEMKTILRGVVLKEYLTMKAFVAKVVALTAGLGSGIPVGKEGPFVHIASICAAVLSKFMSVFCGVYEQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFFAATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGLPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL","Homo sapiens","CLCN1, CLC1","Chloride channel protein 1","1","6QVU"
"6QVW",,"SOLUTION NMR",,,,,,,"10.3390/cells8090966",,"6QVW",13.21,,,"Solution structure of the free FOXO1 DNA binding domain","GPLGSAWGNLSYADLITKAIESSAEKRLTLSQIYEWMVKSVPYFKDKGDSNSSAGWKNSIRHNLSLHSKFIRVQNEGTGKSSWWMLNPEGGKSGKSPRRRAASMDNNSKFAKSRGRAAK","Homo sapiens","FOXO1, FKHR, FOXO1A","Forkhead box protein O1","1","6QVW"
"6QW3",,"X-RAY DIFFRACTION",1.8,31.74,"VAPOR DIFFUSION, SITTING DROP",5.5,"36% PEG5000 MME, 0.1M Sodium Acetate",298,"10.1016/j.bbrc.2019.08.013",,"6QW3",13.21,"1.3","1.3","Calcium-bound gelsolin domain 2","GSHHVVPNEVVVQRLFQVKGRRVVRATEVPVSWESFNNGDCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAA","Homo sapiens","GSN","Gelsolin","1","6QW3"
"6QWV",,"X-RAY DIFFRACTION",2.92,57.84,"VAPOR DIFFUSION",,"2% Tacsimate pH=7, 5% v/v 2-Propanol, 0.1 M Imidazole pH=7, 8% w/v polyethylene glycol 3350",293,"10.1016/j.jmb.2019.06.030",,"6QWV",305.93,"2.47","2.47","SARM1 SAM1-2 domains","GSSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTWLQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYSTCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILTAAREMLHS","Homo sapiens","SARM1, KIAA0524, SAMD2, SARM","Sterile alpha and TIR motif-containing protein 1","1","6QWV"
"6QXG",,"X-RAY DIFFRACTION",2.4,48.74,"VAPOR DIFFUSION, HANGING DROP",9,"27-30 % wt/vol PEG4000, 30 mM ammonium sulfate and 0.1 M TRIS, pH 9",293,"10.3390/molecules24071257","UFP","6QXG",112.58,"2.08","2.08","Crystal structure of His-tag human thymidylate synthase (HT-hTS) in complex with FdUMP","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","6QXG"
"6QXH",,"X-RAY DIFFRACTION",2.59,52.43,"VAPOR DIFFUSION, HANGING DROP",9,"27-30 % wt/vol PEG4000, 30 mM ammonium sulfate and 0.1 M TRIS, pH 9",293,"10.3390/molecules24071257",,"6QXH",112.81,"2.04","2.04","Crystal structure of His-tag human thymidylate synthase (HT-hTS) in complex with dUMP","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","6QXH"
"6QXU",,"X-RAY DIFFRACTION",2.37,48.19,"VAPOR DIFFUSION, HANGING DROP",7,"1.0 M Ammonium Sulfate, 0.1 M HEPES pH 7.0, 0.5% w/v PEG 8000",277,"10.1021/acs.jmedchem.9b00656","JKN","6QXU",24.67,"1.2","1.2","Human TNKS1 in complex with 6,8-Difluoro-2-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-3H-quinazolin-4-one","QGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTMKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPE","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Poly [ADP-ribose] polymerase tankyrase-1","1","6QXU"
"6QY7",,"X-RAY DIFFRACTION",3.17,61.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"10% PEG6000, 2M sodium chloride",277,,,"6QY7",81.23,"2.1","2.1","Human CSNK2A1 bound to ERB-041","SMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6QY7"
"6QY8",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% (w/v) PEG10000, 0.1M HEPES pH 7.5",293,,,"6QY8",160.82,"1.7","1.7","Human CSNK2A2 bound to ERB-041","SMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQP","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6QY8"
"6QY9",,"X-RAY DIFFRACTION",2.24,45.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M potassium nitrate",277,,,"6QY9",40.5,"1.5","1.5","Human CSNK2A2 bound to a Pyrrolo[2,3-d]pyrimidinyl inhibitor","SMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQP","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","6QY9"
"6QYP",,"X-RAY DIFFRACTION",1.96,37.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M BIS-TRIS pH 6.5; 30% Pentaerythritol ethoxylate (15/4 EO/OH), 0.05M Ammonium Sulphate",293,"10.1021/acs.jmedchem.9b00134",,"6QYP",20.06,"2.2","2.2","Structure of Mcl-1 in complex with compound 13","MHHHHHHLVPRGSEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6QYP"
"6QYQ",,"X-RAY DIFFRACTION",2.21,44.48,"VAPOR DIFFUSION, HANGING DROP",8.3,"25 % saturated ammonium sulfate, 20 mM beta-mercaptoethanol and 0.1 M TRIS, pH 8.3",293,"10.3390/molecules24071362",,"6QYQ",150.77,"2.25","2.25","Crystal structure of human thymidylate synthase (hTS) variant R175C","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDCRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","6QYQ"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDCRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","2","6QYQ"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDCRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","3","6QYQ"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDCRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","4","6QYQ"
"6QZ5",,"X-RAY DIFFRACTION",1.93,36.25,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M BIS-TRIS pH 6.5, 30% v/v Pentaerythritol ethoxylate (15/4 EO/OH), 0.05M Ammonium Sulphate",293,"10.1021/acs.jmedchem.9b00134",,"6QZ5",19.94,"2","2","Structure of Mcl-1 in complex with compound 8a","MHHHHHHLVPRGSEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6QZ5"
"6QZ6",,"X-RAY DIFFRACTION",2.02,39.15,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M BIS-TRIS pH 6.5, 30% v/v Pentaerythritol ethoxylate (15/4 EO/OH), 0.05M Ammonium Sulphate",293,"10.1021/acs.jmedchem.9b00134",,"6QZ6",19.94,"1.9","1.9","Structure of Mcl-1 in complex with compound 8b","MHHHHHHLVPRGSEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6QZ6"
"6QZ8",,"X-RAY DIFFRACTION",1.88,34.71,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M BIS-TRIS pH 6.5, 30% v/v Pentaerythritol ethoxylate (15/4 EO/OH), 0.05M Ammonium Sulphate",293,"10.1021/acs.jmedchem.9b00134",,"6QZ8",19.96,"2.15","2.15","Structure of Mcl-1 in complex with compound 10d","MHHHHHHLVPRGSEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6QZ8"
"6QZB",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M BIS-TRIS pH 6.5, 30% v/v Pentaerythritol ethoxylate (15/4 EO/OH), 0.05M Ammonium Sulphate",293,"10.1021/acs.jmedchem.9b00134",,"6QZB",19.91,"2","2","Structure of Mcl-1 in complex with compound 8d","MHHHHHHLVPRGSEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6QZB"
"6QZI",,"X-RAY DIFFRACTION",2.86,56.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"85 mM Tris pH 8.0, 37 % v/v PEG 200 and 0.80 % v/v OG",277,"10.1016/j.str.2019.11.011",,"6QZI",28.34,"1.9","1.9","Crystal structure of human Aquaporin 7 at 1.9 A resolution","MVREFLAEFMSTYVMMVFGLGSVAHMVLNKKYGSYLGVNLGFGFGVTMGVHVAGRISGAHMNAAVTFANCALGRVPWRKFPVYVLGQFLGSFLAAATIYSLFYTAILHFSGGQLMVTGPVATAGIFATYLPDHMTLWRGFLNEAWLTGMLQLCLFAITDQENNPALPGTEALVIGILVVIIGVSLGMNTGYAINPSRDLPPRIFTFIAGWGKQVFSNGENWWWVPVVAPLLGAYLGGIIYLVFIGST","Homo sapiens","AQP7, AQP7L, AQP9","Aquaporin-7","1","6QZI"
"6QZJ",,"X-RAY DIFFRACTION",2.94,58.12,"VAPOR DIFFUSION, HANGING DROP",8.5,"85 mM Tris pH 8.0, 37 % v/v PEG 200 and 0.80 % v/v OG",277,"10.1016/j.str.2019.11.011",,"6QZJ",27.97,"2.2","2.2","Crystal structure of human Aquaporin 7 at 2.2 A resolution","MVREFLAEFMSTYVMMVFGLGSVAHMVLNKKYGSYLGVNLGFGFGVTMGVHVAGRISGAHMNAAVTFANCALGRVPWRKFPVYVLGQFLGSFLAAATIYSLFYTAILHFSGGQLMVTGPVATAGIFATYLPDHMTLWRGFLNEAWLTGMLQLCLFAITDQENNPALPGTEALVIGILVVIIGVSLGMNTGYAINPSRDLPPRIFTFIAGWGKQVFSNGENWWWVPVVAPLLGAYLGGIIYLVFIGST","Homo sapiens","AQP7, AQP7L, AQP9","Aquaporin-7","1","6QZJ"
"6QZL",,"X-RAY DIFFRACTION",2.14,42.6,"VAPOR DIFFUSION, SITTING DROP",,"21% PEG Smear Broad -- 0.1M citrate/phosphate pH 5.7",293,,,"6QZL",71.66,"1.98","1.98","Structure of the H1 domain of human KCTD12","SMDGSRRSGYITIGYRGSYTIGRDAQADAKFRRVARITVCGKTSLAKEVFGDTLNESRDPDRPPERYTSRYYLKFNFLEQAFDKLSESGFHMVACSSTGTCAFASSTDQSEDKIWTSYTEYVFCRE","Homo sapiens","KCTD12, C13orf2, KIAA1778, PFET1","BTB/POZ domain-containing protein KCTD12","1","6QZL"
"6R14",,"SOLUTION NMR",,,,,,,,,"6R14",7.71,,,"Structure of kiteplatinated dsDNA","CCTCAGGCCTCC","Homo sapiens",,"Kiteplatinated DNA oligomer, chain A","1","6R14"
,,,,,,,,,,,,,,,,"GGAGGCCTGAGG","Homo sapiens",,"Kiteplatinated DNA oligomer, chain B","2","6R14"
"6R2E",,"X-RAY DIFFRACTION",4.18,70.56,"VAPOR DIFFUSION, HANGING DROP",9,"2.0-2.2 M ammonium sulfate, 0.1 M bicine pH 9.0",293,"10.3390/biom9040134",,"6R2E",304.63,"2.55","2.55","Crystal structure of the human thymidylate synthase (hTS) interface variant Q62R","MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMRARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","6R2E"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMRARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","2","6R2E"
"6R2F",,"X-RAY DIFFRACTION",2.78,55.69,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M lithum nitrate, 40 % MPD",293,,,"6R2F",37.3,"2.29","2.29","Crystal structure of TEX12 F102A F109E V116A in an alternative conformation","GSMGKDEALEKDLNDVSKEINLMLSTYAKLLSERAAVDASYIDEIDELFKEANAIENALIQKREELRQRFTAIANTLHR","Homo sapiens","TEX12","Testis-expressed protein 12","1","6R2F"
"6R2U",,"X-RAY DIFFRACTION",3.7,66.73,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.3 M (NH4)2SO4, 100 mM Hepes",294,"10.1042/BCJ20190354","11D","6R2U",198.75,"2.49","2.49","Zinc-alpha2-Glycoprotein with a Fluorescent Dansyl C 11 Fatty Acid","MQENQDGRYSLTYIYTGLSKHVEDVPAFQALGSLNDLQFFRYNSKDRKSQPMGLWRQVEGMEDWKQDSQLQKAREDIFMETLKDIVEYYNDSNGSHVLQGRFGCEIENNRSSGAFWKYYYDGKDYIEFNKEIPAWVPFDPAAQITKQKWEAEPVYVQRAKAYLEEECPATLRKYLKYSKNILDRQDPPSVVVTSHQAPGEKKKLKCLAYDFYPGKIDVHWTRAGEVQEPELRGDVLHNGNGTYQSWVVVAVPPQDTAPYSCHVQHSSLAQPLVVPWEAS","Homo sapiens","AZGP1, ZAG, ZNGP1","Zinc-alpha-2-glycoprotein","1","6R2U"
"6R2X",,"SOLUTION NMR",,,,,,,"10.1039/c9cc08518a",,"6R2X",3.04,,,"NMR structure of Chromogranin A (F39-D63)","FETLRGDERILSILRHQNLLKELQD","Homo sapiens","CHGA","Chromogranin-A","1","6R2X"
"6R3D",,"X-RAY DIFFRACTION",2.46,49.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"24% PEG 3350, 200mM MgCl2, 100mM BisTris (pH 6.5)",293,,,"6R3D",39.73,"1.85","1.85","Crystal structure of di-phosphorylated human CLK1 in complex with 4-(6,7-dichloro-1H-indol-3-yl)pyrimidin-2-amine","HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRRCKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6R3D"
"6R3E",,"X-RAY DIFFRACTION",3.77,67.37,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES, 0.2 M Li2SO4, 23-33% PEG3350",298,,,"6R3E",62.33,"2.269","2.269","Human DNMT3B PWWP domain in complex with triisopropanolamine","SEYQDGKEFGIGDLVWGKIKGFSWWPAMVVSWKATSKRQAMSGMRWVQWFGDGKFSEVSADKLVALGLFSQHFNLATFNKLVSYRKAMYHALEKARVRAGKTFPSSPGDSLEDQLKPMLEWAHGGFKPTGIEGLKPNSEYQDGKEFGIGDLVWGKIKGFSWWPAMVVSWKATSKRQAMSGMRWVQWFGDGKFSEVSADKLVALGLFSQHFNLATFNKLVSYRKAMYHALEKARVRAGKTFPSSPGDSLEDQLKPMLEWAHGGFKPTGIEGLKPN","Homo sapiens","DNMT3B","DNA (cytosine-5)-methyltransferase 3B,DNA (cytosine-5)-methyltransferase 3B","1","6R3E"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNMT3B"
"6R3K",,"X-RAY DIFFRACTION",2.4,48.67,"VAPOR DIFFUSION, SITTING DROP",,"0.01 M Tris pH 8.4 containing 0.28 M sodium chloride and 27% (w/v) PEG 4000",298,"10.1021/acs.jmedchem.1c00957","JQT","6R3K",60.12,"2.2","2.2","Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor","AFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALEHHHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6R3K"
"6R3P",,"X-RAY DIFFRACTION",2.96,58.43,"VAPOR DIFFUSION, HANGING DROP",7.2,"50 mM HEPES-NaOH pH 7.2, 50 mM MgCl2, 500 mM NaCl, 7.5 % PEG3350",293,,,"6R3P",116.81,"2.05","2.05","Crystal structure of human DMC1 ATPase domain","GSMPGFLTAFEYSEKRKMVFHITTGSQEFDKLLGGGIESMAITEAFGEFRTGKTQLSHTLCVTAQLPGAGGYPGGKIIFIDTENTFRPDRLRDIADRFNVDHDAVLDNVLYARAYTSEHQMELLDYVAAKFHEEAGIFKLLIIDSIMALFRVDFSGRGELAERQQKLAQMLSRLQKISEEYNVAVFVTNQMTADPGATMTFQADPKKPIGGHILAHASTTRISLRKGRGELRIAKIYDSPEMPENEATFAITAGGIGDAKE","Homo sapiens","DMC1, DMC1H, LIM15","Meiotic recombination protein DMC1/LIM15 homolog","1","6R3P"
"6R49",,"X-RAY DIFFRACTION",2.58,52.31,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, pH 8.5: 0.5 M NaCl: 0.2 M MgCl2: 32.5 % v/v PEG 3350",298,"10.1002/chem.201900815",,"6R49",33.73,"2.209","2.209","Aurora-A in complex with shape-diverse fragment 39","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLAGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNAQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6R49"
"6R4A",,"X-RAY DIFFRACTION",2.55,51.78,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, pH 8.5: 0.5 M NaCl: 0.2 M MgCl2: 32.5 % v/v PEG 3350",298,"10.1002/chem.201900815",,"6R4A",34.05,"1.937","1.937","Aurora-A in complex with shape-diverse fragment 55","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLAGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNAQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6R4A"
"6R4B",,"X-RAY DIFFRACTION",2.56,51.91,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, pH 8.5: 0.5 M NaCl: 0.2 M MgCl2: 32.5 % v/v PEG 3350",298,"10.1002/chem.201900815",,"6R4B",33.88,"2.15","2.15","Aurora-A in complex with shape-diverse fragment 56","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLAGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNAQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6R4B"
"6R4C",,"X-RAY DIFFRACTION",2.56,51.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, pH 8.5: 0.5 M NaCl: 0.2 M MgCl2: 32.5 % v/v PEG 3350",298,"10.1002/chem.201900815",,"6R4C",33.84,"2.04","2.04","Aurora-A in complex with shape-diverse fragment 57","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLAGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNAQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6R4C"
"6R4D",,"X-RAY DIFFRACTION",2.6,52.77,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, pH 8.5: 0.5 M NaCl: 0.2 M MgCl2: 32.5 % v/v PEG 3350",298,"10.1002/chem.201900815",,"6R4D",33.79,"2.009","2.009","Aurora-A in complex with shape-diverse fragment 58","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLAGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNAQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6R4D"
"6R4E",,"X-RAY DIFFRACTION",3.16,61.11,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.25, 0.4 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6R4E",156.22,"2.353","2.353","Crystal structure of human GFAT-1 in complex with Glucose-6-Phosphate and L-Glu","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6R4E"
"6R4F",,"X-RAY DIFFRACTION",3.16,61.12,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 9.0, 0.25 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6R4F",155.91,"2.501","2.501","Crystal structure of human GFAT-1 in complex with Glucose-6-Phosphate","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6R4F"
"6R4G",,"X-RAY DIFFRACTION",3.16,61.12,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.75, 0.4 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6R4G",157.18,"2.501","2.501","Crystal structure of human GFAT-1 in complex with UDP-GlcNAc","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6R4G"
"6R4H",,"X-RAY DIFFRACTION",3.11,60.39,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.25, 0.4 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6R4H",156.36,"2.244","2.244","Crystal structure of human GFAT-1 G451E","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVESSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6R4H"
"6R4I",,"X-RAY DIFFRACTION",3.11,60.44,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 8.5, 0.35 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6R4I",156.2,"2.586","2.586","Crystal structure of human GFAT-1 G461E","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVGSSISRETDCEVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6R4I"
"6R4J",,"X-RAY DIFFRACTION",3.07,59.9,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis tris propane pH 9.0, 0.4 M Potassium sodium tartrate, 20 % PEG3350",293.15,"10.1038/s41467-020-14524-5",,"6R4J",157.47,"2.42","2.42","Crystal structure of human GFAT-1 G451E in complex with UDP-GlcNAc","MCGIFAYLNYHVPRTRREILETLIKGLQRLEYRGYDSAGVGFDGGNDKDWEANACKIQLIKKKGKVKALDEEVHKQQDMDLDIEFDVHLGIAHTRWATHGEPSPVNSHPQRSDKNNEFIVIHNGIITNYKDLKKFLESKGYDFESETDTETIAKLVKYMYDNRESQDTSFTTLVERVIQQLEGAFALVFKSVHFPGQAVGTRRGSPLLIGVRSEHKLSTDHIPILYRTGKDKKGSCNLSRVDSTTCLFPVEEKAVEYYFASDASAVIEHTNRVIFLEDDDVAAVVDGRLSIHRIKRTAGHHHHHHDHPGRAVQTLQMELQQIMKGNFSSFMQKEIFEQPESVVNTMRGRVNFDDYTVNLGGLKDHIKEIQRCRRLILIACGTSYHAGVATRQVLEELTELPVMVELASDFLDRNTPVFRDDVCFFLSQSGETADTLMGLRYCKERGALTVGITNTVESSISRETDCGVHINAGPEIGVASTKAYTSQFVSLVMFALMMCDDRISMQERRKEIMLGLKRLPDLIKEVLSMDDEIQKLATELYHQKSVLIMGRGYHYATCLEGALKIKEITYMHSEGILAGELKHGPLALVDKLMPVIMIIMRDHTYAKCQNALQQVVARQGRPVVICDKEDTETIKNTKRTIKVPHSVDCLQGILSVIPLQLLAFHLAVLRGYDVDFPRNLAKSVTVE","Homo sapiens","GFPT1, GFAT, GFPT","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1","1","6R4J"
"6R4S",,"X-RAY DIFFRACTION",2.51,50.91,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 10% ethylene glycol, 200 mM Na/K tartrate",292,"10.1021/acschembio.9b00367",,"6R4S",98.81,"2.75","2.75","Crystal structure of the Pri1 subunit of human primase bound to ATP","GTSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDAISTNEEEKEENEAESDVKHRTRDYKKTSLAPYVKVFEHFLENLDKSRK","Homo sapiens","PRIM1","DNA primase small subunit","1","6R4S"
"6R4T",,"X-RAY DIFFRACTION",2.56,51.87,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 10% ethylene glycol, 200 mM Na/K tartrate",292,"10.1021/acschembio.9b00367",,"6R4T",98.82,"2.35","2.35","Crystal structure of the Pri1 subunit of human primase bound to vidarabine triphosphate","GTSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDAISTNEEEKEENEAESDVKHRTRDYKKTSLAPYVKVFEHFLENLDKSRK","Homo sapiens","PRIM1","DNA primase small subunit","1","6R4T"
"6R4U",,"X-RAY DIFFRACTION",2.49,50.55,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 10% ethylene glycol, 200 mM Na/K tartrate",292,"10.1021/acschembio.9b00367",,"6R4U",98.9,"2.2","2.2","Crystal structure of the Pri1 subunit of human primase bound to fludarabine triphosphate","GTSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDAISTNEEEKEENEAESDVKHRTRDYKKTSLAPYVKVFEHFLENLDKSRK","Homo sapiens","PRIM1","DNA primase small subunit","1","6R4U"
"6R4V",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M sodium formate, 12% w/v PEG 3350.Soaked with mother liquor + 350 uM ibandronate.",292,"10.1124/mol.119.117499","BFQ","6R4V",215.13,"2.202","2.202","Crystal structure of human geranylgeranyl diphosphate synthase bound to ibandronate","GSGSGSGMEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIIIEVTEMLHNASLLIDDIEDNSKLRRGFPVAHSIYGIPSVINSANYVYFLGLEKVLTLDHQDAVKLFTRQLLELHQGQGLDIYWRDNYTCPTEEEYKAMVLQKTGGLFGLAVGLMQLFSDYKEDLKPLLNTLGLFFQIRDDYANLHSKEYSENKSFCEDLTEGKFSFPTIHAIWSRPESTQVQNILRQRTENIDIKKYCVHYLEDVGSFEYTRNTLKELEAKAYKQIDARGGNPELVALVKHLSKMFKEENE","Homo sapiens","GGPS1","Geranylgeranyl pyrophosphate synthase","1","6R4V"
"6R5D",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 10% ethylene glycol, 200 mM Na/K tartrate",292,"10.1021/acschembio.9b00367",,"6R5D",99.46,"1.95","1.95","Crystal structure of the Pri1 subunit of human primase bound to dATP","GTSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDAISTNEEEKEENEAESDVKHRTRDYKKTSLAPYVKVFEHFLENLDKSRK","Homo sapiens","PRIM1","DNA primase small subunit","1","6R5D"
"6R5E",,"X-RAY DIFFRACTION",2.52,51.26,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 10% ethylene glycol, 200 mM Na/K tartrate",292,"10.1021/acschembio.9b00367",,"6R5E",99.46,"1.85","1.85","Crystal structure of the Pri1 subunit of human primase bound to 2F-ATP","GTSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDAISTNEEEKEENEAESDVKHRTRDYKKTSLAPYVKVFEHFLENLDKSRK","Homo sapiens","PRIM1","DNA primase small subunit","1","6R5E"
"6R5F",,"X-RAY DIFFRACTION",2.21,44.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M Ammonium Fluoride, 20% PEG3350 and 4mM DHP77",277,"10.1021/acs.jmedchem.9b00318",,"6R5F",139.9,"3.25","3.25","Crystal structure of RIP1 kinase in complex with DHP77","MDYKDDDDKMQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6R5F"
"6R63",,"X-RAY DIFFRACTION",3.15,61,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 1500, 0.1 M Tris pH 8.5, 0.15 M Potassium thiocyanate",291,"10.1021/acs.jmedchem.9b00942",,"6R63",96.83,"2.894","2.894","Crystal structure of indoleamine 2,3-dioxygenase 1 (IDO1) in complex with ferric heme and MMG-0358","MGSSHHHHHHSSGLVPRGSHMASAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6R63"
"6R65",,"X-RAY DIFFRACTION",4.34,71.66,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M calcium acetate
0.1M HEPES pH 7.0
22% PEG400
1CMC C12E9",293,"10.1038/s41467-019-11753-1",,"6R65",154.79,"3.5","3.5","Crystal Structure of human TMEM16K / Anoctamin 10 (Form 2)","MKVTLSALDTSESSFTPLVVIELAQDVKEETKEWLKNRIIAKKKDGGAQLLFRPLLNKYEQETLENQNLYLVGASKIRMLLGAEAVGLVKECNDNTMRAFTYRTRQNFKGFDDNNDDFLTMAECQFIIKHELENLRAKDEKMIPGYPQAKLYPGKSLLRRLLTSGIVIQVFPLHDSEALKKLEDTWYTRFALKYQPIDSIRGYFGETIALYFGFLEYFTFALIPMAVIGLPYYLFVWEDYDKYVIFASFNLIWSTVILELWKRGCANMTYRWGTLLMKRKFEEPRPGFHGVLGINSITGKEEPLYPSYKRQLRIYLVSLPFVCLCLYFSLYVMMIYFDMEVWALGLHENSGSEWTSVLLYVPSIIYAIVIEIMNRLYRYAAEFLTSWENHRLESAYQNHLILKVLVFNFLNCFASLFYIAFVLKDMKLLRQSLATLLITSQILNQIMESFLPYWLQRKHGVRVKRKVQALKADIDATLYEQVILEKEMGTYLGTFDDYLELFLQFGYVSLFSCVYPLAAAFAVLNNFTEVNSDALKMCRVFKRPFSEPSANIGVWQLAFETMSVISVVTNCALIGMSPQVNAVFPESKADLILIVVAVEHALLALKFILAFAIPDKPRHIQMKLARLEFESLEALKQQQMKLVTENLKEEPMESGKEKATAENLYFQ","Homo sapiens","ANO10, TMEM16K","Anoctamin-10","1","6R65"
"6R66",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, HANGING DROP",7,"2.2 M ammonium sulfate, 0.1M KCl, 30 mM sodium phosphate, pH 7.0",298,"10.1016/j.jsb.2019.08.011",,"6R66",32.46,"1.3","1.3","Crystal structure of transthyretin in complex with CHF5075, a flurbiprofen analogue","MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6R66"
"6R67",,"X-RAY DIFFRACTION",1.81,31.87,"VAPOR DIFFUSION, HANGING DROP",7,"2.2 M ammonium sulfate, 0.1M KCl, 30 mM sodium phosphate, pH 7.0",293,"10.1016/j.jsb.2019.08.011",,"6R67",32.35,"1.3","1.3","Crystal structure of transthyretin in complex with CHF5075, a flurbiprofen analogue","MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6R67"
"6R68",,"X-RAY DIFFRACTION",2.32,47.07,"VAPOR DIFFUSION, HANGING DROP",7,"2.2 M ammonium sulfate, 0.1M KCl, 30 mM sodium phosphate, pH 7.0",293,"10.1016/j.jsb.2019.08.011",,"6R68",32.44,"1.45","1.45","Crystal structure of transthyretin in complex with CHF4795, a flurbiprofen analogue","MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6R68"
"6R6E",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, SITTING DROP",6.5,"24% PEG 3350, 200mM MgCl2, 100mM BisTris (pH 6.5)",293,,,"6R6E",39.74,"2.25","2.25","Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1-methyl-1H-indol-3-yl)pyrimidin-4-amine","HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRRCKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6R6E"
"6R6F",,"X-RAY DIFFRACTION",2.11,41.82,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer: 0.1M sodium bicine (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1016/j.ejmech.2019.111825",,"6R6F",29.83,"1.2","1.2","Crystal structure of human carbonic anhydrase isozyme II with 4-chloro-2-cyclohexylsulfanyl-N-(2-hydroxyethyl)-5-sulfamoyl-benzamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6R6F"
"6R6I",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION, HANGING DROP",7,"2.2 M ammonium sulfate, 0.1M KCl, 30 mM sodium phosphate, pH 7.0",293,"10.1016/j.jsb.2019.08.011",,"6R6I",32.71,"1.467","1.467","Crystal structure of transthyretin mutant A25T in complex with CHF5074, a flurbiprofen analogue","MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPTINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6R6I"
"6R6J",,"X-RAY DIFFRACTION",2.04,39.72,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer: 0.1M sodium bicine (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1016/j.ejmech.2019.111825","JTW","6R6J",30.05,"1.55","1.55","Crystal structure of human carbonic anhydrase isozyme II with 2-(benzenesulfonyl)-4-chloro-N-(2-hydroxyethyl)-5-sulfamoyl-benzamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6R6J"
"6R6U",,"X-RAY DIFFRACTION",2.08,40.74,"VAPOR DIFFUSION, SITTING DROP",8.7,"0.1 M Tris-HCl pH 8.7, 1.2 M Na3-citrate",293,"10.1073/pnas.1908770116",,"6R6U",101.88,"1.705","1.705","Crystal structure of human cis-aconitate decarboxylase","GGGRKSITESFATAIHGLKVGHLTDRVIQRSKRMILDTLGAGFLGTTTEVFHIASQYSKIYSSNISSTVWGQPDIRLPPTYAAFVNGVAIHSMDFDDTWHPATHPSGAVLPVLTALAEALPRSPKFSGLDLLLAFNVGIEVQGRLLHFAKEANDMPKRFHPPSVVGTLGSAAAASKFLGLSSTKCREALAIAVSHAGAPMANAATQTKPLHIGNAAKHGIEAAFLAMLGLQGNKQVLDLEAGFGAFYANYSPKVLPSIASYSWLLDQQDVAFKRFPAHLSTHWVADAAASVRKHLVAERALLPTDYIKRIVLRIPNVQYVNRPFPVSEHEARHSFQYVACAMLLDGGITVPSFHECQINRPQVRELLSKVELEYPPDNLPSFNILYCEISVTLKDGATFTDRSDTFYGHWRKPLSQEDLEEKFRANASKMLSWDTVESLIKIVKNLEDLEDCSVLTTLLKGP","Homo sapiens","ACOD1, IRG1","Cis-aconitate decarboxylase","1","6R6U"
"6R6V",,"X-RAY DIFFRACTION",3.24,61.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"Ammonium sulfate",293,"10.1080/14756366.2019.1710502","JU5","6R6V",62.56,"2.5","2.5","Structure of recombinant human butyrylcholinesterase in complex with a fluorescent coumarin-based probe","IIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6R6V"
"6R6W",,"X-RAY DIFFRACTION",3.2,61.59,"VAPOR DIFFUSION, HANGING DROP",6.5,"Ammonium sulfate",293,"10.1080/14756366.2019.1710502","JUB","6R6W",62.85,"2.474","2.474","Structure of recombinant human butyrylcholinesterase in complex with a fluorescent NBD-based probe","IIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6R6W"
"6R6X",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"24% PEG 3350, 200mM MgCl2, 100mM BisTris (pH 6.5)",293,,,"6R6X",39.67,"2.05","2.05","Crystal structure of di-phosphorylated human CLK1 in complex with 5-(1-methyl-1H-indol-3-yl)pyrimidin-4-amine","HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRRCKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6R6X"
"6R6Y",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION, SITTING DROP",7.2,"Crystallization buffer: 0.1M ammonium citrate (pH 7.2), 0.2 M ammonium sulfate and 26% PEG4000",291,"10.1016/j.ejmech.2019.111825","EA3","6R6Y",122.16,"1.38","1.38","Crystal structure of human carbonic anhydrase isozyme XII with 4-chloro-2-cyclohexylsulfanyl-N-(2-hydroxyethyl)-5-sulfamoyl-benzamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6R6Y"
"6R71",,"X-RAY DIFFRACTION",1.93,36.15,"VAPOR DIFFUSION, SITTING DROP",7.2,"Crystallization buffer: 0.1M ammonium citrate (pH 7.2), 0.2 M ammonium sulfate and 26% PEG4000",291,"10.1016/j.ejmech.2019.111825","JTW","6R71",60.87,"2","2","Crystal structure of human carbonic anhydrase isozyme XII with 2-(benzenesulfonyl)-4-chloro-N-(2-hydroxyethyl)-5-sulfamoyl-benzamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6R71"
"6R75",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris-HCl pH 8.5, 20% v/v glycerol ethoxylate, 3% v/v poly(ethylene imine)",277,"10.1038/s41589-019-0426-z",,"6R75",22.88,"2","2","Crystal structure of human Ube2T E54R mutant","GPGSMQRASRLKRELHMLATEPPPGITCWQDKDQMDDLRAQILGGANTPYEKGVFKLRVIIPERYPFEPPQIRFLTPIYHPNIDSAGRICLDVLKLPPKGAWRPSLNIATVLTSIQLLMSEPNPDDPLMADISSEFKYNKPAFLKNARQWTEKHARQKQKADEEEMLDNLPEAGDSRVHNSTQKRKASQLVGIEKKFHPDV","Homo sapiens","UBE2T, HSPC150, PIG50","Ubiquitin-conjugating enzyme E2 T","1","6R75"
"6R7D",,"X-RAY DIFFRACTION",4.28,71.28,"VAPOR DIFFUSION, HANGING DROP",,"CaCl2, PEG400, Hepes",293,"10.1021/acs.jmedchem.9b00555","JUQ","6R7D",226.81,"2.35","2.35","Crystal structure of LTC4S in complex with AZ13690257","MAHHHHHHKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","6R7D"
"6R7O",,"X-RAY DIFFRACTION",2.86,57.05,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",277,"10.26508/lsa.202000725",,"6R7O",105.51,"2.31","2.31","Crystal structure of the central region of human cohesin subunit STAG1","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","6R7O"
"6R7S",,"X-RAY DIFFRACTION",2.31,46.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"HSA was dissolved in 50 mM potassium phosphate, 150 mM sodium chloride (pH 7.5) and concentrated to 2 mM (140 mg/mL). The HSA solution was incubated with a six fold excess of sulfasalazine at 4-5 degrees C for 4 hours.The crystal was grown by the hanging drop vapor diffusion method using a reservoir solution containing buffer (2.5 mM potassium phosphate, 7.5 mM sodium chloride, pH 7.0), 0.3% glycerol and polyethylene glycol 3350 (~30%). For crystallization 1 uL protein solution was equilibrated against 1 uL of reservoir solution.",293,"10.1002/cmdc.202000069",,"6R7S",68.02,"2.21","2.21","Human Serum Albumin, complexed with Sulfasalazine","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6R7S"
"6R7X","3.47","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-11753-1",,"6R7X",166.3,"3.47",,"CryoEM structure of calcium-bound human TMEM16K / Anoctamin 10 in detergent (2mM Ca2+, closed form)","MKVTLSALDTSESSFTPLVVIELAQDVKEETKEWLKNRIIAKKKDGGAQLLFRPLLNKYEQETLENQNLYLVGASKIRMLLGAEAVGLVKECNDNTMRAFTYRTRQNFKGFDDNNDDFLTMAECQFIIKHELENLRAKDEKMIPGYPQAKLYPGKSLLRRLLTSGIVIQVFPLHDSEALKKLEDTWYTRFALKYQPIDSIRGYFGETIALYFGFLEYFTFALIPMAVIGLPYYLFVWEDYDKYVIFASFNLIWSTVILELWKRGCANMTYRWGTLLMKRKFEEPRPGFHGVLGINSITGKEEPLYPSYKRQLRIYLVSLPFVCLCLYFSLYVMMIYFDMEVWALGLHENSGSEWTSVLLYVPSIIYAIVIEIMNRLYRYAAEFLTSWENHRLESAYQNHLILKVLVFNFLNCFASLFYIAFVLKDMKLLRQSLATLLITSQILNQIMESFLPYWLQRKHGVRVKRKVQALKADIDATLYEQVILEKEMGTYLGTFDDYLELFLQFGYVSLFSCVYPLAAAFAVLNNFTEVNSDALKMCRVFKRPFSEPSANIGVWQLAFETMSVISVVTNCALIGMSPQVNAVFPESKADLILIVVAVEHALLALKFILAFAIPDKPRHIQMKLARLEFESLEALKQQQMKLVTENLKEEPMESGKEKATAENLYFQ","Homo sapiens","ANO10, TMEM16K","Anoctamin-10","1","6R7X"
"6R7Y","4.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-11753-1",,"6R7Y",154.79,"4.2",,"CryoEM structure of calcium-bound human TMEM16K / Anoctamin 10 in detergent (low Ca2+, closed form)","MKVTLSALDTSESSFTPLVVIELAQDVKEETKEWLKNRIIAKKKDGGAQLLFRPLLNKYEQETLENQNLYLVGASKIRMLLGAEAVGLVKECNDNTMRAFTYRTRQNFKGFDDNNDDFLTMAECQFIIKHELENLRAKDEKMIPGYPQAKLYPGKSLLRRLLTSGIVIQVFPLHDSEALKKLEDTWYTRFALKYQPIDSIRGYFGETIALYFGFLEYFTFALIPMAVIGLPYYLFVWEDYDKYVIFASFNLIWSTVILELWKRGCANMTYRWGTLLMKRKFEEPRPGFHGVLGINSITGKEEPLYPSYKRQLRIYLVSLPFVCLCLYFSLYVMMIYFDMEVWALGLHENSGSEWTSVLLYVPSIIYAIVIEIMNRLYRYAAEFLTSWENHRLESAYQNHLILKVLVFNFLNCFASLFYIAFVLKDMKLLRQSLATLLITSQILNQIMESFLPYWLQRKHGVRVKRKVQALKADIDATLYEQVILEKEMGTYLGTFDDYLELFLQFGYVSLFSCVYPLAAAFAVLNNFTEVNSDALKMCRVFKRPFSEPSANIGVWQLAFETMSVISVVTNCALIGMSPQVNAVFPESKADLILIVVAVEHALLALKFILAFAIPDKPRHIQMKLARLEFESLEALKQQQMKLVTENLKEEPMESGKEKATAENLYFQ","Homo sapiens","ANO10, TMEM16K","Anoctamin-10","1","6R7Y"
"6R7Z","5.14","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-11753-1",,"6R7Z",154.55,"5.14",,"CryoEM structure of calcium-free human TMEM16K / Anoctamin 10 in detergent (closed form)","MKVTLSALDTSESSFTPLVVIELAQDVKEETKEWLKNRIIAKKKDGGAQLLFRPLLNKYEQETLENQNLYLVGASKIRMLLGAEAVGLVKECNDNTMRAFTYRTRQNFKGFDDNNDDFLTMAECQFIIKHELENLRAKDEKMIPGYPQAKLYPGKSLLRRLLTSGIVIQVFPLHDSEALKKLEDTWYTRFALKYQPIDSIRGYFGETIALYFGFLEYFTFALIPMAVIGLPYYLFVWEDYDKYVIFASFNLIWSTVILELWKRGCANMTYRWGTLLMKRKFEEPRPGFHGVLGINSITGKEEPLYPSYKRQLRIYLVSLPFVCLCLYFSLYVMMIYFDMEVWALGLHENSGSEWTSVLLYVPSIIYAIVIEIMNRLYRYAAEFLTSWENHRLESAYQNHLILKVLVFNFLNCFASLFYIAFVLKDMKLLRQSLATLLITSQILNQIMESFLPYWLQRKHGVRVKRKVQALKADIDATLYEQVILEKEMGTYLGTFDDYLELFLQFGYVSLFSCVYPLAAAFAVLNNFTEVNSDALKMCRVFKRPFSEPSANIGVWQLAFETMSVISVVTNCALIGMSPQVNAVFPESKADLILIVVAVEHALLALKFILAFAIPDKPRHIQMKLARLEFESLEALKQQQMKLVTENLKEEPMESGKEKATAENLYFQ","Homo sapiens","ANO10, TMEM16K","Anoctamin-10","1","6R7Z"
"6R80",,"X-RAY DIFFRACTION",2.94,58.13,"EVAPORATION",,"PEG 8000  14%-16% 
KH2PO4 0.04 M
Glycerol 20%",291.15,"10.1074/jbc.RA119.008577",,"6R80",32.3,"2.2","2.2","Structure of AFF4 C-terminal homology domain","MGSSHHHHHHENLYFQSNASKPRRTKLVFDDRNYSADHYLQEAKKLKHNADALSDRFEKAVYYLDAVVSFIECGNALEKNAQESKSPFPMYSETVDLIKYTMKLKNYLAPDATAADKRLTVLCLRCESLLYLRLFKLKKENALKYSKTLTEHLKNSYNNSQAPSPGLGSKAVGMPSPVSPKLSPGNSGNYSSGASSASASGSSVTIPQKIHQMAASYVQVTSNFLYATEIWDQAEQLSKEQKEFFAELDKVMGPLIFNASIMTDLVRYTRQGLHWLRQDAKLIS","Homo sapiens","AFF4, AF5Q31, MCEF, HSPC092","AF4/FMR2 family member 4","1","6R80"
"6R8J",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, SITTING DROP",6.5,"24% PEG 3350, 200mM MgCl2, 100mM BisTris (pH 6.5)",293,,,"6R8J",39.9,"1.75","1.75","Crystal structure of di-phosphorylated human CLK1 in complex with 4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine","HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRRCKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6R8J"
"6R8L",,"X-RAY DIFFRACTION",2.67,53.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350",298,"10.1016/j.bmcl.2019.126717","JUZ","6R8L",18.15,"1.64","1.64","Human Cyclophilin D in complex with 1-((1S,9S,10S)-10-Hydroxy-12-oxa-8-aza-tricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ylmethyl)-3- {2-[(R)-2-(2-methylsulfanyl-phenyl)-pyrrolidin-1-yl]-2-oxo-ethyl}-urea","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6R8L"
"6R8O",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350",298,"10.1016/j.bmcl.2019.126717","JV2","6R8O",18.53,"1.36","1.36","Human Cyclophilin D in complex with 1-(((2R,3S,6R)-3-hydroxy-2,3,4,6-tetrahydro-1H-2,6-methanobenzo[c][1,5]oxazocin-8-yl)methyl)-3-(2-((R)-2-(2-(methylthio)phenyl)pyrrolidin-1-yl)-2-oxoethyl)urea","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6R8O"
"6R8P",,"X-RAY DIFFRACTION",2,38.4,"VAPOR DIFFUSION, SITTING DROP",4.2,"1.5M Ammonium sulfate
0.1 M Sodium citrate
pH4.2",300,"10.1039/c9md00096h","JVB","6R8P",45.45,"1.45","1.45","Notum fragment 723","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6R8P"
"6R8Q",,"X-RAY DIFFRACTION",1.92,36.04,"VAPOR DIFFUSION, SITTING DROP",4,"1.4 M AMMONIUM SULPHATE, 
0.1 M CITRIC ACID, 
PH 4.0",295,"10.1039/c9md00096h","JV5","6R8Q",45.15,"1.5","1.5","STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A BENZOTRIAZOLE FRAGMENT","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6R8Q"
"6R8R",,"X-RAY DIFFRACTION",1.94,36.6,"VAPOR DIFFUSION, SITTING DROP",4,"1.4 M ammonium sulphate, 0.1 M citric acid, pH 4",300,"10.1039/c9md00096h","JV8","6R8R",45.86,"1.27","1.27","Structure of the Wnt deacylase Notum in complex with isoquinoline 45","ETGSAQQLNEDLRLHLLLNTSVTCNDGSPAGYYLKESRGSRRWLLFLEGGWYCFNRENCDSRYDTMRRLMSSRDWPRTRTGTGILSSQPEENPYWWNANMVFIPYCSSDVWSGASSKSEKNEYAFMGALIIQEVVRELLGRGLSGAKVLLLAGSSAGGTGVLLNVDRVAEQLEKLGYPAIQVRGLADSGWFLDNKQYRHTDCVDTITCAPTEAIRRGIRYWNGVVPERCRRQFQEGEEWNCFFGYKVYPTLRSPVFVVQWLFDEAQLTVDNVHLTGQPVQEGLRLYIQNLGRELRHTLKDVPASFAPACLSHEIIIRSHWTDVQVKGTSLPRALHCWDRSLHDSHKASKTPLKGCPVHLVDSCPWPHCNPSCPTGTKHHHHHH","Homo sapiens","NOTUM, OK/SW-CL.30","Palmitoleoyl-protein carboxylesterase NOTUM","1","6R8R"
"6R8W",,"X-RAY DIFFRACTION",2.68,54.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350",298,"10.1016/j.bmcl.2019.126717","JVH","6R8W",18.62,"1.4","1.4","Human Cyclophilin D in complex with 2-(exo-3,5-Dioxo-4-aza-tricyclo[5.2.1.02,6]dec-4-yl)-N-((1R,9R,10S)-10-hydroxy-12-oxa-8-aza-tricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ylmethyl)-acetamide","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6R8W"
"6R99",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, magnesium nitrate",293,"10.1126/sciadv.abj8633",,"6R99",48.36,"2.7","2.7","Crystal Structure of Human CLN protein 5 (Ceroid Lipofuscinosis Neuronal Protein 5)","MRRNLRLGPSSGADAQGQGAPRPGLAAPRMLLPPASQASRGSGSTGCSLMAQEVDTAQGAEMRRGAGAARGRASWCWALALLWLAVVPGWSRVSGIPSRRHWPVPYKRFDFRPKPDPYCQAKYTFCPTGSPIPVMEGDDDIEVFRLQAPVWEFKYGDLLGHLKIMHDAIGFRSTLTGKNYTMEWYELFQLGNCTFPHLRPEMDAPFWCNQGAACFFEGIDDVHWKENGTLVQVATISGNMFNQMAKWVKQDNETGIYYETWNVKASPEKGAETWFDSYDCSKFVLRTFNKLAEFGAEFKNIETNYTRIFLYSGEPTYLGNETSVFGPTGNKTLGLAIKRFYYPFKPHLPTKEFLLSLLQIFDAVIVHKQFYLFYNFEYWFLPMKFPFIKITYEEIPLPIRNKTLSGL","Homo sapiens","CLN5, hCG_28176","Ceroid-lipofuscinosis neuronal protein 5","1","6R99"
"6R9H",,"X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Sodium Acetate pH 4.6, 200mM Ammonium Acetate, 22% PEG 3350",277,"10.1002/jev2.12039",,"6R9H",73.24,"2","2","Crystal structure of the PDZ tandem of syntenin in complex with fragment C58","GAMDPREVILCKDQDGKIGLRLKSIDNGIFVQLVQANSPASLVGLRFGDQVLQINGENCAGWSSDKAHKVLKQAFGEKITMTIRDRPFERTITMHKDSTGHVGFIFKNGKITSIVKDSSAARNGLLTEHNICEINGQNVIGLKDSQIADILSTSGTVVTITIMPAF","Homo sapiens","SDCBP, MDA9, SYCL","Syntenin-1","1","6R9H"
"6R9K",,"SOLUTION NMR",,,,,,,"10.1002/anie.201905372",,"6R9K",8.05,,,"A quadruplex hybrid structure with lpp loop orientation and 3 syn residues","GCGTGGGTCAGGGTGGGTGGGACGC","Homo sapiens",,"DNA (25-MER)","1","6R9K"
"6R9L",,"SOLUTION NMR",,,,,,,"10.1002/anie.201905372",,"6R9L",8.05,,,"A quadruplex hybrid structure with lpp loop orientation and 5 syn residues","GCGTGGGTCAGGGTGGGTGGGACGC","Homo sapiens",,"DNA (25-MER)","1","6R9L"
"6R9S",,"X-RAY DIFFRACTION",1.97,37.47,"VAPOR DIFFUSION, SITTING DROP",7.2,"50 mM potassium phosphate",298,"10.1016/j.bmcl.2019.126717","JVN","6R9S",18.6,"2","2","Human Cyclophilin D in complex with bicyclic fragment","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6R9S"
"6R9T","6.2","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2019.08.034",,"6R9T",270.77,"6.2",,"Cryo-EM structure of autoinhibited human talin-1","MVALSLKISIGNVVKTMQFEPSTMVYDACRIIRERIPEAPAGPPSDFGLFLSDDDPKKGIWLEAGKALDYYMLRNGDTMEYRKKQRPLKIRMLDGTVKTIMVDDSKTVTDMLMTICARIGITNHDEYSLVRELMEEKKEEITGTLRKDKTLLRDEKKMEKLKQKLHTDDELNWLDHGRTLREQGVEEHETLLLRRKFFYSDQNVDSRDPVQLNLLYVQARDDILNGSHPVSFDKACEFAGFQCQIQFGPHNEQKHKAGFLDLKDFLPKEYVKQKGERKIFQAHKNCGQMSEIEAKVRYVKLARSLKTYGVSFFLVKEKMKGKNKLVPRLLGITKECVMRVDEKTKEVIQEWNLTNIKRWAASPKSFTLDFGDYQDGYYSVQTTEGEQIAQLIAGYIDIILKKKKSKDHFGLEGDEESTMLEDSVSPKKSTVLQQQYNRVGKVEHGSVALPAIMRSGASGPENFQVGSMPPAQQQITSGQMHRGHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASKAWRKNKMDESKHEIHSQVDAITAGTASVVNLTAGDPAETDYTAVGCAVTTISSNLTEMSRGVKLLAALLEDEGGSGRPLLQAAKGLAGAVSELLRSAQPASAEPRQNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAKAVASAAAALVLKAKSVAQRTEDSGLQTQVIAAATQCALSTSQLVACTKVVAPTISSPVCQEQLVEAGRLVAKAVEGCVSASQAATEDGQLLRGVGAAATAVTQALNELLQHVKAHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEMVRQARILAQATSDLVNAIKADAEGESDLENSRKLLSAAKILADATAKMVEAAKGAAAHPDSEEQQQRLREAAEGLRMATNAAAQNAIKKKLVQRLEHAAKQAAASATQTIAAAQHAASTPKASAGPQPLLVQSCKAVAEQIPLLVQGVRGSQAQPDSPSAQLALIAASQSFLQPGGKMVAAAKASVPTIQDQASAMQLSQCAKNLGTALAELRTAAQKAQEACGPLEMDSALSVVQNLEKDLQEVKAAARDGKLKPLPGETMEKCTQDLGNSTKAVSSAIAQLLGEVAQGNENYAGIAARDVAGGLRSLAQAARGVAALTSDPAVQAIVLDTASDVLDKASSLIEEAKKAAGHPGDPESQQRLAQVAKAVTQALNRCVSCLPGQRDVDNALRAVGDASKRLLSDSLPPSTGTFQEAQSRLNEAAAGLNQAATELVQASRGTPQDLARASGRFGQDFSTFLEAGVEMAGQAPSQEDRAQVVSNLKGISMSSSKLLLAAKALSTDPAAPNLKSQLAAAARAVTDSINQLITMCTQQAPGQKECDNALRELETVRELLENPVQPINDMSYFGCLDSVMENSKVLGEAMTGISQNAKNGNLPEFGDAISTASKALCGFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFARANQAIQMACQSLGEPGCTQAQVLSAATIVAKHTSALCNSCRLASARTTNPTAKRQFVQSAKEVANSTANLVKTIKALDGAFTEENRAQCRAATAPLLEAVDNLSAFASNPEFSSIPAQISPEGRAAMEPIVISAKTMLESAGGLIQTARALAVNPRDPPSWSVLAGHSRTVSDSIKKLITSMRDKAPGQLECETAIAALNSCLRDLDQASLAAVSQQLAPREGISQEALHTQMLTAVQEISHLIEPLANAARAEASQLGHKVSQMAQYFEPLTLAAVGAASKTLSHPQQMALLDQTKTLAESALQLLYTAKEAGGNPKQAAHTQEALEEAVQMMTEAVEDLTTTLNEAASAAGVVGGMVDSITQAINQLDEGPMGEPEGSFVDYQTTMVRTAKAIAVTVQEMVTKSNTSPEELGPLANQLTSDYGRLASEAKPAAVAAENEEIGSHIKHRVQELGHGCAALVTKAGALQCSPSDAYTKKELIECARRVSEKVSHVLAALQAGNRGTQACITAASAVSGIIADLDTTIMFATAGTLNREGTETFADHREGILKTAKVLVEDTKVLVQNAAGSQEKLAQAAQSSVATITRLADVVKLGAASLGAEDPETQVVLINAVKDVAKALGDLISATKAAAGKVGDDPAVWQLKNSAKVMVTNVTSLLKTVKAVEDEATKGTRALEATTEHIRQELAVFCSPEPPAKTSTPEDFIRMTKGITMATAKAVAAGNSCRQEDVIATANLSRRAIADMLRACKEAAYHPEVAPDVRLRALHYGRECANGYLELLDHVLLTLQKPSPELKQQLTGHSKRVAGSVTELIQAAEAMKGTEWVDPEDPTVIAENELLGAAAAIEAAAKKLEQLKPRAKPKEADESLNFEEQILEAAKSIAAATSALVKAASAAQRELVAQGKVGAIPANALDDGQWSQGLISAARMVAAATNNLCEAANAAVQGHASQEKLISSAKQVAASTAQLLVACKVKADQDSEAMKRLQAAGNAVKRASDNLVKAAQKAAAFEEQENETVVVKEKMVGGIAQIIAAQEEMLRKERELEEARKKLAQIRQQQYKFLPSELRDEHLVVLFQ","Homo sapiens","TLN1, KIAA1027, TLN","Talin-1","1","6R9T"
"6R9U",,"X-RAY DIFFRACTION",2.63,53.32,"VAPOR DIFFUSION, SITTING DROP",7.2,"50 mM potassium phosphate",298,"10.1016/j.bmcl.2019.126717","JVQ","6R9U",18.64,"1.26","1.26","Human Cyclophilin D in complex with fragment","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6R9U"
"6R9X",,"X-RAY DIFFRACTION",2.15,42.92,"VAPOR DIFFUSION, SITTING DROP",,"PEG4000",298,"10.1016/j.bmcl.2019.126717","JW2","6R9X",17.9,"1.66","1.66","Human Cyclophilin D in complex with N-cyclopentyl-N'-pyridin-2-ylmethyl-oxalamide","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6R9X"
"6RA1",,"X-RAY DIFFRACTION",2.66,53.79,"VAPOR DIFFUSION, SITTING DROP",7.2,"50 mM potassium phosphate",298,"10.1016/j.bmcl.2019.126717",,"6RA1",18.62,"2","2","Human Cyclophilin D in complex with norbornane fragment derivative","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","6RA1"
"6RA5",,"X-RAY DIFFRACTION",3.13,60.71,"VAPOR DIFFUSION, SITTING DROP",,"8% PEG 8K w/v, 0.1M PCTP (pH 8.0), 0.8% ethylene glycol v/v",298,,,"6RA5",70.56,"2.9","2.9","Human tnik in complex with compound 9","GSDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRG","Homo sapiens","TNIK, KIAA0551","TRAF2 and NCK-interacting protein kinase","1","6RA5"
"6RA7",,"X-RAY DIFFRACTION",2.39,48.57,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350 w/v, 0.1M PCTP (pH 8.0), 200 mM sodium formate w/v",298,,,"6RA7",35.49,"1.2","1.2","Human tnik in complex with compound 9","GSDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRG","Homo sapiens","TNIK, KIAA0551","TRAF2 and NCK-interacting protein kinase","1","6RA7"
"6RAA",,"X-RAY DIFFRACTION",2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Bicine, 14% PEG 6000",277,,,"6RAA",40.13,"2.1","2.1","CLK1 Kinase domain with bound imidazopyridin inhibitor TP003","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6RAA"
"6RAV",,"X-RAY DIFFRACTION",2.54,51.59,"VAPOR DIFFUSION, SITTING DROP",,"24 % (w/v) PEG3350, 0.2 M ammonium acetate, 0.1 M Bis-Tris (pH 5.5), 2mM inhibitor",293,"10.1073/pnas.1820892116",,"6RAV",67.37,"1.7","1.7","Complement factor B protease domain in complex with the reversible inhibitor 4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid","SLSLCGMVWEHRKGTDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWGVVDVCKNQKRQKQVPAHARDFHINLFQVLPWLKEKLQDEDLGFL","Homo sapiens","CFB, BF, BFD","Complement factor B","1","6RAV"
"6RB1",,"X-RAY DIFFRACTION",2,38.54,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1016/j.ejmech.2020.112267","JWQ","6RB1",40.94,"1.5","1.5","Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 1","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6RB1"
"6RB4",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION, SITTING DROP",,"100mM Bis Tris propane pH 6.5, 24 % PEG 3350, 150 mM NaF",292,"10.1021/acschembio.9b00367",,"6RB4",49.03,"1.5","1.5","Crystal structure of the Pri1 subunit of human primase","GTSMETFDPTELPELLKLYYRRLFPYSQYYRWLNYGGVIKNYFQHREFSFTLKDDIYIRYQSFNNQSDLEKEMQKMNPYKIDIGAVYSHRPNQHNTVKLGAFQAQEKELVFDIDMTDYDDVRRCCSSADICPKCWTLMTMAIRIIDRALKEDFGFKHRLWVYSGRRGVHCWVCDESVRKLSSAVRSGIVEYLSLVKGGQDVKKKVHLSEKIHPFIRKSINIIKKYFEEYALVNQDILENKESWDKILALVPETIHDELQQSFQKSHNSLQRWEHLKKVASRYQNNIKNDKYGPWLEWEIMLQYCFPRLDINVSKGINHLLKSPFSVHPKTGRISVPIDLQKVDQFDPFTVPTISFICRELDAISTNEEEKEENEAESDVKHRTRDYKKTSLAPYVKVFEHFLENLDKSRK","Homo sapiens","PRIM1","DNA primase small subunit","1","6RB4"
"6RBC",,"X-RAY DIFFRACTION",3.31,62.82,"VAPOR DIFFUSION, HANGING DROP",8,"32% (v/v) pentaerythritol propoxylate, PO/OH 5/4, 2 % (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0",293,"10.1021/acs.jmedchem.9b02022","JX5","6RBC",82.9,"1.77","1.77","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor KB1157","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6RBC"
"6RBF",,"X-RAY DIFFRACTION",3.05,59.66,"VAPOR DIFFUSION, HANGING DROP",,"105 mM lithium sulfate, 100 mM citrate/phosphate buffer, pH 4.2, 10% glycerol, and 14% PEG 1500",293,"10.1016/j.jmb.2019.07.018",,"6RBF",185.27,"2.704","2.704","Mucin 2 D3 domain","APGTCSIYGSGHYITFDGKYYDFDGHCSYVAVQDYCGQNSSLGSFSIITENVPCGTTGVTCSKAIKIFMGRTELKLEDKHRVVIQRDEGHHVAYTTREVGQYLVVESSTGIIVIWDKRTTVFIKLAPSYKGTVCGLCGNFDHRSNNDFTTRDHMVVSSELDFGNSWKEAPTCPDVSTNPEPCSLNPHRRSWAEKQCSILKSSVFSICHSKVDPKPFYEACVHDSCSCDTGGDCECFCSAVASYAQECTKEGACVFWRTPDLCPIFCDYYNPPHECEWHYEPCGNRSFETCRTINGIHSNISVSYLEGCYPRCPKDRPIYEEDLKKCVTADKCGCYVEDTHYPPGASVPTEETCKSCVCTNSSQVVCRPEEGKILNQTQDGAFCYWEICGPNGTVEKHFNICSITHHHHHH","Homo sapiens","MUC2, SMUC","Mucin-2","1","6RBF"
"6RBI",,"X-RAY DIFFRACTION",3.98,69.13,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.8 M Potassium Phosphate-dibasic, 0.8 M Sodium Phosphate monobasic",277,,,"6RBI",56.25,"2.21","2.21","Crystal structure of KDM5B in complex with 5-(1H-tetrazol-5-yl)quinolin-8-ol","SMFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKLGGGGARDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAESYNEWALNVNEALEAKINK","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6RBI"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6RBJ",,"X-RAY DIFFRACTION",2.88,57.3,"VAPOR DIFFUSION, SITTING DROP",6.6,"0.1 M bis-tris pH 6.6 , 0.1 M magnesium chloride, 28% PEG 3350",277,,,"6RBJ",81.93,"2.093","2.093","Crystal structure of KDM3B in complex with 5-(1H-tetrazol-5-yl)quinolin-8-ol","SMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKQRIHDGKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","6RBJ"
"6RCB",,"X-RAY DIFFRACTION",1.89,34.96,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1016/j.ejmech.2020.112267","JYZ","6RCB",40.75,"2.05","2.05","Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 14","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6RCB"
"6RCF",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION, SITTING DROP",7,"1.27M ammonium sulfate, 1000mM ammonium nitrate",300.15,"10.1073/pnas.2007213117","K0K","6RCF",13.37,"1.1","1.1","ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-15]-OH","GSMSEQSICQARAAVMVYDDANKKWVPAGGSTGFSRVHIYHHTGNNTFRVVGRKIQDHQVVINCAIPKGLKYNQATQTFHQWRDARQVYGLNFGSKEDANVFASAMMHALEVL","Homo sapiens","ENAH, MENA","Protein enabled homolog","1","6RCF"
"6RCG",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.1M succinic acid",277.15,,,"6RCG",35.03,"1.4","1.4","Crystal structure of Casein kinase 1 delta (CK1 delta) complexed with SR3029 inhibitor","SMMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6RCG"
"6RCH",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, SITTING DROP",5.9,"25% PEG3350, 0.2M sodium sulfate, 0.1M citrate pH 5.9",277.15,,,"6RCH",70.45,"1.45","1.45","Crystal structure of Casein kinase I isoform delta (CK1 delta) complexed with SR4133 inhibitor","SMMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6RCH"
"6RCI",,"X-RAY DIFFRACTION",2.37,48.01,"VAPOR DIFFUSION",,"100 mM Hepes pH 7.0, 200 mM sodium malonate, and 20 % polyethylene glycol 3350",298,"10.1016/j.molcel.2019.09.010",,"6RCI",41.79,"2","2","Crystal structure of REXO2","GAMAQRMVWVDLEMTGLDIEKDQIIEMACLITDSDLNILAEGPNLIIKQPDELLDSMSDWCKEHHGKSGLTKAVKESTITLQQAEYEFLSFVRQQTPPGLCPLAGNSVHEDKKFLDKYMPQFMKHLHYRIIDVSTVKELCRRWYPEEYEFAPKKAASHRALDDISESIKELQFYRNNIFK","Homo sapiens","REXO2, SFN, SMFN, CGI-114","Oligoribonuclease, mitochondrial","1","6RCI"
"6RCJ",,"X-RAY DIFFRACTION",2.13,42.2,"VAPOR DIFFUSION, SITTING DROP",7,"1.8M ammonium sulfate, 240mM ammonium nitrate",300.15,"10.1073/pnas.2007213117","K0H","6RCJ",13.54,"1.35","1.35","ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-15]-OMe","GSMSEQSICQARAAVMVYDDANKKWVPAGGSTGFSRVHIYHHTGNNTFRVVGRKIQDHQVVINCAIPKGLKYNQATQTFHQWRDARQVYGLNFGSKEDANVFASAMMHALEVL","Homo sapiens","ENAH, MENA","Protein enabled homolog","1","6RCJ"
"6RCM",,"X-RAY DIFFRACTION",1.98,38.01,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1016/j.ejmech.2020.112267","K0N","6RCM",40.86,"1.7","1.7","Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 3","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6RCM"
"6RCO",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M lithium sulfate, 
0.1 M NaAc pH 4.5, 
30% PEG 8000 
0.33% hexamminecobalt(III) chloride, 
0.06 M MES monohydrate, 
0.06 PIPES, 
0.02 M HEPES chloride",298,"10.1016/j.cell.2019.05.025",,"6RCO",96.02,"1.66","1.66","PfRH5-binding monoclonal antibody R5.004","VHSEVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAINWVRQAPGQGLEWMGGIIPIFATTNYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYFCARDKHSWSYAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTC","Homo sapiens",,"R5.004 heavy chain","1","6RCO"
,,,,,,,,,,,,,,,,"SWAQSVLTQPPSASGTPGLRVTISCSGSSSNIGSNTVNWYQHLPGTAPKLLIHSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGWVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"R5.004 light chain","2","6RCO"
"6RCQ",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION, SITTING DROP",,"0.16 M ZnAc, 
0.108 M Na cacodylate pH 6.5, 
14.4% PEG 8000, 
20% glycerol",298,"10.1016/j.cell.2019.05.025",,"6RCQ",48.95,"2.28","2.28","PfRH5-binding monoclonal antibody R5.011","VHSEVQLVQSGSDLKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWVGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARESPNYYDSSGYYSGYYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTC","Homo sapiens",,"R5.011 heavy chain","1","6RCQ"
,,,,,,,,,,,,,,,,"SVTSYELTQPPSVSVAPGQTATITCGGKNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHRVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"R5.011 light chain","2","6RCQ"
"6RCS",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M lithium sulfate, 
0.1 M NaAc pH 4.5, 
50% PEG 400",298,"10.1016/j.cell.2019.05.025",,"6RCS",75.07,"2.1","2.1","PfRH5-binding monoclonal antibody R5.016","TGVHSQVQLVQSGAEVKKPGASVRVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISGYDGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDGPQVGDFDWQVYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"R5.016 heavy chain","1","6RCS"
,,,,,,,,,,,,,,,,"TGVHCAIRMTQSPSTLSASVGDRVTITCRASQSINTWLAWYQQKPGKAPNLLISKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYFCQQYNSYLYTFGQGTKVEIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"R5.016 light chain","2","6RCS"
"6RCT",,"X-RAY DIFFRACTION",3.13,60.7,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 10% ethylene glycol, 0.2M sodium nitrate",277.15,,,"6RCT",86.22,"2.32","2.32","Crystal structure of CLK3 in complex with T3-CLK","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6RCT"
"6RCW",,"X-RAY DIFFRACTION",2.65,53.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene glycol, 0.1 M HEPES pH 7.5",293,"10.1016/j.bmc.2019.06.026",,"6RCW",172.55,"2.08","2.08","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-053","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6RCW"
"6RCY",,"X-RAY DIFFRACTION",2.97,58.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M potassium phosphate, 0.8M sodium phosphate, 0.1M HEPES, pH 7.5",293,"10.1021/acs.jmedchem.0c00825","K0T","6RCY",16.91,"2.3","2.3","CRYSTAL STRUCTURE OF FK1 DOMAIN OF FKBP52 IN COMPLEX WITH A BIO-INSPIRED HYBRID FLUORESCENT LIGAND","MTAEEMKATESGAQSAPLPMEGVDISPKQDEGVLKVIKREGTGTEMPMIGDRVFVHYTGWLLDGTKFDSSLDRKDKFSFDLGKGEVIKAWDIAIATMKVGEVCHITCKPEYAYGSAGSPPKIPPNATLVFEVELFEFKGEDLTEEEDG","Homo sapiens","FKBP4, FKBP52","Peptidyl-prolyl cis-trans isomerase FKBP4","1","6RCY"
"6RD0",,"X-RAY DIFFRACTION",2.31,46.81,"VAPOR DIFFUSION, SITTING DROP",8,"25% PEH 6000, 0.1 M Tris-HCl",293,"10.1016/j.bmc.2019.115177","K0Q","6RD0",18.25,"1.9","1.9","Human MMP12 catalytic domain in complex with AP280","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","6RD0"
"6RFE",,"X-RAY DIFFRACTION",1.96,37.1,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1016/j.ejmech.2020.112267","K0Z","6RFE",40.95,"1.54","1.54","Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 4","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6RFE"
"6RFF",,"X-RAY DIFFRACTION",1.87,34.09,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG4000, 0.2 M Lithium Sulfate",293,"10.1016/j.ejmech.2020.112267","K1B","6RFF",40.9,"1.8","1.8","Human protein kinase CK2 alpha in complex with 2-cyano-2-propenamide compound 7","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6RFF"
"6RFH",,"X-RAY DIFFRACTION",2.06,40.17,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammoniumsulfate 2.7 M, TRIS 0.1 M, pH = 7.8, saturated with para-chloromercuribenzoic acid and 4-carboxybenzenesulfonamide",291,,,"6RFH",31.21,"0.969","0.969","Human Carbonic Anhydrase II in complex with 4-Carboxybenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RFH"
"6RFI",,"X-RAY DIFFRACTION",2.48,50.42,"VAPOR DIFFUSION, HANGING DROP",,"pH7.5",298,"10.1021/acs.jmedchem.9b01346","K1H","6RFI",74.04,"2.31","2.31","IRAK4 IN COMPLEX WITH inhibitor","MHHHHHHHENLYFQGENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6RFI"
"6RFJ",,"X-RAY DIFFRACTION",2.56,51.94,"VAPOR DIFFUSION, HANGING DROP",,"pH7.5",298,"10.1021/acs.jmedchem.9b01346",,"6RFJ",74.16,"2.61","2.61","IRAK4 IN COMPLEX WITH inhibitor","MHHHHHHHENLYFQGENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6RFJ"
"6RG3",,"X-RAY DIFFRACTION",2.09,41.12,"VAPOR DIFFUSION, HANGING DROP",8.3,"1.5 M sodium citrate",286,"10.1016/j.bioorg.2019.103130","K1W","6RG3",29.81,"1.32","1.32","Crystal structure of human Carbonic anhydrase II in complex with (R)-4-(2-benzylpiperazin-1-yl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RG3"
"6RG4",,"X-RAY DIFFRACTION",2.08,40.91,"VAPOR DIFFUSION, HANGING DROP",8.3,"1.6 sodium citrate",286,"10.1016/j.bioorg.2019.103130","K45","6RG4",29.91,"1.25","1.25","Crystal structure of human Carbonic anhydrase II in complex with (R)-4-(2-benzyl-4-methylpiperazin-1-yl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RG4"
"6RG5",,"X-RAY DIFFRACTION",2.07,40.7,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, Tris 0.1 M, pH = 7.8, saturated with para-Chloromercuribenzenesulfonamide",291,,,"6RG5",31.23,"1.089","1.089","Human Carbonic Anhydrase II in complex with 4-(2-hydroxyethyl)benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RG5"
"6RH4",,"X-RAY DIFFRACTION",2.07,40.77,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.40 M, TRIS 0.1 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RH4",31.37,"0.948","0.948","Human Carbonic Anhydrase II in complex with 4-Nitrobenzenesulfonamide.","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RH4"
"6RH5",,"SOLUTION NMR",,,,,,,"10.1016/j.devcel.2019.07.017",,"6RH5",15.56,,,"Solution structure and 1H, 13C and 15N chemical shift assignments for NECAP1 PHear domain","GSPNSMATELEYESVLCVKPDVSVYRIPPRASNRGYRASDWKLDQPDWTGRLRITSKGKTAYIKLEDKVSGELFAQAPVEQYPGIAVETVTDSSRYFVIRIQDGTGRSAFIGIGFTDRGDAFDFNVSLQDHFKWVKQE","Homo sapiens","NECAP1","Adaptin ear-binding coat-associated protein 1","1","6RH5"
"6RHJ",,"X-RAY DIFFRACTION",2.08,40.85,"VAPOR DIFFUSION, HANGING DROP",8.3,"1.6 sodium citrate",296,"10.1016/j.bioorg.2019.103130","K4H","6RHJ",29.82,"1.44","1.44","Crystal structure of human carbonic anhydrase isozyme II with 4-(4-benzyl-1,4-diazepane-1-carbonyl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RHJ"
"6RHK",,"X-RAY DIFFRACTION",2.12,41.99,"VAPOR DIFFUSION, HANGING DROP",8.3,"1.6 M sodium citrate",296,"10.1016/j.bioorg.2019.103130","K4B","6RHK",29.88,"1.44","1.44","The crystal structure of human carbonic anhydrase II in complex with 4-(3-benzylimidazolidine-1-carbonyl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RHK"
"6RHL",,"X-RAY DIFFRACTION",2.21,44.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,"10.1039/c9cp02504a",,"6RHL",16.26,"1.299","1.299","Room temperature data of Galectin-3C in complex with a pair of enantiomeric ligands: R enantiomer","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RHL"
"6RHM",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,"10.1039/c9cp02504a",,"6RHM",16.26,"1.596","1.596","Room temperature data of Galectin-3C in complex with a pair of enantiomeric ligands: S enantiomer","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RHM"
"6RHY",,"SOLUTION NMR",,,,,,,"10.1038/s41467-020-16566-1",,"6RHY",18.08,,,"Structure of pore-forming amyloid-beta tetramers","DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","6RHY"
"6RIG",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammoniumsulfate 2.7 M, Tris 0.1 M, pH 7.8, saturated with para-Chloromercuribenzoic acid",291,,,"6RIG",31.51,"0.999","0.999","Human Carbonic Anhydrase II in complex with 4-Hydroxybenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RIG"
"6RIH",,"X-RAY DIFFRACTION",2.55,51.79,"VAPOR DIFFUSION, HANGING DROP",6.6,"25 % PEG 8000, 0.1 M MES, 0.2M Lithium sulphate",277,"10.1021/acs.jmedchem.9b00718","K4T","6RIH",67.84,"2.15","2.15","Crystal structure of PHGDH in complex with compound 9","SMANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGV","Homo sapiens","PHGDH, PGDH3","D-3-phosphoglycerate dehydrogenase","1","6RIH"
"6RIT",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RIT",31.32,"1.007","1.007","Human Carbonic Anhydrase II in complex with 2-Fluorobenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RIT"
"6RJ2",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, HANGING DROP",6.6,"25 % PEG 8000, 0.1 M MES, 0.2 M Lithium sulphate",277,"10.1021/acs.jmedchem.9b00718","K52","6RJ2",68.21,"2","2","Crystal structure of PHGDH in complex with compound 40","SMANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGV","Homo sapiens","PHGDH, PGDH3","D-3-phosphoglycerate dehydrogenase","1","6RJ2"
"6RJ3",,"X-RAY DIFFRACTION",2.36,47.95,"VAPOR DIFFUSION, HANGING DROP",6.6,"25 % PEG 8000, 0.1 M MES, 0.2 M Lithium sulphate",277,"10.1021/acs.jmedchem.9b00718","K58","6RJ3",68.15,"1.42","1.42","Crystal structure of PHGDH in complex with compound 15","SMANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGV","Homo sapiens","PHGDH, PGDH3","D-3-phosphoglycerate dehydrogenase","1","6RJ3"
"6RJ5",,"X-RAY DIFFRACTION",2.35,47.71,"VAPOR DIFFUSION, HANGING DROP",6.6,"25 % PEG 8000, 0.1 M MES, 0.2 M Lithium sulphate",277,"10.1021/acs.jmedchem.9b00718","K5N","6RJ5",68.31,"1.89","1.89","Crystal structure of PHGDH in complex with compound 39","SMANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGV","Homo sapiens","PHGDH, PGDH3","D-3-phosphoglycerate dehydrogenase","1","6RJ5"
"6RJ6",,"X-RAY DIFFRACTION",2.24,45.18,"VAPOR DIFFUSION, HANGING DROP",6.6,"25 % PEG 8000, 0.1 M MES, 0.2 M Lithium sulphate",277,"10.1021/acs.jmedchem.9b00718","K5K","6RJ6",68.26,"1.984","1.984","Crystal structure of PHGDH in complex with BI-4924","SMANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGV","Homo sapiens","PHGDH, PGDH3","D-3-phosphoglycerate dehydrogenase","1","6RJ6"
"6RJB",,"X-RAY DIFFRACTION",2.13,42.39,"VAPOR DIFFUSION, HANGING DROP",7.9,"PEG6000, PPG400, Glycerol",279.15,"10.1038/s41586-019-1581-9",,"6RJB",143.26,"1.15","1.15","Human transketolase variant T382E","MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSEGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNREVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKALVPRGSLEHHHHHH","Homo sapiens","TKT","Transketolase","1","6RJB"
"6RJJ",,"X-RAY DIFFRACTION",2.09,41.05,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RJJ",31.18,"1.056","1.056","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RJJ"
"6RKB",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG4000, lithium sulphate, ADA buffer",277,"10.1021/acs.jmedchem.9b01886",,"6RKB",120.41,"2.3","2.3","Crystal structure of human monoamine oxidase B in complex with styrylpiperidine analogue 1","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","6RKB"
"6RKF",,"X-RAY DIFFRACTION",2.96,58.51,"EVAPORATION",8,"20 mM Tris-HCl pH 8.0, 10 % glycerol, 50 mM NaCl",291,"10.1096/fj.201901703R",,"6RKF",238.11,"3.219","3.219","Structure of human DASPO","MHHHHHHASMDTARIAVVGAGVVGLSTAVCISKLVPRCSVTIISDKFTPDTTSDVAAGMLIPHTYPDTPIHTQKQWFRETFNHLFAIANSAEAGDAGVHLVSGWQIFQSTPTEEVPFWADVVLGFRKMTEAELKKFPQYVFGQAFTTLKYEGPAYLPWLEKRIKGSGGWTLTRRIEDLWELHPSFDIVVNCSGLGSRQLAGDSKIFPVRGQVLQVQAPWVEHFIRDGSGLTYIYPGTSHVTLGGTRQKGDWNLSPDAENSREILSRCCALEPSLHGACNIREKVGLRPYRPGVRLQTELLARDGQRLPVVHHYGHGSGGISVHWGTALEAARLVSECVHALRTPIPKSNL","Homo sapiens","DDO","D-aspartate oxidase","1","6RKF"
"6RKN",,"X-RAY DIFFRACTION",2.06,40.42,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RKN",31.32,"0.959","0.959","Human Carbonic Anhydrase II in complex with a fluorinated Benzenesulfonamide.","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RKN"
"6RKP",,"X-RAY DIFFRACTION",2.74,55.08,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 4000, lithium sulphate, ADA buffer",277,"10.1021/acs.jmedchem.9b01886",,"6RKP",120.69,"1.7","1.7","Crystal structure of human monoamine oxidase B in complex with styrylpiperidine analogue 84","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","6RKP"
"6RL9",,"X-RAY DIFFRACTION",2.06,40.38,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7, TRIS 0.1 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RL9",31.69,"1","1","Human Carbonic Anhydrase II in complex with 4-Aminobenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RL9"
"6RLA","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0286-y",,"6RLA",1034.07,"3.9",,"Structure of the dynein-2 complex; motor domains","GDKDCEMKRTTLDSPLGKLELSGCEQGLHRIIFLGKGTSAADAVEVPAPAAVLGGPEPLMQATAWLNAYFHQPEAIEEFPVPALHHPVFQQESFTRQVLWKLLKVVKFGEVISYSHLAALAGNPAATAAVKTALSGNPVPILIPCHRVVQGDLDVGGYEGGLAVKEWLLAHEGHRLGKPGLGGSLEVLFQGPDYDIPTTLEVLFQGPANGTADVRKLFIFTTTQNYFGLMSELWDQPLLCNCLEINNFLDDGNQMLLRVQRSDAGISFSNTIEFGDTKDKVLVFFKLRPEVITDENLHDNILVSSMLESPISSLYQAVRQVFAPMLLKDQEWSRNFDPKLQNLLSELEAGLGIVLRRSDTNLTKLKFKEDDTRGILTPSDEFQFWIEQAHRGNKQISKERANYFKELFETIAREFYNLDSLSLLEVVDLVETTQDVVDDVWRQTEHDHYPESRMLHLLDIIGGSFGRFVQKKLGTLNLWEDPYYLVKESLKAGISICEQWVIVCNHLTGQVWQRYVPHPWKNEKYFPETLDKLGKRLEEVLAIRTIHEKFLYFLPASEEKIICLTRVFEPFTGLNPVQYNPYTEPLWKAAVSQYEKIIAPAEQKIAGKLKNYISEIQDSPQQLLQAFLKYKELVKRPTISKELMLERETLLARLVDSIKDFRLDFENRCRGIPGDASGPLSGKNLSEVVNSIVWVRQLELKVDDTIKIAEALLSDLPGFRCFHQSAKDLLDQLKLYEQEQFDDWSRDIQSGLSDSRSGLCIEASSRIMELDSNDGLLKVHYSDRLVILLREVRQLSALGFVIPAKIQQVANIAQKFCKQAIILKQVAHFYNSIDQQMIQSQRPMMLQSALAFEQIIKNSKAGSGGKSQITWDNPKELEGYIQKLQNAAERLATENRKLRKWHTTFCEKVVVLMNIDLLRQQQRWKDGLQELRTGLATVEAQGFQASDMHAWKQHWNHQLYKALEHQYQMGLEALNENLPEINIDLTYKQGRLQFRPPFEEIRAKYYREMKRFIGIPNQFKGVGEAGDESIFSIMIDRNASGFLTIFSKAEDLFRRLSAVLHQHKEWIVIGQVDMEALVEKHLFTVHDWEKNFKALKIKGKEVERLPSAVKVDCLNINCNPVKTVIDDLIQKLFDLLVLSLKKSIQAHLHEIDTFVTEAMEVLTIMPQSVEEIGDANLQYSKLQERKPEILPLFQEAEDKNRLLRTVAGGGLETISNLKAKWDKFELMMESHQLMIKDQIEVMKGNVKSRLQIYYQELEKFKARWDQLKPGDDVIETGQHNTLDKSAKLIKEKKIEFDDLEVTRKKLVDDCHHFRLEEPNFSLASSISKDIESCAQIWAFYEEFQQGFQEMANEDWITFRTKTYLFEEFLMNWHDRLRKVEEHSVMTVKLQSEVDKYKIVIPILKYVRGEHLSPDHWLDLFRLLGLPRGTSLEKLLFGDLLRVADTIVAKAADLKDLNSRAQGEVTIREALRELDLWGVGAVFTLIDYEDSQSRTMKLIKDWKDIVNQVGDNRCLLQSLKDSPYYKGFEDKVSIWERKLAELDEYLQNLNHIQRKWVYLEPIFGRGALPKEQTRFNRVDEDFRSIMTDIKKDNRVTTLTTHAGIRNSLLTILDQLQRCQRSLNEFLEEKRSAFPRFYFIGDDDLLEILGQSTNPSVIQSHLKKLFAGINSVCFDEKSKHITAMKSLEGEVVPFKNKVPLSNNVETWLNDLALEMKKTLEQLLKECVTTGRSSQGAVDPSLFPSQILCLAEQIKFTEDVENAIKDHSLHQIETQLVNKLEQYTNIDTSSEDPGNTESGILELKLKALILDIIHNIDVVKQLNQIQVHTTEDWAWKKQLRFYMKSDHTCCVQMVDSEFQYTYEYQGNASKLVYTPLTDKCYLTLTQAMKMGLGGNPYGPAGTGKTESVKALGGLLGRQVLVFNCDEGIDVKSMGRIFVGLVKCGAWGCFDEFNRLEESVLSAVSMQIQTIQDALKNHRTVCELLGKEVEVNSNSGIFITMNPAGKGYGGRQKLPDNLKQLFRPVAMSHPDNELIAEVILYSEGFKDAKVLSRKLVAIFNLSRELLTPQQHYDWGLRALKTVLRGSGNLLRQLNKSGTTQNANESHIVVQALRLNTMSKFTFTDCTRFDALIKDVFPGIELKEVEYDELSAALKQVFEEANYEIIPNQIKKALELYEQLCQRMGVVIVGPSGAGKSTLWRMLRAALCKTGKVVKQYTMNPKAMPRYQLLGHIDMDTREWSDGVLTNSARQVVREPQDVSSWIICDGDIDPEWIESLNSVLDDNRLLTMPSGERIQFGPNVNFVFETHDLSCASPATISRMGMIFLSDEETDLNSLIKSWLRNQPAEYRNNLENWIGDYFEKALQWVLKQNDYVVETSLVGTVMNGLSHLHGCRDHDEFIINLIRGLGGNLNMKSRLEFTKEVFHWARESPPDFHKPMDTYYDSTRGRLATYVLKKPEDLTADDFSNGLTLPVIQTPDMQRGLDYFKPWLSSDTKQPFILVGPEGCGKGMLLRYAFSQLRSTQIATVHCSAQTTSRHLLQKLSQTCMVISTNTGRVYRPKDCERLVLYLKDINLPKLDKWGTSTLVAFLQQVLTYQGFYDENLEWVGLENIQIVASMSAGGRLGRHKLTTRFTSIVRLCSIDYPEREQLQTIYGAYLEPVLHKNLKNHSIWGSSSKIYLLAGSMVQVYEQVRAKFTVDDYSHYFFTPCILTQWVLGLFRYDLEGGSSNHPLDYVLEIVAYEARRLFRDKIVGAKELHLFDIILTSVFQGDWGSDILDNMSDSFYVTWGARHNSGARAAPGQPLPPHGKPLGKLNSTDLKDVIKKGLIHYGRDNQNLDILLFHEVLEYMSRIDRVLSFPGGSLLLAGRSGVGRRTITSLVSHMHGAVLFSPKISRGYELKQFKNDLKHVLQLAGIEAQQVVLLLEDYQFVHPTFLEMINSLLSSGEVPGLYTLEELEPLLLPLKDQASQDGFFGPVFNYFTYRIQQNLHIVLIMDSANSNFMINCESNPALHKKCQVLWMEGWSNSSMKKIPEMLFSETGGGEKYNDKKRKEEKKKNSVDPDFLKSFLLIHESCKAYGATPSQYMTFLHVYSAISSSKKKELLKRQSHLQAGVSKLNEAKALVDELNRKAGEQSVLLKTKQDEADAALQMITVSMQDASEQKTELERLKHRIAEEVVKIEERKNKIDDELKEVQPLVNEAKLAVGNIKPESLSEIRSLRMPPDVIRDILEGVLRLMGIFDTSWVSMKSFLAKRGVREDIATFDARNISKEIRESVEELLFKNKGSFDPKNAKRASTAAAPLAAWVKANIQYSHVLERIHPLETEQAGLESNLKKTEDRKRKLEELLNSVGQKVSELKEKFQSRTSEAAKLEAEVSKAQETIKAAEVLINQLDREHKRWNAQVVEITEELATLPKRAQLAAAFITYLSAAPESLRKTCLEEWTKSAGLEKFDLRRFLCTESEQLIWKSEGLPSDDLSIENALVILQSRVCPFLIDPSSQATEWLKTHLKDSRLEVINQQDSNFITALELAVRFGKTLIIQEMDGVEPVLYPLLRRDLVAQGPRYVVQIGDKIIDYNEEFRLFLSTRNPNPFIPPDAASIVTEVNFTTTRSGLRGQLLALTIQHEKPDLEEQKTKLLQQEEDKKIQLAKLEESLLETLATSQGNILENKDLIESLNQTKASSALIQESLKESYKLQISLDQERDAYLPLAESASKMYFIISDLSKINNMYRFSLAAFLRLFQRALQNKQDSENTEQRIQSLISSLQHMVYEYICRCLFKADQLMFALHFVRGMHPELFQENEWDTFTGVVVGDMLRKADSQQKIRDQLPSWIDQERSWAVATLKIALPSLYQTLCFEDAALWRTYYNNSMCEQEFPSILAKKVSLFQQILVVQVLRPDRLQSAMALFACKTLGLKEVSPLPLNLKRLYKETLEIEPILIIISPGADPSQELQELANAERSGECYHQVAMGQGQADLAIQMLKECARNGDWLCLKNLHLVVSWLPVLEKELNTLQPKDTFRLWLTAEVHPNFTPILLQSSLKITYESPPGLKKNLMRTYESWTPEQISKKDNTHRAHALFSLAWFHAACQERRNYIPQGWTKFYEFSLSDLRAGYNIIDRLFDGAKDVQWEFVHGLLENAIYGGRIDNYFDLRVLQSYLKQFFNSSVIDVFNQRNKKSIFPYSVSLPQSCSILDYRAVIEKIPEDDKPSFFGLPANIARSSQRMISSQVISQLRILGRSITAGSKFDREIWSNELSPVLNLWKKLNQNSNLIHQKVPPPNDRQGSPILSFIILEQFNAIRLVQSVHQSLAALSKVIRGTTLLSSEVQKLASALLNQKCPLAWQSKWEGPEDPLQYLRGLVARALAIQNWVDKAEKQALLSETLDLSELFHPDTFLNALRQETARAVGRSVDSLKFVASWKGRLQEAKLQIKISGLLLEGCSFDGNQLSENQLDSPSVSSVLPCFMGWIPQDACGPYSPDECISLPVYTSAERDRVVTNIDVPCGGNQDQWIQCGAALFLKNQ","Homo sapiens",,"O6-alkylguanine-DNA alkyltransferase mutant,DYNC2H1 variant protein","1","6RLA"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6RLC",,"X-RAY DIFFRACTION",2.22,44.61,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM Sodium Acetate pH 4.6, 200mM Ammonium Acetate, 22% PEG 3350",277,"10.1002/jev2.12039",,"6RLC",73.52,"2.2","2.2","Crystal structure of the PDZ tandem of syntenin in complex with fragment F13","GAMDPREVILCKDQDGKIGLRLKSIDNGIFVQLVQANSPASLVGLRFGDQVLQINGENCAGWSSDKAHKVLKQAFGEKITMTIRDRPFERTITMHKDSTGHVGFIFKNGKITSIVKDSSAARNGLLTEHNICEINGQNVIGLKDSQIADILSTSGTVVTITIMPAF","Homo sapiens","SDCBP, MDA9, SYCL","Syntenin-1","1","6RLC"
"6RLE",,"X-RAY DIFFRACTION",2.73,54.93,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 4000, lithium sulphate, ADA buffer",277,"10.1021/acs.jmedchem.9b01886",,"6RLE",120.55,"2.3","2.3","Crystal structure of human monoamine oxidase B in complex with styrylpiperidine analogue 97","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","6RLE"
"6RLM",,"X-RAY DIFFRACTION",3.74,67.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 400, potassium chloride, TRIS",277.15,,,"6RLM",388.5,"2.5","2.5","Crystal structure of AT1412dm Fab fragment","EVQVVESGGGLVQPGRSLRLSCAASGFTFDDYAMYWVRQAPGKGLEWVSGISWNSGSIVYADSVKGRFTISRDNAKNSLYLQLNSLRAEDTAFYYCAKAVSGYFPYFDYWGQGILVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"AT1412dm Fab (Heavy Chain)","1","6RLM"
,,,,,,,,,,,,,,,,"DIVMTQSPDSLSVSLGERATINCKSSQSVLYSSNNKNYLGWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPSTFGQGTRLEIKRTAAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"AT1412dm Fab (Light Chain)","2","6RLM"
"6RLN",,"X-RAY DIFFRACTION",2.35,47.66,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MES (pH 6.5), 25% PEG 8k",277,"10.1021/acsmedchemlett.9b00108",,"6RLN",69.99,"2.87","2.87","Crystal structure of RIP1 kinase in complex with GSK3145095","MDYKDDDDKMQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6RLN"
"6RLR",,"X-RAY DIFFRACTION",2.52,51.25,"VAPOR DIFFUSION, SITTING DROP",6,"pentaerythritol propoxylate, potassium chloride, sodium citrate",293.15,"10.26508/lsa.202000883",,"6RLR",41.04,"2","2","Crystal structure of CD9 large extracellular loop","MGSKDEVIKEVQEFYKDTYNKLKTKDEPQRETLKAIHYALNCCGLAGGVEQFISDICPKKDVLETFTVKSCPDAIKEVFDNAAAHHHHHH","Homo sapiens","CD9, MIC3, TSPAN29, GIG2","CD9 antigen","1","6RLR"
"6RLW",,"X-RAY DIFFRACTION",2.3,46.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.12 M Alcohols, 0.1 M Buffer System 2 pH 7.5, 48 % v/v Precipitant Mix from 4 Morpheus screen (Molecular Dimensions)",294,"10.1093/nar/gkaa1048",,"6RLW",192.32,"2","2","Structure of the human 8-oxoguanine DNA Glycosylase hOGG1 in complex with inhibitor TH5487","MGSSHHHHHHSSGLVPRGSHMGHRTLASTPALWASIPCPRSELRLDLVLPSGQSFRWREQSPAHWSGVLADQVWTLTQTEEQLHCTVYRGDKSQASRPTPDELEAVRKYFQLDVTLAQLYHHWGSVDSHFQEVAQKFQGVRLLRQDPIECLFSFICSSNNNIARITGMVERLCQAFGPRLIQLDDVTYHGFPSLQALAGPEVEAHLRKLGLGYRARYVSASARAILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTKVADCICLMALDKPQAVPVDVHMWHIAQRDYSWHPTTSQAKGPSPQTNKELGNFFRSLWGPYAGWAQAVLFSADLRQSR","Homo sapiens","OGG1, MMH, MUTM, OGH1","N-glycosylase/DNA lyase","1","6RLW"
"6RLX",,"X-RAY DIFFRACTION",2.02,39.07,,,,,,,"6RLX",11.72,"1.5","1.5","X-RAY STRUCTURE OF HUMAN RELAXIN AT 1.5 ANGSTROMS. COMPARISON TO INSULIN AND IMPLICATIONS FOR RECEPTOR BINDING DETERMINANTS","SWMEEVIKLCGRELVRAQIAICGMSTWS","Homo sapiens","RLN2","RELAXIN, B-CHAIN","2","6RLX"
,,,,,,,,,,,,,,,,"QLYSALANKCCHVGCTKRSLARFC","Homo sapiens","RLN2","RELAXIN, A-CHAIN","1","6RLX"
"6RLY",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, SITTING DROP",8,"25% PEG 6000, 0.1 M Tris-HCl",293,"10.1016/j.bmc.2019.115177","K8T","6RLY",18.29,"2.2","2.2","Human MMP12 (catalytic domain) in complex with AP316","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","6RLY"
"6RM0",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Lithium sulphate, 20% (w/v) PEG 3350",291,"10.1107/S2053230X19010999",,"6RM0",23.88,"2.513","2.513","Human wtSTING in complex with 3'3'-c-di-GMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6RM0"
"6RM1",,"X-RAY DIFFRACTION",2.12,42.08,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, pH = 7.8, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040518",,"6RM1",30.46,"1.68","1.68","Human Carbonic Anhydrase II in complex with fragment.","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RM1"
"6RMH","9.6","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2020.06.008",,"6RMH",347.97,"9.6",,"The Rigid-body refined model of the normal Huntingtin.","MATLEKLMKAFESLKSFQQQQQQQQQQQQQQQQQQQQQPPPPPPPPPPPQLPQPPPQAQPLLPQPQPPPPPPPPPPGPAVAEEPLHRPKKELSATKKDRVNHCLTICENIVAQSVRNSPEFQKLLGIAMELFLLCSDDAESDVRMVADECLNKVIKALMDSNLPRLQLELYKEIKKNGAPRSLRAALWRFAELAHLVRPQKCRPYLVNLLPCLTRTSKRPEESVQETLAAAVPKIMASFGNFANDNEIKVLLKAFIANLKSSSPTIRRTAAGSAVSICQHSRRTQYFYSWLLNVLLGLLVPVEDEHSTLLILGVLLTLRYLVPLLQQQVKDTSLKGSFGVTRKEMEVSPSAEQLVQVYELTLHHTQHQDHNVVTGALELLQQLFRTPPPELLQTLTAVGGIGQLTAAKEESGGRSRSGSIVELIAGGGSSCSPVLSRKQKGKVLLGEEEALEDDSESRSDVSSSALTASVKDEISGELAASSGVSTPGSAGHDIITEQPRSQHTLQADSVDLASCDLTSSATDGDEEDILSHSSSQVSAVPSDPAMDLNDGTQASSPISDSSQTTTEGPDSAVTPSDSSEIVLDGTDNQYLGLQIGQPQDEDEEATGILPDEASEAFRNSSMALQQAHLLKNMSHCRQPSDSSVDKFVLRDEATEPGDQENKPCRIKGDIGQSTDDDSAPLVHCVRLLSASFLLTGGKNVLVPDRDVRVSVKALALSCVGAAVALHPESFFSKLYKVPLDTTEYPEEQYVSDILNYIDHGDPQVRGATAILCGTLICSILSRSRFHVGDWMGTIRTLTGNTFSLADCIPLLRKTLKDESSVTCKLACTAVRNCVMSLCSSSYSELGLQLIIDVLTLRNSSYWLVRTELLETLAEIDFRLVSFLEAKAENLHRGAHHYTGLLKLQERVLNNVVIHLLGDEDPRVRHVAAASLIRLVPKLFYKCDQGQADPVVAVARDQSSVYLKLLMHETQPPSHFSVSTITRIYRGYNLLPSITDVTMENNLSRVIAAVSHELITSTTRALTFGCCEALCLLSTAFPVCIWSLGWHCGVPPLSASDESRKSCTVGMATMILTLLSSAWFPLDLSAHQDALILAGNLLAASAPKSLRSSWASEEEANPAATKQEEVWPALGDRALVPMVEQLFSHLLKVINICAHVLDDVAPGPAIKAALPSLTNPPSLSPIRRKGKEKEPGEQASVPLSPKKGSEASAASRQSDTSGPVTTSKSSSLGSFYHLPSYLRLHDVLKATHANYKVTLDLQNSTEKFGGFLRSALDVLSQILELATLQDIGKCVEEILGYLKSCFSREPMMATVCVQQLLKTLFGTNLASQFDGLSSNPSKSQGRAQRLGSSSVRPGLYHYCFMAPYTHFTQALADASLRNMVQAEQENDTSGWFDVLQKVSTQLKTNLTSVTKNRADKNAIHNHIRLFEPLVIKALKQYTTTTCVQLQKQVLDLLAQLVQLRVNYCLLDSDQVFIGFVLKQFEYIEVGQFRESEAIIPNIFFFLVLLSYERYHSKQIIGIPKIIQLCDGIMASGRKAVTHAIPALQPIVHDLFVLRGTNKADAGKELETQKEVVVSMLLRLIQYHQVLEMFILVLQQCHKENEDKWKRLSRQIADIILPMLAKQQMHIDSHEALGVLNTLFEILAPSSLRPVDMLLRSMFVTPNTMASVSTVQLWISGILAILRVLISQSTEDIVLSRIQELSFSPYLISCTVINRLRDGDSTSTLEEHSEGKQIKNLPEETFSRFLLQLVGILLEDIVTKQLKVEMSEQQHTFYCQELGTLLMCLIHIFKSGMFRRITAAATRLFRSDGCGGSFYTLDSLNLRARSMITTHPALVLLWCQILLLVNHTDYRWWAEVQQTPKRHSLSSTKLLSPQMSGEEEDSDLAAKLGMCNREIVRRGALILFCDYVCQNLHDSEHLTWLIVNHIQDLISLSHEPPVQDFISAVHRNSAASGLFIQAIQSRCENLSTPTMLKKTLQCLEGIHLSQSGAVLTLYVDRLLCTPFRVLARMVDILACRRVEMLLAANLQSSMAQLPMEELNRIQEYLQSSGLAQRHQRLYSLLDRFRLSTMQDSLSPSPPVSSHPLDGDGHVSLETVSPDKDWYVHLVKSQCWTRSDSALLEGAELVNRIPAEDMNAFMMNSEFNLSLLAPCLSLGMSEISGGQKSALFEAAREVTLARVSGTVQQLPAVHHVFQPELPAEPAAYWSKLNDLFGDAALYQSLPTLARALAQYLVVVSKLPSHLHLPPEKEKDIVKFVVATLEALSWHLIHEQIPLSLDLQAGLDCCCLALQLPGLWSVVSSTEFVTHACSLIHCVHFILEAVAVQPGEQLLSPERRTNTPKAISEEEEEVDPNTQNPKYITAACEMVAEMVESLQSVLALGHKRNSGVPAFLTPLLRNIIISLARLPLVNSYTRVPPLVWKLGWSPKPGGDFGTAFPEIPVEFLQEKEVFKEFIYRINTLGWTSRTQFEETWATLLGVLVTQPLVMEQEESPPEEDTERTQINVLAVQAITSLVLSAMTVPVAGNPAVSCLEQQPRNKPLKALDTRFGRKLSIIRGIVEQEIQAMVSKRENIATHHLYQAWDPVPSLSPATTGALISHEKLLLQINPERELGSMSYKLGQVSIHSVWLGNSITPLREEEWDEEEEEEADAPAPSSPPTSPVNSRKHRAGVDIHSCSQFLLELYSRWILPSSSARRTPAILISEVVRSLLVVSDLFTERNQFELMYVTLTELRRVHPSEDEILAQYLVPATCKAAAVLGMDKAVAEPVSRLLESTLRSSHLPSRVGALHGVLYVLECDLLDDTAKQLIPVISDYLLSNLKGIAHCVNIHSQQHVLVMCATAFYLIENYPLDVGPEFSASIIQMCGVMLSGSEESTPSIIYHCALRGLERLLLSEQLSRLDAESLVKLSVDRVNVHSPHRAMAALGLMLTCMYTGKEKVSPGRTSDPNPAAPDSESVIVAMERVSVLFDRIRKGFPCEARVVARILPQFLDDFFPPQDIMNKVIGEFLSNQQPYPQFMATVVYKVFQTLHSTGQSSMVRDWVMLSLSNFTQRAPVAMATWSLSCFFVSASTSPWVAAILPHVISRMGKLEQVDVNLFCLVATDFYRHQIEEELDRRAFQSVLEVVAAPGSPYHRLLTCLRNVHKVTTC","Homo sapiens","HTT, HD, IT15","Huntingtin","1","6RMH"
"6RMJ",,"X-RAY DIFFRACTION",2.3,46.41,"VAPOR DIFFUSION, HANGING DROP",6.2,"50 mM MES, 2.8 M magnesium sulfate, 1 M NaCL, 2% isopropanol",293,"10.3390/ijms20184511",,"6RMJ",53.89,"2.65","2.65","Crystal structure of human NGR-TNF","CNGRCGVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","6RMJ"
"6RMP",,"X-RAY DIFFRACTION",2.2,44.11,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040518",,"6RMP",30.49,"1.22","1.22","Human Carbonic Anhydrase II in complex with fragment.","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RMP"
"6RMT",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris pH 8, 200 mM NaCl, 24% PEG 4000",291,"10.3389/fimmu.2021.714055",,"6RMT",69.7,"2","2","Crystal structure of disulphide-linked human C3d dimer","MLDAERLKHLIVTPSGCGEQNMIGMTPTVIAVHYLDETEQWEKFGLEKRQGALELIKKGYTQQLAFRQPSSAFAAFVKRAPSTWLTAYVVKVFSLAVNLIAIDSQVLCGAVKWLILEKQKPDGVFQEDAPVIHQEMIGGLRNNNEKDMALTAFVLISLQEAKDICEEQVNSLPGSITKAGDFLEANYMNLQRSYTVAIAGYALAQMGRLKGPLLNKFLTTAKDKNRWEDPGKQLYNVEATSYALLALLQLKDFDFVPPVVRWLNEQRYYGGGYGSTQATFMVFQALAQYQKDAPDHQELNLDVSLQLPSR","Homo sapiens","C3, CPAMD1","Complement C3","1","6RMT"
"6RMX",,"X-RAY DIFFRACTION",2.09,41.05,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,,,"6RMX",29.64,"1.6","1.6","Human Carbonic anhydrase II mutant T199V bound by 2-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTVPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RMX"
"6RMY",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE (pH 9) and 2M sodium malonate (pH 7).",291,,,"6RMY",30.23,"1.5","1.5","Human Carbonic anhydrase II mutant T199V bound by 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTVPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RMY"
"6RN6",,"X-RAY DIFFRACTION",2.98,58.7,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 3350, 0.2 M Ammoniumsulphate, 0.1 M sodium acetate",293,"10.1021/acsmedchemlett.9b00261",,"6RN6",80.19,"2.4","2.4","DPP1 in complex with inhibitor","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","6RN6"
,,,,,,,,,,,,,,,,"AHLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHT","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","2","6RN6"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","3","6RN6"
"6RN7",,"X-RAY DIFFRACTION",2.77,55.61,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 3350, 0.2 M Ammonium sulphate, 0.1 M Sodium acetate",293,"10.1021/acsmedchemlett.9b00261",,"6RN7",41.21,"1.66","1.66","DPP1 in complex with inhibitor","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","6RN7"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","2","6RN7"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","3","6RN7"
"6RN8",,"X-RAY DIFFRACTION",3.79,67.56,"VAPOR DIFFUSION, SITTING DROP",6.5,"Morpheus G2.
0.1M Carboxylic acids, 0.1M buffer system 1 pH6.5, 50% Precipitant Mix 2",293,"10.1021/acs.jmedchem.9b00575",,"6RN8",72.48,"2.69","2.69","RIP2 Kinase Catalytic Domain complex with 2(4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)quinazolin7yl)oxy)ethyl phosphate","GMNGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLK","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6RN8"
"6RN9",,"X-RAY DIFFRACTION",2.76,55.47,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 3350, 0.2 M Ammonium sulphate, 0.1 M Sodium acetate",293,"10.1021/acsmedchemlett.9b00261",,"6RN9",41.2,"1.9","1.9","DPP1 in complex with inhibitor","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","6RN9"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","2","6RN9"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","3","6RN9"
"6RNA",,"X-RAY DIFFRACTION",3.8,67.64,"VAPOR DIFFUSION, HANGING DROP",7,"100mM Mes pH7, 12% PEG 400, 250mM CaCl2",293,"10.1021/acs.jmedchem.9b00575",,"6RNA",72.28,"2.62","2.62","RIP2 Kinase Catalytic Domain complex with 2({4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)quinazolin7yl}oxy)ethan1ol","GMNGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLK","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6RNA"
"6RNE",,"X-RAY DIFFRACTION",2.77,55.59,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 3350, 0.2 M Ammonium sulphate, 0.1 M Sodium acetate",293,"10.1021/acsmedchemlett.9b00261",,"6RNE",41.52,"1.65","1.65","DPP1 in complex with inhibitor","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","6RNE"
,,,,,,,,,,,,,,,,"HLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","2","6RNE"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","3","6RNE"
"6RNI",,"X-RAY DIFFRACTION",2.79,55.89,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 3350, 0.2 M Ammonium sulphate, 0.1 M Sodium acetate",293,"10.1021/acsmedchemlett.9b00261",,"6RNI",41.5,"1.54","1.54","DPP1 in complex with inhibitor","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVG","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","6RNI"
,,,,,,,,,,,,,,,,"LHLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLR","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","2","6RNI"
,,,,,,,,,,,,,,,,"DPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKL","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","3","6RNI"
"6RNP",,"X-RAY DIFFRACTION",2.06,40.37,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RNP",31.36,"1.07","1.07","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RNP"
"6RNQ",,"X-RAY DIFFRACTION",3.27,62.33,"VAPOR DIFFUSION, SITTING DROP",,"200 mM NaK Tartrate, 25% PEG 3350 and 100 mM BisTris Methane pH 8.5",293.15,"10.1093/nar/gkz1126",,"6RNQ",56.05,"1.95","1.95","Crystal structure of the dimerization domain of Gemin5 at 1.95 A","ARSLLPLSTSLDHRSKEELHQDCLVLATAKHSRELNEDVSADVEERFHLGLFTDRATLYRMIDIEGKGHLENGHPELFHQLMLWKGDLKGVLQTAAERGELTDNLVAMAPAAGYHVWLWAVEAFAKQLCFQDQYVKAASHLLSIHKVYEAVELLKSNHFYREAIAIAKARLRPEDPVLKDLYLSWGTVLERDGHYAVAAKCYLGATCAYDAAKVLAKKGDAASLRTAAELAAIVGEDELSASLALRCAQELL","Homo sapiens","GEMIN5","Gem-associated protein 5","1","6RNQ"
"6RNS",,"X-RAY DIFFRACTION",3.34,63.18,"VAPOR DIFFUSION, SITTING DROP",8.5,"200 mM NaI, 25% PEG 3350 and 100 mM BisTris Methane pH 8.5",293.15,"10.1093/nar/gkz1126",,"6RNS",57.66,"2.69","2.69","Crystal structure of the dimerization domain of Gemin5 at 2.7 A","ARSLLPLSTSLDHRSKEELHQDCLVLATAKHSRELNEDVSADVEERFHLGLFTDRATLYRMIDIEGKGHLENGHPELFHQLMLWKGDLKGVLQTAAERGELTDNLVAMAPAAGYHVWLWAVEAFAKQLCFQDQYVKAASHLLSIHKVYEAVELLKSNHFYREAIAIAKARLRPEDPVLKDLYLSWGTVLERDGHYAVAAKCYLGATCAYDAAKVLAKKGDAASLRTAAELAAIVGEDELSASLALRCAQELL","Homo sapiens","GEMIN5","Gem-associated protein 5","1","6RNS"
"6RNU",,"X-RAY DIFFRACTION",3,58.98,"VAPOR DIFFUSION, SITTING DROP",,"0.2M NaBr, 20% PEG 3350",298,"10.1016/j.bmcl.2019.126682",,"6RNU",41.45,"2.4","2.4","BCL-XL in a complex with a covalent small molecule inhibitor","MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6RNU"
"6ROA",,"X-RAY DIFFRACTION",3.04,59.57,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M Na acetate, 0.1M Na cacodylate pH 6.5, 30% PEG 8000.",293,"10.1111/febs.15010",,"6ROA",26.65,"2.65","2.65","Crystal structure of V57G mutant of human cystatin C","SSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALQVVRARKQIGAGVNYFLDVELGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQIYAVPWQGTMTLSKSTCQDA","Homo sapiens","CST3","Cystatin-C","1","6ROA"
"6ROB",,"X-RAY DIFFRACTION",2.06,40.24,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6ROB",31.33,"0.929","0.929","Human Carbonic Anhydrase II in complex with 4-cyanobenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6ROB"
"6ROD",,"X-RAY DIFFRACTION",2.34,47.36,"VAPOR DIFFUSION, HANGING DROP",5.25,"22.5% PEG 1500, 0.1M SPG (succinate-phosphate-glycine) pH 5.25",293,,,"6ROD",45.74,"1.85","1.85","Alpha-1-antitrypsin (Ser36Arg/Glu78Arg/Glu266Arg) in the native conformation","MRGSHHHHHHTDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFRLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILRGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENRLTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","6ROD"
"6ROE",,"X-RAY DIFFRACTION",2.06,40.34,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6ROE",31.36,"0.939","0.939","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6ROE"
"6ROF",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer was 0.1M sodium BICINE, pH 9, 0.2 M ammonium sulfate and 2M sodium malonate pH 7 made from 1M sodium BICINE and 3.4M sodium malonate",291,,,"6ROF",30.03,"1.5","1.5","Human Carbonic anhydrase II mutant T199V bound by 2-(cyclooctylamino)-3,5,6-trifluoro-4-[(2-hydroxyethyl)thio]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTVPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6ROF"
"6ROG",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",,"4M sodium formate",277,,,"6ROG",64.25,"2.16","2.16","Crystal Structure of the KELCH domain of human KEAP1","SMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6ROG"
"6ROL",,"X-RAY DIFFRACTION",2.9,57.63,"VAPOR DIFFUSION, SITTING DROP",8,"23% PEG-3350, 200mM Ammonium sulfate, 100mM Tris pH 8.0",295,"10.1038/s41467-019-12193-7",,"6ROL",75.9,"2.1","2.1","Structure of IMP2 KH34 domains","GGSEQEIVNLFIPTQAVGAIIGKKGAHIKQLARFAGASIKIAPAEGPDVSERMVIITGPPEAQFKAQGRIFGKLKEENFFNPKEEVKLEAHIRVPSSTAGRVIGKGGKTVNELQNLTSAEVIVPRDQTPDENEEVIVRIIGHFFASQTAQRKIREIVQQVKQQEQK","Homo sapiens","IGF2BP2, IMP2, VICKZ2","Insulin-like growth factor 2 mRNA-binding protein 2","1","6ROL"
"6RPG",,"X-RAY DIFFRACTION",2.78,55.77,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M BIS-Tris pH 5.4, 0.2 M ammonium sulfate and 23 % (w/v) PEG 3350",293,"10.1021/acs.jmedchem.9b00795",,"6RPG",30.27,"2.7","2.7","Structure of human Programmed cell death 1 ligand 1 (PD-L1) with inhibitor","AFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYAAALEHHHHHH","Homo sapiens","CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1","Programmed cell death 1 ligand 1","1","6RPG"
"6RPV",,"SOLUTION NMR, SOLUTION SCATTERING",,,,,,,"10.1111/febs.15010",,"6RPV",13.32,,,"Extremely stable monomeric variant of human cystatin C with single amino acid substitution","SSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALQVVRARKQIGAGVNYFLDVELGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQIYAVPWQGTMTLSKSTCQDA","Homo sapiens","CST3","Cystatin-C","1","6RPV"
"6RQ4",,"X-RAY DIFFRACTION",2.31,46.74,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.25M (NH4)2SO4
33% MPEG 2000
0.02M Mercaptoethanol
0.1M pH=7.2 HEPES/NaOH",291,"10.1158/1535-7163.MCT-19-0505",,"6RQ4",43.1,"1.96","1.96","Inhibitor of ERK2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6RQ4"
"6RQ7",,"X-RAY DIFFRACTION",2.05,40,"VAPOR DIFFUSION, SITTING DROP",5.5,"Stock: 5 mg/ml AFM in 20mM HEPES pH 7.5, 150mM NaCl, incubated with 10mM Gd-DO3A
Drop: 200 nL AFM stock + 200 nL of precipitate in hanging drop vapor diffusion (EMBL HTX)
Precipitant: 23 to 28% PEG4k, 0.2M NH4SO4, 0.1 M CH3COONH4, pH 5.5",293,"10.1107/S2059798319013500",,"6RQ7",70.2,"2.69","2.69","Gadolinium MRI contrast compound binding in human plasma glycoprotein afamin - resurrection of highly anisotropic data","LPTQPRDIENFNSTQKFIEDNIEYITIIAFAQYVQEATFEEMEKLVKDMVEYKDRCMADKTLPECSKLPNNVLQEKICAMEGLPQKHNFSHCCSKVDAQRRLCFFYNKKSDVGFLPPFPTLDPEEKCQAYESNRESLLNHFLYEVARRNPFVFAPTLLTVAVHFEEVAKSCCEEQNKVNCLQTRAIPVTQYLKAFSSYQKHVCGALLKFGTKVVHFIYIAILSQKFPKIEFKELISLVEDVSSNYDGCCEGDVVQCIRDTSKVMNHICSKQDSISSKIKECCEKKIPERGQCIINSNKDDRPKDLSLREGKFTDSENVCQERDADPDTFFAKFTFEYSRRHPDLSIPELLRIVQIYKDLLRNCCNTENPPGCYRYAEDKFNETTEKSLKMVQQECKHFQNLGKDGLKYHYLIRLTKIAPQLSTEELVSLGEKMVTAFTTCCTLSEEFACVDNLADLVFGELCGVNENRTINPAVDHCCKTNFAFRRPCFESLKADKTYVPPPFSQDLFTFHADMCQSQNEELQRKTDRFLVNLVKLKHELTDEELQSLFTNFANVVDKCCKAESPEVCFNEESPKIGNKGENLYFQ","Homo sapiens","AFM, ALB2, ALBA","Afamin","1","6RQ7"
"6RQI",,"X-RAY DIFFRACTION",2.07,40.51,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.25 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RQI",31.15,"0.95","0.95","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RQI"
"6RQN",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% (w/v) PEG 4000, 0.2 M sodium acetate, 0.1 M Tris-HCl pH 8.5",298,"10.1107/S2059798319010027","ACT","6RQN",28.22,"1.777","1.777","X-ray crystal structure of protiated (H) small monoclinic unit cell CA IX SV.","HWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELSGFQLPPLPELRLRNNGHSVQLTLPPGLEMKLGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTKYARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVSLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGVD","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6RQN"
"6RQQ",,"X-RAY DIFFRACTION",2.17,43.23,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% (w/v) PEG 4000, 0.2 M ammonium formate, 0.1 M Tris-HCl pH 8.5",298,"10.1107/S2059798319010027",,"6RQQ",56.41,"1.276","1.276","X-ray crystal structure of protiated (H) large monoclinic unit cell CA IX SV.","HWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELSGFQLPPLPELRLRNNGHSVQLTLPPGLEMKLGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTKYARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVSLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGVD","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6RQQ"
"6RQU",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% (w/v) PEG 4000, 0.2 M sodium acetate, 0.1 M Tris-HCl pH 8.5",298,"10.1107/S2059798319010027","ACT","6RQU",28.22,"1.393","1.393","X-ray crystal structure of H/D exchanged (H/D) small monoclinic unit cell CA IX SV.","HWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELSGFQLPPLPELRLRNNGHSVQLTLPPGLEMKLGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTKYARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVSLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGVD","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6RQU"
"6RQW",,"X-RAY DIFFRACTION",2.18,43.5,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% (w/v) PEG 4000, 0.2 M ammonium formate, 0.1 M Tris-HCl pH 8.5",298,"10.1107/S2059798319010027",,"6RQW",28.2,"1.488","1.488","X-ray crystal structure of perdeuterated (D) small monoclinic unit cell CA IX SV.","HWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELSGFQLPPLPELRLRNNGHSVQLTLPPGLEMKLGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTKYARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVSLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGVD","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6RQW"
"6RR9",,"X-RAY DIFFRACTION",4.32,71.52,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M sodium acetate pH5.0, 1.5M ammonium sulfate",293,"10.1093/nar/gkab1278",,"6RR9",39.71,"3.432","3.432","DNA/RNA binding protein","MSLRIDVDTNFPECVVDAGKVTLGTQQRQEMDPRLREKQNEIILRAVCALLNSGGGIIKAEIENKGYNYERHGVGLDVPPIFRSHLDKMQKENHFLIFVKSWNTEAGVPLATLCSNLYHRERTSTDVMDSQEALAFLKCRTQTPTNINVSNSLGPQAAQGSVQYEGNINVSAAALFDRKRLQYLEKLNLPESTHVEFVMFSTDVSHCVKDRLPKCVSAFANTEGGYVFFGVHDETCQVIGCEKEKIDLTSLRASIDGCIKKLPVHHFCTQRPEIKYVLNFLEVHDKGALRGYVCAIKVEKFCCAVFAKVPSSWQVKDNRVRQLPTREWTAWMMEADLEHHHHHH","Homo sapiens","SLFN5","Schlafen family member 5","1","6RR9"
"6RRG",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RRG",31.16,"1.127","1.127","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RRG"
"6RRI",,"X-RAY DIFFRACTION",2.06,40.23,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RRI",31.25,"1.097","1.097","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RRI"
"6RS2",,"X-RAY DIFFRACTION",4.12,70.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES pH 7.5, 4 M NaCl",291,"10.3390/ijms20246279",,"6RS2",70.55,"3.694","3.694","Structure of the Bateman module of human CNNM4.","LNMIQGALELRTKTVEDIMTQLQDCFMIRSDAILDFNTMSEIMESGYTRIPVFEDEQSNIVDILYVKDLAFVDPDDCTPLKTITRFYNHPVHFVFHDTKLDAMLEEFKKGKSHLAIVQKVNNEGEGDPFYEVLGLVTLEDVIEEIIKSEILDE","Homo sapiens","CNNM4, ACDP4, KIAA1592","Metal transporter CNNM4","1","6RS2"
"6RS5",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RS5",31.28,"1.07","1.07","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RS5"
"6RSB",,"X-RAY DIFFRACTION",2.54,51.56,"VAPOR DIFFUSION",5.6,"0.1M MES, 25-35% PEG 6000",277,,,"6RSB",70.5,"1.8","1.8","Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6RSB"
"6RSC",,"X-RAY DIFFRACTION",2.51,50.99,"VAPOR DIFFUSION",,"0.1 M MES pH5.6 25-30% PEG6000",277,,,"6RSC",70.46,"1.85","1.85","Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6RSC"
"6RSD",,"X-RAY DIFFRACTION",2.53,51.46,"VAPOR DIFFUSION",5.6,"0.1M MES, 25-35% PEG6000",277,,,"6RSD",70.49,"1.76","1.76","Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6RSD"
"6RSE",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION",5.6,"0.1M MES. 25-35% PEG6000",277,,,"6RSE",70.44,"1.8","1.8","Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6RSE"
"6RSH",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M MES, 25-35% PEG600",277,,,"6RSH",70.49,"1.71","1.71","Structure based optimization of JAK1-ATP binding pocket Inhibitors in the aminopyrazole class","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6RSH"
"6RSR",,"X-RAY DIFFRACTION",3.04,59.6,"VAPOR DIFFUSION, HANGING DROP",,"100 mM HEPES pH 7.5, 5-8% PEG 8000",294,"10.1021/acs.jmedchem.9b01460",,"6RSR",76.68,"3.15","3.15","TBK1 in complex with compound 2","GSGSAMGQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6RSR"
"6RSS",,"SOLUTION NMR",,,,,,,"10.3390/ijms20194682",,"6RSS",11.97,,,"Solution structure of the fourth WW domain of WWP2 with GB1-tag","GSHMQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTYTVTEGSGGAGGQGMIQEPALPPGWEMKYTSEGVRYFVDHNTRTTTFKDPRPGFE","Homo sapiens","WWP2","NEDD4-like E3 ubiquitin-protein ligase WWP2","1","6RSS"
"6RST",,"X-RAY DIFFRACTION",3.25,62.11,"VAPOR DIFFUSION, HANGING DROP",,"100 mM HEPES pH 7.5 and 5-8% PEG 8000",294,"10.1021/acs.jmedchem.9b01460",,"6RST",76.72,"3.29","3.29","TBK1 in complex with inhibitor compound 24","GSGSAMGQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6RST"
"6RSU",,"X-RAY DIFFRACTION",3.26,62.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES pH 7.5, 5-8% PEG 8000",294,"10.1021/acs.jmedchem.9b01460",,"6RSU",76.74,"2.75","2.75","TBK1 in complex with Inhibitor compound 35","GSGSAMGQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6RSU"
"6RSZ",,"X-RAY DIFFRACTION",2.06,39.99,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6RSZ",30.87,"1.089","1.089","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RSZ"
"6RT0","3.1","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.48907",,"6RT0",144.76,"3.1",,"cryo-em structure of alpha-synuclein fibril polymorph 2A","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6RT0"
"6RTB","3.46","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.48907",,"6RTB",144.76,"3.46",,"cryo-em structure of alpha-synuclein fibril polymorph 2B","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6RTB"
"6RTX",,"X-RAY DIFFRACTION",2.37,48.14,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M bicine/Trizma base pH 8.5,
0.03M of each ethylene glycol (diethyleneglycol, triethyleneglycol, tetraethyleneglycol and pentaethyleneglycol),
12.5% (v/v) MPD,
12.5% (w/v) PEG 1000,
12.5% (w/v) PEG 3350",293,"10.1038/s41589-019-0370-y",,"6RTX",35.11,"1.95","1.95","Crystal structure of the Patched-1 (PTCH1) ectodomain 1","ETGELNYTRQKIGEEAMFNPQLMIQTPKEEGANVLTTEALLQHLDSALQASRVHVYMYNRQWKLEHLCYKSGELITETGYMDQIIEYLYPCLIITPLDCFWEGAKLQSGTAYLLGKPPLRWTNFDPLEFLEELKKINYQVDSWEEMLNKAEVGHGYMDRPCLNPADPDCPATAPNKNSTKPLDMALVLNGGCHGLSRKYMHWQEELIVGGTVKNSTGKLVSAHALQTMFQLMTPKQMYEHFKGYEYVSHINWNEDKAAAILEAWQRTYVEVVHQSVAQNSTQKVLSFTTTTLDGTKHHHHHH","Homo sapiens","PTCH1, PTCH","Protein patched homolog 1","1","6RTX"
"6RUA",,"X-RAY DIFFRACTION",2.98,58.74,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.2 M ammonium acetate
12% PEG 4000 pH 7.4",293,"10.1080/14756366.2019.1710502",,"6RUA",137.89,"2.75","2.75","Structure of recombinant human butyrylcholinesterase in complex with a coumarin-based fluorescent probe linked to sulfonamide type inhibitor.","EDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTGNIDEAEWEWKAGFHRWNNYMMDWKNQFNDYTSKKESCVGL","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6RUA"
"6RUS",,"X-RAY DIFFRACTION",4.62,73.38,"VAPOR DIFFUSION, SITTING DROP",6,"1.1 M ammonium sulfate, 0.1 M sodium acetate pH 6.0, 1.2%(w/v) myo-inositol",292,"10.3389/fimmu.2019.02007",,"6RUS",54.99,"2.8","2.8","Structure of a functional properdin monomer","DPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCCPEMGGWSGWGPWEPCSVTCSKGTRTRRRACNHPAPKCGGHCPGQAQESEACDTQQVCPTHGAWATWGPWTPCSASCHGGPHEPKETRSRKCSAPEPSQKPPGKPCPGLAYEQRRCTGLPPCPENLYFQ","Homo sapiens","CFP, PFC","Properdin","1","6RUS"
,,,,,,,,,,,,,,,,"GVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEELENLYFQ","Homo sapiens","CFP, PFC","Properdin","2","6RUS"
"6RUU",,"X-RAY DIFFRACTION",4.22,70.87,"VAPOR DIFFUSION, HANGING DROP",5,"20C, 8mg/mL protein, hanging drop vapour diffusion, 2uL :1uL drop ratio (protein:precipitant) + 1mL reservoir, streak seeding from 1:100 seed stock (original seed stock: 10 uL from drops containing previously obtained crystals +50 uL precipitant mix, crushed by vortexing with seed bead, diluted in precipitant mix), crystals appeared after 2-3 days, harvested after 5-7 days, overnight soaking with 1:1 v/v of 5 mM Ethylmercury Phosphate in stabilising solution, Cryo: Precipitant mix +30% Glycerol",293.15,"10.1016/j.str.2020.11.004",,"6RUU",111.18,"2.95","2.95","Pseudokinase domain of human IRAK3","GPLGSKGVLLKSSISFQNIIEGTRNFHKDFLIGEGEIFEVYRVEIQNLTYAVKLFKQEKKMQCKKHWKRFLSELEVLLLFHHPNILELAAYFTETEKFCLIYPYMRNGTLFDRLQCVGDTAPLPWHIRIGILIGISKAIHYLHNVQPCSVICGSISSANILLDDQFQPKLTDFAMAHFRSHLEHQSCTINMTSSSSKHLWYMPEEYIRQGKLSIKTDVYSFGIVIMEVLTGCRVVLDDPKHIQLRDLLRELMEKRGLDSCLSFLDKKVPPCPRNFSAKLFCLAGRCAATRAKLRPSMDEVLNTLESTQASLYFAE","Homo sapiens","IRAK3","Interleukin-1 receptor-associated kinase 3","1","6RUU"
"6RV0",,"X-RAY DIFFRACTION",3.44,64.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"10-12% PEG 6K; 5% 2-methyl-2,4-pentanediol (MPD); 0.1M MES pH 6.5",294,"10.1042/BCJ20190507",,"6RV0",43.31,"2.7","2.7","human Alanine:Glyoxylate Aminotransferase major allele (AGT-Ma); with PMP in the active site","MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL","Homo sapiens","AGXT, AGT1, SPAT","Serine--pyruvate aminotransferase","1","6RV0"
"6RV1",,"X-RAY DIFFRACTION",3.26,62.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"10-12% PEG 6K; 5% 2-methyl-2,4-pentanediol (MPD); 0.1M MES pH 6.5",294,"10.1042/BCJ20190507",,"6RV1",43.31,"3","3","human Alanine:Glyoxylate Aminotransferase major allele (AGT-Ma)","MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL","Homo sapiens","AGXT, AGT1, SPAT","Serine--pyruvate aminotransferase","1","6RV1"
"6RV2",,"X-RAY DIFFRACTION",4.58,73.14,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS pH 8.5, 0.05 M KCl, 32% v/v PEG400, 3% w/v sucrose",293,"10.1038/s41586-020-2250-8",,"6RV2",128.8,"3","3","Crystal structure of the human two pore domain potassium ion channel TASK-1 (K2P3.1) in a closed conformation","MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAENLYFQ","Homo sapiens","KCNK3, TASK, TASK1","Potassium channel subfamily K member 3","1","6RV2"
"6RV3",,"X-RAY DIFFRACTION",4.58,73.17,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS pH 8.5, 0.05 M KCl, 24% v/v PEG 400, 3% w/v sucrose",293,"10.1038/s41586-020-2250-8",,"6RV3",129.48,"2.9","2.9","Crystal structure of the human two pore domain potassium ion channel TASK-1 (K2P3.1) in a closed conformation with a bound inhibitor BAY 1000493","MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAENLYFQ","Homo sapiens","KCNK3, TASK, TASK1","Potassium channel subfamily K member 3","1","6RV3"
"6RV4",,"X-RAY DIFFRACTION",4.64,73.49,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS pH 8.5, 0.05 M KCl, 31% v/v PEG400, 3% w/v sucrose",293,"10.1038/s41586-020-2250-8",,"6RV4",127.89,"3.1","3.1","Crystal structure of the human two pore domain potassium ion channel TASK-1 (K2P3.1) in a closed conformation with a bound inhibitor BAY 2341237","MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAENLYFQ","Homo sapiens","KCNK3, TASK, TASK1","Potassium channel subfamily K member 3","1","6RV4"
"6RV6",,"X-RAY DIFFRACTION",6.61,81.38,"VAPOR DIFFUSION, SITTING DROP",4,"1.0 M lithium sulfate, 0.1 M sodium acetate pH 4.0,
0.1 M barium chloride",292,"10.3389/fimmu.2019.02007",,"6RV6",47.07,"3.507","3.507","Structure of properdin lacking TSR3 based on anomalous data","DPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCCPEMGGWSGWGPWEPCSVTCSKGTRTRRRACNHPAPKCGGHCPGQAQESEACDTQQVCPENLYFQ","Homo sapiens","CFP, PFC","Properdin","1","6RV6"
,,,,,,,,,,,,,,,,"GVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEELENLYFQ","Homo sapiens","CFP, PFC","Properdin","2","6RV6"
"6RVA",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA119.010072",,"6RVA",7.71,,,"STRUCTURE OF [ASP58]-IGF-I ANALOGUE","GGPETLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLDMYCAPLKPAKSA","Homo sapiens","IGF1, IBP1","Insulin-like growth factor I","1","6RVA"
"6RVF",,"X-RAY DIFFRACTION",2.07,40.72,"VAPOR DIFFUSION, HANGING DROP",,"1.3 M sodium citrate, 0.1 M Tris-HCl, pH 8.5",293,"10.1080/14756366.2019.1653291","KKH","6RVF",29.83,"2.07","2.07","Crystal structure of hCA II in complex with Urea, N-(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-6-yl)-N'-phenyl","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RVF"
"6RVK",,"X-RAY DIFFRACTION",2.08,40.82,"VAPOR DIFFUSION, HANGING DROP",,"1.3 M sodium citrate, 0.1 M Tris-HCl, pH 8.5",293,"10.1080/14756366.2019.1653291","R29","6RVK",29.84,"1.58","1.58","Crystal structure of hCA II in complex with Urea, N-(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-6-yl)-N'-(phenylmethyl)-","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RVK"
"6RVL",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION, HANGING DROP",,"1.3 M sodium citrate, 0.1 M Tris-HCl, pH 8.5",293,"10.1080/14756366.2019.1653291","KKE","6RVL",29.84,"1.72","1.72","Crystal structure of hCA II with Urea, N-(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-6-yl)-?N'-phenyl-","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RVL"
"6RVX","3.61","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-11363-x",,"6RVX",172.57,"3.61",,"Inward-open structure of the ASCT2 (SLC1A5) mutant C467R in presence of TBOA","MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIVFGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFARLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLMMKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVTATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSRTVLNVEGDALGAGLLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESVMHHHHHH","Homo sapiens","SLC1A5, ASCT2, M7V1, RDR, RDRC","Neutral amino acid transporter B(0)","1","6RVX"
"6RVY","4.13","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-11363-x",,"6RVY",172.57,"4.13",,"Inward-open structure of the ASCT2 (SLC1A5) mutant C467R in absence of substrate","MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIVFGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFARLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLMMKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVTATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSRTVLNVEGDALGAGLLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESVMHHHHHH","Homo sapiens","SLC1A5, ASCT2, M7V1, RDR, RDRC","Neutral amino acid transporter B(0)","1","6RVY"
"6RVZ",,"X-RAY DIFFRACTION",3.42,64.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M BIS-TRIS propane, pH 7.5, 0.2 M Potassium-Sodium Tartrate, 20% (w/v) PEG 3350",293,"10.1126/science.aba9763",,"6RVZ",49.25,"2.1","2.1","Crystal structure of ANGEL2, a 2',3'-cyclic phosphatase, in complex with adenosine-2',3'-vanadate","SNAEPSSKRRKHQGVIKRNWEYICSHDKEKTKILGDKNVDPKCEDSENKFDFSVMSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQEVQEDHYGAEIRPSLESLGYHCEYKMRTGRKPDGCAICFKHSKFSLLSVNPVEFFRPDISLLDRDNVGLVLLLQPKIPYAACPAICVANTHLLYNPRRGDIKLTQLAMLLAEISSVAHQKDGSFCPIVMCGDFNSVPGSPLYSFIKEGKLNYEGLPIGKVSGQEQSSRGQRILSIPIWPPNLGISQNCVYEVQQVPKVEKTDSDLTQTQLKQTEVLVTAEKLSSNLQHHFSLSSVYSHYFPDTGIPEVTTCHSRSAITVDYIFYSAEKEDVAGHPGAEVALVGGLKLLARLSLLTEQDLWTVNGLPNENNSSDHLPLLAKFRLEL","Homo sapiens","ANGEL2, KIAA0759L","Protein angel homolog 2","1","6RVZ"
"6RW0",,"X-RAY DIFFRACTION",2.69,54.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M BIS-TRIS propane, pH 7.5, 0.1 M Potassium-Sodium Tartrate, 20% (w/v) PEG 3350",293,"10.1126/science.aba9763",,"6RW0",48.67,"1.45","1.45","Crystal structure of ANGEL2, a 2',3'-cyclic phosphatase","SNAEPSSKRRKHQGVIKRNWEYICSHDKEKTKILGDKNVDPKCEDSENKFDFSVMSYNILSQDLLEDNSHLYRHCRRPVLHWSFRFPNILKEIKHFDADVLCLQEVQEDHYGAEIRPSLESLGYHCEYKMRTGRKPDGCAICFKHSKFSLLSVNPVEFFRPDISLLDRDNVGLVLLLQPKIPYAACPAICVANTHLLYNPRRGDIKLTQLAMLLAEISSVAHQKDGSFCPIVMCGDFNSVPGSPLYSFIKEGKLNYEGLPIGKVSGQEQSSRGQRILSIPIWPPNLGISQNCVYEVQQVPKVEKTDSDLTQTQLKQTEVLVTAEKLSSNLQHHFSLSSVYSHYFPDTGIPEVTTCHSRSAITVDYIFYSAEKEDVAGHPGAEVALVGGLKLLARLSLLTEQDLWTVNGLPNENNSSDHLPLLAKFRLEL","Homo sapiens","ANGEL2, KIAA0759L","Protein angel homolog 2","1","6RW0"
"6RW1",,"X-RAY DIFFRACTION",2.08,40.99,"VAPOR DIFFUSION, HANGING DROP",,"1.3 M sodium citrate, 0.1 M Tris-HCl, pH 8.5",293,"10.1080/14756366.2019.1653291","KL5","6RW1",29.86,"1.7","1.7","Crystal structure of hCA II in complex with Urea, N-(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-6-yl)-N'-(phenylmethyl)-","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RW1"
"6RWJ",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"TRIS, PEG3350, NaCl",298,"10.1021/acs.jmedchem.0c00478","KLK","6RWJ",15.32,"1.4","1.4","Crystal Structure of BRD4(1) bound to inhibitor BUG0 (6)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6RWJ"
"6RX1",,"X-RAY DIFFRACTION",2.52,51.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 30% v/v 2-propanol, 0.2 M MgCl2",295,"10.1016/j.jmb.2019.10.020",,"6RX1",12.74,"2.1","2.1","Crystal structure of human syncytin 1 in post-fusion conformation","MHHHHHHENLYFQSTSTQFYYKLSQELNGDMERVADSLVTLQDQLNSLAAVVLQNRRALDLLTAERGGTCLFLGEECCYYVNQSGIVTEKVKEIRDRIQRRAEELRNT","Homo sapiens","ERVW-1, ERVWE1","Syncytin-1","1","6RX1"
"6RX3",,"X-RAY DIFFRACTION",2.3,46.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris pH 8.5, 
25% v/v tert-butanol",291,"10.1016/j.jmb.2019.10.020",,"6RX3",36.63,"2.2","2.2","Crystal structure of human syncytin 2 in post-fusion conformation","MHHHHHHENLYFQSTKASLTYSQLSKEIANNIDTMAKALTTMQEQIDSLAAVVLQNRRGLDMLTAAQGGICLALDEKCCFWVNQSGKVQDNIRQLLNQASSLRERATQ","Homo sapiens","ERVFRD-1, ERVFRDE1, UNQ6191/PRO20218","Syncytin-2","1","6RX3"
"6RX7",,"X-RAY DIFFRACTION",2.46,50.06,"VAPOR DIFFUSION, SITTING DROP",6,"PEG400 1% (v/v)
Ammonium sulfate 2 M
HEPES 0.1 M",294.15,"10.1194/jlr.RA120001023",,"6RX7",38.69,"1.63","1.63","Structure of the KIV type 2 (KIV-2) domain of lipoprotein (a)","MGHHHHHHENLYFQGAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTA","Homo sapiens","LPA","Apolipoprotein(a)","1","6RX7"
"6RY4",,"X-RAY DIFFRACTION",2.79,55.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NH4Cl pH 7.5, 18% PEG 3350",293,"10.1002/open.202100087",,"6RY4",45.61,"1.95","1.95","PARP15 catalytic domain in complex with 4-(3-carbamoylphenoxy)benzamide.","LPEHWTDMNHQLFCMVQLEPGQSEYNTIKDKFTRTCSSYAIEKIERIQNAFLWQSYQVKKRQMDIKNDHKNNERLLFHGTDADSVPYVNQHGFNRSCAGKNAVSYGKGTYFAVDASYSAKDTYSKPDSNGRKHMYVVRVLTGVFTKGRAGLVTPPPKNPHNPTDLFDSVTNNTRSPKLFVVFFDNQAYPEYLITFTA","Homo sapiens","PARP15, BAL3","Protein mono-ADP-ribosyltransferase PARP15","1","6RY4"
"6RZF",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5,, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,"10.1021/jacsau.0c00094",,"6RZF",16.2,"1.016","1.016","Galectin-3C in complex with ortho-fluoroaryltriazole galactopyranosyl 1-thio-D-glucopyranoside derivative","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RZF"
"6RZG",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5,, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,"10.1021/jacsau.0c00094",,"6RZG",16.24,"1.015","1.015","Galectin-3C in complex with meta-fluoroaryltriazole galactopyranosyl 1-thio-D-glucopyranoside derivative","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RZG"
"6RZH",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5,, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,"10.1021/jacsau.0c00094",,"6RZH",16.24,"0.947","0.947","Galectin-3C in complex with para-fluoroaryltriazole galactopyranosyl 1-thio-D-glucopyranoside derivative","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RZH"
"6RZI",,"X-RAY DIFFRACTION",2.02,39.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,,,"6RZI",16.21,"1.095","1.095","Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:1(Hydrogen)","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RZI"
"6RZJ",,"X-RAY DIFFRACTION",2.14,42.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,,,"6RZJ",16.23,"1.097","1.097","Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:2(Fluorine)","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RZJ"
"6RZK",,"X-RAY DIFFRACTION",2.14,42.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,,,"6RZK",16.22,"1.046","1.046","Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:3(Chlorine)","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RZK"
"6RZL",,"X-RAY DIFFRACTION",2.11,41.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,,,"6RZL",16.29,"1.045","1.045","Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:4(Bromine)","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RZL"
"6RZM",,"X-RAY DIFFRACTION",2.03,39.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.4 M NaSCN, 7.9 mM beta-mercaptoethanol",293,,,"6RZM",16.42,"1.345","1.345","Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:5(Iodine)","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6RZM"
"6RZX",,"X-RAY DIFFRACTION",2.07,40.52,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1177/2472555220918836","KPQ","6RZX",29.55,"1","1","Carbonic Anhydrase CAIX mimic in complex with inhibitor FBSA","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVVKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6RZX"
"6S03",,"X-RAY DIFFRACTION",2.1,41.35,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-H2SO4",291,"10.1177/2472555220918836","KPW","6S03",29.73,"1.38","1.38","Carbonic Anhydrase CAIX mimic in complex with inhibitor I39LT379","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVVKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6S03"
"6S08",,"X-RAY DIFFRACTION",3.66,66.41,"VAPOR DIFFUSION, SITTING DROP",,"Potassium Sulphate, PEG 3350",291,"10.3389/fimmu.2019.02097",,"6S08",39.05,"2.03","2.03","Crystal Structure of Properdin (TSR domains N1 & 456)","GSVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEELAAAHHHHHH","Homo sapiens","CFP, PFC","Properdin","1","6S08"
,,,,,,,,,,,,,,,,"GSDPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCAAA","Homo sapiens","CFP, PFC","Properdin","2","6S08"
"6S0A",,"X-RAY DIFFRACTION",4.44,72.3,"VAPOR DIFFUSION, SITTING DROP",5.5,"Sodium Citrate, PEG 3000",291,"10.3389/fimmu.2019.02097",,"6S0A",46.09,"2.52","2.52","Crystal Structure of Properdin (TSR domains N12 & 456)","GSVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEELAAAHHHHHH","Homo sapiens","CFP, PFC","Properdin","1","6S0A"
,,,,,,,,,,,,,,,,"GSDPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCCPEMGGWSGWGPWEPCSVTCSKGTRTRRRACNHPAPKCGGHCPGQAQESEACDTQQVCP","Homo sapiens","CFP, PFC","Properdin","2","6S0A"
"6S0L",,"X-RAY DIFFRACTION",2.75,55.35,"LIPIDIC CUBIC PHASE",,"0.1M sodium citrate pH 5.0, 0.05M sodium
thiocyanate, 34% PEG400, 5mM ZM241385, 2% 1,6-hexanediol",297,"10.1107/S2052252520011379",,"6S0L",52.9,"2.65","2.65","Structure of the A2A adenosine receptor determined at SwissFEL using native-SAD at 4.57 keV from all available diffraction patterns","DYKDDDDGAPPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILVGVLAIPFAITISTGFCAACHGCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKAHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFAAARRQLADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLERARSTLQKEVHAAKSAAIIAGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLAHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAHHHHHHHHHH","Homo sapiens","ADORA2A, ADORA2","A2a adenosine receptor","1","6S0L"
"6S0N",,"SOLUTION NMR",,,,,,,"10.1002/psc.3231",,"6S0N",1,,,"A9 peptide derived from Herceptin fab binding region","QDVNTAVAW","Homo sapiens",,"GLN-ASP-VAL-ASN-THR-ALA-VAL-ALA-TRP","1","6S0N"
"6S11",,"X-RAY DIFFRACTION",3.24,62.08,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG6000 -- 10% ethylene glycol -- 0.2M ammonium chloride",277,,,"6S11",84.91,"2.445","2.445","Crystal Structure of DYRK1A with small molecule inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6S11"
"6S14",,"X-RAY DIFFRACTION",2.72,54.8,"VAPOR DIFFUSION, SITTING DROP",,"2M ammonium sulfate -- 0.1M citrate pH 5.7 -- 0.2M sodium/potassium tartrate",277,,,"6S14",42.92,"1.05","1.05","Crystal Structure of DYRK1A with small molecule inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6S14"
"6S17",,"X-RAY DIFFRACTION",2.69,54.24,"VAPOR DIFFUSION, SITTING DROP",,"1.6M ammonium sulfate -- 0.1M citrate pH 5.3 -- 0.2M sodium/potassium tartrate",277,,,"6S17",43.04,"1.1","1.1","Crystal Structure of DYRK1A with small molecule inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6S17"
"6S1B",,"X-RAY DIFFRACTION",2.74,55.15,"VAPOR DIFFUSION, SITTING DROP",,"2.2M ammonium sulfate -- 0.1M citrate pH 5.3 -- 0.2M sodium/potassium tartrate",277,,,"6S1B",42.95,"1.3","1.3","Crystal Structure of DYRK1A with small molecule inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6S1B"
"6S1F",,"X-RAY DIFFRACTION",3.04,59.49,"VAPOR DIFFUSION, SITTING DROP",,"150 nL sitting drops containing 100 nL protein and 50 nL of a reservoir solution containing the BCS5 condition 20% PEG Smear High, 0.1M citrate pH 5.5",277,,,"6S1F",147.36,"3.11","3.11","Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3","SMGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLKKTKLQSV","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6S1F"
"6S1H",,"X-RAY DIFFRACTION",2.62,53.08,"VAPOR DIFFUSION, SITTING DROP",,"1.8M ammonium sulfate -- 0.1M citrate pH 5.7 -- 0.2M sodium/potassium tartrate",277,,,"6S1H",42.8,"1.05","1.05","Crystal Structure of DYRK1A with small molecule inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6S1H"
"6S1I",,"X-RAY DIFFRACTION",3.25,62.12,"VAPOR DIFFUSION, SITTING DROP",,"37% PEG400 -- 0.2M lithium sulfate -- 0.1M tris pH 8.8",277,"10.1021/acsmedchemlett.0c00279",,"6S1I",171.18,"2.38","2.38","Crystal Structure of DYRK1A with small molecule inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6S1I"
"6S1J",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, SITTING DROP",,"2.2M ammonium sulfate -- 0.1M citrate pH 5.7 -- 0.2M sodium/potassium tartrate",277,,,"6S1J",43.2,"1.408","1.408","Crystal Structure of DYRK1A with small molecule inhibitor","SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6S1J"
"6S1X",,"X-RAY DIFFRACTION",3.3,62.73,"VAPOR DIFFUSION, HANGING DROP",8,"32% (v/v) pentaerythritol propoxylate PO/OH 5/4; 2 % (w/v) PEG 3350; 100 mM Tris-HCl, pH 8.0",293,"10.1021/acs.jmedchem.9b02022","KRZ","6S1X",83.43,"1.76","1.76","X-ray structure of human glutamate carboxypeptidase II (GCPII)-E424M inactive mutant, in complex with a inhibitor KB1160","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAMEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6S1X"
"6S25",,"X-RAY DIFFRACTION",2.14,42.56,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG6000
10% ethylene glycol
0.2M lithium chloride",277,,,"6S25",15.84,"1.1","1.1","Crystal Structure of the first bromodomain of BRD4 in complex with a benzodiazepine ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6S25"
"6S26",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M Sodium dihydrogen phosphate/0.4 M dipotassium hydrogen phosphate,  0.1 M phosphate-citrate pH 4.2",291,"10.1021/acs.jmedchem.9b01062",,"6S26",47.05,"2.05","2.05","Crystal structure of human wild type STING in complex with 2'-3'-cyclic-GMP-7-deaza-AMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6S26"
"6S27",,"X-RAY DIFFRACTION",2.36,47.86,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Calcium Chloride, 20% (w/v) PEG 3350",291,"10.1021/acs.jmedchem.9b01062",,"6S27",23.87,"2.802","2.802","Crystal structure of human wild type STING in complex with 2'3'-cyclic-GMP-2'F-2'dAMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6S27"
"6S2K",,"X-RAY DIFFRACTION",2.6,52.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"100mM Bis-Tris propane
200mM KSCN
20% PEG3350",277,,,"6S2K",116.68,"3.1","3.1","Human Menin in complex with AJ21","GAMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGEERPGEQSQGTQSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSGTVAGTARGPEGGSTAQVPAPAASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQ","Homo sapiens","MEN1, hCG_2017452, SCG2","Multiple endocrine neoplasia I, isoform CRA_b","1","6S2K"
"6S2M",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.25,"24% PEG6000, 0.1 M sodium citrate, pH 5",281,"10.3390/molecules24173044",,"6S2M",15.56,"0.72","0.72","Perdeuterated human myelin protein P2 at 0.72-A resolution","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6S2M"
"6S2S",,"X-RAY DIFFRACTION",2.84,56.62,"VAPOR DIFFUSION, SITTING DROP",5,"24% PEG6000, 0.1 M sodium citrate",277,"10.3390/molecules24173044",,"6S2S",15.91,"0.86","0.86","Hydrogenated human myelin protein P2 at 0.86-A resolution","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6S2S"
"6S34",,"X-RAY DIFFRACTION",3.42,64.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M Sodium Citrate, 0.1 M Sodium Hepes, pH 7.5, 20 % isopropanol",293,,,"6S34",5.88,"1.35","1.35","Zinc free, dimeric human insulin determined to 1.35 Angstrom resolution","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","6S34"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","6S34"
"6S3Q","3.34","ELECTRON MICROSCOPY",,,,,,,,,"6S3Q",174.35,"3.34",,"Structure of human excitatory amino acid transporter 3 (EAAT3) in complex with TFB-TBOA","MGKPARKGCEWKRFLKNNWVLLSTVAAVVLGITTGVLVREHRNLSTLEKFYFAFPGEILMRMLKLIILPLIISSMITGVAALDSNVSGKIGVRAVVYYFCTTLIAVILGIVLVVSIKPGVTQKVGEIARTGSTPEVSTVDAMLDLIRNMFPENLVQACFQQYKTKREEVKPPSDPEMNMTEESFTAVMTTAISKNKTKEYKIVGMYSDGINVLGLIVFCLVFGLVIGKMGEKGQILVDFFNALSDATMKIVQIIMCYMPLGILFLIAGKIIEVEDWEIFRKLGLYMATVLTGLAIHSIVILPLIYFIVVRKNPFRFAMGMAQALLTALMISSSSATLPVTFRCAEENNQVDKRITRFVLPVGATINMDGTALYEAVAAVFIAQLNDLDLGIGQIITISITATSASIGAAGVPQAGLVTMVIVLSAVGLPAEDVTLIIAVDWLLDRFRTMVNVLGDAFGTGIVEKLSKKELEQMDVSSEVNAENLYFQ","Homo sapiens","SLC1A1, EAAC1, EAAT3, HEAAC1","Excitatory amino acid transporter 3","1","6S3Q"
"6S41",,"X-RAY DIFFRACTION",2.79,55.98,"VAPOR DIFFUSION, SITTING DROP",,,277,"10.1021/acs.jmedchem.9b01032",,"6S41",74.51,"2.7","2.7","CRYSTAL STRUCTURE OF PXR IN COMPLEX WITH XPC-7455","LGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGSGGSGGSSHSSLTERHKILHRLLQEGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","6S41"
"6S4A",,"X-RAY DIFFRACTION",3.16,61.1,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 7.8, 80 % v/v MPD",293,"10.1038/s43018-022-00331-y",,"6S4A",72.27,"1.95","1.95","Structure of human MTHFD2 in complex with TH9028","MEAVVISGRKLAQQIKQEVRQEVEEWVASGNKRPHLSVILVGENPASHSYVLNKTRAAAVVGINSETIMKPASISEEELLNLINKLNNDDNVDGLLVQLPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWEIIKRTGIPTLGKNVVVAGRSKNVGMPIAMLLHTDGAHERPGGDATVTISHRYTPKEQLKKHTILADIVISAAGIPNLITADMIKEGAAVIDVGINRVHDPVTAKPKLVGDVDFEGVRQKAGYITPVPGGVGPMTVAMLMKNTIIAAKKVLRLEEREVLKSKELGVATN","Homo sapiens","MTHFD2, NMDMC","Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial","1","6S4A"
"6S4B",,"X-RAY DIFFRACTION",1.87,34.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG3350, NaCl, CaCl2, HEPES",293,"10.1021/acs.jmedchem.0c00478","KUH","6S4B",15.68,"1.6","1.6","Crystal Structure of BRD4(1) bound to inhibitor BUX1 (8)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6S4B"
"6S4E",,"X-RAY DIFFRACTION",2.01,38.8,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Phosphate/Citrate pH 4.3, 42 % v/v PEG300",293,"10.1038/s43018-022-00331-y",,"6S4E",35.79,"1.9","1.9","Structure of human MTHFD2 in complex with TH7299","MEAVVISGRKLAQQIKQEVRQEVEEWVASGNKRPHLSVILVGENPASHSYVLNKTRAAAVVGINSETIMKPASISEEELLNLINKLNNDDNVDGLLVQLPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWEIIKRTGIPTLGKNVVVAGRSKNVGMPIAMLLHTDGAHERPGGDATVTISHRYTPKEQLKKHTILADIVISAAGIPNLITADMIKEGAAVIDVGINRVHDPVTAKPKLVGDVDFEGVRQKAGYITPVPGGVGPMTVAMLMKNTIIAAKKVLRLEEREVLKSKELGVATN","Homo sapiens","MTHFD2, NMDMC","Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial","1","6S4E"
"6S4F",,"X-RAY DIFFRACTION",3.25,62.11,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 7.6, 75 % v/v MPD",293,"10.1038/s43018-022-00331-y",,"6S4F",70.9,"2.2","2.2","Structure of human MTHFD2 in complex with TH9619","MEAVVISGRKLAQQIKQEVRQEVEEWVASGNKRPHLSVILVGENPASHSYVLNKTRAAAVVGINSETIMKPASISEEELLNLINKLNNDDNVDGLLVQLPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWEIIKRTGIPTLGKNVVVAGRSKNVGMPIAMLLHTDGAHERPGGDATVTISHRYTPKEQLKKHTILADIVISAAGIPNLITADMIKEGAAVIDVGINRVHDPVTAKPKLVGDVDFEGVRQKAGYITPVPGGVGPMTVAMLMKNTIIAAKKVLRLEEREVLKSKELGVATN","Homo sapiens","MTHFD2, NMDMC","Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial","1","6S4F"
"6S4I",,"X-RAY DIFFRACTION",3.42,64,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein solution: 25 mg/ml insulin added 0.1% (w/v) NVoy
Precipitant: 6.0 M ammonium nitrate, 0.1 M Tris pH 8.5",310,"10.1038/s41467-020-17487-9",,"6S4I",5.8,"1.511","1.511","Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB30 human insulin","GIVEQCCTSICSLEQLENYCN","Homo sapiens","INS","Insulin","1","6S4I"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFHYTPK","Homo sapiens","INS","Insulin","2","6S4I"
"6S4J",,"X-RAY DIFFRACTION",2.41,48.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.12M monosaccharides, 0.1M buffer system 1 pH 6.5, 20% (v/v) PEG500MME, 10% (w/v) Peg 20000 (F1 from Marpheus screen, Molecular Dimensions)",293,"10.1038/s41467-020-17487-9",,"6S4J",6.36,"1.5","1.5","Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB27, desB30 human insulin","GIVEQCCTSICSLEQLENYCN","Homo sapiens","INS","Insulin","1","6S4J"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFHYPK","Homo sapiens","INS","Insulin","2","6S4J"
"6S4L",,"X-RAY DIFFRACTION",2.75,55.23,"VAPOR DIFFUSION, SITTING DROP",7.8,"12% PEG3350 -- 0.1M bis-tris-propane pH 7.8 -- 0.2M sodium iodide -- 10% ethylene glycol",293,,,"6S4L",134.16,"2.42","2.42","Structure of human KCTD1","SMSNAPVHIDVGGHMYTSSLATLTKYPESRIGRLFDGTDPIVLDSLKQHYFIDRDGQMFRYILNFLRTSKLLIPDDFKDYTLLYEEAKYFQLQPMLLEMERWKQDRETGRFSRPCECLVVRVAPDLGERITLSGDKSLIEEVFPEIGDVMCNSVNAGWNHDSTHVIRFPLNGYCHLNSVQVLERLQQRGFEIVGSCGGGVDSSQFSEYVLRRELRRTPRVPSVIRIKQEPLD","Homo sapiens","KCTD1, C18orf5","BTB/POZ domain-containing protein KCTD1","1","6S4L"
"6S4M",,"X-RAY DIFFRACTION",2.35,47.79,"LIPIDIC CUBIC PHASE",6.5,"0.1M ADA pH6.5 -- 0.2M lithium citrate -- 30% PEG400",293,,,"6S4M",48.94,"2.4","2.4","Crystal structure of the human organic anion transporter MFSD10 (TETRAN)","MGWGGGGGCTPRPPIHQQPPERRVVTVVFLGLLLDLLAFTLLLPLLPGLLESHGRAHDPLYGSWQGGVDWFATAIGMPVEKRYNSVLFGGLIGSAFSVLQFLCAPLTGATSDCLGRRPVMLLCLMGVATSYAVWATSRSFAAFLASRLIGGISKGNVSLSTAIVADLGSPLARSQGMAVIGVAFSLGFTLGPMLGASLPLEMAPWFALLFAASDLLFIFCFLPETLPLEKRAPSIALGFRDAADLLSPLALLRFSAVARGQDPPSGDRLSSLRRLGLVYFLYLFLFSGLEYTLSFLTHQRFQFSSLQQGKMFFLIGLTMATIQGAYARRIHPGGEVAAVKRALLLLVPAFLLIGWGRSLPVLGLGLLLYSFAAAVVVPCLSSVVAGYGSPGQKGTVMGTLRSLGALARAAGPLVAASVYWLAGAQACFTTWSGLFLLPFFLLQKAENLYFQ","Homo sapiens","MFSD10, TETRAN","Major facilitator superfamily domain-containing protein 10","1","6S4M"
"6S4N",,"X-RAY DIFFRACTION",2.44,49.49,"VAPOR DIFFUSION",7.5,"0.1 M HEPES pH 7.5 and 18% PEG6000",293,"10.1038/s42003-019-0675-0","KUW","6S4N",116.82,"1.9","1.9","LXRbeta ligand binding domain in comlpex with small molecule inhibitors","GVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","6S4N"
"6S4T",,"X-RAY DIFFRACTION",2.82,56.4,"VAPOR DIFFUSION",6.5,"100 mM Bis-Tris pH 6.5, 2 M sodium formate and 100 mM NaCl",293,"10.1038/s42003-019-0675-0","KVB","6S4T",29.33,"2","2","LXRbeta ligand binding domain in comlpex with small molecule inhibitors","GVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","6S4T"
"6S4U",,"X-RAY DIFFRACTION",3.65,66.3,"VAPOR DIFFUSION",,"Unknown.",293,"10.1038/s42003-019-0675-0",,"6S4U",86.26,"2.81","2.81","LXRbeta ligand binding domain in comlpex with small molecule inhibitors","GVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","6S4U"
"6S55",,"X-RAY DIFFRACTION",4.07,69.78,"VAPOR DIFFUSION, SITTING DROP",,"0.1M trisHCl pH 7.0-8.0, 1.2-1.5M ammonium sulphate and 20-25% PEG3350",278,"10.1021/acs.jmedchem.9b00673",,"6S55",16.24,"2.09","2.09","Crystal structure of human ATAD2 bromodomain in complex with N-(4-bromo-3-((3-methylpiperidin-1-yl)sulfonyl)phenyl)-2-(2,5-dioxoimidazolidin-1-yl)acetamide","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6S55"
"6S56",,"X-RAY DIFFRACTION",3.99,69.15,"VAPOR DIFFUSION, SITTING DROP",,"0.1M trisHCl pH 7.0-8.0, 1.2-1.5M ammonium sulphate and 20-25% PEG3350",278,"10.1021/acs.jmedchem.9b00673",,"6S56",16.26,"2.01","2.01","Crystal structure of human ATAD2 bromodomain in complex with N-(4-chloro-3-(N,N-dimethylsulfamoyl)phenyl)-2-(2,5-dioxo-3',4'-dihydro-2'H-spiro[imidazolidine-4,1'-naphthalen]-1-yl)acetamide","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6S56"
"6S57",,"X-RAY DIFFRACTION",4.07,69.79,"VAPOR DIFFUSION, SITTING DROP",,"0.1M trisHCl pH 7.0-8.0, 1.2-1.5M ammonium sulphate and 20-25% PEG3350",278,"10.1021/acs.jmedchem.9b00673",,"6S57",16.14,"1.82","1.82","Crystal structure of human ATAD2 bromodomain in complex withN-(3-(azepan-1-ylsulfonyl)-4-methylphenyl)-2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)acetamide","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6S57"
"6S5F",,"X-RAY DIFFRACTION",1.98,37.97,"VAPOR DIFFUSION, SITTING DROP",7.1,"0.1 M HEPES pH 7.1, 19 % PEG3350",293,,,"6S5F",24.66,"1.7","1.7","Structure of the human RAB39B in complex with GMPPNP","SMEAIWLYQFRLIVIGDSTVGKSCLIRRFTEGRFAQVSDPTVGVDFFSRLVEIEPGKRIKLQIWDTAGQERFRSITRAYYRNSVGGLLLFDITNRRSFQNVHEWLEETKVHVQPYQIVFVLVGHKCDLDTQRQVTRHEAEKLAAAYGMKYIETSARDAINVEKAFTDLTRDIYELVKRGEITIQEGWEGVKSGFVPNVVHSSEEVVKS","Homo sapiens","RAB39B","Ras-related protein Rab-39B","1","6S5F"
"6S5H",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, SITTING DROP",6.5,"20 % PEG3350, 10 % ethylene glycol, 0.1 M Bis-Tris-propane pH6 .5, 0.2 M sodium bromide",293.15,,,"6S5H",24.79,"2","2","Structure of the human RAB38 in complex with GTP","SMQAPHKEHLYKLLVIGDLGVGKTSIIKRYVHQNFSSHYRATIGVDFALKVLHWDPETVVRLQLWDIAGQERFGNMTRVYYREAMGAFIVFDVTRPATFEAVAKWKNDLDSKLSLPNGKPVSVVLLANKCDQGKDVLMNNGLKMDQFCKEHGFVGWFETSAKENINIDEASRCLVKHILANECDLMESIEPDVVKPHLTSTKVASCSG","Homo sapiens","RAB38","Ras-related protein Rab-38","1","6S5H"
"6S5K",,"X-RAY DIFFRACTION",2.61,52.81,"VAPOR DIFFUSION, HANGING DROP",,"100 mM PIPES pH 7 and 17% PEG4000",,"10.1038/s42003-019-0675-0","KWE","6S5K",28.7,"1.6","1.6","LXRbeta ligand binding domain in complex with small molecule inhibitors","GVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE","Homo sapiens","NR1H2, LXRB, NER, UNR","Oxysterols receptor LXR-beta","1","6S5K"
"6S60",,"X-RAY DIFFRACTION",2.46,49.99,"VAPOR DIFFUSION, HANGING DROP",,"2.8M sodium formate",298,"10.1016/j.ejmech.2021.113835",,"6S60",55.87,"2","2","Crystal structure of hTEAD2 in complex with a trisubstituted pyrazole inhibitor","MAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDVEHHHHHH","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6S60"
"6S64",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, HANGING DROP",,"2.8M sodium formate",298,"10.1016/j.ejmech.2021.113835",,"6S64",55.88,"2.22","2.22","Crystal structure of hTEAD2 in complex with a trisubstituted pyrazole inhibitor","MAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDVEHHHHHH","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6S64"
"6S66",,"X-RAY DIFFRACTION",2.43,49.34,"VAPOR DIFFUSION, HANGING DROP",,"2.8M sodium formate",298,"10.1016/j.ejmech.2021.113835",,"6S66",55.82,"2.2","2.2","Crystal structure of hTEAD2 in complex with a trisubstituted pyrazole inhibitor","MAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDVEHHHHHH","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6S66"
"6S69",,"X-RAY DIFFRACTION",2.42,49.1,"VAPOR DIFFUSION, HANGING DROP",,"2.8M sodium formate",298,"10.1016/j.ejmech.2021.113835",,"6S69",55.87,"2.15","2.15","Crystal structure of hTEAD2 in complex with a trisubstituted pyrazole inhibitor","MAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDVEHHHHHH","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6S69"
"6S6J",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, HANGING DROP",,"2.8M sodium formate",298,"10.1016/j.ejmech.2021.113835",,"6S6J",55.79,"2.1","2.1","Crystal structure of hTEAD2 in complex with a trisubstituted pyrazole inhibitor","MAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDVEHHHHHH","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6S6J"
"6S6K",,"X-RAY DIFFRACTION",1.84,33.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES, PEG3350, NaCl",293,"10.1021/acs.jmedchem.0c00478","KXK","6S6K",15.93,"1.4","1.4","Crystal Structure of BRD4(1) bound to inhibitor BUX2 (9)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6S6K"
"6S6M",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, HANGING DROP",,"Reservoir contained 0.2 M Sodium Acetate, 0.1 M TRIS pH 8.5, 30 %w/v PEG 4K",293,"10.1038/s41467-020-17736-x",,"6S6M",3.45,"1.35","1.35","Crystal structure of the human LL37(17-29) antimicrobial peptide","FKRIVQRIKDFLR","Homo sapiens","CAMP, CAP18, FALL39, HSD26","Cathelicidin antimicrobial peptide","1","6S6M"
"6S6W",,"X-RAY DIFFRACTION",2.73,54.95,"VAPOR DIFFUSION, SITTING DROP",,"2.4M NaMalonate pH 7.0",293.15,"10.1021/acs.jmedchem.9b01910",,"6S6W",109.41,"3.25","3.25","Crystal Structure of human ALDH1A3 in complex with 2,6-diphenylimidazo[1,2-a]pyridine (compound GA11) and NAD+","LPRPIRNLEVKFTKIFINNEWHESKSGKKFATCNPSTREQICEVEEGDKPDVDKAVEAAQVAFQRGSPWRRLDALSRGRLLHQLADLVERDRATLAALETMDTGKPFLHAFFIDLEGCIRTLRYFAGWADKIQGKTIPTDDNVVCFTRHEPIGVCGAITPWNFPLLMLVWKLAPALCCGNTMVLKPAEQTPLTALYLGSLIKEAGFPPGVVNIVPGFGPTVGAAISSHPQINKIAFTGSTEVGKLVKEAASRSNLKRVTLELGGKNPCIVCADADLDLAVECAHQGVFFNQGQCCTAASRVFVEEQVYSEFVRRSVEYAKKRPVGDPFDVKTEQGPQIDQKQFDKILELIESGKKEGAKLECGGSAMEDKGLFIKPTVFSEVTDNMRIAKEEIFGPVQPILKFKSIEEVIKRANSTDYGLTAAVFTKNLDKALKLASALESGTVWINCYNALYAQAPFGGFKMSGNGRELGEYALAEYTEVKTVTIKLG","Homo sapiens","ALDH1A3, ALDH6","Aldehyde dehydrogenase family 1 member A3","1","6S6W"
"6S70",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis-tris propane, 0.2 M sodium acetate, 24 % (w/v) PEG 3350",293,"10.1042/BCJ20190826","KYB","6S70",162.17,"2.3","2.3","Crystal structure of CARM1 in complex with inhibitor UM251","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTHHHHHH","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6S70"
"6S71",,"X-RAY DIFFRACTION",2.44,49.62,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis-tris propane, 0.2 M sodium acetate, 20 % (w/v) PEG 3350",293,"10.1042/BCJ20190826","KYE","6S71",162.72,"2.062","2.062","Crystal structure of CARM1 in complex with inhibitor WH5C","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTHHHHHH","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6S71"
"6S73",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.02 M Sodium/potassium phosphate, 0.1 M Bis-Tris propane pH 6.5, 20 % w/v PEG 3350",291,"10.1042/BCJ20200128",,"6S73",144.32,"3.5","3.5","Crystal structure of Nek7 SRS mutant bound to compound 51","MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLHKQLNHPNVIKFYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDFGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHHH","Homo sapiens","NEK7","Serine/threonine-protein kinase Nek7","1","6S73"
"6S74",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis-tris propane, 0.02 M sodium phosphate, 22 % (w/v) PEG 3350",293,"10.1042/BCJ20190826","KY8","6S74",162.2,"2.1","2.1","Crystal structure of CARM1 in complex with inhibitor UM305","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTHHHHHH","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6S74"
"6S75",,"X-RAY DIFFRACTION",2.52,51.27,"VAPOR DIFFUSION, SITTING DROP",7,"20 % w/v Polyethylene glycol 3,350, 150 mM di-Sodium DL-malate; pH 7.0, 3% w/v 1,6-Hexanediol",293,"10.1042/BCJ20200128",,"6S75",144.14,"3.3","3.3","Crystal structure of Nek7 bound to compound 51","MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHHH","Homo sapiens","NEK7","Serine/threonine-protein kinase Nek7","1","6S75"
"6S76",,"X-RAY DIFFRACTION",2.89,57.4,"VAPOR DIFFUSION, SITTING DROP",7,"20 % w/v Polyethylene glycol 3,350, 150 mM di-Sodium DL-malate; pH 7.0",293,"10.1042/BCJ20200128",,"6S76",142.79,"3.38","3.38","Crystal structure of human Nek7","MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHHH","Homo sapiens","NEK7","Serine/threonine-protein kinase Nek7","1","6S76"
"6S77",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis-tris propane, 0.02 M sodium phosphate, 26 % (w/v) PEG 3350",293,"10.1042/BCJ20190826","KXW","6S77",162.3,"2.12","2.12","Crystal structure of CARM1 N265Y mutant in complex with inhibitor AA183","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFYERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTHHHHHH","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6S77"
"6S79",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Bis-tris propane, 0.2 M sodium formate, 20 % (w/v) PEG 3350",293,"10.1042/BCJ20190826","KXW","6S79",162.28,"2.1","2.1","Crystal structure of CARM1 in complex with inhibitor AA183","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTHHHHHH","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6S79"
"6S7A",,"X-RAY DIFFRACTION",2.39,48.44,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Bis-tris propane, 0.2 M sodium formate, 20 % (w/v) PEG 3350",293,"10.1042/BCJ20190826","KY5","6S7A",162.48,"1.86","1.86","Crystal structure of CARM1 in complex with inhibitor AA175","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTHHHHHH","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6S7A"
"6S7B",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis-tris propane, 0.02 M potassium phosphate, 22 % (w/v) PEG 3350",293,"10.1042/BCJ20190826",,"6S7B",161.84,"2.659","2.659","Crystal structure of CARM1 in complex with inhibitor UM249","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTHHHHHH","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6S7B"
"6S7C",,"X-RAY DIFFRACTION",2.39,48.46,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis-tris propane, 0.02 M sodium phosphate, 21 % (w/v) PEG 3350",293,"10.1042/BCJ20190826","KY2","6S7C",161.78,"2.3","2.3","Crystal structure of CARM1 in complex with inhibitor UM079","SVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTHHHHHH","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6S7C"
"6S7F",,"X-RAY DIFFRACTION",2.54,51.49,"VAPOR DIFFUSION, HANGING DROP",,"Enter some text here...Crystallization buffer: 5 % (w/v) polyethylene glycol 6000, 0.1 M citric acid pH 5.0-6.0. Crystallization drop:1 uL crystallization buffer + 1 uL of 3 mg/mL protein in 10 mM Tris pH 8.0, 100 uM ZnCl2, 1 mM Inhibitor. Cryobuffer: 25 % (v/v) polyethylene glycol 200, 0.1 MES pH 5.5",292.15,,,"6S7F",59.98,"2.05","2.05","Human CD73 (5'-nucleotidase) in complex with PSB12379 (an AOPCP derivative) in the closed state","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6S7F"
"6S7H",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION, HANGING DROP",,"Crystallization buffer: 5 % (w/v) polyethylene glycol 6000, 0.1 M citric acid pH 5.0-6.0. Crystallization drop:1 uL crystallization buffer + 1 uL of 3 mg/mL protein in 10 mM Tris pH 8.0, 100 uM ZnCl2, 1 mM Inhibitor. Cryobuffer: 25 % (v/v) polyethylene glycol 200, 0.1 MES pH 5.5",292.15,,,"6S7H",60.03,"1.85","1.85","Human CD73 (5'-nucleotidase) in complex with PSB12489 (an AOPCP derivative) in the closed state","MWELTILHTNDVHSRLEQTSEDSSKCVDASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLDSSIPEDPSIKADINKWRIKLDDYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNDGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSLEHHHHHH","Homo sapiens","NT5E, NT5, NTE","5'-nucleotidase","1","6S7H"
"6S7P","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-019-0354-3",,"6S7P",144.97,"3.2",,"Nucleotide bound ABCB4","MDLEAAKNGTAWRPTSAEGDFELGISSKQKRKKTKTVKMIGVLTLFRYSDWQDKLFMSLGTIMAIAHGSGLPLMMIVFGEMTDKFVDTAGNFSFPVNFSLSLLNPGKILEEEMTRYAYYYSGLGAGVLVAAYIQVSFWTLAAGRQIRKIRQKFFHAILRQEIGWFDINDTTELNTRLTDDISKISEGIGDKVGMFFQAVATFFAGFIVGFIRGWKLTLVIMAISPILGLSAAVWAKILSAFSDKELAAYAKAGAVAEEALGAIRTVIAFGGQNKELERYQKHLENAKEIGIKKAISANISMGIAFLLIYASYALAFWYGSTLVISKEYTIGNAMTVFFSILIGAFSVGQAAPCIDAFANARGAAYVIFDIIDNNPKIDSFSERGHKPDSIKGNLEFNDVHFSYPSRANVKILKGLNLKVQSGQTVALVGSSGCGKSTTVQLIQRLYDPDEGTINIDGQDIRNFNVNYLREIIGVVSQEPVLFSTTIAENICYGRGNVTMDEIKKAVKEANAYEFIMKLPQKFDTLVGERGAQLSGGQKQRIAIARALVRNPKILLLDQATSALDTESEAEVQAALDKAREGRTTIVIAHRLSTVRNADVIAGFEDGVIVEQGSHSELMKKEGVYFKLVNMQTSGSQIQSEEFELNDEKAATRMAPNGWKSRLFRHSTQKNLKNSQMCQKSLDVETDGLEANVPPVSFLKVLKLNKTEWPYFVVGTVCAIANGGLQPAFSVIFSEIIAIFGPGDDAVKQQKCNIFSLIFLFLGIISFFTFFLQGFTFGKAGEILTRRLRSMAFKAMLRQDMSWFDDHKNSTGALSTRLATDAAQVQGATGTRLALIAQNIANLGTGIIISFIYGWQLTLLLLAVVPIIAVSGIVEMKLLAGNAKRDKKELEAAGKIATEAIENIRTVVSLTQERKFESMYVEKLYGPYRNSVQKAHIYGITFSISQAFMYFSYAGCFRFGAYLIVNGHMRFRDVILVFSAIVFGAVALGHASSFAPDYAKAKLSAAHLFMLFERQPLIDSYSEEGLKPDKFEGNITFNEVVFNYPTRANVPVLQGLSLEVKKGQTLALVGSSGCGKSTVVQLLERFYDPLAGTVLLDGQEAKKLNVQWLRAQLGIVSQEPILFDCSIAENIAYGDNSRVVSQDEIVSAAKAANIHPFIETLPHKYETRVGDKGTQLSGGQKQRIAIARALIRQPQILLLDQATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQLLAQKGIYFSMVSVQAGTQNL","Homo sapiens","ABCB4, MDR3, PGY3","Phosphatidylcholine translocator ABCB4","1","6S7P"
"6S86",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Lithium sulphate, 20% (w/v) PEG 3350",291,"10.1107/S2053230X19010999",,"6S86",47.07,"2.6","2.6","Human wtSTING in complex with 3'3'-c-di-GMP","APAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of Interferon genes","1","6S86"
"6S89",,"X-RAY DIFFRACTION",3.3,62.67,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.35 K-Na-tartrate, 100 mM Na-MES (pH 6.5), 2 % 1,3-Propanediol, 5.5 mg/ml EGFR T790M/C797 (in 100 mM NaCl, 25mM Tris-HCl, 10 % Glycerol, 1mM TCEP, pH 8.0), 1 ul reservoir + 1 ul protein solution",293,"10.1039/c9sc03445e",,"6S89",38.41,"2.701","2.701","Crystal Structure of EGFR-T790M/C797S in Complex with Covalent Pyrrolopyrimidine 19g","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6S89"
"6S8A",,"X-RAY DIFFRACTION",3.35,63.26,"VAPOR DIFFUSION, HANGING DROP",,"1.15 K-Na-tartrate, 100 mM Na-MES (pH 6.5), 2 % 1,3-Propanediol, 5.3 mg/ml EGFR T790M/C797 (in 100 mM NaCl, 25mM Tris-HCl, 10 % Glycerol, 1mM TCEP, pH 8.0), 1 ul reservoir + 1 ul protein solution",293,"10.1039/c9sc03445e",,"6S8A",38.42,"2.6","2.6","Crystal Structure of EGFR-T790M/C797S in Complex with Covalent Pyrrolopyrimidine 19h","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6S8A"
"6S8O",,"X-RAY DIFFRACTION",3.45,64.34,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M sodium citrate, 1.5M sodium malonate",291.15,"10.1074/jbc.RA119.010964",,"6S8O",199.67,"3.172","3.172","Human Brr2 Helicase Region M641C/A1582C","GAEFMDLDQGGEALAPRQVLDLEDLVFTQGSHFMANKRCQLPDGSFRRQRKGYEEVHVPALKPKPFGSEEQLLPVEKLPKYAQAGFEGFKTLNRIQSKLYRAALETDENLLLCAPTGAGKTNVALMCMLREIGKHINMDGTINVDDFKIIYIAPMRSLVQEMVGSFGKRLATYGITVAELTGDHQLCKEEISATQIIVCTPEKWDIITRKGGERTYTQLVRLIILDEIHLLHDDRGPVLEALVARAIRNIECTQEDVRLIGLSATLPNYEDVATFLRVDPAKGLFYFDNSFRPVPLEQTYVGITEKKAIKRFQIMNEIVYEKIMEHAGKNQVLVFVHSRKETGKTARAIRDMCLEKDTLGLFLREGSASTEVLRTEAEQCKNLELKDLLPYGFAIHHAGMTRVDRTLVEDLFADKHIQVLVSTATLAWGVNLPAHTVIIKGTQVYSPEKGRWTELGALDILQMLGRAGRPQYDTKGEGILITSHGELQYYLSLLNQQLPIESQMVSKLPDMLNAEIVLGNVQNAKDAVNWLGYAYLYIRMLRSPTLYGISHDDLKGDPLLDQRRLDLVHTAALMLDKNNLVKYDKKTGNFQVTELGRIASHYYITNDTVQTYNQLLKPTLSEIELFRVFSLSSEFKNITVREEEKLELQKLLERVPIPVKESIEEPSAKINVLLQAFISQLKLEGFALMADMVYVTQSAGRLMRAIFEIVLNRGWAQLTDKTLNLCKMIDKRMWQSMCPLRQFRKLPEEVVKKIEKKNFPFERLYDLNHNEIGELIRMPKMGKTIHKYVHLFPKLELSVHLQPITRSTLKVELTITPDFQWDEKVHGSSEAFWILVEDVDSEVILHHEYFLLKAKYAQDEHLITFFVPVFEPLPPQYFIRVVSDRWLSCETQLPVSFRHLILPEKYPPPTELLDLQPLPVSALRNSAFESLYQDKFPFFNPIQTQVFNTVYNSDDNVFVGAPTGSGKTICAEFAILRMLLQSSEGRCVYITPMEALAEQVYMDWYEKFQDRLNKKVVLLTGETSTDLKLLGKGNIIISTPEKWDILSRRWKQRKNVQNINLFVVDEVHLIGGENGPVLEVICSRMRYISSQIERPIRIVALSSSLSNAKDVAHWLGCSATSTFNFHPNVRPVPLELHIQGFNISHTQTRLLSMAKPVYHAITKHSPKKPVIVFVPSRKQTRLTAIDILTTCACDIQRQRFLHCTEKDLIPYLEKLSDSTLKETLLNGVGYLHEGLSPMERRLVEQLFSSGAIQVVVASRSLCWGMNVAAHLVIIMDTQYYNGKIHAYVDYPIYDVLQMVGHANRPLQDDEGRCVIMCQGSKKDFFKKFLYEPLPVESHLDHCMHDHFNAEIVTKTIENKQDAVDYLTWTFLYRRMTQNPNYYNLQGISHRHLSDHLSELVEQTLSDLEQSKCISIEDEMDVAPLNLGMIAAYYYINYTTIELFSMSLNAKTKVRGLIEIISNAAEYENIPIRHHEDNLLRQLAQKVPHKLNNPKFNDPHVKTNLLLQAHLSRMQLSAELQSDTEEILSKAIRLIQACVDVLSSNGWLSPALAAMELAQMVTQAMWSKDSYLKQLPHFTSEHIKRCTDKGVESVFDIMEMEDEERNALLQLTDSQIADVARFCNRYPNIELSYEVVDKDSIRSGGPVVVLVQLEREEEVTGPVIAPLFPQKREEGWWVVIGDAKSNSLISIKRLTLQQKAKVKLDFVAPATGAHNYTLYFMSDAYMGCDQEYKFSVDVKEAETDSDSD","Homo sapiens","SNRNP200, ASCC3L1, HELIC2, KIAA0788","U5 small nuclear ribonucleoprotein 200 kDa helicase","1","6S8O"
"6S8X",,"X-RAY DIFFRACTION",3.75,67.17,"VAPOR DIFFUSION, SITTING DROP",,"0.01M cobat chloride
0.1M NaOAc, pH 4.7
1M 1,6 hexanediol",290,"10.1107/S2053230X20009164",,"6S8X",36.6,"2.29","2.29","Crystal structure of the Rab-binding domain of FIP2","GSHMSNPFDATAGYRSLTYEEVLQELVKHKELLRRKDTHIRELEDYIDNLLVRVMEETPSILRVPYEPSRKAGKFSNS","Homo sapiens","RAB11FIP2, KIAA0941","Rab11 family-interacting protein 2","1","6S8X"
"6S90",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCL pH 8.5, 200 mM sodium formate, 50 mM CaCl2, 25% (w/v) PEGMME 5000",298,"10.1021/acsmedchemlett.9b00317","L0Z","6S90",63.42,"1.82","1.82","BTK in complex with an inhibitor","GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6S90"
"6S96",,"X-RAY DIFFRACTION",2.9,57.56,"VAPOR DIFFUSION",6.5,"2.5 M potassium formate, 0.1 M sodium cacodylate",293.15,"10.1126/scisignal.aba8208",,"6S96",35.13,"2.18","2.18","Crystal structure of the catalytic domain of UBE2S C118A.","EMNSNVENLPPHIIRLVYKEVTTLTADPPDGIKVFPNEEDLTDLQVTIEGPEGTPYAGGLFRMKLLLGKDFPASPPKGYFLTKIFHPNVGANGEICVNVLKRDWTAELGIRHVLLTIKALLIHPNPESALNEEAGRLLLENYEEYAARARLLTEIHG","Homo sapiens","UBE2S, E2EPF, OK/SW-cl.73","Ubiquitin-conjugating enzyme E2 S","1","6S96"
"6S98",,"X-RAY DIFFRACTION",2.27,45.88,"VAPOR DIFFUSION",8.5,"0.2 M sodium-acetate-trihydrate; 0.1 M Tris; 30% PEG4000",293,"10.1126/scisignal.aba8208",,"6S98",35.19,"1.55","1.55","Crystal structure of the catalytic domain of UBE2S WT.","MNSNVENLPPHIIRLVYKEVTTLTADPPDGIKVFPNEEDLTDLQVTIEGPEGTPYAGGLFRMKLLLGKDFPASPPKGYFLTKIFHPNVGANGEICVNVLKRDWTAELGIRHVLLTIKCLLIHPNPESALNEEAGRLLLENYEEYAARARLLTEIHG","Homo sapiens","UBE2S, E2EPF, OK/SW-cl.73","Ubiquitin-conjugating enzyme E2 S","1","6S98"
"6S9A",,"X-RAY DIFFRACTION",2.35,47.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Tris-HCl, 0.25M KBr, 30% (w/v) PEG MME 2000",293,"10.1073/pnas.2101144118",,"6S9A",79.51,"1.86","1.86","Artificial GTPase-BSE dimer of human Dynamin1","GAMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHSKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTHVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLAHSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPNTLMEESAEQAQRRDEMLRMYHALKEALSIIGDIN","Homo sapiens","DNM1, DNM","Dynamin-1,Dynamin-1","1","6S9A"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNM1, DNM"
"6S9B",,"X-RAY DIFFRACTION",3.47,64.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG 10000
8% Ethylene glycol
0.1 M HEPES",293,"10.1021/acs.jmedchem.9b01169",,"6S9B",37.55,"3.25","3.25","EGFR-KINASE IN COMPLEX WITH COMPOUND 1","EAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6S9B"
"6S9C",,"X-RAY DIFFRACTION",3.5,64.84,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 % PEG 10000
8 % ethylene glycol
0.1 M HEPES",293,"10.1021/acs.jmedchem.9b01169",,"6S9C",37.89,"2.73","2.73","EGFR-KINASE IN COMPLEX WITH COMPOUND 5","SMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6S9C"
"6S9D",,"X-RAY DIFFRACTION",3.54,65.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 % PEG 10000
8 % ethylene glycol
0.1 M HEPES",293,"10.1021/acs.jmedchem.9b01169",,"6S9D",37.9,"2.67","2.67","EGFR-KINASE IN COMPLEX WITH COMPOUND 6","SMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAAAAEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6S9D"
"6S9G",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6S9G",31.15,"1.14","1.14","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6S9G"
"6S9W",,"X-RAY DIFFRACTION",2.2,44.08,"VAPOR DIFFUSION, HANGING DROP",7,"1.25 mM Na-acetate, 3.75 mM Na-citrate, 24% v/v PEG 2000 MME, pH 7.0, 3 mg/mL Akt1 (in 25 mM TRIS, 100 mM NaCl, 10% v/v Glycerol, 5 mM DTT, pH 7.5), 1 uL reservoir + 1 uL protein solution",293,"10.1002/anie.201909857",,"6S9W",52.31,"2.3","2.3","Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a","GSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","6S9W"
"6S9X",,"X-RAY DIFFRACTION",2.24,45.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.25 mM Na-acetate, 3.75 mM Na-citrate, 15% v/v PEG 2000 MME, pH 7.5, 3 mg/mL Akt1 (in 25 mM TRIS, 100 mM NaCl, 10% v/v Glycerol, 5 mM DTT, pH 7.5), 1 uL reservoir + 1 uL protein solution",293,"10.1002/anie.201909857",,"6S9X",52.4,"2.6","2.6","Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c","GSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","6S9X"
"6S9Z",,"X-RAY DIFFRACTION",2.06,40.23,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M",291,"10.3390/biom10040518",,"6S9Z",31.01,"0.95","0.95","Expression tag modified N-terminus of human Carbonic Anhydrase II covalently linked to fragment","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6S9Z"
"6SA2",,"X-RAY DIFFRACTION",1.81,32.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"MMW PEG, NaCl",293,"10.1021/acs.jmedchem.0c00478","L25","6SA2",15.74,"1.5","1.5","Crystal Structure of BRD4(1) bound to inhibitor BUX3 (10)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6SA2"
"6SA3",,"X-RAY DIFFRACTION",1.9,35.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"NaCl, MMW PEG",293,"10.1021/acs.jmedchem.0c00478","L2N","6SA3",15.57,"1.8","1.8","Crystal Structure of BRD4(1) bound to inhibitor BUX4 (13)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6SA3"
"6SA4",,"X-RAY DIFFRACTION",2.49,50.51,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M MgCl2 hexahydrate, 10 5 (w/v) PEG8000, 0.1 M Tris, pH 7.0",293.15,"10.26508/lsa.201900502",,"6SA4",15.79,"1.77","1.77","SALSA / DMBT1 / GP340 SRCR domain 1","MKLCILLAVVAFVGLSLGGSDSGLALRLVNGDGRCQGRVEILYRGSWGTVCDDSWDTNDANVVCRQLGCGWAMSAPGNAWFGQGSGPIALDDVRCSGHESYLWSCPHNGWLSHNCGHGEDAGVICSATGENLYFQGRHHHHHH","Homo sapiens","DMBT1, GP340","Deleted in malignant brain tumors 1 protein","1","6SA4"
"6SA5",,"X-RAY DIFFRACTION",1.85,33.39,"VAPOR DIFFUSION, SITTING DROP",6.5,"50 % dilution of 0.1 M LiSO4, 20 % (w/v) PEG6000, 0.01 M HEPES, pH 6.5",293.15,"10.26508/lsa.201900502",,"6SA5",14.97,"1.29","1.29","SALSA / DMBT1 / GP340 SRCR domain 8","MKLCILLAVVAFVGLSLGGSESSLALRLVNGGDRCQGRVEVLYQGSWGTVCDDSWDTNDANVVCRQLGCGWAMSAPGNARFGQGSGPIVLDDVRCSGHESYLWSCPHNGWLSHNCGHSEDAGVICSAVNIDHHHHHH","Homo sapiens","DMBT1, GP340","Deleted in malignant brain tumors 1 protein","1","6SA5"
"6SA9",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION",,"0.2 M Sodium Acetate Trihydrate, 0.1 M Tris Hydrochloride and 15% (w/v) PEG 4000",291,"10.1038/s41467-019-13786-y",,"6SA9",37.41,"1.8","1.8","Endogenous Retrovirus HML2 Capsid NTD","MPVTLEPMPPGEGAQEGEPPTVEARYKSFSIKMLKDMKEGVKQYGPNSPYMRTLLDSIAHGHRLIPYDWEILAKSSLSPSQFLQFKTWWIDGVQEQVRRNRAANPPVNIDADQLLGIGQNWSTISQQALMQNEAIEQVRAICLRAWEKIQDPLEHHHHHH","Homo sapiens","ERVK-9","Endogenous retrovirus group K member 9 Pol protein","1","6SA9"
"6SAC",,"X-RAY DIFFRACTION",2.06,40.02,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 Mte, Tris 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040518",,"6SAC",31.07,"1.02","1.02","N-terminal expression tag remainder of human Carbonic Anhydrase II covalently modified by fragment","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SAC"
"6SAF",,"X-RAY DIFFRACTION",2.4,48.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"28 % PEG-3350, 0.2 M NH4-acetate and 0.1 M HEPES-NaOH pH 7.5",293,"10.1021/acs.jmedchem.9b01157","L2Q","6SAF",14.72,"2.05","2.05","The Fk1 domain of FKBP51 in complex with (S)-(R)-3-(3,4-dimethoxyphenyl)-1-(3-(2-morpholinoethoxy)phenyl)propyl 1-((1R,4aR,8aR)-4-oxodecahydronaphthalene-1-carbonyl)piperidine-2-carboxylate","GAPATVTEQGEDITSKKDRGVLKIVKRVGNGEETPMIGDKVYVHYKGKLSNGKKFDSSHDRNEPFVFSLGKGQVIKAWDIGVATMKKGEICHLLCKPEYAYGSAGSLPKIPSNATLFFEIELLDFKGE","Homo sapiens","FKBP5, AIG6, FKBP51","Peptidyl-prolyl cis-trans isomerase FKBP5","1","6SAF"
"6SAH",,"X-RAY DIFFRACTION",1.79,31.41,"VAPOR DIFFUSION, SITTING DROP",5.5,"Index D6, 0.1 M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3,350",293,"10.1021/acs.jmedchem.0c00478","L2W","6SAH",15.56,"1.5","1.5","Crystal Structure of BRD4(1) bound to inhibitor BUX5 (11)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6SAH"
"6SAJ",,"X-RAY DIFFRACTION",1.85,33.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEPES, PEG3350",293,"10.1021/acs.jmedchem.0c00478","L2Z","6SAJ",15.84,"1.5","1.5","Crystal Structure of BRD4(1) bound to inhibitor BUX6 (12)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6SAJ"
"6SAL",,"X-RAY DIFFRACTION",2.95,58.31,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.6 M AmSO4, 0.1 M Tris",293.15,"10.1021/acs.jmedchem.9b01372","L3E","6SAL",28.8,"1.61","1.61","ROR(gamma)t ligand binding domain in complex with allosteric ligand FM26","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6SAL"
"6SAM",,"X-RAY DIFFRACTION",3.19,61.44,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate",293,"10.1016/j.ejmech.2020.112282","L3H","6SAM",63.03,"2.5","2.5","Structure of human butyrylcholinesterase in complex with 1-(2,3-dihydro-1H-inden2-yl)piperidin-3-yl N-phenyl carbamate","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6SAM"
"6SAN",,"X-RAY DIFFRACTION",2.48,50.39,"VAPOR DIFFUSION, SITTING DROP",,"50 % of 0.2 M MgCl2 hexahydrate, 20 % (v/v) isopropanol, 0.1 M HEPES, pH: 7.5. After crystal-formation, crystals were soaked in 10 mM MgCl2 and 10 mM CaCl2.",293.15,"10.26508/lsa.201900502",,"6SAN",29.74,"1.36","1.36","SALSA / DMBT1 / GP340 SRCR domain 8 soaked in calcium and magnesium","MKLCILLAVVAFVGLSLGGSESSLALRLVNGGDRCQGRVEVLYQGSWGTVCDDSWDTNDANVVCRQLGCGWAMSAPGNARFGQGSGPIVLDDVRCSGHESYLWSCPHNGWLSHNCGHSEDAGVICSAVNIDHHHHHH","Homo sapiens","DMBT1, GP340","Deleted in malignant brain tumors 1 protein","1","6SAN"
"6SAP",,"SOLUTION NMR",,,,,,,"10.3390/biom9120876",,"6SAP",13.82,,,"Structure of the PUB domain from Ubiquitin Regulatory X domain protein 1 (UBXD1)","GSHMSTDPVAASIMKIYTFNKDQDRVKLGVDTIAKYLDNIHLHPEEEKYRKIKLQNKVFQERINCLEGTHEFFEAIGFQKVLLPAQDQEDPEEFYVLSETTLAQPQSLERHKEQLLAAE","Homo sapiens","UBXN6, UBXD1, UBXDC2","UBX domain-containing protein 6","1","6SAP"
"6SAS",,"X-RAY DIFFRACTION",2.13,42.48,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040518",,"6SAS",30.67,"1.1","1.1","Human Carbonic Anhydrase II in complex with fragment.","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SAS"
"6SAY",,"X-RAY DIFFRACTION",2.13,42.23,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040518",,"6SAY",31.05,"0.95","0.95","Human Carbonic Anhydrase II in complex with fragment.","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SAY"
"6SB7",,"X-RAY DIFFRACTION",2.15,42.89,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040518",,"6SB7",31.43,"1.09","1.09","Human Carbonic Anhydrase II in complex with fragment.","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SB7"
"6SB8",,"X-RAY DIFFRACTION",1.89,34.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"NaCl, PEG3350, HEPES",293,"10.1021/acs.jmedchem.0c00478","L45","6SB8",15.62,"1.5","1.5","Crystal Structure of BRD4(1) bound to inhibitor BUX14 (7)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6SB8"
"6SBH",,"X-RAY DIFFRACTION",2.06,40.33,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.1021/acschembio.9b00895",,"6SBH",31.2,"0.95","0.95","Human Carbonic Anhydrase II in complex with 4-pentylbenzenesulfonamide.","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SBH"
"6SBL",,"X-RAY DIFFRACTION",2.06,40.39,"VAPOR DIFFUSION, HANGING DROP",7.8,"Sodium citrate 1.40 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,,,"6SBL",30.98,"0.94","0.94","Human Carbonic Anhydrase II in complex with 4-hexylbenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SBL"
"6SBM",,"X-RAY DIFFRACTION",2.06,40.42,"VAPOR DIFFUSION, HANGING DROP",7.8,"Sodium citrate 1.4 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,,,"6SBM",31.03,"0.95","0.95","Human Carbonic Anhydrase II in complex with 4-(pentyloxy)benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SBM"
"6SBO",,"X-RAY DIFFRACTION",2.29,46.17,"VAPOR DIFFUSION, HANGING DROP",,"22% PEG4000, NaCacodylate 0.1M pH 6.5, MgCl2 200mM",298,"10.1021/acs.jmedchem.9b01293","L5B","6SBO",60.33,"1.48","1.48","Estrogen receptor mutant L536S","GAMIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6SBO"
"6SBU",,"X-RAY DIFFRACTION",2.99,58.91,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES pH 7.5-7.7, 4-8% PEG 8000, 20% ethylene glycol, and 10% acetonitrile",293,"10.1021/acsomega.0c00715",,"6SBU",298.14,"2.91","2.91","X-ray Structure of Human LDHA with an Allosteric Inhibitor (Compound 3)","GATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6SBU"
"6SBV",,"X-RAY DIFFRACTION",3.09,60.2,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES pH 7.5-7.7, 4-8% PEG 8000, 20% ethylene glycol, and 10% acetonitrile",293,"10.1021/acsomega.0c00715",,"6SBV",297.02,"2.6","2.6","X-ray Structure of Human LDH-A with an Allosteric Inhibitor (Compound 7)","GATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6SBV"
"6SCJ","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-020-1995-4",,"6SCJ",617.95,"3.6",,"The structure of human thyroglobulin","MALVLEIFTLLASICWVSANIFEYQVDAQPLRPCELQRETAFLKQADYVPQCAEDGSFQTVQCQNDGRSCWCVGANGSEVLGSRQPGRPVACLSFCQLQKQQILLSGYINSTDTSYLPQCQDSGDYAPVQCDVQQVQCWCVDAEGMEVYGTRQLGRPKRCPRSCEIRNRRLLHGVGDKSPPQCSAEGEFMPVQCKFVNTTDMMIFDLVHSYNRFPDAFVTFSSFQRRFPEVSGYCHCADSQGRELAETGLELLLDEIYDTIFAGLDLPSTFTETTLYRILQRRFLAVQSVISGRFRCPTKCEVERFTATSFGHPYVPSCRRNGDYQAVQCQTEGPCWCVDAQGKEMHGTRQQGEPPSCAEGQSCASERQQALSRLYFGTSGYFSQHDLFSSPEKRWASPRVARFATSCPPTIKELFVDSGLLRPMVEGQSQQFSVSENLLKEAIRAIFPSRGLARLALQFTTNPKRLQQNLFGGKFLVNVGQFNLSGALGTRGTFNFSQFFQQLGLASFLNGGRQEDLAKPLSVGLDSNSSTGTPEAAKKDGTMNKPTVGSFGFEINLQENQNALKFLASLLELPEFLLFLQHAISVPEDVARDLGDVMETVLSSQTCEQTPERLFVPSCTTEGSYEDVQCFSGECWCVNSWGKELPGSRVRGGQPRCPTDCEKQRARMQSLMGSQPAGSTLFVPACTSEGHFLPVQCFNSECYCVDAEGQAIPGTRSAIGKPKKCPTPCQLQSEQAFLRTVQALLSNSSMLPTLSDTYIPQCSTDGQWRQVQCNGPPEQVFELYQRWEAQNKGQDLTPAKLLVKIMSYREAASGNFSLFIQSLYEAGQQDVFPVLSQYPSLQDVPLAALEGKRPQPRENILLEPYLFWQILNGQLSQYPGSYSDFSTPLAHFDLRNCWCVDEAGQELEGMRSEPSKLPTCPGSCEEAKLRVLQFIRETEEIVSASNSSRFPLGESFLVAKGIRLRNEDLGLPPLFPPREAFAEQFLRGSDYAIRLAAQSTLSFYQRRRFSPDDSAGASALLRSGPYMPQCDAFGSWEPVQCHAGTGHCWCVDEKGGFIPGSLTARSLQIPQCPTTCEKSRTSGLLSSWKQARSQENPSPKDLFVPACLETGEYARLQASGAGTWCVDPASGEELRPGSSSSAQCPSLCNVLKSGVLSRRVSPGYVPACRAEDGGFSPVQCDQAQGSCWCVMDSGEEVPGTRVTGGQPACESPRCPLPFNASEVVGGTILCETISGPTGSAMQQCQLLCRQGSWSVFPPGPLICSLESGRWESQLPQPRACQRPQLWQTIQTQGHFQLQLPPGKMCSADYADLLQTFQVFILDELTARGFCQIQVKTFGTLVSIPVCNNSSVQVGCLTRERLGVNVTWKSRLEDIPVASLPDLHDIERALVGKDLLGRFTDLIQSGSFQLHLDSKTFPAETIRFLQGDHFGTSPRTWFGCSEGFYQVLTSEASQDGLGCVKCPEGSYSQDEECIPCPVGFYQEQAGSLACVPCPVGRTTISAGAFSQTHCVTDCQRNEAGLQCDQNGQYRASQKDRGSGKAFCVDGEGRRLPWWETEAPLEDSQCLMMQKFEKVPESKVIFDANAPVAVRSKVPDSEFPVMQCLTDCTEDEACSFFTVSTTEPEISCDFYAWTSDNVACMTSDQKRDALGNSKATSFGSLRCQVKVRSHGQDSPAVYLKKGQGSTTTLQKRFEPTGFQNMLSGLYNPIVFSASGANLTDAHLFCLLACDRDLCCDGFVLTQVQGGAIICGLLSSPSVLLCNVKDWMDPSEAWANATCPGVTYDQESHQVILRLGDQEFIKSLTPLEGTQDTFTNFQQVYLWKDSDMGSRPESMGCRKDTVPRPASPTEAGLTTELFSPVDLNQVIVNGNQSLSSQKHWLFKHLFSAQQANLWCLSRCVQEHSFCQLAEITESASLYFTCTLYPEAQVCDDIMESNAQGCRLILPQMPKALFRKKVILEDKVKNFYTRLPFQKLMGISIRNKVPMSEKSISNGFFECERRCDADPCCTGFGFLNVSQLKGGEVTCLTLNSLGIQMCSEENGGAWRILDCGSPDIEVHTYPFGWYQKPIAQNNAPSFCPLVVLPSLTEKVSLDSWQSLALSSVVVDPSIRHFDVAHVSTAATSNFSAVRDLCLSECSQHEACLITTLQTQPGAVRCMFYADTQSCTHSLQGQNCRLLLREEATHIYRKPGISLLSYEASVPSVPISTHGRLLGRSQAIQVGTSWKQVDQFLGVPYAAPPLAERRFQAPEPLNWTGSWDASKPRASCWQPGTRTSTSPGVSEDCLYLNVFIPQNVAPNASVLVFFHNTMDREESEGWPAIDGSFLAAVGNLIVVTASYRVGVFGFLSSGSGEVSGNWGLLDQVAALTWVQTHIRGFGGDPRRVSLAADRGGADVASIHLLTARATNSQLFRRAVLMGGSALSPAAVISHERAQQQAIALAKEVSCPMSSSQEVVSCLRQKPANVLNDAQTKLLAVSGPFHYWGPVIDGHFLREPPARALKRSLWVEVDLLIGSSQDDGLINRAKAVKQFEESRGRTSSKTAFYQALQNSLGGEDSDARVEAAATWYYSLEHSTDDYASFSRALENATRDYFIICPIIDMASAWAKRARGNVFMYHAPENYGHGSLELLADVQFALGLPFYPAYEGQFSLEEKSLSLKIMQYFSHFIRSGNPNYPYEFSRKVPTFATPWPDFVPRAGGENYKEFSELLPNRQGLKKADCSFWSKYISSLKTSADGAKGGQSAESEEEELTAGSGLREDLLSLQEPGSKTYSK","Homo sapiens","TG","Thyroglobulin","1","6SCJ"
"6SCM",,"X-RAY DIFFRACTION",2.21,44.43,"VAPOR DIFFUSION, SITTING DROP",8,"13% PEG8000, 0.1M Imidazole pH=8.0",277,"10.1158/2159-8290.CD-20-0142",,"6SCM",58.01,"1.866","1.866","SOS1 in Complex with Inhibitor BI-3406","GEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","6SCM"
"6SCX",,"X-RAY DIFFRACTION",3.53,65.19,"VAPOR DIFFUSION",8.3,"20% (w/v) PEG 3350
0.2M potassium citrate tribasic monohydrate
0.02M CdCl(2)
0.02M m7GTP",293,"10.1016/j.celrep.2019.11.108",,"6SCX",122.63,"2.92","2.92","Crystal structure of the catalytic domain of human NUDT12 in complex with 7-methyl-guanosine-5'-triphosphate","TNEVEECENYFSKTLLDRKSEKRNNSDWLLAKESHPATVFILFSDLNPLVTLGGNKESFQQPEVRLCQLNYTDIKDYLAQPEKITLIFLGVELEIKDKLLNYAGEVPREEEDGLVAWFALGIDPIAAEEFKQRHENCYFLHPPMPALLQLKEKEAGVVAQARSVLAWHSRYKFCPTCGNATKIEEGGYKRLCLKEDCPSLNGVHNTSYPRVDPVVIMQVIHPDGTKCLLGRQKRFPPGMFTCLAGFIEPGETIEDAVRREVEEESGVKVGHVQYVACQPWPMPSSLMIGCLALAVSTEIKVDKNEIEDARWFTREQVLDVLTKGKQQAFFVPPSRAIAHQLIKHWIRINPNL","Homo sapiens","NUDT12","Peroxisomal NADH pyrophosphatase NUDT12","1","6SCX"
"6SD7",,"X-RAY DIFFRACTION",2.05,40.09,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040509",,"6SD7",31.33,"1.05","1.05","Human Carbonic Anhydrase II in complex with fluorinated benzenesulfonamide and its dimer","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SD7"
"6SD9",,"X-RAY DIFFRACTION",2.34,47.54,"VAPOR DIFFUSION, SITTING DROP",8,"15 % 2-propanol, 17 % PEG4K, 0.1 M NaHEPES pH 8",293,"10.1021/acsmedchemlett.9b00276","88Z","6SD9",35.51,"2.35","2.35","Crystal structure of wild-type cMET bound by foretinib","GDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","6SD9"
"6SDC",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION, SITTING DROP",,"15 % 2-propanol, 10 % PEG4K, 0.1 M NaHEPES pH 8",293,"10.1021/acsmedchemlett.9b00276","88Z","6SDC",35.46,"1.67","1.67","Crystal structure of D1228V cMET bound by foretinib","GDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARVMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","6SDC"
"6SDD",,"X-RAY DIFFRACTION",2.87,57.09,"VAPOR DIFFUSION, SITTING DROP",,"8 % ethanol, 20 % PEG8K, 0.1 M PCPT pH 7.5",293,"10.1021/acsmedchemlett.9b00276","353","6SDD",35.43,"1.93","1.93","Crystal structure of D1228V cMET bound by BMS-777607","GDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARVMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","6SDD"
"6SDE",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, SITTING DROP",,"15 % 2-propanol, 15 % PEG4K, 0.2 M PCPT pH 7.5",293,"10.1021/acsmedchemlett.9b00276","V0L","6SDE",35.19,"2.49","2.49","Crystal structure of wild-type cMET bound by savolitinib","GDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","6SDE"
"6SDF",,"X-RAY DIFFRACTION",3.46,64.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes, 55% (v/v) MPD",277,"10.1107/S2053230X20007232",,"6SDF",14.7,"2.5","2.5","N-terminal SH3 domain of Grb2 protein","GSEAIAKYDFKATADDELSFKRGDILKVLNEESDQNWYKAELNGKDGFIPKNYIEMKPHPG","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","6SDF"
"6SDH",,"X-RAY DIFFRACTION",2.08,40.89,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,,,"6SDH",30.73,"1.04","1.04","Human Carbonic Anhydrase II in complex with an inhibitor soaked at a concentration of 5 mM","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SDH"
"6SDI",,"X-RAY DIFFRACTION",2.07,40.64,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,,,"6SDI",30.73,"1.03","1.03","Human Carbonic Anhydrase II in complex with an inhibitor soaked at a concentration of 0.01 mM","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SDI"
"6SDJ",,"X-RAY DIFFRACTION",2.05,39.9,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate 2.7 M, TRIS 0.1, saturated with para-Chloromercuribenzoic acid",291,"10.3390/biom10040518",,"6SDJ",31.06,"1.02","1.02","Human Carbonic Anhydrase II in complex with (R)-1-aminopropan-2-ol","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SDJ"
"6SDL",,"X-RAY DIFFRACTION",2.07,40.61,"VAPOR DIFFUSION, HANGING DROP",7.8,"Sodium citrate 1.4 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,,,"6SDL",30.9,"1.08","1.08","Human Carbonic Anhydrase II in complex with (R)-N-(3-(1H-indol-1-yl)-2-methylpropyl)-4-sulfamoylbenzamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SDL"
"6SDS",,"X-RAY DIFFRACTION",2.07,40.7,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M SODIUM CITRATE, 60 mM TRIS-HCL",293,"10.1021/acs.jmedchem.9b02135","L8N","6SDS",29.75,"1.26","1.26","HUMAN CARBONIC ANHYDRASE II IN COMPLEX WITH A SULFONAMIDE INHIBITOR","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SDS"
"6SDT",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% (W/V) POLYETHYLENE GLYCOL 3350, 0.2 M AMMONIUM ACETATE, 0.1 M TRIS-HCL,",293,"10.1021/acs.jmedchem.9b02135","L8N","6SDT",31.3,"1.94","1.94","HUMAN CARBONIC ANHYDRASE VII IN COMPLEX WITH A SULFONAMIDE INHIBITOR","MGMTGHHGWGYGQDDGPSHWHKLYPIAQGDRQSPINIISSQAVYSPSLQPLELSYEACMSLSITNNGHSVQVDFNDSDDRTVVTGGPLEGPYRLKQFHFHWGKKHDVGSEHTVDGKSFPSELHLVHWNAKKYSTFGEAASAPDGLAVVGVFLETGDEHPSMNRLTDALYMVRFKGTKAQFSCFNPKSLLPASRHYWTYPGSLTTPPLSESVTWIVLREPISISERQMGKFRSLLFTSEDDERIHMVNNFRPPQPLKGRVVKASFRALEHHHHHH","Homo sapiens","CA7","Carbonic anhydrase 7","1","6SDT"
"6SDZ","2.97","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-019-13038-z",,"6SDZ",151.9,"2.97",,"transthyritin derived amyloid fibril from patient with hereditary V30M ATTR amyloidosis","GPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6SDZ"
"6SE4",,"X-RAY DIFFRACTION",2.16,43.01,"VAPOR DIFFUSION, SITTING DROP",8,"60% MPD, 0.1M MIB pH 8.0",277,,,"6SE4",15.95,"1.38","1.38","Crystal Structure of the first bromodomain of human BRD4 in complex with (+)-JD1, an Organometallic BET Bromodomain Inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6SE4"
"6SEJ",,"X-RAY DIFFRACTION",6.74,,"VAPOR DIFFUSION, SITTING DROP",4,"1.0 M lithium sulfate, 0.1 M sodium acetate pH 4.0, 0.1 M barium chloride",292,"10.3389/fimmu.2019.02007",,"6SEJ",47.07,"3.501","3.501","Structure of a functional monomeric properdin lacking TSR3","GVAGGWGPWGPVSPCPVTCGLGQTMEQRTCNHPVPQHGGPFCAGDATRTHICNTAVPCPVDGEWDSWGEWSPCIRRNMKSISCQEIPGQQSRGRTCRGRKFDGHRCAGQQQDIRHCYSIQHCPLKGSWSEWSTWGLCMPPCGPNPTRARQRLCTPLLPKYPPTVSMVEGQGEKNVTFWGRPLPRCEELQGQKLVVEEKRPCLHVPACKDPEEEELENLYFQ","Homo sapiens","CFP, PFC","Properdin","2","6SEJ"
,,,,,,,,,,,,,,,,"DPVLCFTQYEESSGKCKGLLGGGVSVEDCCLNTAFAYQKRSGGLCQPCRSPRWSLWSTWAPCSVTCSEGSQLRYRRCVGWNGQCSGKVAPGTLEWQLQACEDQQCCPEMGGWSGWGPWEPCSVTCSKGTRTRRRACNHPAPKCGGHCPGQAQESEACDTQQVCPENLYFQ","Homo sapiens","CFP, PFC","Properdin","1","6SEJ"
"6SEQ",,"X-RAY DIFFRACTION",3.05,59.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"LMTK3 at 3.2 mg/ml in 20 mM Tris pH 7.5, 200 mM NaCl was crystallised with 70 mM bis-Tris Propane pH 6.5, 14 % w/v Polyethylene Glycol 3350, 14 mM Sodium/Potassium Phosphate, 30 % w/v sucrose",277,"10.1126/sciadv.abc3099",,"6SEQ",153.8,"2.1","2.1","Lemur tyrosine kinase 3 (LMTK3)","MPAPGALILLAAVSASGCLASPAHPDGFALGRAPLAPPYAVVLISCSGLLAFIFLLLTCLCCKRGDVGFKEFENPEGEDCSGEYTPPAEETSSSQSLPDVYILPLAEVSLPMPAPQPSHSDMTTPLGLSRQHLSYLQEIGSGWFGKVILGEIFSDYTPAQVVVKELRASAGPLEQRKFISEAQPYRSLQHPNVLQCLGLCVETLPFLLIMEFCQLGDLKRYLRAQRPPEGLSPELPPRDLRTLQRMGLEIARGLAHLHSHNYVHSDLALRNCLLTSDLTVRIGDYGLAHSNYKEDYYLTPERLWIPLRWAAPELLGELHGTFMVVDQSRESNIWSLGVTLWELFEFGAQPYRHLSDEEVLAFVVRQQHVKLARPRLKLPYADYWYDILQSCWRPPAQRPSASDLQLQLTYLLSERPPRPPPPPPPPRDGPFPWPWPPAHSAPRPGTLSSPFPLLDGFPGADPDDVLTVTESSRGLNLECLWEKARRGAGRGGGAPAWQPASAPPAPHANPSNPFYEALSTPSVLPVISARSPSVSSEYYIRLEEHGSPPEPLFPNDWDPLDPGVPAPQAPQAPSEVPQLVSETWASPLFPAPRPFPAQSSASGSFLLSGWDPEGRGAGETLAGDPAEVLGERGTAPWVEEEEEEEEGSSPGEDSSSLGGGPSRRGPLPCPLCSREGACSCLPLERGDAVAGWGGHPALGCPHPPEDDSSLRAERGSLADLPMAPPASAPPEFLDPLMGAAAPQYPGRGPPPAPPPPPPPPRAPADPAASPDPPSAVASPGSGLSSPGPKPGDSGYETETPFSPEGAFPGGGAAEEEGVPRPRAPPEPPDPGAPRPPPDPGPLPLPGPREKPTFVVQVSTEQLLMSLREDVTRNLLGEKGATARETGPRKAGRGPGNREKVPGLNRDPTVLGNGKQAPSLSLPVNGVTVLENGDQRAPGIEEKAAENGALGSPEREEKVLENGELTPPRREEKALENGELRSPEAGEKVLVNGGLTPPKSEDKVSENGGLRFPRNTERPPETGPWRAPGPWEKTPESWGPAPTIGEPAPETSLERAPAPSAVVSSRNGGETAPGPLGPAPKNGTLEPGTERRAPETGGAPRAPGAGRLDLGSGGRAPVGTGTAPGGGPGSGVDAKAGWVDNTRPQPPPPPLPPPPEAQPRRLEPAPPRARPEVAPEGEPGAPDSRAGGDTALSGDGDPPKPERKGPEMPRLFLDLGPPQGNSEQIKARLSRLSLALPPLTLTPFPGPGPRRPPWEGADAGAAGGEAGGAGAPGPAEEDGEDEDEDEEEDEEAAAPGAAAGPRGPGRARAAPVPVVVSSADADAARPLRGLLKSPRGADEPEDSELERKRKMVSFHGDVTVYLFDQETPTNELSVQAPPEGDTDPSTPPAPPTPPHPATPGDGFPSNDSGFGGSFEWAEDFPLLPPPGPPLCFSRFSVSPALETPGPPARAPDARPAGPVEN","Homo sapiens","LMTK3, KIAA1883, TYKLM3","Serine/threonine-protein kinase LMTK3","1","6SEQ"
"6SER",,"X-RAY DIFFRACTION",3.28,62.55,"VAPOR DIFFUSION, SITTING DROP",,"50% (v/v) PEG 200, 100 mM Sodium phosphate dibasic/ Potassium phosphate monobasic (pH 6.2), 200 mM NaCl",293,,,"6SER",34.06,"2.299","2.299","Crystal structure of human STARD10","MEKLAASTEPQGPRPVLGRESVQVPDDQDFRSFRSECEAEVGWNLTYSRAGVSVWVQAVEMDRTLHKIKCRMECCDVPAETLYDVLHDIEYRKKWDSNVIETFDIARLTVNADVGYYSWRCPKPLKNRDVITLRSWLPMGADYIIMNYSVKHPKYPPRKDLVRAVSIQTGYLIQSTGPKSCVITYLAQVDPKGSLPKWVVNKSSQFLAPKAMKKMYKACLKYPEWKQKHLPHFKPWLHPEQSPLPSLALSELSVQHADSLENIDESAVAESREERMGGAGGEGSDDDTSLT","Homo sapiens","STARD10, SDCCAG28, CGI-52","START domain-containing protein 10","1","6SER"
"6SEY",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammonium sulfate 2.7 M, TRIS 0.1 M, saturated para-Chloromercuribenzoic acid",291,,,"6SEY",31.43,"1.23","1.23","Human Carbonic Anhydrase II in complex with aliphatically substituted benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SEY"
"6SFB",,"X-RAY DIFFRACTION",2.42,49.19,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 0.1 M PCTP pH 8.5, 200 mM MgCl2, 10 mM TCEP",298,"10.1021/acschembio.9b00468",,"6SFB",85.53,"1.52","1.52","EED in complex with a triazolopyrimidine","KKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","6SFB"
"6SFC",,"X-RAY DIFFRACTION",2.25,45.34,"VAPOR DIFFUSION, SITTING DROP",,"23% PEG3350, 0.1 M PCTP pH 8.5, 200 mM MgCl2, 10 mM TCEP",298,"10.1021/acschembio.9b00468","L9T, L9W","6SFC",85.43,"2","2","EED in complex with a methyl-thiazole","KKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","6SFC"
"6SFI",,"X-RAY DIFFRACTION",2.28,46.02,"VAPOR DIFFUSION, SITTING DROP",6.2,"25% MMW PEG smears, 0.1M MES pH 6.2",277.15,"10.1021/acs.jmedchem.9b01227",,"6SFI",41.9,"1.6","1.6","Crystal structure of p38 alpha in complex with compound 75 (MCP33)","GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6SFI"
"6SFJ",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, SITTING DROP",6.2,"17.5% MMW PEG smears, 0.1M MES pH 6.2",277.15,"10.1021/acs.jmedchem.9b01227",,"6SFJ",41.9,"1.95","1.95","Crystal structure of p38 alpha in complex with compound 77 (MCP41)","GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6SFJ"
"6SFK",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION, SITTING DROP",6,"17.5% MMW PEG smears, 0.1M MES pH 6.0",277.15,"10.1021/acs.jmedchem.9b01227",,"6SFK",42.2,"1.8","1.8","Crystal structure of p38 alpha in complex with compound 81 (MCP42)","GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6SFK"
"6SFO",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, SITTING DROP",6.5,"5% HMW PEG smears, 0.1M MES",278,,,"6SFO",41.97,"1.75","1.75","MAPK14 with bound inhibitor SR-318","GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6SFO"
"6SFQ",,"X-RAY DIFFRACTION",2.13,42.39,"VAPOR DIFFUSION, HANGING DROP",7.8,"Sodium citrate 1.4 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,,,"6SFQ",30.91,"1","1","Atomic resolution structure of human Carbonic Anhydrase II in complex with (R)-5-phenyloxazolidine-2,4-dione","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SFQ"
"6SFR",,"X-RAY DIFFRACTION",2.66,53.8,"VAPOR DIFFUSION",7.4,"0.1 M Imidazole, 3% PEG8000",277,"10.1158/2159-8290.CD-20-0142",,"6SFR",115.1,"1.917","1.917","SOS1 in Complex with Inhibitor BI-68BS","GEEQMRLPSADVYRFAEPDSEENIIFEENMQPKAGIPIIKAGTVIKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLIIERFEIPEPEPTEADRIAIENGDQPLSAELKRFRKEYIQPVQLRVLNVCRHWVEHHFYDFERDAYLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPGHNITFQSSPPTVEWHISRPGHIETFDLLTLHPIEIARQLTLLESDLYRAVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVETENLEERVAVVSRIIEILQVFQELNNFNGVLEVVSAMNSSPVYRLDHTFEQIPSRQKKILEEAHELSEDHYKKYLAKLRSINPPCVPFFGIYLTNILKTEEGNPEVLKRHGKELINFSKRRKVAEITGEIQQYQNQPYCLRVESDIKRFFENLNPMGNSMEKEFTDYLFNKSLEIEPRNPKPLPRFPKKYSYPLKSPGVRPSNPRPGT","Homo sapiens","SOS1","Son of sevenless homolog 1","1","6SFR"
"6SFU",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, HANGING DROP",7.8,"Sodium citrate 1.4 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,,,"6SFU",31.06,"1.04","1.04","Human Carbonic Anhydrase II in complex with a furan-containing benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SFU"
"6SG0",,"X-RAY DIFFRACTION",2.14,42.64,"VAPOR DIFFUSION, HANGING DROP",7.8,"Sodium citrate 1.4 M, TRIS 0.1, saturated with para-Chloromercuribenzoic acid",291,,,"6SG0",30.98,"1.13","1.13","Atomic resolution structure of Human Carbonic Anhydrase II in complex with furosemide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SG0"
"6SG6",,"X-RAY DIFFRACTION",2.14,42.45,"VAPOR DIFFUSION, HANGING DROP",7.8,"Sodium citrate 1.4 M, TRIS 0.1 M, saturated with para-Chloromercuribenzoic acid",291,,,"6SG6",30.63,"0.98","0.98","Human Carbonic Anhydrase II in complex with furan-containing benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6SG6"
"6SGD",,"X-RAY DIFFRACTION",2.71,54.66,"VAPOR DIFFUSION, HANGING DROP",8.5,"50 mM Tris pH 8.5, 3% PEG 8000",291,"10.1039/d0md00074d",,"6SGD",33.07,"2","2","Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 24","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","Serine/threonine-protein kinase Nek2","1","6SGD"
"6SGH",,"X-RAY DIFFRACTION",2.87,57.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"50 mM Tris pH 8.5, 3% PEG 8000",291,"10.1039/d0md00074d",,"6SGH",32.96,"3","3","Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 66","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","Serine/threonine-protein kinase Nek2","1","6SGH"
"6SGI",,"X-RAY DIFFRACTION",2.73,54.91,"VAPOR DIFFUSION, HANGING DROP",8.5,"50 mM Tris pH 8.5, 3% PEG 8000",291,"10.1039/d0md00074d",,"6SGI",33.09,"2.3","2.3","Nek2 kinase bound to inhibitor 96","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","Serine/threonine-protein kinase Nek2","1","6SGI"
"6SGK",,"X-RAY DIFFRACTION",2.77,55.61,"VAPOR DIFFUSION, HANGING DROP",8.5,"50 mM Tris pH 8.5, 3% PEG 8000",291,"10.1039/d0md00074d",,"6SGK",32.9,"2","2","Nek2 kinase bound to inhibitor 102","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","Serine/threonine-protein kinase Nek2","1","6SGK"
"6SGP",,"X-RAY DIFFRACTION",3.36,63.37,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4
1 % (w/v) PEG 3350 
100 mM Tris-HCl, pH 8.0",293,,,"6SGP",84.14,"1.58","1.58","X-ray structure of human glutamate carboxypeptidase II (GCPII) - the E424M inactive mutant, in complex with a sulfamide inhibitor GluGlu","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAMEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6SGP"
